{\rtf1\adeflang1025\ansi\ansicpg10000\uc1\adeff0\deff0\stshfdbch0\stshfloch0\stshfhich0\stshfbi0\deflang1033\deflangfe1033\themelang1033\themelangfe0\themelangcs0{\fonttbl{\f0\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f1\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial;}{\f2\fbidi \fnil\fcharset0\fprq2{\*\panose 02070309020205020404}Courier New{\*\falt Courier};}{\f3\fbidi \fnil\fcharset2\fprq2{\*\panose 00000000000000000000}Symbol;}{\f4\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Times;}{\f5\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Helvetica;}{\f6\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Courier;}{\f7\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503030404040204}Geneva;}{\f8\fbidi \froman\fcharset77\fprq2{\*\panose 00000000000000000000}Tms Rmn;}{\f9\fbidi \fswiss\fcharset77\fprq2{\*\panose 00000000000000000000}Helv;}{\f10\fbidi \froman\fcharset77\fprq2{\*\panose 00000000000000000000}MS Serif;}{\f11\fbidi \fswiss\fcharset77\fprq2{\*\panose 00000000000000000000}MS Sans Serif;}{\f12\fbidi \froman\fcharset77\fprq2{\*\panose 00000000000000000000}New York;}{\f13\fbidi \fswiss\fcharset77\fprq2{\*\panose 00000000000000000000}System;}{\f14\fbidi \fnil\fcharset2\fprq2{\*\panose 05000000000000000000}Wingdings;}{\f15\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9;}{\f16\fbidi \fnil\fcharset79\fprq2 \'b9\'d9\'c5\'c1;}{\f17\fbidi \fnil\fcharset80\fprq2 \'cb\'ce\'cc\'e5;}{\f18\fbidi \fnil\fcharset81\fprq2 \'b7\'73\'b2\'d3\'a9\'fa\'c5\'e9;}{\f19\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e;}{\f20\fbidi \fnil\fcharset0\fprq2{\*\panose 02040604050505020304}Century;}{\f21\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604030504040204}Verdana;}{\f22\fbidi \froman\fcharset222\fprq2{\*\panose 00000000000000000000}Angsana New;}{\f23\fbidi \froman\fcharset222\fprq2{\*\panose 00000000000000000000}Cordia New;}{\f24\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Mangal;}{\f25\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Latha;}{\f26\fbidi \froman\fcharset77\fprq2{\*\panose 00000000000000000000}Sylfaen;}{\f27\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Vrinda;}{\f28\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Raavi;}{\f29\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Shruti;}{\f30\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Sendnya;}{\f31\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Gautami;}{\f32\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Tunga;}{\f33\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Estrangelo Edessa;}{\f34\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria Math;}{\f35\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0502020204030204}Calibri;}{\f36\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria;}{\f37\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0a06030101010103}Abadi MT Condensed Extra Bold;}{\f38\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0306030101010103}Abadi MT Condensed Light;}{\f39\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Academy Engraved LET;}{\f40\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201020203}Adobe Arabic;}{\f41\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060201020203}Adobe Arabic Bold;}{\f42\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060201090203}Adobe Arabic Bold Italic;}{\f43\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201090203}Adobe Arabic Italic;}{\f44\fbidi \fnil\fcharset0\fprq2{\*\panose 0205050205050a020403}Adobe Caslon Pro;}{\f45\fbidi \fnil\fcharset0\fprq2{\*\panose 0205070206050a020403}Adobe Caslon Pro Bold;}{\f46\fbidi \fnil\fcharset0\fprq2{\*\panose 0205070206050b090a03}Adobe Caslon Pro Bold Italic;}{\f47\fbidi \fnil\fcharset0\fprq2{\*\panose 0205050205050b090a03}Adobe Caslon Pro Italic;}{\f48\fbidi \fnil\fcharset0\fprq2{\*\panose 0205060205050a020403}Adobe Caslon Pro SmBd;}{\f49\fbidi \fnil\fcharset0\fprq2{\*\panose 0205060205050b090a03}Adobe Caslon Pro SmBd Italic;}{\f50\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201020203}Adobe Devanagari;}{\f51\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060201020203}Adobe Devanagari Bold;}{\f52\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060201090203}Adobe Devanagari Bold Italic;}{\f53\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201090203}Adobe Devanagari Italic;}{\f54\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060506020403}Adobe Garamond Pro;}{\f55\fbidi \fnil\fcharset0\fprq2{\*\panose 02020702060506020403}Adobe Garamond Pro Bold;}{\f56\fbidi \fnil\fcharset0\fprq2{\*\panose 02020702060506090403}Adobe Garamond Pro Bold Italic;}{\f57\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502050506090403}Adobe Garamond Pro Italic;}{\f58\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201020203}Adobe Hebrew;}{\f59\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603060201020203}Adobe Hebrew Bold;}{\f60\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603060201090203}Adobe Hebrew Bold Italic;}{\f61\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201090203}Adobe Hebrew Italic;}{\f62\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Adobe Naskh Medium;}{\f63\fbidi \fnil\fcharset0\fprq2{\*\panose 02090604020004020304}American Typewriter;}{\f64\fbidi \fnil\fcharset0\fprq2{\*\panose 02090606020004020304}American Typewriter Condensed;}{\f65\fbidi \fnil\fcharset0\fprq2{\*\panose 02090304020004020304}American Typewriter Light;}{\f66\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0509000000000004}Andale Mono;}{\f67\fbidi \fnil\fcharset0\fprq2{\*\panose 03020702040506060504}Apple Chancery;}{\f68\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Apple Symbols;}{\f69\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0a04020102020204}Arial Black;}{\f70\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0704020202020204}Arial Bold;}{\f71\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0704020202090204}Arial Bold Italic;}{\f72\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202090204}Arial Italic;}{\f73\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020202030204}Arial Narrow;}{\f74\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706020202030204}Arial Narrow Bold;}{\f75\fbidi \fnil\fcharset0\fprq2{\*\panose 020b07060202020a0204}Arial Narrow Bold Italic;}{\f76\fbidi \fnil\fcharset0\fprq2{\*\panose 020b06060202020a0204}Arial Narrow Italic;}{\f77\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0704030504030204}Arial Rounded MT Bold;}{\f78\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial Unicode MS;}{\f79\fbidi \fnil\fcharset0\fprq2{\*\panose 02000803070000020003}Athelas Bold;}{\f80\fbidi \fnil\fcharset0\fprq2{\*\panose 02000803000000090003}Athelas Bold Italic;}{\f81\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503000000090003}Athelas Italic;}{\f82\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503000000020003}Athelas Regular;}{\f83\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803020203020204}Avenir Black;}{\f84\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803020203090204}Avenir Black Oblique;}{\f85\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503020000020003}Avenir Book;}{\f86\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503020000020003}Avenir Book Oblique;}{\f87\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203020204}Avenir Heavy;}{\f88\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203090204}Avenir Heavy Oblique;}{\f89\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0402020203020204}Avenir Light;}{\f90\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0402020203090204}Avenir Light Oblique;}{\f91\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603020000020003}Avenir Medium;}{\f92\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603020000020003}Avenir Medium Oblique;}{\f93\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803020202020204}Avenir Next Bold;}{\f94\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803020202090204}Avenir Next Bold Italic;}{\f95\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0806020202020204}Avenir Next Condensed Bold;}{\f96\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706020202020204}Avenir Next Condensed Demi Bold;}{\f97\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0906020202020204}Avenir Next Condensed Heavy;}{\f98\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020202090204}Avenir Next Condensed Italic;}{\f99\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0606020202020204}Avenir Next Condensed Medium;}{\f100\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020202020204}Avenir Next Condensed Regular;}{\f101\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020202020204}Avenir Next Demi Bold;}{\f102\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020202090204}Avenir Next Demi Bold Italic;}{\f103\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0903020202020204}Avenir Next Heavy;}{\f104\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0903020202090204}Avenir Next Heavy Italic;}{\f105\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020202090204}Avenir Next Italic;}{\f106\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020202020204}Avenir Next Medium;}{\f107\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020202090204}Avenir Next Medium Italic;}{\f108\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020202020204}Avenir Next Regular;}{\f109\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0203020202020204}Avenir Next Ultra Light;}{\f110\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0203020202090204}Avenir Next Ultra Light Italic;}{\f111\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020203090204}Avenir Oblique;}{\f112\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020203020204}Avenir Roman;}{\f113\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Ayuthaya;}{\f114\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500020000000000}Bangla MN;}{\f115\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500020000000000}Bangla MN Bold;}{\f116\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Bangla Sangam MN;}{\f117\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Bangla Sangam MN Bold;}{\f118\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bank Gothic;}{\f119\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Baoli SC Regular;}{\f120\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502070401020303}Baskerville;}{\f121\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802070401020303}Baskerville Bold;}{\f122\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802070401090303}Baskerville Bold Italic;}{\f123\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502070401020303}Baskerville Italic;}{\f124\fbidi \fnil\fcharset0\fprq2{\*\panose 02020602080505020303}Baskerville Old Face;}{\f125\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802070401020303}Baskerville SemiBold;}{\f126\fbidi \fnil\fcharset0\fprq2{\*\panose 02020702070400090203}Baskerville SemiBold Italic;}{\f127\fbidi \fnil\fcharset0\fprq2{\*\panose 04030905020b02020c02}Bauhaus 93;}{\f128\fbidi \fnil\fcharset0\fprq2{\*\panose 00000600000000000000}Beirut;}{\f129\fbidi \fnil\fcharset0\fprq2{\*\panose 02020503060305020303}Bell MT;}{\f130\fbidi \fnil\fcharset0\fprq2{\*\panose 02050806060905020404}Bernard MT Condensed;}{\f131\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603090000020003}Big Caslon;}{\f132\fbidi \fnil\fcharset0\fprq2{\*\panose 03060502040705060204}Birch Std;}{\f133\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Blackmoor LET;}{\f134\fbidi \fnil\fcharset0\fprq2{\*\panose 04050907060602020202}Blackoak Std;}{\f135\fbidi \fnil\fcharset0\fprq2{\*\panose 00000500000000000000}BlairMdITC TT-Medium;}{\f136\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Bodoni Ornaments ITC TT;}{\f137\fbidi \fnil\fcharset0\fprq2{\*\panose 00000700000000000000}Bodoni SvtyTwo ITC TT-Bold;}{\f138\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo ITC TT-Book;}{\f139\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo ITC TT-BookIta;}{\f140\fbidi \fnil\fcharset0\fprq2{\*\panose 00000700000000000000}Bodoni SvtyTwo OS ITC TT-Bold;}{\f141\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo OS ITC TT-Book;}{\f142\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo OS ITC TT-BookIt;}{\f143\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo SC ITC TT-Book;}{\f144\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602050305030304}Book Antiqua;}{\f145\fbidi \fnil\fcharset0\fprq2{\*\panose 02050604050505020204}Bookman Old Style;}{\f146\fbidi \fnil\fcharset0\fprq2{\*\panose 05010101010101010101}Bookshelf Symbol 7;}{\f147\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Bordeaux Roman Bold LET;}{\f148\fbidi \fnil\fcharset0\fprq2{\*\panose 00000700000000000000}Bradley Hand ITC TT-Bold;}{\f149\fbidi \fnil\fcharset0\fprq2{\*\panose 04030b070d0b02020403}Braggadocio;}{\f150\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0903060703020204}Britannic Bold;}{\f151\fbidi \fnil\fcharset0\fprq2{\*\panose 03060802040406070304}Brush Script MT Italic;}{\f152\fbidi \fnil\fcharset0\fprq2{\*\panose 03060802040607070404}Brush Script Std;}{\f153\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0702030404030204}Calibri Bold;}{\f154\fbidi \fnil\fcharset0\fprq2{\*\panose 020f07020304040a0204}Calibri Bold Italic;}{\f155\fbidi \fnil\fcharset0\fprq2{\*\panose 020f05020202040a0204}Calibri Italic;}{\f156\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0302020204030204}Calibri Light;}{\f157\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603050505030304}Calisto MT;}{\f158\fbidi \fnil\fcharset0\fprq2{\*\panose 02040803050406030204}Cambria Bold;}{\f159\fbidi \fnil\fcharset0\fprq2{\*\panose 020408030504060a0204}Cambria Bold Italic;}{\f160\fbidi \fnil\fcharset0\fprq2{\*\panose 020405030504060a0204}Cambria Italic;}{\f161\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0502030303020204}Candara;}{\f162\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0702030303020204}Candara Bold;}{\f163\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0702030303090204}Candara Bold Italic;}{\f164\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0502030303090204}Candara Italic;}{\f165\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Capitals;}{\f166\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502020202020204}Century Gothic;}{\f167\fbidi \fnil\fcharset0\fprq2{\*\panose 02040604050505020304}Century Schoolbook;}{\f168\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard;}{\f169\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard Bold;}{\f170\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard SE Bold;}{\f171\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard SE Light;}{\f172\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard SE Regular;}{\f173\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkduster;}{\f174\fbidi \fnil\fcharset0\fprq2{\*\panose 02060503040505020203}Chaparral Pro;}{\f175\fbidi \fnil\fcharset0\fprq2{\*\panose 02060503040505020203}Chaparral Pro Bold;}{\f176\fbidi \fnil\fcharset0\fprq2{\*\panose 02060803050505090203}Chaparral Pro Bold Ital;}{\f177\fbidi \fnil\fcharset0\fprq2{\*\panose 02060503040505090203}Chaparral Pro Ital;}{\f178\fbidi \fnil\fcharset0\fprq2{\*\panose 02060403030505090203}Chaparral Pro Light Ital;}{\f179\fbidi \fnil\fcharset0\fprq2{\*\panose 04020705060702020204}Charlemagne Std Bold;}{\f180\fbidi \fnil\fcharset0\fprq2{\*\panose 02040803050506020203}Charter Black;}{\f181\fbidi \fnil\fcharset0\fprq2{\*\panose 02040803050506090203}Charter Black Italic;}{\f182\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703050506020203}Charter Bold;}{\f183\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703050506090203}Charter Bold Italic;}{\f184\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050506090203}Charter Italic;}{\f185\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050506020203}Charter Roman;}{\f186\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603020000020003}Cochin;}{\f187\fbidi \fnil\fcharset0\fprq2{\*\panose 04020805060202030203}Colonna MT;}{\f188\fbidi \fnil\fcharset0\fprq2{\*\panose 030f0702030302020204}Comic Sans MS;}{\f189\fbidi \fnil\fcharset0\fprq2{\*\panose 030f0902030302020204}Comic Sans MS Bold;}{\f190\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0609020204030204}Consolas;}{\f191\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0709020204030204}Consolas Bold;}{\f192\fbidi \fnil\fcharset0\fprq2{\*\panose 020b07090202040a0204}Consolas Bold Italic;}{\f193\fbidi \fnil\fcharset0\fprq2{\*\panose 020b06090202040a0204}Consolas Italic;}{\f194\fbidi \fnil\fcharset0\fprq2{\*\panose 02030602050306030303}Constantia;}{\f195\fbidi \fnil\fcharset0\fprq2{\*\panose 02030702060306030303}Constantia Bold;}{\f196\fbidi \fnil\fcharset0\fprq2{\*\panose 020307020603060a0303}Constantia Bold Italic;}{\f197\fbidi \fnil\fcharset0\fprq2{\*\panose 020306020503060a0303}Constantia Italic;}{\f198\fbidi \fnil\fcharset0\fprq2{\*\panose 0208090404030b020404}Cooper Black;}{\f199\fbidi \fnil\fcharset0\fprq2{\*\panose 0208090305030b090404}Cooper Black Std Italic;}{\f200\fbidi \fnil\fcharset0\fprq2{\*\panose 0208090304030b020404}Cooper Std Black;}{\f201\fbidi \fnil\fcharset0\fprq2{\*\panose 02000504000000020004}Copperplate;}{\f202\fbidi \fnil\fcharset0\fprq2{\*\panose 02000904050000020004}Copperplate Bold;}{\f203\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0705020206020404}Copperplate Gothic Bold;}{\f204\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0507020206020404}Copperplate Gothic Light;}{\f205\fbidi \fnil\fcharset0\fprq2{\*\panose 02000604030000020004}Copperplate Light;}{\f206\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020204020204}Corbel;}{\f207\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020204020204}Corbel Bold;}{\f208\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020204090204}Corbel Bold Italic;}{\f209\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020204090204}Corbel Italic;}{\f210\fbidi \fnil\fcharset0\fprq2{\*\panose 02070609020205020404}Courier New Bold;}{\f211\fbidi \fnil\fcharset0\fprq2{\*\panose 02070609020205090404}Courier New Bold Italic;}{\f212\fbidi \fnil\fcharset0\fprq2{\*\panose 02070409020205090404}Courier New Italic;}{\f213\fbidi \fnil\fcharset0\fprq2{\*\panose 04040404050702020202}Curlz MT;}{\f214\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Damascus;}{\f215\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Damascus Bold;}{\f216\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Damascus Medium;}{\f217\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Damascus Semi Bold;}{\f218\fbidi \fnil\fcharset0\fprq2{\*\panose 04020505020e03040504}Desdemona;}{\f219\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Devanagari Sangam MN;}{\f220\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Devanagari Sangam MN Bold;}{\f221\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0500000000000000}DIN Alternate Bold;}{\f222\fbidi \fnil\fcharset0\fprq2{\*\panose 00000500000000000000}DIN Condensed Bold;}{\f223\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503000000020003}Didot;}{\f224\fbidi \fnil\fcharset0\fprq2{\*\panose 030303020407070d0804}Edwardian Script ITC;}{\f225\fbidi \fnil\fcharset0\fprq2{\*\panose 02090707080505020304}Engravers MT;}{\f226\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040102020104}Euphemia UCAS;}{\f227\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803040102020104}Euphemia UCAS Bold;}{\f228\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040102020104}Euphemia UCAS Italic;}{\f229\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0504020202050204}Eurostile;}{\f230\fbidi \fnil\fcharset0\fprq2{\*\panose 0204060206030a020304}Footlight MT Light;}{\f231\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020102020204}Franklin Gothic Book;}{\f232\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020102090204}Franklin Gothic Book Italic;}{\f233\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020102020204}Franklin Gothic Medium;}{\f234\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020102090204}Franklin Gothic Medium Italic;}{\f235\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602020204020303}Futura;}{\f236\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020204030204}Futura Condensed;}{\f237\fbidi \fnil\fcharset0\fprq2{\*\panose 04040605051002020d02}Gabriola;}{\f238\fbidi \fnil\fcharset0\fprq2{\*\panose 02020404030301010803}Garamond;}{\f239\fbidi \fnil\fcharset0\fprq2{\*\panose 02040502050405020303}Georgia;}{\f240\fbidi \fnil\fcharset0\fprq2{\*\panose 02040802050405020203}Georgia Bold;}{\f241\fbidi \fnil\fcharset0\fprq2{\*\panose 02040802050405090203}Georgia Bold Italic;}{\f242\fbidi \fnil\fcharset0\fprq2{\*\panose 02040502050405090303}Georgia Italic;}{\f243\fbidi \fnil\fcharset0\fprq2{\*\panose 03050402040302040404}Giddyup Std;}{\f244\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502020104020203}Gill Sans;}{\f245\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0302020104020203}Gill Sans Light;}{\f246\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502020104020203}Gill Sans MT;}{\f247\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802020104020203}Gill Sans MT Bold;}{\f248\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802020104090203}Gill Sans MT Bold Italic;}{\f249\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502020104090203}Gill Sans MT Italic;}{\f250\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0702020104020203}Gill Sans SemiBold;}{\f251\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0702020104090203}Gill Sans SemiBold Italic;}{\f252\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0b04020104020203}Gill Sans UltraBold;}{\f253\fbidi \fnil\fcharset0\fprq2{\*\panose 02030808020601010101}Gloucester MT Extra Condensed;}{\f254\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502050305020303}Goudy Old Style;}{\f255\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Gujarati Sangam MN;}{\f256\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Gujarati Sangam MN Bold;}{\f257\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Gurmukhi MN;}{\f258\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Gurmukhi MN Bold;}{\f259\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Gurmukhi Sangam MN;}{\f260\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Gurmukhi Sangam MN Bold;}{\f261\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706040902060204}Haettenschweiler;}{\f262\fbidi \fnil\fcharset0\fprq2{\*\panose 04040505050a02020702}Harrington;}{\f263\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0403020202020204}Helvetica Light;}{\f264\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503000000020004}Helvetica Neue;}{\f265\fbidi \fnil\fcharset0\fprq2{\*\panose 02000a06000000020004}Helvetica Neue Black Condensed;}{\f266\fbidi \fnil\fcharset0\fprq2{\*\panose 02000806000000020004}Helvetica Neue Bold Condensed;}{\f267\fbidi \fnil\fcharset0\fprq2{\*\panose 02000403000000020004}Helvetica Neue Light;}{\f268\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Helvetica Neue Medium;}{\f269\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0403020202020204}Helvetica Neue Thin;}{\f270\fbidi \fnil\fcharset0\fprq2{\*\panose 02000206000000020004}Helvetica Neue UltraLight;}{\f271\fbidi \fnil\fcharset0\fprq2{\*\panose 02000505000000020004}Herculanum;}{\f272\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803040709020204}Hobo Std;}{\f273\fbidi \fnil\fcharset0\fprq2{\*\panose 02030602050506020203}Hoefler Text;}{\f274\fbidi \fnil\fcharset2\fprq2{\*\panose 00000000000000000000}Hoefler Text Ornaments;}{\f275\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0806030902050204}Impact;}{\f276\fbidi \fnil\fcharset0\fprq2{\*\panose 04020605060303030202}Imprint MT Shadow;}{\f277\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}InaiMathi;}{\f278\fbidi \fnil\fcharset0\fprq2{\*\panose 02040805050506020204}Iowan Old Style Black;}{\f279\fbidi \fnil\fcharset0\fprq2{\*\panose 02040805050506090204}Iowan Old Style Black Italic;}{\f280\fbidi \fnil\fcharset0\fprq2{\*\panose 02040702050506020204}Iowan Old Style Bold;}{\f281\fbidi \fnil\fcharset0\fprq2{\*\panose 02040702050506090204}Iowan Old Style Bold Italic;}{\f282\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602040506090204}Iowan Old Style Italic;}{\f283\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602040506020204}Iowan Old Style Roman;}{\f284\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602040506020204}Iowan Old Style Titling;}{\f285\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Jazz LET;}{\f286\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Kaiti SC Black;}{\f287\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Kannada MN;}{\f288\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Kannada MN Bold;}{\f289\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Kannada Sangam MN;}{\f290\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Kannada Sangam MN Bold;}{\f291\fbidi \fnil\fcharset0\fprq2{\*\panose 02000506000000020004}Kefa;}{\f292\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Khmer MN;}{\f293\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Khmer MN Bold;}{\f294\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Khmer Sangam MN;}{\f295\fbidi \fnil\fcharset0\fprq2{\*\panose 040307050d0c02020703}Kino MT;}{\f296\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Krungthep;}{\f297\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}KufiStandardGK;}{\f298\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Lantinghei SC Demibold;}{\f299\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Lantinghei SC Extralight;}{\f300\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Lantinghei SC Heavy;}{\f301\fbidi \fnil\fcharset0\fprq2{\*\panose 03000509000000000000}Lantinghei TC Demibold;}{\f302\fbidi \fnil\fcharset0\fprq2{\*\panose 03000509000000000000}Lantinghei TC Extralight;}{\f303\fbidi \fnil\fcharset0\fprq2{\*\panose 03000509000000000000}Lantinghei TC Heavy;}{\f304\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Lao MN;}{\f305\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Lao MN Bold;}{\f306\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Lao Sangam MN;}{\f307\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0409020202030304}Letter Gothic Std;}{\f308\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0509020202030304}Letter Gothic Std Bold;}{\f309\fbidi \fnil\fcharset0\fprq2{\*\panose 020b05090202020a0304}Letter Gothic Std Bold Slanted;}{\f310\fbidi \fnil\fcharset0\fprq2{\*\panose 020b04090202020a0304}Letter Gothic Std Slanted;}{\f311\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Libian SC Regular;}{\f312\fbidi \fnil\fcharset0\fprq2{\*\panose 04020905040e02020a04}Lithos Pro Black;}{\f313\fbidi \fnil\fcharset0\fprq2{\*\panose 04020505030e02020a04}Lithos Pro Regular;}{\f314\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Lucida Blackletter;}{\f315\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602050505020304}Lucida Bright;}{\f316\fbidi \fnil\fcharset0\fprq2{\*\panose 03010101010101010101}Lucida Calligraphy;}{\f317\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0609040504020204}Lucida Console;}{\f318\fbidi \fnil\fcharset0\fprq2{\*\panose 02060602050505020204}Lucida Fax;}{\f319\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0600040502020204}Lucida Grande;}{\f320\fbidi \fnil\fcharset0\fprq2{\*\panose 03010101010101010101}Lucida Handwriting;}{\f321\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602030504020204}Lucida Sans;}{\f322\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0509030504030204}Lucida Sans Typewriter;}{\f323\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602030504020204}Lucida Sans Unicode;}{\f324\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Malayalam MN;}{\f325\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Malayalam MN Bold;}{\f326\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Malayalam Sangam MN;}{\f327\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Malayalam Sangam MN Bold;}{\f328\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802060400020003}Marion Bold;}{\f329\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060400020003}Marion Italic;}{\f330\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060400020003}Marion Regular;}{\f331\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Marker Felt;}{\f332\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Marlett;}{\f333\fbidi \fnil\fcharset0\fprq2{\*\panose 03020802060602070202}Matura MT Script Capitals;}{\f334\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0709030604020204}Menlo Bold;}{\f335\fbidi \fnil\fcharset0\fprq2{\*\panose 020b07090303040b0204}Menlo Bold Italic;}{\f336\fbidi \fnil\fcharset0\fprq2{\*\panose 020b06090303040b0204}Menlo Italic;}{\f337\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0609030804020204}Menlo Regular;}{\f338\fbidi \fnil\fcharset0\fprq2{\*\panose 04090703060e02020a04}Mesquite Std;}{\f339\fbidi \fnil\fcharset0\fprq2{\*\panose 01010100010101010101}Microsoft Himalaya;}{\f340\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Microsoft Sans Serif;}{\f341\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502040204020203}Microsoft Tai Le;}{\f342\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802040204020203}Microsoft Tai Le Bold;}{\f343\fbidi \fnil\fcharset0\fprq2{\*\panose 03000500000000000000}Microsoft Yi Baiti;}{\f344\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}MingLiU-ExtB;}{\f345\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}@MingLiU-ExtB;}{\f346\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}MingLiU_HKSCS-ExtB;}{\f347\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}@MingLiU_HKSCS-ExtB;}{\f348\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050306020203}Minion Pro;}{\f349\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060306020203}Minion Pro Bold;}{\f350\fbidi \fnil\fcharset0\fprq2{\*\panose 02040706060306020203}Minion Pro Bold Cond;}{\f351\fbidi \fnil\fcharset0\fprq2{\*\panose 02040706060306090203}Minion Pro Bold Cond Ital;}{\f352\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060306090203}Minion Pro Bold Ital;}{\f353\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050306090203}Minion Pro Ital;}{\f354\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050306020203}Minion Pro Med;}{\f355\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050306090203}Minion Pro Med Ital;}{\f356\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603060306020203}Minion Pro SmBd;}{\f357\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603060306090203}Minion Pro SmBd Ital;}{\f358\fbidi \fnil\fcharset0\fprq2{\*\panose 03090702030407020403}Mistral;}{\f359\fbidi \fnil\fcharset0\fprq2{\*\panose 02070704070505020303}Modern No. 20;}{\f360\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Mona Lisa Solid ITC TT;}{\f361\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Monaco;}{\f362\fbidi \fnil\fcharset0\fprq2{\*\panose 03000500000000000000}Mongolian Baiti;}{\f363\fbidi \fnil\fcharset0\fprq2{\*\panose 03010101010201010101}Monotype Corsiva;}{\f364\fbidi \fnil\fcharset2\fprq2{\*\panose 01010601010101010101}Monotype Sorts;}{\f365\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604030504040204}MS Reference Sans Serif;}{\f366\fbidi \fnil\fcharset0\fprq2{\*\panose 05000500000000000000}MS Reference Specialty;}{\f367\fbidi \fnil\fcharset2\fprq2{\*\panose 05050102010205020202}MT Extra;}{\f368\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Myanmar MN;}{\f369\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Myanmar MN Bold;}{\f370\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Myanmar Sangam MN;}{\f371\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Arabic;}{\f372\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Arabic Bold;}{\f373\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Arabic Bold Italic;}{\f374\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Arabic Italic;}{\f375\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Hebrew Bold;}{\f376\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Hebrew Bold Italic;}{\f377\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Hebrew Italic;}{\f378\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Hebrew Regular;}{\f379\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503030403020204}Myriad Pro;}{\f380\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703030403020204}Myriad Pro Bold;}{\f381\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706030403020204}Myriad Pro Bold Cond;}{\f382\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706030403090204}Myriad Pro Bold Cond It;}{\f383\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703030403090204}Myriad Pro Bold It;}{\f384\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506030403020204}Myriad Pro Cond;}{\f385\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506030403090204}Myriad Pro Cond It;}{\f386\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503030403090204}Myriad Pro It;}{\f387\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603030403020204}Myriad Pro Semibold;}{\f388\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603030403090204}Myriad Pro Semibold It;}{\f389\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0504020203020204}News Gothic MT;}{\f390\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Noteworthy Bold;}{\f391\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Noteworthy Light;}{\f392\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803070504020203}Nueva Std Bold;}{\f393\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0806070504020203}Nueva Std Bold Cond;}{\f394\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0806070504090203}Nueva Std Bold Cond Italic;}{\f395\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506070504020203}Nueva Std Cond;}{\f396\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506070504090203}Nueva Std Cond Italic;}{\f397\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503070504090203}Nueva Std Italic;}{\f398\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0609000104060307}OCR A Std;}{\f399\fbidi \fnil\fcharset0\fprq2{\*\panose 04050602080702020203}Onyx;}{\f400\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503060000020004}Optima;}{\f401\fbidi \fnil\fcharset0\fprq2{\*\panose 02000b03000000020004}Optima ExtraBlack;}{\f402\fbidi \fnil\fcharset0\fprq2{\*\panose 020d0509020203030204}Orator Std;}{\f403\fbidi \fnil\fcharset0\fprq2{\*\panose 020d05090202030a0204}Orator Std Slanted;}{\f404\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Oriya MN;}{\f405\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Oriya MN Bold;}{\f406\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Oriya Sangam MN;}{\f407\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Oriya Sangam MN Bold;}{\f408\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Palatino;}{\f409\fbidi \fnil\fcharset0\fprq2{\*\panose 02000800000000000000}Palatino Bold;}{\f410\fbidi \fnil\fcharset0\fprq2{\*\panose 02000800000000000000}Palatino Bold Italic;}{\f411\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Palatino Italic;}{\f412\fbidi \fnil\fcharset0\fprq2{\*\panose 02040502050505030304}Palatino Linotype;}{\f413\fbidi \fnil\fcharset0\fprq2{\*\panose 020407020603050a0204}Palatino Linotype Bold;}{\f414\fbidi \fnil\fcharset0\fprq2{\*\panose 020407020603050a0204}Palatino Linotype Bold Italic;}{\f415\fbidi \fnil\fcharset0\fprq2{\*\panose 020405020503050a0304}Palatino Linotype Italic;}{\f416\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602040200020303}Papyrus;}{\f417\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602040200020303}Papyrus Condensed;}{\f418\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Party LET;}{\f419\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060401020303}Perpetua;}{\f420\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802060401020303}Perpetua Bold;}{\f421\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802060401090303}Perpetua Bold Italic;}{\f422\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060401090303}Perpetua Italic;}{\f423\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060505020804}Perpetua Titling MT;}{\f424\fbidi \fnil\fcharset0\fprq2{\*\panose 02020000000000000000}Plantagenet Cherokee;}{\f425\fbidi \fnil\fcharset0\fprq2{\*\panose 040506030a0602020202}Playbill;}{\f426\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}PMingLiU-ExtB;}{\f427\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}@PMingLiU-ExtB;}{\f428\fbidi \fnil\fcharset0\fprq2{\*\panose 04020903030b02020202}Poplar Std;}{\f429\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}PortagoITC TT;}{\f430\fbidi \fnil\fcharset0\fprq2{\*\panose 02060509020206020304}Prestige Elite Std Bold;}{\f431\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Princetown LET;}{\f432\fbidi \fnil\fcharset0\fprq2{\*\panose 02060509020205020204}PT Mono;}{\f433\fbidi \fnil\fcharset0\fprq2{\*\panose 02060709020205020204}PT Mono Bold;}{\f434\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020203020204}PT Sans;}{\f435\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203020204}PT Sans Bold;}{\f436\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203090204}PT Sans Bold Italic;}{\f437\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020203020204}PT Sans Caption;}{\f438\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203020204}PT Sans Caption Bold;}{\f439\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020203090204}PT Sans Italic;}{\f440\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020203020204}PT Sans Narrow;}{\f441\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706020203020204}PT Sans Narrow Bold;}{\f442\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0603040505020204}PT Serif;}{\f443\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0703040505020204}PT Serif Bold;}{\f444\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0703040505090204}PT Serif Bold Italic;}{\f445\fbidi \fnil\fcharset0\fprq2{\*\panose 02060603050505020204}PT Serif Caption;}{\f446\fbidi \fnil\fcharset0\fprq2{\*\panose 02060603050505090204}PT Serif Caption Italic;}{\f447\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0603040505090204}PT Serif Italic;}{\f448\fbidi \fnil\fcharset0\fprq2{\*\panose 02060603020205020403}Rockwell;}{\f449\fbidi \fnil\fcharset0\fprq2{\*\panose 02060903040505020403}Rockwell Extra Bold;}{\f450\fbidi \fnil\fcharset0\fprq2{\*\panose 04090804040204020202}Rosewood Std Regular;}{\f451\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0802070306020202}Sabon Next LT Pro Bold;}{\f452\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0802070306090202}Sabon Next LT Pro Bold Italic;}{\f453\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0702070306020202}Sabon Next LT Pro Demi;}{\f454\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0702070306090202}Sabon Next LT Pro Demi Italic;}{\f455\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0902070306020202}Sabon Next LT Pro Extra Bold;}{\f456\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0902070306090202}Sabon Next LT Pro Extra Bold It;}{\f457\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0502070306090202}Sabon Next LT Pro Italic;}{\f458\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0502070306020202}Sabon Next LT Pro Regular;}{\f459\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Santa Fe LET;}{\f460\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Sathu;}{\f461\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Savoye LET;}{\f462\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Savoye LET Plain CC.:1.0;}{\f463\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}SchoolHouse Cursive B;}{\f464\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}SchoolHouse Printed A;}{\f465\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000020004}Seravek;}{\f466\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803050000020004}Seravek Bold;}{\f467\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803050000090004}Seravek Bold Italic;}{\f468\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000020004}Seravek ExtraLight;}{\f469\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000090004}Seravek ExtraLight Italic;}{\f470\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503050000090004}Seravek Italic;}{\f471\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000020004}Seravek Light;}{\f472\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000090004}Seravek Light Italic;}{\f473\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703050000020004}Seravek Medium;}{\f474\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703050000090004}Seravek Medium Italic;}{\f475\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Silom;}{\f476\fbidi \fnil\fcharset81\fprq2{\*\panose 02010609060101010101}SimSun-ExtB;}{\f477\fbidi \fnil\fcharset81\fprq2{\*\panose 02010609060101010101}@SimSun-ExtB;}{\f478\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503080000020003}Sinhala MN;}{\f479\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503080000020003}Sinhala MN Bold;}{\f480\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Sinhala Sangam MN;}{\f481\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Sinhala Sangam MN Bold;}{\f482\fbidi \fnil\fcharset0\fprq2{\*\panose 020d0502020204020204}Skia;}{\f483\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603080000090004}Snell Roundhand;}{\f484\fbidi \fnil\fcharset0\fprq2{\*\panose 02000a04090000090004}Snell Roundhand Black;}{\f485\fbidi \fnil\fcharset0\fprq2{\*\panose 02000803090000090004}Snell Roundhand Bold;}{\f486\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Songti SC Black;}{\f487\fbidi \fnil\fcharset0\fprq2{\*\panose 00000800000000000000}STIXGeneral-Bold;}{\f488\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXGeneral-BoldItalic;}{\f489\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXGeneral-Italic;}{\f490\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXGeneral-Regular;}{\f491\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsD-Bold;}{\f492\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsD-Regular;}{\f493\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsSm-Bold;}{\f494\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsSm-Regular;}{\f495\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUp-Bold;}{\f496\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUp-Regular;}{\f497\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUpD-Bold;}{\f498\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUpD-Regular;}{\f499\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUpSm-Bold;}{\f500\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUpSm-Regular;}{\f501\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXNonUnicode-Bold;}{\f502\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXNonUnicode-BoldItalic;}{\f503\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXNonUnicode-Italic;}{\f504\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXNonUnicode-Regular;}{\f505\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeFiveSym-Regular;}{\f506\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeFourSym-Bold;}{\f507\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeFourSym-Regular;}{\f508\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeOneSym-Bold;}{\f509\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeOneSym-Regular;}{\f510\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeThreeSym-Bold;}{\f511\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeThreeSym-Regular;}{\f512\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeTwoSym-Bold;}{\f513\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeTwoSym-Regular;}{\f514\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXVariants-Bold;}{\f515\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXVariants-Regular;}{\f516\fbidi \fnil\fcharset0\fprq2{\*\panose 040409050d0802020404}Stencil;}{\f517\fbidi \fnil\fcharset0\fprq2{\*\panose 04020904080802020404}Stencil Std;}{\f518\fbidi \fnil\fcharset0\fprq2{\*\panose 00000700000000000000}Stone Sans ITC TT-Bold;}{\f519\fbidi \fnil\fcharset0\fprq2{\*\panose 00000600000000000000}Stone Sans ITC TT-Semi;}{\f520\fbidi \fnil\fcharset0\fprq2{\*\panose 00000600000000000000}Stone Sans ITC TT-SemiIta;}{\f521\fbidi \fnil\fcharset0\fprq2{\*\panose 02060a05060000020003}Superclarendon Black;}{\f522\fbidi \fnil\fcharset0\fprq2{\*\panose 02060a05060000020003}Superclarendon Black Italic;}{\f523\fbidi \fnil\fcharset0\fprq2{\*\panose 02060805060000020003}Superclarendon Bold;}{\f524\fbidi \fnil\fcharset0\fprq2{\*\panose 02060805060000020003}Superclarendon Bold Italic;}{\f525\fbidi \fnil\fcharset0\fprq2{\*\panose 02060605060000020003}Superclarendon Italic;}{\f526\fbidi \fnil\fcharset0\fprq2{\*\panose 02060305060000020003}Superclarendon Light;}{\f527\fbidi \fnil\fcharset0\fprq2{\*\panose 02060305060000020003}Superclarendon Light Italic;}{\f528\fbidi \fnil\fcharset0\fprq2{\*\panose 02060605060000020003}Superclarendon Regular;}{\f529\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Synchro LET;}{\f530\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604030504040204}Tahoma;}{\f531\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0804030504040204}Tahoma Bold;}{\f532\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Tamil MN;}{\f533\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Tamil MN Bold;}{\f534\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Tamil Sangam MN;}{\f535\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Tamil Sangam MN Bold;}{\f536\fbidi \fnil\fcharset0\fprq2{\*\panose 050b0102010101010101}TeamViewer8;}{\f537\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0603020208020904}Tekton Pro Bold;}{\f538\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0606020208020904}Tekton Pro BoldCond;}{\f539\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0605020208020904}Tekton Pro BoldExt;}{\f540\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0603020208090904}Tekton Pro BoldObl;}{\f541\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Telugu MN;}{\f542\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Telugu MN Bold;}{\f543\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Telugu Sangam MN;}{\f544\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Telugu Sangam MN Bold;}{\f545\fbidi \fnil\fcharset0\fprq2{\*\panose 00000300000000000000}Thonburi Light;}{\f546\fbidi \fnil\fcharset0\fprq2{\*\panose 02020803070505020304}Times New Roman Bold;}{\f547\fbidi \fnil\fcharset0\fprq2{\*\panose 02020703060505090304}Times New Roman Bold Italic;}{\f548\fbidi \fnil\fcharset0\fprq2{\*\panose 02020503050405090304}Times New Roman Italic;}{\f549\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502050506020301}Trajan Pro;}{\f550\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802050506020301}Trajan Pro Bold;}{\f551\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020202020204}Trebuchet MS;}{\f552\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020202020204}Trebuchet MS Bold;}{\f553\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020202090204}Trebuchet MS Bold Italic;}{\f554\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020202090204}Trebuchet MS Italic;}{\f555\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602020104020603}Tw Cen MT;}{\f556\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802020104020603}Tw Cen MT Bold;}{\f557\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802020104090603}Tw Cen MT Bold Italic;}{\f558\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602020104090603}Tw Cen MT Italic;}{\f559\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Type Embellishments One LET;}{\f560\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0804030504040204}Verdana Bold;}{\f561\fbidi \fnil\fcharset0\fprq2{\*\panose 020b08040305040b0204}Verdana Bold Italic;}{\f562\fbidi \fnil\fcharset0\fprq2{\*\panose 020b06040305040b0204}Verdana Italic;}{\f563\fbidi \fnil\fcharset0\fprq2{\*\panose 040b0500000000000000}Wawati SC Regular;}{\f564\fbidi \fnil\fcharset0\fprq2{\*\panose 040b0500000000000000}Wawati TC Regular;}{\f565\fbidi \fnil\fcharset2\fprq2{\*\panose 05030102010509060703}Webdings;}{\f566\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0a07050505020404}Wide Latin;}{\f567\fbidi \fnil\fcharset2\fprq2{\*\panose 05020102010507070707}Wingdings 2;}{\f568\fbidi \fnil\fcharset2\fprq2{\*\panose 05040102010807070707}Wingdings 3;}{\f569\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Xingkai SC Bold;}{\f570\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Xingkai SC Light;}{\f571\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Yuanti SC Bold;}{\f572\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Yuanti SC Regular;}{\f573\fbidi \fnil\fcharset2\fprq2{\*\panose 05020102010704020609}Zapf Dingbats;}{\f574\fbidi \fnil\fcharset0\fprq2{\*\panose 03030300040707070c03}Zapfino;}{\f575\fbidi \fnil\fcharset88\fprq2{\*\panose 020b0600040502020204}Lucida Grande CE;}{\f576\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Charcoal CY;}{\f577\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Geneva CY;}{\f578\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Helvetica CY;}{\f579\fbidi \fnil\fcharset89\fprq2{\*\panose 020b0600040502020204}Lucida Grande CY;}{\f580\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Thonburi;}{\f581\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Thonburi Bold;}{\f582\fbidi \fnil\fcharset81\fprq2 Adobe \'a9\'fa\'c5\'e9 Std L;}{\f583\fbidi \fnil\fcharset81\fprq2 @Adobe \'a9\'fa\'c5\'e9 Std L;}{\f584\fbidi \fnil\fcharset81\fprq2 Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B;}{\f585\fbidi \fnil\fcharset81\fprq2 @Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B;}{\f586\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}Apple LiGothic Medium;}{\f587\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}@Apple LiGothic Medium;}{\f588\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}Apple LiSung Light;}{\f589\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}@Apple LiSung Light;}{\f590\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}BiauKai;}{\f591\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}@BiauKai;}{\f592\fbidi \fnil\fcharset81\fprq2{\*\panose 03000700000000000000}Hannotate TC Bold;}{\f593\fbidi \fnil\fcharset81\fprq2{\*\panose 03000700000000000000}@Hannotate TC Bold;}{\f594\fbidi \fnil\fcharset81\fprq2{\*\panose 03000500000000000000}Hannotate TC Regular;}{\f595\fbidi \fnil\fcharset81\fprq2{\*\panose 03000500000000000000}@Hannotate TC Regular;}{\f596\fbidi \fnil\fcharset81\fprq2{\*\panose 03000500000000000000}HanziPen TC Bold;}{\f597\fbidi \fnil\fcharset81\fprq2{\*\panose 03000500000000000000}@HanziPen TC Bold;}{\f598\fbidi \fnil\fcharset81\fprq2{\*\panose 03000300000000000000}HanziPen TC Regular;}{\f599\fbidi \fnil\fcharset81\fprq2{\*\panose 03000300000000000000}@HanziPen TC Regular;}{\f600\fbidi \fnil\fcharset81\fprq2{\*\panose 02000000000000000000}Heiti TC Light;}{\f601\fbidi \fnil\fcharset81\fprq2{\*\panose 02000000000000000000}@Heiti TC Light;}{\f602\fbidi \fnil\fcharset81\fprq2{\*\panose 00000000000000000000}Heiti TC Medium;}{\f603\fbidi \fnil\fcharset81\fprq2{\*\panose 00000000000000000000}@Heiti TC Medium;}{\f604\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Kaiti TC Bold;}{\f605\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Kaiti TC Bold;}{\f606\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Kaiti TC Regular;}{\f607\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Kaiti TC Regular;}{\f608\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Songti TC Bold;}{\f609\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Songti TC Bold;}{\f610\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Songti TC Light;}{\f611\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Songti TC Light;}{\f612\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Songti TC Regular;}{\f613\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Songti TC Regular;}{\f614\fbidi \fnil\fcharset81\fprq2{\*\panose 03000800000000000000}Weibei TC Bold;}{\f615\fbidi \fnil\fcharset81\fprq2{\*\panose 03000800000000000000}@Weibei TC Bold;}{\f616\fbidi \fnil\fcharset81\fprq2{\*\panose 00000600000000000000}Yuppy TC Regular;}{\f617\fbidi \fnil\fcharset81\fprq2{\*\panose 00000600000000000000}@Yuppy TC Regular;}{\f618\fbidi \fnil\fcharset81\fprq2 \'b2\'d3\'a9\'fa\'c5\'e9;}{\f619\fbidi \fnil\fcharset81\fprq2 @\'b2\'d3\'a9\'fa\'c5\'e9;}{\f620\fbidi \fnil\fcharset81\fprq2 \'b2\'d3\'a9\'fa\'c5\'e9_HKSCS;}{\f621\fbidi \fnil\fcharset81\fprq2 @\'b2\'d3\'a9\'fa\'c5\'e9_HKSCS;}{\f622\fbidi \fnil\fcharset81\fprq2 @\'b7\'73\'b2\'d3\'a9\'fa\'c5\'e9;}{\f623\fbidi \fnil\fcharset81\fprq2 \'c4\'d7\'a7\'ba Pro;}{\f624\fbidi \fnil\fcharset81\fprq2 @\'c4\'d7\'a7\'ba Pro;}{\f625\fbidi \fnil\fcharset81\fprq2 \'c4\'d7\'b6\'c2 Pro;}{\f626\fbidi \fnil\fcharset81\fprq2 @\'c4\'d7\'b6\'c2 Pro;}{\f627\fbidi \fnil\fcharset80\fprq2 Adobe \'b7\'c2\'cb\'ce Std R;}{\f628\fbidi \fnil\fcharset80\fprq2 @Adobe \'b7\'c2\'cb\'ce Std R;}{\f629\fbidi \fnil\fcharset80\fprq2 Adobe \'ba\'da\'cc\'e5 Std R;}{\f630\fbidi \fnil\fcharset80\fprq2 @Adobe \'ba\'da\'cc\'e5 Std R;}{\f631\fbidi \fnil\fcharset80\fprq2 Adobe \'bf\'ac\'cc\'e5 Std R;}{\f632\fbidi \fnil\fcharset80\fprq2 @Adobe \'bf\'ac\'cc\'e5 Std R;}{\f633\fbidi \fnil\fcharset80\fprq2 Adobe \'cb\'ce\'cc\'e5 Std L;}{\f634\fbidi \fnil\fcharset80\fprq2 @Adobe \'cb\'ce\'cc\'e5 Std L;}{\f635\fbidi \fnil\fcharset80\fprq2 GB18030 Bitmap;}{\f636\fbidi \fnil\fcharset80\fprq2 @GB18030 Bitmap;}{\f637\fbidi \fnil\fcharset80\fprq2{\*\panose 03000700000000000000}Hannotate SC Bold;}{\f638\fbidi \fnil\fcharset80\fprq2{\*\panose 03000700000000000000}@Hannotate SC Bold;}{\f639\fbidi \fnil\fcharset80\fprq2{\*\panose 03000500000000000000}Hannotate SC Regular;}{\f640\fbidi \fnil\fcharset80\fprq2{\*\panose 03000500000000000000}@Hannotate SC Regular;}{\f641\fbidi \fnil\fcharset80\fprq2{\*\panose 03000500000000000000}HanziPen SC Bold;}{\f642\fbidi \fnil\fcharset80\fprq2{\*\panose 03000500000000000000}@HanziPen SC Bold;}{\f643\fbidi \fnil\fcharset80\fprq2{\*\panose 03000300000000000000}HanziPen SC Regular;}{\f644\fbidi \fnil\fcharset80\fprq2{\*\panose 03000300000000000000}@HanziPen SC Regular;}{\f645\fbidi \fnil\fcharset80\fprq2{\*\panose 02000500000000000000}Hei;}{\f646\fbidi \fnil\fcharset80\fprq2{\*\panose 02000500000000000000}@Hei;}{\f647\fbidi \fnil\fcharset80\fprq2{\*\panose 02000000000000000000}Heiti SC Light;}{\f648\fbidi \fnil\fcharset80\fprq2{\*\panose 02000000000000000000}@Heiti SC Light;}{\f649\fbidi \fnil\fcharset80\fprq2{\*\panose 00000000000000000000}Heiti SC Medium;}{\f650\fbidi \fnil\fcharset80\fprq2{\*\panose 00000000000000000000}@Heiti SC Medium;}{\f651\fbidi \fnil\fcharset80\fprq2{\*\panose 020b0300000000000000}Hiragino Sans GB W3;}{\f652\fbidi \fnil\fcharset80\fprq2{\*\panose 020b0300000000000000}@Hiragino Sans GB W3;}{\f653\fbidi \fnil\fcharset80\fprq2{\*\panose 020b0600000000000000}Hiragino Sans GB W6;}{\f654\fbidi \fnil\fcharset80\fprq2{\*\panose 020b0600000000000000}@Hiragino Sans GB W6;}{\f655\fbidi \fnil\fcharset80\fprq2{\*\panose 02000500000000000000}Kai;}{\f656\fbidi \fnil\fcharset80\fprq2{\*\panose 02000500000000000000}@Kai;}{\f657\fbidi \fnil\fcharset80\fprq2{\*\panose 02010800040101010101}Kaiti SC Bold;}{\f658\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Kaiti SC Bold;}{\f659\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Kaiti SC Regular;}{\f660\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Kaiti SC Regular;}{\f661\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Songti SC Bold;}{\f662\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Songti SC Bold;}{\f663\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Songti SC Light;}{\f664\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Songti SC Light;}{\f665\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Songti SC Regular;}{\f666\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Songti SC Regular;}{\f667\fbidi \fnil\fcharset80\fprq2{\*\panose 03000800000000000000}Weibei SC Bold;}{\f668\fbidi \fnil\fcharset80\fprq2{\*\panose 03000800000000000000}@Weibei SC Bold;}{\f669\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Yuanti SC Light;}{\f670\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Yuanti SC Light;}{\f671\fbidi \fnil\fcharset80\fprq2{\*\panose 00000500000000000000}Yuppy SC Regular;}{\f672\fbidi \fnil\fcharset80\fprq2{\*\panose 00000500000000000000}@Yuppy SC Regular;}{\f673\fbidi \fnil\fcharset80\fprq2 \'ba\'da\'cc\'e5;}{\f674\fbidi \fnil\fcharset80\fprq2 @\'ba\'da\'cc\'e5;}{\f675\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce;}{\f676\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce;}{\f677\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5;}{\f678\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5;}{\f679\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5;}{\f680\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5;}{\f681\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5;}{\f682\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5;}{\f683\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'cf\'b8\'ba\'da;}{\f684\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'cf\'b8\'ba\'da;}{\f685\fbidi \fnil\fcharset80\fprq2 @\'cb\'ce\'cc\'e5;}{\f686\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e;}{\f687\fbidi \fnil\fcharset78\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e;}{\f688\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9;}{\f689\fbidi \fnil\fcharset78\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9;}{\f690\fbidi \fnil\fcharset78\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e;}{\f691\fbidi \fnil\fcharset78\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9;}{\f692\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0600000000000000}Osaka;}{\f693\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0600000000000000}@Osaka;}{\f694\fbidi \fnil\fcharset78\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d;}{\f695\fbidi \fnil\fcharset78\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d;}{\f696\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0700000000000000}YuGothic Bold;}{\f697\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0700000000000000}@YuGothic Bold;}{\f698\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0500000000000000}YuGothic Medium;}{\f699\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0500000000000000}@YuGothic Medium;}{\f700\fbidi \fnil\fcharset78\fprq2{\*\panose 02020600000000000000}YuMincho Demibold;}{\f701\fbidi \fnil\fcharset78\fprq2{\*\panose 02020600000000000000}@YuMincho Demibold;}{\f702\fbidi \fnil\fcharset78\fprq2{\*\panose 02020500000000000000}YuMincho Medium;}{\f703\fbidi \fnil\fcharset78\fprq2{\*\panose 02020500000000000000}@YuMincho Medium;}{\f704\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3;}{\f705\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3;}{\f706\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6;}{\f707\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6;}{\f708\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3;}{\f709\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3;}{\f710\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6;}{\f711\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6;}{\f712\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8;}{\f713\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8;}{\f714\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8;}{\f715\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8;}{\f716\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4;}{\f717\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4;}{\f718\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4;}{\f719\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4;}{\f720\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3;}{\f721\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3;}{\f722\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6;}{\f723\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6;}{\f724\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3;}{\f725\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3;}{\f726\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6;}{\f727\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6;}{\f728\fbidi \fnil\fcharset78\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49;}{\f729\fbidi \fnil\fcharset78\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49;}{\f730\fbidi \fnil\fcharset78\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e;}{\f731\fbidi \fnil\fcharset78\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e;}{\f732\fbidi \fnil\fcharset78\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68;}{\f733\fbidi \fnil\fcharset78\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68;}{\f734\fbidi \fnil\fcharset78\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e;}{\f735\fbidi \fnil\fcharset78\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e;}{\f736\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B;}{\f737\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B;}{\f738\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL;}{\f739\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL;}{\f740\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H;}{\f741\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H;}{\f742\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L;}{\f743\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L;}{\f744\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M;}{\f745\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M;}{\f746\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R;}{\f747\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R;}{\f748\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B;}{\f749\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B;}{\f750\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL;}{\f751\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL;}{\f752\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H;}{\f753\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H;}{\f754\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L;}{\f755\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L;}{\f756\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M;}{\f757\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M;}{\f758\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R;}{\f759\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R;}{\f760\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B;}{\f761\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B;}{\f762\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL;}{\f763\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL;}{\f764\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H;}{\f765\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H;}{\f766\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L;}{\f767\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L;}{\f768\fbidi \fnil\fcharset0\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M;}{\f769\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R;}{\f770\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R;}{\f771\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B;}{\f772\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B;}{\f773\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL;}{\f774\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL;}{\f775\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H;}{\f776\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H;}{\f777\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L;}{\f778\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L;}{\f779\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M;}{\f780\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M;}{\f781\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R;}{\f782\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R;}{\f783\fbidi \fnil\fcharset79\fprq2 Adobe \'b0\'ed\'b5\'f1 Std B;}{\f784\fbidi \fnil\fcharset79\fprq2 @Adobe \'b0\'ed\'b5\'f1 Std B;}{\f785\fbidi \fnil\fcharset79\fprq2 Adobe \'b8\'ed\'c1\'b6 Std M;}{\f786\fbidi \fnil\fcharset79\fprq2 @Adobe \'b8\'ed\'c1\'b6 Std M;}{\f787\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee;}{\f788\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee;}{\f789\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc;}{\f790\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc;}{\f791\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc;}{\f792\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc;}{\f793\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc;}{\f794\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc;}{\f795\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc;}{\f796\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc;}{\f797\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc;}{\f798\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc;}{\f799\fbidi \fnil\fcharset79\fprq2{\*\panose 02000500000000000000}AppleGothic;}{\f800\fbidi \fnil\fcharset79\fprq2{\*\panose 02000500000000000000}@AppleGothic;}{\f801\fbidi \fnil\fcharset79\fprq2{\*\panose 02000500000000000000}AppleMyungjo;}{\f802\fbidi \fnil\fcharset79\fprq2{\*\panose 02000500000000000000}@AppleMyungjo;}{\f803\fbidi \fnil\fcharset79\fprq2 PC\'b8\'ed\'c1\'b6;}{\f804\fbidi \fnil\fcharset79\fprq2 @PC\'b8\'ed\'c1\'b6;}{\f805\fbidi \fnil\fcharset79\fprq2 \'b1\'bc\'b8\'b2;}{\f806\fbidi \fnil\fcharset79\fprq2 @\'b1\'bc\'b8\'b2;}{\f807\fbidi \fnil\fcharset79\fprq2 \'b1\'c3\'bc\'ad\'c3\'bc;}{\f808\fbidi \fnil\fcharset79\fprq2 @\'b1\'c3\'bc\'ad\'c3\'bc;}{\f809\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1;}{\f810\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1;}{\f811\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Bold;}{\f812\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Bold;}{\f813\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 ExtraBold;}{\f814\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 ExtraBold;}{\f815\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6;}{\f816\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6;}{\f817\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Bold;}{\f818\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Bold;}{\f819\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 ExtraBold;}{\f820\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 ExtraBold;}{\f821\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'ba\'d7;}{\f822\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'ba\'d7;}{\f823\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'c6\'e6;}{\f824\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'c6\'e6;}{\f825\fbidi \fnil\fcharset79\fprq2 @\'b9\'d9\'c5\'c1;}{\f826\fbidi \fnil\fcharset79\fprq2 \'c7\'ca\'b1\'e2\'c3\'bc;}{\f827\fbidi \fnil\fcharset79\fprq2 @\'c7\'ca\'b1\'e2\'c3\'bc;}{\f828\fbidi \fnil\fcharset79\fprq2 \'c7\'ec\'b5\'e5\'b6\'f3\'c0\'ceA;}{\f829\fbidi \fnil\fcharset79\fprq2 @\'c7\'ec\'b5\'e5\'b6\'f3\'c0\'ceA;}{\f830\fbidi \froman\fcharset77\fprq0{\*\panose 00000000000000000000}Ming(for ISO10646) {\*\falt &#39636,MingLiU_HKSCS};}{\flomajor\f31500\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial;}{\fdbmajor\f31501\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e;}{\fhimajor\f31502\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0502020204030204}Calibri;}{\fbimajor\f31503\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\flominor\f31504\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\fdbminor\f31505\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9;}{\fhiminor\f31506\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria;}{\fbiminor\f31507\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f831\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\f832\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\f834\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\f835\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\f836\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\f837\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\f838\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\f839\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\f841\fbidi \fnil\fcharset238\fprq2 Arial CE;}{\f842\fbidi \fnil\fcharset204\fprq2 Arial Cyr;}{\f844\fbidi \fnil\fcharset161\fprq2 Arial Greek;}{\f845\fbidi \fnil\fcharset162\fprq2 Arial Tur;}{\f846\fbidi \fnil\fcharset177\fprq2 Arial (Hebrew);}{\f847\fbidi \fnil\fcharset178\fprq2 Arial (Arabid);}{\f848\fbidi \fnil\fcharset186\fprq2 Arial Baltic;}{\f849\fbidi \fnil\fcharset163\fprq2 Arial (Vietnamese);}{\f851\fbidi \fnil\fcharset238\fprq2 Courier CE{\*\falt Courier};}{\f852\fbidi \fnil\fcharset204\fprq2 Courier Cyr{\*\falt Courier};}{\f854\fbidi \fnil\fcharset161\fprq2 Courier Greek{\*\falt Courier};}{\f855\fbidi \fnil\fcharset162\fprq2 Courier Tur{\*\falt Courier};}{\f856\fbidi \fnil\fcharset177\fprq2 Courier (Hebrew){\*\falt Courier};}{\f857\fbidi \fnil\fcharset178\fprq2 Courier (Arabid){\*\falt Courier};}{\f858\fbidi \fnil\fcharset186\fprq2 Courier Baltic{\*\falt Courier};}{\f859\fbidi \fnil\fcharset163\fprq2 Courier (Vietnamese){\*\falt Courier};}{\f881\fbidi \fnil\fcharset238\fprq2 Helvetica CE;}{\f882\fbidi \fnil\fcharset204\fprq2 Helvetica Cyr;}{\f884\fbidi \fnil\fcharset161\fprq2 Helvetica Greek;}{\f885\fbidi \fnil\fcharset162\fprq2 Helvetica Tur;}{\f888\fbidi \fnil\fcharset186\fprq2 Helvetica Baltic;}{\f889\fbidi \fnil\fcharset163\fprq2 Helvetica (Vietnamese);}{\f901\fbidi \fnil\fcharset238\fprq2 Geneva CE;}{\f905\fbidi \fnil\fcharset162\fprq2 Geneva Tur;}{\f908\fbidi \fnil\fcharset186\fprq2 Geneva Baltic;}{\f983\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Western;}{\f981\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 CE;}{\f982\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Cyr;}{\f984\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Greek;}{\f985\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Tur;}{\f988\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Baltic;}{\f993\fbidi \fnil\fcharset0\fprq2 \'b9\'d9\'c5\'c1 Western;}{\f991\fbidi \fnil\fcharset238\fprq2 \'b9\'d9\'c5\'c1 CE;}{\f992\fbidi \fnil\fcharset204\fprq2 \'b9\'d9\'c5\'c1 Cyr;}{\f994\fbidi \fnil\fcharset161\fprq2 \'b9\'d9\'c5\'c1 Greek;}{\f995\fbidi \fnil\fcharset162\fprq2 \'b9\'d9\'c5\'c1 Tur;}{\f998\fbidi \fnil\fcharset186\fprq2 \'b9\'d9\'c5\'c1 Baltic;}{\f1003\fbidi \fnil\fcharset0\fprq2 \'cb\'ce\'cc\'e5 Western;}{\f1013\fbidi \fnil\fcharset0\fprq2 \'b7\'73\'b2\'d3\'a9\'fa\'c5\'e9 Western;}{\f1023\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\f1021\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\f1022\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\f1024\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\f1025\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\f1028\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\f1031\fbidi \fnil\fcharset238\fprq2 Century CE;}{\f1032\fbidi \fnil\fcharset204\fprq2 Century Cyr;}{\f1034\fbidi \fnil\fcharset161\fprq2 Century Greek;}{\f1035\fbidi \fnil\fcharset162\fprq2 Century Tur;}{\f1038\fbidi \fnil\fcharset186\fprq2 Century Baltic;}{\f1041\fbidi \fnil\fcharset238\fprq2 Verdana CE;}{\f1042\fbidi \fnil\fcharset204\fprq2 Verdana Cyr;}{\f1044\fbidi \fnil\fcharset161\fprq2 Verdana Greek;}{\f1045\fbidi \fnil\fcharset162\fprq2 Verdana Tur;}{\f1048\fbidi \fnil\fcharset186\fprq2 Verdana Baltic;}{\f1049\fbidi \fnil\fcharset163\fprq2 Verdana (Vietnamese);}{\f1092\fbidi \froman\fcharset204\fprq2 Sylfaen Cyr;}{\f1094\fbidi \froman\fcharset161\fprq2 Sylfaen Greek;}{\f1171\fbidi \fnil\fcharset238\fprq2 Cambria Math CE;}{\f1172\fbidi \fnil\fcharset204\fprq2 Cambria Math Cyr;}{\f1174\fbidi \fnil\fcharset161\fprq2 Cambria Math Greek;}{\f1175\fbidi \fnil\fcharset162\fprq2 Cambria Math Tur;}{\f1178\fbidi \fnil\fcharset186\fprq2 Cambria Math Baltic;}{\f1179\fbidi \fnil\fcharset163\fprq2 Cambria Math (Vietnamese);}{\f1181\fbidi \fnil\fcharset238\fprq2 Calibri CE;}{\f1182\fbidi \fnil\fcharset204\fprq2 Calibri Cyr;}{\f1184\fbidi \fnil\fcharset161\fprq2 Calibri Greek;}{\f1185\fbidi \fnil\fcharset162\fprq2 Calibri Tur;}{\f1188\fbidi \fnil\fcharset186\fprq2 Calibri Baltic;}{\f1189\fbidi \fnil\fcharset163\fprq2 Calibri (Vietnamese);}{\f1191\fbidi \fnil\fcharset238\fprq2 Cambria CE;}{\f1192\fbidi \fnil\fcharset204\fprq2 Cambria Cyr;}{\f1194\fbidi \fnil\fcharset161\fprq2 Cambria Greek;}{\f1195\fbidi \fnil\fcharset162\fprq2 Cambria Tur;}{\f1198\fbidi \fnil\fcharset186\fprq2 Cambria Baltic;}{\f1199\fbidi \fnil\fcharset163\fprq2 Cambria (Vietnamese);}{\f1237\fbidi \fnil\fcharset178\fprq2 Adobe Arabic (Arabid);}{\f1247\fbidi \fnil\fcharset178\fprq2 Adobe Arabic Bold (Arabid);}{\f1257\fbidi \fnil\fcharset178\fprq2 Adobe Arabic Bold Italic (Arabid);}{\f1267\fbidi \fnil\fcharset178\fprq2 Adobe Arabic Italic (Arabid);}{\f1271\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro CE;}{\f1275\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro Tur;}{\f1278\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro Baltic;}{\f1281\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro Bold CE;}{\f1285\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro Bold Tur;}{\f1288\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro Bold Baltic;}{\f1291\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro Bold Italic CE;}{\f1295\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro Bold Italic Tur;}{\f1298\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro Bold Italic Baltic;}{\f1301\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro Italic CE;}{\f1305\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro Italic Tur;}{\f1308\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro Italic Baltic;}{\f1311\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro SmBd CE;}{\f1315\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro SmBd Tur;}{\f1318\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro SmBd Baltic;}{\f1321\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro SmBd Italic CE;}{\f1325\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro SmBd Italic Tur;}{\f1328\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro SmBd Italic Baltic;}{\f1371\fbidi \fnil\fcharset238\fprq2 Adobe Garamond Pro CE;}{\f1375\fbidi \fnil\fcharset162\fprq2 Adobe Garamond Pro Tur;}{\f1378\fbidi \fnil\fcharset186\fprq2 Adobe Garamond Pro Baltic;}{\f1381\fbidi \fnil\fcharset238\fprq2 Adobe Garamond Pro Bold CE;}{\f1385\fbidi \fnil\fcharset162\fprq2 Adobe Garamond Pro Bold Tur;}{\f1388\fbidi \fnil\fcharset186\fprq2 Adobe Garamond Pro Bold Baltic;}{\f1391\fbidi \fnil\fcharset238\fprq2 Adobe Garamond Pro Bold Italic CE;}{\f1395\fbidi \fnil\fcharset162\fprq2 Adobe Garamond Pro Bold Italic Tur;}{\f1398\fbidi \fnil\fcharset186\fprq2 Adobe Garamond Pro Bold Italic Baltic;}{\f1401\fbidi \fnil\fcharset238\fprq2 Adobe Garamond Pro Italic CE;}{\f1405\fbidi \fnil\fcharset162\fprq2 Adobe Garamond Pro Italic Tur;}{\f1408\fbidi \fnil\fcharset186\fprq2 Adobe Garamond Pro Italic Baltic;}{\f1416\fbidi \fnil\fcharset177\fprq2 Adobe Hebrew (Hebrew);}{\f1426\fbidi \fnil\fcharset177\fprq2 Adobe Hebrew Bold (Hebrew);}{\f1436\fbidi \fnil\fcharset177\fprq2 Adobe Hebrew Bold Italic (Hebrew);}{\f1446\fbidi \fnil\fcharset177\fprq2 Adobe Hebrew Italic (Hebrew);}{\f1457\fbidi \fnil\fcharset178\fprq2 Adobe Naskh Medium (Arabid);}{\f1465\fbidi \fnil\fcharset162\fprq2 American Typewriter Tur;}{\f1469\fbidi \fnil\fcharset163\fprq2 American Typewriter (Vietnamese);}{\f1475\fbidi \fnil\fcharset162\fprq2 American Typewriter Condensed Tur;}{\f1479\fbidi \fnil\fcharset163\fprq2 American Typewriter Condensed (Vietnamese);}{\f1485\fbidi \fnil\fcharset162\fprq2 American Typewriter Light Tur;}{\f1489\fbidi \fnil\fcharset163\fprq2 American Typewriter Light (Vietnamese);}{\f1491\fbidi \fnil\fcharset238\fprq2 Andale Mono CE;}{\f1492\fbidi \fnil\fcharset204\fprq2 Andale Mono Cyr;}{\f1494\fbidi \fnil\fcharset161\fprq2 Andale Mono Greek;}{\f1495\fbidi \fnil\fcharset162\fprq2 Andale Mono Tur;}{\f1498\fbidi \fnil\fcharset186\fprq2 Andale Mono Baltic;}{\f1501\fbidi \fnil\fcharset238\fprq2 Apple Chancery CE;}{\f1505\fbidi \fnil\fcharset162\fprq2 Apple Chancery Tur;}{\f1506\fbidi \fnil\fcharset177\fprq2 Apple Chancery (Hebrew);}{\f1507\fbidi \fnil\fcharset178\fprq2 Apple Chancery (Arabid);}{\f1508\fbidi \fnil\fcharset186\fprq2 Apple Chancery Baltic;}{\f1509\fbidi \fnil\fcharset163\fprq2 Apple Chancery (Vietnamese);}{\f1511\fbidi \fnil\fcharset238\fprq2 Apple Symbols CE;}{\f1514\fbidi \fnil\fcharset161\fprq2 Apple Symbols Greek;}{\f1515\fbidi \fnil\fcharset162\fprq2 Apple Symbols Tur;}{\f1516\fbidi \fnil\fcharset177\fprq2 Apple Symbols (Hebrew);}{\f1517\fbidi \fnil\fcharset178\fprq2 Apple Symbols (Arabid);}{\f1518\fbidi \fnil\fcharset186\fprq2 Apple Symbols Baltic;}{\f1519\fbidi \fnil\fcharset163\fprq2 Apple Symbols (Vietnamese);}{\f1521\fbidi \fnil\fcharset238\fprq2 Arial Black CE;}{\f1522\fbidi \fnil\fcharset204\fprq2 Arial Black Cyr;}{\f1524\fbidi \fnil\fcharset161\fprq2 Arial Black Greek;}{\f1525\fbidi \fnil\fcharset162\fprq2 Arial Black Tur;}{\f1528\fbidi \fnil\fcharset186\fprq2 Arial Black Baltic;}{\f1531\fbidi \fnil\fcharset238\fprq2 Arial Bold CE;}{\f1532\fbidi \fnil\fcharset204\fprq2 Arial Bold Cyr;}{\f1534\fbidi \fnil\fcharset161\fprq2 Arial Bold Greek;}{\f1535\fbidi \fnil\fcharset162\fprq2 Arial Bold Tur;}{\f1536\fbidi \fnil\fcharset177\fprq2 Arial Bold (Hebrew);}{\f1537\fbidi \fnil\fcharset178\fprq2 Arial Bold (Arabid);}{\f1538\fbidi \fnil\fcharset186\fprq2 Arial Bold Baltic;}{\f1539\fbidi \fnil\fcharset163\fprq2 Arial Bold (Vietnamese);}{\f1541\fbidi \fnil\fcharset238\fprq2 Arial Bold Italic CE;}{\f1542\fbidi \fnil\fcharset204\fprq2 Arial Bold Italic Cyr;}{\f1544\fbidi \fnil\fcharset161\fprq2 Arial Bold Italic Greek;}{\f1545\fbidi \fnil\fcharset162\fprq2 Arial Bold Italic Tur;}{\f1546\fbidi \fnil\fcharset177\fprq2 Arial Bold Italic (Hebrew);}{\f1548\fbidi \fnil\fcharset186\fprq2 Arial Bold Italic Baltic;}{\f1549\fbidi \fnil\fcharset163\fprq2 Arial Bold Italic (Vietnamese);}{\f1551\fbidi \fnil\fcharset238\fprq2 Arial Italic CE;}{\f1552\fbidi \fnil\fcharset204\fprq2 Arial Italic Cyr;}{\f1554\fbidi \fnil\fcharset161\fprq2 Arial Italic Greek;}{\f1555\fbidi \fnil\fcharset162\fprq2 Arial Italic Tur;}{\f1556\fbidi \fnil\fcharset177\fprq2 Arial Italic (Hebrew);}{\f1558\fbidi \fnil\fcharset186\fprq2 Arial Italic Baltic;}{\f1559\fbidi \fnil\fcharset163\fprq2 Arial Italic (Vietnamese);}{\f1561\fbidi \fnil\fcharset238\fprq2 Arial Narrow CE;}{\f1562\fbidi \fnil\fcharset204\fprq2 Arial Narrow Cyr;}{\f1564\fbidi \fnil\fcharset161\fprq2 Arial Narrow Greek;}{\f1565\fbidi \fnil\fcharset162\fprq2 Arial Narrow Tur;}{\f1568\fbidi \fnil\fcharset186\fprq2 Arial Narrow Baltic;}{\f1571\fbidi \fnil\fcharset238\fprq2 Arial Narrow Bold CE;}{\f1572\fbidi \fnil\fcharset204\fprq2 Arial Narrow Bold Cyr;}{\f1574\fbidi \fnil\fcharset161\fprq2 Arial Narrow Bold Greek;}{\f1575\fbidi \fnil\fcharset162\fprq2 Arial Narrow Bold Tur;}{\f1578\fbidi \fnil\fcharset186\fprq2 Arial Narrow Bold Baltic;}{\f1581\fbidi \fnil\fcharset238\fprq2 Arial Narrow Bold Italic CE;}{\f1582\fbidi \fnil\fcharset204\fprq2 Arial Narrow Bold Italic Cyr;}{\f1584\fbidi \fnil\fcharset161\fprq2 Arial Narrow Bold Italic Greek;}{\f1585\fbidi \fnil\fcharset162\fprq2 Arial Narrow Bold Italic Tur;}{\f1588\fbidi \fnil\fcharset186\fprq2 Arial Narrow Bold Italic Baltic;}{\f1591\fbidi \fnil\fcharset238\fprq2 Arial Narrow Italic CE;}{\f1592\fbidi \fnil\fcharset204\fprq2 Arial Narrow Italic Cyr;}{\f1594\fbidi \fnil\fcharset161\fprq2 Arial Narrow Italic Greek;}{\f1595\fbidi \fnil\fcharset162\fprq2 Arial Narrow Italic Tur;}{\f1598\fbidi \fnil\fcharset186\fprq2 Arial Narrow Italic Baltic;}{\f1611\fbidi \fnil\fcharset238\fprq2 Arial Unicode MS CE;}{\f1612\fbidi \fnil\fcharset204\fprq2 Arial Unicode MS Cyr;}{\f1614\fbidi \fnil\fcharset161\fprq2 Arial Unicode MS Greek;}{\f1615\fbidi \fnil\fcharset162\fprq2 Arial Unicode MS Tur;}{\f1616\fbidi \fnil\fcharset177\fprq2 Arial Unicode MS (Hebrew);}{\f1617\fbidi \fnil\fcharset178\fprq2 Arial Unicode MS (Arabid);}{\f1618\fbidi \fnil\fcharset186\fprq2 Arial Unicode MS Baltic;}{\f1619\fbidi \fnil\fcharset163\fprq2 Arial Unicode MS (Vietnamese);}{\f1620\fbidi \fnil\fcharset222\fprq2 Arial Unicode MS (That);}{\f1621\fbidi \fnil\fcharset238\fprq2 Athelas Bold CE;}{\f1625\fbidi \fnil\fcharset162\fprq2 Athelas Bold Tur;}{\f1628\fbidi \fnil\fcharset186\fprq2 Athelas Bold Baltic;}{\f1631\fbidi \fnil\fcharset238\fprq2 Athelas Bold Italic CE;}{\f1634\fbidi \fnil\fcharset161\fprq2 Athelas Bold Italic Greek;}{\f1635\fbidi \fnil\fcharset162\fprq2 Athelas Bold Italic Tur;}{\f1638\fbidi \fnil\fcharset186\fprq2 Athelas Bold Italic Baltic;}{\f1641\fbidi \fnil\fcharset238\fprq2 Athelas Italic CE;}{\f1644\fbidi \fnil\fcharset161\fprq2 Athelas Italic Greek;}{\f1645\fbidi \fnil\fcharset162\fprq2 Athelas Italic Tur;}{\f1648\fbidi \fnil\fcharset186\fprq2 Athelas Italic Baltic;}{\f1651\fbidi \fnil\fcharset238\fprq2 Athelas Regular CE;}{\f1654\fbidi \fnil\fcharset161\fprq2 Athelas Regular Greek;}{\f1655\fbidi \fnil\fcharset162\fprq2 Athelas Regular Tur;}{\f1658\fbidi \fnil\fcharset186\fprq2 Athelas Regular Baltic;}{\f1661\fbidi \fnil\fcharset238\fprq2 Avenir Black CE;}{\f1664\fbidi \fnil\fcharset161\fprq2 Avenir Black Greek;}{\f1665\fbidi \fnil\fcharset162\fprq2 Avenir Black Tur;}{\f1668\fbidi \fnil\fcharset186\fprq2 Avenir Black Baltic;}{\f1671\fbidi \fnil\fcharset238\fprq2 Avenir Black Oblique CE;}{\f1674\fbidi \fnil\fcharset161\fprq2 Avenir Black Oblique Greek;}{\f1675\fbidi \fnil\fcharset162\fprq2 Avenir Black Oblique Tur;}{\f1678\fbidi \fnil\fcharset186\fprq2 Avenir Black Oblique Baltic;}{\f1681\fbidi \fnil\fcharset238\fprq2 Avenir Book CE;}{\f1684\fbidi \fnil\fcharset161\fprq2 Avenir Book Greek;}{\f1685\fbidi \fnil\fcharset162\fprq2 Avenir Book Tur;}{\f1688\fbidi \fnil\fcharset186\fprq2 Avenir Book Baltic;}{\f1691\fbidi \fnil\fcharset238\fprq2 Avenir Book Oblique CE;}{\f1694\fbidi \fnil\fcharset161\fprq2 Avenir Book Oblique Greek;}{\f1695\fbidi \fnil\fcharset162\fprq2 Avenir Book Oblique Tur;}{\f1698\fbidi \fnil\fcharset186\fprq2 Avenir Book Oblique Baltic;}{\f1701\fbidi \fnil\fcharset238\fprq2 Avenir Heavy CE;}{\f1704\fbidi \fnil\fcharset161\fprq2 Avenir Heavy Greek;}{\f1705\fbidi \fnil\fcharset162\fprq2 Avenir Heavy Tur;}{\f1708\fbidi \fnil\fcharset186\fprq2 Avenir Heavy Baltic;}{\f1711\fbidi \fnil\fcharset238\fprq2 Avenir Heavy Oblique CE;}{\f1714\fbidi \fnil\fcharset161\fprq2 Avenir Heavy Oblique Greek;}{\f1715\fbidi \fnil\fcharset162\fprq2 Avenir Heavy Oblique Tur;}{\f1718\fbidi \fnil\fcharset186\fprq2 Avenir Heavy Oblique Baltic;}{\f1721\fbidi \fnil\fcharset238\fprq2 Avenir Light CE;}{\f1724\fbidi \fnil\fcharset161\fprq2 Avenir Light Greek;}{\f1725\fbidi \fnil\fcharset162\fprq2 Avenir Light Tur;}{\f1728\fbidi \fnil\fcharset186\fprq2 Avenir Light Baltic;}{\f1731\fbidi \fnil\fcharset238\fprq2 Avenir Light Oblique CE;}{\f1734\fbidi \fnil\fcharset161\fprq2 Avenir Light Oblique Greek;}{\f1735\fbidi \fnil\fcharset162\fprq2 Avenir Light Oblique Tur;}{\f1738\fbidi \fnil\fcharset186\fprq2 Avenir Light Oblique Baltic;}{\f1741\fbidi \fnil\fcharset238\fprq2 Avenir Medium CE;}{\f1744\fbidi \fnil\fcharset161\fprq2 Avenir Medium Greek;}{\f1745\fbidi \fnil\fcharset162\fprq2 Avenir Medium Tur;}{\f1748\fbidi \fnil\fcharset186\fprq2 Avenir Medium Baltic;}{\f1751\fbidi \fnil\fcharset238\fprq2 Avenir Medium Oblique CE;}{\f1754\fbidi \fnil\fcharset161\fprq2 Avenir Medium Oblique Greek;}{\f1755\fbidi \fnil\fcharset162\fprq2 Avenir Medium Oblique Tur;}{\f1758\fbidi \fnil\fcharset186\fprq2 Avenir Medium Oblique Baltic;}{\f1761\fbidi \fnil\fcharset238\fprq2 Avenir Next Bold CE;}{\f1764\fbidi \fnil\fcharset161\fprq2 Avenir Next Bold Greek;}{\f1765\fbidi \fnil\fcharset162\fprq2 Avenir Next Bold Tur;}{\f1768\fbidi \fnil\fcharset186\fprq2 Avenir Next Bold Baltic;}{\f1771\fbidi \fnil\fcharset238\fprq2 Avenir Next Bold Italic CE;}{\f1774\fbidi \fnil\fcharset161\fprq2 Avenir Next Bold Italic Greek;}{\f1775\fbidi \fnil\fcharset162\fprq2 Avenir Next Bold Italic Tur;}{\f1778\fbidi \fnil\fcharset186\fprq2 Avenir Next Bold Italic Baltic;}{\f1781\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Bold CE;}{\f1784\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Bold Greek;}{\f1785\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Bold Tur;}{\f1788\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Bold Baltic;}{\f1791\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Demi Bold CE;}{\f1794\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Demi Bold Greek;}{\f1795\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Demi Bold Tur;}{\f1798\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Demi Bold Baltic;}{\f1801\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Heavy CE;}{\f1804\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Heavy Greek;}{\f1805\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Heavy Tur;}{\f1808\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Heavy Baltic;}{\f1811\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Italic CE;}{\f1814\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Italic Greek;}{\f1815\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Italic Tur;}{\f1818\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Italic Baltic;}{\f1821\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Medium CE;}{\f1824\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Medium Greek;}{\f1825\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Medium Tur;}{\f1828\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Medium Baltic;}{\f1831\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Regular CE;}{\f1834\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Regular Greek;}{\f1835\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Regular Tur;}{\f1838\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Regular Baltic;}{\f1841\fbidi \fnil\fcharset238\fprq2 Avenir Next Demi Bold CE;}{\f1844\fbidi \fnil\fcharset161\fprq2 Avenir Next Demi Bold Greek;}{\f1845\fbidi \fnil\fcharset162\fprq2 Avenir Next Demi Bold Tur;}{\f1848\fbidi \fnil\fcharset186\fprq2 Avenir Next Demi Bold Baltic;}{\f1851\fbidi \fnil\fcharset238\fprq2 Avenir Next Demi Bold Italic CE;}{\f1854\fbidi \fnil\fcharset161\fprq2 Avenir Next Demi Bold Italic Greek;}{\f1855\fbidi \fnil\fcharset162\fprq2 Avenir Next Demi Bold Italic Tur;}{\f1858\fbidi \fnil\fcharset186\fprq2 Avenir Next Demi Bold Italic Baltic;}{\f1861\fbidi \fnil\fcharset238\fprq2 Avenir Next Heavy CE;}{\f1864\fbidi \fnil\fcharset161\fprq2 Avenir Next Heavy Greek;}{\f1865\fbidi \fnil\fcharset162\fprq2 Avenir Next Heavy Tur;}{\f1868\fbidi \fnil\fcharset186\fprq2 Avenir Next Heavy Baltic;}{\f1871\fbidi \fnil\fcharset238\fprq2 Avenir Next Heavy Italic CE;}{\f1874\fbidi \fnil\fcharset161\fprq2 Avenir Next Heavy Italic Greek;}{\f1875\fbidi \fnil\fcharset162\fprq2 Avenir Next Heavy Italic Tur;}{\f1878\fbidi \fnil\fcharset186\fprq2 Avenir Next Heavy Italic Baltic;}{\f1881\fbidi \fnil\fcharset238\fprq2 Avenir Next Italic CE;}{\f1884\fbidi \fnil\fcharset161\fprq2 Avenir Next Italic Greek;}{\f1885\fbidi \fnil\fcharset162\fprq2 Avenir Next Italic Tur;}{\f1888\fbidi \fnil\fcharset186\fprq2 Avenir Next Italic Baltic;}{\f1891\fbidi \fnil\fcharset238\fprq2 Avenir Next Medium CE;}{\f1894\fbidi \fnil\fcharset161\fprq2 Avenir Next Medium Greek;}{\f1895\fbidi \fnil\fcharset162\fprq2 Avenir Next Medium Tur;}{\f1898\fbidi \fnil\fcharset186\fprq2 Avenir Next Medium Baltic;}{\f1901\fbidi \fnil\fcharset238\fprq2 Avenir Next Medium Italic CE;}{\f1904\fbidi \fnil\fcharset161\fprq2 Avenir Next Medium Italic Greek;}{\f1905\fbidi \fnil\fcharset162\fprq2 Avenir Next Medium Italic Tur;}{\f1908\fbidi \fnil\fcharset186\fprq2 Avenir Next Medium Italic Baltic;}{\f1911\fbidi \fnil\fcharset238\fprq2 Avenir Next Regular CE;}{\f1914\fbidi \fnil\fcharset161\fprq2 Avenir Next Regular Greek;}{\f1915\fbidi \fnil\fcharset162\fprq2 Avenir Next Regular Tur;}{\f1918\fbidi \fnil\fcharset186\fprq2 Avenir Next Regular Baltic;}{\f1921\fbidi \fnil\fcharset238\fprq2 Avenir Next Ultra Light CE;}{\f1924\fbidi \fnil\fcharset161\fprq2 Avenir Next Ultra Light Greek;}{\f1925\fbidi \fnil\fcharset162\fprq2 Avenir Next Ultra Light Tur;}{\f1928\fbidi \fnil\fcharset186\fprq2 Avenir Next Ultra Light Baltic;}{\f1931\fbidi \fnil\fcharset238\fprq2 Avenir Next Ultra Light Italic CE;}{\f1934\fbidi \fnil\fcharset161\fprq2 Avenir Next Ultra Light Italic Greek;}{\f1935\fbidi \fnil\fcharset162\fprq2 Avenir Next Ultra Light Italic Tur;}{\f1938\fbidi \fnil\fcharset186\fprq2 Avenir Next Ultra Light Italic Baltic;}{\f1941\fbidi \fnil\fcharset238\fprq2 Avenir Oblique CE;}{\f1944\fbidi \fnil\fcharset161\fprq2 Avenir Oblique Greek;}{\f1945\fbidi \fnil\fcharset162\fprq2 Avenir Oblique Tur;}{\f1948\fbidi \fnil\fcharset186\fprq2 Avenir Oblique Baltic;}{\f1951\fbidi \fnil\fcharset238\fprq2 Avenir Roman CE;}{\f1954\fbidi \fnil\fcharset161\fprq2 Avenir Roman Greek;}{\f1955\fbidi \fnil\fcharset162\fprq2 Avenir Roman Tur;}{\f1958\fbidi \fnil\fcharset186\fprq2 Avenir Roman Baltic;}{\f1961\fbidi \fnil\fcharset238\fprq2 Ayuthaya CE;}{\f1962\fbidi \fnil\fcharset204\fprq2 Ayuthaya Cyr;}{\f1964\fbidi \fnil\fcharset161\fprq2 Ayuthaya Greek;}{\f1965\fbidi \fnil\fcharset162\fprq2 Ayuthaya Tur;}{\f1966\fbidi \fnil\fcharset177\fprq2 Ayuthaya (Hebrew);}{\f1967\fbidi \fnil\fcharset178\fprq2 Ayuthaya (Arabid);}{\f1968\fbidi \fnil\fcharset186\fprq2 Ayuthaya Baltic;}{\f1969\fbidi \fnil\fcharset163\fprq2 Ayuthaya (Vietnamese);}{\f1970\fbidi \fnil\fcharset222\fprq2 Ayuthaya (That);}{\f2011\fbidi \fnil\fcharset238\fprq2 Bank Gothic CE;}{\f2015\fbidi \fnil\fcharset162\fprq2 Bank Gothic Tur;}{\f2018\fbidi \fnil\fcharset186\fprq2 Bank Gothic Baltic;}{\f2019\fbidi \fnil\fcharset163\fprq2 Bank Gothic (Vietnamese);}{\f2031\fbidi \fnil\fcharset238\fprq2 Baskerville CE;}{\f2032\fbidi \fnil\fcharset204\fprq2 Baskerville Cyr;}{\f2034\fbidi \fnil\fcharset161\fprq2 Baskerville Greek;}{\f2035\fbidi \fnil\fcharset162\fprq2 Baskerville Tur;}{\f2038\fbidi \fnil\fcharset186\fprq2 Baskerville Baltic;}{\f2039\fbidi \fnil\fcharset163\fprq2 Baskerville (Vietnamese);}{\f2041\fbidi \fnil\fcharset238\fprq2 Baskerville Bold CE;}{\f2042\fbidi \fnil\fcharset204\fprq2 Baskerville Bold Cyr;}{\f2044\fbidi \fnil\fcharset161\fprq2 Baskerville Bold Greek;}{\f2045\fbidi \fnil\fcharset162\fprq2 Baskerville Bold Tur;}{\f2048\fbidi \fnil\fcharset186\fprq2 Baskerville Bold Baltic;}{\f2049\fbidi \fnil\fcharset163\fprq2 Baskerville Bold (Vietnamese);}{\f2051\fbidi \fnil\fcharset238\fprq2 Baskerville Bold Italic CE;}{\f2052\fbidi \fnil\fcharset204\fprq2 Baskerville Bold Italic Cyr;}{\f2054\fbidi \fnil\fcharset161\fprq2 Baskerville Bold Italic Greek;}{\f2055\fbidi \fnil\fcharset162\fprq2 Baskerville Bold Italic Tur;}{\f2058\fbidi \fnil\fcharset186\fprq2 Baskerville Bold Italic Baltic;}{\f2059\fbidi \fnil\fcharset163\fprq2 Baskerville Bold Italic (Vietnamese);}{\f2061\fbidi \fnil\fcharset238\fprq2 Baskerville Italic CE;}{\f2062\fbidi \fnil\fcharset204\fprq2 Baskerville Italic Cyr;}{\f2064\fbidi \fnil\fcharset161\fprq2 Baskerville Italic Greek;}{\f2065\fbidi \fnil\fcharset162\fprq2 Baskerville Italic Tur;}{\f2068\fbidi \fnil\fcharset186\fprq2 Baskerville Italic Baltic;}{\f2069\fbidi \fnil\fcharset163\fprq2 Baskerville Italic (Vietnamese);}{\f2081\fbidi \fnil\fcharset238\fprq2 Baskerville SemiBold CE;}{\f2082\fbidi \fnil\fcharset204\fprq2 Baskerville SemiBold Cyr;}{\f2084\fbidi \fnil\fcharset161\fprq2 Baskerville SemiBold Greek;}{\f2085\fbidi \fnil\fcharset162\fprq2 Baskerville SemiBold Tur;}{\f2088\fbidi \fnil\fcharset186\fprq2 Baskerville SemiBold Baltic;}{\f2089\fbidi \fnil\fcharset163\fprq2 Baskerville SemiBold (Vietnamese);}{\f2091\fbidi \fnil\fcharset238\fprq2 Baskerville SemiBold Italic CE;}{\f2092\fbidi \fnil\fcharset204\fprq2 Baskerville SemiBold Italic Cyr;}{\f2094\fbidi \fnil\fcharset161\fprq2 Baskerville SemiBold Italic Greek;}{\f2095\fbidi \fnil\fcharset162\fprq2 Baskerville SemiBold Italic Tur;}{\f2098\fbidi \fnil\fcharset186\fprq2 Baskerville SemiBold Italic Baltic;}{\f2099\fbidi \fnil\fcharset163\fprq2 Baskerville SemiBold Italic (Vietnamese);}{\f2141\fbidi \fnil\fcharset238\fprq2 Big Caslon CE;}{\f2144\fbidi \fnil\fcharset161\fprq2 Big Caslon Greek;}{\f2145\fbidi \fnil\fcharset162\fprq2 Big Caslon Tur;}{\f2146\fbidi \fnil\fcharset177\fprq2 Big Caslon (Hebrew);}{\f2147\fbidi \fnil\fcharset178\fprq2 Big Caslon (Arabid);}{\f2148\fbidi \fnil\fcharset186\fprq2 Big Caslon Baltic;}{\f2149\fbidi \fnil\fcharset163\fprq2 Big Caslon (Vietnamese);}{\f2315\fbidi \fnil\fcharset162\fprq2 Bradley Hand ITC TT-Bold Tur;}{\f2319\fbidi \fnil\fcharset163\fprq2 Bradley Hand ITC TT-Bold (Vietnamese);}{\f2341\fbidi \fnil\fcharset238\fprq2 Brush Script MT Italic CE;}{\f2344\fbidi \fnil\fcharset161\fprq2 Brush Script MT Italic Greek;}{\f2345\fbidi \fnil\fcharset162\fprq2 Brush Script MT Italic Tur;}{\f2346\fbidi \fnil\fcharset177\fprq2 Brush Script MT Italic (Hebrew);}{\f2350\fbidi \fnil\fcharset222\fprq2 Brush Script MT Italic (That);}{\f2361\fbidi \fnil\fcharset238\fprq2 Calibri Bold CE;}{\f2362\fbidi \fnil\fcharset204\fprq2 Calibri Bold Cyr;}{\f2364\fbidi \fnil\fcharset161\fprq2 Calibri Bold Greek;}{\f2365\fbidi \fnil\fcharset162\fprq2 Calibri Bold Tur;}{\f2368\fbidi \fnil\fcharset186\fprq2 Calibri Bold Baltic;}{\f2369\fbidi \fnil\fcharset163\fprq2 Calibri Bold (Vietnamese);}{\f2371\fbidi \fnil\fcharset238\fprq2 Calibri Bold Italic CE;}{\f2372\fbidi \fnil\fcharset204\fprq2 Calibri Bold Italic Cyr;}{\f2374\fbidi \fnil\fcharset161\fprq2 Calibri Bold Italic Greek;}{\f2375\fbidi \fnil\fcharset162\fprq2 Calibri Bold Italic Tur;}{\f2378\fbidi \fnil\fcharset186\fprq2 Calibri Bold Italic Baltic;}{\f2379\fbidi \fnil\fcharset163\fprq2 Calibri Bold Italic (Vietnamese);}{\f2381\fbidi \fnil\fcharset238\fprq2 Calibri Italic CE;}{\f2382\fbidi \fnil\fcharset204\fprq2 Calibri Italic Cyr;}{\f2384\fbidi \fnil\fcharset161\fprq2 Calibri Italic Greek;}{\f2385\fbidi \fnil\fcharset162\fprq2 Calibri Italic Tur;}{\f2388\fbidi \fnil\fcharset186\fprq2 Calibri Italic Baltic;}{\f2389\fbidi \fnil\fcharset163\fprq2 Calibri Italic (Vietnamese);}{\f2391\fbidi \fnil\fcharset238\fprq2 Calibri Light CE;}{\f2392\fbidi \fnil\fcharset204\fprq2 Calibri Light Cyr;}{\f2394\fbidi \fnil\fcharset161\fprq2 Calibri Light Greek;}{\f2395\fbidi \fnil\fcharset162\fprq2 Calibri Light Tur;}{\f2398\fbidi \fnil\fcharset186\fprq2 Calibri Light Baltic;}{\f2411\fbidi \fnil\fcharset238\fprq2 Cambria Bold CE;}{\f2412\fbidi \fnil\fcharset204\fprq2 Cambria Bold Cyr;}{\f2414\fbidi \fnil\fcharset161\fprq2 Cambria Bold Greek;}{\f2415\fbidi \fnil\fcharset162\fprq2 Cambria Bold Tur;}{\f2418\fbidi \fnil\fcharset186\fprq2 Cambria Bold Baltic;}{\f2419\fbidi \fnil\fcharset163\fprq2 Cambria Bold (Vietnamese);}{\f2421\fbidi \fnil\fcharset238\fprq2 Cambria Bold Italic CE;}{\f2422\fbidi \fnil\fcharset204\fprq2 Cambria Bold Italic Cyr;}{\f2424\fbidi \fnil\fcharset161\fprq2 Cambria Bold Italic Greek;}{\f2425\fbidi \fnil\fcharset162\fprq2 Cambria Bold Italic Tur;}{\f2428\fbidi \fnil\fcharset186\fprq2 Cambria Bold Italic Baltic;}{\f2429\fbidi \fnil\fcharset163\fprq2 Cambria Bold Italic (Vietnamese);}{\f2431\fbidi \fnil\fcharset238\fprq2 Cambria Italic CE;}{\f2432\fbidi \fnil\fcharset204\fprq2 Cambria Italic Cyr;}{\f2434\fbidi \fnil\fcharset161\fprq2 Cambria Italic Greek;}{\f2435\fbidi \fnil\fcharset162\fprq2 Cambria Italic Tur;}{\f2438\fbidi \fnil\fcharset186\fprq2 Cambria Italic Baltic;}{\f2439\fbidi \fnil\fcharset163\fprq2 Cambria Italic (Vietnamese);}{\f2441\fbidi \fnil\fcharset238\fprq2 Candara CE;}{\f2442\fbidi \fnil\fcharset204\fprq2 Candara Cyr;}{\f2444\fbidi \fnil\fcharset161\fprq2 Candara Greek;}{\f2445\fbidi \fnil\fcharset162\fprq2 Candara Tur;}{\f2448\fbidi \fnil\fcharset186\fprq2 Candara Baltic;}{\f2449\fbidi \fnil\fcharset163\fprq2 Candara (Vietnamese);}{\f2451\fbidi \fnil\fcharset238\fprq2 Candara Bold CE;}{\f2452\fbidi \fnil\fcharset204\fprq2 Candara Bold Cyr;}{\f2454\fbidi \fnil\fcharset161\fprq2 Candara Bold Greek;}{\f2455\fbidi \fnil\fcharset162\fprq2 Candara Bold Tur;}{\f2458\fbidi \fnil\fcharset186\fprq2 Candara Bold Baltic;}{\f2459\fbidi \fnil\fcharset163\fprq2 Candara Bold (Vietnamese);}{\f2461\fbidi \fnil\fcharset238\fprq2 Candara Bold Italic CE;}{\f2462\fbidi \fnil\fcharset204\fprq2 Candara Bold Italic Cyr;}{\f2464\fbidi \fnil\fcharset161\fprq2 Candara Bold Italic Greek;}{\f2465\fbidi \fnil\fcharset162\fprq2 Candara Bold Italic Tur;}{\f2468\fbidi \fnil\fcharset186\fprq2 Candara Bold Italic Baltic;}{\f2469\fbidi \fnil\fcharset163\fprq2 Candara Bold Italic (Vietnamese);}{\f2471\fbidi \fnil\fcharset238\fprq2 Candara Italic CE;}{\f2472\fbidi \fnil\fcharset204\fprq2 Candara Italic Cyr;}{\f2474\fbidi \fnil\fcharset161\fprq2 Candara Italic Greek;}{\f2475\fbidi \fnil\fcharset162\fprq2 Candara Italic Tur;}{\f2478\fbidi \fnil\fcharset186\fprq2 Candara Italic Baltic;}{\f2479\fbidi \fnil\fcharset163\fprq2 Candara Italic (Vietnamese);}{\f2571\fbidi \fnil\fcharset238\fprq2 Chaparral Pro CE;}{\f2575\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Tur;}{\f2578\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Baltic;}{\f2581\fbidi \fnil\fcharset238\fprq2 Chaparral Pro Bold CE;}{\f2585\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Bold Tur;}{\f2588\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Bold Baltic;}{\f2591\fbidi \fnil\fcharset238\fprq2 Chaparral Pro Bold Ital CE;}{\f2595\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Bold Ital Tur;}{\f2598\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Bold Ital Baltic;}{\f2601\fbidi \fnil\fcharset238\fprq2 Chaparral Pro Ital CE;}{\f2605\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Ital Tur;}{\f2608\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Ital Baltic;}{\f2611\fbidi \fnil\fcharset238\fprq2 Chaparral Pro Light Ital CE;}{\f2615\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Light Ital Tur;}{\f2618\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Light Ital Baltic;}{\f2635\fbidi \fnil\fcharset162\fprq2 Charter Black Tur;}{\f2645\fbidi \fnil\fcharset162\fprq2 Charter Black Italic Tur;}{\f2655\fbidi \fnil\fcharset162\fprq2 Charter Bold Tur;}{\f2665\fbidi \fnil\fcharset162\fprq2 Charter Bold Italic Tur;}{\f2675\fbidi \fnil\fcharset162\fprq2 Charter Italic Tur;}{\f2685\fbidi \fnil\fcharset162\fprq2 Charter Roman Tur;}{\f2691\fbidi \fnil\fcharset238\fprq2 Cochin CE;}{\f2692\fbidi \fnil\fcharset204\fprq2 Cochin Cyr;}{\f2711\fbidi \fnil\fcharset238\fprq2 Comic Sans MS CE;}{\f2712\fbidi \fnil\fcharset204\fprq2 Comic Sans MS Cyr;}{\f2714\fbidi \fnil\fcharset161\fprq2 Comic Sans MS Greek;}{\f2715\fbidi \fnil\fcharset162\fprq2 Comic Sans MS Tur;}{\f2718\fbidi \fnil\fcharset186\fprq2 Comic Sans MS Baltic;}{\f2721\fbidi \fnil\fcharset238\fprq2 Comic Sans MS Bold CE;}{\f2722\fbidi \fnil\fcharset204\fprq2 Comic Sans MS Bold Cyr;}{\f2724\fbidi \fnil\fcharset161\fprq2 Comic Sans MS Bold Greek;}{\f2725\fbidi \fnil\fcharset162\fprq2 Comic Sans MS Bold Tur;}{\f2728\fbidi \fnil\fcharset186\fprq2 Comic Sans MS Bold Baltic;}{\f2731\fbidi \fnil\fcharset238\fprq2 Consolas CE;}{\f2732\fbidi \fnil\fcharset204\fprq2 Consolas Cyr;}{\f2734\fbidi \fnil\fcharset161\fprq2 Consolas Greek;}{\f2735\fbidi \fnil\fcharset162\fprq2 Consolas Tur;}{\f2738\fbidi \fnil\fcharset186\fprq2 Consolas Baltic;}{\f2739\fbidi \fnil\fcharset163\fprq2 Consolas (Vietnamese);}{\f2741\fbidi \fnil\fcharset238\fprq2 Consolas Bold CE;}{\f2742\fbidi \fnil\fcharset204\fprq2 Consolas Bold Cyr;}{\f2744\fbidi \fnil\fcharset161\fprq2 Consolas Bold Greek;}{\f2745\fbidi \fnil\fcharset162\fprq2 Consolas Bold Tur;}{\f2748\fbidi \fnil\fcharset186\fprq2 Consolas Bold Baltic;}{\f2749\fbidi \fnil\fcharset163\fprq2 Consolas Bold (Vietnamese);}{\f2751\fbidi \fnil\fcharset238\fprq2 Consolas Bold Italic CE;}{\f2752\fbidi \fnil\fcharset204\fprq2 Consolas Bold Italic Cyr;}{\f2754\fbidi \fnil\fcharset161\fprq2 Consolas Bold Italic Greek;}{\f2755\fbidi \fnil\fcharset162\fprq2 Consolas Bold Italic Tur;}{\f2758\fbidi \fnil\fcharset186\fprq2 Consolas Bold Italic Baltic;}{\f2759\fbidi \fnil\fcharset163\fprq2 Consolas Bold Italic (Vietnamese);}{\f2761\fbidi \fnil\fcharset238\fprq2 Consolas Italic CE;}{\f2762\fbidi \fnil\fcharset204\fprq2 Consolas Italic Cyr;}{\f2764\fbidi \fnil\fcharset161\fprq2 Consolas Italic Greek;}{\f2765\fbidi \fnil\fcharset162\fprq2 Consolas Italic Tur;}{\f2768\fbidi \fnil\fcharset186\fprq2 Consolas Italic Baltic;}{\f2769\fbidi \fnil\fcharset163\fprq2 Consolas Italic (Vietnamese);}{\f2771\fbidi \fnil\fcharset238\fprq2 Constantia CE;}{\f2772\fbidi \fnil\fcharset204\fprq2 Constantia Cyr;}{\f2774\fbidi \fnil\fcharset161\fprq2 Constantia Greek;}{\f2775\fbidi \fnil\fcharset162\fprq2 Constantia Tur;}{\f2778\fbidi \fnil\fcharset186\fprq2 Constantia Baltic;}{\f2779\fbidi \fnil\fcharset163\fprq2 Constantia (Vietnamese);}{\f2781\fbidi \fnil\fcharset238\fprq2 Constantia Bold CE;}{\f2782\fbidi \fnil\fcharset204\fprq2 Constantia Bold Cyr;}{\f2784\fbidi \fnil\fcharset161\fprq2 Constantia Bold Greek;}{\f2785\fbidi \fnil\fcharset162\fprq2 Constantia Bold Tur;}{\f2788\fbidi \fnil\fcharset186\fprq2 Constantia Bold Baltic;}{\f2789\fbidi \fnil\fcharset163\fprq2 Constantia Bold (Vietnamese);}{\f2791\fbidi \fnil\fcharset238\fprq2 Constantia Bold Italic CE;}{\f2792\fbidi \fnil\fcharset204\fprq2 Constantia Bold Italic Cyr;}{\f2794\fbidi \fnil\fcharset161\fprq2 Constantia Bold Italic Greek;}{\f2795\fbidi \fnil\fcharset162\fprq2 Constantia Bold Italic Tur;}{\f2798\fbidi \fnil\fcharset186\fprq2 Constantia Bold Italic Baltic;}{\f2799\fbidi \fnil\fcharset163\fprq2 Constantia Bold Italic (Vietnamese);}{\f2801\fbidi \fnil\fcharset238\fprq2 Constantia Italic CE;}{\f2802\fbidi \fnil\fcharset204\fprq2 Constantia Italic Cyr;}{\f2804\fbidi \fnil\fcharset161\fprq2 Constantia Italic Greek;}{\f2805\fbidi \fnil\fcharset162\fprq2 Constantia Italic Tur;}{\f2808\fbidi \fnil\fcharset186\fprq2 Constantia Italic Baltic;}{\f2809\fbidi \fnil\fcharset163\fprq2 Constantia Italic (Vietnamese);}{\f2845\fbidi \fnil\fcharset162\fprq2 Copperplate Tur;}{\f2849\fbidi \fnil\fcharset163\fprq2 Copperplate (Vietnamese);}{\f2855\fbidi \fnil\fcharset162\fprq2 Copperplate Bold Tur;}{\f2859\fbidi \fnil\fcharset163\fprq2 Copperplate Bold (Vietnamese);}{\f2885\fbidi \fnil\fcharset162\fprq2 Copperplate Light Tur;}{\f2889\fbidi \fnil\fcharset163\fprq2 Copperplate Light (Vietnamese);}{\f2891\fbidi \fnil\fcharset238\fprq2 Corbel CE;}{\f2892\fbidi \fnil\fcharset204\fprq2 Corbel Cyr;}{\f2894\fbidi \fnil\fcharset161\fprq2 Corbel Greek;}{\f2895\fbidi \fnil\fcharset162\fprq2 Corbel Tur;}{\f2898\fbidi \fnil\fcharset186\fprq2 Corbel Baltic;}{\f2899\fbidi \fnil\fcharset163\fprq2 Corbel (Vietnamese);}{\f2901\fbidi \fnil\fcharset238\fprq2 Corbel Bold CE;}{\f2902\fbidi \fnil\fcharset204\fprq2 Corbel Bold Cyr;}{\f2904\fbidi \fnil\fcharset161\fprq2 Corbel Bold Greek;}{\f2905\fbidi \fnil\fcharset162\fprq2 Corbel Bold Tur;}{\f2908\fbidi \fnil\fcharset186\fprq2 Corbel Bold Baltic;}{\f2909\fbidi \fnil\fcharset163\fprq2 Corbel Bold (Vietnamese);}{\f2911\fbidi \fnil\fcharset238\fprq2 Corbel Bold Italic CE;}{\f2912\fbidi \fnil\fcharset204\fprq2 Corbel Bold Italic Cyr;}{\f2914\fbidi \fnil\fcharset161\fprq2 Corbel Bold Italic Greek;}{\f2915\fbidi \fnil\fcharset162\fprq2 Corbel Bold Italic Tur;}{\f2918\fbidi \fnil\fcharset186\fprq2 Corbel Bold Italic Baltic;}{\f2919\fbidi \fnil\fcharset163\fprq2 Corbel Bold Italic (Vietnamese);}{\f2921\fbidi \fnil\fcharset238\fprq2 Corbel Italic CE;}{\f2922\fbidi \fnil\fcharset204\fprq2 Corbel Italic Cyr;}{\f2924\fbidi \fnil\fcharset161\fprq2 Corbel Italic Greek;}{\f2925\fbidi \fnil\fcharset162\fprq2 Corbel Italic Tur;}{\f2928\fbidi \fnil\fcharset186\fprq2 Corbel Italic Baltic;}{\f2929\fbidi \fnil\fcharset163\fprq2 Corbel Italic (Vietnamese);}{\f2931\fbidi \fnil\fcharset238\fprq2 Courier New Bold CE;}{\f2932\fbidi \fnil\fcharset204\fprq2 Courier New Bold Cyr;}{\f2934\fbidi \fnil\fcharset161\fprq2 Courier New Bold Greek;}{\f2935\fbidi \fnil\fcharset162\fprq2 Courier New Bold Tur;}{\f2936\fbidi \fnil\fcharset177\fprq2 Courier New Bold (Hebrew);}{\f2937\fbidi \fnil\fcharset178\fprq2 Courier New Bold (Arabid);}{\f2938\fbidi \fnil\fcharset186\fprq2 Courier New Bold Baltic;}{\f2939\fbidi \fnil\fcharset163\fprq2 Courier New Bold (Vietnamese);}{\f2941\fbidi \fnil\fcharset238\fprq2 Courier New Bold Italic CE;}{\f2942\fbidi \fnil\fcharset204\fprq2 Courier New Bold Italic Cyr;}{\f2944\fbidi \fnil\fcharset161\fprq2 Courier New Bold Italic Greek;}{\f2945\fbidi \fnil\fcharset162\fprq2 Courier New Bold Italic Tur;}{\f2946\fbidi \fnil\fcharset177\fprq2 Courier New Bold Italic (Hebrew);}{\f2948\fbidi \fnil\fcharset186\fprq2 Courier New Bold Italic Baltic;}{\f2949\fbidi \fnil\fcharset163\fprq2 Courier New Bold Italic (Vietnamese);}{\f2951\fbidi \fnil\fcharset238\fprq2 Courier New Italic CE;}{\f2952\fbidi \fnil\fcharset204\fprq2 Courier New Italic Cyr;}{\f2954\fbidi \fnil\fcharset161\fprq2 Courier New Italic Greek;}{\f2955\fbidi \fnil\fcharset162\fprq2 Courier New Italic Tur;}{\f2956\fbidi \fnil\fcharset177\fprq2 Courier New Italic (Hebrew);}{\f2958\fbidi \fnil\fcharset186\fprq2 Courier New Italic Baltic;}{\f2959\fbidi \fnil\fcharset163\fprq2 Courier New Italic (Vietnamese);}{\f2987\fbidi \fnil\fcharset178\fprq2 Damascus Bold (Arabid);}{\f3045\fbidi \fnil\fcharset162\fprq2 DIN Alternate Bold Tur;}{\f3049\fbidi \fnil\fcharset163\fprq2 DIN Alternate Bold (Vietnamese);}{\f3061\fbidi \fnil\fcharset238\fprq2 Didot CE;}{\f3064\fbidi \fnil\fcharset161\fprq2 Didot Greek;}{\f3065\fbidi \fnil\fcharset162\fprq2 Didot Tur;}{\f3066\fbidi \fnil\fcharset177\fprq2 Didot (Hebrew);}{\f3067\fbidi \fnil\fcharset178\fprq2 Didot (Arabid);}{\f3068\fbidi \fnil\fcharset186\fprq2 Didot Baltic;}{\f3069\fbidi \fnil\fcharset163\fprq2 Didot (Vietnamese);}{\f3091\fbidi \fnil\fcharset238\fprq2 Euphemia UCAS CE;}{\f3095\fbidi \fnil\fcharset162\fprq2 Euphemia UCAS Tur;}{\f3096\fbidi \fnil\fcharset177\fprq2 Euphemia UCAS (Hebrew);}{\f3097\fbidi \fnil\fcharset178\fprq2 Euphemia UCAS (Arabid);}{\f3098\fbidi \fnil\fcharset186\fprq2 Euphemia UCAS Baltic;}{\f3099\fbidi \fnil\fcharset163\fprq2 Euphemia UCAS (Vietnamese);}{\f3101\fbidi \fnil\fcharset238\fprq2 Euphemia UCAS Bold CE;}{\f3105\fbidi \fnil\fcharset162\fprq2 Euphemia UCAS Bold Tur;}{\f3106\fbidi \fnil\fcharset177\fprq2 Euphemia UCAS Bold (Hebrew);}{\f3107\fbidi \fnil\fcharset178\fprq2 Euphemia UCAS Bold (Arabid);}{\f3108\fbidi \fnil\fcharset186\fprq2 Euphemia UCAS Bold Baltic;}{\f3109\fbidi \fnil\fcharset163\fprq2 Euphemia UCAS Bold (Vietnamese);}{\f3111\fbidi \fnil\fcharset238\fprq2 Euphemia UCAS Italic CE;}{\f3115\fbidi \fnil\fcharset162\fprq2 Euphemia UCAS Italic Tur;}{\f3116\fbidi \fnil\fcharset177\fprq2 Euphemia UCAS Italic (Hebrew);}{\f3117\fbidi \fnil\fcharset178\fprq2 Euphemia UCAS Italic (Arabid);}{\f3118\fbidi \fnil\fcharset186\fprq2 Euphemia UCAS Italic Baltic;}{\f3119\fbidi \fnil\fcharset163\fprq2 Euphemia UCAS Italic (Vietnamese);}{\f3141\fbidi \fnil\fcharset238\fprq2 Franklin Gothic Book CE;}{\f3142\fbidi \fnil\fcharset204\fprq2 Franklin Gothic Book Cyr;}{\f3144\fbidi \fnil\fcharset161\fprq2 Franklin Gothic Book Greek;}{\f3145\fbidi \fnil\fcharset162\fprq2 Franklin Gothic Book Tur;}{\f3148\fbidi \fnil\fcharset186\fprq2 Franklin Gothic Book Baltic;}{\f3151\fbidi \fnil\fcharset238\fprq2 Franklin Gothic Book Italic CE;}{\f3152\fbidi \fnil\fcharset204\fprq2 Franklin Gothic Book Italic Cyr;}{\f3154\fbidi \fnil\fcharset161\fprq2 Franklin Gothic Book Italic Greek;}{\f3155\fbidi \fnil\fcharset162\fprq2 Franklin Gothic Book Italic Tur;}{\f3158\fbidi \fnil\fcharset186\fprq2 Franklin Gothic Book Italic Baltic;}{\f3161\fbidi \fnil\fcharset238\fprq2 Franklin Gothic Medium CE;}{\f3162\fbidi \fnil\fcharset204\fprq2 Franklin Gothic Medium Cyr;}{\f3164\fbidi \fnil\fcharset161\fprq2 Franklin Gothic Medium Greek;}{\f3165\fbidi \fnil\fcharset162\fprq2 Franklin Gothic Medium Tur;}{\f3168\fbidi \fnil\fcharset186\fprq2 Franklin Gothic Medium Baltic;}{\f3171\fbidi \fnil\fcharset238\fprq2 Franklin Gothic Medium Italic CE;}{\f3172\fbidi \fnil\fcharset204\fprq2 Franklin Gothic Medium Italic Cyr;}{\f3174\fbidi \fnil\fcharset161\fprq2 Franklin Gothic Medium Italic Greek;}{\f3175\fbidi \fnil\fcharset162\fprq2 Franklin Gothic Medium Italic Tur;}{\f3178\fbidi \fnil\fcharset186\fprq2 Franklin Gothic Medium Italic Baltic;}{\f3181\fbidi \fnil\fcharset238\fprq2 Futura CE;}{\f3184\fbidi \fnil\fcharset161\fprq2 Futura Greek;}{\f3185\fbidi \fnil\fcharset162\fprq2 Futura Tur;}{\f3186\fbidi \fnil\fcharset177\fprq2 Futura (Hebrew);}{\f3187\fbidi \fnil\fcharset178\fprq2 Futura (Arabid);}{\f3188\fbidi \fnil\fcharset186\fprq2 Futura Baltic;}{\f3189\fbidi \fnil\fcharset163\fprq2 Futura (Vietnamese);}{\f3191\fbidi \fnil\fcharset238\fprq2 Futura Condensed CE;}{\f3194\fbidi \fnil\fcharset161\fprq2 Futura Condensed Greek;}{\f3195\fbidi \fnil\fcharset162\fprq2 Futura Condensed Tur;}{\f3196\fbidi \fnil\fcharset177\fprq2 Futura Condensed (Hebrew);}{\f3197\fbidi \fnil\fcharset178\fprq2 Futura Condensed (Arabid);}{\f3198\fbidi \fnil\fcharset186\fprq2 Futura Condensed Baltic;}{\f3199\fbidi \fnil\fcharset163\fprq2 Futura Condensed (Vietnamese);}{\f3201\fbidi \fnil\fcharset238\fprq2 Gabriola CE;}{\f3202\fbidi \fnil\fcharset204\fprq2 Gabriola Cyr;}{\f3204\fbidi \fnil\fcharset161\fprq2 Gabriola Greek;}{\f3205\fbidi \fnil\fcharset162\fprq2 Gabriola Tur;}{\f3208\fbidi \fnil\fcharset186\fprq2 Gabriola Baltic;}{\f3221\fbidi \fnil\fcharset238\fprq2 Georgia CE;}{\f3222\fbidi \fnil\fcharset204\fprq2 Georgia Cyr;}{\f3224\fbidi \fnil\fcharset161\fprq2 Georgia Greek;}{\f3225\fbidi \fnil\fcharset162\fprq2 Georgia Tur;}{\f3228\fbidi \fnil\fcharset186\fprq2 Georgia Baltic;}{\f3231\fbidi \fnil\fcharset238\fprq2 Georgia Bold CE;}{\f3232\fbidi \fnil\fcharset204\fprq2 Georgia Bold Cyr;}{\f3234\fbidi \fnil\fcharset161\fprq2 Georgia Bold Greek;}{\f3235\fbidi \fnil\fcharset162\fprq2 Georgia Bold Tur;}{\f3238\fbidi \fnil\fcharset186\fprq2 Georgia Bold Baltic;}{\f3241\fbidi \fnil\fcharset238\fprq2 Georgia Bold Italic CE;}{\f3242\fbidi \fnil\fcharset204\fprq2 Georgia Bold Italic Cyr;}{\f3244\fbidi \fnil\fcharset161\fprq2 Georgia Bold Italic Greek;}{\f3245\fbidi \fnil\fcharset162\fprq2 Georgia Bold Italic Tur;}{\f3248\fbidi \fnil\fcharset186\fprq2 Georgia Bold Italic Baltic;}{\f3251\fbidi \fnil\fcharset238\fprq2 Georgia Italic CE;}{\f3252\fbidi \fnil\fcharset204\fprq2 Georgia Italic Cyr;}{\f3254\fbidi \fnil\fcharset161\fprq2 Georgia Italic Greek;}{\f3255\fbidi \fnil\fcharset162\fprq2 Georgia Italic Tur;}{\f3258\fbidi \fnil\fcharset186\fprq2 Georgia Italic Baltic;}{\f3271\fbidi \fnil\fcharset238\fprq2 Gill Sans CE;}{\f3272\fbidi \fnil\fcharset204\fprq2 Gill Sans Cyr;}{\f3275\fbidi \fnil\fcharset162\fprq2 Gill Sans Tur;}{\f3276\fbidi \fnil\fcharset177\fprq2 Gill Sans (Hebrew);}{\f3277\fbidi \fnil\fcharset178\fprq2 Gill Sans (Arabid);}{\f3278\fbidi \fnil\fcharset186\fprq2 Gill Sans Baltic;}{\f3279\fbidi \fnil\fcharset163\fprq2 Gill Sans (Vietnamese);}{\f3281\fbidi \fnil\fcharset238\fprq2 Gill Sans Light CE;}{\f3282\fbidi \fnil\fcharset204\fprq2 Gill Sans Light Cyr;}{\f3285\fbidi \fnil\fcharset162\fprq2 Gill Sans Light Tur;}{\f3286\fbidi \fnil\fcharset177\fprq2 Gill Sans Light (Hebrew);}{\f3287\fbidi \fnil\fcharset178\fprq2 Gill Sans Light (Arabid);}{\f3288\fbidi \fnil\fcharset186\fprq2 Gill Sans Light Baltic;}{\f3289\fbidi \fnil\fcharset163\fprq2 Gill Sans Light (Vietnamese);}{\f3291\fbidi \fnil\fcharset238\fprq2 Gill Sans MT CE;}{\f3301\fbidi \fnil\fcharset238\fprq2 Gill Sans MT Bold CE;}{\f3311\fbidi \fnil\fcharset238\fprq2 Gill Sans MT Bold Italic CE;}{\f3321\fbidi \fnil\fcharset238\fprq2 Gill Sans MT Italic CE;}{\f3332\fbidi \fnil\fcharset204\fprq2 Gill Sans SemiBold Cyr;}{\f3342\fbidi \fnil\fcharset204\fprq2 Gill Sans SemiBold Italic Cyr;}{\f3351\fbidi \fnil\fcharset238\fprq2 Gill Sans UltraBold CE;}{\f3352\fbidi \fnil\fcharset204\fprq2 Gill Sans UltraBold Cyr;}{\f3354\fbidi \fnil\fcharset161\fprq2 Gill Sans UltraBold Greek;}{\f3355\fbidi \fnil\fcharset162\fprq2 Gill Sans UltraBold Tur;}{\f3358\fbidi \fnil\fcharset186\fprq2 Gill Sans UltraBold Baltic;}{\f3359\fbidi \fnil\fcharset163\fprq2 Gill Sans UltraBold (Vietnamese);}{\f3501\fbidi \fnil\fcharset238\fprq2 Helvetica Neue Light CE;}{\f3502\fbidi \fnil\fcharset204\fprq2 Helvetica Neue Light Cyr;}{\f3511\fbidi \fnil\fcharset238\fprq2 Helvetica Neue Medium CE;}{\f3514\fbidi \fnil\fcharset161\fprq2 Helvetica Neue Medium Greek;}{\f3515\fbidi \fnil\fcharset162\fprq2 Helvetica Neue Medium Tur;}{\f3518\fbidi \fnil\fcharset186\fprq2 Helvetica Neue Medium Baltic;}{\f3521\fbidi \fnil\fcharset238\fprq2 Helvetica Neue Thin CE;}{\f3522\fbidi \fnil\fcharset204\fprq2 Helvetica Neue Thin Cyr;}{\f3524\fbidi \fnil\fcharset161\fprq2 Helvetica Neue Thin Greek;}{\f3525\fbidi \fnil\fcharset162\fprq2 Helvetica Neue Thin Tur;}{\f3528\fbidi \fnil\fcharset186\fprq2 Helvetica Neue Thin Baltic;}{\f3561\fbidi \fnil\fcharset238\fprq2 Hoefler Text CE;}{\f3562\fbidi \fnil\fcharset204\fprq2 Hoefler Text Cyr;}{\f3565\fbidi \fnil\fcharset162\fprq2 Hoefler Text Tur;}{\f3568\fbidi \fnil\fcharset186\fprq2 Hoefler Text Baltic;}{\f3569\fbidi \fnil\fcharset163\fprq2 Hoefler Text (Vietnamese);}{\f3573\fbidi \fnil\fcharset0\fprq2 Hoefler Text Ornaments;}{\f3576\fbidi \fnil\fcharset177\fprq2 Hoefler Text Ornaments (Hebrew);}{\f3577\fbidi \fnil\fcharset178\fprq2 Hoefler Text Ornaments (Arabid);}{\f3580\fbidi \fnil\fcharset222\fprq2 Hoefler Text Ornaments (That);}{\f3581\fbidi \fnil\fcharset238\fprq2 Impact CE;}{\f3582\fbidi \fnil\fcharset204\fprq2 Impact Cyr;}{\f3584\fbidi \fnil\fcharset161\fprq2 Impact Greek;}{\f3585\fbidi \fnil\fcharset162\fprq2 Impact Tur;}{\f3588\fbidi \fnil\fcharset186\fprq2 Impact Baltic;}{\f3611\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Black CE;}{\f3615\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Black Tur;}{\f3618\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Black Baltic;}{\f3621\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Black Italic CE;}{\f3625\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Black Italic Tur;}{\f3628\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Black Italic Baltic;}{\f3631\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Bold CE;}{\f3635\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Bold Tur;}{\f3638\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Bold Baltic;}{\f3641\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Bold Italic CE;}{\f3645\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Bold Italic Tur;}{\f3648\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Bold Italic Baltic;}{\f3651\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Italic CE;}{\f3655\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Italic Tur;}{\f3658\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Italic Baltic;}{\f3661\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Roman CE;}{\f3665\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Roman Tur;}{\f3668\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Roman Baltic;}{\f3671\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Titling CE;}{\f3675\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Titling Tur;}{\f3678\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Titling Baltic;}{\f3791\fbidi \fnil\fcharset238\fprq2 Krungthep CE;}{\f3795\fbidi \fnil\fcharset162\fprq2 Krungthep Tur;}{\f3798\fbidi \fnil\fcharset186\fprq2 Krungthep Baltic;}{\f3799\fbidi \fnil\fcharset163\fprq2 Krungthep (Vietnamese);}{\f3951\fbidi \fnil\fcharset238\fprq2 Lithos Pro Black CE;}{\f3954\fbidi \fnil\fcharset161\fprq2 Lithos Pro Black Greek;}{\f3955\fbidi \fnil\fcharset162\fprq2 Lithos Pro Black Tur;}{\f3958\fbidi \fnil\fcharset186\fprq2 Lithos Pro Black Baltic;}{\f3961\fbidi \fnil\fcharset238\fprq2 Lithos Pro Regular CE;}{\f3964\fbidi \fnil\fcharset161\fprq2 Lithos Pro Regular Greek;}{\f3965\fbidi \fnil\fcharset162\fprq2 Lithos Pro Regular Tur;}{\f3968\fbidi \fnil\fcharset186\fprq2 Lithos Pro Regular Baltic;}{\f4001\fbidi \fnil\fcharset238\fprq2 Lucida Console CE;}{\f4002\fbidi \fnil\fcharset204\fprq2 Lucida Console Cyr;}{\f4004\fbidi \fnil\fcharset161\fprq2 Lucida Console Greek;}{\f4005\fbidi \fnil\fcharset162\fprq2 Lucida Console Tur;}{\f4021\fbidi \fnil\fcharset238\fprq2 Lucida Grande CE;}{\f4022\fbidi \fnil\fcharset204\fprq2 Lucida Grande Cyr;}{\f4024\fbidi \fnil\fcharset161\fprq2 Lucida Grande Greek;}{\f4025\fbidi \fnil\fcharset162\fprq2 Lucida Grande Tur;}{\f4026\fbidi \fnil\fcharset177\fprq2 Lucida Grande (Hebrew);}{\f4028\fbidi \fnil\fcharset186\fprq2 Lucida Grande Baltic;}{\f4029\fbidi \fnil\fcharset163\fprq2 Lucida Grande (Vietnamese);}{\f4061\fbidi \fnil\fcharset238\fprq2 Lucida Sans Unicode CE;}{\f4062\fbidi \fnil\fcharset204\fprq2 Lucida Sans Unicode Cyr;}{\f4064\fbidi \fnil\fcharset161\fprq2 Lucida Sans Unicode Greek;}{\f4065\fbidi \fnil\fcharset162\fprq2 Lucida Sans Unicode Tur;}{\f4066\fbidi \fnil\fcharset177\fprq2 Lucida Sans Unicode (Hebrew);}{\f4068\fbidi \fnil\fcharset186\fprq2 Lucida Sans Unicode Baltic;}{\f4111\fbidi \fnil\fcharset238\fprq2 Marion Bold CE;}{\f4118\fbidi \fnil\fcharset186\fprq2 Marion Bold Baltic;}{\f4119\fbidi \fnil\fcharset163\fprq2 Marion Bold (Vietnamese);}{\f4121\fbidi \fnil\fcharset238\fprq2 Marion Italic CE;}{\f4128\fbidi \fnil\fcharset186\fprq2 Marion Italic Baltic;}{\f4129\fbidi \fnil\fcharset163\fprq2 Marion Italic (Vietnamese);}{\f4131\fbidi \fnil\fcharset238\fprq2 Marion Regular CE;}{\f4138\fbidi \fnil\fcharset186\fprq2 Marion Regular Baltic;}{\f4139\fbidi \fnil\fcharset163\fprq2 Marion Regular (Vietnamese);}{\f4145\fbidi \fnil\fcharset162\fprq2 Marker Felt Tur;}{\f4149\fbidi \fnil\fcharset163\fprq2 Marker Felt (Vietnamese);}{\f4171\fbidi \fnil\fcharset238\fprq2 Menlo Bold CE;}{\f4172\fbidi \fnil\fcharset204\fprq2 Menlo Bold Cyr;}{\f4174\fbidi \fnil\fcharset161\fprq2 Menlo Bold Greek;}{\f4175\fbidi \fnil\fcharset162\fprq2 Menlo Bold Tur;}{\f4177\fbidi \fnil\fcharset178\fprq2 Menlo Bold (Arabid);}{\f4178\fbidi \fnil\fcharset186\fprq2 Menlo Bold Baltic;}{\f4179\fbidi \fnil\fcharset163\fprq2 Menlo Bold (Vietnamese);}{\f4181\fbidi \fnil\fcharset238\fprq2 Menlo Bold Italic CE;}{\f4182\fbidi \fnil\fcharset204\fprq2 Menlo Bold Italic Cyr;}{\f4184\fbidi \fnil\fcharset161\fprq2 Menlo Bold Italic Greek;}{\f4185\fbidi \fnil\fcharset162\fprq2 Menlo Bold Italic Tur;}{\f4188\fbidi \fnil\fcharset186\fprq2 Menlo Bold Italic Baltic;}{\f4189\fbidi \fnil\fcharset163\fprq2 Menlo Bold Italic (Vietnamese);}{\f4191\fbidi \fnil\fcharset238\fprq2 Menlo Italic CE;}{\f4192\fbidi \fnil\fcharset204\fprq2 Menlo Italic Cyr;}{\f4194\fbidi \fnil\fcharset161\fprq2 Menlo Italic Greek;}{\f4195\fbidi \fnil\fcharset162\fprq2 Menlo Italic Tur;}{\f4198\fbidi \fnil\fcharset186\fprq2 Menlo Italic Baltic;}{\f4199\fbidi \fnil\fcharset163\fprq2 Menlo Italic (Vietnamese);}{\f4201\fbidi \fnil\fcharset238\fprq2 Menlo Regular CE;}{\f4202\fbidi \fnil\fcharset204\fprq2 Menlo Regular Cyr;}{\f4204\fbidi \fnil\fcharset161\fprq2 Menlo Regular Greek;}{\f4205\fbidi \fnil\fcharset162\fprq2 Menlo Regular Tur;}{\f4207\fbidi \fnil\fcharset178\fprq2 Menlo Regular (Arabid);}{\f4208\fbidi \fnil\fcharset186\fprq2 Menlo Regular Baltic;}{\f4209\fbidi \fnil\fcharset163\fprq2 Menlo Regular (Vietnamese);}{\f4231\fbidi \fnil\fcharset238\fprq2 Microsoft Sans Serif CE;}{\f4232\fbidi \fnil\fcharset204\fprq2 Microsoft Sans Serif Cyr;}{\f4234\fbidi \fnil\fcharset161\fprq2 Microsoft Sans Serif Greek;}{\f4235\fbidi \fnil\fcharset162\fprq2 Microsoft Sans Serif Tur;}{\f4236\fbidi \fnil\fcharset177\fprq2 Microsoft Sans Serif (Hebrew);}{\f4237\fbidi \fnil\fcharset178\fprq2 Microsoft Sans Serif (Arabid);}{\f4238\fbidi \fnil\fcharset186\fprq2 Microsoft Sans Serif Baltic;}{\f4239\fbidi \fnil\fcharset163\fprq2 Microsoft Sans Serif (Vietnamese);}{\f4240\fbidi \fnil\fcharset222\fprq2 Microsoft Sans Serif (That);}{\f4273\fbidi \fnil\fcharset0\fprq2 MingLiU-ExtB Western;}{\f4283\fbidi \fnil\fcharset0\fprq2 @MingLiU-ExtB Western;}{\f4293\fbidi \fnil\fcharset0\fprq2 MingLiU_HKSCS-ExtB Western;}{\f4303\fbidi \fnil\fcharset0\fprq2 @MingLiU_HKSCS-ExtB Western;}{\f4311\fbidi \fnil\fcharset238\fprq2 Minion Pro CE;}{\f4312\fbidi \fnil\fcharset204\fprq2 Minion Pro Cyr;}{\f4314\fbidi \fnil\fcharset161\fprq2 Minion Pro Greek;}{\f4315\fbidi \fnil\fcharset162\fprq2 Minion Pro Tur;}{\f4318\fbidi \fnil\fcharset186\fprq2 Minion Pro Baltic;}{\f4319\fbidi \fnil\fcharset163\fprq2 Minion Pro (Vietnamese);}{\f4321\fbidi \fnil\fcharset238\fprq2 Minion Pro Bold CE;}{\f4322\fbidi \fnil\fcharset204\fprq2 Minion Pro Bold Cyr;}{\f4324\fbidi \fnil\fcharset161\fprq2 Minion Pro Bold Greek;}{\f4325\fbidi \fnil\fcharset162\fprq2 Minion Pro Bold Tur;}{\f4328\fbidi \fnil\fcharset186\fprq2 Minion Pro Bold Baltic;}{\f4329\fbidi \fnil\fcharset163\fprq2 Minion Pro Bold (Vietnamese);}{\f4331\fbidi \fnil\fcharset238\fprq2 Minion Pro Bold Cond CE;}{\f4332\fbidi \fnil\fcharset204\fprq2 Minion Pro Bold Cond Cyr;}{\f4334\fbidi \fnil\fcharset161\fprq2 Minion Pro Bold Cond Greek;}{\f4335\fbidi \fnil\fcharset162\fprq2 Minion Pro Bold Cond Tur;}{\f4338\fbidi \fnil\fcharset186\fprq2 Minion Pro Bold Cond Baltic;}{\f4339\fbidi \fnil\fcharset163\fprq2 Minion Pro Bold Cond (Vietnamese);}{\f4341\fbidi \fnil\fcharset238\fprq2 Minion Pro Bold Cond Ital CE;}{\f4342\fbidi \fnil\fcharset204\fprq2 Minion Pro Bold Cond Ital Cyr;}{\f4344\fbidi \fnil\fcharset161\fprq2 Minion Pro Bold Cond Ital Greek;}{\f4345\fbidi \fnil\fcharset162\fprq2 Minion Pro Bold Cond Ital Tur;}{\f4348\fbidi \fnil\fcharset186\fprq2 Minion Pro Bold Cond Ital Baltic;}{\f4349\fbidi \fnil\fcharset163\fprq2 Minion Pro Bold Cond Ital (Vietnamese);}{\f4351\fbidi \fnil\fcharset238\fprq2 Minion Pro Bold Ital CE;}{\f4352\fbidi \fnil\fcharset204\fprq2 Minion Pro Bold Ital Cyr;}{\f4354\fbidi \fnil\fcharset161\fprq2 Minion Pro Bold Ital Greek;}{\f4355\fbidi \fnil\fcharset162\fprq2 Minion Pro Bold Ital Tur;}{\f4358\fbidi \fnil\fcharset186\fprq2 Minion Pro Bold Ital Baltic;}{\f4359\fbidi \fnil\fcharset163\fprq2 Minion Pro Bold Ital (Vietnamese);}{\f4361\fbidi \fnil\fcharset238\fprq2 Minion Pro Ital CE;}{\f4362\fbidi \fnil\fcharset204\fprq2 Minion Pro Ital Cyr;}{\f4364\fbidi \fnil\fcharset161\fprq2 Minion Pro Ital Greek;}{\f4365\fbidi \fnil\fcharset162\fprq2 Minion Pro Ital Tur;}{\f4368\fbidi \fnil\fcharset186\fprq2 Minion Pro Ital Baltic;}{\f4369\fbidi \fnil\fcharset163\fprq2 Minion Pro Ital (Vietnamese);}{\f4371\fbidi \fnil\fcharset238\fprq2 Minion Pro Med CE;}{\f4372\fbidi \fnil\fcharset204\fprq2 Minion Pro Med Cyr;}{\f4374\fbidi \fnil\fcharset161\fprq2 Minion Pro Med Greek;}{\f4375\fbidi \fnil\fcharset162\fprq2 Minion Pro Med Tur;}{\f4378\fbidi \fnil\fcharset186\fprq2 Minion Pro Med Baltic;}{\f4379\fbidi \fnil\fcharset163\fprq2 Minion Pro Med (Vietnamese);}{\f4381\fbidi \fnil\fcharset238\fprq2 Minion Pro Med Ital CE;}{\f4382\fbidi \fnil\fcharset204\fprq2 Minion Pro Med Ital Cyr;}{\f4384\fbidi \fnil\fcharset161\fprq2 Minion Pro Med Ital Greek;}{\f4385\fbidi \fnil\fcharset162\fprq2 Minion Pro Med Ital Tur;}{\f4388\fbidi \fnil\fcharset186\fprq2 Minion Pro Med Ital Baltic;}{\f4389\fbidi \fnil\fcharset163\fprq2 Minion Pro Med Ital (Vietnamese);}{\f4391\fbidi \fnil\fcharset238\fprq2 Minion Pro SmBd CE;}{\f4392\fbidi \fnil\fcharset204\fprq2 Minion Pro SmBd Cyr;}{\f4394\fbidi \fnil\fcharset161\fprq2 Minion Pro SmBd Greek;}{\f4395\fbidi \fnil\fcharset162\fprq2 Minion Pro SmBd Tur;}{\f4398\fbidi \fnil\fcharset186\fprq2 Minion Pro SmBd Baltic;}{\f4399\fbidi \fnil\fcharset163\fprq2 Minion Pro SmBd (Vietnamese);}{\f4401\fbidi \fnil\fcharset238\fprq2 Minion Pro SmBd Ital CE;}{\f4402\fbidi \fnil\fcharset204\fprq2 Minion Pro SmBd Ital Cyr;}{\f4404\fbidi \fnil\fcharset161\fprq2 Minion Pro SmBd Ital Greek;}{\f4405\fbidi \fnil\fcharset162\fprq2 Minion Pro SmBd Ital Tur;}{\f4408\fbidi \fnil\fcharset186\fprq2 Minion Pro SmBd Ital Baltic;}{\f4409\fbidi \fnil\fcharset163\fprq2 Minion Pro SmBd Ital (Vietnamese);}{\f4435\fbidi \fnil\fcharset162\fprq2 Mona Lisa Solid ITC TT Tur;}{\f4439\fbidi \fnil\fcharset163\fprq2 Mona Lisa Solid ITC TT (Vietnamese);}{\f4481\fbidi \fnil\fcharset238\fprq2 MS Reference Sans Serif CE;}{\f4482\fbidi \fnil\fcharset204\fprq2 MS Reference Sans Serif Cyr;}{\f4484\fbidi \fnil\fcharset161\fprq2 MS Reference Sans Serif Greek;}{\f4485\fbidi \fnil\fcharset162\fprq2 MS Reference Sans Serif Tur;}{\f4488\fbidi \fnil\fcharset186\fprq2 MS Reference Sans Serif Baltic;}{\f4489\fbidi \fnil\fcharset163\fprq2 MS Reference Sans Serif (Vietnamese);}{\f4503\fbidi \fnil\fcharset0\fprq2 MT Extra;}{\f4541\fbidi \fnil\fcharset238\fprq2 Myriad Arabic CE;}{\f4547\fbidi \fnil\fcharset178\fprq2 Myriad Arabic (Arabid);}{\f4551\fbidi \fnil\fcharset238\fprq2 Myriad Arabic Bold CE;}{\f4557\fbidi \fnil\fcharset178\fprq2 Myriad Arabic Bold (Arabid);}{\f4561\fbidi \fnil\fcharset238\fprq2 Myriad Arabic Bold Italic CE;}{\f4567\fbidi \fnil\fcharset178\fprq2 Myriad Arabic Bold Italic (Arabid);}{\f4571\fbidi \fnil\fcharset238\fprq2 Myriad Arabic Italic CE;}{\f4577\fbidi \fnil\fcharset178\fprq2 Myriad Arabic Italic (Arabid);}{\f4581\fbidi \fnil\fcharset238\fprq2 Myriad Hebrew Bold CE;}{\f4586\fbidi \fnil\fcharset177\fprq2 Myriad Hebrew Bold (Hebrew);}{\f4591\fbidi \fnil\fcharset238\fprq2 Myriad Hebrew Bold Italic CE;}{\f4596\fbidi \fnil\fcharset177\fprq2 Myriad Hebrew Bold Italic (Hebrew);}{\f4601\fbidi \fnil\fcharset238\fprq2 Myriad Hebrew Italic CE;}{\f4606\fbidi \fnil\fcharset177\fprq2 Myriad Hebrew Italic (Hebrew);}{\f4611\fbidi \fnil\fcharset238\fprq2 Myriad Hebrew Regular CE;}{\f4616\fbidi \fnil\fcharset177\fprq2 Myriad Hebrew Regular (Hebrew);}{\f4621\fbidi \fnil\fcharset238\fprq2 Myriad Pro CE;}{\f4622\fbidi \fnil\fcharset204\fprq2 Myriad Pro Cyr;}{\f4624\fbidi \fnil\fcharset161\fprq2 Myriad Pro Greek;}{\f4625\fbidi \fnil\fcharset162\fprq2 Myriad Pro Tur;}{\f4628\fbidi \fnil\fcharset186\fprq2 Myriad Pro Baltic;}{\f4629\fbidi \fnil\fcharset163\fprq2 Myriad Pro (Vietnamese);}{\f4631\fbidi \fnil\fcharset238\fprq2 Myriad Pro Bold CE;}{\f4632\fbidi \fnil\fcharset204\fprq2 Myriad Pro Bold Cyr;}{\f4634\fbidi \fnil\fcharset161\fprq2 Myriad Pro Bold Greek;}{\f4635\fbidi \fnil\fcharset162\fprq2 Myriad Pro Bold Tur;}{\f4638\fbidi \fnil\fcharset186\fprq2 Myriad Pro Bold Baltic;}{\f4639\fbidi \fnil\fcharset163\fprq2 Myriad Pro Bold (Vietnamese);}{\f4641\fbidi \fnil\fcharset238\fprq2 Myriad Pro Bold Cond CE;}{\f4642\fbidi \fnil\fcharset204\fprq2 Myriad Pro Bold Cond Cyr;}{\f4644\fbidi \fnil\fcharset161\fprq2 Myriad Pro Bold Cond Greek;}{\f4645\fbidi \fnil\fcharset162\fprq2 Myriad Pro Bold Cond Tur;}{\f4648\fbidi \fnil\fcharset186\fprq2 Myriad Pro Bold Cond Baltic;}{\f4649\fbidi \fnil\fcharset163\fprq2 Myriad Pro Bold Cond (Vietnamese);}{\f4651\fbidi \fnil\fcharset238\fprq2 Myriad Pro Bold Cond It CE;}{\f4652\fbidi \fnil\fcharset204\fprq2 Myriad Pro Bold Cond It Cyr;}{\f4654\fbidi \fnil\fcharset161\fprq2 Myriad Pro Bold Cond It Greek;}{\f4655\fbidi \fnil\fcharset162\fprq2 Myriad Pro Bold Cond It Tur;}{\f4658\fbidi \fnil\fcharset186\fprq2 Myriad Pro Bold Cond It Baltic;}{\f4659\fbidi \fnil\fcharset163\fprq2 Myriad Pro Bold Cond It (Vietnamese);}{\f4661\fbidi \fnil\fcharset238\fprq2 Myriad Pro Bold It CE;}{\f4662\fbidi \fnil\fcharset204\fprq2 Myriad Pro Bold It Cyr;}{\f4664\fbidi \fnil\fcharset161\fprq2 Myriad Pro Bold It Greek;}{\f4665\fbidi \fnil\fcharset162\fprq2 Myriad Pro Bold It Tur;}{\f4668\fbidi \fnil\fcharset186\fprq2 Myriad Pro Bold It Baltic;}{\f4669\fbidi \fnil\fcharset163\fprq2 Myriad Pro Bold It (Vietnamese);}{\f4671\fbidi \fnil\fcharset238\fprq2 Myriad Pro Cond CE;}{\f4672\fbidi \fnil\fcharset204\fprq2 Myriad Pro Cond Cyr;}{\f4674\fbidi \fnil\fcharset161\fprq2 Myriad Pro Cond Greek;}{\f4675\fbidi \fnil\fcharset162\fprq2 Myriad Pro Cond Tur;}{\f4678\fbidi \fnil\fcharset186\fprq2 Myriad Pro Cond Baltic;}{\f4679\fbidi \fnil\fcharset163\fprq2 Myriad Pro Cond (Vietnamese);}{\f4681\fbidi \fnil\fcharset238\fprq2 Myriad Pro Cond It CE;}{\f4682\fbidi \fnil\fcharset204\fprq2 Myriad Pro Cond It Cyr;}{\f4684\fbidi \fnil\fcharset161\fprq2 Myriad Pro Cond It Greek;}{\f4685\fbidi \fnil\fcharset162\fprq2 Myriad Pro Cond It Tur;}{\f4688\fbidi \fnil\fcharset186\fprq2 Myriad Pro Cond It Baltic;}{\f4689\fbidi \fnil\fcharset163\fprq2 Myriad Pro Cond It (Vietnamese);}{\f4691\fbidi \fnil\fcharset238\fprq2 Myriad Pro It CE;}{\f4692\fbidi \fnil\fcharset204\fprq2 Myriad Pro It Cyr;}{\f4694\fbidi \fnil\fcharset161\fprq2 Myriad Pro It Greek;}{\f4695\fbidi \fnil\fcharset162\fprq2 Myriad Pro It Tur;}{\f4698\fbidi \fnil\fcharset186\fprq2 Myriad Pro It Baltic;}{\f4699\fbidi \fnil\fcharset163\fprq2 Myriad Pro It (Vietnamese);}{\f4701\fbidi \fnil\fcharset238\fprq2 Myriad Pro Semibold CE;}{\f4702\fbidi \fnil\fcharset204\fprq2 Myriad Pro Semibold Cyr;}{\f4704\fbidi \fnil\fcharset161\fprq2 Myriad Pro Semibold Greek;}{\f4705\fbidi \fnil\fcharset162\fprq2 Myriad Pro Semibold Tur;}{\f4708\fbidi \fnil\fcharset186\fprq2 Myriad Pro Semibold Baltic;}{\f4709\fbidi \fnil\fcharset163\fprq2 Myriad Pro Semibold (Vietnamese);}{\f4711\fbidi \fnil\fcharset238\fprq2 Myriad Pro Semibold It CE;}{\f4712\fbidi \fnil\fcharset204\fprq2 Myriad Pro Semibold It Cyr;}{\f4714\fbidi \fnil\fcharset161\fprq2 Myriad Pro Semibold It Greek;}{\f4715\fbidi \fnil\fcharset162\fprq2 Myriad Pro Semibold It Tur;}{\f4718\fbidi \fnil\fcharset186\fprq2 Myriad Pro Semibold It Baltic;}{\f4719\fbidi \fnil\fcharset163\fprq2 Myriad Pro Semibold It (Vietnamese);}{\f4735\fbidi \fnil\fcharset162\fprq2 Noteworthy Bold Tur;}{\f4739\fbidi \fnil\fcharset163\fprq2 Noteworthy Bold (Vietnamese);}{\f4745\fbidi \fnil\fcharset162\fprq2 Noteworthy Light Tur;}{\f4749\fbidi \fnil\fcharset163\fprq2 Noteworthy Light (Vietnamese);}{\f4846\fbidi \fnil\fcharset177\fprq2 Optima ExtraBlack (Hebrew);}{\f4847\fbidi \fnil\fcharset178\fprq2 Optima ExtraBlack (Arabid);}{\f4850\fbidi \fnil\fcharset222\fprq2 Optima ExtraBlack (That);}{\f4911\fbidi \fnil\fcharset238\fprq2 Palatino CE;}{\f4915\fbidi \fnil\fcharset162\fprq2 Palatino Tur;}{\f4918\fbidi \fnil\fcharset186\fprq2 Palatino Baltic;}{\f4919\fbidi \fnil\fcharset163\fprq2 Palatino (Vietnamese);}{\f4921\fbidi \fnil\fcharset238\fprq2 Palatino Bold CE;}{\f4925\fbidi \fnil\fcharset162\fprq2 Palatino Bold Tur;}{\f4928\fbidi \fnil\fcharset186\fprq2 Palatino Bold Baltic;}{\f4929\fbidi \fnil\fcharset163\fprq2 Palatino Bold (Vietnamese);}{\f4931\fbidi \fnil\fcharset238\fprq2 Palatino Bold Italic CE;}{\f4935\fbidi \fnil\fcharset162\fprq2 Palatino Bold Italic Tur;}{\f4938\fbidi \fnil\fcharset186\fprq2 Palatino Bold Italic Baltic;}{\f4939\fbidi \fnil\fcharset163\fprq2 Palatino Bold Italic (Vietnamese);}{\f4941\fbidi \fnil\fcharset238\fprq2 Palatino Italic CE;}{\f4945\fbidi \fnil\fcharset162\fprq2 Palatino Italic Tur;}{\f4948\fbidi \fnil\fcharset186\fprq2 Palatino Italic Baltic;}{\f4949\fbidi \fnil\fcharset163\fprq2 Palatino Italic (Vietnamese);}{\f4951\fbidi \fnil\fcharset238\fprq2 Palatino Linotype CE;}{\f4952\fbidi \fnil\fcharset204\fprq2 Palatino Linotype Cyr;}{\f4954\fbidi \fnil\fcharset161\fprq2 Palatino Linotype Greek;}{\f4955\fbidi \fnil\fcharset162\fprq2 Palatino Linotype Tur;}{\f4958\fbidi \fnil\fcharset186\fprq2 Palatino Linotype Baltic;}{\f4959\fbidi \fnil\fcharset163\fprq2 Palatino Linotype (Vietnamese);}{\f4961\fbidi \fnil\fcharset238\fprq2 Palatino Linotype Bold CE;}{\f4962\fbidi \fnil\fcharset204\fprq2 Palatino Linotype Bold Cyr;}{\f4964\fbidi \fnil\fcharset161\fprq2 Palatino Linotype Bold Greek;}{\f4965\fbidi \fnil\fcharset162\fprq2 Palatino Linotype Bold Tur;}{\f4968\fbidi \fnil\fcharset186\fprq2 Palatino Linotype Bold Baltic;}{\f4969\fbidi \fnil\fcharset163\fprq2 Palatino Linotype Bold (Vietnamese);}{\f4971\fbidi \fnil\fcharset238\fprq2 Palatino Linotype Bold Italic CE;}{\f4972\fbidi \fnil\fcharset204\fprq2 Palatino Linotype Bold Italic Cyr;}{\f4974\fbidi \fnil\fcharset161\fprq2 Palatino Linotype Bold Italic Greek;}{\f4975\fbidi \fnil\fcharset162\fprq2 Palatino Linotype Bold Italic Tur;}{\f4978\fbidi \fnil\fcharset186\fprq2 Palatino Linotype Bold Italic Baltic;}{\f4979\fbidi \fnil\fcharset163\fprq2 Palatino Linotype Bold Italic (Vietnamese);}{\f4981\fbidi \fnil\fcharset238\fprq2 Palatino Linotype Italic CE;}{\f4982\fbidi \fnil\fcharset204\fprq2 Palatino Linotype Italic Cyr;}{\f4984\fbidi \fnil\fcharset161\fprq2 Palatino Linotype Italic Greek;}{\f4985\fbidi \fnil\fcharset162\fprq2 Palatino Linotype Italic Tur;}{\f4988\fbidi \fnil\fcharset186\fprq2 Palatino Linotype Italic Baltic;}{\f4989\fbidi \fnil\fcharset163\fprq2 Palatino Linotype Italic (Vietnamese);}{\f4996\fbidi \fnil\fcharset177\fprq2 Papyrus (Hebrew);}{\f4997\fbidi \fnil\fcharset178\fprq2 Papyrus (Arabid);}{\f5006\fbidi \fnil\fcharset177\fprq2 Papyrus Condensed (Hebrew);}{\f5007\fbidi \fnil\fcharset178\fprq2 Papyrus Condensed (Arabid);}{\f5071\fbidi \fnil\fcharset238\fprq2 Plantagenet Cherokee CE;}{\f5075\fbidi \fnil\fcharset162\fprq2 Plantagenet Cherokee Tur;}{\f5076\fbidi \fnil\fcharset177\fprq2 Plantagenet Cherokee (Hebrew);}{\f5077\fbidi \fnil\fcharset178\fprq2 Plantagenet Cherokee (Arabid);}{\f5078\fbidi \fnil\fcharset186\fprq2 Plantagenet Cherokee Baltic;}{\f5079\fbidi \fnil\fcharset163\fprq2 Plantagenet Cherokee (Vietnamese);}{\f5093\fbidi \fnil\fcharset0\fprq2 PMingLiU-ExtB Western;}{\f5103\fbidi \fnil\fcharset0\fprq2 @PMingLiU-ExtB Western;}{\f5151\fbidi \fnil\fcharset238\fprq2 PT Mono CE;}{\f5152\fbidi \fnil\fcharset204\fprq2 PT Mono Cyr;}{\f5155\fbidi \fnil\fcharset162\fprq2 PT Mono Tur;}{\f5158\fbidi \fnil\fcharset186\fprq2 PT Mono Baltic;}{\f5161\fbidi \fnil\fcharset238\fprq2 PT Mono Bold CE;}{\f5162\fbidi \fnil\fcharset204\fprq2 PT Mono Bold Cyr;}{\f5165\fbidi \fnil\fcharset162\fprq2 PT Mono Bold Tur;}{\f5168\fbidi \fnil\fcharset186\fprq2 PT Mono Bold Baltic;}{\f5171\fbidi \fnil\fcharset238\fprq2 PT Sans CE;}{\f5172\fbidi \fnil\fcharset204\fprq2 PT Sans Cyr;}{\f5175\fbidi \fnil\fcharset162\fprq2 PT Sans Tur;}{\f5178\fbidi \fnil\fcharset186\fprq2 PT Sans Baltic;}{\f5181\fbidi \fnil\fcharset238\fprq2 PT Sans Bold CE;}{\f5182\fbidi \fnil\fcharset204\fprq2 PT Sans Bold Cyr;}{\f5185\fbidi \fnil\fcharset162\fprq2 PT Sans Bold Tur;}{\f5188\fbidi \fnil\fcharset186\fprq2 PT Sans Bold Baltic;}{\f5191\fbidi \fnil\fcharset238\fprq2 PT Sans Bold Italic CE;}{\f5192\fbidi \fnil\fcharset204\fprq2 PT Sans Bold Italic Cyr;}{\f5195\fbidi \fnil\fcharset162\fprq2 PT Sans Bold Italic Tur;}{\f5198\fbidi \fnil\fcharset186\fprq2 PT Sans Bold Italic Baltic;}{\f5201\fbidi \fnil\fcharset238\fprq2 PT Sans Caption CE;}{\f5202\fbidi \fnil\fcharset204\fprq2 PT Sans Caption Cyr;}{\f5205\fbidi \fnil\fcharset162\fprq2 PT Sans Caption Tur;}{\f5208\fbidi \fnil\fcharset186\fprq2 PT Sans Caption Baltic;}{\f5211\fbidi \fnil\fcharset238\fprq2 PT Sans Caption Bold CE;}{\f5212\fbidi \fnil\fcharset204\fprq2 PT Sans Caption Bold Cyr;}{\f5215\fbidi \fnil\fcharset162\fprq2 PT Sans Caption Bold Tur;}{\f5218\fbidi \fnil\fcharset186\fprq2 PT Sans Caption Bold Baltic;}{\f5221\fbidi \fnil\fcharset238\fprq2 PT Sans Italic CE;}{\f5222\fbidi \fnil\fcharset204\fprq2 PT Sans Italic Cyr;}{\f5225\fbidi \fnil\fcharset162\fprq2 PT Sans Italic Tur;}{\f5228\fbidi \fnil\fcharset186\fprq2 PT Sans Italic Baltic;}{\f5231\fbidi \fnil\fcharset238\fprq2 PT Sans Narrow CE;}{\f5232\fbidi \fnil\fcharset204\fprq2 PT Sans Narrow Cyr;}{\f5235\fbidi \fnil\fcharset162\fprq2 PT Sans Narrow Tur;}{\f5238\fbidi \fnil\fcharset186\fprq2 PT Sans Narrow Baltic;}{\f5241\fbidi \fnil\fcharset238\fprq2 PT Sans Narrow Bold CE;}{\f5242\fbidi \fnil\fcharset204\fprq2 PT Sans Narrow Bold Cyr;}{\f5245\fbidi \fnil\fcharset162\fprq2 PT Sans Narrow Bold Tur;}{\f5248\fbidi \fnil\fcharset186\fprq2 PT Sans Narrow Bold Baltic;}{\f5251\fbidi \fnil\fcharset238\fprq2 PT Serif CE;}{\f5252\fbidi \fnil\fcharset204\fprq2 PT Serif Cyr;}{\f5255\fbidi \fnil\fcharset162\fprq2 PT Serif Tur;}{\f5258\fbidi \fnil\fcharset186\fprq2 PT Serif Baltic;}{\f5261\fbidi \fnil\fcharset238\fprq2 PT Serif Bold CE;}{\f5262\fbidi \fnil\fcharset204\fprq2 PT Serif Bold Cyr;}{\f5265\fbidi \fnil\fcharset162\fprq2 PT Serif Bold Tur;}{\f5268\fbidi \fnil\fcharset186\fprq2 PT Serif Bold Baltic;}{\f5271\fbidi \fnil\fcharset238\fprq2 PT Serif Bold Italic CE;}{\f5272\fbidi \fnil\fcharset204\fprq2 PT Serif Bold Italic Cyr;}{\f5275\fbidi \fnil\fcharset162\fprq2 PT Serif Bold Italic Tur;}{\f5278\fbidi \fnil\fcharset186\fprq2 PT Serif Bold Italic Baltic;}{\f5281\fbidi \fnil\fcharset238\fprq2 PT Serif Caption CE;}{\f5282\fbidi \fnil\fcharset204\fprq2 PT Serif Caption Cyr;}{\f5285\fbidi \fnil\fcharset162\fprq2 PT Serif Caption Tur;}{\f5288\fbidi \fnil\fcharset186\fprq2 PT Serif Caption Baltic;}{\f5291\fbidi \fnil\fcharset238\fprq2 PT Serif Caption Italic CE;}{\f5292\fbidi \fnil\fcharset204\fprq2 PT Serif Caption Italic Cyr;}{\f5295\fbidi \fnil\fcharset162\fprq2 PT Serif Caption Italic Tur;}{\f5298\fbidi \fnil\fcharset186\fprq2 PT Serif Caption Italic Baltic;}{\f5301\fbidi \fnil\fcharset238\fprq2 PT Serif Italic CE;}{\f5302\fbidi \fnil\fcharset204\fprq2 PT Serif Italic Cyr;}{\f5305\fbidi \fnil\fcharset162\fprq2 PT Serif Italic Tur;}{\f5308\fbidi \fnil\fcharset186\fprq2 PT Serif Italic Baltic;}{\f5341\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Bold CE;}{\f5344\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Bold Greek;}{\f5345\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Bold Tur;}{\f5348\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Bold Baltic;}{\f5351\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Bold Italic CE;}{\f5354\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Bold Italic Greek;}{\f5355\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Bold Italic Tur;}{\f5358\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Bold Italic Baltic;}{\f5361\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Demi CE;}{\f5364\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Demi Greek;}{\f5365\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Demi Tur;}{\f5368\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Demi Baltic;}{\f5371\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Demi Italic CE;}{\f5374\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Demi Italic Greek;}{\f5375\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Demi Italic Tur;}{\f5378\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Demi Italic Baltic;}{\f5381\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Extra Bold CE;}{\f5384\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Extra Bold Greek;}{\f5385\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Extra Bold Tur;}{\f5388\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Extra Bold Baltic;}{\f5391\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Extra Bold It CE;}{\f5394\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Extra Bold It Greek;}{\f5395\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Extra Bold It Tur;}{\f5398\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Extra Bold It Baltic;}{\f5401\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Italic CE;}{\f5404\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Italic Greek;}{\f5405\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Italic Tur;}{\f5408\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Italic Baltic;}{\f5411\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Regular CE;}{\f5414\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Regular Greek;}{\f5415\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Regular Tur;}{\f5418\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Regular Baltic;}{\f5431\fbidi \fnil\fcharset238\fprq2 Sathu CE;}{\f5432\fbidi \fnil\fcharset204\fprq2 Sathu Cyr;}{\f5435\fbidi \fnil\fcharset162\fprq2 Sathu Tur;}{\f5438\fbidi \fnil\fcharset186\fprq2 Sathu Baltic;}{\f5439\fbidi \fnil\fcharset163\fprq2 Sathu (Vietnamese);}{\f5451\fbidi \fnil\fcharset238\fprq2 Savoye LET Plain CC.:1.0 CE;}{\f5452\fbidi \fnil\fcharset204\fprq2 Savoye LET Plain CC.:1.0 Cyr;}{\f5454\fbidi \fnil\fcharset161\fprq2 Savoye LET Plain CC.:1.0 Greek;}{\f5455\fbidi \fnil\fcharset162\fprq2 Savoye LET Plain CC.:1.0 Tur;}{\f5458\fbidi \fnil\fcharset186\fprq2 Savoye LET Plain CC.:1.0 Baltic;}{\f5459\fbidi \fnil\fcharset163\fprq2 Savoye LET Plain CC.:1.0 (Vietnamese);}{\f5481\fbidi \fnil\fcharset238\fprq2 Seravek CE;}{\f5482\fbidi \fnil\fcharset204\fprq2 Seravek Cyr;}{\f5484\fbidi \fnil\fcharset161\fprq2 Seravek Greek;}{\f5485\fbidi \fnil\fcharset162\fprq2 Seravek Tur;}{\f5488\fbidi \fnil\fcharset186\fprq2 Seravek Baltic;}{\f5491\fbidi \fnil\fcharset238\fprq2 Seravek Bold CE;}{\f5492\fbidi \fnil\fcharset204\fprq2 Seravek Bold Cyr;}{\f5494\fbidi \fnil\fcharset161\fprq2 Seravek Bold Greek;}{\f5495\fbidi \fnil\fcharset162\fprq2 Seravek Bold Tur;}{\f5498\fbidi \fnil\fcharset186\fprq2 Seravek Bold Baltic;}{\f5501\fbidi \fnil\fcharset238\fprq2 Seravek Bold Italic CE;}{\f5502\fbidi \fnil\fcharset204\fprq2 Seravek Bold Italic Cyr;}{\f5504\fbidi \fnil\fcharset161\fprq2 Seravek Bold Italic Greek;}{\f5505\fbidi \fnil\fcharset162\fprq2 Seravek Bold Italic Tur;}{\f5508\fbidi \fnil\fcharset186\fprq2 Seravek Bold Italic Baltic;}{\f5511\fbidi \fnil\fcharset238\fprq2 Seravek ExtraLight CE;}{\f5512\fbidi \fnil\fcharset204\fprq2 Seravek ExtraLight Cyr;}{\f5514\fbidi \fnil\fcharset161\fprq2 Seravek ExtraLight Greek;}{\f5515\fbidi \fnil\fcharset162\fprq2 Seravek ExtraLight Tur;}{\f5518\fbidi \fnil\fcharset186\fprq2 Seravek ExtraLight Baltic;}{\f5521\fbidi \fnil\fcharset238\fprq2 Seravek ExtraLight Italic CE;}{\f5522\fbidi \fnil\fcharset204\fprq2 Seravek ExtraLight Italic Cyr;}{\f5524\fbidi \fnil\fcharset161\fprq2 Seravek ExtraLight Italic Greek;}{\f5525\fbidi \fnil\fcharset162\fprq2 Seravek ExtraLight Italic Tur;}{\f5528\fbidi \fnil\fcharset186\fprq2 Seravek ExtraLight Italic Baltic;}{\f5531\fbidi \fnil\fcharset238\fprq2 Seravek Italic CE;}{\f5532\fbidi \fnil\fcharset204\fprq2 Seravek Italic Cyr;}{\f5534\fbidi \fnil\fcharset161\fprq2 Seravek Italic Greek;}{\f5535\fbidi \fnil\fcharset162\fprq2 Seravek Italic Tur;}{\f5538\fbidi \fnil\fcharset186\fprq2 Seravek Italic Baltic;}{\f5541\fbidi \fnil\fcharset238\fprq2 Seravek Light CE;}{\f5542\fbidi \fnil\fcharset204\fprq2 Seravek Light Cyr;}{\f5544\fbidi \fnil\fcharset161\fprq2 Seravek Light Greek;}{\f5545\fbidi \fnil\fcharset162\fprq2 Seravek Light Tur;}{\f5548\fbidi \fnil\fcharset186\fprq2 Seravek Light Baltic;}{\f5551\fbidi \fnil\fcharset238\fprq2 Seravek Light Italic CE;}{\f5552\fbidi \fnil\fcharset204\fprq2 Seravek Light Italic Cyr;}{\f5554\fbidi \fnil\fcharset161\fprq2 Seravek Light Italic Greek;}{\f5555\fbidi \fnil\fcharset162\fprq2 Seravek Light Italic Tur;}{\f5558\fbidi \fnil\fcharset186\fprq2 Seravek Light Italic Baltic;}{\f5561\fbidi \fnil\fcharset238\fprq2 Seravek Medium CE;}{\f5562\fbidi \fnil\fcharset204\fprq2 Seravek Medium Cyr;}{\f5564\fbidi \fnil\fcharset161\fprq2 Seravek Medium Greek;}{\f5565\fbidi \fnil\fcharset162\fprq2 Seravek Medium Tur;}{\f5568\fbidi \fnil\fcharset186\fprq2 Seravek Medium Baltic;}{\f5571\fbidi \fnil\fcharset238\fprq2 Seravek Medium Italic CE;}{\f5572\fbidi \fnil\fcharset204\fprq2 Seravek Medium Italic Cyr;}{\f5574\fbidi \fnil\fcharset161\fprq2 Seravek Medium Italic Greek;}{\f5575\fbidi \fnil\fcharset162\fprq2 Seravek Medium Italic Tur;}{\f5578\fbidi \fnil\fcharset186\fprq2 Seravek Medium Italic Baltic;}{\f5581\fbidi \fnil\fcharset238\fprq2 Silom CE;}{\f5585\fbidi \fnil\fcharset162\fprq2 Silom Tur;}{\f5588\fbidi \fnil\fcharset186\fprq2 Silom Baltic;}{\f5589\fbidi \fnil\fcharset163\fprq2 Silom (Vietnamese);}{\f5593\fbidi \fnil\fcharset0\fprq2 SimSun-ExtB Western;}{\f5603\fbidi \fnil\fcharset0\fprq2 @SimSun-ExtB Western;}{\f5665\fbidi \fnil\fcharset162\fprq2 Snell Roundhand Tur;}{\f5669\fbidi \fnil\fcharset163\fprq2 Snell Roundhand (Vietnamese);}{\f5675\fbidi \fnil\fcharset162\fprq2 Snell Roundhand Black Tur;}{\f5679\fbidi \fnil\fcharset163\fprq2 Snell Roundhand Black (Vietnamese);}{\f5685\fbidi \fnil\fcharset162\fprq2 Snell Roundhand Bold Tur;}{\f5689\fbidi \fnil\fcharset163\fprq2 Snell Roundhand Bold (Vietnamese);}{\f5701\fbidi \fnil\fcharset238\fprq2 STIXGeneral-Bold CE;}{\f5702\fbidi \fnil\fcharset204\fprq2 STIXGeneral-Bold Cyr;}{\f5704\fbidi \fnil\fcharset161\fprq2 STIXGeneral-Bold Greek;}{\f5705\fbidi \fnil\fcharset162\fprq2 STIXGeneral-Bold Tur;}{\f5706\fbidi \fnil\fcharset177\fprq2 STIXGeneral-Bold (Hebrew);}{\f5707\fbidi \fnil\fcharset178\fprq2 STIXGeneral-Bold (Arabid);}{\f5708\fbidi \fnil\fcharset186\fprq2 STIXGeneral-Bold Baltic;}{\f5709\fbidi \fnil\fcharset163\fprq2 STIXGeneral-Bold (Vietnamese);}{\f5711\fbidi \fnil\fcharset238\fprq2 STIXGeneral-BoldItalic CE;}{\f5712\fbidi \fnil\fcharset204\fprq2 STIXGeneral-BoldItalic Cyr;}{\f5714\fbidi \fnil\fcharset161\fprq2 STIXGeneral-BoldItalic Greek;}{\f5715\fbidi \fnil\fcharset162\fprq2 STIXGeneral-BoldItalic Tur;}{\f5716\fbidi \fnil\fcharset177\fprq2 STIXGeneral-BoldItalic (Hebrew);}{\f5717\fbidi \fnil\fcharset178\fprq2 STIXGeneral-BoldItalic (Arabid);}{\f5718\fbidi \fnil\fcharset186\fprq2 STIXGeneral-BoldItalic Baltic;}{\f5719\fbidi \fnil\fcharset163\fprq2 STIXGeneral-BoldItalic (Vietnamese);}{\f5721\fbidi \fnil\fcharset238\fprq2 STIXGeneral-Italic CE;}{\f5722\fbidi \fnil\fcharset204\fprq2 STIXGeneral-Italic Cyr;}{\f5724\fbidi \fnil\fcharset161\fprq2 STIXGeneral-Italic Greek;}{\f5725\fbidi \fnil\fcharset162\fprq2 STIXGeneral-Italic Tur;}{\f5726\fbidi \fnil\fcharset177\fprq2 STIXGeneral-Italic (Hebrew);}{\f5727\fbidi \fnil\fcharset178\fprq2 STIXGeneral-Italic (Arabid);}{\f5728\fbidi \fnil\fcharset186\fprq2 STIXGeneral-Italic Baltic;}{\f5729\fbidi \fnil\fcharset163\fprq2 STIXGeneral-Italic (Vietnamese);}{\f5731\fbidi \fnil\fcharset238\fprq2 STIXGeneral-Regular CE;}{\f5732\fbidi \fnil\fcharset204\fprq2 STIXGeneral-Regular Cyr;}{\f5734\fbidi \fnil\fcharset161\fprq2 STIXGeneral-Regular Greek;}{\f5735\fbidi \fnil\fcharset162\fprq2 STIXGeneral-Regular Tur;}{\f5736\fbidi \fnil\fcharset177\fprq2 STIXGeneral-Regular (Hebrew);}{\f5737\fbidi \fnil\fcharset178\fprq2 STIXGeneral-Regular (Arabid);}{\f5738\fbidi \fnil\fcharset186\fprq2 STIXGeneral-Regular Baltic;}{\f5739\fbidi \fnil\fcharset163\fprq2 STIXGeneral-Regular (Vietnamese);}{\f5889\fbidi \fnil\fcharset163\fprq2 STIXSizeFiveSym-Regular (Vietnamese);}{\f5909\fbidi \fnil\fcharset163\fprq2 STIXSizeFourSym-Regular (Vietnamese);}{\f5929\fbidi \fnil\fcharset163\fprq2 STIXSizeOneSym-Regular (Vietnamese);}{\f5949\fbidi \fnil\fcharset163\fprq2 STIXSizeThreeSym-Regular (Vietnamese);}{\f5969\fbidi \fnil\fcharset163\fprq2 STIXSizeTwoSym-Regular (Vietnamese);}{\f6041\fbidi \fnil\fcharset238\fprq2 Superclarendon Black CE;}{\f6048\fbidi \fnil\fcharset186\fprq2 Superclarendon Black Baltic;}{\f6049\fbidi \fnil\fcharset163\fprq2 Superclarendon Black (Vietnamese);}{\f6051\fbidi \fnil\fcharset238\fprq2 Superclarendon Black Italic CE;}{\f6058\fbidi \fnil\fcharset186\fprq2 Superclarendon Black Italic Baltic;}{\f6059\fbidi \fnil\fcharset163\fprq2 Superclarendon Black Italic (Vietnamese);}{\f6061\fbidi \fnil\fcharset238\fprq2 Superclarendon Bold CE;}{\f6068\fbidi \fnil\fcharset186\fprq2 Superclarendon Bold Baltic;}{\f6069\fbidi \fnil\fcharset163\fprq2 Superclarendon Bold (Vietnamese);}{\f6071\fbidi \fnil\fcharset238\fprq2 Superclarendon Bold Italic CE;}{\f6078\fbidi \fnil\fcharset186\fprq2 Superclarendon Bold Italic Baltic;}{\f6079\fbidi \fnil\fcharset163\fprq2 Superclarendon Bold Italic (Vietnamese);}{\f6081\fbidi \fnil\fcharset238\fprq2 Superclarendon Italic CE;}{\f6088\fbidi \fnil\fcharset186\fprq2 Superclarendon Italic Baltic;}{\f6089\fbidi \fnil\fcharset163\fprq2 Superclarendon Italic (Vietnamese);}{\f6091\fbidi \fnil\fcharset238\fprq2 Superclarendon Light CE;}{\f6098\fbidi \fnil\fcharset186\fprq2 Superclarendon Light Baltic;}{\f6099\fbidi \fnil\fcharset163\fprq2 Superclarendon Light (Vietnamese);}{\f6101\fbidi \fnil\fcharset238\fprq2 Superclarendon Light Italic CE;}{\f6108\fbidi \fnil\fcharset186\fprq2 Superclarendon Light Italic Baltic;}{\f6109\fbidi \fnil\fcharset163\fprq2 Superclarendon Light Italic (Vietnamese);}{\f6111\fbidi \fnil\fcharset238\fprq2 Superclarendon Regular CE;}{\f6118\fbidi \fnil\fcharset186\fprq2 Superclarendon Regular Baltic;}{\f6119\fbidi \fnil\fcharset163\fprq2 Superclarendon Regular (Vietnamese);}{\f6131\fbidi \fnil\fcharset238\fprq2 Tahoma CE;}{\f6132\fbidi \fnil\fcharset204\fprq2 Tahoma Cyr;}{\f6134\fbidi \fnil\fcharset161\fprq2 Tahoma Greek;}{\f6135\fbidi \fnil\fcharset162\fprq2 Tahoma Tur;}{\f6136\fbidi \fnil\fcharset177\fprq2 Tahoma (Hebrew);}{\f6137\fbidi \fnil\fcharset178\fprq2 Tahoma (Arabid);}{\f6138\fbidi \fnil\fcharset186\fprq2 Tahoma Baltic;}{\f6139\fbidi \fnil\fcharset163\fprq2 Tahoma (Vietnamese);}{\f6140\fbidi \fnil\fcharset222\fprq2 Tahoma (That);}{\f6141\fbidi \fnil\fcharset238\fprq2 Tahoma Bold CE;}{\f6142\fbidi \fnil\fcharset204\fprq2 Tahoma Bold Cyr;}{\f6144\fbidi \fnil\fcharset161\fprq2 Tahoma Bold Greek;}{\f6145\fbidi \fnil\fcharset162\fprq2 Tahoma Bold Tur;}{\f6146\fbidi \fnil\fcharset177\fprq2 Tahoma Bold (Hebrew);}{\f6147\fbidi \fnil\fcharset178\fprq2 Tahoma Bold (Arabid);}{\f6148\fbidi \fnil\fcharset186\fprq2 Tahoma Bold Baltic;}{\f6149\fbidi \fnil\fcharset163\fprq2 Tahoma Bold (Vietnamese);}{\f6150\fbidi \fnil\fcharset222\fprq2 Tahoma Bold (That);}{\f6201\fbidi \fnil\fcharset238\fprq2 Tekton Pro Bold CE;}{\f6205\fbidi \fnil\fcharset162\fprq2 Tekton Pro Bold Tur;}{\f6208\fbidi \fnil\fcharset186\fprq2 Tekton Pro Bold Baltic;}{\f6211\fbidi \fnil\fcharset238\fprq2 Tekton Pro BoldCond CE;}{\f6215\fbidi \fnil\fcharset162\fprq2 Tekton Pro BoldCond Tur;}{\f6218\fbidi \fnil\fcharset186\fprq2 Tekton Pro BoldCond Baltic;}{\f6221\fbidi \fnil\fcharset238\fprq2 Tekton Pro BoldExt CE;}{\f6225\fbidi \fnil\fcharset162\fprq2 Tekton Pro BoldExt Tur;}{\f6228\fbidi \fnil\fcharset186\fprq2 Tekton Pro BoldExt Baltic;}{\f6231\fbidi \fnil\fcharset238\fprq2 Tekton Pro BoldObl CE;}{\f6235\fbidi \fnil\fcharset162\fprq2 Tekton Pro BoldObl Tur;}{\f6238\fbidi \fnil\fcharset186\fprq2 Tekton Pro BoldObl Baltic;}{\f6281\fbidi \fnil\fcharset238\fprq2 Thonburi Light CE;}{\f6285\fbidi \fnil\fcharset162\fprq2 Thonburi Light Tur;}{\f6288\fbidi \fnil\fcharset186\fprq2 Thonburi Light Baltic;}{\f6289\fbidi \fnil\fcharset163\fprq2 Thonburi Light (Vietnamese);}{\f6291\fbidi \fnil\fcharset238\fprq2 Times New Roman Bold CE;}{\f6292\fbidi \fnil\fcharset204\fprq2 Times New Roman Bold Cyr;}{\f6294\fbidi \fnil\fcharset161\fprq2 Times New Roman Bold Greek;}{\f6295\fbidi \fnil\fcharset162\fprq2 Times New Roman Bold Tur;}{\f6296\fbidi \fnil\fcharset177\fprq2 Times New Roman Bold (Hebrew);}{\f6297\fbidi \fnil\fcharset178\fprq2 Times New Roman Bold (Arabid);}{\f6298\fbidi \fnil\fcharset186\fprq2 Times New Roman Bold Baltic;}{\f6299\fbidi \fnil\fcharset163\fprq2 Times New Roman Bold (Vietnamese);}{\f6301\fbidi \fnil\fcharset238\fprq2 Times New Roman Bold Italic CE;}{\f6302\fbidi \fnil\fcharset204\fprq2 Times New Roman Bold Italic Cyr;}{\f6304\fbidi \fnil\fcharset161\fprq2 Times New Roman Bold Italic Greek;}{\f6305\fbidi \fnil\fcharset162\fprq2 Times New Roman Bold Italic Tur;}{\f6306\fbidi \fnil\fcharset177\fprq2 Times New Roman Bold Italic (Hebrew);}{\f6308\fbidi \fnil\fcharset186\fprq2 Times New Roman Bold Italic Baltic;}{\f6309\fbidi \fnil\fcharset163\fprq2 Times New Roman Bold Italic (Vietnamese);}{\f6311\fbidi \fnil\fcharset238\fprq2 Times New Roman Italic CE;}{\f6312\fbidi \fnil\fcharset204\fprq2 Times New Roman Italic Cyr;}{\f6314\fbidi \fnil\fcharset161\fprq2 Times New Roman Italic Greek;}{\f6315\fbidi \fnil\fcharset162\fprq2 Times New Roman Italic Tur;}{\f6316\fbidi \fnil\fcharset177\fprq2 Times New Roman Italic (Hebrew);}{\f6318\fbidi \fnil\fcharset186\fprq2 Times New Roman Italic Baltic;}{\f6319\fbidi \fnil\fcharset163\fprq2 Times New Roman Italic (Vietnamese);}{\f6321\fbidi \fnil\fcharset238\fprq2 Trajan Pro CE;}{\f6325\fbidi \fnil\fcharset162\fprq2 Trajan Pro Tur;}{\f6328\fbidi \fnil\fcharset186\fprq2 Trajan Pro Baltic;}{\f6331\fbidi \fnil\fcharset238\fprq2 Trajan Pro Bold CE;}{\f6335\fbidi \fnil\fcharset162\fprq2 Trajan Pro Bold Tur;}{\f6338\fbidi \fnil\fcharset186\fprq2 Trajan Pro Bold Baltic;}{\f6341\fbidi \fnil\fcharset238\fprq2 Trebuchet MS CE;}{\f6342\fbidi \fnil\fcharset204\fprq2 Trebuchet MS Cyr;}{\f6344\fbidi \fnil\fcharset161\fprq2 Trebuchet MS Greek;}{\f6345\fbidi \fnil\fcharset162\fprq2 Trebuchet MS Tur;}{\f6348\fbidi \fnil\fcharset186\fprq2 Trebuchet MS Baltic;}{\f6351\fbidi \fnil\fcharset238\fprq2 Trebuchet MS Bold CE;}{\f6352\fbidi \fnil\fcharset204\fprq2 Trebuchet MS Bold Cyr;}{\f6354\fbidi \fnil\fcharset161\fprq2 Trebuchet MS Bold Greek;}{\f6355\fbidi \fnil\fcharset162\fprq2 Trebuchet MS Bold Tur;}{\f6358\fbidi \fnil\fcharset186\fprq2 Trebuchet MS Bold Baltic;}{\f6361\fbidi \fnil\fcharset238\fprq2 Trebuchet MS Bold Italic CE;}{\f6362\fbidi \fnil\fcharset204\fprq2 Trebuchet MS Bold Italic Cyr;}{\f6364\fbidi \fnil\fcharset161\fprq2 Trebuchet MS Bold Italic Greek;}{\f6365\fbidi \fnil\fcharset162\fprq2 Trebuchet MS Bold Italic Tur;}{\f6368\fbidi \fnil\fcharset186\fprq2 Trebuchet MS Bold Italic Baltic;}{\f6371\fbidi \fnil\fcharset238\fprq2 Trebuchet MS Italic CE;}{\f6372\fbidi \fnil\fcharset204\fprq2 Trebuchet MS Italic Cyr;}{\f6374\fbidi \fnil\fcharset161\fprq2 Trebuchet MS Italic Greek;}{\f6375\fbidi \fnil\fcharset162\fprq2 Trebuchet MS Italic Tur;}{\f6378\fbidi \fnil\fcharset186\fprq2 Trebuchet MS Italic Baltic;}{\f6381\fbidi \fnil\fcharset238\fprq2 Tw Cen MT CE;}{\f6391\fbidi \fnil\fcharset238\fprq2 Tw Cen MT Bold CE;}{\f6401\fbidi \fnil\fcharset238\fprq2 Tw Cen MT Bold Italic CE;}{\f6411\fbidi \fnil\fcharset238\fprq2 Tw Cen MT Italic CE;}{\f6431\fbidi \fnil\fcharset238\fprq2 Verdana Bold CE;}{\f6432\fbidi \fnil\fcharset204\fprq2 Verdana Bold Cyr;}{\f6434\fbidi \fnil\fcharset161\fprq2 Verdana Bold Greek;}{\f6435\fbidi \fnil\fcharset162\fprq2 Verdana Bold Tur;}{\f6438\fbidi \fnil\fcharset186\fprq2 Verdana Bold Baltic;}{\f6439\fbidi \fnil\fcharset163\fprq2 Verdana Bold (Vietnamese);}{\f6441\fbidi \fnil\fcharset238\fprq2 Verdana Bold Italic CE;}{\f6442\fbidi \fnil\fcharset204\fprq2 Verdana Bold Italic Cyr;}{\f6444\fbidi \fnil\fcharset161\fprq2 Verdana Bold Italic Greek;}{\f6445\fbidi \fnil\fcharset162\fprq2 Verdana Bold Italic Tur;}{\f6448\fbidi \fnil\fcharset186\fprq2 Verdana Bold Italic Baltic;}{\f6449\fbidi \fnil\fcharset163\fprq2 Verdana Bold Italic (Vietnamese);}{\f6451\fbidi \fnil\fcharset238\fprq2 Verdana Italic CE;}{\f6452\fbidi \fnil\fcharset204\fprq2 Verdana Italic Cyr;}{\f6454\fbidi \fnil\fcharset161\fprq2 Verdana Italic Greek;}{\f6455\fbidi \fnil\fcharset162\fprq2 Verdana Italic Tur;}{\f6458\fbidi \fnil\fcharset186\fprq2 Verdana Italic Baltic;}{\f6459\fbidi \fnil\fcharset163\fprq2 Verdana Italic (Vietnamese);}{\f6461\fbidi \fnil\fcharset238\fprq2 Wawati SC Regular CE;}{\f6471\fbidi \fnil\fcharset238\fprq2 Wawati TC Regular CE;}{\f6571\fbidi \fnil\fcharset238\fprq2 Zapfino CE;}{\f6575\fbidi \fnil\fcharset162\fprq2 Zapfino Tur;}{\f6578\fbidi \fnil\fcharset186\fprq2 Zapfino Baltic;}{\f6583\fbidi \fnil\fcharset0\fprq2 Lucida Grande CE;}{\f6582\fbidi \fnil\fcharset204\fprq2 Lucida Grande CE Cyr;}{\f6584\fbidi \fnil\fcharset161\fprq2 Lucida Grande CE Greek;}{\f6585\fbidi \fnil\fcharset162\fprq2 Lucida Grande CE Tur;}{\f6586\fbidi \fnil\fcharset177\fprq2 Lucida Grande CE (Hebrew);}{\f6588\fbidi \fnil\fcharset186\fprq2 Lucida Grande CE Baltic;}{\f6589\fbidi \fnil\fcharset163\fprq2 Lucida Grande CE (Vietnamese);}{\f6591\fbidi \fnil\fcharset238\fprq2 Charcoal CY CE;}{\f6597\fbidi \fnil\fcharset178\fprq2 Charcoal CY (Arabid);}{\f6598\fbidi \fnil\fcharset186\fprq2 Charcoal CY Baltic;}{\f6599\fbidi \fnil\fcharset163\fprq2 Charcoal CY (Vietnamese);}{\f6601\fbidi \fnil\fcharset238\fprq2 Geneva CY CE;}{\f6607\fbidi \fnil\fcharset178\fprq2 Geneva CY (Arabid);}{\f6608\fbidi \fnil\fcharset186\fprq2 Geneva CY Baltic;}{\f6609\fbidi \fnil\fcharset163\fprq2 Geneva CY (Vietnamese);}{\f6611\fbidi \fnil\fcharset238\fprq2 Helvetica CY CE;}{\f6617\fbidi \fnil\fcharset178\fprq2 Helvetica CY (Arabid);}{\f6618\fbidi \fnil\fcharset186\fprq2 Helvetica CY Baltic;}{\f6619\fbidi \fnil\fcharset163\fprq2 Helvetica CY (Vietnamese);}{\f6623\fbidi \fnil\fcharset0\fprq2 Lucida Grande CY;}{\f6621\fbidi \fnil\fcharset238\fprq2 Lucida Grande CY CE;}{\f6624\fbidi \fnil\fcharset161\fprq2 Lucida Grande CY Greek;}{\f6625\fbidi \fnil\fcharset162\fprq2 Lucida Grande CY Tur;}{\f6626\fbidi \fnil\fcharset177\fprq2 Lucida Grande CY (Hebrew);}{\f6628\fbidi \fnil\fcharset186\fprq2 Lucida Grande CY Baltic;}{\f6629\fbidi \fnil\fcharset163\fprq2 Lucida Grande CY (Vietnamese);}{\f6633\fbidi \fnil\fcharset0\fprq2 Thonburi;}{\f6631\fbidi \fnil\fcharset238\fprq2 Thonburi CE;}{\f6635\fbidi \fnil\fcharset162\fprq2 Thonburi Tur;}{\f6638\fbidi \fnil\fcharset186\fprq2 Thonburi Baltic;}{\f6639\fbidi \fnil\fcharset163\fprq2 Thonburi (Vietnamese);}{\f6643\fbidi \fnil\fcharset0\fprq2 Thonburi Bold;}{\f6641\fbidi \fnil\fcharset238\fprq2 Thonburi Bold CE;}{\f6645\fbidi \fnil\fcharset162\fprq2 Thonburi Bold Tur;}{\f6648\fbidi \fnil\fcharset186\fprq2 Thonburi Bold Baltic;}{\f6649\fbidi \fnil\fcharset163\fprq2 Thonburi Bold (Vietnamese);}{\f6653\fbidi \fnil\fcharset0\fprq2 Adobe \'a9\'fa\'c5\'e9 Std L Western;}{\f6652\fbidi \fnil\fcharset204\fprq2 Adobe \'a9\'fa\'c5\'e9 Std L Cyr;}{\f6663\fbidi \fnil\fcharset0\fprq2 @Adobe \'a9\'fa\'c5\'e9 Std L Western;}{\f6662\fbidi \fnil\fcharset204\fprq2 @Adobe \'a9\'fa\'c5\'e9 Std L Cyr;}{\f6673\fbidi \fnil\fcharset0\fprq2 Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B Western;}{\f6672\fbidi \fnil\fcharset204\fprq2 Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B Cyr;}{\f6683\fbidi \fnil\fcharset0\fprq2 @Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B Western;}{\f6682\fbidi \fnil\fcharset204\fprq2 @Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B Cyr;}{\f6753\fbidi \fnil\fcharset0\fprq2 Hannotate TC Bold Western;}{\f6763\fbidi \fnil\fcharset0\fprq2 @Hannotate TC Bold Western;}{\f6773\fbidi \fnil\fcharset0\fprq2 Hannotate TC Regular Western;}{\f6783\fbidi \fnil\fcharset0\fprq2 @Hannotate TC Regular Western;}{\f6793\fbidi \fnil\fcharset0\fprq2 HanziPen TC Bold Western;}{\f6803\fbidi \fnil\fcharset0\fprq2 @HanziPen TC Bold Western;}{\f6813\fbidi \fnil\fcharset0\fprq2 HanziPen TC Regular Western;}{\f6823\fbidi \fnil\fcharset0\fprq2 @HanziPen TC Regular Western;}{\f6873\fbidi \fnil\fcharset0\fprq2 Kaiti TC Bold Western;}{\f6871\fbidi \fnil\fcharset238\fprq2 Kaiti TC Bold CE;}{\f6872\fbidi \fnil\fcharset204\fprq2 Kaiti TC Bold Cyr;}{\f6874\fbidi \fnil\fcharset161\fprq2 Kaiti TC Bold Greek;}{\f6875\fbidi \fnil\fcharset162\fprq2 Kaiti TC Bold Tur;}{\f6883\fbidi \fnil\fcharset0\fprq2 @Kaiti TC Bold Western;}{\f6881\fbidi \fnil\fcharset238\fprq2 @Kaiti TC Bold CE;}{\f6882\fbidi \fnil\fcharset204\fprq2 @Kaiti TC Bold Cyr;}{\f6884\fbidi \fnil\fcharset161\fprq2 @Kaiti TC Bold Greek;}{\f6885\fbidi \fnil\fcharset162\fprq2 @Kaiti TC Bold Tur;}{\f6893\fbidi \fnil\fcharset0\fprq2 Kaiti TC Regular Western;}{\f6891\fbidi \fnil\fcharset238\fprq2 Kaiti TC Regular CE;}{\f6892\fbidi \fnil\fcharset204\fprq2 Kaiti TC Regular Cyr;}{\f6894\fbidi \fnil\fcharset161\fprq2 Kaiti TC Regular Greek;}{\f6895\fbidi \fnil\fcharset162\fprq2 Kaiti TC Regular Tur;}{\f6903\fbidi \fnil\fcharset0\fprq2 @Kaiti TC Regular Western;}{\f6901\fbidi \fnil\fcharset238\fprq2 @Kaiti TC Regular CE;}{\f6902\fbidi \fnil\fcharset204\fprq2 @Kaiti TC Regular Cyr;}{\f6904\fbidi \fnil\fcharset161\fprq2 @Kaiti TC Regular Greek;}{\f6905\fbidi \fnil\fcharset162\fprq2 @Kaiti TC Regular Tur;}{\f6913\fbidi \fnil\fcharset0\fprq2 Songti TC Bold Western;}{\f6911\fbidi \fnil\fcharset238\fprq2 Songti TC Bold CE;}{\f6912\fbidi \fnil\fcharset204\fprq2 Songti TC Bold Cyr;}{\f6914\fbidi \fnil\fcharset161\fprq2 Songti TC Bold Greek;}{\f6915\fbidi \fnil\fcharset162\fprq2 Songti TC Bold Tur;}{\f6918\fbidi \fnil\fcharset186\fprq2 Songti TC Bold Baltic;}{\f6923\fbidi \fnil\fcharset0\fprq2 @Songti TC Bold Western;}{\f6921\fbidi \fnil\fcharset238\fprq2 @Songti TC Bold CE;}{\f6922\fbidi \fnil\fcharset204\fprq2 @Songti TC Bold Cyr;}{\f6924\fbidi \fnil\fcharset161\fprq2 @Songti TC Bold Greek;}{\f6925\fbidi \fnil\fcharset162\fprq2 @Songti TC Bold Tur;}{\f6928\fbidi \fnil\fcharset186\fprq2 @Songti TC Bold Baltic;}{\f6933\fbidi \fnil\fcharset0\fprq2 Songti TC Light Western;}{\f6931\fbidi \fnil\fcharset238\fprq2 Songti TC Light CE;}{\f6932\fbidi \fnil\fcharset204\fprq2 Songti TC Light Cyr;}{\f6934\fbidi \fnil\fcharset161\fprq2 Songti TC Light Greek;}{\f6935\fbidi \fnil\fcharset162\fprq2 Songti TC Light Tur;}{\f6943\fbidi \fnil\fcharset0\fprq2 @Songti TC Light Western;}{\f6941\fbidi \fnil\fcharset238\fprq2 @Songti TC Light CE;}{\f6942\fbidi \fnil\fcharset204\fprq2 @Songti TC Light Cyr;}{\f6944\fbidi \fnil\fcharset161\fprq2 @Songti TC Light Greek;}{\f6945\fbidi \fnil\fcharset162\fprq2 @Songti TC Light Tur;}{\f6953\fbidi \fnil\fcharset0\fprq2 Songti TC Regular Western;}{\f6951\fbidi \fnil\fcharset238\fprq2 Songti TC Regular CE;}{\f6952\fbidi \fnil\fcharset204\fprq2 Songti TC Regular Cyr;}{\f6954\fbidi \fnil\fcharset161\fprq2 Songti TC Regular Greek;}{\f6955\fbidi \fnil\fcharset162\fprq2 Songti TC Regular Tur;}{\f6958\fbidi \fnil\fcharset186\fprq2 Songti TC Regular Baltic;}{\f6963\fbidi \fnil\fcharset0\fprq2 @Songti TC Regular Western;}{\f6961\fbidi \fnil\fcharset238\fprq2 @Songti TC Regular CE;}{\f6962\fbidi \fnil\fcharset204\fprq2 @Songti TC Regular Cyr;}{\f6964\fbidi \fnil\fcharset161\fprq2 @Songti TC Regular Greek;}{\f6965\fbidi \fnil\fcharset162\fprq2 @Songti TC Regular Tur;}{\f6968\fbidi \fnil\fcharset186\fprq2 @Songti TC Regular Baltic;}{\f6973\fbidi \fnil\fcharset0\fprq2 Weibei TC Bold Western;}{\f6971\fbidi \fnil\fcharset238\fprq2 Weibei TC Bold CE;}{\f6972\fbidi \fnil\fcharset204\fprq2 Weibei TC Bold Cyr;}{\f6978\fbidi \fnil\fcharset186\fprq2 Weibei TC Bold Baltic;}{\f6979\fbidi \fnil\fcharset163\fprq2 Weibei TC Bold (Vietnamese);}{\f6983\fbidi \fnil\fcharset0\fprq2 @Weibei TC Bold Western;}{\f6981\fbidi \fnil\fcharset238\fprq2 @Weibei TC Bold CE;}{\f6982\fbidi \fnil\fcharset204\fprq2 @Weibei TC Bold Cyr;}{\f6988\fbidi \fnil\fcharset186\fprq2 @Weibei TC Bold Baltic;}{\f6989\fbidi \fnil\fcharset163\fprq2 @Weibei TC Bold (Vietnamese);}{\f6993\fbidi \fnil\fcharset0\fprq2 Yuppy TC Regular Western;}{\f6992\fbidi \fnil\fcharset204\fprq2 Yuppy TC Regular Cyr;}{\f7003\fbidi \fnil\fcharset0\fprq2 @Yuppy TC Regular Western;}{\f7002\fbidi \fnil\fcharset204\fprq2 @Yuppy TC Regular Cyr;}{\f7013\fbidi \fnil\fcharset0\fprq2 \'b2\'d3\'a9\'fa\'c5\'e9 Western;}{\f7023\fbidi \fnil\fcharset0\fprq2 @\'b2\'d3\'a9\'fa\'c5\'e9 Western;}{\f7033\fbidi \fnil\fcharset0\fprq2 \'b2\'d3\'a9\'fa\'c5\'e9_HKSCS Western;}{\f7043\fbidi \fnil\fcharset0\fprq2 @\'b2\'d3\'a9\'fa\'c5\'e9_HKSCS Western;}{\f7053\fbidi \fnil\fcharset0\fprq2 @\'b7\'73\'b2\'d3\'a9\'fa\'c5\'e9 Western;}{\f7103\fbidi \fnil\fcharset0\fprq2 Adobe \'b7\'c2\'cb\'ce Std R Western;}{\f7101\fbidi \fnil\fcharset238\fprq2 Adobe \'b7\'c2\'cb\'ce Std R CE;}{\f7102\fbidi \fnil\fcharset204\fprq2 Adobe \'b7\'c2\'cb\'ce Std R Cyr;}{\f7113\fbidi \fnil\fcharset0\fprq2 @Adobe \'b7\'c2\'cb\'ce Std R Western;}{\f7111\fbidi \fnil\fcharset238\fprq2 @Adobe \'b7\'c2\'cb\'ce Std R CE;}{\f7112\fbidi \fnil\fcharset204\fprq2 @Adobe \'b7\'c2\'cb\'ce Std R Cyr;}{\f7123\fbidi \fnil\fcharset0\fprq2 Adobe \'ba\'da\'cc\'e5 Std R Western;}{\f7121\fbidi \fnil\fcharset238\fprq2 Adobe \'ba\'da\'cc\'e5 Std R CE;}{\f7122\fbidi \fnil\fcharset204\fprq2 Adobe \'ba\'da\'cc\'e5 Std R Cyr;}{\f7133\fbidi \fnil\fcharset0\fprq2 @Adobe \'ba\'da\'cc\'e5 Std R Western;}{\f7131\fbidi \fnil\fcharset238\fprq2 @Adobe \'ba\'da\'cc\'e5 Std R CE;}{\f7132\fbidi \fnil\fcharset204\fprq2 @Adobe \'ba\'da\'cc\'e5 Std R Cyr;}{\f7143\fbidi \fnil\fcharset0\fprq2 Adobe \'bf\'ac\'cc\'e5 Std R Western;}{\f7141\fbidi \fnil\fcharset238\fprq2 Adobe \'bf\'ac\'cc\'e5 Std R CE;}{\f7142\fbidi \fnil\fcharset204\fprq2 Adobe \'bf\'ac\'cc\'e5 Std R Cyr;}{\f7153\fbidi \fnil\fcharset0\fprq2 @Adobe \'bf\'ac\'cc\'e5 Std R Western;}{\f7151\fbidi \fnil\fcharset238\fprq2 @Adobe \'bf\'ac\'cc\'e5 Std R CE;}{\f7152\fbidi \fnil\fcharset204\fprq2 @Adobe \'bf\'ac\'cc\'e5 Std R Cyr;}{\f7163\fbidi \fnil\fcharset0\fprq2 Adobe \'cb\'ce\'cc\'e5 Std L Western;}{\f7161\fbidi \fnil\fcharset238\fprq2 Adobe \'cb\'ce\'cc\'e5 Std L CE;}{\f7162\fbidi \fnil\fcharset204\fprq2 Adobe \'cb\'ce\'cc\'e5 Std L Cyr;}{\f7173\fbidi \fnil\fcharset0\fprq2 @Adobe \'cb\'ce\'cc\'e5 Std L Western;}{\f7171\fbidi \fnil\fcharset238\fprq2 @Adobe \'cb\'ce\'cc\'e5 Std L CE;}{\f7172\fbidi \fnil\fcharset204\fprq2 @Adobe \'cb\'ce\'cc\'e5 Std L Cyr;}{\f7183\fbidi \fnil\fcharset0\fprq2 GB18030 Bitmap Western;}{\f7181\fbidi \fnil\fcharset238\fprq2 GB18030 Bitmap CE;}{\f7182\fbidi \fnil\fcharset204\fprq2 GB18030 Bitmap Cyr;}{\f7184\fbidi \fnil\fcharset161\fprq2 GB18030 Bitmap Greek;}{\f7185\fbidi \fnil\fcharset162\fprq2 GB18030 Bitmap Tur;}{\f7188\fbidi \fnil\fcharset186\fprq2 GB18030 Bitmap Baltic;}{\f7193\fbidi \fnil\fcharset0\fprq2 @GB18030 Bitmap Western;}{\f7191\fbidi \fnil\fcharset238\fprq2 @GB18030 Bitmap CE;}{\f7192\fbidi \fnil\fcharset204\fprq2 @GB18030 Bitmap Cyr;}{\f7194\fbidi \fnil\fcharset161\fprq2 @GB18030 Bitmap Greek;}{\f7195\fbidi \fnil\fcharset162\fprq2 @GB18030 Bitmap Tur;}{\f7198\fbidi \fnil\fcharset186\fprq2 @GB18030 Bitmap Baltic;}{\f7203\fbidi \fnil\fcharset0\fprq2 Hannotate SC Bold Western;}{\f7213\fbidi \fnil\fcharset0\fprq2 @Hannotate SC Bold Western;}{\f7223\fbidi \fnil\fcharset0\fprq2 Hannotate SC Regular Western;}{\f7233\fbidi \fnil\fcharset0\fprq2 @Hannotate SC Regular Western;}{\f7243\fbidi \fnil\fcharset0\fprq2 HanziPen SC Bold Western;}{\f7253\fbidi \fnil\fcharset0\fprq2 @HanziPen SC Bold Western;}{\f7263\fbidi \fnil\fcharset0\fprq2 HanziPen SC Regular Western;}{\f7273\fbidi \fnil\fcharset0\fprq2 @HanziPen SC Regular Western;}{\f7343\fbidi \fnil\fcharset0\fprq2 Hiragino Sans GB W3 Western;}{\f7341\fbidi \fnil\fcharset238\fprq2 Hiragino Sans GB W3 CE;}{\f7342\fbidi \fnil\fcharset204\fprq2 Hiragino Sans GB W3 Cyr;}{\f7353\fbidi \fnil\fcharset0\fprq2 @Hiragino Sans GB W3 Western;}{\f7351\fbidi \fnil\fcharset238\fprq2 @Hiragino Sans GB W3 CE;}{\f7352\fbidi \fnil\fcharset204\fprq2 @Hiragino Sans GB W3 Cyr;}{\f7363\fbidi \fnil\fcharset0\fprq2 Hiragino Sans GB W6 Western;}{\f7361\fbidi \fnil\fcharset238\fprq2 Hiragino Sans GB W6 CE;}{\f7362\fbidi \fnil\fcharset204\fprq2 Hiragino Sans GB W6 Cyr;}{\f7373\fbidi \fnil\fcharset0\fprq2 @Hiragino Sans GB W6 Western;}{\f7371\fbidi \fnil\fcharset238\fprq2 @Hiragino Sans GB W6 CE;}{\f7372\fbidi \fnil\fcharset204\fprq2 @Hiragino Sans GB W6 Cyr;}{\f7403\fbidi \fnil\fcharset0\fprq2 Kaiti SC Bold Western;}{\f7401\fbidi \fnil\fcharset238\fprq2 Kaiti SC Bold CE;}{\f7402\fbidi \fnil\fcharset204\fprq2 Kaiti SC Bold Cyr;}{\f7404\fbidi \fnil\fcharset161\fprq2 Kaiti SC Bold Greek;}{\f7405\fbidi \fnil\fcharset162\fprq2 Kaiti SC Bold Tur;}{\f7413\fbidi \fnil\fcharset0\fprq2 @Kaiti SC Bold Western;}{\f7411\fbidi \fnil\fcharset238\fprq2 @Kaiti SC Bold CE;}{\f7412\fbidi \fnil\fcharset204\fprq2 @Kaiti SC Bold Cyr;}{\f7414\fbidi \fnil\fcharset161\fprq2 @Kaiti SC Bold Greek;}{\f7415\fbidi \fnil\fcharset162\fprq2 @Kaiti SC Bold Tur;}{\f7423\fbidi \fnil\fcharset0\fprq2 Kaiti SC Regular Western;}{\f7421\fbidi \fnil\fcharset238\fprq2 Kaiti SC Regular CE;}{\f7422\fbidi \fnil\fcharset204\fprq2 Kaiti SC Regular Cyr;}{\f7424\fbidi \fnil\fcharset161\fprq2 Kaiti SC Regular Greek;}{\f7425\fbidi \fnil\fcharset162\fprq2 Kaiti SC Regular Tur;}{\f7433\fbidi \fnil\fcharset0\fprq2 @Kaiti SC Regular Western;}{\f7431\fbidi \fnil\fcharset238\fprq2 @Kaiti SC Regular CE;}{\f7432\fbidi \fnil\fcharset204\fprq2 @Kaiti SC Regular Cyr;}{\f7434\fbidi \fnil\fcharset161\fprq2 @Kaiti SC Regular Greek;}{\f7435\fbidi \fnil\fcharset162\fprq2 @Kaiti SC Regular Tur;}{\f7443\fbidi \fnil\fcharset0\fprq2 Songti SC Bold Western;}{\f7441\fbidi \fnil\fcharset238\fprq2 Songti SC Bold CE;}{\f7442\fbidi \fnil\fcharset204\fprq2 Songti SC Bold Cyr;}{\f7444\fbidi \fnil\fcharset161\fprq2 Songti SC Bold Greek;}{\f7445\fbidi \fnil\fcharset162\fprq2 Songti SC Bold Tur;}{\f7448\fbidi \fnil\fcharset186\fprq2 Songti SC Bold Baltic;}{\f7453\fbidi \fnil\fcharset0\fprq2 @Songti SC Bold Western;}{\f7451\fbidi \fnil\fcharset238\fprq2 @Songti SC Bold CE;}{\f7452\fbidi \fnil\fcharset204\fprq2 @Songti SC Bold Cyr;}{\f7454\fbidi \fnil\fcharset161\fprq2 @Songti SC Bold Greek;}{\f7455\fbidi \fnil\fcharset162\fprq2 @Songti SC Bold Tur;}{\f7458\fbidi \fnil\fcharset186\fprq2 @Songti SC Bold Baltic;}{\f7463\fbidi \fnil\fcharset0\fprq2 Songti SC Light Western;}{\f7461\fbidi \fnil\fcharset238\fprq2 Songti SC Light CE;}{\f7462\fbidi \fnil\fcharset204\fprq2 Songti SC Light Cyr;}{\f7464\fbidi \fnil\fcharset161\fprq2 Songti SC Light Greek;}{\f7465\fbidi \fnil\fcharset162\fprq2 Songti SC Light Tur;}{\f7473\fbidi \fnil\fcharset0\fprq2 @Songti SC Light Western;}{\f7471\fbidi \fnil\fcharset238\fprq2 @Songti SC Light CE;}{\f7472\fbidi \fnil\fcharset204\fprq2 @Songti SC Light Cyr;}{\f7474\fbidi \fnil\fcharset161\fprq2 @Songti SC Light Greek;}{\f7475\fbidi \fnil\fcharset162\fprq2 @Songti SC Light Tur;}{\f7483\fbidi \fnil\fcharset0\fprq2 Songti SC Regular Western;}{\f7481\fbidi \fnil\fcharset238\fprq2 Songti SC Regular CE;}{\f7482\fbidi \fnil\fcharset204\fprq2 Songti SC Regular Cyr;}{\f7484\fbidi \fnil\fcharset161\fprq2 Songti SC Regular Greek;}{\f7485\fbidi \fnil\fcharset162\fprq2 Songti SC Regular Tur;}{\f7488\fbidi \fnil\fcharset186\fprq2 Songti SC Regular Baltic;}{\f7493\fbidi \fnil\fcharset0\fprq2 @Songti SC Regular Western;}{\f7491\fbidi \fnil\fcharset238\fprq2 @Songti SC Regular CE;}{\f7492\fbidi \fnil\fcharset204\fprq2 @Songti SC Regular Cyr;}{\f7494\fbidi \fnil\fcharset161\fprq2 @Songti SC Regular Greek;}{\f7495\fbidi \fnil\fcharset162\fprq2 @Songti SC Regular Tur;}{\f7498\fbidi \fnil\fcharset186\fprq2 @Songti SC Regular Baltic;}{\f7503\fbidi \fnil\fcharset0\fprq2 Weibei SC Bold Western;}{\f7501\fbidi \fnil\fcharset238\fprq2 Weibei SC Bold CE;}{\f7502\fbidi \fnil\fcharset204\fprq2 Weibei SC Bold Cyr;}{\f7508\fbidi \fnil\fcharset186\fprq2 Weibei SC Bold Baltic;}{\f7509\fbidi \fnil\fcharset163\fprq2 Weibei SC Bold (Vietnamese);}{\f7513\fbidi \fnil\fcharset0\fprq2 @Weibei SC Bold Western;}{\f7511\fbidi \fnil\fcharset238\fprq2 @Weibei SC Bold CE;}{\f7512\fbidi \fnil\fcharset204\fprq2 @Weibei SC Bold Cyr;}{\f7518\fbidi \fnil\fcharset186\fprq2 @Weibei SC Bold Baltic;}{\f7519\fbidi \fnil\fcharset163\fprq2 @Weibei SC Bold (Vietnamese);}{\f7523\fbidi \fnil\fcharset0\fprq2 Yuanti SC Light Western;}{\f7521\fbidi \fnil\fcharset238\fprq2 Yuanti SC Light CE;}{\f7522\fbidi \fnil\fcharset204\fprq2 Yuanti SC Light Cyr;}{\f7524\fbidi \fnil\fcharset161\fprq2 Yuanti SC Light Greek;}{\f7525\fbidi \fnil\fcharset162\fprq2 Yuanti SC Light Tur;}{\f7528\fbidi \fnil\fcharset186\fprq2 Yuanti SC Light Baltic;}{\f7533\fbidi \fnil\fcharset0\fprq2 @Yuanti SC Light Western;}{\f7531\fbidi \fnil\fcharset238\fprq2 @Yuanti SC Light CE;}{\f7532\fbidi \fnil\fcharset204\fprq2 @Yuanti SC Light Cyr;}{\f7534\fbidi \fnil\fcharset161\fprq2 @Yuanti SC Light Greek;}{\f7535\fbidi \fnil\fcharset162\fprq2 @Yuanti SC Light Tur;}{\f7538\fbidi \fnil\fcharset186\fprq2 @Yuanti SC Light Baltic;}{\f7543\fbidi \fnil\fcharset0\fprq2 Yuppy SC Regular Western;}{\f7541\fbidi \fnil\fcharset238\fprq2 Yuppy SC Regular CE;}{\f7542\fbidi \fnil\fcharset204\fprq2 Yuppy SC Regular Cyr;}{\f7553\fbidi \fnil\fcharset0\fprq2 @Yuppy SC Regular Western;}{\f7551\fbidi \fnil\fcharset238\fprq2 @Yuppy SC Regular CE;}{\f7552\fbidi \fnil\fcharset204\fprq2 @Yuppy SC Regular Cyr;}{\f7563\fbidi \fnil\fcharset0\fprq2 \'ba\'da\'cc\'e5 Western;}{\f7573\fbidi \fnil\fcharset0\fprq2 @\'ba\'da\'cc\'e5 Western;}{\f7583\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Western;}{\f7581\fbidi \fnil\fcharset238\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce CE;}{\f7582\fbidi \fnil\fcharset204\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Cyr;}{\f7584\fbidi \fnil\fcharset161\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Greek;}{\f7585\fbidi \fnil\fcharset162\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Tur;}{\f7588\fbidi \fnil\fcharset186\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Baltic;}{\f7593\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Western;}{\f7591\fbidi \fnil\fcharset238\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce CE;}{\f7592\fbidi \fnil\fcharset204\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Cyr;}{\f7594\fbidi \fnil\fcharset161\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Greek;}{\f7595\fbidi \fnil\fcharset162\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Tur;}{\f7598\fbidi \fnil\fcharset186\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Baltic;}{\f7603\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Western;}{\f7601\fbidi \fnil\fcharset238\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 CE;}{\f7602\fbidi \fnil\fcharset204\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Cyr;}{\f7604\fbidi \fnil\fcharset161\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Greek;}{\f7605\fbidi \fnil\fcharset162\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Tur;}{\f7608\fbidi \fnil\fcharset186\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Baltic;}{\f7613\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Western;}{\f7611\fbidi \fnil\fcharset238\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 CE;}{\f7612\fbidi \fnil\fcharset204\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Cyr;}{\f7614\fbidi \fnil\fcharset161\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Greek;}{\f7615\fbidi \fnil\fcharset162\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Tur;}{\f7618\fbidi \fnil\fcharset186\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Baltic;}{\f7623\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Western;}{\f7621\fbidi \fnil\fcharset238\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 CE;}{\f7622\fbidi \fnil\fcharset204\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Cyr;}{\f7624\fbidi \fnil\fcharset161\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Greek;}{\f7625\fbidi \fnil\fcharset162\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Tur;}{\f7633\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Western;}{\f7631\fbidi \fnil\fcharset238\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 CE;}{\f7632\fbidi \fnil\fcharset204\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Cyr;}{\f7634\fbidi \fnil\fcharset161\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Greek;}{\f7635\fbidi \fnil\fcharset162\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Tur;}{\f7643\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Western;}{\f7641\fbidi \fnil\fcharset238\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 CE;}{\f7642\fbidi \fnil\fcharset204\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Cyr;}{\f7644\fbidi \fnil\fcharset161\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Greek;}{\f7645\fbidi \fnil\fcharset162\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Tur;}{\f7653\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Western;}{\f7651\fbidi \fnil\fcharset238\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 CE;}{\f7652\fbidi \fnil\fcharset204\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Cyr;}{\f7654\fbidi \fnil\fcharset161\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Greek;}{\f7655\fbidi \fnil\fcharset162\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Tur;}{\f7663\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'cf\'b8\'ba\'da Western;}{\f7673\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'cf\'b8\'ba\'da Western;}{\f7683\fbidi \fnil\fcharset0\fprq2 @\'cb\'ce\'cc\'e5 Western;}{\f7693\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\f7691\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\f7692\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\f7694\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\f7695\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\f7698\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\f7703\fbidi \fnil\fcharset0\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\f7701\fbidi \fnil\fcharset238\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\f7702\fbidi \fnil\fcharset204\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\f7704\fbidi \fnil\fcharset161\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\f7705\fbidi \fnil\fcharset162\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\f7708\fbidi \fnil\fcharset186\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\f7713\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Western;}{\f7711\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 CE;}{\f7712\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Cyr;}{\f7714\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Greek;}{\f7715\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Tur;}{\f7718\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Baltic;}{\f7723\fbidi \fnil\fcharset0\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Western;}{\f7721\fbidi \fnil\fcharset238\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 CE;}{\f7722\fbidi \fnil\fcharset204\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Cyr;}{\f7724\fbidi \fnil\fcharset161\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Greek;}{\f7725\fbidi \fnil\fcharset162\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Tur;}{\f7728\fbidi \fnil\fcharset186\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Baltic;}{\f7733\fbidi \fnil\fcharset0\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\f7731\fbidi \fnil\fcharset238\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\f7732\fbidi \fnil\fcharset204\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\f7734\fbidi \fnil\fcharset161\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\f7735\fbidi \fnil\fcharset162\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\f7738\fbidi \fnil\fcharset186\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\f7743\fbidi \fnil\fcharset0\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Western;}{\f7741\fbidi \fnil\fcharset238\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 CE;}{\f7742\fbidi \fnil\fcharset204\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Cyr;}{\f7744\fbidi \fnil\fcharset161\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Greek;}{\f7745\fbidi \fnil\fcharset162\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Tur;}{\f7748\fbidi \fnil\fcharset186\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Baltic;}{\f7753\fbidi \fnil\fcharset0\fprq2 Osaka Western;}{\f7751\fbidi \fnil\fcharset238\fprq2 Osaka CE;}{\f7755\fbidi \fnil\fcharset162\fprq2 Osaka Tur;}{\f7758\fbidi \fnil\fcharset186\fprq2 Osaka Baltic;}{\f7763\fbidi \fnil\fcharset0\fprq2 @Osaka Western;}{\f7761\fbidi \fnil\fcharset238\fprq2 @Osaka CE;}{\f7765\fbidi \fnil\fcharset162\fprq2 @Osaka Tur;}{\f7768\fbidi \fnil\fcharset186\fprq2 @Osaka Baltic;}{\f7773\fbidi \fnil\fcharset0\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d Western;}{\f7771\fbidi \fnil\fcharset238\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d CE;}{\f7775\fbidi \fnil\fcharset162\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d Tur;}{\f7778\fbidi \fnil\fcharset186\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d Baltic;}{\f7783\fbidi \fnil\fcharset0\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d Western;}{\f7781\fbidi \fnil\fcharset238\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d CE;}{\f7785\fbidi \fnil\fcharset162\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d Tur;}{\f7788\fbidi \fnil\fcharset186\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d Baltic;}{\f7793\fbidi \fnil\fcharset0\fprq2 YuGothic Bold Western;}{\f7791\fbidi \fnil\fcharset238\fprq2 YuGothic Bold CE;}{\f7792\fbidi \fnil\fcharset204\fprq2 YuGothic Bold Cyr;}{\f7794\fbidi \fnil\fcharset161\fprq2 YuGothic Bold Greek;}{\f7795\fbidi \fnil\fcharset162\fprq2 YuGothic Bold Tur;}{\f7798\fbidi \fnil\fcharset186\fprq2 YuGothic Bold Baltic;}{\f7803\fbidi \fnil\fcharset0\fprq2 @YuGothic Bold Western;}{\f7801\fbidi \fnil\fcharset238\fprq2 @YuGothic Bold CE;}{\f7802\fbidi \fnil\fcharset204\fprq2 @YuGothic Bold Cyr;}{\f7804\fbidi \fnil\fcharset161\fprq2 @YuGothic Bold Greek;}{\f7805\fbidi \fnil\fcharset162\fprq2 @YuGothic Bold Tur;}{\f7808\fbidi \fnil\fcharset186\fprq2 @YuGothic Bold Baltic;}{\f7813\fbidi \fnil\fcharset0\fprq2 YuGothic Medium Western;}{\f7811\fbidi \fnil\fcharset238\fprq2 YuGothic Medium CE;}{\f7812\fbidi \fnil\fcharset204\fprq2 YuGothic Medium Cyr;}{\f7814\fbidi \fnil\fcharset161\fprq2 YuGothic Medium Greek;}{\f7815\fbidi \fnil\fcharset162\fprq2 YuGothic Medium Tur;}{\f7818\fbidi \fnil\fcharset186\fprq2 YuGothic Medium Baltic;}{\f7823\fbidi \fnil\fcharset0\fprq2 @YuGothic Medium Western;}{\f7821\fbidi \fnil\fcharset238\fprq2 @YuGothic Medium CE;}{\f7822\fbidi \fnil\fcharset204\fprq2 @YuGothic Medium Cyr;}{\f7824\fbidi \fnil\fcharset161\fprq2 @YuGothic Medium Greek;}{\f7825\fbidi \fnil\fcharset162\fprq2 @YuGothic Medium Tur;}{\f7828\fbidi \fnil\fcharset186\fprq2 @YuGothic Medium Baltic;}{\f7833\fbidi \fnil\fcharset0\fprq2 YuMincho Demibold Western;}{\f7831\fbidi \fnil\fcharset238\fprq2 YuMincho Demibold CE;}{\f7832\fbidi \fnil\fcharset204\fprq2 YuMincho Demibold Cyr;}{\f7834\fbidi \fnil\fcharset161\fprq2 YuMincho Demibold Greek;}{\f7835\fbidi \fnil\fcharset162\fprq2 YuMincho Demibold Tur;}{\f7838\fbidi \fnil\fcharset186\fprq2 YuMincho Demibold Baltic;}{\f7843\fbidi \fnil\fcharset0\fprq2 @YuMincho Demibold Western;}{\f7841\fbidi \fnil\fcharset238\fprq2 @YuMincho Demibold CE;}{\f7842\fbidi \fnil\fcharset204\fprq2 @YuMincho Demibold Cyr;}{\f7844\fbidi \fnil\fcharset161\fprq2 @YuMincho Demibold Greek;}{\f7845\fbidi \fnil\fcharset162\fprq2 @YuMincho Demibold Tur;}{\f7848\fbidi \fnil\fcharset186\fprq2 @YuMincho Demibold Baltic;}{\f7853\fbidi \fnil\fcharset0\fprq2 YuMincho Medium Western;}{\f7851\fbidi \fnil\fcharset238\fprq2 YuMincho Medium CE;}{\f7852\fbidi \fnil\fcharset204\fprq2 YuMincho Medium Cyr;}{\f7854\fbidi \fnil\fcharset161\fprq2 YuMincho Medium Greek;}{\f7855\fbidi \fnil\fcharset162\fprq2 YuMincho Medium Tur;}{\f7858\fbidi \fnil\fcharset186\fprq2 YuMincho Medium Baltic;}{\f7863\fbidi \fnil\fcharset0\fprq2 @YuMincho Medium Western;}{\f7861\fbidi \fnil\fcharset238\fprq2 @YuMincho Medium CE;}{\f7862\fbidi \fnil\fcharset204\fprq2 @YuMincho Medium Cyr;}{\f7864\fbidi \fnil\fcharset161\fprq2 @YuMincho Medium Greek;}{\f7865\fbidi \fnil\fcharset162\fprq2 @YuMincho Medium Tur;}{\f7868\fbidi \fnil\fcharset186\fprq2 @YuMincho Medium Baltic;}{\f7873\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Western;}{\f7872\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Cyr;}{\f7874\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Greek;}{\f7883\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Western;}{\f7882\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Cyr;}{\f7884\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Greek;}{\f7893\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Western;}{\f7892\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Cyr;}{\f7894\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Greek;}{\f7903\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Western;}{\f7902\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Cyr;}{\f7904\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Greek;}{\f7913\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Western;}{\f7912\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Cyr;}{\f7914\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Greek;}{\f7923\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Western;}{\f7922\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Cyr;}{\f7924\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Greek;}{\f7933\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Western;}{\f7932\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Cyr;}{\f7934\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Greek;}{\f7943\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Western;}{\f7942\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Cyr;}{\f7944\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Greek;}{\f7953\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Western;}{\f7952\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Cyr;}{\f7954\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Greek;}{\f7963\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Western;}{\f7962\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Cyr;}{\f7964\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Greek;}{\f7973\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Western;}{\f7972\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Cyr;}{\f7974\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Greek;}{\f7983\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Western;}{\f7982\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Cyr;}{\f7984\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Greek;}{\f7993\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Western;}{\f7992\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Cyr;}{\f7994\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Greek;}{\f8003\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Western;}{\f8002\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Cyr;}{\f8004\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Greek;}{\f8013\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Western;}{\f8012\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Cyr;}{\f8014\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Greek;}{\f8023\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Western;}{\f8022\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Cyr;}{\f8024\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Greek;}{\f8033\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Western;}{\f8032\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Cyr;}{\f8034\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Greek;}{\f8043\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Western;}{\f8042\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Cyr;}{\f8044\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Greek;}{\f8053\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Western;}{\f8052\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Cyr;}{\f8054\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Greek;}{\f8063\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Western;}{\f8062\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Cyr;}{\f8064\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Greek;}{\f8073\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Western;}{\f8072\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Cyr;}{\f8074\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Greek;}{\f8083\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Western;}{\f8082\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Cyr;}{\f8084\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Greek;}{\f8093\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Western;}{\f8092\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Cyr;}{\f8094\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Greek;}{\f8103\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Western;}{\f8102\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Cyr;}{\f8104\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Greek;}{\f8113\fbidi \fnil\fcharset0\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Western;}{\f8111\fbidi \fnil\fcharset238\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 CE;}{\f8112\fbidi \fnil\fcharset204\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Cyr;}{\f8114\fbidi \fnil\fcharset161\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Greek;}{\f8115\fbidi \fnil\fcharset162\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Tur;}{\f8118\fbidi \fnil\fcharset186\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Baltic;}{\f8123\fbidi \fnil\fcharset0\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Western;}{\f8121\fbidi \fnil\fcharset238\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 CE;}{\f8122\fbidi \fnil\fcharset204\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Cyr;}{\f8124\fbidi \fnil\fcharset161\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Greek;}{\f8125\fbidi \fnil\fcharset162\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Tur;}{\f8128\fbidi \fnil\fcharset186\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Baltic;}{\f8133\fbidi \fnil\fcharset0\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Western;}{\f8131\fbidi \fnil\fcharset238\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e CE;}{\f8132\fbidi \fnil\fcharset204\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Cyr;}{\f8134\fbidi \fnil\fcharset161\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Greek;}{\f8135\fbidi \fnil\fcharset162\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Tur;}{\f8138\fbidi \fnil\fcharset186\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Baltic;}{\f8143\fbidi \fnil\fcharset0\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Western;}{\f8141\fbidi \fnil\fcharset238\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e CE;}{\f8142\fbidi \fnil\fcharset204\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Cyr;}{\f8144\fbidi \fnil\fcharset161\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Greek;}{\f8145\fbidi \fnil\fcharset162\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Tur;}{\f8148\fbidi \fnil\fcharset186\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Baltic;}{\f8153\fbidi \fnil\fcharset0\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Western;}{\f8151\fbidi \fnil\fcharset238\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 CE;}{\f8152\fbidi \fnil\fcharset204\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Cyr;}{\f8154\fbidi \fnil\fcharset161\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Greek;}{\f8155\fbidi \fnil\fcharset162\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Tur;}{\f8158\fbidi \fnil\fcharset186\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Baltic;}{\f8163\fbidi \fnil\fcharset0\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Western;}{\f8161\fbidi \fnil\fcharset238\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 CE;}{\f8162\fbidi \fnil\fcharset204\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Cyr;}{\f8164\fbidi \fnil\fcharset161\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Greek;}{\f8165\fbidi \fnil\fcharset162\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Tur;}{\f8168\fbidi \fnil\fcharset186\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Baltic;}{\f8173\fbidi \fnil\fcharset0\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Western;}{\f8171\fbidi \fnil\fcharset238\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e CE;}{\f8172\fbidi \fnil\fcharset204\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Cyr;}{\f8174\fbidi \fnil\fcharset161\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Greek;}{\f8175\fbidi \fnil\fcharset162\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Tur;}{\f8178\fbidi \fnil\fcharset186\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Baltic;}{\f8183\fbidi \fnil\fcharset0\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Western;}{\f8181\fbidi \fnil\fcharset238\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e CE;}{\f8182\fbidi \fnil\fcharset204\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Cyr;}{\f8184\fbidi \fnil\fcharset161\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Greek;}{\f8185\fbidi \fnil\fcharset162\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Tur;}{\f8188\fbidi \fnil\fcharset186\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Baltic;}{\f8193\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Western;}{\f8191\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B CE;}{\f8192\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Cyr;}{\f8194\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Greek;}{\f8195\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Tur;}{\f8198\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Baltic;}{\f8203\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Western;}{\f8201\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B CE;}{\f8202\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Cyr;}{\f8204\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Greek;}{\f8205\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Tur;}{\f8208\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Baltic;}{\f8213\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Western;}{\f8211\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL CE;}{\f8212\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Cyr;}{\f8214\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Greek;}{\f8215\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Tur;}{\f8218\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Baltic;}{\f8223\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Western;}{\f8221\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL CE;}{\f8222\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Cyr;}{\f8224\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Greek;}{\f8225\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Tur;}{\f8228\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Baltic;}{\f8233\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Western;}{\f8231\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H CE;}{\f8232\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Cyr;}{\f8234\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Greek;}{\f8235\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Tur;}{\f8238\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Baltic;}{\f8243\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Western;}{\f8241\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H CE;}{\f8242\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Cyr;}{\f8244\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Greek;}{\f8245\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Tur;}{\f8248\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Baltic;}{\f8253\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Western;}{\f8251\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L CE;}{\f8252\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Cyr;}{\f8254\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Greek;}{\f8255\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Tur;}{\f8258\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Baltic;}{\f8263\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Western;}{\f8261\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L CE;}{\f8262\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Cyr;}{\f8264\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Greek;}{\f8265\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Tur;}{\f8268\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Baltic;}{\f8273\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Western;}{\f8271\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M CE;}{\f8272\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Cyr;}{\f8274\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Greek;}{\f8275\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Tur;}{\f8278\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Baltic;}{\f8283\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Western;}{\f8281\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M CE;}{\f8282\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Cyr;}{\f8284\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Greek;}{\f8285\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Tur;}{\f8288\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Baltic;}{\f8293\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Western;}{\f8291\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R CE;}{\f8292\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Cyr;}{\f8294\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Greek;}{\f8295\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Tur;}{\f8298\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Baltic;}{\f8303\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Western;}{\f8301\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R CE;}{\f8302\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Cyr;}{\f8304\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Greek;}{\f8305\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Tur;}{\f8308\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Baltic;}{\f8313\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B Western;}{\f8312\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B Cyr;}{\f8323\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B Western;}{\f8322\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B Cyr;}{\f8333\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL Western;}{\f8332\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL Cyr;}{\f8343\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL Western;}{\f8342\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL Cyr;}{\f8353\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H Western;}{\f8352\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H Cyr;}{\f8363\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H Western;}{\f8362\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H Cyr;}{\f8373\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L Western;}{\f8372\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L Cyr;}{\f8383\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L Western;}{\f8382\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L Cyr;}{\f8393\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M Western;}{\f8392\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M Cyr;}{\f8403\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M Western;}{\f8402\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M Cyr;}{\f8413\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R Western;}{\f8412\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R Cyr;}{\f8423\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R Western;}{\f8422\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R Cyr;}{\f8433\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Western;}{\f8431\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B CE;}{\f8432\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Cyr;}{\f8434\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Greek;}{\f8435\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Tur;}{\f8438\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Baltic;}{\f8443\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Western;}{\f8441\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B CE;}{\f8442\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Cyr;}{\f8444\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Greek;}{\f8445\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Tur;}{\f8448\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Baltic;}{\f8453\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Western;}{\f8451\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL CE;}{\f8452\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Cyr;}{\f8454\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Greek;}{\f8455\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Tur;}{\f8458\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Baltic;}{\f8463\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Western;}{\f8461\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL CE;}{\f8462\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Cyr;}{\f8464\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Greek;}{\f8465\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Tur;}{\f8468\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Baltic;}{\f8473\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Western;}{\f8471\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H CE;}{\f8472\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Cyr;}{\f8474\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Greek;}{\f8475\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Tur;}{\f8478\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Baltic;}{\f8483\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Western;}{\f8481\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H CE;}{\f8482\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Cyr;}{\f8484\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Greek;}{\f8485\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Tur;}{\f8488\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Baltic;}{\f8493\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Western;}{\f8491\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L CE;}{\f8492\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Cyr;}{\f8494\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Greek;}{\f8495\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Tur;}{\f8498\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Baltic;}{\f8503\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Western;}{\f8501\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L CE;}{\f8502\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Cyr;}{\f8504\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Greek;}{\f8505\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Tur;}{\f8508\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Baltic;}{\f8511\fbidi \fnil\fcharset238\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M CE;}{\f8512\fbidi \fnil\fcharset204\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M Cyr;}{\f8514\fbidi \fnil\fcharset161\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M Greek;}{\f8515\fbidi \fnil\fcharset162\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M Tur;}{\f8518\fbidi \fnil\fcharset186\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M Baltic;}{\f8523\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Western;}{\f8521\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R CE;}{\f8522\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Cyr;}{\f8524\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Greek;}{\f8525\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Tur;}{\f8528\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Baltic;}{\f8533\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Western;}{\f8531\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R CE;}{\f8532\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Cyr;}{\f8534\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Greek;}{\f8535\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Tur;}{\f8538\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Baltic;}{\f8543\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B Western;}{\f8542\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B Cyr;}{\f8553\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B Western;}{\f8552\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B Cyr;}{\f8563\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL Western;}{\f8562\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL Cyr;}{\f8573\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL Western;}{\f8572\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL Cyr;}{\f8583\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H Western;}{\f8582\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H Cyr;}{\f8593\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H Western;}{\f8592\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H Cyr;}{\f8603\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L Western;}{\f8602\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L Cyr;}{\f8613\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L Western;}{\f8612\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L Cyr;}{\f8623\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M Western;}{\f8622\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M Cyr;}{\f8633\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M Western;}{\f8632\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M Cyr;}{\f8643\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R Western;}{\f8642\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R Cyr;}{\f8653\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R Western;}{\f8652\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R Cyr;}{\f8663\fbidi \fnil\fcharset0\fprq2 Adobe \'b0\'ed\'b5\'f1 Std B Western;}{\f8662\fbidi \fnil\fcharset204\fprq2 Adobe \'b0\'ed\'b5\'f1 Std B Cyr;}{\f8673\fbidi \fnil\fcharset0\fprq2 @Adobe \'b0\'ed\'b5\'f1 Std B Western;}{\f8672\fbidi \fnil\fcharset204\fprq2 @Adobe \'b0\'ed\'b5\'f1 Std B Cyr;}{\f8683\fbidi \fnil\fcharset0\fprq2 Adobe \'b8\'ed\'c1\'b6 Std M Western;}{\f8682\fbidi \fnil\fcharset204\fprq2 Adobe \'b8\'ed\'c1\'b6 Std M Cyr;}{\f8693\fbidi \fnil\fcharset0\fprq2 @Adobe \'b8\'ed\'c1\'b6 Std M Western;}{\f8692\fbidi \fnil\fcharset204\fprq2 @Adobe \'b8\'ed\'c1\'b6 Std M Cyr;}{\f8703\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee Western;}{\f8702\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee Cyr;}{\f8713\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee Western;}{\f8712\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee Cyr;}{\f8723\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc Western;}{\f8722\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc Cyr;}{\f8733\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc Western;}{\f8732\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc Cyr;}{\f8743\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc Western;}{\f8742\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc Cyr;}{\f8753\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc Western;}{\f8752\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc Cyr;}{\f8763\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc Western;}{\f8762\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc Cyr;}{\f8773\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc Western;}{\f8772\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc Cyr;}{\f8783\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc Western;}{\f8782\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc Cyr;}{\f8793\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc Western;}{\f8792\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc Cyr;}{\f8803\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc Western;}{\f8802\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc Cyr;}{\f8813\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc Western;}{\f8812\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc Cyr;}{\f8883\fbidi \fnil\fcharset0\fprq2 \'b1\'bc\'b8\'b2 Western;}{\f8881\fbidi \fnil\fcharset238\fprq2 \'b1\'bc\'b8\'b2 CE;}{\f8882\fbidi \fnil\fcharset204\fprq2 \'b1\'bc\'b8\'b2 Cyr;}{\f8884\fbidi \fnil\fcharset161\fprq2 \'b1\'bc\'b8\'b2 Greek;}{\f8885\fbidi \fnil\fcharset162\fprq2 \'b1\'bc\'b8\'b2 Tur;}{\f8888\fbidi \fnil\fcharset186\fprq2 \'b1\'bc\'b8\'b2 Baltic;}{\f8893\fbidi \fnil\fcharset0\fprq2 @\'b1\'bc\'b8\'b2 Western;}{\f8891\fbidi \fnil\fcharset238\fprq2 @\'b1\'bc\'b8\'b2 CE;}{\f8892\fbidi \fnil\fcharset204\fprq2 @\'b1\'bc\'b8\'b2 Cyr;}{\f8894\fbidi \fnil\fcharset161\fprq2 @\'b1\'bc\'b8\'b2 Greek;}{\f8895\fbidi \fnil\fcharset162\fprq2 @\'b1\'bc\'b8\'b2 Tur;}{\f8898\fbidi \fnil\fcharset186\fprq2 @\'b1\'bc\'b8\'b2 Baltic;}{\f8923\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Western;}{\f8933\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Western;}{\f8943\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Bold Western;}{\f8953\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Bold Western;}{\f8963\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 ExtraBold Western;}{\f8973\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 ExtraBold Western;}{\f8983\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Western;}{\f8993\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Western;}{\f9003\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Bold Western;}{\f9013\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Bold Western;}{\f9023\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 ExtraBold Western;}{\f9033\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 ExtraBold Western;}{\f9043\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'ba\'d7 Western;}{\f9053\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'ba\'d7 Western;}{\f9063\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'c6\'e6 Western;}{\f9073\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'c6\'e6 Western;}{\f9083\fbidi \fnil\fcharset0\fprq2 @\'b9\'d9\'c5\'c1 Western;}{\f9081\fbidi \fnil\fcharset238\fprq2 @\'b9\'d9\'c5\'c1 CE;}{\f9082\fbidi \fnil\fcharset204\fprq2 @\'b9\'d9\'c5\'c1 Cyr;}{\f9084\fbidi \fnil\fcharset161\fprq2 @\'b9\'d9\'c5\'c1 Greek;}{\f9085\fbidi \fnil\fcharset162\fprq2 @\'b9\'d9\'c5\'c1 Tur;}{\f9088\fbidi \fnil\fcharset186\fprq2 @\'b9\'d9\'c5\'c1 Baltic;}{\flomajor\f31508\fbidi \fnil\fcharset238\fprq2 Arial CE;}{\flomajor\f31509\fbidi \fnil\fcharset204\fprq2 Arial Cyr;}{\flomajor\f31511\fbidi \fnil\fcharset161\fprq2 Arial Greek;}{\flomajor\f31512\fbidi \fnil\fcharset162\fprq2 Arial Tur;}{\flomajor\f31513\fbidi \fnil\fcharset177\fprq2 Arial (Hebrew);}{\flomajor\f31514\fbidi \fnil\fcharset178\fprq2 Arial (Arabid);}{\flomajor\f31515\fbidi \fnil\fcharset186\fprq2 Arial Baltic;}{\flomajor\f31516\fbidi \fnil\fcharset163\fprq2 Arial (Vietnamese);}{\fdbmajor\f31520\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\fdbmajor\f31518\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\fdbmajor\f31519\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\fdbmajor\f31521\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\fdbmajor\f31522\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\fdbmajor\f31525\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\fhimajor\f31528\fbidi \fnil\fcharset238\fprq2 Calibri CE;}{\fhimajor\f31529\fbidi \fnil\fcharset204\fprq2 Calibri Cyr;}{\fhimajor\f31531\fbidi \fnil\fcharset161\fprq2 Calibri Greek;}{\fhimajor\f31532\fbidi \fnil\fcharset162\fprq2 Calibri Tur;}{\fhimajor\f31535\fbidi \fnil\fcharset186\fprq2 Calibri Baltic;}{\fhimajor\f31536\fbidi \fnil\fcharset163\fprq2 Calibri (Vietnamese);}{\fbimajor\f31538\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\fbimajor\f31539\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\fbimajor\f31541\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\fbimajor\f31542\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\fbimajor\f31543\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbimajor\f31544\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\fbimajor\f31545\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\fbimajor\f31546\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\flominor\f31548\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\flominor\f31549\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\flominor\f31551\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\flominor\f31552\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\flominor\f31553\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\flominor\f31554\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\flominor\f31555\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\flominor\f31556\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\fdbminor\f31560\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Western;}{\fdbminor\f31558\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 CE;}{\fdbminor\f31559\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Cyr;}{\fdbminor\f31561\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Greek;}{\fdbminor\f31562\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Tur;}{\fdbminor\f31565\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Baltic;}{\fhiminor\f31568\fbidi \fnil\fcharset238\fprq2 Cambria CE;}{\fhiminor\f31569\fbidi \fnil\fcharset204\fprq2 Cambria Cyr;}{\fhiminor\f31571\fbidi \fnil\fcharset161\fprq2 Cambria Greek;}{\fhiminor\f31572\fbidi \fnil\fcharset162\fprq2 Cambria Tur;}{\fhiminor\f31575\fbidi \fnil\fcharset186\fprq2 Cambria Baltic;}{\fhiminor\f31576\fbidi \fnil\fcharset163\fprq2 Cambria (Vietnamese);}{\fbiminor\f31578\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\fbiminor\f31579\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\fbiminor\f31581\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\fbiminor\f31582\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\fbiminor\f31583\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbiminor\f31584\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\fbiminor\f31585\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\fbiminor\f31586\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}}{\colortbl;\red0\green0\blue0;\red0\green0\blue255;\red0\green255\blue255;\red0\green255\blue0;\red255\green0\blue255;\red255\green0\blue0;\red255\green255\blue0;\red255\green255\blue255;\red0\green0\blue128;\red0\green128\blue128;\red0\green128\blue0;\red128\green0\blue128;\red128\green0\blue0;\red128\green128\blue0;\red128\green128\blue128;\red192\green192\blue192;\red235\green235\blue216;\red204\green0\blue51;}{\*\defchp }{\*\defpap \ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 }\noqfpromote {\stylesheet{\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 \snext0 \sqformat \spriority0 Normal;}{\*\cs10 \additive \ssemihidden \sunhideused \spriority1 Default Paragraph Font;}{\*\ts11\tsrowd\trftsWidthB3\trpaddl108\trpaddr108\trpaddfl3\trpaddft3\trpaddfb3\trpaddfr3\tblind0\tblindtype3\tsvertalt\tsbrdrt\tsbrdrl\tsbrdrb\tsbrdrr\tsbrdrdgl\tsbrdrdgr\tsbrdrh\tsbrdrv \ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 \snext11 \ssemihidden \sunhideused Normal Table;}}{\*\revtbl {Unknown;}}{\*\rsidtbl \rsid10898414\rsid15085367}{\mmathPr\mmathFont34\mbrkBin0\mbrkBinSub0\msmallFrac0\mdispDef1\mlMargin0\mrMargin0\mdefJc1\mwrapIndent1440\mintLim0\mnaryLim1}{\info{\operator Duco Wiertsema}{\creatim\yr2013\mo11\dy26\hr21}{\revtim\yr2013\mo11\dy26\hr21}{\version2}{\edmins0}{\nofpages298}{\nofwords137190}{\nofchars781988}{\nofcharsws917344}{\vern49555}{\*\saveprevpict}}{\*\xmlnstbl {\xmlns1 http://schemas.microsoft.com/office/word/2003/wordml}}\paperw12240\paperh15840\margl1296\margr1296\margt1728\margb1296\gutter0\ltrsect \ftnbj\aenddoc\trackmoves0\trackformatting1\donotembedsysfont0\relyonvml0\donotembedlingdata1\grfdocevents0\validatexml0\showplaceholdtext0\ignoremixedcontent0\saveinvalidxml0\showxmlerrors0\hyphauto1\horzdoc\dghspace120\dgvspace120\dghorigin1701\dgvorigin1984\dghshow0\dgvshow3\jcompress\viewkind1\viewscale140\rsidroot15085367\outdisponlyhtml \fet0{\*\wgrffmtfilter 2450}\ilfomacatclnup0{\*\ftnsep \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid10898414 \chftnsep \par }}{\*\ftnsepc \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid10898414 \chftnsepc \par }}{\*\aftnsep \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid10898414 \chftnsep \par }}{\*\aftnsepc \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid10898414 \chftnsepc \par }}\ltrpar \sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}{\*\pnseclvl1\pnucrm\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl2\pnucltr\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl3\pndec\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl4\pnlcltr\pnstart1\pnindent720\pnhang {\pntxta )}}{\*\pnseclvl5\pndec\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl6\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl7\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl8\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl9\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}\ltrrow\trowd \irow0\irowband0\ltrrow\ts11\trgaph60\trleft-60\trhdr\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth540\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth9180\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx9660\pard\plain \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_1_0}{\*\bkmkstart cite_id_1}{\*\bkmkend DOC_ID_1_0}{\*\bkmkend cite_id_1} \cell Results\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\ltrrow\ts11\trgaph60\trleft-60\trhdr\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth540\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth9180\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx9660\row \ltrrow}\trowd \irow1\irowband1\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 1.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_1"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Fighting pain and suffering}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The Age (Melbourne, Australia), November 21, 2012 Wednesday, NEWS; Focus; Pg. 20, 1667 words, Amrit Dhillon is a Delhi-based journalist.\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow1\irowband1\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_2_0}{\*\bkmkstart cite_id_2}{\*\bkmkend DOC_ID_2_0}{\*\bkmkend cite_id_2}2.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_2"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Cost a bitter pill to swallow}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   South China Morning Post, July 31, 2012 Tuesday, FEATURES; Pg. 09, 1016 words, Amrit Dhillon healthpost@scmp.com\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_3_0}{\*\bkmkstart cite_id_3}{\*\bkmkend DOC_ID_3_0}{\*\bkmkend cite_id_3}3.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_3"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  Quality Chemicals Giving Locals Fighting Chance}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, May 18, 2012 Friday, 947 words, New Vision (Kampala)\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_4_0}{\*\bkmkstart cite_id_4}{\*\bkmkend DOC_ID_4_0}{\*\bkmkend cite_id_4}4.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_4"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Quality Chemicals Giving Locals Fighting Chance}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   New Vision (Kampala), May 18, 2012 Friday, 947 words, Raymond Baguma\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_5_0}{\*\bkmkstart cite_id_5}{\*\bkmkend DOC_ID_5_0}{\*\bkmkend cite_id_5}5.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_5"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Health and Medicine;  Patents Versus Access to Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, May 14, 2012 Monday, 941 words, Health-e (Cape Town)\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_6_0}{\*\bkmkstart cite_id_6}{\*\bkmkend DOC_ID_6_0}{\*\bkmkend cite_id_6}6.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_6"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Patents Versus Access to Drugs [analysis]}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Health-e (Cape Town), May 14, 2012 Monday, 941  words, Anso Thom\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_7_0}{\*\bkmkstart cite_id_7}{\*\bkmkend DOC_ID_7_0}{\*\bkmkend cite_id_7}7.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_7"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Martin Khor}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The Nation (Thailand), February 8, 2012 Wednesday, 818 words, The Nation\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_8_0}{\*\bkmkstart cite_id_8}{\*\bkmkend DOC_ID_8_0}{\*\bkmkend cite_id_8}8.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_8"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  Lives At Risk As 90 Per Cent of Aids Drugs Could Be Declared Illegal}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, November 16, 2011 Wednesday, 728 words, The Monitor (Kampala)\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_9_0}{\*\bkmkstart cite_id_9}{\*\bkmkend DOC_ID_9_0}{\*\bkmkend cite_id_9}9.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_9"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Lives At Risk As 90 Per Cent of Aids Drugs Could Be Declared Illegal [opinion]}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The Monitor (Kampala), November 16, 2011 Wednesday, 728 words, Henry Zakumumpa\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_10_0}{\*\bkmkstart cite_id_10}{\*\bkmkend DOC_ID_10_0}{\*\bkmkend cite_id_10}10.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_10"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Africa;  The End of Cheap Medicine?}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, November 15, 2011 Tuesday, 2987 words, This is Africa (London)\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_11_0}{\*\bkmkstart cite_id_11}{\*\bkmkend DOC_ID_11_0}{\*\bkmkend cite_id_11}11.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_11"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 A Deadly Misdiagnosis;  Is it possible to save the millions of people who die from TB?}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The New Yorker, November 15, 2010, FACT; Letter From India; Pg. 48, 5120 words, Michael Specter\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_12_0}{\*\bkmkstart cite_id_12}{\*\bkmkend DOC_ID_12_0}{\*\bkmkend cite_id_12}12.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_12"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  Bill Shouldn't Block Generics, Minister Agrees}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, April 29, 2010 Thursday, 875 words, Inter Press Service (Johannesburg)\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_13_0}{\*\bkmkstart cite_id_13}{\*\bkmkend DOC_ID_13_0}{\*\bkmkend cite_id_13}13.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_13"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Bill Shouldn't Block Generics, Minister Agrees}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Inter Press Service (Johannesburg), April 29, 2010 Thursday, 875  words, Wambi Michael\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_14_0}{\*\bkmkstart cite_id_14}{\*\bkmkend DOC_ID_14_0}{\*\bkmkend cite_id_14}14.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_14"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Mittal sits on top of the pile;  RICH LIST 2010 THE TOP 100}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The Sunday Times (London), April 25, 2010  Correction Appended, RICH LIST 2010;FEATURES; Pg. 14,73, 59576 words\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_15_0}{\*\bkmkstart cite_id_15}{\*\bkmkend DOC_ID_15_0}{\*\bkmkend cite_id_15}15.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_15"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  Counterfeits Bill Threatens Access to Medicine}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, November 6, 2009 Friday, 1120 words, Inter Press Service (Johannesburg)\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_16_0}{\*\bkmkstart cite_id_16}{\*\bkmkend DOC_ID_16_0}{\*\bkmkend cite_id_16}16.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_16"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Experts Fear Flu Will Join Trip to Mecca}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The New York Times, October 30, 2009 Friday, Section A; Column 0; Foreign Desk; Pg. 1, 1036 words, By DONALD G. McNEIL Jr.\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_17_0}{\*\bkmkstart cite_id_17}{\*\bkmkend DOC_ID_17_0}{\*\bkmkend cite_id_17}17.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_17"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 The Safety Gap}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The New York Times, November 2, 2008 Sunday, Section MM; Column 0; Magazine Desk; Pg. 46, 5079 words, By GARDINER HARRIS.  Gardiner Harris, a correspondent in The New York Times's Washington bureau, reports on public health.\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_18_0}{\*\bkmkstart cite_id_18}{\*\bkmkend DOC_ID_18_0}{\*\bkmkend cite_id_18}18.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_18"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  $10m HIV Drugs Ordered From New Factory}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, January 28, 2008 Monday, 719 words, East African Business Week\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_19_0}{\*\bkmkstart cite_id_19}{\*\bkmkend DOC_ID_19_0}{\*\bkmkend cite_id_19}19.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_19"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 India patent battle over Tarceva opens new CL front}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Pharma Marketletter, January 15, 2008 Tuesday, 326 words\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_20_0}{\*\bkmkstart cite_id_20}{\*\bkmkend DOC_ID_20_0}{\*\bkmkend cite_id_20}20.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_20"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda joint venture with Indian Rx firm}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Pharma Marketletter, November 30, 2007 Friday, 264 words\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_21_0}{\*\bkmkstart cite_id_21}{\*\bkmkend DOC_ID_21_0}{\*\bkmkend cite_id_21}21.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_21"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  New Factory to Improve Access to Arvs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, October 24, 2007 Wednesday, 753 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_22_0}{\*\bkmkstart cite_id_22}{\*\bkmkend DOC_ID_22_0}{\*\bkmkend cite_id_22}22.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_22"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Africa;  Daily HIV/Aids Report}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, October 9, 2007 Tuesday, 3231 words, Kaisernetwork.org\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_23_0}{\*\bkmkstart cite_id_23}{\*\bkmkend DOC_ID_23_0}{\*\bkmkend cite_id_23}23.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_23"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda begins making triple therapy AIDS drug}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   BBC Monitoring Africa - Political Supplied by BBC Worldwide Monitoring, October 8, 2007 Monday, 953 words\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_24_0}{\*\bkmkstart cite_id_24}{\*\bkmkend DOC_ID_24_0}{\*\bkmkend cite_id_24}24.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_24"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  Factory Opens to Produce HIV/Aids Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, October 5, 2007 Friday, 908 words, New Vision\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_25_0}{\*\bkmkstart cite_id_25}{\*\bkmkend DOC_ID_25_0}{\*\bkmkend cite_id_25}25.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_25"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  ARVs Production Starts Monday}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, October 5, 2007 Friday, 908 words, New Vision\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_26_0}{\*\bkmkstart cite_id_26}{\*\bkmkend DOC_ID_26_0}{\*\bkmkend cite_id_26}26.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_26"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  Country to Begin Producing ARVs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, September 21, 2007 Friday, 371 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_27_0}{\*\bkmkstart cite_id_27}{\*\bkmkend DOC_ID_27_0}{\*\bkmkend cite_id_27}27.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_27"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Africa;  Q&A on Second-Line HIV/Aids Treatment}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, May 8, 2007 Tuesday, 3336 words, William J. Clinton Foundation\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_28_0}{\*\bkmkstart cite_id_28}{\*\bkmkend DOC_ID_28_0}{\*\bkmkend cite_id_28}28.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_28"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  Quality Courts Cipla for Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, April 3, 2007 Tuesday, 591 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_29_0}{\*\bkmkstart cite_id_29}{\*\bkmkend DOC_ID_29_0}{\*\bkmkend cite_id_29}29.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_29"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 The one-pill wonder}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Daily Deal/The Deal, August 31, 2006 Thursday, NEWSWEEKLY, 3061 words, by Alex Lash and Tara Croft\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_30_0}{\*\bkmkstart cite_id_30}{\*\bkmkend DOC_ID_30_0}{\*\bkmkend cite_id_30}30.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_30"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 In AIDS battle, Clinton making up for lost time}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The International Herald Tribune, August 30, 2006 Wednesday, NEWS; Pg. 1, 1696 words, Celia W. Dugger\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_31_0}{\*\bkmkstart cite_id_31}{\*\bkmkend DOC_ID_31_0}{\*\bkmkend cite_id_31}31.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_31"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Clinton revels in post-presidential life}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The International Herald Tribune, August 29, 2006 Tuesday, NEWS; Pg. 1, 2409 words, Celia W. Dugger\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_32_0}{\*\bkmkstart cite_id_32}{\*\bkmkend DOC_ID_32_0}{\*\bkmkend cite_id_32}32.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_32"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Clinton Makes Up for Lost Time in Battling AIDS}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The New York Times, August 29, 2006 Tuesday, Section A; Column 2; Foreign Desk; Pg. 1, 2648 words, By CELIA W. DUGGER\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_33_0}{\*\bkmkstart cite_id_33}{\*\bkmkend DOC_ID_33_0}{\*\bkmkend cite_id_33}33.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_33"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  New Law Will Hinder ARV Supply}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, July 25, 2006 Tuesday, 486 words, New Vision\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_34_0}{\*\bkmkstart cite_id_34}{\*\bkmkend DOC_ID_34_0}{\*\bkmkend cite_id_34}34.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_34"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 U.S. pushes to limit generic drug rights;  Agreements seek to extend monopolies in exchange for improvements in trade}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The International Herald Tribune, April 19, 2006 Wednesday, NEWS; Pg. 1, 1610 words, Anand Giridharadas\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_35_0}{\*\bkmkstart cite_id_35}{\*\bkmkend DOC_ID_35_0}{\*\bkmkend cite_id_35}35.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_35"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 U.S. pushes to limit generic-drug rights in trade pacts}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   The International Herald Tribune, April 19, 2006 Wednesday, FINANCE; Pg. 13, 1381 words, Anand Giridharadas\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_36_0}{\*\bkmkstart cite_id_36}{\*\bkmkend DOC_ID_36_0}{\*\bkmkend cite_id_36}36.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_36"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Same determination but a new purpose}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Sunday Times (South Africa), February 26, 2006, ECONOMY, BUSINESS & FINANCE; Pg. 8, 953  words, Bobby Jordan\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_37_0}{\*\bkmkstart cite_id_37}{\*\bkmkend DOC_ID_37_0}{\*\bkmkend cite_id_37}37.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_37"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda;  Uganda Enters HIV/Aids Drug Deal With India}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414   Africa News, December 13, 2005 Tuesday, 417 words, The East African\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_38_0}{\*\bkmkstart cite_id_38}{\*\bkmkend DOC_ID_38_0}{\*\bkmkend cite_id_38}38.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_38"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 G2: What Grace did next: Three years ago the Guardian published an award-winning supplement featuring the story of Grace Mathanga, an ordinary African woman with HIV. To launch this year's Christmas appeal, which focuses on Aids in Africa, Sarah Boseley returns to Malawi to find out how Grace is doing now, and what her life can tell us about the future of the continent}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Guardian (London) - Final Edition, November 24, 2005, Guardian Features Pages, Pg. 8, 4076 words, Sarah Boseley\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_39_0}{\*\bkmkstart cite_id_39}{\*\bkmkend DOC_ID_39_0}{\*\bkmkend cite_id_39}39.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_39"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 IN BRIEF}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Evening Standard (London), November 7, 2005, A_MERGE; Pg. 30, 508 words\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_40_0}{\*\bkmkstart cite_id_40}{\*\bkmkend DOC_ID_40_0}{\*\bkmkend cite_id_40}40.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_40"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Science races bird flu clock}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Weekend Australian, October 29, 2005 Saturday Travel Edition, REVIEW; HealthTable; Pg. 28, 1305 words, Leigh Dayton\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_41_0}{\*\bkmkstart cite_id_41}{\*\bkmkend DOC_ID_41_0}{\*\bkmkend cite_id_41}41.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_41"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda; Indian Drugs Firm to Invest in Uganda}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Africa News, August 15, 2005 Monday, 395 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_42_0}{\*\bkmkstart cite_id_42}{\*\bkmkend DOC_ID_42_0}{\*\bkmkend cite_id_42}42.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_42"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Uganda; Indian Drugs Firm to Invest in Uganda}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Africa News, August 15, 2005 Monday, 395 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_43_0}{\*\bkmkstart cite_id_43}{\*\bkmkend DOC_ID_43_0}{\*\bkmkend cite_id_43}43.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_43"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 HIV-Aids and STDs; Global Aids Treatment Drive Takes Off}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Africa News, April 28, 2005 Thursday, 3207 words, Africa Renewal\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_44_0}{\*\bkmkstart cite_id_44}{\*\bkmkend DOC_ID_44_0}{\*\bkmkend cite_id_44}44.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_44"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Is it the end of cheap drugs from India?; Medicine prices may soar in a few years as the country can no longer make generic drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Business Times Singapore, April 12, 2005 Tuesday, VIEWS AND OPINIONS; BT Comment Others, 1347 words, Yogi Aggarwal\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_45_0}{\*\bkmkstart cite_id_45}{\*\bkmkend DOC_ID_45_0}{\*\bkmkend cite_id_45}45.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_45"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Zambia; India's Cheap Medicines}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Africa News, March 29, 2005 Tuesday, 776 words, The Post\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_46_0}{\*\bkmkstart cite_id_46}{\*\bkmkend DOC_ID_46_0}{\*\bkmkend cite_id_46}46.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_46"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 PanAfrica; Goodbye to Cheap Indian Aids Drugs?}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Africa News, November 26, 2004 Friday, 1225 words, Inter Press Service\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_47_0}{\*\bkmkstart cite_id_47}{\*\bkmkend DOC_ID_47_0}{\*\bkmkend cite_id_47}47.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_47"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 India's pharma ache; The upcoming amendment to the Indian Patent Act may lead to increased competition from MNCs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Business Times Singapore, November 4, 2004 Thursday, mviews, 1251 words, YOGI AGGARWAL\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_48_0}{\*\bkmkstart cite_id_48}{\*\bkmkend DOC_ID_48_0}{\*\bkmkend cite_id_48}48.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_48"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 AIDS; Daily HIV/Aids Report}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Africa News, July 15, 2004 Thursday, 6123 words, Kaisernetwork.org\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_49_0}{\*\bkmkstart cite_id_49}{\*\bkmkend DOC_ID_49_0}{\*\bkmkend cite_id_49}49.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_49"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Indian drug firms stand to gain much from WTO talks; Potential to carve out slice of US$15b US generics market}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Business Times Singapore, June 7, 2004 Monday, THE NEWS; South Asia, 632 words, Yogi Aggarwal in Bombay\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_50_0}{\*\bkmkstart cite_id_50}{\*\bkmkend DOC_ID_50_0}{\*\bkmkend cite_id_50}50.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_50"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00350030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Zambia; New Hope to Beat Malaria}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Africa News, April 22, 2004 Thursday, 1131 words, Business Day\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_51_0}{\*\bkmkstart cite_id_51}{\*\bkmkend DOC_ID_51_0}{\*\bkmkend cite_id_51}51.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_51"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00350031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 WTO drug deal to spark competition}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Business Times Singapore, September 2, 2003 Tuesday, THE NEWS; World, 610 words, By RAVI KANTH IN GENEVA\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_52_0}{\*\bkmkstart cite_id_52}{\*\bkmkend DOC_ID_52_0}{\*\bkmkend cite_id_52}52.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_52"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00350032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Proposed WTO deal set to bring hope to poorer nations; It calls for relaxing patent provisions, issuing of licences to producers in poorer nations}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Business Times Singapore, August 29, 2003 Friday, THE NEWS; World, 416 words, Ravi Kanth\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_53_0}{\*\bkmkstart cite_id_53}{\*\bkmkend DOC_ID_53_0}{\*\bkmkend cite_id_53}53.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_53"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00350033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Bush in Africa: The diplomacy: SPECIAL REPORT by Jo Revill in Gaborone: How the Aids battle can be won: In Botswana, where a third of the population has the condition, one pioneering clinic has shown it is not too late for a ravaged continent to fight back and survive the epidemic}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Observer, July 6, 2003, Observer News Pages, Pg. 21, 1244 words, Jo Revill\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_54_0}{\*\bkmkstart cite_id_54}{\*\bkmkend DOC_ID_54_0}{\*\bkmkend cite_id_54}54.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_54"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00350034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 PanAfrica; Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  Africa News, May 5, 2003 Monday, 1233 words, The East African\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 {\*\bkmkstart DOC_ID_55_0}{\*\bkmkstart cite_id_55}{\*\bkmkend DOC_ID_55_0}{\*\bkmkend cite_id_55}55.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 HYPERLINK \\l"doc_id_55"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00350035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid10898414 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414  The Guardian (London), February 18, 2003, Guardian Special Supplement, Pg. 8, 1353 words\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid10898414 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Fighting pain and suffering The Age (Melbourne, Australia) November 21, 2012 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_56}{\*\bkmkstart DOC_ID_56_0}{\*\bkmkstart doc_id_1}{\*\bkmkend DOC_ID_56}{\*\bkmkend DOC_ID_56_0}{\*\bkmkend doc_id_1}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_1"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Age (Melbourne, Australia)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  21, 2012 Wednesday  \par First Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Fighting pain and suffering}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Amrit Dhillon is a Delhi-based journalist.\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEWS; Focus; Pg. 20\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1667 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Yusuf Hamied took on multinational pharmaceutical companies to become the champion of cheap drugs for the poor. By Amrit Dhillon.\par PRASHANT Dhingre felt he had failed as a husband when his wife, Ruchira, 45, would howl from the pain of her breast cancer. On some days she was quieter and he would breathe more easily. On others she would make little noises of distress that he found more unsettling.\par Their family doctor was unable to help. The government hospital outside Pune where they live had no cancer ward, never mind pain management experts. Unable to relieve his wife's agony, he felt useless.\par A few weeks ago, when the couple walked through the gates of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Palliative Care and Training Ce}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tre, he felt a surge of relief. \par "When the doctor told me he would ease her pain, I felt a terrible weight had been taken off me," Dhingre says. "Friends told us about this place and said we would be in good hands."\par Ruchira, a magazine journalist, can now manage a smile. Her disease is advanced and the prognosis bleak but she will be going home soon now that the hospital staff have taught her husband how to administer the right painkillers and to be alert for dangerous symptoms.\par The small hospital is free. It has just 52 beds and is run by committed doctors and nurses. Volunteers come in every day to lift patients' spirits. Cheerful paintings hang everywhere.\par But there is no portrait of Yusuf Hamied, who set up the hospital and, more importantly, manufactures the drugs used to treat Ruchira and the other patients.\par If the patients had not received the low-cost drugs made by Hamied's company, the Indian drug giant }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , they would have faced the same fate as millions of poor Indians who have cancer: told to go home and die. Many branded cancer drugs cost, per month, what patients earn in five years.\par I ask Vilas Naik, 62, who has mouth cancer, if he knows who Hamied is. He shakes his head. "Have you heard of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ?"\par "No."\par Hamied, the champion of affordable medicines, may not yet be a household name in India, but many think he should be, given how his generic drugs for cancer, AIDS and other diseases have mitigated the suffering of many Indians and millions of others around the world.\par A billionaire born into a distinguished Muslim family, Hamied set up the Pune hospital 15 years ago after a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tending a talk in England about palliative care, then an unknown subject in India.\par Sitting in }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  head office in Mumbai, a four-hour drive from Pune, Hamied explains why he established the hospital. "We were making cancer drugs but I also wanted to do something else to relieve the pain of cancer patients. I didn't want a hospice, I wanted a place of hope," he says.\par He is 76, but looks younger. His eyes twinkle and he speaks energetically about his passion to supply cheap drugs to those who need them. He looks fit and healthy, but as someone who has chronic back pain he can identify what his patients go though. "Alleviation of suffering is my fundamental principle," he says.\par To do this he has had to take on the big drug companies over their patents and monopolies, and wage a campaign emphasising the need for generic unbranded drugs that cost a fraction of branded ones but are equally effective.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , along with other Indian generic drug makers, has led India to become known as the "pharmacy of the world".\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  exports to 170 countries. International health aid organisations such as Medecins Sans Frontieres buy some of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  2000 drugs for diseases such as AIDS, malaria and asthma, and supply them at affordable prices to Africa and developing countries.\par In 2001, Hamied, who manufactures drugs cheaply at his 36 plants in India, sent tremors through the boar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rooms of every drugs multinational when he slashed the price of life-saving triple-therapy drug cocktails for AIDS from $10,000 per person a year to $150.\par "I had seen AIDS patients in India and Africa, and knowing that people were dying even though drugs existed that could help them was shattering for me," he says.\par An estimated 7 million Africans have been treated with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  AIDS drugs (now even cheaper at $80 per year), making the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  name famous in Africa. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  presence there is a prime demonstration of Hamied's business philosophy - the pursuit of profit by a healthcare company in developing countries must be acco}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panied by humanitarian concerns.\par "Reducing the price of AIDS drugs gave me so much satisfaction that I've been thinking what else I could do. One day, I thought let's look at cancer and see how we can spare cancer patients' unnecessary suffering.\par In India, poor people are treated for free at government hospitals, but they have to pay for medicines. But millions cannot afford medicines that can cost 300,000 rupees ($A5250) a month when they earn only 5000 rupees a month.\par "The people I see are in despair when they hear the cost. Even if they sell everything they possess they still won't be able to afford them. So they go back to their villages to die in agony," says New Delhi oncologist Dr Bhavna Sirohi.\par In May, the price of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  cancer drugs was slashed by 75 per cent.\par "This is a great blessing. I have always hated the look on people's faces - the despair - when they hear what the drugs are going to cost," says Harmala Gupta, who runs CanSupport, a voluntary cancer support group in New Delhi.\par It is }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  cancer drugs that are being used to treat Sulochana Awate, 62, who had a radical mastectomy four months ago but arrived at the Pune hospital suffering from lymphoedema, a swelling of the hand and arm that can follow surgery for breast cancer. "I used to cry all night from the pain," says Awate. "Now the pain has gone and I'm hoping to go home soon."\par When cancer comes to the poor, it's like a biblical pestilence, ravaging everything. Families have no money and even less knowledge. In the countryside, the local hospital is usually a joke. Priyadarshini Kulkarni, the medical director at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  hospital, says most government hospitals have no oncologists. Hardly any offer palliative care. "We invite doctors and nurses from all over India to come here for training in palliative care," she says.\par In India, treatment for cancer exists only for the rich. The poor, after being diagnosed, are packed off to die in great pain at home. According to the World Health Organisation, more than 2.5 million Indians are diagnosed with cancer every year.\par However, the Indian government plans to make it mandatory for doctors in government hospitals to prescribe low-cost generic medicines, a move that will help poor patients get the drugs they need.\par The Indian government has awarded Hamied one of its highest honours, the Padma Bhushan. And last year, Cambridge University (where he received his doctorate in organic chemistry) unveiled a bust of him in ho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 our of his humanitarian work.\par Hamied is continuing the humanitarian work of his father, Khwaja Abdul Hamied, who established }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  in 1935. During the Second World War, when India was under British rule, demand for medicines from the Ind}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 an army surged while supplies from Europe's drug makers collapsed.\par Mahatma Gandhi visited Hamied snr to ask for help. He said Britain had promised India independence if I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dia could help in the war effort. He asked }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to meet the drugs requirements of the British Army. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  provided quinine to treat malaria and injections for dysentery.\par "The genesis of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  lies in that visit by Mahatma Gandhi. What I learnt during my childhood was the ethos that we must work for what is best for India, not what is best for the company," Hamied says. Even at 76 he is involved in the company he has run for four decades because of his passion for generic drugs and making them widely available. While his brother's children (he has none of his own) handle the day to day affairs of the firm, he travels around the world railing against the patents and monopolies of the big drug companies, who describe him as a "pirate".\par The Indian generic drugs revolution began in 1972 when India passed a law allowing medicines to be copied even if they were under patent, provided the process was not the same. Many multinationals left. The gap was filled by hundreds of Indian generic drug companies such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 . But in 2005, in a move that Hamied calls "disastrous" for poor patients, India signed the intellectual property agreement known as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (Trade Related Intellectual Property Rights), which requires every nation to protect patents on new drugs for 20 years.\par "India made a big mistake by signing up to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  With a population of 1.3 billion, India can't afford a m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nopoly in healthcare. Monopolies lead to higher prices and we can't allow them in a country like India with so much poverty and misery. It was like signing our own death warrant," he says.\par Instead of patent protection, Hamied would like India to follow Canada's example. From 1969 to 1992, Can}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 da copied any drug or product it chose to, provided it paid a 4 per cent royalty to the patent holder on the sales. There were no protests from the multinationals, he says.\par If this system was good enough for Canada, it should be good enough for India. He would be happy to pay any multinational a 4 per cent royalty in return for being able to produce a generic version of its patented drug. But }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  does not provide for that.\par Moreover, he loathes what he calls the "underhand tricks" of the big multinationals to maintain patents on drugs in perpetuity.\par "Just before a patent is due to expire, they make a minor modification to it and call it 'new' to extend the life of a patent by many years," he says.\par In the industry this is known as "ever-greening", or as Hamied describes it, "ever-greeding".\par At the hospital, Kulkarni is saying goodbye to an elderly woman who is being discharged. Wearing a bright fuchsia sari, she is being wheeled out by several male relatives fussing over her and beaming with delight. "Access to affordable medicines should be a human right. Every hour of life is precious and it should be pain free," she says.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICALS INDUSTRY (90%); CANCER (90%); DEATH & DYING (89%); PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CEUTICAL PREPARATION MFG (89%); PALLIATIVE CARE (89%); DISEASES & DISORDERS (89%); CANCER DRUGS (89%); PAIN MANAGEMENT (89%); GENERIC DRUGS (78%); ANALGESICS (77%); HOSPICE (77%); FAMILY PRACTICE (76%); NURSES & NURSING (76%); PHYSICIANS & SURGEONS (76%); HOSPITALS (76%); AIDS & HIV (73%); BREAST CANCER (72%); ORAL CANCER (72%); WRI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ERS (67%); WEALTHY PEOPLE (62%) Health/Drugs; Industry/Pharmaceutical; Social Welfare/Poverty\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (85%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (85%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (85%); SIC2834 PHARMACEUTICAL PREPARATIONS (85%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MUMBAI, INDIA (72%) INDIA (93%); ENGLAND (72%) India\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 March 11, 2013\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHOTO: Yusuf Hamied was inspired to ease the suffering of millions by developing generic drugs that cost a fraction of branded products, but are just as effective.\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2012 The Age Company Limited\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Cost a bitter pill to swallow South China Morning Post July 31, 2012 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_57}{\*\bkmkstart DOC_ID_57_0}{\*\bkmkstart doc_id_2}{\*\bkmkend DOC_ID_57}{\*\bkmkend DOC_ID_57_0}{\*\bkmkend doc_id_2}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_2"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 2 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 South China Morning Post\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  31, 2012 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Cost a bitter pill to swallow}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Amrit Dhillon healthpost@scmp.com\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 FEATURES; Pg. 09\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1016 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 A few months ago, Arun Bharati, 18, walked into the state-run All India Institute of Medical Sciences in New Delhi with his father, a farm labourer in eastern Bihar state.\par The doctor diagnosed Hodgkin's lymphoma and said the drugs would cost 300,000 rupees (HK$42,000) a month. Bharati's father earns just a few dollars a month.\par That night, father and son caught the overnight train home to their village where they broke the news to the family. A week later, unable to cope with not being able to afford the drugs, the father committed suicide by swallowing pesticide.  \par  Harmala Gupta, a cancer survivor and head of the voluntary group CanSupport, comes across many such cases every month - not necessarily of suicide but of families devastated by the cost of cancer drugs. A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cording to World Health Organisation figures, 2.5 million Indians are diagnosed with cancer every year.\par  "The first question patients ask doctors is how much the treatment will cost," says Gupta. "The middle class run around borrowing from relatives, selling their property and jewellery and bankrupting themselves. The poor walk out of the hospital and you never see them again." \par  This mental agony, exacerbating the physical pain, is something Dr Yusuf Khwaja Hamied, chairman of I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dian generic drugs giant }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , saw in Aids patients in India and Africa. Knowing that people were dying d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 spite the existence of drugs that could help them was, to him, devastating. \par  In 2001, the Cambridge-educated multimillionaire sent tremors through the boardrooms of every multin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tional drug maker when he offered an affordable Aids treatment option. Hamied slashed the price of life-saving triple therapy Aids drug cocktails from US$10,000 per person per year to US$150. He could do this because making the drug at his Goa plant - which is approved by the US Food and Drug Administration - is cheaper than making it elsewhere.\par An estimated seven million Africans have been treated with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Aids drugs (now even cheaper at US$80 a year), making the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  name a legend in Africa.\par "Reducing the price of Aids drugs gave me so much satisfaction that I've been thinking of what else I can do," Hamied says.\par His next target: cancer. In May, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  cut the price of its generic drugs for lung, brain and kidney cancer by 75 per cent. \par "This decision by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is a great gift to cancer patients," says New Delhi oncologist Bhavna Sirohi. \par Manufacturers of generic drugs \par such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  have given India the name "pharmacy of the developing world" for making low cost, high-quality generic drugs that have saved or prolonged millions of lives. International aid organisations buy these drugs and supply them to Africa and other countries.  \par The Indian generic drugs revolution began in 1972 when India passed a law allowing medicines to be copied even if under patent, provided the process was not the same. It led to the creation of hundreds companies making generic drugs. \par But in 2005, in a move that Hamied calls "disastrous", India signed the intellectual property agreement }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (Trade Related Intellectual Property), which requires every nation to protect patents on new drugs for 20 years. \par "With a population of 1.3 billion, India can't afford a monopoly in health care. Monopolies lead to higher pri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es and we can't allow them in a country with so much poverty and misery," says Hamied, who runs a free cancer hospital in Pune, western India. \par The only redeeming feature of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is that it allows governments the option of "compulsory licensing" - granting a licence to a domestic drug company, without the consent of the patent owner, permitting it to pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 duce a generic version if it is in "the public interest". \par The drawback is that applying for this licence is a cumbersome process. Hamied has been pushing the go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ernment to allow the widespread use of licences for the production of life-saving patented drugs for the ben}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fit of the poor.\par  In March, New Delhi granted its first compulsory licence, allowing domestic drug company Natco Pharma to make Nexavar available to cancer patients for a fraction of the price of Bayer's version. \par In keeping with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  rules, Natco Pharma will pay Bayer 6 per cent in royalties. There were howls of protest from Western drug giants. "If compulsory licences are misused, the research and innovation being done to save future lives will be in danger and will harm patients," says Ranjit Shahani, head of the Organisation of Pharmaceutical Producers of India, which represents foreign drug makers. \par  Indian Commerce Minister Anand Sharma defended the move, saying millions of Indians were dying b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause they could not afford the branded Nexavar. Bayer is suing India's patent office. \par While the drugs giants condemn Hamied for being a "pirate", he is unperturbed. "Western multinationals do not understand what it means to be poor in a developing country and unable to afford drugs," he says. \par He says India should have a "permanent compulsory licensing" system for drugs. "We can follow Canada's example. From 1969 to 1992, Canada copied any drug or product it liked, provided it paid a 4 per cent roya}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty to the patent holder. No multinational protested. If this system was good enough for Canada, it should be good enough for us," he says. \par Hamied has a family history to live up to. His father, Khwaja Abdul Hamied, set up }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  in 1935. During the second world war, as demand for medicines from the Indian army surged and supplies from Europe's drug makers collapsed, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  provided quinine to treat malaria and injections for dysentery. \par The government seems to be listening. The Planning Commission has called for more compulsory licences to be issued for patented and expensive drugs so that India can build up its "drug security". \par The government has instigated a US$5.4 billion plan to provide free generic medicine. From November, state institutions will be able to prescribe them to all patients. Those who prescribe branded drugs will face pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ishment.\par $5.4b \par From November, India's state institutions will be providing free generic drugs to all patients in a programme costing this many US dollars\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CANCER (90%); AIDS & HIV TREATMENT (89%); DRUG PRICES (89%); PRESCRIPTION DRUGS (89%); GENERIC DRUGS (89%); PRICE CUTTING (86%); DRUG & MEDICAL DEVICES A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PROVAL (78%); ONCOLOGY (77%); CANCER DRUGS (77%); PHARMACEUTICALS INDUSTRY (77%); LYMPHOMA (77%); FAMILY (75%); PESTICIDES (73%); HEALTH DEPARTMENTS (73%); FARM LABOR (73%); UROGENITAL DISORDERS & INJURIES (72%); KIDNEY DISEASE (72%); SUICIDE (70%); G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NERIC PRODUCTS (70%); KIDNEY CANCER (69%); BRAIN CANCER (69%); PHARMACEUTICAL PRE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ARATION MFG (69%); PHYSICIANS & SURGEONS (68%); RELIEF ORGANIZATIONS (68%); WEALTHY PEOPLE (68%); APPROVALS (62%); PUBLIC HEALTH ADMINISTRATION (54%); LEGISLATION (50%); INTERNATIONAL ASSISTANCE (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (85%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD HEALTH ORGANIZATION (56%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (85%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (85%); SIC2834 PHARMACEUTICAL PREPARATIONS (85%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW DELHI, INDIA (88%); DELHI, INDIA (73%); KOLKATA, INDIA (58%) BIHAR, INDIA (73%); WEST BENGAL, INDIA (58%); GOA, INDIA (58%) INDIA (97%); AFRICA (94%); UNITED STATES (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 July 31, 2012\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 A man waits outside a cancer hospital in Calcutta. Many cancer drugs are prohibitively expensive for most Indians. Photo: AFP\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2012 South China Morning Post Ltd.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; Quality Chemicals Giving Locals Fighting Chance Africa News May 18, 2012 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_58}{\*\bkmkstart DOC_ID_58_0}{\*\bkmkstart doc_id_3}{\*\bkmkend DOC_ID_58}{\*\bkmkend DOC_ID_58_0}{\*\bkmkend doc_id_3}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_3"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 3 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  18, 2012 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par Quality Chemicals Giving Locals Fighting Chance}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 New Vision (Kampala)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 947 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Quality Chemical Industries home in Luzira is a glassy modern piece of architecture with an exterior that would pass for a grand hotel instead of a pharmaceutical plant.\par But behind this fa\u193\'e7ade is the adherence to a high degree of quality control that is extremely important in the pharmaceutical manufacturing industry.\par This strict compliance to a set of good management practices in pharmaceutical manufacturing has won the plant approval and certification from World Health Organisation (WHO). \par The journey of Quality Chemicals began in Katwe, a slummy Kampala suburb. In 1995, the World Trade O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ganisation's (WTO) Trade-Related Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  were introduced, exempting low i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come countries from using patented pharmaceuticals in favour of affordable generic drugs.\par This restricted India and China from manufacturing generic drugs in respect of patents. As a result, the Asian pharmaceuticals had to transfer technology to low income countries, leading to a partnership between Qual}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty Chemical and Indian pharmaceutical giant }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  - the world's largest manufacturer of antiretroviral drugs.\par This brought about the reduction of prices for first line antiretroviral drugs sold in low income countries today, including Uganda.\par Today, the Luzira-based pharmaceutical manufacturer stands on 12 acres, with a built-up area of seven acres.\par It starts with mundane things such as the green well-kept lawn with flowers at the factory's premises.\par This is not a matter of aesthetics because the greenery helps in absorbing the carbon dioxide emitted from the factory.\par Equipment at the plant is sterilised before beginning the production process to ensure the drugs are not co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 taminated.\par There are strict rules that are adhered to, even in cleaning the floor. The air in the building is ultra-filtered and the water undergoes a rigorous filtration and purification process.\par The equipment is also calibrated in order to get the right measurements of the chemical raw materials b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause this determines the final outcome of the actual dosage in the tablets.\par Even the walls and floors have no corners which might attract dust and mites. The walls are painted white, and the amount of lighting in the building is measured to ensure proper visibility.\par An insect killer is on standby to trap any bugs coming into the factory.\par The plant employs 300 people, of whom about 250 are pharmacists. After recruitment, the employees are trained in the production processes to ensure the maintenance of accurate dosages of active pharmaceutical ingredients.\par They are taught how to document the various tasks and keep records for future reference, showing the tasks accomplished, by whom, when and at what time.\par It is this army of employees that is charged with weighing and mixing the ingredients, which are then taken into a compressor and turned into granules.\par The process of tablet manufacturing involves filtering to remove air and lumps, which are further compressed into tablets or capsule form.\par Other production processes include coating, filling and packaging. The processes are computerised in order to monitor the set standards of quality, which makes the drugs safe and effective for the patients.\par In another room, the tablets are subjected to quality tests to establish their hardness. This is intended to e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sure the tablets will not chip or break during packaging and transportation.\par The tablets are also tested for their ability to dissolve.\par Experts warn that breaking a tablet into half, as is commonly practiced by patients, reduces the medicine's effectiveness because a tablet may be designed to dissolve slowly in the body.\par If a drug passes all the specification tests, but fails one, it is deemed to have failed all the tests because each step is a mandatory aspect in the pharmaceutical manufacturing process.\par According to Samuel Opio Acuti, the company pharmacist, the quality control measures have kept out the possibility of local suppliers benefiting through the supply of pharmaceutical-grade packaging materials such as paper boxes and HDPE containers.\par However, Quality Chemicals is providing technical assistance to the local packaging manufacturers and a pilot project is being run with the Namanve-based Riley Packaging.\par Upon entry of the factory, one must wear a white gown, a head cap, cover the shoes and disinfect hands.\par The WHO approval has opened the regional market for the company's products and soon, the first consig}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment of drugs worth $13m will be exported to Kenya.\par In order to meet this anticipated regional demand, the plant is set to expand its operations by setting up a second plant with a bigger capacity.\par The $50m new plant will manufacture 18 million tablets of antimalarial and antiretroviral drugs per day at full capacity. Currently, the plant manufactures six million tablets per day.\par This will include the antiretroviral one-pill-a-day, which is a single dose combination therapy for the treatment of HIV/AIDS, according to Frederick Kitaka, the company chief financial officer.\par Kitaka explains that whereas 60% of raw materials needed for pharmaceuticals are available in Africa - i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cluding Artemisia, which is grown in Uganda, the industry is unable to purify the ingredients.\par So, Afro Alpine Pharma exports Uganda's Artemisia to India for purification before it is brought back into the country.\par Kitaka says under the third phase, the company will set up an active pharmaceutical ingredients plant, which will extract and purify ingredients from locally sourced raw materials.\par However, the plant management expressed concern that the market is flooded with cheap drugs imported from India and China, which is threatening the indigenous pharmaceutical companies.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICAL PREPARATION MFG (92%); CHEMICALS MFG (90%); CHEMICALS SECTOR PERFORMANCE (90%); PHARMACEUTICALS INDUSTRY (90%); CHEMICALS (90%); GENE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 IC DRUGS (90%); PATENTS (90%); PRESCRIPTION DRUGS (89%); MANUFACTURING FACILITIES (89%); INSECTICIDES (78%); PHARMACEUTICALS PATENTS (77%); PHARMACISTS (77%); INTELLE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TUAL PROPERTY (77%); HEALTH DEPARTMENTS (76%); INTELLECTUAL PROPERTY LAW (75%); TRADE DEVELOPMENT (75%); ANTIVIRALS (74%); QUALITY CONTROL (72%); MANUFACTURING OUTPUT (72%); DRUG PRICES (72%); INTERNATIONAL ECONOMIC ORGANIZATIONS (72%); PUBLIC HEALTH ADMINISTRATION (71%); GENERIC PRODUCTS (69%); INSECTS & ARACHNIDS (61%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANIZATION (83%); WORLD HEALTH ORGANIZATION (83%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 KAMPALA, UGANDA (57%) UGANDA (92%); INDIA (79%); CHINA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 May 18, 2012\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2012 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Quality Chemicals Giving Locals Fighting Chance New Vision (Kampala) May 18, 2012 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_59}{\*\bkmkstart DOC_ID_59_0}{\*\bkmkstart doc_id_4}{\*\bkmkend DOC_ID_59}{\*\bkmkend DOC_ID_59_0}{\*\bkmkend doc_id_4}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_4"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 4 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 New Vision (Kampala)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  18, 2012 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Quality Chemicals Giving Locals Fighting Chance}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Raymond Baguma\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 947 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Quality Chemical Industries home in Luzira is a glassy modern piece of architecture with an exterior that would pass for a grand hotel instead of a pharmaceutical plant.\par But behind this fa\u193\'e7ade is the adherence to a high degree of quality control that is extremely important in the pharmaceutical manufacturing industry.\par This strict compliance to a set of good management practices in pharmaceutical manufacturing has won the plant approval and certification from World Health Organisation (WHO). \par The journey of Quality Chemicals began in Katwe, a slummy Kampala suburb. In 1995, the World Trade O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ganisation's (WTO) Trade-Related Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  were introduced, exempting low i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come countries from using patented pharmaceuticals in favour of affordable generic drugs.\par This restricted India and China from manufacturing generic drugs in respect of patents. As a result, the Asian pharmaceuticals had to transfer technology to low income countries, leading to a partnership between Qual}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty Chemical and Indian pharmaceutical giant }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  - the world's largest manufacturer of antiretroviral drugs.\par This brought about the reduction of prices for first line antiretroviral drugs sold in low income countries today, including Uganda.\par Today, the Luzira-based pharmaceutical manufacturer stands on 12 acres, with a built-up area of seven acres.\par It starts with mundane things such as the green well-kept lawn with flowers at the factory's premises.\par This is not a matter of aesthetics because the greenery helps in absorbing the carbon dioxide emitted from the factory.\par Equipment at the plant is sterilised before beginning the production process to ensure the drugs are not co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 taminated.\par There are strict rules that are adhered to, even in cleaning the floor. The air in the building is ultra-filtered and the water undergoes a rigorous filtration and purification process.\par The equipment is also calibrated in order to get the right measurements of the chemical raw materials b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause this determines the final outcome of the actual dosage in the tablets.\par Even the walls and floors have no corners which might attract dust and mites. The walls are painted white, and the amount of lighting in the building is measured to ensure proper visibility.\par An insect killer is on standby to trap any bugs coming into the factory.\par The plant employs 300 people, of whom about 250 are pharmacists. After recruitment, the employees are trained in the production processes to ensure the maintenance of accurate dosages of active pharmaceutical ingredients.\par They are taught how to document the various tasks and keep records for future reference, showing the tasks accomplished, by whom, when and at what time.\par It is this army of employees that is charged with weighing and mixing the ingredients, which are then taken into a compressor and turned into granules.\par The process of tablet manufacturing involves filtering to remove air and lumps, which are further compressed into tablets or capsule form.\par Other production processes include coating, filling and packaging. The processes are computerised in order to monitor the set standards of quality, which makes the drugs safe and effective for the patients.\par In another room, the tablets are subjected to quality tests to establish their hardness. This is intended to e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sure the tablets will not chip or break during packaging and transportation.\par The tablets are also tested for their ability to dissolve.\par Experts warn that breaking a tablet into half, as is commonly practiced by patients, reduces the medicine's effectiveness because a tablet may be designed to dissolve slowly in the body.\par If a drug passes all the specification tests, but fails one, it is deemed to have failed all the tests because each step is a mandatory aspect in the pharmaceutical manufacturing process.\par According to Samuel Opio Acuti, the company pharmacist, the quality control measures have kept out the possibility of local suppliers benefiting through the supply of pharmaceutical-grade packaging materials such as paper boxes and HDPE containers.\par However, Quality Chemicals is providing technical assistance to the local packaging manufacturers and a pilot project is being run with the Namanve-based Riley Packaging.\par Upon entry of the factory, one must wear a white gown, a head cap, cover the shoes and disinfect hands.\par The WHO approval has opened the regional market for the company's products and soon, the first consig}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment of drugs worth $13m will be exported to Kenya.\par In order to meet this anticipated regional demand, the plant is set to expand its operations by setting up a second plant with a bigger capacity.\par The $50m new plant will manufacture 18 million tablets of antimalarial and antiretroviral drugs per day at full capacity. Currently, the plant manufactures six million tablets per day.\par This will include the antiretroviral one-pill-a-day, which is a single dose combination therapy for the treatment of HIV/AIDS, according to Frederick Kitaka, the company chief financial officer.\par Kitaka explains that whereas 60% of raw materials needed for pharmaceuticals are available in Africa - i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cluding Artemisia, which is grown in Uganda, the industry is unable to purify the ingredients.\par So, Afro Alpine Pharma exports Uganda's Artemisia to India for purification before it is brought back into the country.\par Kitaka says under the third phase, the company will set up an active pharmaceutical ingredients plant, which will extract and purify ingredients from locally sourced raw materials.\par However, the plant management expressed concern that the market is flooded with cheap drugs imported from India and China, which is threatening the indigenous pharmaceutical companies.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICAL PREPARATION MFG (92%); CHEMICALS MFG (90%); CHEMICALS SECTOR PERFORMANCE (90%); PHARMACEUTICALS INDUSTRY (90%); CHEMICALS (90%); GENE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 IC DRUGS (90%); PATENTS (90%); PRESCRIPTION DRUGS (89%); MANUFACTURING FACILITIES (89%); INSECTICIDES (78%); PHARMACEUTICALS PATENTS (77%); PHARMACISTS (77%); INTELLE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TUAL PROPERTY (77%); HEALTH DEPARTMENTS (76%); INTELLECTUAL PROPERTY LAW (75%); TRADE DEVELOPMENT (75%); ANTIVIRALS (74%); QUALITY CONTROL (72%); MANUFACTURING OUTPUT (72%); DRUG PRICES (72%); INTERNATIONAL ECONOMIC ORGANIZATIONS (72%); PUBLIC HEALTH ADMINISTRATION (71%); BIOTECHNOLOGY & GENETIC SCIENCE (69%); GENERIC PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UCTS (69%); INSECTS & ARACHNIDS (61%) Uganda; Science and Biotechnology; Manufacturing\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 KAMPALA, UGANDA (57%) UGANDA (91%); INDIA (79%); CHINA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 May 18, 2012\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2012 AllAfrica Global Media.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Health and Medicine; Patents Versus Access to Drugs Africa News May 14, 2012 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_60}{\*\bkmkstart DOC_ID_60_0}{\*\bkmkstart doc_id_5}{\*\bkmkend DOC_ID_60}{\*\bkmkend DOC_ID_60_0}{\*\bkmkend doc_id_5}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_5"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 5 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  14, 2012 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Health and Medicine; \par Patents Versus Access to Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Health-e (Cape Town)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 941 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Lifesaving drugs under disputed patents could become more easily available in future depending on the ou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come of a case before the Supreme Court of Appeal in Bloemfontein on Tuesday.\par The case revolves around a Sanofi-Aventis cancer drug docetaxel, an important drug used to treat many forms of cancer. It has the potential to save lives or improve the quality of life of cancer patients, but remains expensive as it is under patent.\par The Treatment Action Campaign, represented by SECTION27, has intervened in the dispute between Indian generic manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Sanofi-Aventis as amicus curiae (friend of the court) to argue that the court has an obligation to consider the the public interest and the right to have access to healthcare services in disputes of this kind. \par The validity of the patent is at the centre of the dispute with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  alleging it is invalid because it is essentially not a new drug.\par The product patent on the medicine has expired. The outstanding patent relates "to a composition of unpa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ented products, which - when mixed - facilitate the intravenous administration of Docetaxel." }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is saying the patent is not valid, as it is unclear and what is patented is not new.\par Unlike many other countries where patents can only be registered following substantive examinations, in South Africa it is relatively easy to register patents under the Patents Act, 57 of 1978.\par Arguing on behalf of the TAC, SECTION27 makes the case that the Patents Act, like any other statute, must be interpreted in light of provisions of the Constitution, and requires the Court to balance the rights of any patentee with the rights of those who need access to medicines, which are protected in section 27 of the Constitution.\par In other words, the Court needs to consider the public interest factors that arise and the impact of an interdict on cancer patients.\par Sanofi-Aventis sought an interim interdict from the Commissioner of Patents to stop }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  from selling the drug in South Africa. However, the Commissioner refused to grant the interdict, ruling in respect of Sanofi-Aventis's claim, "their prospects of success at a trial are so slender that interim relief must be refused".\par Sanofi-Aventis appealed the Patent Commissioner's decision to the Supreme Court of Appeal.\par After the Commissioner's ruling, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  began manufacturing and marketing its generic drug in South Africa, with over 70 people in South Africa already accessing the generic medication.\par So why is this case important to South Africa, in fact so important that TAC and SECTION27 opted to b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come involved?\par More often than not, in South Africa patented medicines are more expensive than generic versions of drugs, with most cancer medicines being extremely expensive. It is not unusual for cancer patients on medical aid to exhaust their oncology benefits, facing crippling bills at the end of their treatment regimen.\par This specific generic drug is half the price of the original drug and it is known that once a generic enters the market it encourages competition driving prices down even further.\par TAC is not leading evidence or making any arguments about how effective the drugs are, or about the nu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bers of people who will benefit from the availability of a generic drug entering the market.\par Its intervention is essentially aimed at establishing as a principle something the Court has not considered before, and that is that constitutional rights must be factored into the adjudication process when deciding p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tent infringement cases.\par In this case TAC is arguing that it is in the interests of cancer patients that the generic drugs be available, and that the harm to patients will be greater than the harm to Sanofi-Aventis if they are granted the interim interdict. This is especially so given the fact that the patent only has approximately one year left to run and the fact that there are questions about the patents' validity.\par If the Court accepts TAC's argument it will be an important advance for the rights of access to affordable medicines.\par It will mean that in future in any dispute over patents in respect of medicines, the courts will have to consider the public interest and the Constitutional right of access to health care services.\par South Africa currently provides patent protection beyond what is required by the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement. "There are a number of amendments that South Africa must make to its Patents Act to promote public health," said Catherine Tomlinson, a senior researcher with the TAC. Unlike South Africa, India, Brazil and Thailand, among others, have used flexibilities allowed under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to curb excessive patenting of pharmaceuticals and promote public health. While South Africa granted 2 442 pharmaceutical patents in 2008 alone, Brazil only granted 278 pharmaceutical patents between 2003 and 2008."\par It is also interesting to note that generic versions of the disputed drug are now available in the United States - a country that upholds strict patent protection. Following the expiration of the product patent, outstanding patents on the medicine that related to the administration of the medicine were declared invalid on 9 April 2012.\par "The consequences of South Africa's strict patent protection are high medicine costs and the delayed avail}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bility of affordable generic medicines," Tomlinson said.\par Mediscor reported in their 2009 and 2010 Medicines Reviews that medicine expenditure increased 25.2% between 2008 and 2010, while medicine use only increased 5.8%. In other words, there is a greater need to promote access to affordable medicines in South Africa.\par Access to lifesaving medicine is a human right, not a nice to have dictated by a bank balance.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PATENTS (93%); PHARMACEUTICALS INDUSTRY (91%); PATENT LAW (90%); PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CEUTICAL PREPARATION MFG (90%); CANCER (90%); CANCER DRUGS (90%); APPEALS COURTS (89%); CONSTITUTIONAL LAW (89%); PHARMACEUTICALS PATENTS (89%); LAW COURTS & TRIB}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NALS (89%); PRESCRIPTION DRUGS (89%); SUPREME COURTS (89%); INTELLECTUAL PROPERTY LAW (89%); GENERIC DRUGS (89%); APPELLATE DECISIONS (89%); HEALTH CARE ACCESS (89%); GENERIC PRODUCTS (89%); PATENT INVALIDATION & REVOCATION (78%); ONCOLOGY (77%); HEALTH CARE (76%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SANOFI SA (94%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SNY (NYSE) (94%); SANF (BIT) (94%); SAN (PAR) (94%); GCVRZ (NASDAQ) (94%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (94%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (94%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SOUTH AFRICA (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 May 14, 2012\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2012 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Patents Versus Access to Drugs [analysis] Health-e (Cape Town) May 14, 2012 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_61}{\*\bkmkstart DOC_ID_61_0}{\*\bkmkstart doc_id_6}{\*\bkmkend DOC_ID_61}{\*\bkmkend DOC_ID_61_0}{\*\bkmkend doc_id_6}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_6"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 6 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Health-e (Cape Town)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  14, 2012 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Patents Versus Access to Drugs [analysis]}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Anso Thom\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 941  words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Lifesaving drugs under disputed patents could become more easily available in future depending on the ou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come of a case before the Supreme Court of Appeal in Bloemfontein on Tuesday.\par The case revolves around a Sanofi-Aventis cancer drug docetaxel, an important drug used to treat many forms of cancer. It has the potential to save lives or improve the quality of life of cancer patients, but remains expensive as it is under patent.\par The Treatment Action Campaign, represented by SECTION27, has intervened in the dispute between Indian generic manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Sanofi-Aventis as amicus curiae (friend of the court) to argue that the court has an obligation to consider the the public interest and the right to have access to healthcare services in disputes of this kind. \par The validity of the patent is at the centre of the dispute with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  alleging it is invalid because it is essentially not a new drug.\par The product patent on the medicine has expired. The outstanding patent relates "to a composition of unpa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ented products, which - when mixed - facilitate the intravenous administration of Docetaxel." }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is saying the patent is not valid, as it is unclear and what is patented is not new.\par Unlike many other countries where patents can only be registered following substantive examinations, in South Africa it is relatively easy to register patents under the Patents Act, 57 of 1978.\par Arguing on behalf of the TAC, SECTION27 makes the case that the Patents Act, like any other statute, must be interpreted in light of provisions of the Constitution, and requires the Court to balance the rights of any patentee with the rights of those who need access to medicines, which are protected in section 27 of the Constitution.\par In other words, the Court needs to consider the public interest factors that arise and the impact of an interdict on cancer patients.\par Sanofi-Aventis sought an interim interdict from the Commissioner of Patents to stop }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  from selling the drug in South Africa. However, the Commissioner refused to grant the interdict, ruling in respect of Sanofi-Aventis's claim, "their prospects of success at a trial are so slender that interim relief must be refused".\par Sanofi-Aventis appealed the Patent Commissioner's decision to the Supreme Court of Appeal.\par After the Commissioner's ruling, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  began manufacturing and marketing its generic drug in South Africa, with over 70 people in South Africa already accessing the generic medication.\par So why is this case important to South Africa, in fact so important that TAC and SECTION27 opted to b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come involved?\par More often than not, in South Africa patented medicines are more expensive than generic versions of drugs, with most cancer medicines being extremely expensive. It is not unusual for cancer patients on medical aid to exhaust their oncology benefits, facing crippling bills at the end of their treatment regimen.\par This specific generic drug is half the price of the original drug and it is known that once a generic enters the market it encourages competition driving prices down even further.\par TAC is not leading evidence or making any arguments about how effective the drugs are, or about the nu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bers of people who will benefit from the availability of a generic drug entering the market.\par Its intervention is essentially aimed at establishing as a principle something the Court has not considered before, and that is that constitutional rights must be factored into the adjudication process when deciding p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tent infringement cases.\par In this case TAC is arguing that it is in the interests of cancer patients that the generic drugs be available, and that the harm to patients will be greater than the harm to Sanofi-Aventis if they are granted the interim interdict. This is especially so given the fact that the patent only has approximately one year left to run and the fact that there are questions about the patents' validity.\par If the Court accepts TAC's argument it will be an important advance for the rights of access to affordable medicines.\par It will mean that in future in any dispute over patents in respect of medicines, the courts will have to consider the public interest and the Constitutional right of access to health care services.\par South Africa currently provides patent protection beyond what is required by the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement. "There are a number of amendments that South Africa must make to its Patents Act to promote public health," said Catherine Tomlinson, a senior researcher with the TAC. Unlike South Africa, India, Brazil and Thailand, among others, have used flexibilities allowed under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to curb excessive patenting of pharmaceuticals and promote public health. While South Africa granted 2 442 pharmaceutical patents in 2008 alone, Brazil only granted 278 pharmaceutical patents between 2003 and 2008."\par It is also interesting to note that generic versions of the disputed drug are now available in the United States - a country that upholds strict patent protection. Following the expiration of the product patent, outstanding patents on the medicine that related to the administration of the medicine were declared invalid on 9 April 2012.\par "The consequences of South Africa's strict patent protection are high medicine costs and the delayed avail}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bility of affordable generic medicines," Tomlinson said.\par Mediscor reported in their 2009 and 2010 Medicines Reviews that medicine expenditure increased 25.2% between 2008 and 2010, while medicine use only increased 5.8%. In other words, there is a greater need to promote access to affordable medicines in South Africa.\par Access to lifesaving medicine is a human right, not a nice to have dictated by a bank balance.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PATENTS (93%); PHARMACEUTICALS INDUSTRY (91%); CANCER (90%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CAL PREPARATION MFG (90%); PATENT LAW (90%); CANCER DRUGS (90%); GENERIC PRODUCTS (89%); CONSTITUTIONAL LAW (89%); APPEALS COURTS (89%); APPELLATE DECISIONS (89%); G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NERIC DRUGS (89%); INTELLECTUAL PROPERTY LAW (89%); LAW COURTS & TRIBUNALS (89%); SUPREME COURTS (89%); PHARMACEUTICALS PATENTS (89%); PRESCRIPTION DRUGS (89%); HEALTH CARE ACCESS (89%); PATENT INVALIDATION & REVOCATION (78%); ONCOLOGY (77%); HEALTH CARE (76%) South Africa; Health and Medicine; Sustainable Development; Legal and Judicial A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fairs; Company News\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SANOFI SA (94%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SNY (NYSE) (94%); SANF (BIT) (94%); SAN (PAR) (94%); GCVRZ (NASDAQ) (94%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (94%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (94%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SOUTH AFRICA (95%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 May 14, 2012\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Web Publication\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2012 AllAfrica Global Media.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Martin Khor The Nation (Thailand) February 8, 2012 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_62}{\*\bkmkstart DOC_ID_62_0}{\*\bkmkstart doc_id_7}{\*\bkmkend DOC_ID_62}{\*\bkmkend DOC_ID_62_0}{\*\bkmkend doc_id_7}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_7"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 7 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Nation (Thailand)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  8, 2012 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Martin Khor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Nation\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 818 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Star/Asia News Network\par India may be more famous for the Taj Mahal, its religious ceremonies, Bollywood films and one of the hig}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 est economic growth rates in recent years.\par But more than all these, India has had positive worldwide impact through its large supplies of low-cost, good-quality generic medicines. These have saved or prolonged millions of lives.\par Many people travel to India to buy life-saving generic medicines from pharmacies and bring them back in suitcases to give to relatives who cannot afford the expensive original products. \par A decade ago, an Indian company called }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  produced HIV-Aids generic drugs that could treat a patient for US 300 (Bt9,700) a year \u8218\'e2\u8364\'db" a fraction of the branded product's cost of US 10,000 per patient per year. Today, the Indian drug cost has been cut further to below US 80 (Bt2,470).\par This has enabled millions more Aids patients to be treated. India supplies 70 per cent of the HIV-Aids drugs obtained by Unicef, the Global Fund and Clinton Foundation for developing countries.\par And 75-80 per cent of medicines (not only for Aids) distributed by the International Dispensary Association to developing countries come from India. No wonder India has been termed the pharmacy of the developing world.\par Last month, the Indian Drug Manufacturers' Association, which has 700 drug companies as members, cel}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 brated its 50th anniversary. There was much to celebrate, including the industry's high growth, wide range of medicines, and its contribution to good affordable drugs. But there are also many factors that may hinder the continuation of the companies' role as chief supplier of medicines for developing countries.\par A main factor of the industry's success has been the government's move in 1970 to exclude pharmaceutical drugs from product patents.\par This paved the way for local companies to produce generic versions of expensive foreign drugs, and within a few decades they had taken 80 per cent of the local market while also supplying cheap medicines abroad.\par The situation took a negative turn when the intellectual property agreement known as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  was esta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lished in 1995 together with the World Trade Organisation. It disallowed countries from excluding medicines from patentability.\par However, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  allowed countries to determine the criteria for an invention that can be granted a patent, and the ability of the government to grant a compulsory licence to local companies to produce the patented products if their requests to patent owners to give a voluntary licence do not succeed.\par To implement its }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  obligations, India passed changes to its patent law in 2005 so drugs could now be patented.\par However, the new law also contained flexibilities such as strict criteria for patentability (trivial changes to a patent-expired product would not qualify for a new patent), allowance for public opposition to a patent appl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cation before a decision is made, and compulsory licensing.\par India has one of the best patent laws in the world that still gives some space to its producers to make generic drugs.\par But it is also true that the old policy space has been eroded because many new drugs since 2005 have been patented by multinational companies, which are selling them at exorbitant prices.\par Indian companies can no longer make their own generic versions of these new medicines unless they su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cessfully apply to the government for compulsory licences, and that is quite cumbersome; or unless they o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tain a licence from the patent-owning multinational, and that usually comes with stringent conditions, esp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cially for export.\par Another worry is that India is negotiating a free trade agreement with the European Union. Such agreements usually contain provisions such as data exclusivity and extension of the patent term, which prevents or hi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ders generic production.\par Finally, six Indian companies have recently been bought up by large foreign firms. If this trend continues, the Indian drug market may be dominated by multinationals again.\par It is uncertain whether they will continue to supply the developing world with cheap generic medicines when this may be in conflict with their own branded products.\par International health organisations such as Unaids, Unitaid and Doctors Without Borders have raised serious concerns that these recent trends may threaten India's role as the chief supplier of affordable medicines to Africa and other developing countries.\par "Millions will die if India cannot produce the new HIV-Aids medicines in future. It is a matter of life and death," said Michel Sidibe, Unaids executive director, during a visit to India last year.\par Thus, a strategy is needed that involves the government and the drug companies, that ensures the local drug industry continues to thrive, that it produces not only the existing medicines but also new medicines even if they are patented, and that they are supplied at cheap prices not only in India but to the developing world, too.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GENERIC DRUGS (91%); PHARMACEUTICALS INDUSTRY (90%); AIDS & HIV (90%); EMERGING MARKETS (90%); DEVELOPING COUNTRIES (90%); ECONOMIC DEVELOPMENT (89%); INTELLECTUAL PROPERTY LAW (89%); PATENTS (89%); ECONOMIC GROWTH (89%); AIDS & HIV TREATMENT (77%); PHARMACIES (76%); BUSINESS & PROFESSIONAL ASSOCIATIONS (75%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TELLECTUAL PROPERTY (74%); ANNIVERSARIES (73%); FILM (73%); PHARMACEUTICAL PREPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TION MFG (71%); PATENT LAW (67%); RELIEF ORGANIZATIONS (66%); INTERNATIONAL ASSI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TANCE (66%); LEGISLATION (62%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UNITED NATIONS CHILDREN'S FUND (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 INDIA (99%); ASIA (92%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 February 7, 2012\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2012 Nation Multimedia Group\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; Lives At Risk As 90 Per Cent of Aids Drugs Could Be Declared Illegal Africa News November 16, 2011 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_63}{\*\bkmkstart DOC_ID_63_0}{\*\bkmkstart doc_id_8}{\*\bkmkend DOC_ID_63}{\*\bkmkend DOC_ID_63_0}{\*\bkmkend doc_id_8}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_8"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 8 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  16, 2011 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par Lives At Risk As 90 Per Cent of Aids Drugs Could Be Declared Illegal}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Monitor (Kampala)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 728 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Thousands of Ugandans enrolled on antiretroviral treatment in Uganda risk an Aids drugs shortage unless a grace period placed on the manufacture of generic Aids drugs imposed under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  an international trade law, is extended beyond July 2013.\par According to Denis Kibira of the Health Rights NGO, HEPS-Uganda, almost 90 per cent of Aids drugs avai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 able on the Ugandan market are generic drugs from India.\par A generic drug is an identical copy of a brand name. Under World Trade Organisation (WTO)'s }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, to which Uganda is a signatory, poor countries were given a transitional period to consume g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neric Aids drugs based on original formulas developed by mainly Western pharmaceutical companies such as Pfizer and Smith Kline Beecham, which invest heavily in developing new Aids drugs. For pharmaceutical products, this ban will take effect in 2016. \par According to the WHO, 'Developing countries are failing to make full use of flexibilities built into the World Trade Organisation's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to overcome patent barriers and, in turn, allow them to acquire the medicines they need for high priority disea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es, in particular, HIV/Aids.\par According to Mr Kibira, almost all Aids drugs used in Uganda are manufactured in India and Uganda under an international intellectual property law that permits drug manufacturers in developing countries to manufa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture pharmaceutical products that imitate those originally made by Western pharmaceutical companies on account of public health emergencies in poor countries.\par For developing countries such as India, the ban on manufacture of generic Aids drugs came into force in 2005 under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement of the WTO whereas a similar ban on poorer developing countries such as Uganda will take effect in 2016 unless Uganda passes a national law that allows for extension of this dea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 line.\par Pharmaceutical products have a deadline of 2016. UNAIDS,UNDAP and WHO have urged all developing countries to enact }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  'flexibilities' or provisions with the international trade law that allows poor countries to use patented medicines under a public health emergency provision.\par "Unless the Ugandan Parliament revisits and passes the Industrial Properties Bill, the permission to man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 facture cheap generic ARV drugs will cease in 2016 with thousands affected since Quality Chemicals man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 factures generic Aids drug," said Moses Mulumba,Executive Director of CEHURD, a healthcare access rights NGO advocacy group.\par With the expiry of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  grace period, the alternative in Uganda would be to buy these drugs much more expensively from the original Western manufacturers at prices beyond the reach of the majority Ugandan ARV user.\par Aids triple-combination therapy, which costs $10,000 per patient per year in industrialised countries, can now be obtained from Indian generic drugs company, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , for less than $200 per year. Generic Aids drugs en}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bled millions gain access to Aids treatment in poor countries. The 2013 and 2016 }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  deadlines threaten to reverse these gains and turn Aids treatment into a preserve of patients in rich Western world.\par Recently, Dr Raymond Byarugaba, head of Uganda Aids Information Centre, announced that this year, there will be 150,000 new HIV infections in Uganda up from 130,000 last year and 100,000 in years before adding to the already rising number of those in need of antiretroviral treatment which they can't access.\par At the moment, passing the Industrial Properties Bill in Uganda, after amending it to take full advantage of the 'flexibility' in the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, which would, inter alia, extend the grace period for manufacturing generic Aids drugs remains the best hope for the thousands on Aids treatment most of whom rely on generic drugs manufactured by Indian pharmaceutical companies such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  or its subsidiaries in Africa.\par On Monday, November 14, the world marked 10 years since the DOHA Declaration, which secured a grace period for developing countries to implement patents for pharmaceutical products. Sadly, poor countries, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cluding Uganda, have not taken full advantage of this grace period and this puts the lives of millions at stake as the clock ticks to the 2013 and 2016 deadlines.\par Mr Zakumumpa is an HIV/Aids specialist at Makerere University and a key correspondent for the Internatio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 al HIV/Aids Alliance.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GENERIC DRUGS (93%); PHARMACEUTICAL PREPARATION MFG (92%); AIDS & HIV TREATMENT (92%); PHARMACEUTICALS INDUSTRY (91%); INTERNATIONAL TRADE (91%); PATENT LAW (90%); INTERNATIONAL TRADE LAW (90%); INTERNATIONAL LAW (90%); ANTIVIRALS (90%); INTELLECTUAL PROPERTY LAW (90%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NERIC PRODUCTS (90%); DEVELOPING COUNTRIES (90%); INTELLECTUAL PROPERTY (90%); NONGOVERNMENTAL ORGANIZATIONS (89%); CHEMICALS MFG (78%); DISEASES & DISORDERS (78%); PHARMACEUTICALS PATENTS (78%); TRADE TREATIES & AGREEMENTS (78%); CHEMICALS (78%); DRUG SHORTAGES (78%); AIDS & HIV (78%); HEALTH CARE ACCESS (78%); DRUG DESIGN & DISCOVERY (78%); PUBLIC HEALTH ADMINISTRATION (74%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PFIZER INC (90%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (57%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANIZATION (91%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PFZ (LSE) (90%); PFEB (BRU) (90%); PFE (NYSE) (90%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (57%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (90%); NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (90%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UGANDA (99%); INDIA (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 16, 2011\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2011 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Lives At Risk As 90 Per Cent of Aids Drugs Could Be Declared Illegal [opinion] The Monitor (Kampala) November 16, 2011 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_64}{\*\bkmkstart DOC_ID_64_0}{\*\bkmkstart doc_id_9}{\*\bkmkend DOC_ID_64}{\*\bkmkend DOC_ID_64_0}{\*\bkmkend doc_id_9}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_9"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 9 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Monitor (Kampala)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  16, 2011 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Lives At Risk As 90 Per Cent of Aids Drugs Could Be Declared Illegal [opinion]}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Henry Zakumumpa\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 728 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Thousands of Ugandans enrolled on antiretroviral treatment in Uganda risk an Aids drugs shortage unless a grace period placed on the manufacture of generic Aids drugs imposed under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  an international trade law, is extended beyond July 2013.\par According to Denis Kibira of the Health Rights NGO, HEPS-Uganda, almost 90 per cent of Aids drugs avai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 able on the Ugandan market are generic drugs from India.\par A generic drug is an identical copy of a brand name. Under World Trade Organisation (WTO)'s }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, to which Uganda is a signatory, poor countries were given a transitional period to consume g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neric Aids drugs based on original formulas developed by mainly Western pharmaceutical companies such as Pfizer and Smith Kline Beecham, which invest heavily in developing new Aids drugs. For pharmaceutical products, this ban will take effect in 2016. \par According to the WHO, 'Developing countries are failing to make full use of flexibilities built into the World Trade Organisation's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to overcome patent barriers and, in turn, allow them to acquire the medicines they need for high priority disea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es, in particular, HIV/Aids.\par According to Mr Kibira, almost all Aids drugs used in Uganda are manufactured in India and Uganda under an international intellectual property law that permits drug manufacturers in developing countries to manufa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture pharmaceutical products that imitate those originally made by Western pharmaceutical companies on account of public health emergencies in poor countries.\par For developing countries such as India, the ban on manufacture of generic Aids drugs came into force in 2005 under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement of the WTO whereas a similar ban on poorer developing countries such as Uganda will take effect in 2016 unless Uganda passes a national law that allows for extension of this dea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 line.\par Pharmaceutical products have a deadline of 2016. UNAIDS,UNDAP and WHO have urged all developing countries to enact }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  'flexibilities' or provisions with the international trade law that allows poor countries to use patented medicines under a public health emergency provision.\par "Unless the Ugandan Parliament revisits and passes the Industrial Properties Bill, the permission to man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 facture cheap generic ARV drugs will cease in 2016 with thousands affected since Quality Chemicals man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 factures generic Aids drug," said Moses Mulumba,Executive Director of CEHURD, a healthcare access rights NGO advocacy group.\par With the expiry of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  grace period, the alternative in Uganda would be to buy these drugs much more expensively from the original Western manufacturers at prices beyond the reach of the majority Ugandan ARV user.\par Aids triple-combination therapy, which costs $10,000 per patient per year in industrialised countries, can now be obtained from Indian generic drugs company, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , for less than $200 per year. Generic Aids drugs en}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bled millions gain access to Aids treatment in poor countries. The 2013 and 2016 }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  deadlines threaten to reverse these gains and turn Aids treatment into a preserve of patients in rich Western world.\par Recently, Dr Raymond Byarugaba, head of Uganda Aids Information Centre, announced that this year, there will be 150,000 new HIV infections in Uganda up from 130,000 last year and 100,000 in years before adding to the already rising number of those in need of antiretroviral treatment which they can't access.\par At the moment, passing the Industrial Properties Bill in Uganda, after amending it to take full advantage of the 'flexibility' in the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, which would, inter alia, extend the grace period for manufacturing generic Aids drugs remains the best hope for the thousands on Aids treatment most of whom rely on generic drugs manufactured by Indian pharmaceutical companies such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  or its subsidiaries in Africa.\par On Monday, November 14, the world marked 10 years since the DOHA Declaration, which secured a grace period for developing countries to implement patents for pharmaceutical products. Sadly, poor countries, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cluding Uganda, have not taken full advantage of this grace period and this puts the lives of millions at stake as the clock ticks to the 2013 and 2016 deadlines.\par Mr Zakumumpa is an HIV/Aids specialist at Makerere University and a key correspondent for the Internatio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 al HIV/Aids Alliance.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GENERIC DRUGS (93%); PHARMACEUTICAL PREPARATION MFG (92%); AIDS & HIV TREATMENT (92%); PHARMACEUTICALS INDUSTRY (91%); INTERNATIONAL TRADE (91%); PATENT LAW (90%); INTERNATIONAL TRADE LAW (90%); ANTIVIRALS (90%); INTELLECTUAL PROPERTY LAW (90%); AIDS & HIV (90%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); INTELLECTUAL PROPERTY (90%); GENERIC PRODUCTS (90%); INTERNATIONAL LAW (90%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TRIES (90%); NONGOVERNMENTAL ORGANIZATIONS (89%); DISEASES & DISORDERS (78%); TRADE TREATIES & AGREEMENTS (78%); CHEMICALS (78%); DRUG SHORTAGES (78%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CALS PATENTS (78%); HEALTH CARE ACCESS (78%); DRUG DESIGN & DISCOVERY (78%); CHEM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CALS MFG (78%); PUBLIC HEALTH ADMINISTRATION (74%); SEXUALLY TRANSMITTED DISEASE (73%) Uganda; Health and Medicine; HIV-Aids and STDs\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PFIZER INC (90%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (57%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PFZ (LSE) (90%); PFEB (BRU) (90%); PFE (NYSE) (90%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (57%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (90%); NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (90%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UGANDA (99%); INDIA (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 16, 2011\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2011 AllAfrica Global Media.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa; The End of Cheap Medicine? Africa News November 15, 2011 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_65}{\*\bkmkstart DOC_ID_65_0}{\*\bkmkstart doc_id_10}{\*\bkmkend DOC_ID_65}{\*\bkmkend DOC_ID_65_0}{\*\bkmkend doc_id_10}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_10"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 10 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  15, 2011 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Africa; \par The End of Cheap Medicine?}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 This is Africa (London)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 2987 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Bric countries have redefined affordable drugs, making access to medicines possible for millions in low income regions. Yet changing priorities for major generic drug producers, such as India, could reshape the African pharmaceutical landscape.\par Access to medicines has improved dramatically over the last decade, driven by the rise of cheap pharmace}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ticals from Asia, domestic efforts by governments of developing countries, commitment from donors, and price cuts from brand producers.\par Smallpox is eradicated, the end of polio is nigh, and the number of children dying from measles has dropped by over 80 per cent. HIV-Aids, once a hopeless diagnosis for most people in developing countries, is now treatable for as little as $87 per person each year, down from around $10,000 in the late 1990s.\par Brazil, India and China have been essential in driving this transformation, pushing down the price of drugs and introducing new business models that have re-shaped how medicines are consumed in Africa. But their changing interests, and greater adoption of intellectual property rules, some warn, could unleash price rises. How African governments respond to this changing terrain will determine whether the progress of the last decade can be quickened. \par To understand the global health revolution of the last decade, and the decisions that confront African go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ernments now if they are to sustain that progress, it is necessary to step back to the 1980s when the Brazil}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 an government helped public labs develop yellow fever vaccines that Western producers were not providing - becoming the first developing country to enable cheap copies of brand drugs, now known as generics.\par A more assertive stance was taken in 1996 when, to tackle a potential Aids epidemic, policy makers passed a law guaranteeing free, universal access to treatment. Brazilian domestic manufacturers were allowed to make copies of patented antiretroviral (ARV) drugs, which delay the onset of Aids from the HIV virus, provo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing at times hostile responses from some Western governments, particularly the US. Drug companies were pressured to lower their prices or have their products copied.\par "Brazil changed the landscape by proving that treatment in resource-limited settings was possible, by forcing pharmaceutical companies to reduce prices, and by ushering in global policy changes to promote more equ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 table access to essential medicines" says Amy Nunn, assistant professor of medicine at the Division of Infe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tious Diseases, Brown University Medical School.\par In 2001, the Doha Declaration globalized Brazil's innovation, allowing all developing countries to copy brand drugs - whose patent life is typically 20 years - if public health demands were serious enough, or to import generics if they did not have manufacturing capacity. India seized the opportunity, producing and later e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 porting cheap generics around the world. Africa became India's second largest market after the US, with Kenya, Nigeria and South Africa the biggest recipients. India also provides most essential medicines pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cured by global health funds.\par China later emerged as an exporter of chemical raw materials - especially artemisinin for malaria. At the S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 no-African Summit in 2006, President Hu Jintao pledged Africa $37.5m in grants for artemisinin, part of a broader charm offensive geared to boost pharmaceutical exports, says Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations and an associate professor at Seton Hall University. "China wants to use health aid not just to expand political influence and improve its international image, but also to open the market for Chinese medicines and equipment," says Professor Huang. In its most blatant form, do}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tors dispatched to Africa are encouraged to dispense Chinese-made drugs.\par In 2005, China joined a network promoting Aids prevention, pooling its chemical exports to Brazil s advanced infrastructure and Russia s scale capacity. While Beijing took interest in global rule-setting after the Sars cr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sis in 2003, it shows little appetite for a major advocacy role. The elite are sceptical about calls to take grea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er responsibility for global welfare issues, believing this a Western conspiracy to slow China s growth, claims Professor Huang. Beijing prefers bilateral health aid rather than playing too heavily into multilateral initiatives, he says. Expectations of major charitable efforts are unrealistic. Brazil, in contrast, is becoming a major d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nor; the first developing country to sign up to a bond-based financing facility for immunization programmes last June.\par Perhaps China s most promising public contribution is in research. At a Shanghai Institute college, Chinese scientists are working on malaria, tuberculosis, African sleeping sickness and dengue fever treatments. Xi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 jiang Medical University also partners a South African company in developing implants for bone disease.\par Changing priorities\par Although the rise of these three countries pushed down the price of medicines in Africa, the engagement of India and China has become increasingly ambiguous. In 2005, India implemented the Trade Related Aspects of Intellectual Property Rights, or }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  part of its subscription to World Trade Organisation rules, which e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 forces tighter rules on patent protection. The implication is that all new drugs produced in India are under patent for twenty years, with flexibility for emergencies so producers can set higher prices since they have a monopoly for a set period.  Any treatment dependent on drugs or a vaccine is subject to price rises under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414   argues Michelle Childs, director of policy advocacy of MSF s Access Campaign.\par Ninety-five per cent of essential medicines are already off-patent, and available generics will not be affected, so at first glance the regulation seems harmless. However, many diseases require continuous innovations. HIV patients, for example, develop treatment immunity over time, so second and third generation drugs are needed. Moreover, current drugs require improvements; pregnant women, for example, are often unable to take some due to high toxicity. India s new trade laws have already pushed up the price of newer medicines by between 7 and 27 percent, says Ms Childs. This is echoed by Emmanuel Mujuru, chair of the Southern Africa Generic Medicines Association, who testifies to a rise in Aids and anti-malaria drug prices in Africa since 2005.\par These price rises may be accentuated by a 2016 deadline for African countries to implement their own }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  legislation, making the continent a less attractive export market for generic producers looking for countries where there is no risk of patent infringement, says Christoph Spennemann of the Intellectual Property Unit at Unctad. The concern is that a global roll out of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  puts an end to the very flexibilities which transformed access. While }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  could potentially increase profits for Africa s domestic producers, the sector needs  10 more years  to be ready to benefit, says SAGMA s Mr Mujuru, who anticipates  major shortages  if the dea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 line is not extended.\par Voices from industry downplay these fears.  The approaches that companies adopt in terms of pricing d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pend on the markets they are looking at,  says Andrew Jenner, director of innovation, intellectual property and trade at the International Federation of Pharmaceutical Manufacturers and Association, which repr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sents the brand industry.  Companies will not generally take legal action against low income countries if pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ducers manufacture decent quality copies,  he says. GlaxoSmithKline has already offered free licenses for generic companies to copy a range of their drugs in 69 countries around the world, including all of Africa s low income states. If anybody is vulnerable to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  it is probably the poorest in large emerging economies such as India, where pricing is likely to be more competitive.\par Most of Africa simply is not a business concern yet for big pharmaceutical companies, who are highly unlik}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly to sue governments after the public relations disaster in 2001 when a consortium took legal action against South Africa for its generics policies. The industry is also open to an extension to the 2016 deadline, says John Pender, vice-president of intellectual property and access at GlaxoSmithKline s government affairs o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fice.  I believe that the actions of the industry over the past few years have demonstrated that we can help address the health challenges of the developing world without weakening intellectual property,  he says.\par The changing commercial interests of pharmaceutical producers in India and China present a second set of dangers, according to Unctad. Indian companies are increasingly aiming their sights on richer markets, where several blockbuster drugs are coming off patent. Chinese companies want access too, and as the di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ease burden within India and China starts to resemble that of rich countries, with more diabetes and cancer for example, tropical diseases may move off the radar.\par However, non communicable diseases are a growing problem in Africa too, so more research effort is not simply to the benefit of the rich. Secondly, higher exports to OECD markets may give Indian and Chinese producers more resources to subsidise pricing in Africa, and to invest in research. In 2010, India s Serum Institute, in partnership with a non-profit group, released a highly effective vaccine for the  meningitis belt  that stretches from Senegal to Ethiopia. With ambitions to be powerhouses of innovation rather than merely copy cats, the research contribution that India and China could make to diseases in developing countries is potentially enormous.\par Perhaps the greater commercial concern may be not disinterest, but crowding out. Chinese firms are selling a particular form of  monotherapy  malaria drugs in Africa which, while cheap, are less effective than comb}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nation therapy because patients develop resistance. Yet attempts to get low income patients to buyhealthier combination therapy drugs are made difficult by the Chinese undercutting, says Amanda Glassman at the Centre for Global Development.\par Domestic production\par Worried about }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and business trends, Unctad and Unido are calling for Africa to raise pharmaceutical output. South Africa has the largest industry, with some proposing a state-owned pharmaceutical company based on the Brazilian experience. South African firms have marketing collaborations with over 20 African countries, and strong linkages with Botswana, Namibia and Nigeria. Egypt is strong on distribution with 10 African partners and a steady flow of graduates, but lacks export drive, according to Unctad s Mr Spenn}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mann. Morocco, Tunisia, Cameroon, Ghana, Tanzania, Nigeria and Zimbabwe have some production, with donors, especially Germany, offering support.\par Yet most small economies face an uphill struggle. Countries need to be at a threshold of competitiveness in terms of energy supply, skills, infrastructure, and regulatory efficiency, which few in sub-Saharan Africa have attained. It is not, however, impossible. Prior to 1982, eight transnational pharmaceutical companies co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 trolled up to 70 per cent of Bangladesh s local industry. Bangladeshi firms now take that share. In Indonesia between 1991 and 2010, the same reversal has taken place.\par Foreign investment is one stimulus, and there are forays from the Brics. India s }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is a partner in }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Medpro, South Africa s fourth largest pharmaceutical company and third largest generics company, and has established a joint venture in Uganda with a Kampala-based manufacturer producing Aids and malaria drugs. Ranbaxy, the first international company to establish a presence in French West Africa when it settled in Cameroon in 1987, provides ARVs, anti-infectives, anti-inflammatory drugs and cardiovascular medic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions there, and distributes products through offices in Nigeria, C\u217\'f4te d Ivoire, Egypt, Kenya and Morocco. Indian firms have supported Zimbabwe s efforts to produce Aids treatments through a Harare-based man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 facturer, and Cadila recently announced a $65m joint venture in Rwanda.\par Brazil and China have modest commitments. Brazil has significant pharmaceutical trade with South Africa, with minor investments in Angola and Mozambique. Chinese entities have made occasional investments   in Zanzibar in the 1970s, joint ventures in Mali and C\u217\'f4te d Ivoire in the 1990s and, recently, in drug capsule production in Ethiopia through Jianxi Corporation, but Chinese firms are unlikely to want African production to emerge since they see the continent as a potential export market for themselves.\par Some helpful technology transfer occurring through public initiatives such as Expand-TB, which provides l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 boratory-strengthening in 10 African countries, can stimulate production. Technical assistance from Western universities can help too. Recently, a team of researchers from New York University, Columbia University, Kigali, and Amsterdam launched the  mChip , a stamp-size, portable pad that can diagnose HIV for just $1.\par These inflows could increase if }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is fully implemented, says Mario Ottiglio, associate director, public a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fairs and global health policy at IFPMA.  An innovation-friendly environment would encourage technology transfer by creating a level of trust, transparency and certainty for investors,  he claims. A larger domestic skills base, with graduates in pharmacy, biochemistry and industrial production, is also needed. Such dome}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tic talent was vital to India s rise.\par One of the best ways to boost industry, says SAGMA s Mr Mujuru, is for African producers to be given pre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erential treatment by global procurement agencies who currently source most drugs from industrialised cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tries or emerging economies, especially India. But preferential purchasing is problematic since African pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ducers are pricier than their Indian counterparts. Should public agencies be interested in the cheapest drugs, or the development of the drug industry?\par  From a public health perspective what matters is that medicines reach the person in need, on time, in the right place and at the right price,  says Juergen Reinhardt at Unido. But the venue of production should not be ignored, he says. Continuity of supply, strengthening national regulation and readying for a period beyond charitable donation are all worthy goals, he says, but proposals to build the pharmaceutical industry are ba}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ted from ministries of health to ministries of industry, and back again, Reinhardt claims, identifying a  tr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mendous disconnect  between public health and industrial actors\par Tax may further hamper industry. While pharmaceuticals are a strategic priority in Ethiopia, high tariffs on imported raw materials are stifling local production, according to public statements by the Ethiopian Pharm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ceutical and Medical Supplies Manufacturers Association. Yet even if African producers were given prefere}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tial treatment, quality control could make that an empty privilege. Only a handful of companies   in South A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rica, Zimbabwe and Uganda  are qualified by the WHO to sell into procurement funds.\par While a  business case  needs to emerge in the long term, low purchasing power among low income groups means most interventions are going to be more public-initiated than private for the time being.  Africa is out there as a market, but it is on the horizon,  says Simon Friend, partner at PricewaterhouseCoopers.\par If production looks overly ambitious, streamlining regulation across smaller economies could boost Africa s attractiveness as a destination to sell into. When US pharmaceutical company Eli Lilly developed two antib}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 otics for tuburculosis and sought generic companies to sell them on in Africa, those identified   including South Africa s Aspen   said the mountain to climb to secure regulatory approval in each country made it u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 viable. It may be more effective to build regional regulators, perhaps incorporated into existing regional ec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nomic blocs such as Ecowas. A smaller number of better-resourced agencies might also help tackle the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ruption that dogs some nations. In 2006, almost a million Aids drugs delivered to the Democratic Republic of Congo went missing. The following year, Uganda had vaccines grants suspended for mass corruption.\par Political will\par While the price of final drugs is important, access to medicine depends on how well the entire health system works. It can often be costs along the supply chain   from import taxes to handling fees   which drive prices up. Fragmented distribution networks, meanwhile, hinder the transit of drugs.  Even where you have med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cines, getting them to people is difficult, both in pharmaceuticals and, more pertinently, in vaccines,  says Stephen Rea, a spokesperson at GlaxoSmithKline.\par Refrigeration facilities, good roads, detailed country maps and skilled staff to administer drugs are key parts of that puzzle. Security and public goods are critical too.  If people don t have clean water, or there is a war, those will be huge factors in how health access works,  says IFPMA s Mr Jenner. Water is particularly i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 portant for Africa s cholera burden which is rising, even as global incidences fall. While Indian firms are wor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing on a $3 treatment, the solution lies in fixing sanitation systems.\par While the sheer breadth of the challenge may seem overwhelming   and costly   there is no evidence that bigger economies necessarily have better health outcomes. Rwanda has among the highest rates of Aids treatment coverage in Africa, at around 95 percent, while in South Africa only 66 percent of those needing treatment receive it. Governments, not companies, emerge as the most important actors in ensuring wide access to medicines for their populations. Their policies, from intellectual property rules to public investments in higher education and roads, may prove more important than the whims of companies in Delhi, Geneva or Beijing.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (90%); PHARMACEUTICAL PREPARATION MFG (90%); GENERIC DRUGS (90%); BRIC COUNTRIES (90%); HEALTH CARE ACCESS (90%); DISEASES & DISORDERS (89%); PRICE CUTTING (89%); PHARMACEUTICALS INDUSTRY (89%); INFECTIOUS DISEASE (89%); E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 X}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PORT TRADE (89%); GENERIC PRODUCTS (89%); PRICE CHANGES (89%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TRIES (89%); PATENTS (87%); DRUG PRICES (78%); ANTIVIRALS (78%); IMPORT TRADE (78%); DRUG DESIGN & DISCOVERY (78%); AIDS & HIV TREATMENT (78%); PRICE INCREASES (77%); GLOBALIZATION (76%); PUBLIC POLICY (76%); TROPICAL DISEASES (76%); EPIDEMICS (76%); SMALLPOX (76%); MANUFACTURING OUTPUT (75%); MEASLES (75%); MOSQUITO BORNE DISEA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ES (75%); INTELLECTUAL PROPERTY (73%); VACCINES (72%); INTELLECTUAL PROPERTY LAW (72%); VIRUSES (69%); PLANT CAPACITY (63%); MANUFACTURING FACILITIES (63%); COLLEGE & UNIVERSITY PROFESSORS (60%); CHEMICALS EXPORTS & IMPORTS (60%); GRADUATE & PR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 FESSIONAL SCHOOLS (60%); LEGISLATION (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 INDIA (95%); AFRICA (95%); BRAZIL (94%); CHINA (92%); ASIA (92%); KENYA (79%); NIGERIA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 December 13, 2011\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2011 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 A Deadly Misdiagnosis; Is it possible to save the millions of people who die from TB? The New Yorker November 15, 2010 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_66}{\*\bkmkstart DOC_ID_66_0}{\*\bkmkstart doc_id_11}{\*\bkmkend DOC_ID_66}{\*\bkmkend DOC_ID_66_0}{\*\bkmkend doc_id_11}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_11"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 11 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\shppict{\pict{\*\picprop\shplid1025{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw7726\pich2434\picwgoal4380\pichgoal1380\pngblip\bliptag-1881402559 89504e470d0a1a0a0000000d49484452000000db000000450803000000f431634100000300504c5445000000ffffffcccccc666666333333c3001dfdf6f7f6e6e9fef8f9c7002ccf254cd33459ca0738cb113dcd1845ce1f4ad12853d22c56d53b62d7456ad94f72db597adf6a87e06f8ce1728ee27691e17d96e4849ce68ca3e994a9eba4b5eda9baefb2c1eab1bff0bbc8f1c2ceeec2cdf4c9d4efc7d1f5ced8f8e0e6faeaeedd6282e99cb0ecaebef3c5d1f5d3dcf7dae2f5e2e7fcf1f4f9e4eaf7e9edf9eff2fefbfcfcfcfdfbfffffdfffffefffff9fcfbfcfefdfffefefefdfdf9f9f9999999000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000694df58900000b614944415478daed5a895b134916af2b043ae4e05039d5281360148fd5517789e9bf5d07be8f99d51957941dbc5102311048d2b9d3c77655577757773a870aeea7637f9fe675751def57efa8f75e0121f86e1f7c7ad8a0e190c4240d806903d2015dd2fa868dd3c4864e6feafb4486260c02115603769040884e576ef094e56600a259b429379d6ea6c6e5c6dac1372a37a30bfdd51ef4ff34f653f663e46b42c1e29b4a800abf1fb919e623f84e837c3f723374cf66eadfb5bdfdc0f6ad6283f03bb1b7806d85da372c37420c874ad39f3421d69b29330857bf59a5f81bda9b19249b4f069e3e36ba8eaf3183329405e43efc2dc386d884d89911c862b77342e88ec82043d735f379a01b18415f2feb1161b346083c4b889cb1868cf8e28be930f43c8426209e0c44e6ba6b7de5047b903d1a39ad84f5f74e081023646e6c1863cb8b1104c5a91c33459e46ce1fe614f266a09c25f7953f3c5e95bb61a35c60f68eed91b2670a6cb38d9d462462f7f0c478c036df1650ecc566a3963bb16196f4091dadbe886333df785ee8c50650176c5c2658e69bc5c68882739813dab04f13f8fcb20719ef28c80801b123f263931dbe91c831c6822a11119c9367f4c4e63222434182c16273c178a1ca9d0ac2370cf95926c0a304ce701480cd6b26e217071be98b0d39dd84cd7006127135599c0f01773a1f34286883c8b20cbc32c2d66f87803bb1618167373fc4fdb041e2119ccc99903bd1789172d712e0b36c18a2192187f26013a17d0a360c7cfea40b36870d578244f08dc82b0ee29521f62b7ec78e892c7760f3f0d7039becc726fbfc49176cd61448e047160e0012e81a6ddb0bd648afaa7bb17974d27bacf4919b2c62b393fd7ed81cc1d904113c89dcc1b108b2abd804c179ed4df61e7a180e8c0d79b0f1c38ff4c10681577001e7b65f70483837703036e7bcf4fa49ff812e1c1ebdfd24f6c5021afbaaf68b2eb11dc9b0f87ddda4d27670837d5d750234c8bec876f4930e9ef42163c013f3a9be4017230c343d3350784c7431e6c22e46b9436e569c86b1ef38f29e1c41fac67c886d87b8233e08d8755b1c581492ad3db2ff0c903967c89d81c63dbe980b3b9ae1a804098adac463dbe35b71a0be51fbb70db287b9b9c03936d0e93778cc483a034fc144d86e8afbe760e3dc92ded89ca31689de8704ca040903c927606371a6dc810dfb6c90b047c46686861e744834106a72d87fcf63c59376198e753215dfc08efd51f320014571abef6754cb1f9a16f3a0c3b8d2d6c22ebf3451d26c7de3454219a83a74f3447e076192d68ff986557a11c1def937e7c229f3806e99fdd5baafc02a404110cc76c0bf30b25b328a34ab1f9b92f5a72d7c4a870b4a889c8a4bbad31bc0bd441114cfb0682dd3ebe2e22115869ae15251590e1b2cb62f79a88cee7fd6485393dc4a3cf4e6620c6fd7f34d3cbfb140c8ddfd1f827dfd24f6f9498bf2e701fe5865d0b8c40b8ef4c2669fdf080804ec874dee1a72059c010131d7c0d8908767c7de1cc5152d0aeb81d64134a4f18e2681834bfb82bd7599cbd5776741abbfe198a73bd235a51ef62658a5bfce35c0fd039b52b58ba68ce83f8a5967973a2bb3efd5532809fbb019727f3631df04ec1003acb3dabd60b846fffbf514ae2c7d3ac955ae974eda678539d4967d172f29e8241737eca592a2aad1a19fad93f621d0b1953a1948bfa8b40cee7a063a00e46e8243012af905777c3debcada60fa050c7ba2c1ee081fe2e0b393192e79d843b5041b54bfb466de23d1b1bc2f3bbfe99fbd30090e7a6e338578000357d383b6fffe0078032fa6d4ee40bafa930cd2d38ee00c9ba781d589e588fe24cc6393dec0642d405d60d07e67fcbb9209884bdc23dc9fbfc9bcda0b3b2b77b0eb43028f58310d9141470919b95d696a209cddc8ae44b9f91b2b2c634f9a61f792fd7189c344478ee32d5a609b05b95ba120109b1df7c8b4d1dc2f1250fa472e6a226356b710b3309a817baf52882f85e2bd48376c08076373be3b452d023f059b9b2c399c752b5f612e52e4cf8c09ea969b766ac7d7be7dcbac399e98887f6fd2b18ff7d73abec2fbe0d7feae0bc234ebf5e3def407b61fd87e60fb81edef8b6df004f726086fd0df1bf8f16dcdccb7317a7c4b8facdd805b4dda7cbb859e805b15a9fe17efbfb84d3bd78de1180d0c43cb46058cc6d64d72896cb701483577c00d58d324bcd55c328c268a3e1516bbdb52500485d882e983a1a6f484522b0679e274490d3fed57f31af87c33f6d432fd1d2a5eddcd56aba54229a5bf2f2e57f7865339b3792c1b2e5cdf818795cb07b4d72db575fdc3c2b96cf448c92752fbe0dafea1a61e1f2f7c3427c84d17c1dc2151c2ad7db59e2f0fdfac158a466c37beb46faf7521976b1d170e5b0d1dfc03e4eaf5c8dec5a9bc3972bfced6a2cfcf594d39316c235575b668fe461b2f43adc814096124e51a60e6b06a988bdc788fcf255f372ed68eeb170a34deafcf3e9a2b1c8f4989885a3a982fe624e5ecc78b5955d3c070657ab17534767e77e5a81d8f4ba1b15154a82eb65ac7b06cad74472b0d8d4f46468cf6fce1d577cdd1e8648b64cb131530a6b4d4a53dd6e772b6317a72d82ed4d4eab2b97931b52eb5a32f8f4acaf2c65cc5884a2535790840ebec2651ce6e2d69d5d6720eccd42ec68c9c74693b9fcb2b73b5eaf2c74863ec70badcbab20fa2f5a17cfdccec06982aa9e32f8fcb17f11f612d974f96508dc74c47898fc57ca1f8f38754e20db8f0fa2857282e149599f25cd9688012ed726d4747927262bee4603ed9ce86bc459c59a956df1c692ae07a35fe227c34ff163c3a9494ddf0ecd1d8a65222639675bc8d36f7ee5242d122cfe86fb93c3cbbe12cff689d11c760981b5249b264f3a8d5fec04780bf66496111841220ff1335ee6c28894fd44f4ab1dac42f16d9beb692ba14066b71b01f9ac1d5d0be3609265868db9e8f28d1c2e59d55b51e89f281e1e17a03023d991b99657e2704abbbdc95adac2c24297165ae3ccadb6af5081f77afd60ac56c0543edba02a612e0e34d70ef7d75a2a29d28b6c77343456eeed58fb983420a80bd4839f5546ac4abd34fae95e3cc45fe673c549c780ee001709cda38015553f78d219d2914884e35951b8ccae6d53de67b9e19505bb1d2eb96935d6f1c6bd8de9fc98899e51b606aa4f51e64cbf1b7c6c99e6fabd1383ebec4367234317ee6bca915cd51b2b73a462a2367405ee72e6c97906996d03b5510b549d741efceb70e965829222cb5ebec4b6c2674798a79e1f9f1f6ee3dd636e116ab2030aa9cfc8d35369ecc85aa1325e9e8c4cfeef50f71ede88015e6b7b75f6c52b1e4a4ba323eaf4637ae56cfb59d8e9ba6314e02ed067fad6014a34037130d8bd5d7a1fa90e57ca5a79baf984e6e4c0fd52b6c9112a8d937e371acdb859dcb35304c65b8390eaa60eed629c42573c98642b1d99a029ad3385bdc21c5bbfbe1b7deaee191263789d54623fa88dfa230fca36d022cb90dad3b4c6c602ee870b8facedea3612e5f7a451fb59cfe7c02cf4b1ba780ed7769986da4e57e6f9bff5e851b7990acbf6dcdd87dae583f7f9ed7f6c38c2a9587ce7206ed32f5046800f05f40ff379fa485099be75b7ad174abe0709657cf26a172cdfaf8c6f4ba4c2dd766275f0d04ed53b0319b7f3c1f327881f6d619aaf5cdb8563b130e95e34e04f4dcfebd5c9752f7c09df33bc622f72abb43cd7f5aac4694952ba6370f9b67c3ca7493398fb3b071076ce72e81c204286ccd24171792a1ed05f5edfc1d702f25e9136f6c97b6d33ce958195be587cd337815622591486c01e65666a4c8d927d248d2e978ddbea37c7e2994df9e78a1c496251eb8b667f4ad0b98d4c19fe7d0ced110c41fb613891d1867d7257fc41acf5250db05edec7cb45d3adcdfd3ef82cde558e5c5c4769efcb46332db1e765689f58f3a06af97ac425e0c5d5d4f83df926d189a64c602564cd7714b7911d0d3944baa120b315b5bd530ed9efef72f6bff82eb169106951204893f40da2ab4dede34dbacb1e9baf17cc532d2dbedf2e88ba66f629336d6fb70fc3f41df862ba8884ab80000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw219\pich69\picwgoal4380\pichgoal1380\macpict\bliptag-1881402559 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000004500db001102ff0c00fffe0000004800000048000000000000004500db00000000001e0001000a00000000004500db82000000ecb60000000100000000000000000000000000000001000000000000000000000000000040000000000000000000000000000000000000000000004500db000003000000000000000056726177200000000000000000000000006170706c000004000000040000db004500480000004800000000ec1c000100000000000000000000000000000000000000000000000000000000000000000020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff333333ff999999ffffffffffffffffff000000ff000000ff333333ffffffffffccccccff666666ff000000ffccccccffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffccccccff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffccccccffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ff333333ff333333ff333333ff333333ff333333ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ff333333ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ff666666ff666666ff666666ff666666ff333333ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ff666666ff666666ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffccccccffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff666666ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff333333ff666666ff666666ff666666ff666666ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff333333ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff333333ff999999ffffffffffffffffffffffffffffffffff999999ff333333ff333333ffffffffffffffffffffffffffffffffff333333ff333333ff333333ff333333ff333333ff333333ff333333ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccffccccccff666666ff666666ff666666ff666666ff999999ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff666666ff666666ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff666666ff999999ffffffffffffffffffffffffffccccccff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ffffffffffffffffffccccccff666666ff666666ff666666ff666666ff999999ffffffffffffffffffffffffffffffffff666666ff666666ff666666ff666666ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff666666ff999999ffffffffffffffffffffffffffffffffffffffffffffffffff999999ff666666ff666666ffccccccffffffffffffffffffffffffffffffffffffffffff666666ff666666ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff666666ff666666ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff666666ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff999999ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff666666ff666666ff666666ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff666666ff666666ffccccccffffffffffffffffffffffffffccccccff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ffccccccffffffffffffffffffffffffff999999ff666666ff666666ff666666ff666666ff666666ff666666ff666666ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff999999ffffffffffffffffff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff999999ff333333ff000000ff000000ff000000ff000000ff333333ff333333ff666666ff666666ff666666ff333333ff000000ff000000ff000000ff000000ff000000ff333333ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff333333ff666666ff666666ff666666ff666666ff333333ff000000ff333333ffffffffffffffffff666666ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffccccccff333333ff000000ff000000ff000000ff000000ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff333333ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ff666666ff666666ff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ff666666ff666666ff666666ff666666ff666666ff333333ff000000ff000000ffccccccffffffffffffffffff333333ff000000ff000000ff000000ff000000ff666666ff666666ff666666ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffccccccff666666ff999999ffffffffffccccccff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ffccccccffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff333333ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff999999ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff666666ffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffff999999ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffccccccff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffff999999ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff999999ffffffffffffffffffffffffff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffccccccff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ff000000ff000000ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffff333333ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff333333ffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ff999999ff000000ff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffff999999ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ffccccccffffffffffffffffffccccccff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ff333333ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffff666666ff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff333333ffffffffffffffffff333333ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffff333333ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffccccccff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffccccccff000000ff000000ff000000ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff333333ff666666ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ffccccccffffffffffffffffff666666ff000000ff000000ff999999ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffff999999ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffccccccff666666ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffff666666ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffccccccffccccccffccccccffccccccffccccccffccccccff666666ff666666ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff333333ffffffffffccccccff000000ff000000ff333333ffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffff666666ff000000ff000000ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffff999999ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff999999ffccccccffccccccffccccccffccccccffccccccffccccccff666666ffccccccffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffccccccff333333ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff999999ff333333ff000000ff000000ffccccccffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffff333333ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffff999999ff000000ff000000ff333333ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffff999999ff333333ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffff666666ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff333333ff333333ff333333ff333333ff333333ff333333ff000000ff000000ffccccccffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffccccccff666666ff000000ff000000ff333333ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffccccccff666666ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffccccccff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffff999999ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffff999999ffccccccffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff999999ffffffffff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffccccccff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff000000ffccccccff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffff666666ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff333333ff333333ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ffccccccffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ffccccccffffffffffccccccff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff333333ffffffffff666666ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffffffffff666666ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffccccccff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ff666666ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff666666ffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff666666ff000000ff999999ffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff666666ff999999ffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff666666ffccccccffccccccffccccccffccccccffccccccffccccccff999999ff666666ff666666ff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff333333ffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff333333ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff000000ff000000ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ffccccccffffffffffffffffffccccccffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff333333ffffffffffffffffffffffffffccccccffffffffffccccccff000000ff000000ff000000ff000000ff999999ffccccccffccccccffccccccff666666ff666666ff666666ff333333ff000000ff666666ffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff333333ffffffffffffffffffffffffff999999ffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff333333ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff333333ff999999ffccccccffffffffffffffffffffffffffccccccff999999ff666666ff333333ff000000ff000000ff000000ff000000ff333333ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffff999999ff000000ff000000ff000000ff333333ff999999ff666666ff000000ff999999ffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff666666ffccccccff666666ff000000ffccccccffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff666666ffccccccff666666ff333333ffffffffffffffffffffffffff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff666666ffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff666666ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ff999999ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff000000ff999999ffffffffffccccccff000000ff000000ff000000ff000000ff666666ffffffffffffffffffffffffffffffffffffffffffffffffff666666ff000000ff000000ff000000ff000000ff333333ffccccccffffffffffccccccff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffccccccffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff333333ff000000ff000000ff000000ff000000ff333333ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff999999ff666666ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff333333ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff999999ff666666ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff999999ff999999ffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccff666666ff999999ffccccccfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9e4eafff9e4eafffefffffffffffffffffffffffffffffffffffffffffffffffcf1f4fff9eff2fffffffffffefbfcfff9e4eafff9e4eafff5d3dcfff7dae2fff9e4eafff9eff2fffffffffff9eff2fff9e4eafffefdfdfffffffffffcf1f4fff9e4eafffef8f9fffffffffffffffffffffffffffffffffffffffffffefbfcfff7dae2fffcf1f4fffffffffffffffffff9eff2fff8e0e6fff9e4eafffaeaeefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8e0e6fffffffffffffffffffffffffffffffffffcf1f4fff8e0e6fff5ced8fff7dae2fffefdfdfffffffffffffffffffffffffffffffffffdf6f7fff7dae2fff5d3dcfff0bbc8fff0bbc8fff5d3dcfffffefefffffffffffffffffffffffffffffffffffaeaeefff3c5d1fffdf6f7fffffffffffffffffffffffffff5ced8ffefb2c1fffffffffffffffffffcf1f4fff9e4eafff8e0e6fff4c9d4fff7dae2fff9e4eafffef8f9fffffffffffaeaeefff8e0e6fff5ced8ffefb2c1fff0bbc8fff7dae2fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfffffff9e4eafff4c9d4fff5ced8fff9e4eafff9eff2fffefffffffffffffffffffffffffffffffffffffffffffffffefdfdfff8e0e6fff5d3dcfff5ced8fffcf1f4fffffffffffffffffffffffffffffffffffffffffff5d3dcfff3c5d1fffcf1f4fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff5ced8fff7dae2ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe1728effd33459ffeba4b5ffffffffffffffffffffffffffffffffffffffffffeda9baffe27691fffeffffffe4849cffd33459ffd7456affdb597affd7456affce1f4affd53b62fff7dae2fff7dae2ffd53b62ffe06f8cfffefbfcfff8e0e6ffd7456affdb597afffcf1f4ffffffffffffffffffffffffffffffffffecaebeffd53b62fff8e0e6fffffffffff5e2e7ffd7456affeba4b5ffd94f72ffd53b62ffecaebefffffffffffffffffffffffffffffffffffffffffff9eff2ffdf6a87ffe27691fffffefefffffffffff4c9d4ffdd6282ffd53b62ffdd6282ffdf6a87ffdb597affd7456affe17d96fff7e9edfffffffffffffffffffcf1f4ffe06f8cffcd1845ffdb597affe06f8cffd22c56ffdb597afff7dae2ffffffffffffffffffffffffffe4849cffca0738fff0bbc8ffffffffffffffffffe994a9ffcd1845ffe4849cfffffffffffef8f9ffdf6a87ffd33459ffdb597affd94f72ffd33459ffd12853ffd94f72fffcfefdfff8e0e6ffdb597affcd1845ffdf6a87ffdd6282ffd12853ffe06f8cfff9eff2ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefb2c1ffd94f72ffd33459ffd53b62ffd33459ffd33459ffd33459ffe68ca3fffdf6f7fffffffffffffffffff7e9edffe17d96ffd7456affd94f72ffe1728effdd6282ffd7456affdd6282fff3c5d1ffffffffffffffffffffffffffe994a9ffca0738ffdb597afffcf1f4ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe99cb0ffcd1845ffe4849cffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affc3001dffcb113dfff0bbc8ffffffffffffffffffffffffffffffffffe994a9ffd7456affffffffffd7456affc7002cffe27691fff7dae2fff4c9d4ffeda9baffe4849cfff5ced8fffefbfcffd33459ffc7002cffeda9bafffefdfdffd94f72ffc7002cffe68ca3fffffffffffffffffffffffffffcf1f4ffd12853ffd94f72fffefbfcfffffefeffd7456affd33459fff9eff2ffe17d96ffc3001dffce1f4afff5ced8ffffffffffffffffffffffffffffffffffe1728effcd1845fff5d3dcffffffffffe994a9ffcd1845ffd33459ffeda9bafff5d3dcfff9e4eafff5d3dcffe68ca3ffca0738ffcf254cfff0bbc8ffffffffffffffffffdf6a87ffc3001dfff1c2cefffdf6f7ffe99cb0ffc3001dffdf6a87fffef8f9ffffffffffffffffffdf6a87ffc3001dffecaebefffefdfdffe27691ffc7002cffe68ca3fffefffffffffffffffcf1f4ffd22c56ffc7002cffeba4b5fff8e0e6fff1c2ceffeba4b5ffdd6282fff9f9f9fffefbfcffd53b62ffc3001dfff9eff2fffaeaeeffdf6a87ffc3001dffe994a9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbffffffe27691ffcb113dffdf6a87fff0bbc8fff5d3dcfff5ced8fff0bbc8ffdb597affd7456afffaeaeefffffffffff3c5d1ffd12853ffcd1845ffe68ca3fff4c9d4fff9e4eafff8e0e6ffeab1bfffcf254cffcb113dffe17d96ffffffffffffffffffefb2c1ffc7002cffc7002cffe27691fffefbfcffffffffffffffffffffffffffffffffffffffffffffffffffeec2cdffca0738ffc3001dffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdd6282ffcb113dffc7002cffcf254cfff5d3dcffffffffffffffffffffffffffe994a9ffd94f72ffffffffffd94f72ffc7002cffeba4b5fffffffffffffffffffffffffffffffffffefdfdfffffffffff0bbc8ffc7002cffd7456afffefbfcfff5d3dcffca0738ffd12853fffaeaeeffffffffffffffffffe27691ffcd1845fff5ced8fffffffffff0bbc8ffcb113dfff0bbc8fffffffffffefbfcffe17d96ffc7002cffd53b62fff9e4eaffffffffffffffffffe4849cffce1f4afff5d3dcfffffefeffe994a9ffc3001dffd7456afffcf1f4fffffffffffffffffffffffffffffffffffffffffff0bbc8ffca0738ffca0738fff7dae2ffffffffffdf6a87ffc3001dfff4c9d4fffffffffff7dae2ffca0738ffd33459fff9eff2ffffffffffffffffffe1728effc3001dffeba4b5ffe06f8cffce1f4affeab1bffffefffffffffffffffffffffffcf1f4ffd53b62ffc7002cfff4c9d4fffffffffffffffffffffffffffefbfcfffffefefffdf6f7ffd7456affc7002cfffdf6f7ffffffffffecaebeffc7002cffdb597affffffffffffffffffffffffffffffffffffffffffffffffffffffffffe994a9ffc7002cffe4849cfffffffffffffffffffffffffffffffffffffffffffefbfcfff6e6e9fff9f9f9fff7dae2ffca0738ffcd1845fff3c5d1fffffffffffffffffffffffffffffffffffffffffffaeaeeffd33459ffc3001dffe994a9ffffffffffecaebeffca0738ffc7002cffc7002cffeda9bafffffffffffffffffffffffffffffffffffffffffff7dae2ffcf254cffc7002cffc7002cffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affdd6282ffdd6282ffc3001dffd7456afffdf6f7ffffffffffffffffffe994a9ffd94f72ffffffffffd94f72ffc7002cffeba4b5fffffffffffffffffffffffffffffffffffffffffffffffffffefdfdffd7456affc7002cffecaebeffffffffffdb597affc7002cffe68ca3fffffffffff5e2e7ffcd1845ffe994a9fffffffffffef8f9ffd12853ffdd6282fffffffffffffffffffffffffffdf6f7ffd7456affc3001dffdf6a87fffef8f9ffe68ca3ffc7002cffefb2c1fffffffffff7dae2ffcd1845ffc7002cffeec2cdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe27691ffc3001dffdb597afffdffffffdf6a87ffc3001dfff4c9d4fffffffffff0bbc8ffc7002cffdf6a87fffef8f9ffffffffffffffffffe1728effc3001dffd12853ffc7002cffe06f8cfffffefefffffffffffffffffffffffffffcf1f4ffd53b62ffc7002cfff5ced8fffffffffffffffffffffffffffffffffffffffffffdf6f7ffd7456affc7002cfffef8f9ffffffffffe4849cffc7002cffe994a9fffffffffffffffffffffffffffffffffffffffffffffffffff5ced8ffcd1845ffd7456afffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeffffffd53b62ffc7002cffe27691ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefc7d1ffc7002cffcf254cfff8e0e6ffecaebeffd22c56ffe27691ffc7002cffc7002cffefc7d1fffffffffffffffffffffffffffefbfcffd94f72ffce1f4affdd6282ffca0738ffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affdd6282fff9eff2ffd7456affc7002cffe27691fffcfcfdffffffffffe994a9ffd94f72ffffffffffd94f72ffc7002cffe27691fff7dae2fff5d3dcfff5ced8fff1c2cefffef8f9fffffffffffffffffff0bbc8ffc7002cffd7456afffdf6f7fff7dae2ffca0738ffd22c56fffdf6f7ffe06f8cffd33459fffcf1f4ffffffffffe4849cffce1f4afffaeaeefffffffffffffffffffffffffffffffffff5e2e7ffd12853ffc7002cffdb597affc7002cffecaebefffffffffffffefeffe99cb0ffc3001dffd94f72fffcf1f4ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefb2c1ffcb113dffca0738fff5e2e7ffe06f8cffc3001dfff1c2cefff0bbc8ffcf254cffd53b62fffcf1f4ffffffffffffffffffffffffffe1728effc3001dffdb597affcf254cffca0738ffefb2c1fffffffffffffffffffffffffffcf1f4ffd53b62ffc7002cffe99cb0fff5d3dcfff5d3dcfff4c9d4fff0bbc8fffffffffffdf6f7ffd7456affc7002cfff7e9edffe994a9ffcb113dffdb597affffffffffffffffffffffffffffffffffffffffffffffffffffffffffe994a9ffc3001dffeba4b5fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefffffff7dae2ffca0738ffcd1845fff5ced8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffaeaeeffd33459ffc3001dffeda9baffeda9baffd22c56fffcf1f4ffe27691ffc7002cffce1f4afff9e4eafffffffffffeffffffe06f8cffc7002cfff0bbc8ffeba4b5ffc7002cffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affdd6282fffffffffff7dae2ffce1f4affc7002cffe994a9ffffffffffe994a9ffd94f72ffffffffffd94f72ffc7002cffcd1845ffe1728effdf6a87ffd53b62ffd12853fff5d3dcfffffffffffffffffffef8f9ffd94f72ffc3001dffecaebeffffffffffdf6a87ffc7002cffdb597affca0738ffeec2cdfffffffffff7dae2ffcb113dffeba4b5fffffffffffffffffffffffffffffffffffffffffffffffffff0bbc8ffcd1845ffc3001dffe68ca3fffffffffffffffffffefdfdffdf6a87ffc3001dffe1728efffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9e4eaffd22c56ffca0738fff4c9d4ffe1728effc3001dfff1c2ceffeab1bfffd12853ffd12853fff0bbc8ffffffffffffffffffffffffffe1728effc3001dfff0bbc8fff0bbc8ffc3001dffd7456afffcf1f4fffffffffffffffffffcf1f4ffd53b62ffc7002cffd12853ffe1728effdd6282ffd33459ffcb113dfffffffffffdf6f7ffd7456affc7002cfff6e6e9ffe68ca3ffcd1845ffd53b62fff5d3dcfffffffffffffffffffffffffffffffffffffffffffffefeffe06f8cffc3001dffeda9baffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeba4b5ffc7002cffd22c56fff9eff2fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefdfdffdf6a87ffc3001dffe994a9ffeda9baffd12853fffcf1f4fffcf1f4ffd53b62ffc7002cffd94f72ffffffffffeba4b5ffc7002cffe1728effffffffffe994a9ffc7002cffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affdd6282fffffefefffffefeffeba4b5ffca0738ffca0738fff1c2ceffe99cb0ffd94f72ffffffffffd94f72ffc7002cffe17d96fff8e0e6fff8e0e6fff5ced8fff5d3dcfffcf1f4ffffffffffffffffffffffffffefb2c1ffc7002cffd53b62fffffefefff5ced8ffcb113dffc7002cffdb597afffeffffffffffffffe27691ffd33459fffdf6f7fffffffffffffffffffffffffffffffffffffffffffffffffffdf6f7ffd53b62ffc7002cfffefbfcfffffffffffffffffffefdfdffe06f8cffc3001dffdf6a87fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff5d3dcffcf254cffca0738fff5ced8ffe1728effc3001dfff4c9d4fffffffffff5d3dcffcf254cffcb113dfffaeaeeffffffffffffffffffe1728effc3001dffefb2c1fffaeaeeffce1f4affcd1845fff8e0e6fffffffffffffffffffcf1f4ffd53b62ffc7002cffeba4b5fff9e4eafff7dae2fff5d3dcfff4c9d4fffffffffffdf6f7ffd7456affc7002cfffdf6f7fffeffffffefb2c1ffcb113dffd53b62fffefffffffffffffffffffffffffffffffffffffffffefeffdd6282ffc3001dffeba4b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeda9baffc7002cffd12853fffaeaeefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdf6f7ffdb597affc3001dffe994a9ffeda9baffd12853fffaeaeefffffffffff5d3dcffcd1845ffc7002cffd94f72ffce1f4affd7456afffdf6f7ffffffffffe994a9ffc7002cffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affdd6282fffffefeffffffffffffffffffe4849cffc7002cffd22c56ffdf6a87ffdb597affffffffffd94f72ffc7002cffeba4b5fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffef8f9ffd7456affc7002cfff7dae2fffeffffffdd6282ffc3001dfff0bbc8fffffffffff3c5d1ffcd1845fff0bbc8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdf6f7ffd53b62ffc7002cfffef8f9ffffffffffffffffffffffffffe99cb0ffc3001dffd7456afffcf1f4fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff0bbc8ffcb113dffcd1845fffefbfcffdf6a87ffc3001dfff4c9d4ffffffffffffffffffe17d96ffc3001dffeba4b5ffffffffffffffffffe1728effc3001dffefb2c1fffdf6f7ffd94f72ffc3001dfff5d3dcfffffffffffffffffffcf1f4ffd53b62ffc7002cfff5ced8fffffefefffffffffffffffffffffffffffffffffffdf6f7ffd7456affc7002cfffcf1f4fffffffffffeffffffd7456affc7002cfff3c5d1ffffffffffffffffffffffffffffffffffffffffffe4849cffc3001dffd94f72fffefdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff5d3dcffca0738ffcd1845fff4c9d4fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffaeaeeffd33459ffc3001dfff4c9d4ffecaebeffd12853fffaeaeeffffffffffffffffffefb2c1ffc7002cffc7002cffce1f4afff7dae2fffeffffffffffffffe994a9ffc7002cffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affdd6282fffffefefffffffffffffffffffbffffffdd6282ffc7002cffc7002cffdf6a87ffffffffffd94f72ffc7002cffe99cb0ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffecaebeffca0738ffd94f72fffaeaeeffd33459ffc7002cffd53b62fffdffffffd94f72ffdb597afffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdf6f7ffd53b62ffc7002cfffef8f9fffffffffffffffffffffffffff9e4eaffcd1845ffca0738fff5d3dcfffffffffffffffffffffffffffffffffffffffffffffffffffffefeffe17d96ffc3001dffe4849cffffffffffdf6a87ffc3001dfff4c9d4ffffffffffffffffffeba4b5ffc7002cffe27691ffffffffffffffffffe1728effc3001dffecaebeffffffffffe1728effc3001dfff4c9d4fffffffffffffffffffcf1f4ffd53b62ffc7002cfff3c5d1fffffffffffffffffffffffffffffffffffffffffffef8f9ffd7456affc7002cfffcf1f4ffffffffffffffffffdf6a87ffc7002cffe99cb0fffffffffffffffffffffffffffffffffffffffffff0bbc8ffca0738ffc7002cffe994a9ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd94f72ffc7002cffe68ca3fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3c5d1ffc7002cffd53b62fffcf1f4ffeda9baffd12853fffaeaeefffffffffffffffffffefdfdffe27691ffca0738ffecaebefffeffffffffffffffffffffffe994a9ffc7002cffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affdd6282fffffefefffffffffffffffffffffffffff9eff2ffd22c56ffc3001dffdf6a87ffffffffffd94f72ffc7002cffeba4b5fffffffffffffffffffffffffffffffffffffffffffefbfcfffffffffffffffffffffffffffef8f9ffd7456affca0738ffd7456affd33459ffdd6282ffc7002cffe06f8cffcd1845fff7dae2fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcf1f4ffd53b62ffc7002cfffef8f9ffffffffffffffffffffffffffffffffffecaebeffc7002cffdb597afffef8f9fffffffffffffffffffffffffffffffffffffffffff3c5d1ffca0738ffd33459fffcf1f4ffffffffffdf6a87ffc3001dfff4c9d4fffffffffffffffffff0bbc8ffca0738ffe06f8cffffffffffffffffffe1728effc3001dffecaebeffffffffffe99cb0ffc3001dffe994a9fffffffffffffffffffef8f9ffd53b62ffc7002cfff4c9d4fffffffffffffffffffffffffffffffffffffffffffaeaeeffd7456affc7002cfffcf1f4ffffffffffffffffffe994a9ffca0738ffe994a9fffffffffffffffffffefdfdfff8e0e6ffffffffffffffffffe27691ffc7002cffc7002cffe68ca3fffffefefffffffffffffffffffffffffffffffffffffffffffffffffff8e0e6ffcf254cffce1f4afff7dae2fffffffffffffffffffffffffffffffffffffffffffef8f9ffd33459ffcb113dfff1c2ceffffffffffeba4b5ffd12853fffaeaeefffffffffffffffffffffffffff9eff2ffefb2c1fffef8f9ffffffffffffffffffffffffffe994a9ffc7002cffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdb597affdb597afffffefefffffffffffffffffffffffffffffffffff5d3dcffcf254cffdb597affffffffffd94f72ffc7002cffe4849cfffffffffffffffffffffffffff9eff2ffdf6a87fff1c2cefffffffffffffffffffffffffffffffffff0bbc8ffc7002cffc7002cffefb2c1fffcf1f4ffcd1845ffc7002cffe994a9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdf6f7ffd53b62ffc7002cfffef8f9ffffffffffffffffffffffffffffffffffffffffffecaebeffca0738ffd53b62fff5ced8fffefffffffffffffffbffffffeda9baffcd1845ffd33459fff9e4eaffffffffffffffffffdf6a87ffc3001dfff4c9d4fffffffffffffffffffdf6f7ffd53b62ffd12853fff9fcfbffffffffffe1728effc3001dffecaebefffffffffff9e4eaffd12853ffd12853fff5d3dcffecaebefff3c5d1ffd53b62ffc7002cffecaebefffdfffffffffffffffffffffff5d3dcffe17d96fff0bbc8ffd94f72ffc7002cfffcf1f4fffffffffffffffffff7e9edffcb113dffdb597afffbffffffffffffffdf6a87ffd12853fff1c2cefffffffffffdf6f7ffe68ca3ffc7002cffc7002cffd53b62ffe4849cfff0bbc8fff8e0e6fff4c9d4fff0bbc8fffdf6f7fffffffffff5d3dcffd33459ffcd1845ffeba4b5fffbfffffffffffffffefffffff5ced8ffd53b62ffc7002cffefb2c1ffffffffffffffffffeba4b5ffd12853fffaeaeeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe994a9ffc7002cffe68ca3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe1728effdf6a87fffefdfdffffffffffffffffffffffffffffffffffffffffffeda9baffe1728efffffefeffdb597affca0738ffcd1845ffd22c56ffd22c56ffd22c56ffcf254cffdf6a87fffcf1f4fffffffffffffffffffffffffffffffffffffefeffd7456affd94f72fffcfcfdffffffffffe1728effd53b62fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefbfcffd7456affca0738fffef8f9fffffffffffffffffffffffffffffffffffffffffffffffffff5d3dcffe06f8cffd22c56ffd53b62ffd94f72ffd22c56ffd53b62ffe68ca3fff9eff2fffffefeffffffffffffffffffe17d96ffc3001dfff4c9d4ffffffffffffffffffffffffffecaebeffcd1845ffd12853ffefb2c1ffe4849cffc7002cfff1c2cefffffffffffffffffff5ced8ffd53b62ffce1f4affe17d96fff7e9edffd7456affca0738ffce1f4affd22c56ffd22c56ffd22c56ffce1f4affe4849cfffcf1f4ffd94f72ffca0738fffcf1f4ffffffffffffffffffffffffffe4849cffcb113dffd33459fff5ced8ffe06f8cffcb113dfff6e6e9ffffffffffffffffffffffffffefc7d1ffdf6a87ffcb113dffca0738ffcd1845ffce1f4affd33459ffefb2c1fffefdfdfffffffffffffffffff9eff2ffe68ca3ffd53b62ffd22c56ffd94f72ffd53b62ffd22c56ffdf6a87fff5d3dcffffffffffffffffffffffffffefb2c1ffd33459fffcf1f4ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe99cb0ffca0738ffe994a9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefffefdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefffffffffffefdfdfffefdfdfffdf6f7fff5ced8fff0bbc8fff1c2cefff8e0e6fffffefefffffffffffffffffffffffffffffffffffffffffffffffffff5d3dcfff5d3dcfffffffffffffffffff9eff2fff5ced8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefffefdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffef8f9fff5d3dcfff0bbc8fff5e2e7fffefbfcfffffffffffffffffffffffffffffffffffffffffffffefefffefffffffffefefffffffffffffffffffffffffffffffffffefdfdfffef8f9fffefdfdfffffffffffcfefdfffffefefffffffffffffffffffffffffffefdfdfffef8f9fffefdfdfffffffffffefdfdfffefdfdfffcf1f4fff0bbc8fff1c2cefff1c2cefff7e9edfffffffffffffffffffefdfdfffefdfdfffffffffffffffffffffffffffffffffffffffffffefbfcfffef8f9fffefdfdfffffffffffefdfdfffffffffffffffffffffffffffffffffffffffffffffffffffefdfdfff9eff2fff7e9edfffef8f9fffefbfcfffffffffffffffffffffffffffffffffffffffffffffffffffefbfcfff5e2e7fff0bbc8fff5d3dcfffef8f9fffffffffffffffffffffffffffffffffffffffffffffefefffefdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefffefdfdfffffefeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000700ae00700007000100010003000300040000000d000c001000db00db00db00db00280016003810517569636b54696d65aa20616e642061000028002200400d206465636f6d70726573736f720028002e00101f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par The New Yorker\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  15, 2010\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 A Deadly Misdiagnosis; \par Is it possible to save the millions of people who die from TB?}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Michael Specter\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 FACT; Letter From India; Pg. 48 Vol. 86 No. 36\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 5120 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Every afternoon at about four, a slight woman named Runi slips out of the cramped, airless room that she shares with her husband and their sixteen children. She skirts the drainage ditch in front of the building, then walks toward the pile of hardened dung cakes that people in this slum on the edge of the northeastern Indian city of Patna use for fuel. Dressed in a bright-yellow sari shot with gold threads, Runi is followed by several of her children. Although she can't remember their ages, or her own, Runi must be about forty, because she dates her life from its first crucial memory: the smallpox epidemic that devastated Patna and much of su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rounding Bihar province in 1974.  \par Runi survived that plague, and several others, but, about a year ago, after developing a persistent cough, she visited one of the private medical clinics that line the streets of Patna. There someone who called himself a doctor stuck a needle in her arm, drew a few drops of blood, examined them, and told her that she had t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 berculosis. It is not an uncommon diagnosis. Tuberculosis has always been the signature disease of urban poverty, passed easily in poorly ventilated spaces. India has nearly two million new cases each year, and every day a thousand people die of the disease, the highest number in the world. Tuberculosis is also the leading cause of death among people between fifteen and forty-five-the most productive age group in any country and the key to India's prospects for continued economic growth.\par For most patients, the choices are bleak. Public hospitals are so overcrowded that people are forced to rely on inaccurate tests dispensed at private labs and clinics. They are unregulated enterprises, and peddle blood tests that are responsible for tens of thousands of misdiagnoses every year. "This is deadly," L. S. Chauhan, the director of the National TB Control Program, told me when we met in New Delhi. "But there are tho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sands of labs. Shut one down and the next day ten more appear." \par Runi's test was indeed worthless. It determined the presence of antibodies, which show that a body's i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mune system has begun to respond to an infection. But most TB infections are latent: no more than ten per cent will ever cause illness. This means that ninety per cent of people with antibodies for TB in their blood don't have the disease. Runi's cough was clearly caused by something else. \par Vaccines and antibiotics have long been seen as touchstones of medical progress. To stop tuberculosis, however, particularly in the developing world, an accurate diagnostic exam is needed even more. In India, China, and Africa, at least two billion people have latent infections. Yet every day thousands are told, mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 takenly, that they are sick and need treatment. That's what happened to Runi. Soon after she received her diagnosis, Runi began a regimen of powerful (and toxic) drugs provided by the public-health service, and she stuck to the program for the required six months. Not long after finishing, however, she started to feel worse than she ever had before. "This is the tragedy of our TB-control program,'' Shamim Mannan said as we watched Runi's children play. Mannan, who is from Assam, a few hundred miles from Patna, serves as the Indian government's chief TB consultant in the region. \par "Officially, she is cured,'' he said. "But how would we know? She took a test that showed she had the ant}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 body for TB in her blood. So do I. So do five hundred million Indians." As Runi stooped to gather fuel for the stove, she began to cough, lightly at first and then with alarming force. Every cough sounded as if somebody had shattered a pane of glass.\par "Now she really is sick,'' he continued, explaining that Runi's TB was no longer dormant, and that taking drugs when they are not necessary often makes them ineffective when they are. "This is what happens when tests mislead us. She will need the drugs again. If they don't work properly, she will be in real trouble. She has almost certainly infected some of her children. That makes everything harder, more expensive, more painful.''\par Tuberculosis strikes vulnerable people with special ferocity. Victims are seized by severe night sweats, wasted by fatigue, and punished by the blood-tinged cough that is the disease's defining symbol. In most cases, tuberculosis affects the lungs, but it can invade almost any organ of the body. When an infectious person coughs, sneezes, spits, or even shouts, he sends minute particles of sputum, or phlegm, into the air-exposing anyone nearby. For many years, the disease, which is caused by }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid10898414 Mycobacterium tuberculosis}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , was referred to as "consumption," because without effective treatment patients often wasted away.\par To fight the infection, the body's immune system forms a scar around the TB bacteria which serves as a kind of moat. Afterward, the bacteria lie dormant and cannot spread or infect others. But immune systems fail, and when that happens TB can move from the lungs to the bloodstream and then to the kidneys, the brain, and other organs. (That's why in patients with H.I.V., which ravages the cells that the body uses to defend itself, tuberculosis becomes particularly deadly.) The only way to cure the disease is with a combination of antibiotics. The treatment lasts six months because the drugs work only when the TB bacteria-which grow slowly-are dividing.\par For centuries, tuberculosis has been the source of misguided stereotypes, including the association of co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sumption with creativity and brilliance. "Doctors suspect that tuberculosis develops genius,'' a 1940 article in }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid10898414 Time}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  pointed out, "because 1) apprehension of death inspires a burning awareness of life's beauty, signif}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cance, transience, 2) the bacillus breeds restlessness and an intoxicated hypersensitiveness." Keats, Ch}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 khov, the Bront\u206\'eb sisters, and George Orwell-who was born not far from Patna, where his father managed the regional opium trade-all died of the disease. \par Nonetheless, tuberculosis has always taken its most serious toll on the industrial-labor class-not on artists. The rise of industry throughout the world has been mirrored uncannily by a rise in deaths from tuberculosis. It was the leading cause of death in Europe and the United States from the eighteenth century into the twent}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 eth. Then prosperity-rather than medicine-drove the rate of infection down. As a society becomes richer, the conditions that allow tuberculosis to flourish start to wane. Sanitation and housing improve and so does nutr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion. By the nineteen-fifties, very few people in the West were dying of the disease. \par In the developing world, though, tuberculosis has surged dangerously, and this year, according to the World Health Organization, there will be ten million new cases, the largest number in history. As people join the great migrations from villages to crowded cities, slum life and tuberculosis await them. With India's urban population expected to double in the next thirty years, to seven hundred million, its cities will remain fertile ground for an infectious epidemic. Yet-no doubt owing to the fact that rich people in the West rarely get the disease-tuberculosis receives fewer resources, fewer research dollars, and less attention from the global health community than either AIDS or malaria-the two other most deadly infectious diseases. TB activists don't march on Washington or chain themselves to the gates of pharmaceutical firms to demand better treatment.\par Tuberculosis can be cured, but taking several antibiotics nearly every day for six months is not easy, partic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 larly in parts of the world without running water or refrigeration. In 1994, the W.H.O. instituted a program called DOTS, which stands for "directly observed treatment, short course." DOTS requires health workers to provide medicine-and then to watch people swallow it every day until they complete their treatment. Compl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ance is essential, because stopping treatment in the middle permits the most resilient strains of the bacteria to thrive, greatly increasing the chance that they will become resistant to basic, inexpensive drugs.\par Thirty-six million people have received care under the DOTS program, eight million of whom would have died without it. It has been a triumph by any measure. Even DOTS, though, has not been able to keep the di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ease from spreading. That is largely because there is no cheap, reliable test that can determine who is sick and who is not. \par Blood tests, like the one Runi had, often do more harm than good. One recent study found that Indians u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dergo more than 1.5 million useless TB tests of this kind every year. Other approaches are almost as unrel}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 able. Examining a person's sputum-a diagnostic procedure that was developed more than a century ago-remains the most common way to detect the infection. It is a laborious process. Technicians smear the sp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tum on a slide and then place the specimen under a microscope. The instructions are comically complex. "Spread sputum on the slide using a broomstick,'' a typical recipe, posted on the wall of a clinic in Patna, b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gins. "Allow the slide to air dry for fifteen to thirty minutes. Fix the slide by passing it over a flame from three to five times for three to four seconds each time.'' If the slide isn't held over the flame long enough, false stains will appear-suggesting that people are sick when they are not. Hold the slide too long, though, and the stain will disappear and show nothing at all. The results are accurate little more than half the time. \par "You can treat a lot of people, and India has,'' said Madhukar Pai, an epidemiologist at McGill University and the co-chairman of the international group that assesses new diagnostics for the Stop TB Partnership. "But if you have tests that cause misdiagnosis on a massive scale you are going to have a serious problem. And they do." \par Medicine rarely provides magic bullets, but, for the first time, a technology has been developed that might help countries like India escape the endless cycle of mistaken diagnoses and haphazard treatment. A co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pany called Cepheid, based in Sunnyvale, California, now makes a device, called a GeneXpert, that allows doctors to diagnose TB in under two hours-without error or doubt. "The machine is so powerful that it could help end tuberculosis,'' Mannan told me. "I don't think that is an exaggeration.'' \par An editorial three months ago in the }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid10898414 New England Journal of Medicine}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  also raised the possibility that, with proper use of this device, tuberculosis-a disease that has been around since the days of the Pharaohs-could be eliminated. The cost, however, would be far too high for the Indian Ministry of Health. "Private business would have to take the lead,'' Mannan said. "In the past, countries waited until they got richer and tubercul}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sis mostly went away. India cannot do that. The epidemic is just too big. And we are too poor."\par The GeneXpert was developed in 2002, with initial support from the Department of Defense. After the events of September 11th and the mailing of anthrax spores later that year, biological threats became a national priority. The only sure way to recognize dangerous new organisms, whether made by man or by nature, is to analyze their unique DNA, and the GeneXpert has tested billions of pieces of mail for toxins. Its diagnostic capabilities seemed even more promising, however. In 2008, with funding from the Bill and Melinda Gates Foundation, the Foundation for Innovative New Diagnostics, and the National Institutes of Health, researc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ers at medical centers throughout the world began to assess the machine's effectiveness in diagnosing t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 berculosis. \par Its success was striking. In a study published along with that editorial in the }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid10898414 Journal}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , researchers reported that the GeneXpert identified more than ninety-eight per cent of active TB infections, including many that sputum smears had missed. Because the test looks for the TB bacterium itself, rather than for antibodies, latent infections don't confuse the GeneXpert as they do blood tests. The machine costs nearly twenty-five thousand dollars and each test is about twenty dollars. Prices could plunge if similar machines were intr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 duced and used widely. \par "This is absolutely transformational technology,'' Peter Small, the director of tuberculosis programs for the Gates Foundation, said. "It is a system that removes the guesswork from one of our most deadly diseases.'' Unlike the sputum technique, the molecular approach is straightforward: a patient spits into a cup, and the sample is placed in a cartridge that looks much like the pods used in many espresso machines. A computer examines the sample's DNA to see if it contains the genetic signature of TB. Results are available within hours. \par The GeneXpert can even determine whether the bacteria are resistant to rifampicin, the most effective and widely used component of the four-drug cocktail commonly prescribed for TB. "People often equate sophist}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cated science with complexity, and this is just the opposite," Small said. "As long as there is electricity, the tests could be carried out by unskilled workers in any village. Training them would be easy, and the potential benefits-saving billions of dollars and millions of lives-worth any effort. The question is how do we get there. I have heard people say that we should trust the government bureaucracy. But others say let's put our faith in an unregulated collection of free agents. It's hard to know which approach is more ludicrous." \par I put that question to Mannan, the official responsible for TB control in the Bihar region. A slight, intense man with eyes the color of wet coal, Mannan is a former Army doctor who left the service after he injured his leg jumping from an airplane. He has been frustrated by how rarely the promise of Indian medicine is realized, and by how little entrepreneurs-in one of the world's most entrepreneurial countries-are doing to help.\par "We do know that private enterprise can work in India,'' he said. "Just look at the mobile-phone industry. And the public efforts to halt major diseases have been remarkable. But how do we get them to work together?" Nobody has an answer to that question. The interplay between public and private medicine in India is difficult to navigate, in part because the quality of private medicine varies so wildly. To demonstrate the range of medical options open to most people in Bihar, Mannan suggested that we travel to Darbhanga, about ninety miles northeast of Patna. Before we left, he said, "Everything you find in the country, the good and the bad-it is all in Darbhanga." \par Even at first light, the road that leads from Patna, Bihar's capital, to Darbhanga is impossibly crowded. On the ramp of the Mahatma Gandhi Bridge, which passes over the Ganges and leads north toward Nepal, oxen jostle with motorcycles and giant trucks. On the day I made the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  the traffic was so heavy on the bridge-at more than three and a half miles, it's one of the longest in the world-that it took an hour just to reach the lush banana plantations on the other side. \par Patna and Darbhanga were once important centers of civilization. Buddha found enlightenment under a b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dhi tree in Bihar, twenty-five hundred years ago, and the Fortress of Maharajas still stands in Darbhanga. Today, though, the province lags behind other regions of India in every category of economic and human development. Its eighty-five million residents earn, on average, less than half what people in the rest of the country earn; plumbing and sanitation facilities are meagre. Tens of thousands of migrants pass through Darbhanga each year as they abandon their ancestral villages and seek new lives in Delhi, Mumbai, and other major cities. \par The Medical College Hospital, an imposing white fortress spread over several city blocks, is the largest in the region, but the city is also home to what may well be India's most formidable collection of unregulated pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 maceutical wholesalers, a kind of medical red-light district. Virtually any drug can be purchased, in whatever quantity one desires, without a prescription. Want a thousand polio vaccines? Narcotic painkillers, cancer medication? Scarce AIDS therapies? They are all readily available in Darbhanga. But rarely at the hospital. \par The tuberculosis and AIDS clinics at the Medical College Hospital are open every day from 8 A.M. to 2 P.M. By the time Mannan and I walked into the cavernous waiting room early that morning, patients packed the benches and sprawled across the floor. Most sat silently, their eyes hollow, their heads down. The sound of harsh coughing filled the air. The line for medications snaked into the courtyard, where dozens of women, many of them cradling infants in their arms, waited patiently.\par Like other public hospitals in the developing world, the Medical College Hospital struggles to provide med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cine for its patients. The dispensary is rudimentary: basic tuberculosis drugs are available, but not those needed to treat resistant strains, which now account for nearly twenty per cent of India's growing caseload. For people who do not respond to the first line of TB treatments, there are two choices: find money to buy medicine somewhere else or get sicker. \par Since late 2009, the hospital has had one unique asset: a piece of equipment called a P.C.R., which can multiply tiny samples of DNA and analyze them. The device is not as fast as the GeneXpert, but it can exa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ine the genetics of virtually any organism, including tuberculosis. The hospital's machine, which was pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 chased with money from a government research grant, has never been used. "The hospital has had this for months,'' Mannan said. "But nobody knows how it works." We were standing at the door of the virology lab, where the new P.C.R. Cobas TaqMan 48, made by Roche and sold for roughly fifty thousand dollars, was resting on a shelf, still wrapped in its shipping material.\par How could that be? I was staring at a machine that could alter, even save, the lives of scores of the people who were sitting nearby in the gathering heat. Mannan said nothing, though his anger was palpable. "Ask them,'' he said, referring to the scientists who worked in the hospital, when I tried to get him to explain. "They will tell you." \par We walked down the hall to meet Ravindra Prasad, a doctor in the department of social medicine. He was an agreeable man with a round face and an easy manner. I asked why the P.C.R. machine sat imprisoned and unused. \par "The chemical kit expired,'' he said, smiling politely. The chemicals used in the machine have a short shelf life; but I learned later that they are not hard to replace. That couldn't have been the reason. "The methods we have for diagnosing tuberculosis all function smoothly," Prasad added, as if he were reading from a pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pared statement. He was referring to sputum tests, which are often inaccurate. "We follow the standard manual." Prasad offered us tea, but said nothing more about the medical needs of his patients. "It's a nice lab,'' Mannan said when we left. "Beautiful, actually. But if the doctors used it properly that would interfere with their private practice."\par I asked what he meant.\par "It is simple,'' he said. "If patients are treated at the hospital, they won't need to pay for anything else." \par The Darbhanga medical red-light district lies just a few blocks from the main hospital. On most days, as the public clinics prepare to take their last patients, touts appear in the waiting rooms and on the hospital grounds, eager to steer people toward a private doctor on Hospital Road. More than eighty per cent of med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cal services in India are in private hands, and health-care costs are among the most common reasons for bankruptcy.\par The touts-equal parts salesmen, psychologists, and pimps-are good at their job. If you need TB medication or a test or an X-ray, these men will get you quickly to a clinic that charges for services people are entitled to receive at no cost in public hospitals. According to Mannan, the tout receives ten per cent of any eventual fee from a referral. Rickshaw drivers get five per cent, medical assistants ten, and the referring doctor, almost always a physician based at the Medical College Hospital, thirty-five per cent. That leaves forty per cent for the clinician. \par Much of the time, the referring physician from the public hospital is also the private clinician who does the work. That earns him seventy-five per cent of any fee. Public salaries are not sufficient to support most do}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tors, so, every afternoon, many of the hospital's physicians work in these private clinics. \par Well-trained doctors are not the only people working on Hospital Road, however. Officially, a doctor needs a license to practice medicine in India. In fact, though, there are no mechanisms to verify the validity of licen}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es or to punish people who break the law. It is not rare for "doctors" to lack medical training completely. \par We arrived as darkness began to fall; hundreds of people, having finished the workday, crowded the rutted streets. There were dozens of drug shops, with names like Raj Medical Agency, Krishna Scientific and Su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gical Works, and Zar Whole Sale Drugs-often illuminated by a single bulb. The streets of the medical red-light district are filled with "specialists." Mannan and I wandered into a back alley where two men asked after our health with more solicitousness than was necessary. I asked what they were offering, and one of them let out a loud cackle.\par "Let me show you,'' he said, and led us to a small room with several chairs, a table, and three refrigerators. The man said that his name was Pranay, and he offered a variety of blood tests, for liver function, kidney function, H.I.V., and several other standard diagnostics, all at reasonable prices. Wholesalers make their money through volume sales, not high prices. "We get twenty-five to thirty referrals a day,'' he told me. \par  The stall next door could have been an exhibit in a science museum: it contained an ancient X-ray machine, held together with duct tape and baling wire. The owner had just finished taking chest slides for a middle-aged man. He didn't offer any of the customary lead shields or other protections against possible radiation leaks-and that machine certainly leaked. "It's safe,'' the man said. "They are X-rays." \par He told us that he ran about fifteen to twenty chest X-rays a day; he charges a hundred rupees for each, or a little more than two dollars. His services were also available for broken bones and other routine problems. I asked how he had acquired his equipment and where he had learned to use it. He told us that he had taken the X-ray machine from a hospital in Bihar that was about to throw it away. The idea of training made him laugh. "Did you see 'Slumdog Millionaire'?" he said. "Before this, I was a chai wallah''-a man who serves tea-"just like that kid." \par It was time to return to Patna; driving late at night on the roads of rural India is a risky business. Before we left, though, Mannan insisted that we make one more stop, at another clinic nearby. The place was essentia}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly an open concrete garage; against one wall stood a small table with hot plates on which patients could heat rice. The room was full, and more than a dozen people stood on the street, waiting to get in. "This is the best TB clinic in town,'' a pharmacist who owned the shop next door explained. \par The head of the clinic, Dr. P. M. Srivastav, works at Medical College Hospital, and we had spoken with him earlier. At night, for a hundred and thirty rupees, Srivastav will see anyone who waits in line. He doesn't test for tuberculosis at his clinic, and said that he refers people he suspects of having the disease to the hospital. He does, however, earn a fee from every patient he sees, including those he sends back to the hospital for free treatment. "Now do you understand why that machine is wrapped in plastic?" Mannan asked.\par As we were about to leave, a large car pulled up at the front door. Srivastav climbed out of the back seat, looked at us with surprise, and smiled sheepishly. Before I had a chance to ask a question, he was gone, safely tucked away in his private office. \par The uncertainties and dangers of diagnosis remain the greatest obstacle to successful TB treatment, in India and throughout the developing world. For that to change, investments from international aid organizations and from private companies will be necessary. That may seem unlikely, but it has happened before, most notably with AIDS drugs. In the nineteen-eighties, when AZT became the first effective treatment for H.I.V., the annual cost for each patient was ten thousand dollars. People in the West, who were rich or lucky enough to have good insurance, could afford it. In countries that struggle to provide basic immunizations against diseases like measles, though, AIDS treatments were a fantasy. Then various groups, including the Clinton Foundation, the Gates Foundation, and the Global Fund to Fight AIDS, Tuberculosis and Malaria, joined together to push for lower prices. Generic manufacturers, led by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  the Mumbai-based pharm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ceutical giant, began to churn out highly effective medicine at a small fraction of what it cost in the United States. Political pressure mounted, officials of the World Health Organization joined the call for cheaper AIDS medications, and today the governments of poor countries like India can buy those drugs for an annual price of less than a hundred dollars per patient. These drugs are normally distributed in bulk, through international AIDS organizations.\par A similar effort will be required to lower the cost of diagnosing tuberculosis. There will also have to be a transformation in how TB medicine is regulated. That may seem like an insurmountable barrier, but, with the proper incentives, the system could work. Again, one can look to the history with AIDS medicines for a mo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 el. Because }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and other Indian pharmaceutical companies are frequently inspected by international regulators-such as the U.S. Food and Drug Administration-governments are willing to buy their products. That's one reason that Indian firms have become the most important manufacturers of generic AIDS med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cines in the world. \par Any company that sells molecular diagnostics would need the same sort of oversight. But producing cheap, internationally acceptable versions of the GeneXpert would surely lead to great profits. \par "You have to keep in mind that India has many terrible doctors," Madhukar Pai told me. "But it also has some of the best private medicine available." I saw that in Darbhanga, where, in addition to the shoddy purveyors of the medical red-light district, I visited the Geeta Molecular Diagnostic Lab, a new private facility not far from the center of town. There I was greeted by a team of researchers, all in starched lab coats, including Deepak K. Prasad, a geneticist and the director of the laboratory. He led us on a tour: there were separate sections for gene detection, gene amplification, and histological analysis. Geeta Diagnostics had two P.C.R. machines and other, similarly advanced diagnostic tools. Few facilities in New York are better equipped. P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tients sat on cream-colored couches reading magazines and sipping tea.\par "The genetic approach to diagnosis is really where medicine is going," Prasad told us. The company, which is two years old, offers tests for heart disease, several types of cancer, thyroid disease, H.I.V., and tuberc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 losis, among other disorders. The TB test costs fifteen hundred rupees-a little more than thirty dollars. The lab does between fifty and seventy-five each week, and its doctors are paid well enough so that they don't need to work at second jobs.\par "You can call it expensive, but you have to look at the eventual costs, not the initial price of a single test or one piece of machinery," Prasad said. That would be difficult to dispute. Thirty dollars may be a lot of money for most Indians; but treating drug-resistant strains of tuberculosis costs thousands of dollars and places a terrible burden on the country, not to mention on the people who are sick. In fact, treatment and deaths caused by TB in India cost more than three billion dollars in lost productivity each year. \par The power of machines like the GeneXpert has already become evident at Mumbai's Hinduja Hospital, a pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vate institution that has been using one for three years. Mumbai has one of the worst TB problems in India, particularly with drug-resistant cases. Yet at Hinduja the machine has made it possible for doctors to dia}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nose and treat patients before they are able to spread the disease. "There has always been a pretty standard approach to using fancy medical technology,'' Camilla Rodrigues, who runs the microbiology department, told me when I visited. "You develop it in the West and use it there. Eventually, it trickles down to the poor countries.'' Rodrigues pointed out that, with tuberculosis, the pattern makes no sense. The GeneXpert was invented in the West, but India and Africa need it much more urgently. "Every time we make a correct dia}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nosis, we save not one life but many,'' she said, waving in the direction of the boxy metal-and-Plexiglas m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 chine sitting in a corner of the lab. "And with this machine we make correct diagnoses in two hours." \par Rodrigues has been working with tuberculosis for two decades. "When I started, it seemed hopeless,'' she said as we sat in her office, which is adjacent to a busy lab filled with graduate students, most of whom are focussing on TB. \par "You would ask people why we are not doing more to stop this terrible, crippling epidemic, and the answer was usually a shrug," she continued. Rodrigues has cavernous eyes and long dark hair pulled back in a bun. She speaks frankly but somehow conveys a buoyant sense of optimism. "For so long tuberculosis has been a part of life here. In the past, if you said you have the disease people would hardly flinch. Can you imagine going to a neighbor in New York and saying you have tuberculosis? People would shriek."\par Lately, though, Rodrigues has begun to sense a shift away from the habitual fatalism that has defined the Indian approach to public health. "Sometimes I go to Churchgate Station,'' she continued. "It is the busiest train station in the city, maybe in the country. I go at rush hour. You cannot move or breathe or think. You cannot walk or talk. It is the perfect place to spread tuberculosis.\par "But it is also the perfect place to stop it,'' she said. "I walk around that platform and I look at people and I say to myself, Which of you are sick? We need to know. And, finally, after more than a century we can know. At this point, it is just a matter of will." \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TUBERCULOSIS (91%); DISEASES & DISORDERS (90%); RESPIRATORY DISEASE (90%); INFECTIOUS DISEASE (90%); IMMUNOLOGIC FACTORS (84%); VACCINES (75%); SMALLPOX (74%); VACCINATION & IMMUNIZATION (74%); EPIDEMICS (74%); ANTIBIOTICS (73%); IMMUNOLOGY (73%); DEVELOPING COUNTRIES (73%); DEMOGRAPHIC GROUPS (73%); POVERTY & HOMELESSNESS (72%); DEATHS & DEATH RATES (70%); CLINICS & OUTPATIENT SERVICES (68%); ECONOMIC D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 VELOPMENT (68%); TEST LABORATORIES (68%); HOSPITALS (68%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW DELHI, INDIA (57%) BIHAR, INDIA (90%) INDIA (94%); CHINA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 23, 2010\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Magazine\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2010 The Conde Nast Publications, Inc.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; Bill Shouldn't Block Generics, Minister Agrees Africa News April 29, 2010 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_67}{\*\bkmkstart DOC_ID_67_0}{\*\bkmkstart doc_id_12}{\*\bkmkend DOC_ID_67}{\*\bkmkend DOC_ID_67_0}{\*\bkmkend doc_id_12}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_12"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 12 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  29, 2010 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par Bill Shouldn't Block Generics, Minister Agrees}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Inter Press Service (Johannesburg)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 875 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda's trade minister is in agreement that his government's controversial Counterfeit Goods Bill should not restrict the manufacture or import of life-saving generic medicines.\par The bill, drafted with funding from the European Union, suggests criminal penalties for counterfeiting.\par Counterfeiting is defined expansively as the manufacturing, producing, packaging, re-packaging, labelling or making of any goods which are imitated so as to be substantially similar to the protected goods without the authority of the intellectual property (IP) right owner subsisting in the country or elsewhere. \par With reference to the World Trade Organisation's 2001 Doha Declaration, Gagawala Wambuzi, Uganda's minister for trade who is spearheading the bill, indicated that his government is aware that the U.S. and the EU have agreed that least developed countries (LDCs) should enjoy greater flexibility with regards IP and medicines.\par "Basically the issue of generic drugs for LDCs like Uganda, Tanzania, Rwanda and Burundi is not a big story. They have to allow us to manufacture generics. An LDC must be allowed to do certain things so that we are able to catch up (developmentally) and so that we are able to manufacture generic drugs. That is what it is all about," Wambuzi acknowledged.\par Regarding the civil society campaign about the detrimental consequences of the bill as it currently stands, Wambuzi said, "we cannot make a bill against ourselves. Why would we do it; to favour whom? The bill is for us."\par He added that Uganda's interest in such a law is to have its industries protected from counterfeiters whom he said are targeting all Ugandan products.\par The Uganda Registration Services Bureau, which is charged with the registration of patents, trademarks and copyright, also realises the dangers of the bill in its current form.\par Bisereko Kyomuhendo, acting registrar general of the bureau, told IPS that, "we are trying to highlight to the sponsoring ministry that intellectual property issues should not be mixed up with issue to do with enforc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment and access to medicine".\par The bureau believes the bill should be redrafted to specifically only fill the gaps in the existing IP legal frameworks in the Copyright Act and Trademarks Act.\par Regarding the progress with redrafting, Elizabeth Tamale, the principal commercial officer in the trade mini}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 try, told IPS: "At the moment there are some comments which we have to include into the final document." These were to be forwarded to the drafters of the bill, she confirmed.\par India-based pharmaceutical company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd has partnered with Quality Chemicals in Uganda to locally produce generic antiretroviral (ARVs) and anti-malarial medicines. Similar initiatives, under compulsory l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 censing arrangements, are happening in Ghana, South Africa, and Mozambique.\par Compulsory licensing "is when a government allows someone else to produce the patented product or pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cess without the consent of the patent owner", according to the World Trade Organisation (WTO) website. The WTO's Trade-Related Aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement of 1995 allows for this.\par Apart from the Ugandan Counterfeit Goods Bill and the Kenyan Anti-Counterfeit Act of 2008, Tanzania also adopted new regulations in 2008, attached to the Merchandise Marks Act, that threaten to have a similar e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fect on the production of generic medicines as the legislative measures taken by its neighbours.\par George Baguma, chief commercial officer with Quality Chemicals, told IPS that, "the anti-counterfeits bills in East Africa should be shelved. I think we are comfortable without them. We still need more pharmaceutical companies in East Africa if we are to provide affordable medicines to our people.\par "The effect of these bills is that our plant will close and we shall not produce any more drugs. But what are more important are not even the drugs we are producing now. There are newer drugs which are being pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 duced. We need to access that technology. Basically, if those laws are passed we shall limit our people to old drugs," he cautioned.\par The local production of ARVs by Quality Chemicals will assist Uganda in providing treatment to the projected 263,000 people who will need it by 2012 and the 342,200 people who will require treatment by 2020.\par Hakiel Mgonja, assistant registrar at Tanzania's Business Registration and Licensing Agency, agreed at a recent meeting in Arusha, Tanzania, that it would be a mistake for the region to prevent local production of medicines, given that most people still cannot access essential medicines because of cost.\par "In Tanzania we are saying we have the merchandise law and it is working, even for fighting counterfeits. You cannot make a monster and keep it at home because it will eat your children and later on eat you. So we have to create mechanisms for an atmosphere for the pharmaceutical industry if we are to attain universal access," said Mgonja.\par The 2009 World Health Organisation report titled "Towards Universal Access" indicated that 66 percent (or 6,7 million) of eligible people in sub-Saharan Africa are still not receiving ARV treatment. It also indicated that about three million people, who are already on treatment, will need to continue receiving ARVs for the rest of their lives.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GENERIC PRODUCTS (92%); GENERIC DRUGS (91%); COMMERCE DEPARTMENTS (90%); COUNTERFEITING (90%); INTELLECTUAL PROPERTY LAW (90%); DEVELOPING COUNTRIES (90%); TRADEMARKS (89%); IMPORT TRADE (89%); PATENTS (89%); LICENSING AGREEMENTS (89%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TELLECTUAL PROPERTY (89%); COPYRIGHT (78%); PHARMACEUTICALS INDUSTRY (78%); PHA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MACEUTICAL PREPARATION MFG (78%); PACKAGING MATERIALS (78%); EUROPEAN UNION (78%); COPYRIGHT LAW (77%); INTERNATIONAL ECONOMIC ORGANIZATIONS (77%); TRADEMARK LAW (77%); ANTI-INFECTIVES (73%); ANTIVIRALS (72%); MALARIA (60%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 EUROPEAN UNION (58%); WORLD TRADE ORGANIZATION (57%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (80%); SIC2834 PHARMACEUTICAL PREPARATIONS (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 JOHANNESBURG, SOUTH AFRICA (50%) UGANDA (95%); EUROPE (92%); EUROPEAN UNION MEMBER STATES (88%); INDIA (79%); GHANA (79%); MOZAMBIQUE (79%); UNITED STATES (79%); TANZANIA, UNITED REPUBLIC OF (79%); BURUNDI (79%); RWANDA (79%); SOUTH AFRICA (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 April 29, 2010\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2010 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Bill Shouldn't Block Generics, Minister Agrees Inter Press Service (Johannesburg) April 29, 2010 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_68}{\*\bkmkstart DOC_ID_68_0}{\*\bkmkstart doc_id_13}{\*\bkmkend DOC_ID_68}{\*\bkmkend DOC_ID_68_0}{\*\bkmkend doc_id_13}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_13"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 13 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Inter Press Service (Johannesburg)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  29, 2010 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Bill Shouldn't Block Generics, Minister Agrees}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Wambi Michael\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 875  words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Kampala \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda's trade minister is in agreement that his government's controversial Counterfeit Goods Bill should not restrict the manufacture or import of life-saving generic medicines.\par The bill, drafted with funding from the European Union, suggests criminal penalties for counterfeiting.\par Counterfeiting is defined expansively as the manufacturing, producing, packaging, re-packaging, labelling or making of any goods which are imitated so as to be substantially similar to the protected goods without the authority of the intellectual property (IP) right owner subsisting in the country or elsewhere. \par With reference to the World Trade Organisation's 2001 Doha Declaration, Gagawala Wambuzi, Uganda's minister for trade who is spearheading the bill, indicated that his government is aware that the U.S. and the EU have agreed that least developed countries (LDCs) should enjoy greater flexibility with regards IP and medicines.\par "Basically the issue of generic drugs for LDCs like Uganda, Tanzania, Rwanda and Burundi is not a big story. They have to allow us to manufacture generics. An LDC must be allowed to do certain things so that we are able to catch up (developmentally) and so that we are able to manufacture generic drugs. That is what it is all about," Wambuzi acknowledged.\par Regarding the civil society campaign about the detrimental consequences of the bill as it currently stands, Wambuzi said, "we cannot make a bill against ourselves. Why would we do it; to favour whom? The bill is for us."\par He added that Uganda's interest in such a law is to have its industries protected from counterfeiters whom he said are targeting all Ugandan products.\par The Uganda Registration Services Bureau, which is charged with the registration of patents, trademarks and copyright, also realises the dangers of the bill in its current form.\par Bisereko Kyomuhendo, acting registrar general of the bureau, told IPS that, "we are trying to highlight to the sponsoring ministry that intellectual property issues should not be mixed up with issue to do with enforc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment and access to medicine".\par The bureau believes the bill should be redrafted to specifically only fill the gaps in the existing IP legal frameworks in the Copyright Act and Trademarks Act.\par Regarding the progress with redrafting, Elizabeth Tamale, the principal commercial officer in the trade mini}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 try, told IPS: "At the moment there are some comments which we have to include into the final document." These were to be forwarded to the drafters of the bill, she confirmed.\par India-based pharmaceutical company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd has partnered with Quality Chemicals in Uganda to locally produce generic antiretroviral (ARVs) and anti-malarial medicines. Similar initiatives, under compulsory l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 censing arrangements, are happening in Ghana, South Africa, and Mozambique.\par Compulsory licensing "is when a government allows someone else to produce the patented product or pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cess without the consent of the patent owner", according to the World Trade Organisation (WTO) website. The WTO's Trade-Related Aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement of 1995 allows for this.\par Apart from the Ugandan Counterfeit Goods Bill and the Kenyan Anti-Counterfeit Act of 2008, Tanzania also adopted new regulations in 2008, attached to the Merchandise Marks Act, that threaten to have a similar e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fect on the production of generic medicines as the legislative measures taken by its neighbours.\par George Baguma, chief commercial officer with Quality Chemicals, told IPS that, "the anti-counterfeits bills in East Africa should be shelved. I think we are comfortable without them. We still need more pharmaceutical companies in East Africa if we are to provide affordable medicines to our people.\par "The effect of these bills is that our plant will close and we shall not produce any more drugs. But what are more important are not even the drugs we are producing now. There are newer drugs which are being pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 duced. We need to access that technology. Basically, if those laws are passed we shall limit our people to old drugs," he cautioned.\par The local production of ARVs by Quality Chemicals will assist Uganda in providing treatment to the projected 263,000 people who will need it by 2012 and the 342,200 people who will require treatment by 2020.\par Hakiel Mgonja, assistant registrar at Tanzania's Business Registration and Licensing Agency, agreed at a recent meeting in Arusha, Tanzania, that it would be a mistake for the region to prevent local production of medicines, given that most people still cannot access essential medicines because of cost.\par "In Tanzania we are saying we have the merchandise law and it is working, even for fighting counterfeits. You cannot make a monster and keep it at home because it will eat your children and later on eat you. So we have to create mechanisms for an atmosphere for the pharmaceutical industry if we are to attain universal access," said Mgonja.\par The 2009 World Health Organisation report titled "Towards Universal Access" indicated that 66 percent (or 6,7 million) of eligible people in sub-Saharan Africa are still not receiving ARV treatment. It also indicated that about three million people, who are already on treatment, will need to continue receiving ARVs for the rest of their lives.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GENERIC PRODUCTS (92%); GENERIC DRUGS (91%); COUNTERFEITING (90%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LECTUAL PROPERTY LAW (90%); DEVELOPING COUNTRIES (90%); COMMERCE DEPARTMENTS (90%); LICENSING AGREEMENTS (89%); IMPORT TRADE (89%); TRADEMARKS (89%); INTELLECTUAL PROPERTY (89%); PATENTS (89%); PHARMACEUTICALS INDUSTRY (78%); PHARMACEUTICAL PREPARATION MFG (78%); PACKAGING MATERIALS (78%); EUROPEAN UNION (78%); COPYRIGHT (78%); TRADEMARK LAW (77%); INTERNATIONAL ECONOMIC ORGANIZATIONS (77%); COPYRIGHT LAW (77%); ANTI-INFECTIVES (73%); ANTIVIRALS (72%); MALARIA (60%) Uganda; Legal and Judicial Affairs\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (80%); SIC2834 PHARMACEUTICAL PREPARATIONS (80%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 KAMPALA, UGANDA (79%) UGANDA (95%); EUROPE (92%); EUROPEAN UNION ME}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BER STATES (88%); TANZANIA, UNITED REPUBLIC OF (79%); RWANDA (79%); BURUNDI (79%); INDIA (79%); MOZAMBIQUE (79%); GHANA (79%); UNITED STATES (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 April 29, 2010\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Web Publication\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2010 AllAfrica Global Media.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Mittal sits on top of the pile; RICH LIST 2010 THE TOP 100 The Sunday Times (London) April 25, 2010 Correction Appended \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_69}{\*\bkmkstart DOC_ID_69_0}{\*\bkmkstart doc_id_14}{\*\bkmkend DOC_ID_69}{\*\bkmkend DOC_ID_69_0}{\*\bkmkend doc_id_14}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_14"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 14 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\shppict{\pict{\*\picprop\shplid1026{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw11430\pich2011\picwgoal6480\pichgoal1140\pngblip\bliptag841025759 89504e470d0a1a0a0000000d4948445200000144000000390403000000bc0f4f5e00000030504c5445ffffff2121214a4a4a7b7b7ba5a5a5b5b5b5bdbdbdcececeefe7e7ffceceffa5a5ff7b7bf75252f72121ef0000000000c07b440d00000bde4944415478daed590b5014e71dffefde71b72a772c201635c0f14c20022710437c5e008326c610f26c9ba6544d35993635312d2411dd68846b1ae3a5e933ad29d3e635538334d15613702e3e52b5422e012251394e304278dd721058e0eeb6df63ef38203a9dd19174263bc07efbbdfebfeffffefe005ced67e3d5de5075b53754f7765fe51dd9ab0d91e5e09b07317ffca7f40d1474c485808fedce59e117bf6910b999f71ff77f681c51aaafb422fd285f62854d4b965ba71c627ae6f1f57e146c468fa45677d08f6371cb4f694ff79e9b6a5dd4c6dac3fc0ccd7bd6cb87cc35e59aa856be2a6f9697b9a75cd09e394ea9d38eb1667e212faf3e699047f60407db351e3c58abf3bc3feb919a2ba3c05c29c43c39a1e53abd455b34bb355ab57db5718077ba43b77a54f7e99cc16f2d111b16a97bff33b510d5e9b50099330fe64158c8d9febcea5827638086c5d5f17d723f9b12ad7946359f9f679952416febc8cf9b21a9db79edec90791722db6456ece8d04548495f26ccca6efb6d8d66dbe79ab7a65817e76b3ee889882d8cd03537bd11d399ddc572271e6bb928bf637ab59109cf0c8af8fbace4e8a6298598d0de68eb0e0a09afce88ef0e399ed512d307a923addac3b1de9b6e3b7c2cbe3ab12d7264ffd43a1d7dec10ab0ee9b3a61fad7a3f984935d864de593123c7bde8a8cee6d8e604932c7b84a93597058c6735fb6e94981829e4a6aa418436666ea33ecdadaab582da1832d0db920927a6968b77a6a61d3b94063ddd1f693d0d3cf09f80ac8b0176b06710e02e007748fa7586298e2e36072bb2adc0ef495ba4c9f830f49390688f5a07cef35a5ddef2b67b6a1a431871f61447973371e2d050648cd6f6510b1f0e5c674e5f6b58ffa0a173ae77e1ee996f80bb7de648e595bade2b5a5ddedce20c81d016db0563d3e3faa3d1a2ee0357e16b7c868babbfb5037834c3bb20f2d4540afaf99a841a67cfa9eac687402bf3d55dd618fe8bbbfa0ab3bc51f55d1f4682a1004194d426300b5366d1f907214b0e852cb3b6a8c6e80a3d9f122bd684e756324b2c5bf61b5b6466e078e6dd55ac27d60188935c89708d7531efc709abf891d9b9f143edcdfabb83a789f257997f864629665aec8c9ac29d1b3e8504fdc89def8ac0cf1b0e8b616ecce94eb75e6388e73f4e3a2c4aae7f6aa53b527a9b1bfe1d7c4bd43bbd9ae9798ee437133b9bbbdb0a5847836e7aedca28de3e2c9dcfcad0f7545c6b8b9647d4275bdafb213ec6cbf1bac4bae8ca239979a955badee05b6b3e7dc2106b4d1ed132ba883d2e99d5df983efc424bdd35773adce32e94f1b33f91be1c19fd2c66fa42f7eca5ffd0cded4ad5f12756b57489fbf34fb7af688e8ed4da727b47bff00edd17d5b9ace91a9b4bae23d78942b42d6259ad2866760db069b58c4bfe38d72dcef41c4963f4aae4702be330b5b9550b0594338aa1a1732cd7daa2b99f39bdae50c3d3a8259c13fb3ec04e76b350d6678d4911d46e32017847cc990af8f6f9f6f9df74b15cf4b5439dd8994cd7f491d790af7b9a1215348b1d61abcc52316e8b7f84f53c88151be970799f2c4f1f247a1d5ae25b57b6bb19344fe0d6b085fba141ecfb03d24edff33269feb2988c92fbf8467faf4254bbb8857dc82c01a39de38798d8859a4c74c65e0cfdb6332d4a778883224cb685f724462f7d17f78735e37561452f010475a24bd62e809b3be982d0a403344199fbe92e61cd5e52b0b0aaa344083fa7d2fb216eda8913849ef90efc97dc81508b199ced03936ed5ceb187eb06d2d32c6ad90eae34346c70406c215a976c6bcaaf0258f976f9db368830cabd75b174d1caaa5b0683e6eedd75df012b0cec300faffd53c38e1d2b2bc1b5d50265f955d9d95abc20dddeecca27359ed22d6085371f435b469aacea1f957e675d09f4125af8f7097cba9507ee476b5cbb901c386f2ff46fb15cbcc1068906a7b76e3edc5e79c3e040f2deadc03286a4f2368081477f6e805700fa9b40da875e07e0e94280e0ea9a8f0b68c130a8aaffb8e446339fce411f6680cd8644b3f41e728d8869d2befe13025950d36ed41f2cc20b50347180f49209314700e939d7f79006b8b27719d165e2d1b540681d209be971ec76db90142d308ca6bbab6b4f9b80ab737d571a6924c958fdf7cd78c792178bb09364a8af54dc2546f71e2d187a48dea631923192eb1b945c0e171b18651d07523de8ff85879164b03a230cb8ee24abb0c6a94e082889644a5e33fa7c72289d09b2f21d0638cd947261d4c122e6ba97221a729c2f47da3ec19d2b6aa1a65ca48a2c055c4444a51e1b5c30aefea931c0597c3ab4bc99ee8aaf80772ec638b2c8aee8274364c6174db7b880a6c094ee36845926414c446c504dca6e657a28b40257e1589e747a0925c8114198588f3d1e107250af1174585cf5064c0fdc46d0570177189f83e1c8aebc2206f2b82897eb6ea5d8e830e2d25690b1bebccc03cb26fbef08a6312e2a678cc44056285be971e1a3d4e287c86388fd68d199f1b9aa8988ceabe641b7914afa23186dc37354269f789e37f8b8184f4fe228a0d85a29525581007a5c22f0588095fc89a65431c6c5b167870209ad6fca1e07852ac211005dd538996d22af9d29885378ef5f234ec2aa2c3c3a62f16d352af888b4a1931481f68872cc68325c2609e8089dd75ff2eec250941482af38f832fa3d98845b7e9e45124b47488e050a1a2fb72374bc816e118404bfc2b622e0606220b16184c8066e562148b9b887caf16482f0351065ce6cde4a27a0b54ef353b680c452ff79422044522f1e46c6e99ea89e48740e13722b9f01d14d38d3e04fc414651b3b54065eb525810e0172ee9c79d38748edd009f567ff264c86a81b2a2e7ed6ffd551fc2b87d21c257a74f6fa80b9848b80bca8be22908bb4be7cc4c2604f859ed79169df344943fc168dc4730aec9cd28ff09c2e7e111f9df88973bf990cd1151f1f1fe757c77edc569ea3c40a4f168d2385e67910971a26d79719502143101455b821708c0f547899c54cb79904bfd3098f275ef3f7845e97691244d66eb75fa067440816d82ffadd83e71edc446e590860199e770fc08c2727f821f006c1084f0387c483cb0897d2450649542e6fad10fc4e476f7f00531a594748efbfdc559f1c7678cc2fbf9447583f06511c73f9ef4c1474694c79094f03c778dd9ba88b381ae86b5a41f03b1d1e9e89215bdc6bf047b549973bbf181053c6240dbb9f371049f8882978460ba8f70de0220bd68e9272abf22d4eb87e8cd3451990bd3427c298d341c3f792f6ce4710f3754597703a63317a73c040e9da40831625e528ef8d8b2eb82f0e1c48a78d7ee8325c5217196c2fc85a144153c93c43c73663a8e225b8a81c96b8959b69ecc112df52108891578ea2318e5b8e7c161754ffb0dddea0f09c9fc04271f23dd9e813b412aab9ec20ec414ad7a0cfcbb86e9eba15e53f7a5e1b65d8d75c19a59c71d1056561262f4e539029cb024c8034511765183542bfd1c7452a68703b64c29ebf828b672f7b77c5d33c9402739a2a1983435333c9b6fca45e192768070c546c89570cc14a5031e3208a1328f138a384007341c02538456b8b8ce5f2e6826797fa7cb7408654b82489931eadcde80b876e538082a86c7013d44d53324a07e162802e3ac674d1d79ba1645b015cdc0c8ca748b16756c905894490e67837fa8db697e4a4da4aca0246f73bf47729dc8e3363ddeb66f3c20114533c3ac2925c1ff55350be18fa1fd4da080c949f36124dd15b0321d6fa20229a4e0f8e2f29003d24b2e3c40349425b058c1e852df829ccc310b97587906dbf5e02e5a9c86feedb58865eba24e1a92a5c268e9b63f3459a6989c5858706d01ec83f9e7de1ad4328a8fd220df66dc0e910f660eb9012ce887bdb1afe70d942c7910701d6a30ef70aed2284aa7e83728b5c8354dabd005fef10ad37e1a94af76d08830130b5d17cc029c1c9b8387483915d3312d6afadec7760555047d3cbc9e74f92a44a1f470c23a9d3a7321a522e5267ddb1a7555fbf1af32307a73f11dda881a8ab708ebde6f0396e0e610e13b64ac01bb1e7b437e21d98a2bf1025a6ee67d35eeafdacdb49efeac3c867fec09cb25ac820731f79d51f9ddae7afda2df6ba9611301ca9f322f67258d9cd344270406e341c1790ae96e7e52997e4b2dcac07f0dbcc05168905bf47429b9881ecc09939f25266d1375ac3519a66010f0bbeb9be257436b72e6fc3ff4735e2bfb30a5475afac990b0000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw324\pich57\picwgoal6480\pichgoal1140\macpict\bliptag841025759 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000390144001102ff0c00fffe00000048000000480000000000000039014400000000001e0001000a000000000039014482000001212a000000010000000000000000000000000000000100000000000000000000000000004000000000000000000000000000000000000000000000390144000003000000000000000056726177200000000000000000000000006170706c000004000000040001440039004800000048000000012090000100000000000000000000000000000000000000000000000000000000000000000020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bff7b7b7bff7b7b7bffa5a5a5ff7b7b7bff7b7b7bffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bffa5a5a5ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff4a4a4affa5a5a5ffa5a5a5ffefe7e7ffa5a5a5ffefe7e7ff7b7b7bff7b7b7bff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffcececeffefe7e7ffffffffffffffffffffffffffffffffffffffffffcececeff7b7b7bffcececeffbdbdbdffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff7b7b7bffbdbdbdffbdbdbdff7b7b7bff7b7b7bffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ffa5a5a5ffbdbdbdff7b7b7bffa5a5a5ff7b7b7bffbdbdbdff7b7b7bffefe7e7ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdffbdbdbdffcececeffefe7e7ffffffffffefe7e7ffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeffb5b5b5ffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffb5b5b5ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffa5a5a5ffa5a5a5ffefe7e7ffffffffffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffb5b5b5ffb5b5b5ff7b7b7bffcececeffffffffffa5a5a5ff7b7b7bffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeffcececeffefe7e7ffa5a5a5ffa5a5a5ff7b7b7bffcececeff7b7b7bffa5a5a5ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff7b7b7bffbdbdbdffffffffffffffffffffffffff7b7b7bffbdbdbdffefe7e7ff7b7b7bffffffffffffffffffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ffb5b5b5ffffffffffbdbdbdff7b7b7bffffffffffa5a5a5ffa5a5a5ffffffffffffffffffffffffffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffb5b5b5ff7b7b7bffa5a5a5ffefe7e7ff212121ffcececeffa5a5a5ff7b7b7bffefe7e7ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bffbdbdbdffcececeffa5a5a5ffbdbdbdffbdbdbdff4a4a4affcececeffffffffffffffffffffffffffffffffffcececeffbdbdbdffcececeffefe7e7ffffffffffbdbdbdff4a4a4affefe7e7ffffffffffefe7e7ff7b7b7bffffffffffbdbdbdffb5b5b5ffa5a5a5ffefe7e7ffa5a5a5ffcececeffefe7e7ffefe7e7ffefe7e7ffcececeffcececeffcececeff7b7b7bffefe7e7ffa5a5a5ffffffffff7b7b7bffffffffffffffffffffffffff7b7b7bffb5b5b5ffefe7e7ffbdbdbdffb5b5b5ffb5b5b5ffa5a5a5ffbdbdbdffffffffffffffffffcececeffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ffffffffffefe7e7ffa5a5a5ff7b7b7bffa5a5a5ffcececeff7b7b7bffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff7b7b7bff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff7b7b7bffa5a5a5ffcececeffffffffffffffffffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffb5b5b5ffbdbdbdffbdbdbdffb5b5b5ffa5a5a5ffffffffff7b7b7bff7b7b7bffcececeffcececeff7b7b7bff7b7b7bffb5b5b5ffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ffbdbdbdffa5a5a5ffbdbdbdffa5a5a5ff7b7b7bffefe7e7ffcececeffa5a5a5ff7b7b7bffffffffffb5b5b5ff7b7b7bffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bffbdbdbdff7b7b7bffefe7e7ffbdbdbdff4a4a4affefe7e7ffffffffffefe7e7ffbdbdbdffffffffffffffffffffffffff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ffa5a5a5ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffa5a5a5ffa5a5a5ff7b7b7bffbdbdbdffefe7e7ffcececeffefe7e7ffa5a5a5ffcececeff7b7b7bffb5b5b5ffa5a5a5ff4a4a4affffffffffefe7e7ff7b7b7bffbdbdbdffa5a5a5ffa5a5a5ffbdbdbdffbdbdbdffcececeffa5a5a5ffefe7e7ffbdbdbdffa5a5a5ffffffffffcececeff7b7b7bff7b7b7bffbdbdbdffa5a5a5ffa5a5a5ffa5a5a5ffb5b5b5ff7b7b7bffa5a5a5ff7b7b7bffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bffcececeffffffffffa5a5a5ffefe7e7ffcececeff7b7b7bffa5a5a5ffa5a5a5ffbdbdbdffcececeffbdbdbdffa5a5a5ffefe7e7ffbdbdbdffb5b5b5ffcececeffffffffffffffffffffffffffffffffffffffffffbdbdbdffefe7e7ffbdbdbdff7b7b7bffbdbdbdffa5a5a5ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff4a4a4affcececeff7b7b7bffcececeff7b7b7bff7b7b7bffffffffff4a4a4affefe7e7ffa5a5a5ff7b7b7bffbdbdbdff7b7b7bffefe7e7ffcececeffcececeff7b7b7bffbdbdbdffefe7e7ffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ffffffffff4a4a4affa5a5a5ffffffffffa5a5a5ff7b7b7bffcececeffa5a5a5ffa5a5a5ffcececeffa5a5a5ffefe7e7ffa5a5a5ffbdbdbdffffffffffbdbdbdffefe7e7ffcececeffa5a5a5ffa5a5a5ffa5a5a5ffffffffffa5a5a5ff7b7b7bffffffffffefe7e7ffbdbdbdffbdbdbdffffffffffffffffffffffffffcececeffa5a5a5ffcececeffbdbdbdff4a4a4affbdbdbdffa5a5a5ff7b7b7bffcececeff7b7b7bff7b7b7bffffffffffcececeff7b7b7bffa5a5a5ffbdbdbdffa5a5a5ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffb5b5b5ffa5a5a5ff7b7b7bff7b7b7bffffffffffffffffffffffffffffffffffffffffff4a4a4affbdbdbdffb5b5b5ff7b7b7bffefe7e7ffffffffff7b7b7bffb5b5b5ffefe7e7ffffffffffefe7e7ffb5b5b5ffa5a5a5ffefe7e7ff7b7b7bffa5a5a5ffffffffff4a4a4affb5b5b5ffbdbdbdffa5a5a5ffa5a5a5ffbdbdbdffa5a5a5ffa5a5a5ffcececeffa5a5a5ffbdbdbdffb5b5b5ff7b7b7bffbdbdbdffcececeff7b7b7bffcececeffa5a5a5ff4a4a4affffffffffa5a5a5ff4a4a4affcececeffa5a5a5ffa5a5a5ffb5b5b5ffcececeffcececeffb5b5b5ff4a4a4affffffffffffffffffbdbdbdffb5b5b5ffefe7e7ffffffffff7b7b7bffa5a5a5ffffffffffffffffffbdbdbdff7b7b7bffb5b5b5ffa5a5a5ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff7b7b7bffbdbdbdffa5a5a5ff4a4a4affcececeffffffffff4a4a4affffffffffa5a5a5ff7b7b7bffb5b5b5ffa5a5a5ffa5a5a5ffa5a5a5ffffffffffbdbdbdffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bffb5b5b5ffffffffff4a4a4affa5a5a5ffffffffffffffffff7b7b7bffefe7e7ff7b7b7bffbdbdbdffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ffbdbdbdffb5b5b5ffbdbdbdffa5a5a5ff4a4a4affffffffffcececeffa5a5a5ff4a4a4affefe7e7ffa5a5a5ffffffffffffffffffbdbdbdff4a4a4affffffffffefe7e7ffbdbdbdffa5a5a5ffa5a5a5ffb5b5b5ffffffffffffffffffefe7e7ffefe7e7ffa5a5a5ffcececeffffffffff7b7b7bffefe7e7ffffffffffffffffffb5b5b5ff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bffbdbdbdff7b7b7bffcececeff7b7b7bffa5a5a5ffefe7e7ff4a4a4affefe7e7ffa5a5a5ff7b7b7bffbdbdbdffb5b5b5ff7b7b7bffa5a5a5ff7b7b7bffbdbdbdffefe7e7ffefe7e7ffffffffffffffffffffffffffa5a5a5ff7b7b7bffcececeffffffffffcececeffa5a5a5ffcececeffa5a5a5ffbdbdbdffa5a5a5ffbdbdbdffa5a5a5ffa5a5a5ffcececeffa5a5a5ffefe7e7ffbdbdbdff7b7b7bff7b7b7bffefe7e7ffa5a5a5ffbdbdbdffcececeffa5a5a5ffcececeffffffffffcececeff7b7b7bffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bffcececeff4a4a4affb5b5b5ffffffffffa5a5a5ff7b7b7bffcececeff7b7b7bffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bffbdbdbdffa5a5a5ffbdbdbdff4a4a4affa5a5a5ffcececeffa5a5a5ff4a4a4affbdbdbdffa5a5a5ffb5b5b5ff7b7b7bff7b7b7bffffffffffb5b5b5ffa5a5a5ffa5a5a5ffbdbdbdffffffffffcececeffa5a5a5ffffffffffa5a5a5ffa5a5a5ffefe7e7ffa5a5a5ffcececeffa5a5a5ffcececeffa5a5a5ff7b7b7bffb5b5b5ffa5a5a5ffcececeffa5a5a5ffcececeffcececeffffffffffb5b5b5ffcececeffa5a5a5ffbdbdbdffcececeffbdbdbdffbdbdbdffbdbdbdffbdbdbdffffffffff7b7b7bffbdbdbdffffffffffffffffffffffffffffffffffb5b5b5ff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bff7b7b7bff7b7b7bffa5a5a5ff7b7b7bff7b7b7bffb5b5b5ff7b7b7bffb5b5b5ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff7b7b7bffa5a5a5ffa5a5a5ffbdbdbdffa5a5a5ff7b7b7bffcececeffa5a5a5ffa5a5a5ffa5a5a5ffbdbdbdffb5b5b5ff7b7b7bffa5a5a5ffffffffffffffffffffffffffcececeffa5a5a5ffa5a5a5ff4a4a4affa5a5a5ffbdbdbdffcececeffbdbdbdffa5a5a5ffb5b5b5ffefe7e7ffb5b5b5ffa5a5a5ffb5b5b5ffa5a5a5ffa5a5a5ffbdbdbdffb5b5b5ffa5a5a5ffa5a5a5ffcececeffa5a5a5ffbdbdbdffa5a5a5ffa5a5a5ffbdbdbdffbdbdbdffb5b5b5ffa5a5a5ffcececeffbdbdbdffcececeffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ffa5a5a5ffb5b5b5ff7b7b7bffbdbdbdffefe7e7ffcececeffffffffffffffffffffffffffefe7e7ffa5a5a5ff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bffa5a5a5ffb5b5b5ffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ff7b7b7bff7b7b7bffb5b5b5ffa5a5a5ffcececeff4a4a4affbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff7b7b7bffbdbdbdffcececeffb5b5b5ffbdbdbdffcececeffb5b5b5ffa5a5a5ffcececeffefe7e7ffcececeffbdbdbdffcececeff7b7b7bffcececeffbdbdbdffcececeffb5b5b5ffefe7e7ffa5a5a5ffb5b5b5ffcececeffb5b5b5ffa5a5a5ffefe7e7ffcececeff4a4a4affb5b5b5ffefe7e7ffefe7e7ffefe7e7ffffffffff7b7b7bff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bff4a4a4aff7b7b7bffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffcececeffbdbdbdffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bff4a4a4affa5a5a5ffffffffffefe7e7ff7b7b7bffffffffffffffffffefe7e7ffcececeffbdbdbdffefe7e7ffa5a5a5ffa5a5a5ffefe7e7ffbdbdbdffbdbdbdffbdbdbdffb5b5b5ffb5b5b5ffa5a5a5ffa5a5a5ff4a4a4aff7b7b7bffa5a5a5ffefe7e7ffbdbdbdff4a4a4affa5a5a5ff7b7b7bffa5a5a5ffbdbdbdffbdbdbdffbdbdbdffcececeffb5b5b5ffffffffffa5a5a5ffb5b5b5ffefe7e7ffbdbdbdffcececeffffffffffffffffff7b7b7bffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdffbdbdbdffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffa5a5a5ffa5a5a5ffa5a5a5ffefe7e7ffefe7e7ffffffffffffffffff4a4a4aff7b7b7bff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffefe7e7ff7b7b7bffcececeffffffffffcececeffefe7e7ffbdbdbdffa5a5a5ffffffffff7b7b7bff7b7b7bff4a4a4affbdbdbdffefe7e7ffa5a5a5ffbdbdbdffa5a5a5ff4a4a4affcececeffefe7e7ff7b7b7bffcececeffcececeffcececeffbdbdbdffbdbdbdffefe7e7ffbdbdbdffa5a5a5ffefe7e7ffa5a5a5ff4a4a4aff7b7b7bff7b7b7bffffffffffa5a5a5ffcececeffefe7e7ffefe7e7ffffffffff7b7b7bffbdbdbdffffffffffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffbdbdbdffffffffffefe7e7ffa5a5a5ffa5a5a5ffffffffffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffcececeffffffffffffffffffffffffffffffffff7b7b7bffa5a5a5ff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffcececeffefe7e7ffffffffffffffffffffffffffcececeffbdbdbdffcececeff4a4a4affa5a5a5ffb5b5b5ffa5a5a5ffa5a5a5ffbdbdbdffb5b5b5ffcececeff7b7b7bffefe7e7ffbdbdbdff4a4a4affefe7e7ff7b7b7bffcececeff7b7b7bff7b7b7bffffffffffa5a5a5ff7b7b7bffefe7e7ffbdbdbdff7b7b7bffa5a5a5ff7b7b7bffb5b5b5ffcececeff4a4a4affffffffff4a4a4affefe7e7ffffffffff7b7b7bffb5b5b5ffbdbdbdffb5b5b5ffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bffefe7e7ffffffffffffffffff7b7b7bff7b7b7bffefe7e7ffa5a5a5ff7b7b7bffa5a5a5ff7b7b7bffbdbdbdff7b7b7bff7b7b7bffb5b5b5ffa5a5a5ff7b7b7bffa5a5a5ff7b7b7bffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffa5a5a5ffefe7e7ffefe7e7ffbdbdbdffefe7e7ffefe7e7ffffffffffcececeff7b7b7bff7b7b7bff7b7b7bff7b7b7bff4a4a4affcececeffbdbdbdffcececeffcececeffb5b5b5ffa5a5a5ff7b7b7bff7b7b7bff7b7b7bff4a4a4aff4a4a4affcececeffbdbdbdffefe7e7ffcececeff7b7b7bffb5b5b5ffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ff4a4a4affcececeffffffffffffffffffb5b5b5ffa5a5a5ffa5a5a5ff7b7b7bffffffffff4a4a4affefe7e7ffb5b5b5ffa5a5a5ffcececeffbdbdbdffcececeffbdbdbdffbdbdbdffffffffff4a4a4affbdbdbdffbdbdbdffbdbdbdffffffffffffffffffefe7e7ff4a4a4affa5a5a5ffb5b5b5ffa5a5a5ffa5a5a5ffbdbdbdffcececeffbdbdbdff7b7b7bffa5a5a5ffcececeffcececeffffffffffffffffff7b7b7bff7b7b7bff7b7b7bff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ffbdbdbdffcececeffb5b5b5ffbdbdbdffb5b5b5ffcececeffbdbdbdffa5a5a5ff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ffbdbdbdffa5a5a5ff4a4a4aff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff212121ffa5a5a5ffbdbdbdffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bff7b7b7bff4a4a4affa5a5a5ffffffffff7b7b7bffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffefe7e7ffbdbdbdffefe7e7ffbdbdbdffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bff4a4a4affcececeffffffffffa5a5a5ff7b7b7bffffffffffcececeff7b7b7bffcececeffcececeff4a4a4affffffffffffffffffffffffff4a4a4affefe7e7ff7b7b7bffbdbdbdffcececeff7b7b7bffa5a5a5ff7b7b7bffefe7e7ffb5b5b5ff4a4a4aff7b7b7bffbdbdbdffbdbdbdff7b7b7bffffffffff4a4a4affefe7e7ffffffffffffffffff4a4a4affa5a5a5ffefe7e7ffa5a5a5ffbdbdbdffbdbdbdffa5a5a5ffbdbdbdff4a4a4affefe7e7ffa5a5a5ffa5a5a5ffbdbdbdffa5a5a5ffffffffffffffffffbdbdbdff4a4a4affbdbdbdffcececeffbdbdbdffb5b5b5ffa5a5a5ffa5a5a5ffa5a5a5ffbdbdbdffa5a5a5ffbdbdbdff7b7b7bffbdbdbdffbdbdbdffefe7e7ffefe7e7ffefe7e7ffefe7e7ffa5a5a5ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff7b7b7bffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ffffffffffa5a5a5ffa5a5a5ffcececeffbdbdbdffa5a5a5ffcececeff7b7b7bffefe7e7ffa5a5a5ffcececeffa5a5a5ffbdbdbdffffffffffbdbdbdffefe7e7ffffffffffa5a5a5ff7b7b7bffefe7e7ffffffffff7b7b7bffffffffffffffffffa5a5a5ff7b7b7bffbdbdbdffb5b5b5ffcececeff7b7b7bffffffffffa5a5a5ffa5a5a5ffefe7e7ff7b7b7bff7b7b7bffbdbdbdffefe7e7ffefe7e7ffbdbdbdff7b7b7bff7b7b7bffffffffff7b7b7bffefe7e7ffbdbdbdffbdbdbdff7b7b7bffbdbdbdffa5a5a5ff7b7b7bffa5a5a5ffcececeffbdbdbdffb5b5b5ffefe7e7ffa5a5a5ffcececeffa5a5a5ffbdbdbdffbdbdbdff4a4a4affa5a5a5ffbdbdbdffffffffffffffffff4a4a4affb5b5b5ffa5a5a5ffa5a5a5ffa5a5a5ffbdbdbdffb5b5b5ffa5a5a5ffcececeffefe7e7ffefe7e7ffbdbdbdffcececeffffffffffffffffffbdbdbdff4a4a4affa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffcececeffa5a5a5ffa5a5a5ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffcececeffffffffffb5b5b5ff7b7b7bffa5a5a5ffa5a5a5ffb5b5b5ffb5b5b5ffbdbdbdffcececeffa5a5a5ff7b7b7bffcececeffffffffffcececeffbdbdbdffcececeffcececeffb5b5b5ff7b7b7bffa5a5a5ffa5a5a5ffbdbdbdffffffffffffffffff4a4a4affa5a5a5ffffffffffcececeffa5a5a5ff4a4a4affcececeffbdbdbdffa5a5a5ffb5b5b5ffefe7e7ffcececeffffffffffa5a5a5ffa5a5a5ffefe7e7ffcececeff4a4a4affa5a5a5ffa5a5a5ffffffffffa5a5a5ff212121ffffffffffcececeffbdbdbdffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bffb5b5b5ffefe7e7ffbdbdbdffa5a5a5ff7b7b7bffcececeffffffffffcececeff7b7b7bffa5a5a5ffffffffffffffffff4a4a4affbdbdbdffbdbdbdffa5a5a5ffa5a5a5ffa5a5a5ffcececeffa5a5a5ffa5a5a5ffbdbdbdff7b7b7bffbdbdbdffffffffffefe7e7ffefe7e7ffcececeff7b7b7bff4a4a4aff7b7b7bffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff7b7b7bff4a4a4aff7b7b7bffbdbdbdffbdbdbdffb5b5b5ffb5b5b5ffb5b5b5ffb5b5b5ffb5b5b5ffb5b5b5ffbdbdbdff7b7b7bff7b7b7bff7b7b7bffa5a5a5ffefe7e7ffefe7e7ffcececeffb5b5b5ffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ffbdbdbdffcececeffb5b5b5ff4a4a4affa5a5a5ffbdbdbdffa5a5a5ffefe7e7ffcececeffbdbdbdffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ff7b7b7bffbdbdbdff7b7b7bffb5b5b5ffffffffffa5a5a5ffa5a5a5ffcececeffa5a5a5ff7b7b7bff7b7b7bff7b7b7bffa5a5a5ffcececeffa5a5a5ffa5a5a5ffffffffffcececeff7b7b7bffb5b5b5ff7b7b7bffbdbdbdffa5a5a5ffa5a5a5ffa5a5a5ffcececeffcececeffffffffffefe7e7ff7b7b7bffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ff4a4a4affa5a5a5ffbdbdbdffa5a5a5ffa5a5a5ffcececeffa5a5a5ff7b7b7bffa5a5a5ffbdbdbdffefe7e7ffffffffffffffffffffffffffffffffff7b7b7bff7b7b7bffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bffa5a5a5ffa5a5a5ffb5b5b5ffb5b5b5ffbdbdbdffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffcececeffcececeffbdbdbdffbdbdbdffbdbdbdffa5a5a5ffb5b5b5ffbdbdbdffbdbdbdffcececeffefe7e7ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffbdbdbdffa5a5a5ffb5b5b5ffa5a5a5ffa5a5a5ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffefe7e7ffffffffffffffffffffffffffefe7e7ffbdbdbdffcececeffcececeff7b7b7bffcececeffb5b5b5ffbdbdbdffefe7e7ffffffffffffffffffffffffffffffffffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffcececeffcececeffcececeffcececeffefe7e7ffcececeffbdbdbdffcececeffefe7e7ffbdbdbdffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffefe7e7ffefe7e7ffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffbdbdbdffefe7e7ffffffffffefe7e7ffbdbdbdffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffbdbdbdffefe7e7ffffffffffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdffa5a5a5ff4a4a4aff4a4a4aff4a4a4aff7b7b7bffa5a5a5ffefe7e7ffffffffffffffffffefe7e7ffffffffffffffffffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffbdbdbdffcececeffffffffffffffffffffffffffffffffffbdbdbdffcececeffcececeffcececeffcececeffcececeffbdbdbdffcececeffffffffffcececeffcececeffcececeffcececeffcececeffcececeffcececeffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffcececeffcececeffefe7e7ffcececeffcececeffcececeffbdbdbdffefe7e7ffffffffffcececeffbdbdbdffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdff4a4a4aff7b7b7bffffffffffffffffffffffffffffffffffffffffffbdbdbdffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdffcececeffefe7e7ffcececeffcececeffcececeffbdbdbdffefe7e7ffffffffffffffffffffffffffefe7e7ffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffffffffffefe7e7ffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffffffffffffffffffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffffffffffefe7e7ffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffcececeffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeffa5a5a5ff7b7b7bff4a4a4aff4a4a4aff4a4a4affa5a5a5ffefe7e7ffffffffffffffffffefe7e7ffffffffffffffffffffffffffffffffffffffffffcececeff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff7b7b7bffbdbdbdff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff4a4a4aff7b7b7bffffffffffbdbdbdff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff4a4a4affb5b5b5ffefe7e7ff7b7b7bff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff4a4a4aff000000ff000000ff000000ff212121ff4a4a4aff000000ff000000ff4a4a4affa5a5a5ffa5a5a5ff4a4a4affefe7e7ffffffffff7b7b7bff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff4a4a4aff7b7b7bffffffffffffffffffffffffffcececeff4a4a4aff212121ff212121ff212121ff212121ff212121ff4a4a4aff7b7b7bffefe7e7ff7b7b7bff212121ff212121ff212121ff212121ff212121ff212121ff212121ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ffa5a5a5ffefe7e7ff7b7b7bff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff4a4a4aff4a4a4affa5a5a5ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff212121ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffbdbdbdff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ffa5a5a5ffffffffffffffffffffffffffffffffffa5a5a5ff4a4a4aff212121ff212121ff212121ff212121ff212121ff4a4a4affa5a5a5ffffffffffffffffffffffffff7b7b7bff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ffefe7e7ffa5a5a5ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff7b7b7bffffffffffffffffff7b7b7bff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff4a4a4affffffffffefe7e7ff4a4a4aff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ff212121ffa5a5a5ffffffffffffffffffffffffffffffffffcececeff4a4a4aff212121ff000000ff000000ff212121ff4a4a4aff212121ff000000ff212121ff7b7b7bffa5a5a5ff4a4a4affcececeffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff212121ff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffcececeff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffefe7e7ffa5a5a5ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffefe7e7ffffffffffffffffffefe7e7ffcececeff4a4a4aff000000ff000000ff000000ff000000ff000000ff212121ffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bff212121ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff7b7b7bffefe7e7ffffffffffefe7e7ffffffffffa5a5a5ff212121ff000000ff000000ff212121ffefe7e7ffffffffffefe7e7ffcececeff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffcececeffefe7e7ffffffffffffffffffffffffffffffffffefe7e7ffa5a5a5ff212121ff000000ff000000ff7b7b7bffcececeffefe7e7ffffffffffefe7e7ffb5b5b5ff212121ff000000ff000000ff000000ff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffa5a5a5ff000000ff000000ff000000ff7b7b7bffcececeffefe7e7ffffffffffefe7e7ffcececeff4a4a4aff000000ff000000ff000000ff000000ff000000ff212121ffa5a5a5ffa5a5a5ff7b7b7bff4a4a4aff212121ff000000ff000000ff000000ff212121ff7b7b7bffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffefe7e7ffcececeff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff212121ffcececeffefe7e7ffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ff4a4a4aff000000ff000000ff212121ffbdbdbdffefe7e7ffefe7e7ffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff212121ff212121ff000000ff000000ff000000ff000000ff000000ff000000ff212121ff212121ff000000ff000000ff000000ff000000ff000000ffcececeffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffefe7e7ffffffffffffffffffefe7e7ffcececeff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affcececeffffffffffffffffffffffffffffffffffcececeff4a4a4aff000000ff000000ff000000ff000000ff000000ff4a4a4affa5a5a5ffa5a5a5ffa5a5a5ff7b7b7bff7b7b7bff7b7b7bff212121ff000000ff000000ff7b7b7bffffffffffffffffffffffffffb5b5b5ff212121ff000000ff000000ff4a4a4affcececeffffffffffefe7e7ffffffffffbdbdbdff4a4a4aff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffcececeff212121ff000000ff4a4a4affb5b5b5ffcececeffefe7e7ffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffefe7e7ffefe7e7ffcececeffa5a5a5ff212121ff000000ff4a4a4affffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff212121ffefe7e7ffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff000000ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff212121ff7b7b7bffcececeffefe7e7ffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affcececeffefe7e7ffefe7e7ffbdbdbdff4a4a4aff000000ff000000ffcececeffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bff000000ff7b7b7bffffffffffffffffffefe7e7ff212121ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffcececeff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffcececeff000000ff4a4a4affffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff212121ffefe7e7ffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ffa5a5a5ffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffff4a4a4aff000000ffcececeffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff7b7b7bffffffffffffffffff7b7b7bff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ffcececeffffffffffffffffffffffffffffffffffbdbdbdff212121ffa5a5a5ffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffff4a4a4aff4a4a4affffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff212121ffefe7e7ffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffbdbdbdff212121ffbdbdbdffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff7b7b7bffffffffffffffffff4a4a4aff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff4a4a4affbdbdbdffffffffffffffffffffffffffffffffffbdbdbdff212121ffcececeffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffa5a5a5ff4a4a4affffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff212121ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bffcececeffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4aff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffefe7e7ff212121ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff7b7b7bffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffefe7e7ff212121ffbdbdbdffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff212121ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff7b7b7bffffffffffefe7e7ff212121ff000000ff000000ff000000ff212121ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bffcececeffffffffffffffffffffffffffffffffffefe7e7ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff212121ff000000ff000000ff000000ff000000ff4a4a4affcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff212121ffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4aff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ffbdbdbdff4a4a4aff000000ff000000ff000000ff000000ff000000ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffff7b7b7bff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdffcececeffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffb5b5b5ffefe7e7ffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff212121ffa5a5a5ff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffff212121ff000000ff000000ff000000ff000000ff212121ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffefe7e7ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff212121ffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffefe7e7ff000000ff4a4a4affffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffa5a5a5ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffcececeff4a4a4aff000000ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffffffffffffcececeff000000ff4a4a4affffffffff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffa5a5a5ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ff4a4a4affbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff000000ffa5a5a5ffefe7e7ff212121ff000000ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffff7b7b7bff000000ffa5a5a5ffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffff7b7b7bff4a4a4affffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ff4a4a4affa5a5a5ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffefe7e7ffefe7e7ffefe7e7ffefe7e7ffefe7e7ffefe7e7ffa5a5a5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff212121ffcececeffefe7e7ffefe7e7ffcececeffa5a5a5ff212121ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff212121ffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffff4a4a4aff000000ffcececeffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4aff4a4a4aff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffefe7e7ffcececeff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffefe7e7ff212121ff212121ffefe7e7ffffffffff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffefe7e7ffefe7e7ffcececeff7b7b7bff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4aff7b7b7bffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affcececeffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffcececeff000000ff4a4a4affffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffefe7e7ffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffb5b5b5ff000000ff4a4a4affffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff212121ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff212121ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff000000ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff212121ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffbdbdbdffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff4a4a4affffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffa5a5a5ff000000ff7b7b7bffffffffffffffffffffffffffbdbdbdff212121ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffcececeffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffff4a4a4aff000000ffbdbdbdffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff000000ff000000ff000000ff000000ff000000ff212121ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffcececeff212121ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff4a4a4aff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffcececeffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ffcececeffbdbdbdff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffff4a4a4aff000000ffefe7e7ffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffefe7e7ffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff212121ffefe7e7ffcececeff212121ff212121ffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffefe7e7ffbdbdbdff212121ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffbdbdbdff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff212121ffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4aff7b7b7bff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffcececeff000000ff212121ffcececeffefe7e7ffcececeffcececeffefe7e7ff7b7b7bff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffefe7e7ffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffa5a5a5ffa5a5a5ff000000ff7b7b7bffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffff7b7b7bff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff7b7b7bff212121ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffefe7e7ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bff212121ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffcececeffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff4a4a4aff212121ff212121ffefe7e7ffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffa5a5a5ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff212121ffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffff212121ff000000ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffefe7e7ffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff212121ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffb5b5b5ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffefe7e7ffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bffefe7e7ffffffffffb5b5b5ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff212121ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff4a4a4affcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffff7b7b7bff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffcececeffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff212121ffefe7e7ffffffffffa5a5a5ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff212121ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffefe7e7ff212121ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffefe7e7ffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff212121ffffffffffffffffffa5a5a5ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffffcececeff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff000000ff000000ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff212121ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffa5a5a5ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb5b5b5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ffefe7e7ffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff000000ff212121ffffffffffffffffffb5b5b5ff000000ff212121ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffcececeff4a4a4aff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff212121ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff212121ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff4a4a4affa5a5a5ffefe7e7ffefe7e7ffefe7e7ffefe7e7ffa5a5a5ff212121ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff4a4a4aff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff212121ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffefe7e7ffcececeff7b7b7bff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffcececeff212121ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff000000ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ffb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7b7b7bff000000ff000000ff000000ff000000ff000000ff212121ffefe7e7ffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ffb5b5b5ffffffffffffffffffffffffffffffffffffffffff4a4a4aff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffbdbdbdff000000ff000000ff000000ff000000ff000000ff000000ffbdbdbdffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff000000ff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffcececeff4a4a4aff000000ff212121ffffffffffffffffffbdbdbdff000000ff000000ff212121ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdffa5a5a5ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affa5a5a5ffcececeffefe7e7ffffffffffffffffffefe7e7ffcececeff7b7b7bff212121ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affa5a5a5ffcececeffffffffffefe7e7ffbdbdbdff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affbdbdbdffefe7e7ffffffffffcececeffa5a5a5ff212121ff000000ff000000ff000000ff000000ff000000ff000000ff212121ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff212121ff000000ff000000ff212121ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff000000ff4a4a4aff212121ff000000ff4a4a4affb5b5b5ffcececeffcececeffb5b5b5ff4a4a4aff000000ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff212121ff4a4a4aff4a4a4aff000000ff000000ff000000ff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffcececeffbdbdbdff7b7b7bff212121ff000000ff000000ff4a4a4affa5a5a5ffbdbdbdffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff212121ff000000ff000000ff7b7b7bffffffffffffffffffffffffffffffffffbdbdbdffa5a5a5ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4aff4a4a4aff4a4a4aff000000ff000000ff000000ff212121ff4a4a4affb5b5b5ffffffffffffffffffbdbdbdffa5a5a5ff212121ff000000ff000000ff000000ff7b7b7bffb5b5b5ffefe7e7ffffffffffffffffffffffffffffffffffbdbdbdffcececeff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff212121ffa5a5a5ffefe7e7ffffffffffcececeffa5a5a5ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff212121ff7b7b7bffbdbdbdffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdffbdbdbdff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ff7b7b7bffbdbdbdffefe7e7ffffffffffffffffffffffffffffffffffcececeff7b7b7bff000000ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4affbdbdbdffffffffffffffffffcececeffa5a5a5ff212121ff000000ff000000ff212121ffa5a5a5ffbdbdbdffffffffffffffffffffffffffa5a5a5ff000000ff000000ffa5a5a5ffffffffffffffffffffffffffcececeffa5a5a5ff212121ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffa5a5a5ffcececeffffffffffffffffffcececeffa5a5a5ff212121ff000000ff000000ff000000ff000000ff000000ff000000ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff000000ff000000ff000000ff212121ffffffffffffffffffb5b5b5ff000000ff212121ff212121ff000000ff4a4a4affa5a5a5ffbdbdbdffcececeffbdbdbdff7b7b7bff212121ff000000ff000000ff4a4a4affffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affcececeffffffffffffffffffcececeff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff7b7b7bffffffffffb5b5b5ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affa5a5a5ffefe7e7ff7b7b7bff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff7b7b7bffefe7e7ffefe7e7ff7b7b7bff4a4a4aff000000ff212121ff212121ff212121ff000000ff000000ff4a4a4affa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff4a4a4aff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff212121ffa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffa5a5a5ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affb5b5b5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbdbdbdff4a4a4aff4a4a4affa5a5a5ffffffffffffffffffffffffffefe7e7ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff212121ff4a4a4aff4a4a4aff7b7b7bffa5a5a5ffefe7e7ffffffffffffffffffffffffffcececeff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affa5a5a5ffffffffffffffffffffffffffcececeff7b7b7bff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff7b7b7bffefe7e7ff7b7b7bff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affa5a5a5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcececeff7b7b7bff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affa5a5a5ffffffffffffffffffffffffffefe7e7ff7b7b7bff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affcececeffffffffff7b7b7bff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff7b7b7bffefe7e7ffffffffffffffffffefe7e7ff7b7b7bff4a4a4affefe7e7ffffffffffffffffffffffffff7b7b7bff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff7b7b7bffefe7e7ffefe7e7ff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4aff4a4a4affffffffffffffffffcececeff7b7b7bffefe7e7ffefe7e7ffa5a5a5ff4a4a4aff212121ff212121ff212121ff000000ff000000ff000000ff212121ff7b7b7bffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffffffffffffffffffffffffffffffffffffffffffefe7e7ffffffffffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffcececeffa5a5a5ffa5a5a5ffa5a5a5ffa5a5a5ffcececeffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdffa5a5a5ff7b7b7bff7b7b7bffa5a5a5ffb5b5b5ffcececeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffefe7e7ffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffefe7e7ffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffefe7e7ffefe7e7ffffffffffefe7e7ffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefe7e7ffbdbdbdffa5a5a5ffa5a5a5ffa5a5a5ffbdbdbdffefe7e7ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000700ae00700007000100010003000300040000000d000c0010014401440144014400280010006c10517569636b54696d65aa20616e642061000028001c00750d206465636f6d70726573736f720028002800451f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par The Sunday Times (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  25, 2010 \par Correction Appended  \par Edition 1; \par National Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Mittal sits on top of the pile; \par RICH LIST 2010 THE TOP 100}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RICH LIST 2010;FEATURES; Pg. 14,73\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 59576 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1 \u163\'a322,450m \u163\'a311.65bn, 108%\par Lakshmi Mittal and family Steel\par Mittal reckons that the steel business has rebounded from the worst of the decline in 2008 and early 2009, and is recovering. He ought to know, being the boss of the world's biggest steelmaker, ArcelorMittal. With a strong market share in most of the world's regions, it should be well placed for a profit boost next year. But Londonbased Mittal, 59, still cannot find a way to expand his influence in China, which now accounts for nearly half of global steel output and consumption. ArcelorMittal has minority stakes in two Chinese steelmakers but as long as Beijing blocks foreign takeovers in this industry, the conglomerate's role will r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 main limited. Steel's recovery in the \par markets over the past year has been mirrored by the rising share price of ArcelorMittal - the family's stake is worth \u163\'a318.45 billion, to which we add \u163\'a34 billion of other assets. Mittal, who has expanded his business by acquiring ailing, formerly state-owned mills around the world and turning them round, knows all there is to know about steel. His father, Mohan, built up a steel operation in Calcutta. Mittal moved to Indonesia in 1976 and set up his own steel plant, which he separated from the family's businesses in 1995. Going it alone, he moved to London, a city he loves, although he retains his Indian passport. His son, Aditya, 34, inset top, is chief financial officer and daughter Vanisha, 29, inset, is a director. His enthusiasm for London will soon be on public display - ArcelorMittal is funding up to \u163\'a316m of the \u163\'a319.1m cost of a landmark sculpture to be i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 stalled in the new Olympic Park in time for the 2012 Games. Called the ArcelorMittal Orbit, it will consist of a looping lattice of tubular steel with a viewing platform and will be taller than New York City's Statue of Liberty. The artist who has designed it is Anish Kapoor - like Mittal, an Indian-born but now very British success story (see panel on page 75).\par 2009: \u163\'a310,800m, 1\par 4 \u163\'a35,950m \u163\'a3950m\par Ernesto and Kirsty Bertarelli Pharmaceuticals\par Even before the opening race of the 2010 America's Cup in Valencia, Ernesto Bertarelli, 44, owner of the Swiss Alinghi team, was locked in a legal battle with American tycoon and challenger Larry Ellison in the New York State Supreme Court over their respective yachts. The most contentious America's Cup in its 159-year history was won in February by Ellison's USA-17, after Bertarelli won in 2003 and 2007. He makes it into this list with his wife, Kirsty, a former Miss UK whom we rate as Britain's wealthiest woman (see page 78). Bertarelli is an anglophile who prefers to drink beer in a London pub with his wife than quaff champagne. His childhood was spent being groomed for business - at the age of six, he was handing out employee-of-the-year gifts at his father's Serono pharmaceutical firm. By 31, after his father's death, he was running the Geneva-based multinational group, which was sold to Merck of Germany in 2006 for $13.3 billion. Bilan magazine estimated the Bertarelli fortune at \u163\'a35.95 billion in its December 2009 Swiss rich list. The couple give generously to charity through the Fondation Bertarelli.\par 2009: \u163\'a35,000m, 4\par 5 \u163\'a35,532m \u163\'a33.032bn\par David and Simon Reuben Property and internet\par See panel on page 16\par 6 \u163\'a34,700m \u163\'a33.2bn\par Alisher Usmanov Steel and mines\par Metalloinvest, Russia's biggest iron ore miner, has revived plans for a London stock market listing that could value it at \u163\'a312 billion. The company is half-owned by Usmanov, 56, who also has about 26% of Arsenal FC. His stake in the Gunners is worth \u163\'a3149m. The son of a former state prosecutor in Tashkent, Usmanov was born in Soviet Uzbekistan, although he is now a Russian citizen. He became rich through steel manufacture and iron ore mines. Apart from Metalloinvest, Usmanov's recent investments in media, telecoms and banking suggest a fierce loyalty to Russia's prime minister, Vladimir Putin. He has a \u163\'a348m mansion in north London as well as Sutton Place, the Surrey Tudor manor formerly owned by the late US oil billionaire J Paul Getty. In its 2010 list of world billionaires, Forbes put Usmanov's fortune at \u163\'a34.7 billion.\par 2009: \u163\'a31,500, 18=\par Mr Chelsea stays ahead of his rivals\par 2 \u163\'a37,400m \u163\'a3400m, 6%\par Roman Abramovich Oil and industry\par What do you give a Russian oligarch who has everything? A \u163\'a3400m revival in his fortunes? The world's bi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gest superyacht? A Caribbean island estate? A new son? All of the above? Aside from the odd scandal i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 volving his players, Abramovich was enjoying a good year until Chelsea blew their chance of winning the Champions League. Even oligarchs have to watch the figures, especially with the threat of a $2 billion (\u163\'a31.3 billion) lawsuit from former business partner Boris Berezovsky (qv). Divorce in 2007 from Irina, his wife of 16 years, cost Abramovich \u163\'a3155m. He spent a reported \u163\'a3724m on his yacht, Eclipse, which has two helipads, two swimming pools, a mini submarine and an antipaparazzi shield, said to destroy photographers' shots with a laser beam. The master suite has a retractable roof in case Abramovich, 43, and 28-year-old Daria Zhukova, right, an oligarch's daughter, want to sleep under the stars. Parking can be a problem - time to buy a \u163\'a355m, 70-acre estate on a Caribbean island, St Barth\u200\'e9lemy. Abramovich's start in life was less auspicious. Orphaned at four, he was raised by an uncle on the edge of the Arctic Circle. He moved to Moscow at 14, did army service and started trading in dolls, later graduating to tyres, pig farms and bodyguard recruitment. His big moment came when he moved into oil. With Berezovsky, he bought Sibneft in 1995 for about \u163\'a3120m. When Berezovsky went into exile, he sold out to Abramovich, who picked up much of the \u163\'a37.5 billion paid when Gazprom, the Russian gas monopoly, bought Sibneft in 2005.\par Berezovsky alleges he was coerced into selling cheaply, and the High Court in London has ruled that his lawsuit, which Abramovich disputes, can go ahead. Huge dividends from Sibneft and sales of stakes in his other operations have added \u163\'a32 billion to Abramovich's wealth. He and his partners hold stakes in the Ru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sian steel group Evraz and mining group Highland Gold to the tune of \u163\'a31,014m. Both companies were hit by the stock market turmoil of 2008-09 but have recovered, allowing us to value him at \u163\'a37.4 billion.\par 2009: \u163\'a37,000m, 2\par 3 \u163\'a36,750m \u163\'a3250m, 4%\par The Duke of Westminster Property\par Grosvenor Group, the property giant controlled by the Duke of Westminster, has recovered its appetite for development. In December, it offered more than the \u163\'a3100m asking price for a two-acre site in Kensington that has planning consent for 72 luxury flats. Back in April last year, it put a freeze on developments after posting its 2008 figures, the worst for 16 years. The group, which owns swathes of Mayfair, Belgravia and Knightsbridge, as well as the Liverpool One shopping centre, has seen its performance improve in 2009 with losses down sharply from \u163\'a3594m to \u163\'a3236m. Grosvenor has also built up a war chest of nearly \u163\'a31 billion to return to global property markets such as Shanghai and other Chinese cities. Chief executive Mark Preston says: "We've weathered the downturn well." He had previously pointed out that the group had been around for more than 300 years and experienced 20 recessions and more than 250 wars worldwide during that time. He reckoned the impact of the downturn had been cushioned by Grosvenor's "well-diversified portfolio, low gearing and steps taken since 2007 to curb acquisitions and reduce our development exposure". The group is now working on only three big projects: the residential element of Liverpool One and sites in Australia and Canada. Grosvenor Group's shares are all owned by various trusts set up for the benefit of the Grosvenor family, headed by the 6th Duke, 58, who is chairman of the trustees. He chaired the company until 2007. The net asset value of Grosvenor fell in 2008 by 7.4% to \u163\'a32.8 billion but the top end of the London housing ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ket appears to be in recovery mode now. Adding private estates outside the group into the equation raises our overall valuation of the duke to \u163\'a36.75 billion this year.\par 2009: \u163\'a36,500m, 3\par Didn't we do well?\par 5 \u163\'a35,532m \u163\'a33.032bn, 121%\par David and Simon Reuben Property and internet\par The jewel in the crown of the Reuben brothers' business empire is Global Switch, which runs datacentres across the world - supporting blue-chip companies such as BP, Shell, IBM and Microsoft. Bankers are bea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing a path to their door since Global Switch could be listed this year., valued at more than \u163\'a32.7 billion. The sons of an Iraqi Jewish textile merchant, David, 71, is known as the trader and Simon, 68, the investor. David loves technology and gadgets, while Simon admits: "I can't read a computer screen and never use a calcul}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tor. It's all in my head and by hand." David started in the 1960s in scrap metals while Simon was buying and selling carpets and investing in property. They worked together trading metals, which led eventually to them making about \u163\'a31.3 billion in Russia's aluminium market in the 1990s. Their holdings range from high-end property such as Millbank Tower in London to more than a third of the country's racecourses, including U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 toxeter, Bath and Chepstow through Northern Racing and Arena Leisure, plus shopping centres and London Oxford airport.\par Since 2002 they have supported the Reuben Foundation Children's Cancer Centre at Great Ormond Street hospital as well as the Nancy Reuben primary school in north London, which is named after their mother. Simon and his wife, Joyce, pictured left, divide their time between London and Monaco while David, inset, who is married to Debra, lives in London and the south of France. The brothers have been able to extract hefty profits from investments sold before the crash. Their two main companies, Aldersgate Investments, the parent of Global Switch, and Reuben Brothers, are valued at more than \u163\'a35.5 billion. Additional assets take them to \u163\'a35.532 billion.\par 2009: \u163\'a32,500m, 9=\par 7 \u163\'a34,500m \u163\'a33.6bn\par Galen and George Weston and family Retailing\par Galen Weston, 69, oversees the huge George Weston operation in Canada, spanning the Loblaw superma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ket chain and Weston Foods. But he was born in Marlow, Buckinghamshire, in 1940 when his Canadian f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ther, Garfield, was MP for Macclesfield. Galen grew up in England, the United States and Canada. The fam}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly had an estate at Henley-on-Thames, where they entertained the British upper crust, including members of the royal family. Galen's wife, Hilary, 68, was born in Ireland (see panel on page 85). We add his wealth to that of the British branch of the Weston clan, led by his nephew George Weston, 46, above, but deduct \u163\'a3500m for duplication and crossshareholdings. The British wealth is concentrated in the food and bread pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ducer Associated British Foods (ABF), though there are other choice assets such as Primark, Selfridges and Fortnum & Mason. These retail interests and the Irish stores chain Brown Thomas are held by Wittington Investments, which made \u163\'a3482m profit on \u163\'a39.3 billion sales in 2009. ABF alone, quoted on the London stock market, is worth \u163\'a37 billion. But more than 79% of Wittington Investments, chaired by Galen's nephew Guy, 49, is held by the Garfield Weston Foundation and as a charity we exclude it. The family's British assets and \u163\'a3100m of dividends in recent years are worth \u163\'a31 billionplus. Galen Weston has a 62.5% stake, worth \u163\'a33.68 billion, in the Canadian George Weston operation. He also owns the Canadian fashion retailer Holt Renfrew, with $ 100m in sales. 2009: \u163\'a3900m, 47\par 8 \u163\'a34,400m \u163\'a31.44bn\par Charlene and Michel de Carvalho Inheritance, brewing and banking\par Dutch brewer Heineken took over Femsa, Mexico's biggest beverage company, in January, giving it a pre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ence in the booming Central and South American markets. The $ 5 billion deal reinforces the position of London-and Switzerland-based Charlene de Carvalho, only child of the late Freddy Heineken, as Britain's "queen of brewing". Charlene, 55, and her banker husband, Michel, 65, have a minority stake in Heineken but control the brewer through its complex voting structure.\par 2009: \u163\'a32,960m, 7\par 9 \u163\'a34,105m \u163\'a3275m\par Sir Philip and Lady Green Retailing\par Green's Arcadia retail empire absorbed his Bhs chain in 2009, creating a group with more than 3,100 stores. He is linking up with X Factor supremo Simon Cowell (qv) on a global entertainment operation. While he sees the retail climate as still challenging, Arcadia, which owns Dorothy Perkins, Evans, Wallis, Miss Selfridge and Burton, is firing on all cylinders. Its biggest name, Topshop, is due to open a store in Knightsbridge, opposite Harrods, next month. In the year to August 2009, profits rose 13% to \u163\'a3213m. That does not include Bhs, where operating profits fell 40% to \u163\'a330.2m. We value Bhs and Arcadia at \u163\'a32.9 billion, and the stakes owned by the family, led by Green, 58, and wife, Tina, 60, at \u163\'a32.68 billion. We add \u163\'a31.425 billion for homes, yachts, dividends and property deals. Green recently paid \u163\'a3100,000 for an Alexander McQueen dress in aid of humanitarian relief in Haiti.\par 2009: \u163\'a33,830m, 6\par 10 \u163\'a34,100m \u163\'a33.5bn\par Anil Agarwal Mining\par The share price of mining group Vedanta Resources has soared to more than \u163\'a327.50. London-based Agarwal, Vedanta's founder and chairman, has seen his stake recover rapidly to \u163\'a34.48 billion. He left school at 15 to work as a scrap metal trader in his native India and made his fortune when the Indian government privatised its mining assets. In 2003, Vedanta floated on the London stock market in a blaze of publicity. Agarwal, 57, is worth \u163\'a34.1 billion after lopping off a $ 1 billion donation to construct a university in India for 100,000 students modelled on Harvard, Oxford and Stanford, pledged by him in 2006. We take into account his other assets, including a \u163\'a320m home in Mayfair.\par 2009: \u163\'a3600m, 70=\par 11 \u163\'a34,000m\par Hans Rausing and family Packaging\par Rausing, who moved to Britain from Sweden in the early 1980s, gave more than \u163\'a34m to a Swedish institute to fund a research project on breast cancer this year. One of the key developers of Tetra Pak (later Tetra Laval), the packaging empire founded by his father, Rausing, 84, has donated at least \u163\'a3146m to good cau}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es. He sold his 50% stake in Tetra Laval to his late brother Gad for about \u163\'a34.4 billion in 1995. He has inves}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed in new products such as Ecolean, an environmentally friendly packaging material made from chalk. He also has stakes in a Swedish crystal firm and a Ukrainian ketchup manufacturer. We keep the family at \u163\'a34 billion.\par 2009: \u163\'a34,000m, 5\par 12 \u163\'a33,825m New entry\par Joseph Lau Property\par The Chinese property tycoon recently bought a \u163\'a333m house in London's exclusive Eaton Square. Lau, 58, made his money as one of Hong Kong's corporate raiders and owns 61% of Chinese Estates Holdings, based in the former colony. He owns one of the world's finest wine collections, with at least 10,000 bottles, and is an avid art collector. In 2006 he paid a record \u163\'a39m for Andy Warhol's portrait of Mao Tse-tung and last year he spent nearly \u163\'a36m on a flawless blue diamond. Lau''s fortune was put at \u163\'a33,825m by Forbes in its 2010 list of world billionaires.\par 13 \u163\'a33,500m \u163\'a31bn\par Kirsten and Jorn Rausing Inheritance and investment\par Sales at Tetra Laval, the packaging group based in Switzerland, rose 5% in 2008 to about \u163\'a310 billion. The firm has moved into green projects, such as a facility in China run entirely on renewable electricity. This is good news for Kirsten and Jorn Rausing, whose father, the late Gad Rausing, helped to develop the Swedish Tetra Pak operation, which became Tetra Laval. Jorn, 50, who lives in Surrey, heads Tetra Laval's mergers and acquisitions division. He has a 15% stake in the online retailer Ocado. His sister Kirsten, 57, is also on the board of Tetra Laval, which is worth \u163\'a37 billion. We ascribe half to the brother-andsister team.\par 2009: \u163\'a32,500m, 9=\par 14 \u163\'a33,160m \u163\'a32.616bn\par Vladimir Kim Mining\par Soaring metal and commodities prices have boosted Kazakhmys, Kazakhstan's largest copper producer. Its shares leapt in 2009 from 261.5p in 2009 to more than \u163\'a315 by early 2010. The company's chairman, Mo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cow-educated Kim, effected a huge turnround in the business, which at the collapse of the Soviet Union was $ 200m in debt and not paying wages. It floated in London in 2005 and has its headquarters in Westminster. Kim, 49, has a stake worth \u163\'a33.16 billion.\par 2009: \u163\'a3544m, 81=\par 15 \u163\'a33,000m New entry\par Leonard Blavatnik Industry\par Blavatnik saw the US arm of his Dutch-based LyondellBasell chemicals operation forced to file for Chapter 11 bankruptcy early last year. Its debts had reached $ 19.4 billion. The 52-year-old tycoon, based in New York and London, where he has a \u163\'a341m home in Kensington, has stakes in lucrative Russian oil operations and other investments in the aluminium and chemical industries. In its November 2009 list of the 400 richest people in America, Forbes magazine put the Russian-born engineer's fortune at \u163\'a33 billion.\par 16 \u163\'a32,750m \u163\'a3250m\par John Fredriksen Shipping\par The shipping empire built by Fredriksen has helped make him Norway's richest man. He reaped huge r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 wards from the transport of oil during the 1980-88 IranIraq war and has a \u163\'a3491m stake in Frontline, said to be the world's largest tanker business. It has also provided Fredriksen, 65, with about \u163\'a3500m in dividends since 2003. Other interests include a \u163\'a3275m stake in the travel and shipping group Tui, a \u163\'a3230m slice of the gas tanker business Golar LNG, and Marine Harvest, the seafood producer he took over in a \u163\'a31 billion deal. As well as his main home in London, there are properties in Cyprus, Oslo and Marbella.\par 2009: \u163\'a32,500m, 9=\par 17 \u163\'a32,700m \u163\'a3200m\par Joe Lewis Foreign exchange and investment\par London-born Lewis has a \u163\'a3292m stake in the quoted pub group Mitchells & Butlers. He made much of his fortune from betting against sterling in the 1990s. Tavistock Group, his main investment vehicle, has inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ests in property and a \u163\'a371m stake in Premier League club Tottenham Hotspur. It also has Russian oil and gas interests. His property holdings include 3,600 acres in the Bahamas, where he is based. He lost nearly \u163\'a3500m when the Wall Street bank Bear Stearns failed in 2008, but continued huge foreign-exchange profits and recovering asset prices take 73-year-old Lewis \u163\'a3200m higher this year.\par 2009: \u163\'a32,500m, 9=\par Music mogul calls tune\par 25 \u163\'a31,640m New entry\par Edgar Bronfman and family Inheritance and music\par Music boss Bronfman recently moved from New York to London's Kensington with his second wife, Clarissa, above, and their four children, saying that he wanted the kids to experience life abroad for one or two years. He is chairman and chief executive of the Warner Music Group after part-funding a private equity buyout in 2004. It's all going tickety-boo at Warner, where he has delivered a 140% return for the company's original investors, and in London he is well placed to snap up beleaguered EMI. The former songwriter (who has wri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ten for Celine Dion and Dionne Warwick)\par is due a bit of corporate good luck. Bronfman, 54, who tops our list of music millionaires on page 42, is the grandson of Russian immigrant Sam Bronfman, who started with a liquor store in Montreal in 1916, ran whi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 key across the Canadian-US border during prohibition and built the Seagram drinks empire.\par He made his family one of the wealthiest in Canada. Sam's son, Edgar Bronfman Sr, took over the American operations and in 1994, his son Edgar Jr (known to his friends as Efer)\par became chief executive. Efer's attempts to turn the drinks business into an entertainment force to be rec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 oned with didn't go well. In 1995, he sold a valuable stake in the chemical giant DuPont, from which Seagram earned 75% of its profits, and invested the proceeds in music and entertainment businesses. Five years la}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er, Seagram merged with Vivendi in return for $ 30 billion of stock in what was supposed to be a global e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tertainment conglomerate, but Vivendi sold the Seagram drinks side for \u163\'a35.6 billion and nearly collapsed u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 der debts it took on from an acquisition spree. The deal was described as "one of the worst mergers in hist}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ry". It''s just as well the family could afford to lose a few billion. The Bronfman fortune was put at \u163\'a31,640m by Forbes in its 2010 list of world billionaires.\par 18 \u163\'a32,600m \u163\'a31.4bn\par Sir Richard Branson Transport, internet and mobile phones\par The Necker Nymph, Branson's first submarine, will be hired out to visitors to his Caribbean holiday hideaway. SpaceShipTwo, unveiled last December, will carry passengers on Virgin Galactic. So from the depths of the sea to the edge of space and beyond, the Virgin boss, 59, has it covered. The state investment fund of Abu Dhabi paid $280m for a 32% stake in Virgin Galactic in July.\par Branson's empire now embraces Virgin Money, trains, airlines, the internet, music, wine, health clubs and holidays. Branson's Virgin foundations donated more than \u163\'a312m to charities in the past year, earning him a place among the top 100 on our Giving List. In 2007, the Financial Times stated that Virgin was worth about \u163\'a32.5 billion. The figure fell sharply during the credit crunch but has now roared back to \u163\'a32.6 billion.\par 2009: \u163\'a31,200m, 32=\par 19 \u163\'a32,300m \u163\'a3300m\par Earl Cadogan and family Property\par The 8th earl, 73, has said that his 93 plush acres in Chelsea have the "fundamental resilience" to see out the property crisis. Cadogan Group's 2008 results show a fall in net asset values from \u163\'a32.6 billion to \u163\'a32.1 billion. There was, though, a 31% rise in profits to \u163\'a340.4m. We value the business on its net asset figure and add \u163\'a3200m for dividends, investments and personal property.\par 2009: \u163\'a32,000m, 14\par 20 \u163\'a32,074m \u163\'a3274m\par Alan Parker Duty-free shopping\par For 25 years, Parker added to his stake in Duty Free Shoppers, the Hong Kong-based chain he helped to run. His patience paid off when his holding, then 20%, earned him more than \u163\'a3460m in the 1997 takeover by the luxury goods group LVMH. Parker, 71, born in Britain and based in Geneva, used some of the proceeds to establish the Oak Foundation, which funds humanitarian and conservation projects. Taking account of other assets and charitable donations, we agree with the \u163\'a32,074m figure put on Parker's fortune by Bilan magazine in its 2009 Swiss rich list.\par 2009: \u163\'a31,800m, 15\par 21 \u163\'a31,900m \u163\'a3400m\par Eddie and Sol Zakay Property\par Sol Zakay, 57, has quit Britain for Israel since the introduction of a 50% tax rate on high earners and will now concentrate on finding global opportunities for Topland Group, the London-based property development o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 eration that he runs with his brother Eddie, 59, pictured. Eddie is to remain in the UK, steering the business here. Topland has \u163\'a31.2 billion in the bank and swung from a \u163\'a329m loss to a \u163\'a35.3m profit in the year to May 2009. The Zakays made much of their fortune in a series of deals with chains such as Marks & Spencer and Tesco.\par 2009: \u163\'a31,500m, 18=\par 22 \u163\'a31,800m \u163\'a3800m\par Sir David and Sir Frederick Barclay Property and media\par The 75-year-old twins are investing in a vineyard on the island of Sark with the hope of producing a vintage worthy of the wine list at their Ritz hotel in London. In January their Home Delivery Network bought the UK parcels division of DHL, creating a key rival to Royal Mail. The once low-key Barclays have become more prominent since their \u163\'a3665m purchase of the Telegraph Media Group in 2004. Their main operations are in media, hotels, property and retailing, and we can see assets of more than \u163\'a32 billion in their four main co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panies, led by Ellerman Investments, which had \u163\'a3728m net assets in 2008. We value the brothers at \u163\'a31,800m.\par 2009: \u163\'a31,000m, 40=\par 23 \u163\'a31,778m New entry\par Jean Claude Gandur Industry\par Gandur came into a fortune last summer when the state-owned Chinese group Sinopec bought his oil co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pany, Addax, for \u163\'a34.5 billion. His 38% stake was worth \u163\'a31.68 billion. Gandur, a Swiss citizen who spends much of his time in London, formed Addax in 1994. Last month he gave more than \u163\'a312m to expand Gen}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 va's art and history museum. Assets such as a large collection of antiquities and a stake in a gold business take the 61-year-old to \u163\'a31,778m.\par 24 \u163\'a31,670m \u163\'a3395m\par Bruno Schroder and family Finance\par The blue-chip fund management group Schroders saw quarterly profits come in 30% higher than analysts' forecasts last autumn. Schroder, 77, a non-executive director, and his relatives have a stake worth \u163\'a31,400m and made about \u163\'a3320m from the sale of the investment banking operation in 2000. Dividends, property and the 16,500-acre Islay estate in Scotland, where Schroder breeds pigs, take the family to \u163\'a31,670m after tax.\par 2009: \u163\'a31,275m, 31\par 25 \u163\'a31,640m New entry\par Edgar Bronfman and family Inheritance and music\par See profile on page 17\par 26 \u163\'a31,600m \u163\'a3100m\par Mark Pears and family Property\par Britain's new Home and Savings Bank is being backed to the tune of \u163\'a350m by brothers Mark, Trevor and David Pears, whose Hampstead-based property empire includes thousands of London homes and office blocks. Mark, 47, is managing director of the family's main company, William Pears Family Holdings, and there are at least 23 separate businesses that showed \u163\'a3835m net assets in 2008-09. Some of the wealth goes into the Pears Foundation, which supports causes such as the Duke of Edinburgh's Award and Jewish-Arab co-operation.\par 2009: \u163\'a31,500m, 18= 27=\par \u163\'a31,550m \u163\'a31.11bn\par Richard Elman and family Commodities\par See panel opposite\par 27= \u163\'a31,550m\par Roddie Fleming and family Finance\par Fleming put 700 acres of Oxfordshire farmland on the market at \u163\'a34m last year. "My banks are fully suppor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ive but it's better to have zero debt at the moment," the 56-year-old banker explained. He is a significant shareholder of Fleming Family & Partners, established in 2000 after the sale of the Robert Fleming merchant bank. The family received cash and shares worth \u163\'a31.8 billion for the bank from Chase Manhattan. In 2005 it received \u163\'a345m from Standard Chartered for a 20% stake in Fleming Family & Partners, which provides a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vice on everything from hedge funds to divorce settlements. With other assets, the family fortune totals \u163\'a31,550m.\par 2009: \u163\'a31,550m, 17\par 27= \u163\'a31,550m \u163\'a3150m\par Ian and Richard Livingstone Property\par The Livingstone brothers received \u163\'a3472m in dividends in 2007 and 2008 from their Loopsign holding comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ny. Ian, 47, and Richard, 45, formed London & Regional property group in the 1990s. They now own 60 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tels worldwide, more than half of Cape Town's V&A Waterfront shopping development and a string of health clubs. Loopsign had net assets worth \u163\'a31.37 billion in 2008. We value it at \u163\'a31.2 billion, adding \u163\'a3350m for other assets.\par 2009: \u163\'a31,400m, 25=\par 30 \u163\'a31,540m \u163\'a370m\par Sir Ken Morrison and family Supermarkets Morrison, 78, is enjoying a well-earned rest after 56 years in the supermarket business, having bowed out as chairman of the Wm Morrison group in 2008. Britain's fourth biggest supermarket chain delivered a 31% surge in profits, up to \u163\'a3858m, on sales up 6% to \u163\'a315.4 billion, in 2009-10. Bradford-based Wm Morrison is valued at more than \u163\'a37.8 billion and the Morrison family stake is worth \u163\'a31,405m, to which we add past dividends and share sales.\par 2009: \u163\'a31,610m, 16\par 31= \u163\'a31,500m\par Mahdi al-Tajir Metals, oil and water\par The bottled water supplier Highland Spring agreed the biggest deal in its 30-year history in November, bu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing the bottled water division of an Irish group for \u163\'a317.5m. Highland Spring was on course to make \u163\'a33.5m profit on \u163\'a354m sales in 2009. The Perthshire firm is owned by al-Tajir, 78, a former United Arab Emirates ambassador to the UK who heads our Scottish wealth table on page 82. He spends much of his time at his palatial London home or on his 18,000-acre Perthshire estate. His business interests include metal trading, oil and gas, and property.\par 2009: \u163\'a31,500m, 18=\par 31= \u163\'a31,500m\par Nicky Oppenheimer Diamonds and mining\par The diamond industry is suffering and no group has felt the pain more deeply than De Beers, chaired by O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 penheimer, 64. Its profits fell 99% to \u163\'a31.8m in the first half of 2009 but Anglo American, the mining giant founded in South Africa in 1917 by Oppenheimer's grandfather Ernest, is in better shape. Its shares nearly trebled in value in 2009 and the group is worth more than \u163\'a336 billion. In 2006, Oppenheimer sold a third of his family's interest in Anglo American for \u163\'a3250m and his remaining stake is worth \u163\'a3930m. He divides his time between South Africa and his estate near Maidenhead.\par 2009: \u163\'a31,500m, 18=\par 31= \u163\'a31,500m\par Poju Zabludowicz Property and hotels\par Property magnate Zabludowicz, 57, gave two donations totalling \u163\'a3100,000 to the Conservative party in July last year. He holds a Finnish passport but has lived and worked in London for most of his life. His father, Shlomo, a Holocaust survivor, built the family business around Soltam, an Israeli defence contractor that was a key supplier to the Israeli military. Most of those defence interests have now been offloaded, with the family diversifying into Las Vegas property and hotels. We keep him at last year's figure of \u163\'a31.5 billion. His Newca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tle-born wife, Anita, is a renowned contemporary art collector whose works are displayed in a London gallery.\par 2009: \u163\'a31,500m, 18=\par 34 \u163\'a31,460m New entry\par Antonio Luiz Seabra Cosmetics\par The Brazilian tycoon started the Natura cosmetics company in 1969 with a single shop in Sao Paulo. He later adopted the door-to-door sales model pioneered by Avon, and today there are more than 500,000 home sales consultants across Latin America. Seabra, the 67-year-old co-chairman, is based in London. The Forbes list of 2010 world billionaires puts his wealth at \u163\'a31,460m.\par The knack of all trades\par 27= \u163\'a31,550m \u163\'a31.11bn, 252%\par Richard Elman and family Commodities\par At any one time there are more than 100 ships plying the high seas in the name of the Noble Group, the commodities trading giant run by Elman from Hong Kong. For more than two decades Brighton-born Elman, 69, who dropped out of school at 15 to work in a scrap metal yard, has built Noble into a colossus that not only finds but produces, transports, sells and trades anything from grain to coal and iron ore, employing 11,000 people on six continents. Swiftly rising from his starter job in England, the young Elman ran a yard in San Francisco where he made contact with Japanese steelmakers, the start of a Far Eastern odyssey that took him to Tokyo and, finally, his home for the past four decades, Hong Kong. There he ran Philipp Brothers (Phibro), selling metals and grains to China as it opened up after the death of Mao Tse-tung. When the New York investment bank Salomon Brothers took over Phibro, Elman struck out on his own in 1986. Since his staff called him taipan (boss in Cantonese), Elman took his cue for naming the venture from the author James Clavell, whose novel Taipan chronicled the Noble House, a British merchant dynasty based on the Jardine family of merchant venturers. It has served him well. "Running a business is very much like running an orchestra," Elman, who is married with four children, told Forbes magazine last year. "If the strings are not in tune, then the orchestra sounds terrible." His business, quoted on the Singapore stock exchange, has been music to the ears of investors. Last year it attracted Beijing's sovereign wealth fund, the China Inves}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment Corporation, in a deal that raked in \u163\'a3285m for Elman's family trusts, part of which will fund a charitable foundation. Now executive chairman of the group, Elman relaxes at ski resorts such as St Moritz or at his "paradise" home overlooking the sea in Phuket, Thailand, complete with a "contemplation pond". We value him at \u163\'a31,550m with other assets and sale proceeds.2009: \u163\'a3440m, 120=\par 35= \u163\'a31,400m\par John Caudwell Mobile phones\par Sir Elton John (qv) will top the bill at a concert next month to celebrate the 10th anniversary of Caudwell Children, the charity founded by the mobile phone tycoon. Caudwell, 57, received about \u163\'a31.24 billion for his 88% stake when Caudwell Group was sold in 2006 and three years previously sold his Singlepoint customer billing operation to Vodafone for \u163\'a3405m. The Staffordshire entrepreneur's interests include a marine eng}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neering firm, property and leisure.\par 2009: \u163\'a31,400m, 25=\par 35= \u163\'a31,400m \u163\'a3330m\par Baroness Howard de Walden and family Property\par Welbeck Land, one of the family's companies, appointed a private bank last June to raise \u163\'a3100m to take a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vantage of the depressed property market. In 2008-09, Howard de Walden Estates, which controls 90 acres of central London, made a near-\u163\'a330m profit and its net asset figure increased to \u163\'a31.248 billion. The family - led by the 74-year-old baroness - has \u163\'a31.25 billion of business assets plus \u163\'a3150m in dividends and other property interests.\par 2009: \u163\'a31,070m, 39\par 35= \u163\'a31,400m \u163\'a3100m\par The Swire family Transport, property and trade\par The Hong Kong business empire John Swire & Sons recorded \u163\'a33.8 billion sales in 2008, with profits of \u163\'a3306m. It was run for more than 40 years by brothers Sir Adrian, 78, and Sir John Swire, 83, respectively honorary and life presidents. The group, which has its headquarters in London, owns part of the Cathay P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cific and Dragonair airlines, as well as manufacturing operations. We value the family stake at \u163\'a31,300m, ad}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing \u163\'a3100m for dividends .\par 2009: \u163\'a31,300m, 28=\par 38 \u163\'a31,375m \u163\'a391mt\par Bernie Ecclestone Motor racing\par The Formula One chief executive was interested in buying Saab early this year., but a bid did not materialise. Divorce from his wife Slavica (qv)\par last year cost Ecclestone, 79, about a third of his fortune, amassed largely from the sale of 75% of the F1 business for \u163\'a31.9 billion in 2000. Other interests include a stake in Queens Park Rangers, the Championship football club a short drive from his home in Chelsea. As F1 has been suffering financial woes, we cut Eccl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 stone this year.\par 2009: \u163\'a31,466m, 24\par 39 \u163\'a31,355m \u163\'a3485m\par Simon Keswick and family Finance\par Shares in Jardine Matheson recovered in 2009, raising the value of the Keswick family's stake to \u163\'a31.28 bi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lion. The group, based in Hong Kong, has interests from engineering to hotels and a valuable property por}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 folio. The family is led by Simon, 67.\par 2009: \u163\'a3870m, 48\par 40 \u163\'a31,320m New entry\par Yusuf Hamied Pharmaceuticals\par Affordable pharmaceuticals are big business in India, and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is one of the main manufacturers. The bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness was started by the father of Hamied, the chairman, and today claims its drugs are taken by a third of Aids patients treated in Africa. Hamied, who studied chemistry at Cambridge, opened a recreation centre there, named after him, last year. He divides his time between London and Mumbai. The 2010 Forbes list of world billionaires put his wealth at \u163\'a31,320m.\par 41= \u163\'a31,300m\par Clive Calder Music\par The world has Calder to thank for Britney Spears, who has sold more than 83m records via Zomba, the m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sic company he started after leaving his native South Africa. Calder, 63, a UK citizen based in the Cayman Islands, received \u163\'a31.2 billion when he sold Zomba to BMG in 2002. Calder supports the Elma Philanthropies charitable foundation, which promotes improved education and health for African children.\par 2009: \u163\'a31,300m, 28=\par 41= \u163\'a31,300m \u163\'a3100m\par Mikhail Gutseriyev Oil and finance\par Gutseriyev, 50, a Russian tycoon now based in London, founded BIN Bank in Moscow and then started Russneft, an oil company. In 2007, the Russian authorities issued an arrest warrant for Gutseriyev, alleging tax evasion. Under pressure, he sold his stake in Russneft to Oleg Deripaska, a Russian businessman, for about $3 billion. But he has recently regained control of the company, according to the Moscow press, and there are reports that he will return to Russia as the authorities are believed to have dropped all charges against him.\par 2009: \u163\'a31,200m, 32=\par 43= \u163\'a31,250m \u163\'a3100m\par Eddie and Malcolm Healey Property and kitchens\par Eddie Healey, 72, may be the canniest property man in Yorkshire but his brother Malcolm, 65, is the one ta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing a gamble now, returning to the kitchen trade with retailer Wren Kitchens. Eddie made his fortune from property, turning a derelict site outside Sheffield into the Meadowhall shopping centre with Paul Sykes (qv). Its sale in 1999 netted Eddie \u163\'a3420m. With other assets, he is worth \u163\'a3650m. Malcolm, who built up and sold Hygena Kitchens, is worth about \u163\'a3600m.\par 2009: \u163\'a31,350m, 27\par 45= \u163\'a31,200m\par Nadhmi Auchi Finance\par Auchi, 72, based in Surrey, is the founder and chairman of GMH Group, a Luxembourg-based conglomerate with 120 firms worldwide, from luxury hotels to telecom companies. GMH reports that its total assets are more than \u163\'a32.13 billion and we keep Auchi's valuation at last year's level.\par 2009: \u163\'a31,200m, 32=\par 45= \u163\'a31,200m \u163\'a3200m\par Alki David and the Leventis family Industry\par David, 41, is an actor and entrepreneur. His most recent film role was in The Bank Job, a gangster thriller released in 2008. He owns 80% of Filmon. com, an internet business with a market value of about \u163\'a3577m. David is a member of the Greek Leventis family, whose interests include bottling plants for Coca-Cola in 28 countries and shipping firms.\par 2009: \u163\'a31,000m, 40=\par 45= \u163\'a31,200m\par Laurence Graff Diamonds\par Armed raiders stole gems worth \u163\'a340m from Graff's New Bond Street store in London last year. Britain's bi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gest jewel heist hit Graff, 71, hard. Several people are awaiting trial. In 2008, profits at Graff Diamonds Inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 national fell from \u163\'a359m to \u163\'a353m, though sales rose sharply to a record \u163\'a3371m. But turnover last year was down 20%. Graff's clients include the Sultan of Brunei, the Beckhams (qv), Oprah Winfrey and Donald Trump. There are 35 Graff outlets worldwide. Graff owns a modern art collection valued at \u163\'a3125m.\par 2009: \u163\'a31,200m, 32=\par 45= \u163\'a31,200m\par Lord Grantchester and the Moores family Retailing and football pools\par Cheshire-based Grantchester, 59, is the grandson of Sir John Moores, founder of Littlewoods football pools. The family sold some of its department stores and its pools business in 2000; those proceeds and dividends are worth \u163\'a3445m. In 2002, the other stores and mail-order operation were sold for \u163\'a3750m. In all, the Moores are worth \u163\'a31,200m after charitable donations.\par 2009: \u163\'a31,200m, 32=\par 49 \u163\'a31,100m \u163\'a3450ms\par Louis Bacon Finance\par The 53-year-old is a hedge fund manager whose Moore Capital, based on Wall Street, has more than \u163\'a310 billion under management. Bacon, top of our hedge-fund table on page 36, is based in London but has pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erties in the United States, including a 435-acre island off New York and a 171,400-acre ranch in Colorado, which he bought for $175m in 2007. Forbes magazine estimated his wealth at \u163\'a3987m in its 2010 list but sources high in his company reckon this is well short of the mark.\par 2009: \u163\'a3650m, 63=\par 50 \u163\'a31,060m \u163\'a3240m\par John Whittaker Property\par Whittaker, 68, emerged as a shareholder last year in Forth Ports with a 3.2% stake worth \u163\'a316.2m. Earlier, he took a 5.85% stake, now worth \u163\'a3287m, in Land Securities, Britain's largest commercial property group. He also owns a \u163\'a358m slice of UK Coal, Britain's biggest mining group . His main focus, however, is the nort}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 west, where he has huge land and infrastructure holdings around the Manchester Ship Canal. He has a \u163\'a3660m share in his two main companies, Peel Holdings (TCL) and Peel Holdings (Land and Property), and other wealth.\par 2009: \u163\'a31,300m, 28=\par 52= \u163\'a31,000m \u163\'a350m\par Viscount Portman and family Property\par Portman's Burtley estate consists of 2,000 acres of farmland and woodland in Buckinghamshire, which co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 plements his 3,000-acre Herefordshire spread. His principal property holding is 110 prime London acres that 51-year-old Portman has been developing. The family's assets include 17,000 acres at Wagga Wagga in New South Wales, a share of commercial properties in New York and in Palm Beach, Florida, and a holiday home in Antigua.\par 2009: \u163\'a3950m, 44=\par 43= \u163\'a31,250m \u163\'a3150m, 14%\par Lord Ashcroft Business services\par How can you save the whales, buy Victoria Cross medals for the nation, fight crime by founding Crimesto}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pers, set up a school, pump \u163\'a310m into Anglia Ruskin University - where he has been chancellor since N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vember 2001 - yet regularly incur public wrath? Ashcroft, the Tory party supporter who became infamous for his non-dom tax status, will draw comfort from the fortune he amassed from cleaning and security. In the ea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly 1970s, he borrowed \u163\'a320,000 to buy a struggling cleaning company and then built up the ADT cleaning and security business, which was taken over in 1997 by the American Tyco group. Ashcroft took his proceeds in Tyco shares but sold his stake in stages, making about \u163\'a3500m in total. He stands to make another \u163\'a3100m from the \u163\'a31.3 billion flotation of the Priory, the exclusive drying-out clinic for the rich, famous and addicted. Ashcroft invested \u163\'a345.5m in the business in 2007, so he has more than doubled his money in less than three years. He also has interests in Belize, held by the Nasdaq-quoted BB Holdings, worth \u163\'a336m. He banked a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 other \u163\'a3132m after the sale of OneSource Services, his US cleaning and repair business, where his original investment was just \u163\'a3500,000. More typically, he makes a 30% return on his private investments. We can see more than \u163\'a370m of stakes in seven quoted companies on the London stock market, including Watford Leisure, the trading name for Watford football club, which was saved from administration this year. His sp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cial relationship with the Conservative party has a \u163\'a34m price tag hanging off it. As deputy chairman of the party, with an interest in the Tories' target seats, his confession last month that he has been a "non-dom" since becoming a Tory peer, thereby paying no tax in the UK on his overseas earnings, plunged the party into crisis. However, as someone who has pledged 80% of his fortune to charity when he dies, saying that those who can help others have a "moral duty to do so", and as a funder of campaigns against whale hun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing, Ashcroft, 64, must be wondering what it takes for him to be considered one of the nice guys.\par 2009: \u163\'a31,100m, 37=\par Matalan man is back in fashion\par 51 \u163\'a31,020m \u163\'a3690m, 209%\par John Hargreaves and family Discount fashion\par The man who took discount clothing from the market stall to the shopping mall - helping to make shell suits a must-have fashion item along the way - is still enjoying the fruits of his style success .\par Hargreaves, 66, has billionaire status again for the first time in eight years, after the refinancing of Matalan, his "pile it high, sell it cheap" retail chain. Shoppers hunting bargains over Christmas 2009 helped to push up sales by 13.7%. This was good news for Hargreaves, who had been conducting an auction of the business among private equity players with a \u163\'a31.5 billion asking price. However, when the price appeared to be too high, he took the Skelmersdale-based business off the market and earlier this month refinanced the comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ny in a \u163\'a3525m deal that saw him take a \u163\'a3250m dividend. Hargreaves was born less than half a mile from the Liverpool docks, where his father worked as a labourer. He left school at 14, getting a job on a market stall selling seconds from Marks & Spencer. Within five years, he had started his own business, which grew into a chain of fashion shops called Jaymax. An astute retailer, he went on to found Matalan in 1985, modelled on US-style warehouse stores with low prices.\par Matalan proved to be the retailing success story of the late 1990s. Now living in Monaco, Hargreaves has not forgotten his roots. He is a generous benefactor in the northwest, particularly to children's charities. He has given more than \u163\'a37m to the NSPCC, \u163\'a36m of it for its Safe Place appeal. The money was used to establish the Hargreaves Centre in Liverpool. He cut the turf on the site, right, and is pictured with his daughter Maxine and granddaughter April at its opening, above. In the light of Matalan's aborted auction, we value the firm at \u163\'a31.25 billion and Hargreaves's stake at \u163\'a3840m after borrowings. His dividend and share sales take him and his family to \u163\'a31,020m after tax.\par 2009: \u163\'a3330m, 156=\par Canny trader hedges his bets\par 66= \u163\'a3875m \u163\'a3500m, 133%\par Alan Howard Finance\par His desk is no different from any other in the trading room of Brevan Howard, Europe's biggest hedge fund, in Marylebone, central London. But Howard, 46, is the star of the company he co-founded in 2002. He stu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ied chemical engineering before joining Salomon Brothers investment bank in the City. He was hired in 1997 by Credit Suisse's investment bank, where he shone, and five years later he and four colleagues raised $870m and set up Brevan Howard, where traders wager billions on the direction of interest rates, currencies and commodities. Howard, second in our hedge fund table on page 36, is allergic to publicity. "We prefer to have a low profile," he told Bloomberg News last year in the only on-the-record interview he has granted. He also has an aversion to risk, whether it be in the markets or from London's traffic. "I see these nutty drivers. I have no interest in getting excited or upset," he said of his preference to be chauffeured. Brevan Howard outshines its rivals thanks to Howard's caution and a low threshold for underperforming traders. "When you hire people, you need to give them time to see how well they work out," he told Bloomberg. "Sometimes we have to make changes." The company holds assets under management of \u163\'a320 billion. Howard's lawyer ru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bishes an American survey of hedge fund salaries that put his client's salary at more than \u163\'a3400m. We value Brevan Howard at \u163\'a32 billion, with Howard's stake at about \u163\'a3700m. Last year, he gave more than \u163\'a36.7m to his charitable foundation in support of Jewish and educational causes.\par 2009: \u163\'a3375m, 139=\par 52= \u163\'a31,000m\par Wafic Said Finance\par Syrian-born Said, 70, headed a consortium that bought an office block at London's Canary Wharf for \u163\'a3208m five months ago. Said has an English wife and a \u163\'a330m Oxfordshire mansion. In 1998, he gave \u163\'a320m towards the Said Business School at Oxford University, and has pledged \u163\'a315m towards an extension. His wife Rosemary has donated \u163\'a3250,000 to the Tories and allied causes. With investments worldwide, plus homes in Mayfair, Paris, Marbella and Monaco, Said is worth \u163\'a31 billion .\par 2009: \u163\'a31,000m, 40=\par 54 \u163\'a3977m \u163\'a3507m\par Michael Moritz Internet\par Sequoia Capital, Moritz's firm in California, made $1.35 billion from the sale of two businesses last year. The venture capitalist, raised in Cardiff and top of our Welsh list on page 83, was one of Google's early backers, putting up \u163\'a38m of Sequoia's money in 1999. The stake rose in value to \u163\'a36.3 billion at its peak, and we a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sume he has a significant element of that plus a portion of the 2009 sales. Forbes put Moritz, 56, at \u163\'a31,002m in its 2010 list of the richest Americans. We knock off \u163\'a325m for his support of his Oxford alma mater, Christ Church.\par 2009: \u163\'a3470m, 12=\par 55 \u163\'a3975m \u163\'a3375m\par Sir Terry Matthews Computers\par See panel opposite\par 56 \u163\'a3962m \u163\'a3215m\par Sir Ian Wood and family Oil services and fishing\par The Aberdeen-based Wood Group had a good 2009, with its shares rising steadily. Wood, 67, is its chairman and widely seen as the architect of the boom in the Granite City. The company floated in 2002 with a \u163\'a31 bi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lion valuation. The family has a stake worth \u163\'a3568m and other assets. Since the Wood Family Trust was e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tablished in 2007, it has been endowed with \u163\'a330m and helps young people in Scotland and the Third World.\par 2009: \u163\'a3747m, 57\par 57= \u163\'a3950m\par Sir Anthony Bamford and family Construction equipment\par Job shedding continues at JCB, the construction equipment company based in Staffordshire that is chaired by Bamford, 64. In January, plans to axe 75 office jobs were announced, following hundreds of shop-floor losses in 2008 and 2009. JCB's profits in 2008 fell by nearly 80% to \u163\'a339m on sales down \u163\'a3500m at \u163\'a32 billion. We value the business, founded by Bamford's late father, at about \u163\'a3800m. The family's assets include a Staffordshire estate and homes in Barbados and France.\par 2009: \u163\'a3950m, 4=\par 57= \u163\'a3950m \u163\'a3424m\par Mark Coombs Finance\par Ashmore, the City investment group, is doing what 50-year-old Coombs, the chief executive, predicted during the stock market turmoil - taking advantage of "opportunities to buy assets from distressed sellers". This helped take Ashmore's value above \u163\'a32 billion late last year, though it has fallen back to about \u163\'a31.6 billion. Coombs has a stake worth \u163\'a3802m. He sold \u163\'a3192m of shares at the float in 2006 and has other assets.\par 2009: \u163\'a3526m, 84\par 57= \u163\'a3950m\par Richard Desmond Media and property\par Desmond, a former advertising salesman, bought the Express newspaper titles in 2000 for \u163\'a3125m. The daily and Sunday papers are worth a combined \u163\'a3400m today. Desmond, 58, also owns OK! celebrity magazine, the Express building in London, worth \u163\'a3100m, and a substantial private property portfolio. Figures for his main company, RCD1, show profits falling in 2008 from \u163\'a355.4m to \u163\'a341.6m, on sales down slightly at \u163\'a3483.9m. We keep him at \u163\'a3950m .\par 2009: \u163\'a3950m, 44=\par 57= \u163\'a3950m \u163\'a3200m\par Robert Miller Duty-free shopping and finance\par Hong Kong-based hedge fund Sail Advisors, founded by Miller, 76, has $2.3 billion of funds under manag}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment. Miller was born and educated in America but is a British citizen, with a home in London and a Yor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 shire shooting estate. He made a fortune from co-founding the Duty Free Shoppers chain but much of his wealth is tied up in the Search Investment Group, which runs Sail.\par 2009: \u163\'a3750m, 52=\par 61= \u163\'a3920m \u163\'a3360m\par Sir James Dyson and family Household appliances\par Inventor Dyson, 62, is churning out new products, including a desk fan without blades and a vacuum cleaner small enough to sit on a sheet of A4 paper. Wiltshire-based Dyson commands a 46% share of British vac}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 um cleaner sales and 32% of the American market. In 2008, profits at the Dyson operation came in at \u163\'a385.3m on \u163\'a3628.3m sales and we value the business at \u163\'a3700m. Since 1999, Dyson and his family have ta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 en more than \u163\'a3278m in salaries and dividends. His charitable foundation gave away at least \u163\'a36m last year, including \u163\'a35m to the Royal College of Art.\par 2009: \u163\'a3560m, 76\par 61= \u163\'a3920m \u163\'a3150m\par Bernard Lewis and family Fashion and property\par Record \u163\'a3161m profits for River Island, the high-street fashion chain, helped to ease the impact of falls els}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 where at the Lewis Trust Group in 2008. The retail to property and hotels group, led by Lewis, 84, the chai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 man, saw profits fall from \u163\'a3150m to \u163\'a3108m though sales rose from \u163\'a3888m to \u163\'a3966m. The Lewis family and trusts own all the London-based business, which showed nearly \u163\'a3908m net assets in 2008. We value it at \u163\'a3800m and add \u163\'a3120m for dividends and property assets.\par 2009: \u163\'a3770m, 51\par 63= \u163\'a3900m \u163\'a3300m\par The Grant and Gordon family Spirits\par Profits at William Grant & Sons, the distiller with brands such as Glenfiddich whisky and Hendrick's Gin, rose 55% in 2008 to \u163\'a3129.2m on sales also up at \u163\'a3598.3m. The firm, founded by William Grant in Banffshire in 1886, is controlled by the fifth generation of his family. It also owns 30% of Highland Distillers. Dividends and other assets add \u163\'a3100m to the \u163\'a3800m value of the business .\par 2009: \u163\'a3600m, 70=\par 63= \u163\'a3900m \u163\'a3200m\par Lord Sainsbury and family Supermarkets\par The J Sainsbury supermarket chain enjoyed a good Christmas last year, with sales up 4.2% on 2008. Profits at the group were better than expected in the first half of 2009-10, rising 19% to \u163\'a3307m. It is valued at more than \u163\'a36 billion. Sainsbury, 69, and his family own about 14% of the London operation. The Sainsburys can justifiably lay claim to being the country's most philanthropic family, with \u163\'a3275m spent or generated for char}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty in the past year. They have given huge sums to support education, the arts and medical research.\par 2009: \u163\'a31,100m, 37=\par 65 \u163\'a3890m \u163\'a3190m\par Mike Ashley Sports goods\par See panel on page 24\par 66= \u163\'a3875m \u163\'a3500m\par Alan Howard\par Finance See panel opposite\par 66= \u163\'a3875m New entry\par Helene and Marianne Odfjell and family Shipping\par Sisters Helene, 44, and Marianne, 39, run their Norwegian business interests from London. They are daug}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ters of shipping tycoon Abraham Odfjell and their family fortune comes from a Bergenbased shipping and drilling empire that dates back to 1915. See panel on page 79.\par 68 \u163\'a3850m \u163\'a3350m\par Viscount Cowdray and the Pearson family Media\par The John Cowdray arboretum was opened last November by Cowdray, 65, in memory of his father. It is on the 16,500-acre Cowdray Park estate in West Sussex, bought 100 years previously to the day by the 4th vi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 count's great-grandfather for \u163\'a3340,000. Cowdray also heads the Pearson family, which has a near 10% stake in Pearson, the media group, worth \u163\'a3725m. We add \u163\'a3125m for other property, estates and dividends .\par 2009: \u163\'a3500m, 88=\par 69 \u163\'a3832m \u163\'a3132m\par Russell De Leon and Ruth Parasol Internet gambling\par Party Gaming, the online poker group, is in merger talks with Bwin Interactive Entertainment, an Austrian rival, in a deal that could create a \u163\'a32 billion internet gambling giant. The move comes after a $105m non-prosecution settlement with the justice department in the United States, where Party Gaming's operations were banned in 2006. Founders De Leon, 44, a Berkeley graduate and lawyer, and his British wife Parasol, 43, also a lawyer, own 28.66% of the Gibraltar operation, worth \u163\'a3331m. We add \u163\'a3501m for the proceeds of share sales and additional assets.\par 2009: \u163\'a3700m, 60=\par 70 \u163\'a3826m \u163\'a3476m\par Ayman Asfari and family Oil services\par Asfari runs Petrofac, the oil services group he transformed into an international business managing North Sea rigs and designing drilling and refinery equipment. Syrian-born Asfari, 51, a British citizen, led the \u163\'a3742m flotation of Petrofac in 2005. Its shares have soared and the London-based company is worth \u163\'a34.3 billion today. Earlier this month, Petrofac spun off its North Sea assets into a separate business called EnQuest, which had a strong debut on the stock market. After share sales and deductions for charity giving, we put the family at \u163\'a3826m.\par 2009: \u163\'a3350m, 146=\par 71= \u163\'a3820m \u163\'a3276m\par Sir Stelios Haji-Ioannou and family Airline\par Haji-Ioannou, 43, sold his easyCruise operation to Hellenic Seaways for a reported \u163\'a36.5m last summer. L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton-based easyJet, which launched his budget empire in 1995, reported revenues up 10.5% to \u163\'a3607.5m in the first quarter of 2009-10 and passenger numbers up 9.1%. Haji-Ioannou and his family have a stake in the airline worth \u163\'a3734m. They netted about \u163\'a394m from the sale of the shipping company Stelmar. The Stelios Philanthropic Foundation supports educational, entrepreneurial and environmental causes.\par 2009: \u163\'a3544m, 81=\par 71= \u163\'a3820m \u163\'a370m\par The Earl of Iveagh and the Guinness family Brewing and property\par The \u163\'a3145m Iveagh Wealth Fund, which manages some of the finances of the Guinnesses and other rich families, was launched by the Iveagh private investment house at a difficult time in late 2008. By November last year, however, it had returned 2.5% to its investors, while the FTSE All-Share index had fallen 4.6%. Iveagh, 40, head of the Guinness family and a direct descendant of brewer Arthur Guinness, inventor of the classic black stout in 1759, inherited the title and a tranche of Guinness shares in 1992, when his father died. The family also has a \u163\'a3260m stake in Diageo, the drinks giant that now owns Guinness and \u163\'a331m net assets in two East Anglian companies, Elveden Farms and Burhill Estates Company. Share sales over the past decade and prime property interests in Canada worth \u163\'a3400m take the family to \u163\'a3820m. See panel on page 89.\par 2009: \u163\'a3750m, 52=\par 73= \u163\'a3810m \u163\'a3190m\par Peter Cruddas and family Finance\par Cruddas is considering moving parts of CMC Markets, his London-based financial trading empire, offshore because of burgeoning taxes. CMC had a difficult time in 2008-09, going from a profit to a \u163\'a350.4m loss on \u163\'a390.6m turnover. We value the 88% stake held by 56-year-old Cruddas, the son of a Smithfield meat market porter, and his family at \u163\'a3660m, adding \u163\'a3150m for past salaries, dividends and property .\par 2009: \u163\'a31,000m, 40=\par 55 \u163\'a3975m \u163\'a3375m, 63%\par Sir Terry Matthews Computers\par Matthews will cross his fingers and pray for fine, dry weather as a billion TV viewers tune in to watch golf's Ryder Cup in October. Celtic Manor, Matthews's hotel resort in Newport, South Wales, will be the setting as Colin Montgomerie's European team tries to regain the trophy. Bringing golf's biggest team event to Wales is a personal triumph for Matthews but technology, rather than golf, has been the moneyspinner for the 66-year-old, who founded the Mitel and Newbridge Networks telecom firms after leaving Wales in 1969 for Ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ada. Last December, he announced plans to float Mitel. Celtic House International, his venture capital group, has more than \u163\'a3500m under management. The portfolio of Wesley Clover, his investment vehicle, includes the Brookstreet golf resort in Ottawa. The Canadian Business rich list valued Matthews at \u163\'a3975m in Nove}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ber 2009. We agree.\par 2009: \u163\'a3600m, 70=\par 73= \u163\'a3810m \u163\'a3310m\par Douglas and Dame Mary Perkins Opticians\par Specsavers reported a turnover of \u163\'a31.1 billion in the year to February 2009 and is confident of hitting \u163\'a31.4 billion in 2009-10. The business, based in Guernsey, is the UK's largest optical retailer. Husband-and-wife team Douglas, 67, and Dame Mary, 66, met while studying to be opticians at the University of Wales. They built one chain and sold up in 1980 for \u163\'a32m, before launching Specsavers in 1984. We value the firm at \u163\'a3800m, adding \u163\'a310m for other assets.\par 2009: \u163\'a3500m, 88=\par 75 \u163\'a3802m New entry\par Eugene Shvidler Oil, gas and investments\par Shvidler, 46, co-founded the oil trader Runicom in the 1990s with fellow Russian Roman Abramovich (qv), and the two remain friends and business associates. Their controlling stake in Sibneft, another oil firm, was sold for \u163\'a36.6 billion in 2005. Shvidler advised Abramovich on the purchase of Chelsea FC and taking a 41% stake in Evraz, the Russian steelmaker, and has shares in these investments. Other Shvidler interests i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 clude property in Moscow and a \u163\'a322m London home. He is reckoned to be worth \u163\'a3802m by Forbes.\par 76= \u163\'a3800m \u163\'a340m\par Roger and Peter De Haan Leisure\par A second Folkestone Triennial will be held in 2011. The first, in 2008, was a success, with public artworks by Tracey Emin and Mark Wallinger installed in the town. It was an initiative by Roger De Haan, 61, above, whose Creative Foundation aims to renovate buildings and let them to artists at lower-than-commercial rates. De Haan sold the Saga holiday business, founded by his late father, in 2004 for \u163\'a31.35 billion. We allow at least \u163\'a3400m for tax on the sale proceeds. De Haan's brother, Peter, 58, runs a wine business .\par 2009: \u163\'a3840m, 49\par 76= \u163\'a3800m\par Gerald Hines Property\par The 84-year-old American developer has not escaped the downturn. Last summer, his Hines group had to hand back to the lenders properties it had built in joint ventures in California. Work continues in Britain, where Hines has been based for the past 10 years. Backed by Russian property billionaires Kirill Pisarev and Yuri Zhukov, he is building a \u163\'a3410m office complex over London's Cannon Street station. Hines grew up in Indiana during the Depression and sold vacuum cleaners door-to-door. In 1952, he moved into property and construction. Forbes magazine reckons Hines has put up more steel and concrete than any other American developer.\par 2009: \u163\'a3800m, 50\par 78 \u163\'a3780m New entry\par Eduard Shifrin Industry\par The 49-year-old Ukrainian, co-founder of Midland Group, ran a steel mill after gaining a doctorate in meta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lurgy. He formed Midland with Alex Shnaider, a fellow steel trader, and took control of Ukraine's fourth-largest steel mill. The business has grown into an international private -equity firm, with assets including c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sinos and Trump Tower in Toronto. Forbes magazine put London-based Shifrin's wealth at $1.3 billion in its 2010 list of world billionaires.\par 79 \u163\'a3764m \u163\'a3260m\par Lily Safra Inheritance\par Safra won a court battle in March with a Russian tycoon who was seeking to buy her French estate for \u163\'a3392m. His lawyer did not show up to close the deal and the Russian lost his \u163\'a334m deposit. Safra said she was planning to donate the down payment to 10 charities, including King's College London. Safra, 72, gives heavily through the Edmond J Safra Foundation and supports the Prince's Trust. Banker Edmond Safra, her fourth husband, was killed in an arson attack at their Monaco apartment in 1999. Safra divides her time b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tween Eaton Square in London, New York, Geneva and Monaco. She was reported to have been the buyer of Alberto Giacometti's sculpture, Walking Man I, sold for \u163\'a365m in February. Her wealth is put at \u163\'a3764m by Forbes in its 2010 list of billionaires.\par 2009: \u163\'a3504m, 87\par 80= \u163\'a3750m New entry\par Sergei Pugachev Finance\par See panel opposite\par 80= \u163\'a3750m\par Lord Vestey and family Meat\par Establishment restaurant Green's has opened a new City branch to complement the original one in St James's. Vestey, 69, is a backer. The Gloucestershire-based family's fortune derives from the 19th-century meat trade. In the 1980s the Vesteys moved into property, but suffered heavy losses. The main family oper}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion is Western United Investment Company. Its profits fell from \u163\'a317.7m to \u163\'a38.5m on sales up \u163\'a331m at \u163\'a3491.2m in 2008 .\par 2009: \u163\'a3750m, 52=\par 82 \u163\'a3744m \u163\'a3271m\par Benzion Freshwater and family Property\par Freshwater, 62, has at least 292 directorships. Daejan, the London property group he heads, has seen its share price recover in 2009-10, lifting the family's 79% stake to \u163\'a3309m. Freshwater's three other main co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panies had \u163\'a3720m net assets in 2008-09, with about \u163\'a3400m attributable to the family. Dividends over the years add \u163\'a335m.\par 2009: \u163\'a3473m, 110=\par 83 \u163\'a3740m \u163\'a3135m\par Urs Schwarzenbach Finance\par Schwarzenbach, 61, made his fortune from Interexchange, Switzerland's largest foreign exchange deale}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ship, with clients such as the Sultan of Brunei. He moved to Britain in the 1980s, becoming a renowned polo player and friend of the royal family. His property interests include a Scottish estate, an Australian ranch and the English village of Hambleden, bought for \u163\'a339m in 2007. Bilan, the Swiss business magazine, values him at \u163\'a3740m.\par 2009: \u163\'a3605m, 69\par 84 \u163\'a3734m\par Slavica Ecclestone Divorce\par Ecclestone, 51, became one of the richest women in Britain after her divorce last year. The former model, born in what is now Croatia, ended her 24-year marriage to Bernie Ecclestone (qv), the Formula One tycoon, on the grounds of his "unreasonable behaviour". Much of the family's \u163\'a32.2 billion fortune was held in her name in offshore trusts in Jersey. It is thought he retained about two-thirds of his F1 fortune, leaving her with \u163\'a3734m. She told a gossip columnist recently: "I'm enjoying the freedom of being a woman in my fifties. My life is beautiful."\par 2009: \u163\'a3734m, 58\par 85= \u163\'a3730m \u163\'a3100m\par Lord Laidlaw Conferences\par The Scottish peer escaped with bruises when the helicopter he was piloting ditched off the US coast last summer. Laidlaw, 67, who admitted to "sex addiction" in 2008, moved to America in the 1960s and has homes in Monaco and Britain. He sold the Institute for International Research, which organises conferences, for \u163\'a3768m in 2005. It has funded yachts and an art collection, plus donations to the Conservative party and causes such as the Excelsior academy school in Newcastle.\par 2009: \u163\'a3630m, 66=\par 85= \u163\'a3730m \u163\'a3100m\par Jonathan and David Rowland Finance\par Banque Havilland is the Rowland family's new private banking and wealth management operation. About \u163\'a3173m is being invested in the bank, which Jonathan, 34, said was "one of the best transactions we've done''. He and his father David, 64, sold assets at the top of the market and are looking for bargains through Rowland Capital in London. Jonathan netted \u163\'a344m of shares in Shore Group when it bought his Jellyworks internet business in 2000. His father lives in Guernsey and is a leading investor. The Rowlands were the bi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gest political donors in the UK last year, giving \u163\'a32m to the Tories (see page 28).\par 2009: \u163\'a3630m, 66= 85= \u163\'a3730m\par Lord Sugar Consumer electronics\par Sugar, 63, star of the BBC series The Apprentice, saw profits at his Essex-based Amshold Group fall in 2008-09 from \u163\'a371.1m to \u163\'a34.3m. Net assets also dropped, from \u163\'a3272m to \u163\'a3203m. Its interests include prope}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty trading, aircraft chartering and management services. Sugar has a stake in the Viglen computer firm and at least \u163\'a3400m of property, held via Amshold or overseas. He also has \u163\'a3150m cash and assets including property in London, Florida and Spain. Sugar donated \u163\'a3400,000 to the Labour party this month.\par 2009: \u163\'a3730m, 59\par 88 \u163\'a3719m \u163\'a3219m\par Alexander Knaster Finance\par In 2005, Knaster, 51, set up Pamplona Capital Management in London with funds of $3 billion invested in private equity and hedge funds. Pamplona Capital Advisers, where he is a director, made \u163\'a311.6m profit on \u163\'a324.9m sales in 2008. Forbes values him at \u163\'a3719m.\par 2009: \u163\'a3500m, 88=\par 89 \u163\'a3700m \u163\'a350m\par Lord Lloyd-Webber Entertainment\par Love Never Dies, Lloyd-Webber's sequel to The Phantom of the Opera, opened in London last month and is due to move to Broadway before the end of the year. The original musical has been seen by more than 80m theatregoers. In 2008-09, profits at the 62-year-old composer's Really Useful theatre group fell from \u163\'a373.1m to \u163\'a39m. The previous year's figures had been flattered by a one-off \u163\'a363.5m gain from the sale of a ticketing business. Audiences are holding up well and the business is worth a comfortable \u163\'a3550m. We add \u163\'a3150m for Lloyd-Webber's art collection, his homes in Britain and abroad, and past dividends .\par 2009: \u163\'a3750m, 52=\par 90 \u163\'a3673m \u163\'a3117m\par Peter Jones and family Property\par Jones, 75, believes that the diversity of Emerson Group's portfolio and its strong rental income have helped to lessen the impact of the property downturn. The former joiner moved into housebuilding in 1959 and was one of the first to spot the development potential of south Manchester, buying tracts of land cheaply. His a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tivities have since spread across the country and overseas to Portugal and Florida. Emerson has not been immune to the recession, however, and went from a \u163\'a334.7m profit to a \u163\'a36.1m loss in 2008-09, mainly b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause of exceptional losses on foreignexchange borrowings of more than \u163\'a324m. Net assets dropped from \u163\'a3694m to \u163\'a3607m. Jones has another company, PE Jones (Properties), with about \u163\'a350m net assets. He and family trusts own all of the shares in both businesses, which are based in Alderley Edge.\par 2009: \u163\'a3556m, 78 65\par \u163\'a3890m \u163\'a3190m, 27%\par Mike Ashley Sports goods\par Ashley may be the least popular man on Tyneside, so much so that he stopped sitting with Newcastle United fans while wearing his replica kit and decided it was not a good idea to go out on the toon after matches. Newcastle loves a footballing hero - Bobby Robson, Kevin Keegan, Alan Shearer et al - but Ashley is proof in black and white that \u163\'a3134m can buy you a football club but it can't buy you love from the terraces. If the Toon Army were armed, Ashley would be the first against the wall. He has lessons to learn about how not to run a football club. Lesson one: Don't try to sell it. Lesson two: Don't try to sell it again. Lesson three: Don't keep losing managers. Lesson four: Especially not Wor Kevin. Lesson five: Or Wor Alan. Lesson six: Don't let the club drop out of the Premier League and expect fans to sing, "There's only one Mike Ashley". Lesson seven: Don't rename the stadium sportsdirect.com@StJames' Park. Lesson eight: Ever. This season, manager Chris Hughton turned around the club's fortunes and Newcastle won promotion to the Premier League as champions - that doesn't mean the fans like Ashley any better, despite his pledge to make at least \u163\'a325m available this summer to buy players. Ashley became involved in sportswear after leaving school at 16. Two years later, he opened his first sport and ski shop in Maidenhead. In 2007, he pocketed \u163\'a3929m when he floated Sports Direct, while retaining control. The listing valued it at \u163\'a32.2 billion. Since then it has been a rough ride for investors and the company, which includes Lillywhites, is worth \u163\'a3617m, with Ashley, 45, having a \u163\'a3451m stake. Sports Direct owns more than 360 outlets as well as Slazenger and Dunlop, and has a stake in the outdoor clothing firm Blacks. With his Newcastle holding, property, dividends and salaries, Ashley, who reportedly paid out \u163\'a350m for his divorce in 2003, could be worth \u163\'a31,090m after tax. We reduce that by the \u163\'a3200m he is reckoned to have lost betting on the share price of HBOS two years ago.\par 2009: \u163\'a3700m, 60=\par From the Kremlin with love\par 80= \u163\'a3750m New entry\par Sergei Pugachev Finance\par Pugachev met his girlfriend Alexandra Tolstoy in 2006 in Moscow when they were married to other people. The Russian financier, known as the "Kremlin's banker" for his ties with Vladimir Putin, employed Tolstoy, the daughter of Oxfordshire-based historian Count Nikolai, to teach him English. He says he fell for her the m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nute she walked into the room, but knowing it was unreciprocated he dispensed with her services after three lessons. They met again two years later, and this time love bloomed. Last year, pregnant with Pugachev's child, Tolstoy, above, ditched her husband Shamil Galimzyanov, a former showjumper from peasant stock she had met when he was her guide on a horse trek along the silk route to China. She moved back to Lo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 don to enjoy a life of luxury with her new love and new baby. "Money," Tolstoy, 36, has said, "is a problem that's gone." They are looking for a country pile where Pugachev, inset, can indulge his hobby of bream fis}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing, not a popular sport in Monaco or just outside Moscow, where they also have homes. Tolstoy is expecting their second child and the couple plan to marry when their divorces are finalised. Pugachev, 47, is a friend of Viscount Linley, having taken him bear hunting in Siberia and been treated to a pheasant shoot in Windsor Great Park in return. He became a shareholder in the Linley furniture business in 2008. Pugachev made his fortune through shipyards and property deals. Two years ago he was listed by Russian Forbes with a $2 bi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lion fortune, but that has fallen to \u163\'a3750m today.\par 92= \u163\'a3660m \u163\'a3150m\par Fred and Peter Done Bookmaking\par Brothers Fred, 67, above, and Peter, 63, grew up in Salford, where they started as bookie's runners for their father. Their betting chain, Betfred, has about 800 outlets and is valued at \u163\'a3500m. Peninsula Business Se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vices, the legal advice group that was Peter's brainchild, is worth \u163\'a3120m. The brothers, still based in the northwest, have collected \u163\'a375m in salaries and dividends before tax over the past decade.\par 2009: \u163\'a3510m, 86\par 92= \u163\'a3660m\par Jon Hunt Estate agency and property\par Hunt sold the London estate agency Foxtons in 2007 for \u163\'a3375m. The 56-year-old is starting to dip his toe into the market again: Ocubis, his luxury serviced office business, spent \u163\'a316m last May on a building in London's Kensington and \u163\'a320m on another in Victoria two months later. Hunt, whose CV includes the army and car washing, has a significant residential and commercial portfolio of his own, including a Kensington town house and a Suffolk estate.\par 2009: \u163\'a3660m, 62\par 94= \u163\'a3650m\par Mohamed al-Fayed and family Retailing\par The Harrods clientele of wealthy Londoners and free-spending tourists has been less affected by the dow}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 turn than many - the Knightsbridge store reported record sales of \u163\'a3752m for 2008-09. The boss did not take his annual dividend but should not have felt the loss too keenly, as he and the family have collected \u163\'a3368m in dividends since 1999. This has enabled Fayed to bankroll Fulham FC, who rewarded him with a long run in Europe this season. Harrods, with \u163\'a3414m net assets, is worth \u163\'a3500m and there is other wealth, including a Scottish estate.\par 2009: \u163\'a3650m, 63=\par 94= \u163\'a3650m New entry\par David Bromilow Media and sporting goods Bromilow, 67, may have only one British directorship - Donnin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton Castle Conferences, which has less than \u163\'a31m net assets - but he has proved himself an astute entrepr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neur. In 2003 he teamed up with venture capitalists to take over Survey Sampling, a US information group. That \u163\'a351m deal would have been small change for Bromilow, who made about \u163\'a3600m from his stake in the Adidas sports company during the 1990s. Later he made \u163\'a3150m from the sale of his Medimedia publishing business. Bromilow, who lives in Thailand, is worth \u163\'a3650m.\par 94= \u163\'a3650m \u163\'a3150m\par Peter Green and family Mining and inheritance\par Having made serious money from his investment in the Savoy Hotel Group, Green, 74, joined the same co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sortium to bid \u163\'a3530m for prime property in Knightsbridge, central London. After being widowed, he ran the Canadian mining interests that had been inherited by his wife, Mary-Jean, daughter of the industrialist Sir Harold Mitchell. A substantial part of this was sold for \u163\'a3300m in the 1990s. Green's substantial business a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fairs, including the investment vehicle Greenaap, are run from Dublin. The family still has assets in Canada and homes in London and Bermuda.\par 2009: \u163\'a3500m, 88= 94= \u163\'a3650m \u163\'a3100m\par Paul Sykes Property and forestry\par The Yorkshire entrepreneur has left property development behind and is investing in forestry. Sykes, who left school at 15, built his fortune by breaking up old buses and selling parts to the Far East. He moved into property and, with Eddie Healey (qv), turned 1,500 derelict acres beside the M1 near Sheffield into the Meadowhall Centre. The giant shopping complex was sold in 1999 for \u163\'a31.2 billion. We can see more than \u163\'a3260m net assets in Sykes's Highstone Group and the 66-year-old is worth \u163\'a3650m. He spent \u163\'a36m on a ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 paign to preserve the pound and fight against loss of sovereignty to Europe. So disillusioned is Sykes with Britain that he may follow his forestry investments to live in New Zealand.\par 2009: \u163\'a3550m, 79=\par 98 \u163\'a3635m \u163\'a3285m\par Sir Cameron Mackintosh Entertainment\par Mackintosh, 63, who owns seven London theatres, plans to endow them with enough money to keep them running after his death. His stake in the American licensing business MTI is worth \u163\'a3100m and the rights to shows worldwide - including Les Mis\u200\'e9rables and Miss Saigon - amount to \u163\'a3225m. The London theatres are valued at \u163\'a3125m, while there is \u163\'a385m in the bank. That puts the value of his business assets at \u163\'a3535m. Pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vate wealth, including Mackintosh's property, takes the impresario to \u163\'a3635m.\par 2009: \u163\'a3350m, 146=\par 99 \u163\'a3610m \u163\'a3137m\par Brian Souter and Ann Gloag Transport\par The Stagecoach bus and train operation saw a fall in profits for the first half of 2009-10, although turnover at the Perth business rose 3.5% to \u163\'a31.08 billion. Chief executive Souter, 55, and his sister Gloag, 67, co-founded the company in 1980. Gloag spends much of her time on charity work in the Third World and the pair gave away about \u163\'a320m of their net wealth last year. Their stake in Stagecoach is worth \u163\'a3340m, but other assets and at least \u163\'a3240m in dividends take them to \u163\'a3610m.\par 2009: \u163\'a3473m, 110= 100 \u163\'a3608m \u163\'a3228m\par Viscount Rothermere and family Media\par Rothermere, 42, will be delighted that the Daily Mail and General Trust's share price has recovered from the lows of last year. In the year to September 2009, huge write-offs resulted in an exceptional \u163\'a3394.6m loss on \u163\'a32.08 billion sales but the City scents recovery. The family stake is worth \u163\'a3428m. We add share sales (\u163\'a370.7m in 1999-2000), hefty dividends and properties in London and the southwest.\par 2009: \u163\'a3380m, 138\par Homing in on a fortune\par 91 \u163\'a3670m \u163\'a3350m, 109%\par Will Adderley and family Home furnishing\par Shares in the curtains-tocushions retailer that has opened more than 100 Dunelm Mill stores soared on the back of a 69% rise in pre-tax profits to \u163\'a346.2m for the first half of 2009-10. As a result, Dunelm, the listed company that began as a Leicester market stall in 1979 offering ready-made budget curtains, is worth about \u163\'a3800m. Set up by Bill and Jean Adderley, their son, Will, 38, has been chief executive since 1996 and has his sights set on 150 stores. Dunelm will also invest in new headquarters. Recessionhit customers have no doubt been enticed by Dunelm's Simply Value for Money slogan. Surging profits allowed Dunelm to return a special dividend of \u163\'a343m to shareholders, \u163\'a328m of which went to the Adderleys. The family stake is worth nearly \u163\'a3531m, to which dividends and hefty share sales have been added.\par 2009: \u163\'a3320m, 167=\par 101 \u163\'a3605m \u163\'a355m\par Michael Lemos Inheritance\par A New York apartment owned by Lemos, 54, went on the market in May 2008 with a $33.9m price tag. He raised it to $39.5m and last September the price went up to $45m in what The New York Times called a "game of one-upmanship". Lemos can afford to wait. He is the son of Constantinos Lemos, a Greek tycoon who moved out of shipping during the 1980s, investing in property, insurance and tourism. After his death in 1995, his fortune passed to his son and two daughters. Lemos lives in London .\par 2009: \u163\'a3550m, 79=\par 102 \u163\'a3604m \u163\'a3304m\par Charles Dunstone Mobile phones\par See panel opposite\par 103= \u163\'a3600m \u163\'a3250m\par Richard Caring Fashion and restaurants\par Caring's empire embraces fashion, property, clubs and restaurants. The 61-year-old's Caprice Holdings runs celebrity eateries in the capital such as The Ivy, Le Caprice and Cecconi's, while he owns International Clot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing Designs, a supplier of garments to Next, Bhs and Marks & Spencer. London-based Caring made a fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tune from property deals in Hong Kong, and in 2007 led a consortium that bought the former US navy offices on London's Grosvenor Square for \u163\'a3250m. He plans to turn them into luxury flats.\par 2009: \u163\'a3350m, 146=\par 103= \u163\'a3600m \u163\'a3100m\par The Duke of Devonshire Land\par Devonshire, 65, created a stir in February by declaring Britain's aristocracy was dead. "Coffin's nailed down, it's in the ground. It doesn't exist - except that people have titles," he said, adding that if Labour removed all hereditary peers from the House of Lords, he would revert to his "common" name, Peregrine Cavendish. He is the 12th duke and his seat, Chatsworth House in Derbyshire, reopened last month after a face-lift. He owns Bolton Abbey, a 30,000-acre Yorkshire estate where he has two hotels, as well as Pratt's, the London gentlemen's club, prime acreage in Eastbourne and farming companies .\par 2009: \u163\'a3500m, 88=\par 103= \u163\'a3600m New entry\par Carl Hirschmann and family Aviation\par The Swiss businessman owes his fortune to Jet Aviation, the family business founded in 1967. One of the world's leading airline support services companies, it was sold to the private equity group Permira for an u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 disclosed sum in 2005. Three years later, it was sold again for $2.25 billion. Hirschmann lives in London much of the time. His family fortune was put at about \u163\'a3600m by Bilan, the Swiss business magazine, in its rich list last December .\par 103= \u163\'a3600m \u163\'a3100m\par The Jatania brothers Toiletries\par Lornamead, the toiletry product operation, had a tough time in the American market in 2008-09. But the Su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rey business enjoyed a record 2009-10. Lornamead is run and co-owned by the four Jatania brothers, led by chief executive Mike, 45, with George, 59, Vin, 54, and Danny, 51. The family came to Britain from Uganda in 1969. In 2005 Lornamead snapped up the Yardley brand for \u163\'a360m. Last year, it sold off part of Yardley for \u163\'a330m. With property assets, the Jatanias are worth \u163\'a3600m.\par 2009: \u163\'a3500m, 88=\par 103= \u163\'a3600m \u163\'a3350m\par Peter Simon and family Fashion\par See panel on page 30\par 103= \u163\'a3600m \u163\'a3200m\par The Walker family Aviation, steel and property\par Flybe, the Exeter-based budget airline, is reported to be planning a \u163\'a3300m flotation. This would mean a windfall for the Walker family, which has a 69% stake in the business. The family's fortune was created by the late Jack Walker, the Jersey-based Blackburn Rovers benefactor and steel magnate who built up Flybe before his death 10 years ago.\par 2009: \u163\'a3400m, 128=\par 109 \u163\'a3580m \u163\'a391m\par Sir Anwar Pervez and family Cash and carry\par Profits at London-based Bestway, which was founded by Pervez, 75, rose in 2008-09 to \u163\'a380.6m on sales of \u163\'a32.05 billion. We value parent company Bestway (Holdings)\par at about \u163\'a3750m and Pervez, his family and trusts have a \u163\'a3360m stake. A property operation, Palmbest, and other assets add \u163\'a3220m. The family gives large amounts to charity .\par 2009: \u163\'a3489m, 103=\par 110 \u163\'a3572m \u163\'a3189m\par Henry Engelhardt and family Motor insurance\par Admiral, the Cardiff-based insurance company, has opened a new office in Newport, cementing its position as one of Wales's biggest private-sector employers. Engelhardt, 52, an American, has a stake worth \u163\'a3533m. Share sales and dividends put his worth at \u163\'a3572m.\par 2009: \u163\'a3383m, 136\par 111 \u163\'a3570m \u163\'a3260m\par Peter Hargreaves Finance\par The book In for a Penny: A Business Adventure is Hargreaves's account of how he and Stephen Lansdown (qv) built Hargreaves Lansdown, the independent financial adviser. The Bristol company was founded in 1981 and floated in 2007. Today it is worth \u163\'a31.38 billion and Hargreaves retains a stake worth \u163\'a3497m. The 63-year-old chief executive sold \u163\'a375m of shares in the float and has had \u163\'a330m-plus dividends in the past 10 years.\par 2009: \u163\'a3310m, 176\par 112 \u163\'a3565m \u163\'a3235m\par Tony Buckingham Oil and diamonds\par Heritage Oil, the Canada-based oil exploration company, was set up by Buckingham, 58, who is based in Guernsey. It is worth more than \u163\'a31.4 billion and Buckingham's stake is valued at \u163\'a3475m. He has other inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ests and properties in London, Hampshire, Switzerland and France.\par 2009: \u163\'a3330m, 156=\par 113 \u163\'a3562m \u163\'a38m\par Paddy McNally Sports advertising, hospitality\par The former journalist founded Geneva-based Allsport, which owns trackside advertising rights at Formula One circuits and operates the Paddock Club, an F1 hospitality provider. McNally, 72, sold out to a private equity group in 2006. His properties include a Wiltshire manor and chalets in Verbier. Bilan, the Swiss bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness magazine, put McNally's wealth at \u163\'a3562m in its December 2009 rich list.\par 2009: \u163\'a3570m, 75\par 14 \u163\'a3557m \u163\'a372m\par Sir Donald Gordon and family Property\par South African-born Gordon, 79, was sanguine about a share issue at Liberty International last year. The company raised more than \u163\'a3620m and Gordon and his family saw their stake diluted from 21.7% to 14.82%. He put \u163\'a340m into the pot himself, but said: "I will be slightly reduced but it is not important. I will still be the largest shareholder." The London-based operation has shopping centres such as Lakeside in Essex. We value the family's stake at \u163\'a3427m. There are other assets and we deduct \u163\'a320m in donations to arts organis}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions such as the Royal Opera House and the Wales Millennium Centre.\par 2009: \u163\'a3485m, 105=\par 115= \u163\'a3550m \u163\'a3100m\par Boris Berezovsky Finance\par London-based Russian exile Berezovsky, 64, won \u163\'a3150,000 libel damages in the High Court last month, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ter a Russian TV station wrongly accused him of being behind the murder of former KGB spy Alexander Litvinenko in 2006. He is hoping to win rather more from former business partner Roman Abramovich (qv), who he accuses of coercing him into selling his Sibneft oil stake cheaply. Berezovsky's fortune could soon be open to scrutiny as his estranged wife, Galina, instructed a top London law firm in October to start divorce proceedings. Berezovsky helped to set up the first Mercedes dealership in Moscow.\par 2009: \u163\'a3450m, 14=\par 115= \u163\'a3550m New entry\par Sri Prakash Lohia Industry\par Lohia, 57, was born in India and his father founded Indorama in Indonesia in 1976. It has grown into one of the world's largest textile and plastics operations, with factories in India, Thailand, Turkey, Holland, the Uni}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed States and Indonesia. Lohia is one of three brothers running the family empire and is based in London. Forbes magazine's Indian rich list put his fortune at \u163\'a3550m in 2009.\par 115= \u163\'a3550m \u163\'a350m\par Lord Paul and family Industry\par Paul, 79, saw his Caparo car components-to-metals group push its turnover up to a record \u163\'a3861m in 2008. High borrowing costs, however, turned a \u163\'a36.4m pre-tax profit into a \u163\'a33m loss. Paul's sons run the operation while he sits in the House of Lords. Paul came to Britain from his native India to seek treatment for his daughter's leukaemia in 1966. Staying on after her death, he threw himself into building up Caparo, which is now worth about \u163\'a3450m. We add \u163\'a3100m for his Indian assets, including hotels and restaurants.\par 2009: \u163\'a3500m, 88=\par 115= \u163\'a3550m \u163\'a350m\par Derrick Smith Finance\par As a small but well-connected shareholder in pub group Mitchells & Butlers (M&B), Smith was in the hea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lines by association as his friend Joe Lewis (qv)battled for control of the group, ousting M&B's leadership in January. Smith has a 2.5% stake in the Birminghambased pub group. A former bookie who has made huge profits trading currencies, he spends much of his time in Barbados, where he has a stable of horses. He is part-owner of the Sandy Lane hotel.\par 2009: \u163\'a3500m, 88=\par 119 \u163\'a3542m \u163\'a3447m\par Oleg Novachuk Mining\par As chief executive of Kazakhmys, Novachuk, 39, helps run one of the world's top copper mining groups. The Kazakhstan-based operation has its headquarters in London. Floated on the stock market in 2005, it is now worth \u163\'a38.3 billion. Novachuk's stake is valued at \u163\'a3528m. Share sales add to his wealth.\par 2009: \u163\'a395m, 575=\par 120 \u163\'a3540m\par The Thomson family Media\par Dundee publisher DC Thomson has initiated a "full strategic review" of its business. It could mean that De}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nis the Menace and other characters of The Beano might be up for adoption. A television animation of De}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nis has helped the publisher. The DC Thomson flagship, The Sunday Post, still sells just under 400,000 co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ies. We value the company at \u163\'a3800m. The family's stake is worth \u163\'a3504m and it has other assets.\par 2009: \u163\'a3540m, 83\par 121= \u163\'a3530m \u163\'a330m\par Jim Mellon Property and finance\par Mellon has been investing in German property and about 70% of his wealth is tied up in 40,000 apartments there. Mellon, 53, who was a fund manager in Hong Kong in the 1970s, made his money from investments including a \u163\'a355m return from Charlemagne Capital in 2006. He has stakes of \u163\'a320m in quoted firms including Emerging Metals. Mellon is based in the Isle of Man, where he is a big property owner. He says our \u163\'a3500m ranking last year was "fairly accurate", but owing to recent success selling the euro against the dollar, we raise him by \u163\'a330m.\par 2009: \u163\'a3500m, 88=\par 121= \u163\'a3530m \u163\'a3200m\par Phillip Sheppard and family Recycling\par A tough time for European Metal Recycling, which saw its 2008 profits almost halve to \u163\'a363m, though sales rose by \u163\'a3900m to nearly \u163\'a33.1 billion. Headed by Sheppard, 63, the company's giant shredders are a feature of Liverpool's docks. The outfit was formed in 1994 when Sheppard Group acquired Coopers Holdings in Swindon. Today it stands at the forefront of the recycling industry with sites worldwide. It is worth about \u163\'a3500m. The Sheppard family owns it all and we add \u163\'a330m for past dividends .\par 2009: \u163\'a3330m, 156=\par Still upwardly mobile\par 102 \u163\'a3604m \u163\'a3304m, 101%\par Charles Dunstone Mobile phones\par Six months after tying the knot with Celia Gordon Shute, a PR executive, Dunstone has already been through a divorce. Happily, it was the retail and TalkTalk telecoms arms of his Carphone Warehouse group that parted company in a demerger last month, while the couple, above, remain blissfully hitched. Dunstone, 45, who co-founded the quoted Carphone Warehouse with David Ross in 1989, is chairman of the two r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 structured companies. Formerly billed as one of Britain's most eligible bachelors, he took himself off the ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ket in style at a wedding whose guest list contained big names from business, showbiz and politics. Not many men could count Marks & Spencer's Sir Stuart Rose among their ushers, or Tony Blair and Duran D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ran's Simon Le Bon among the many famous bums on pews. The son of a BP executive, Dunstone followed an unconventional route after leaving Uppingham public school, eschewing university to work in computer sales. At 25, he set up Carphone Warehouse from a London flat with \u163\'a36,000 savings and built it into the bi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gest mobile phone retailer in Europe, winning a royal warrant in 2001. He is a friend of the Prince of Wales and took over from controversial banker Sir Fred Goodwin as chairman of the Prince's Trust last July. He joined the youth charity's council in 2000 and is committed to helping fledgling entrepreneurs. "I had some breaks in my life, and what the Prince's Trust does is give a chance to people who never get a chance," he said. An avid sailor, Dunstone had a triumphant run in his 52ft yacht Rio at last year's Cowes Week, adding the Rocking Chair trophy to his collection of silverware. He also races his 118ft luxury yacht Hamilton 2. His two demerged companies have a stock market value of \u163\'a31.7 billion, making his stakes worth \u163\'a3568m. Share sales, property and other assets add to his wealth.\par 2009: \u163\'a3300m, 178=\par Monsoon season\par 103= \u163\'a3600m \u163\'a3350m, 140%\par Peter Simon and family Fashion\par The sun is shining on Simon, 60, whose Monsoon Accessorize fashion group has more than 1,000 shops and is doing so well that it plans to open another 140. In 2008-09 it made \u163\'a333m profit, which vindicated S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mon's decision to take the London-based retailer off the stock market in 2007. His bid for the 25% of the group that he did not own was accepted by shareholders and recommended by his board and valued the company at \u163\'a3755m. He has come a long way since 1969, when he joined a nudist commune in Ibiza before returning to London to run a market stall. In 1973, he opened his first Monsoon shop and 11 years later he added the Accessorize chain, selling bags, belts, hats and jewellery. In 1998 the company was floated, with Simon's 75.5% stake worth \u163\'a3570m. Simon has an extensive art collection at Monsoon's headquarters. He also has a private property company and owns the Electric Cinema on Portobello Road. We value Monsoon at \u163\'a3550m and add \u163\'a350m for other assets.\par 2009: \u163\'a3250m, 22=\par 121= \u163\'a3530m \u163\'a310m\par Michael Tabor Leisure\par Tabor was entertained by West Ham owners David Sullivan (qv) and David Gold (qv) recently. The Hammers fan's first passion is the turf. Starspangledbanner, his new horse, cost \u163\'a35.8m. Tabor, 68, sold a bookmakers' chain in 1995 for about \u163\'a328m. His fortune then grew through the currency markets. He has stakes in the Sandy Lane hotel in Barbados and Victor Chandler's (qv) gaming operation .\par 2009: \u163\'a3520m, 85\par 124 \u163\'a3524m \u163\'a3124m\par Dieter Bock Property\par The London-based German owns a small property firm, Advanta, but it is a fraction of his wealth. He gave a glimpse of that in 2006, when he sold three Cape Town office blocks for \u163\'a321m. In 1993, Bock, 71, took co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 trol of Lonrho. He later became vice-chairman of an America property company. In the 2009 German rich list compiled by Manager magazine, Bock's fortune was put at \u163\'a3524m. We agree.\par 2009: \u163\'a3400m, 128=\par 125 \u163\'a3522m \u163\'a3116m\par Chris Lazari Property\par Lazari's skill in upgrading buildings in London's West End and getting good tenants is paying off. Profits at Lazari Investments rose in 2008-09 from \u163\'a318.4m to \u163\'a326.7m, and should hit \u163\'a344m in 2009-10. This 45% rise was achieved on the back of falling interest rates on \u163\'a3924m of borrowings and a 10% rise in rental income. Lazari, a Greek Cypriot by birth, has other assets.\par 2009: \u163\'a3638m, 65\par 126= \u163\'a3520m \u163\'a390m\par Lloyd Dorfman Foreign exchange\par Travelex, the foreign exchange and international payments firm, is considering a sale or flotation. The rece}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sion saw less travel and cross-border trade but Dorfman, 57, the chairman, said full-year earnings should be down only slightly on the \u163\'a3133m in 2008. He founded the London firm in 1976, and collected \u163\'a3240m before tax for part of his holding in 2005. He retains a 28% stake worth \u163\'a3350m.\par 2009: \u163\'a3430m, 123=\par 126= \u163\'a3520m \u163\'a3220m\par Mo Ibrahim Mobile phones\par Satya Capital, Ibrahim's private investment firm, is looking to invest \u163\'a3200m in Africa this year. The former BT manager built his fortune from Celtel, the African mobile phone operation, and a consultancy. The proceeds should make Sudanese-born Ibrahim, 63, who is based in London, worth \u163\'a3600m but we cut him back as a result of his charitable initiatives in Africa.\par 2009: \u163\'a3300m, 178=\par 126= \u163\'a3520m \u163\'a3200m\par Patrick McKenna Finance and media\par See panel on page 33\par 129 \u163\'a3519m \u163\'a320m\par Joanne Rowling Novels and films\par See panel opposite\par 130 \u163\'a3515m \u163\'a3200m\par Tom Singh and family Fashion\par The New Look founder saw sales at the Weymouth-based fashion group rise last Christmas. A planned flot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion was shelved in February because of adverse stock market conditions but may be resurrected. We value the company at \u163\'a31.4 billion. Singh, 60, who borrowed money from his parents to start New Look, retains a 22.5% stake, worth about \u163\'a3315m. Share sales add \u163\'a3200m to the family total.\par 2009: \u163\'a3315m, 174=\par 131 \u163\'a3510m \u163\'a3110m\par Marcus Evans Business services\par Evans, 46, who is based in Bermuda, owns 87.5% of Ipswich Town football club. His business events and information company employs more than 3,000 people in 36 countries and is worth \u163\'a3300m. We add another \u163\'a3210m for property and other assets.\par 2009: \u163\'a3400m, 128=\par 132= \u163\'a3500m New entry\par Shwan Al-Mulla Construction\par Al-Mulla, president of Iraqi Consultants & Construction Bureau, has made a fortune from the reconstruction of his home country. He has a number of British directorships, a London flat and a home counties mansion, plus property overseas. Al-Mulla, 49, supports Amar International Charitable Foundation, which helps people in Iraq and Lebanon.\par 132= \u163\'a3500m \u163\'a360m\par Lord Ballyedmond Pharmaceuticals\par Ballyedmond, 66, owns the Newry-based pharmaceutical company Norbrook Laboratories, which last year unveiled a medical treatment it claims could revolutionise cattle farming by eliminating parasites. Norbrook is worth \u163\'a3300m. Ballyedmond also has big property and land interests.\par 2009: \u163\'a3440m, 120=\par 132= \u163\'a3500m \u163\'a3100m\par Peter and Denise Coates Bookmaking and online gambling\par Bet365, the online gaming business, saw profits rise from \u163\'a330.4m to \u163\'a366.5m in 2008-09. Peter Coates, 72, chairman of Stoke City FC, started the Provincial Racing chain in 1974. In 2000 daughter Denise, 42, su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gested a move online and Bet365 was born. Coates sold his shops in 2005 and has disposed of other bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nesses for \u163\'a350m.\par 2009: \u163\'a3400m, 128=\par 132= \u163\'a3500m\par Felix Dennis Media\par Dennis, 62, who started on Oz, the satirical magazine, is expanding his news magazine The Week in Amer}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ca. It is worth \u163\'a3150m, as is his UK media operation, Dennis Publishing. His American lads' magazines sold for more than \u163\'a3120m before tax in 2007. The money is going into the Forest of Dennis in the Midlands, where 600,000 saplings have been planted. We add \u163\'a3100m for his Warwickshire estate and other assets.\par 2009: \u163\'a3500m, 88=\par 132= \u163\'a3500m \u163\'a3200m\par Trevor Hemmings Property\par Hemmings, 74, sold Blackpool Tower to the council for about \u163\'a340m in March. He sold Pontin's holiday group to Scottish & Newcastle for a stake that was worth \u163\'a3218m when S&N was taken over. Net assets at his main company, Northern Trust Group, fell to \u163\'a3132m in 2008-09. His interests include Trust Inns. The reviving ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ket lifts his total this year.\par 2009: \u163\'a3300m, 178=\par 132= \u163\'a3500m \u163\'a3100m\par Leo Noe and family Property\par Noe was part of a consortium that snapped up a Dublin shopping centre in January for about \u163\'a3300m - which was the asking price for a 50% stake two years previously. The 56-year-old is executive chairman of F&C Reit Asset Management, a London fund manager. Last summer Pinton Estates, an investment vehicle of F&C Reit, collapsed because of cashflow problems. Noe and his family have substantial wealth from deals and investments. He gives to charities in Britain and Israel.\par 2009: \u163\'a3600m, 70=\par 132= \u163\'a3500m \u163\'a35m\par Jack Petchey Property\par The property veteran says this recession has been the worst in his 84 years. His empire has included taxis, timeshares and football clubs Aston Villa and Watford. Petchey holds \u163\'a337m of stakes in quoted companies, and keeps an office in London. His charity has given \u163\'a365m to youth projects.\par 2009: \u163\'a3495m, 102\par 132= \u163\'a3500m \u163\'a3320\par Tony Tabatznik and family Pharmaceuticals\par Tabatznik sold Arrow, the Hertfordshire drug operation he co-founded in 2000, to America's Watson Pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 maceuticals last year for $1.75 billion in cash and shares. Its sales grew to more than $650m in 2008. Tabatznik, 62, has joined the Watson board and is also a director of European Healthcare Group, a nursing home operator. The Labour party donor, who was born in South Africa, and his family collected \u163\'a3200m from the sale of Generics (UK), an earlier drug company. We add the Arrow proceeds and other assets.\par 2009: \u163\'a3180m, 309=\par 140 \u163\'a3497m \u163\'a3100m\par Michael Cornish and family Packaging\par Banks took over packaging group Linpac from Montagu Private Equity last year in a refinancing deal. The Cornish family, founder of the Birmingham firm, made \u163\'a3700m from selling to Montagu in 2003. About \u163\'a3120m went back into the business and the takeover may have hit the family, led by Michael, 56.\par 2009: \u163\'a3597m, 74\par 129 \u163\'a3519m \u163\'a320m, 4%\par Joanne Rowling Novels and films\par The Wizarding World of Harry Potter theme park opens at Universal Orlando in Florida on June 18. It is the latest vehicle for the star of Hogwarts, though it is unlikely to make a big difference to the wealth of Rowling, creator of the legend and author of the seven hugely popular books. Not that she needs much money. Sales of the series are approaching \u163\'a3450m, which is why Rowling is easily the world's richest author. Having e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 caped penury as a single mother in Edinburgh with the first Harry Potter novel, published in 1997, royalties should average \u163\'a31 a book. The six Potter films have garnered $5.4 billion at the box office. The final work, Harry Potter and the Deathly Hallows, is being split into two movies, with the first due out in November. Rowling enjoys a cut of royalties and merchandising, which will take her to at least \u163\'a3600m thus far. Unlike many top authors, she has refused to become a tax exile and lives in Scotland. So her \u163\'a3600m of income b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 comes little more than \u163\'a3360m once the Inland Revenue has called. She is an enormous benefactor of char}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ties, giving \u163\'a322m to Comic Relief, and has set up the Children's High Level Group. She also established the Volant Trust, which takes the maiden name of her late mother, Anne. The trust had income of more than \u163\'a34.5m last year and supports research into multiple sclerosis (from which Anne Rowling died in 1990)\par and projects to alleviate social deprivation. In all, Rowling's giving may well have been \u163\'a380m over the years, which cuts that \u163\'a3360m to \u163\'a3280m. She lives pretty frugally and, apart from \u163\'a310m of properties, has invested the income, taking her to perhaps \u163\'a3300m. What cannot be disputed is the value of Potter and a guaranteed future income stream. The US magazine Advertising Age studied the brand last year and suggested it was worth \u163\'a37.5 billion. Should Rowling wish to follow pop stars and sell her share of Harry Potter (as they sell their back catalogues)\par she could add another \u163\'a3220m in intangible brand value for future film and book income. In all, that would place her at \u163\'a3520m. But we must not forget her \u163\'a31m donation to the Labour party, announced in 2008, and clip Rowling back to \u163\'a3519m.\par 2009: \u163\'a3499m, 101\par 141 \u163\'a3495m \u163\'a3165m\par The Warburton family Baking\par Warburtons has spent heavily on advertising as it battles with Hovis for domination of the bread market. The company has come a long way since the days when brothers Thomas and George launched a small grocery in Bolton. The business is worth its \u163\'a3471m net asset figure and dividends of \u163\'a375m since 1994 take the Wa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 burton family, which owns the business, to \u163\'a3495m after tax.\par 2009: \u163\'a3330m, 156=\par 142 \u163\'a3490m \u163\'a31m\par The Duke of Bedford Land\par Bedford, 48, surprised the property community in April 2009 by buying the offices of Time Out magazine in Tottenham Court Road for \u163\'a314.1m. The 340-yearold Bedford Estate in London owns about 180 buildings in Bloomsbury, but this was its first big deal for years. The \u163\'a3200m Center Parcs holiday village on his Woburn estate is due to open later this year and will create 1,500 jobs. The house and grounds are worth \u163\'a3100m and the art treasures inside, including 24 Canalettos, are valued at \u163\'a3300m, although we halve that to \u163\'a3150m to allow for tax. Allowing for inheritance tax following his father's death, we value Bedford at \u163\'a3490m.\par 2009: \u163\'a3489m, 103=\par 143 \u163\'a3481m \u163\'a34m\par Tony Murray and family Plant hire, property and fire protection\par Murray, 90, is as active as ever, but his British companies are having mixed fortunes. Profits slumped in the first half of 2009 at Andrews Sykes, his Wolverhampton-based hirer of heating and air conditioning equi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment. At his other main British operation, the Leedsbased London Security fire protection business, revenues rose in the first half of 2009 by 19.4%. Murray's stake in the two groups is worth \u163\'a3131m. He also has a co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mercial property portfolio, which we value at \u163\'a3250m, as well as cash and personal property of \u163\'a3100m.\par 2009: \u163\'a3485m, 105=\par 144 \u163\'a3480m\par The Duke of Sutherland Art and land\par A vast canvas by the French artist Paul Delaroche depicting Charles I before his execution went on show at the National Gallery in February. It is part of a massive collection owned by Sutherland, 70. While the Del}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 roche has been saved, a more valuable Titian is likely to go abroad - the National Galleries of Scotland has to find \u163\'a350m by the end of 2012 to save Diana and Callista. Sutherland inherited the title in 2000, along with 12,000 acres in the Scottish Borders and East Anglia. We value his art collection at \u163\'a3800m but, allowing for any tax bill, if he sold it he would raise only \u163\'a3400m. We add \u163\'a330m for land holdings and \u163\'a350m from the sale of another Titian, Diana and Actaeon, which was bought for the nation last year .\par 2009: \u163\'a3480m, 107=\par 146= \u163\'a3470m \u163\'a320m\par Charles Cayzer and family Finance\par Four members of the Cayzer family sit on the board of Caledonia Investments. The family has a third of the shares in the group, worth about \u163\'a3320m. Other assets and past dividends take the family to \u163\'a3470m. Charles Cayzer, 53 tomorrow, is here representing the family.\par 2009: \u163\'a3450m, 14=\par 146= \u163\'a3470m\par Ronald Hobson Property\par Hobson, 89, teamed up with Sir Donald Gosling (qv) to build car parks on old bomb sites in London and the rest of Britain. They sold the parent company, National Parking Corporation, collecting about \u163\'a3290m each, and the sale of two other companies made Hobson a further \u163\'a397m. Huge dividends from National Parking before its sale, plus property company sales, keep Hobson at \u163\'a3470m.\par 2009: \u163\'a3470m, 12=\par 148 \u163\'a3466m \u163\'a3291m\par Leif Hoegh and family Shipping\par Oslo business Leif Hoegh & Co specialises in liquid natural gas ships and car carriers. Hoegh, 36, who is based in London, is deputy chairman. The family took the company private in 2003. Hoegh and his family were valued at \u163\'a3466m by the Norwegian rich list in Kapital magazine in 2009 .\par 2009: \u163\'a3175m, 322=\par 149 \u163\'a3464m \u163\'a3282m\par Naresh Goyal and family Airline\par See panel on page 34\par 150 \u163\'a3452m \u163\'a3172m\par Stephen Lansdown Finance\par Lansdown, co-founder of the financial adviser Hargreaves Lansdown, sold \u163\'a347m of shares last spring to fund private projects, including a new stadium for Bristol City football club, which he chairs. The 57-year-old r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tains a \u163\'a3352m stake in the finance firm he set up in Bristol in 1981 with Peter Hargreaves (qv). He sold \u163\'a375m of shares in a 2007 float and has other wealth. Our valuation allows for reinvestment and any tax.\par 2009: \u163\'a3280m, 207=\par 151= \u163\'a3450m \u163\'a350m\par Terry Bramall and family Construction\par Bramall, 67, and his family sold Keepmoat in 2007 for \u163\'a3563m and he is now financing developer 4Urban, which aims to form strategic partnerships with financiers and the public sector. Doncaster-based Keepmoat built and refurbished social housing. Bramall is one of the owners of Doncaster Rovers FC. We assess him after reinvestment and any taxes.\par 2009: \u163\'a3400m, 128=\par 151= \u163\'a3450m \u163\'a320m\par Sir Evelyn and Lady de Rothschild and family Finance\par De Rothschild's son David is sailing a plastic catamaran through the Pacific to highlight the ecological disa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ter created by plastic waste in the sea. Evelyn, 78, netted \u163\'a3134m when the French and British arms of the Rothschild banking dynasty were merged. Lady de Rothschild, 55, an American technology entrepreneur, made \u163\'a3100m from the sale of broadband company, FirstMark.\par 2009: \u163\'a3430m, 123=\par 151= \u163\'a3450m \u163\'a330m\par Jack Dellal Property\par "Black" Jack Dellal, 86, keeps a low profile, apart from occasional forays into the property market, but his granddaughter, Alice, is a darling of the gossip columns. A grunge model, Alice is the face of high-street fashion store Mango and body of luxury lingerie brand Agent Provocateur. Dellal's main company, Allied Commercial Holdings, has net assets of \u163\'a354.6m.\par 2009: \u163\'a3480m, 107=\par 151= \u163\'a3450m\par Sir Donald Gosling Property\par Gosling, 81, was promoted to the rank of Honorary Rear Admiral on his 80th birthday. With Ronald Hobson (qv), Gosling started the National Parking Corporation in 1948, netting about \u163\'a3290m when it was sold. They also sold property businesses. He is worth at least \u163\'a3450m after hefty charitable donations.\par 2009: \u163\'a3450m, 14=\par 151= \u163\'a3450m \u163\'a320m\par David and Richard Thompson Food and horse racing\par Cheveley Park Stud in Newmarket is one of the world's top racehorse breeding operations. It is owned by David, 74, who started the Hillsdown food group in 1975. Thompson sold half his stake in 1987 for \u163\'a3145m and the rest later for a similar amount.\par Son Richard, 45, has \u163\'a310.2m net assets in a company called Amphitrite. They have other assets.\par 2009: \u163\'a3430m, 123=\par 156 \u163\'a3447m \u163\'a3117m\par Mark Dixon Serviced offices\par Dixon, 50, opened his 1,000th Regus business centre in Mauritius last September. He launched Regus, based in Surrey, in 1989 and his stake is worth \u163\'a3356m. He has other assets.\par 2009: \u163\'a3330m, 156=\par 157 \u163\'a3445m \u163\'a35mt\par Freddie Linnett and the Murphy family Property\par Charles Street Buildings (Leicester) has survived the downturn by letting buildings to the government. Li}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nett, 60, is a leading shareholder in the \u163\'a3399m business. Other assets take her and the Leicester-based Murphy family to \u163\'a3445m.\par 2009: \u163\'a3450m, 14=\par 158= \u163\'a3430m\par Felix Grovit Foreign exchange\par Grovit, 68, founded the Chequepoint foreign exchange business in London, and is involved in Berkeley Cre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 it. He started a software operation in India, and has property there.\par 2009: \u163\'a3430m, 123=\par 158= \u163\'a3430m \u163\'a348m\par David Harding Finance\par Harding, 48, runs Winton Capital, a London hedge fund. He has had more than \u163\'a3200m before tax in div}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dends and pay. Goldman Sachs paid \u163\'a350m for a stake in Winton, which values his share at \u163\'a3282.5m.\par 2009: \u163\'a3382m, 137\par 158= \u163\'a3430m \u163\'a3130m\par Lord Kirkham and family Furniture\par Kirkham, 65, terminated the \u163\'a3500m sale of his DFS furniture group in March, saying. "I don't need the mo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ey. I'm loaded." Kirkham bought DFS from the receivers in 1983. In 2004, he took the Doncaster business private in a \u163\'a3507m deal. The family also garnered \u163\'a3180m in share sales.\par 2009: \u163\'a3300m, 178=\par 158= \u163\'a3430m \u163\'a3100m\par Sir Peter Rigby Computers, aviation and hotels\par Rigby, 66, will be delighted that his Mallory Court hotel in Leamington retained its Michelin star but it is in computers that he made his fortune. Midlands-based Specialist Computers supplies British Airways, Kellogg, Orange and Peugeot with IT support. Rigby is a pilot and his Patriot Aviation, based at Cranfield and Gloucester, operates flying schools, helicopter maintenance and charter businesses .\par 2009: \u163\'a3330m, 156=\par 162 \u163\'a3427m \u163\'a3192m\par Mike Lynch Software\par Autonomy, the Cambridge-based software house, is worth more than \u163\'a33.9 billion. It proves Lynch, 44, the founder, is a rare beast: a British high-tech entrepreneur who has cracked the US market. Lynch borrowed \u163\'a32,000 in 1991 to launch his own firm, Aerodynamics. Fast-forward to 2000 and Autonomy was floated. Lynch's stake is worth \u163\'a3351m. Other assets include a farm company, property and share sales.\par 2009: \u163\'a3235m, 238=\par Rocker rolls on\par 145 \u163\'a3475m \u163\'a335m, 8%\par Sir Paul McCartney Music\par Money can't buy him good weather, so Sir Paul McCartney will be hoping for clear skies when he performs open-air concerts in June. As part of his transatlantic Up and Coming tour, he will be appearing at the RDS, Dublin, the Isle of Wight Festival, Glasgow's Hampden Park two days after his 68th birthday and the Mille}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nium stadium, Cardiff - the ex-Beatle's first gig in the Welsh capital for three decades. The series will finish in Hyde Park on June 27. McCartney toured North America and Europe last year, when 19 shows were seen by 438,000 people and grossed $54.7m at the box office. He also performed at the live final of ITV's The X Factor, showing he still seeks a broad audience. In September the original Beatles catalogue was released, digitally remastered, for the first time since 1987 alongside the launch of the music video game The Beatles: Rock Band. Both sold well. EMI initially shipped 5m units of the remastered boxed set round the world and sold 626,000 copies in week one in the US alone. About 1.8m copies of the game were sold worldwide by the year end. The royalties will not be apparent in the accounts yet, but Apple Corps, the main Beatles co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pany, is looking healthy. In the year to January 2009, it made \u163\'a36.2m profit on \u163\'a315.7m sales. That followed a "profit on the sale of fixed assets" of \u163\'a350.6m in the year to January 2008, after which \u163\'a335.1m of dividends were paid to the shareholders, including McCartney. Our rock expert raises the pop veteran's valuation to \u163\'a3475m, slightly more than the wealth disclosed in his divorce battle with Heather Mills in 2007. The settl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment let him retain his homes in Britain and overseas, including a handsome town house in St John's Wood, north London, and a Sussex estate.\par 2009: \u163\'a3440m, 120=\par 126= \u163\'a3520m \u163\'a3200m, 63%\par Patrick McKenna Finance and media\par McKenna has few peers when it comes to sniffing out an investment opportunity in the media and entertai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment industry. His Londonbased Ingenious Media backed blockbuster movie Avatar and is forecasting a \u163\'a3123m profit. McKenna, 53, started at Deloitte and Touche, becoming a partner at 28. He set up Ingenious in 1998 and helped Robbie Williams to secure his \u163\'a380m deal with EMI. McKenna said of his trade: "Showbus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness is about art and commerce. Somebody looks after the art and I look after the commerce." The firm is being investigated by HM Revenue & Customs over alleged tax avoidance in its film finance schemes but it denies any wrongdoing. McKenna is preparing to wind down his investment vehicle, Ingenious Media Active Capital, but there is still plenty of glitter left. Ingenious made a profit \u163\'a325.6m on \u163\'a3502m sales in 2008-09. With the Avatar takings to come, he is worth \u163\'a3520m.\par 2009: \u163\'a3320m, 167=\par 163 \u163\'a3425m \u163\'a375m\par Tony Gallagher Property\par Gallagher, 58, heads his own commercial and residential development group, responsible for schemes such as the 45-acre Warwick Gates business park in Heathcote. His main companies have strong net assets and low levels of borrowing.\par 2009: \u163\'a3500m, 88=\par 164 \u163\'a3420m \u163\'a355m\par Mark Fenwick and family Department stores\par The first Fenwick department store opened in Newcastle upon Tyne in 1882 and the group now has 11 sites, including one in London's Bond Street. The business is chaired by Fenwick, 61. We value it at \u163\'a3400m, ad}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing \u163\'a320m for other assets.\par 2009: \u163\'a3365m, 144\par 165 \u163\'a3417m \u163\'a3117m\par Steven Lamprell Oil services\par Lamprell Energy is worth \u163\'a3385m. British-born Lamprell launched the operation 30 years ago in the United Arab Emirates and has built it into one of the largest oil services companies in the Gulf. He made \u163\'a3230m in a 2006 flotation and kept a 33% stake, now worth \u163\'a3160m. He has other interests, including racehorses in D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bai.\par 2009: \u163\'a3300m, 178=\par 166= \u163\'a3410m \u163\'a3149m\par Anurag Dikshit Internet gambling\par Dikshit sold his remaining shares in Party Gaming in January for \u163\'a3105m, taking his sale proceeds from the business to \u163\'a3661m. About \u163\'a3213m was swallowed up by a fine for breaking US gambling rules. The Indian-born software expert, ranked fourth in our Giving List, lives in Gibraltar. He has given more than \u163\'a3293m to his Kusuma Trust in the past year, which funds educational and humanitarian projects, mostly in India.\par 2009: \u163\'a3559m, 77\par 166= \u163\'a3410m \u163\'a3222m\par Tom Morris and family Discount stores\par The Liverpool-based chain Home Bargains recently announced a \u163\'a325m expansion into Northern Ireland. The discount retailer, which has more than 190 stores, was founded by Morris, 56, in 1976. With \u163\'a3137m net a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets, it is worth \u163\'a3400m. There are other assets.\par 2009: \u163\'a3188m, 303\par 168= \u163\'a3400m\par The Clarke family Property\par The family wants to knock down an old cinema in Jersey and build a superstore to be operated by one of the UK's big four. The Clarke family has large tracts of St Helier, retail outlets and pub sites across Jersey.\par 2009: \u163\'a3400m, 128=\par 168= \u163\'a3400m New entry\par Peter Cullum Insurance\par Cullum, 59, and his Maidstonebased Towergate insurance operation made 17 acquisitions last year, despite the downturn. The Cullum Family Trust focuses on poverty relief and the advancement of education and rel}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gion. Towergate should be worth \u163\'a3600m. That would value Cullum's stake at \u163\'a3345m and he has other wealth.\par 168= \u163\'a3400m \u163\'a350m\par Michael Evans and family Property Evans Property\par Group paid \u163\'a321.3m for a prime slice of real estate in Leeds in March 2009. The Evans family, led by Mo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 acobased Michael, 74, is involved in development work in the north of England. We value the business at \u163\'a3350m and add \u163\'a350m for other assets.\par 2009: \u163\'a3350m, 146=\par 168= \u163\'a3400m \u163\'a350m\par Roy Richardson and family Property\par Richardson, 80, and his late twin brother, Don, built shopping centres all over Europe. The family has a 50% stake in a \u163\'a3600m new-town project that will resurrect the site of Scotland's Ravenscraig steelworks. The fa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ily's main company, Swiftfire, has net assets of \u163\'a3145.2m.\par 2009: \u163\'a3350m, 146=\par 168= \u163\'a3400m \u163\'a350m\par David Sullivan Property and media\par Barely had the ink dried on his sale of Birmingham City than Essex-based Sullivan, 61, and his business partner David Gold (qv) bought a 50% stake in West Ham United in a deal valuing the club at \u163\'a3105m. Sull}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 van made about \u163\'a320m from selling his stake in Birmingham to the new Hong Kong owner. Roldvale, his main company, has paid him \u163\'a354m over the past 11 years. Sport Newspapers was sold in August 2007 for about \u163\'a350m and he has a \u163\'a3300m-plus property portfolio.\par 2009: \u163\'a3450m, 14=\par 168= \u163\'a3400m \u163\'a3100m\par Lawrence Tomlinson Industry\par Tomlinson, 45, develops purposebuilt care homes through Leeds-based LNT Construction, while CoolBlue develops bespoke software for the care industry. He made \u163\'a3200m from the sale of Orchard Care Homes and set up Ideal Care Homes.\par 2009: \u163\'a3300m, 178=\par 174 \u163\'a3390m \u163\'a330m\par Lord Rothschild Finance\par Rothschild, 73, left NM Rothschild & Sons in 1980 to take over RIT Capital, then a small investment trust. He and his family have a \u163\'a3235m stake in the business. In 1989, Rothschild inherited \u163\'a393m from an aunt, and he has substantial other assets.\par 2009: \u163\'a3360m, 145\par 175= \u163\'a3385m \u163\'a3205m\par Keith Miller and family Construction\par Miller Group, the Edinburghbased housebuilder, is run by Miller, 61. We value the family's stake at \u163\'a3350m. Other assets take the Millers to \u163\'a3385m.\par 2009: \u163\'a3180m, 309=\par 175= \u163\'a3385m \u163\'a342m\par Sir David Samworth and family Food\par Samworth, 74, was knighted last June for his charity work. The former chairman of family-owned meat and food firm Samworth Brothers, based in Leicestershire, sponsors three academies in the east Midlands. Samworth Brothers (Holdings)is worth \u163\'a3340m, and we add \u163\'a345m for other assets.\par 2009: \u163\'a3343m, 155\par 177 \u163\'a3380m \u163\'a3135m\par Peter Harris and family Leisure\par Bourne Leisure, which owns Butlins, 13 Warner Leisure hotels and 36 Haven caravan parks, attracts 4m vis}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tors a year. The business, based in Hemel Hempstead, is chaired by its founder, Harris, 76, who is also a racehorse trainer. Harris's stake in Bourne Leisure is worth about \u163\'a3360m. We add \u163\'a320m for his racing inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ests, past salaries and dividends .\par 2009: \u163\'a3245m, 235=\par 178 \u163\'a3377m \u163\'a3112m\par Sir Arnold Clark Car sales\par Recession has not put Clark, 82, off expanding his Glasgow-based car dealerships. The Arnold Clark Orga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 isation is worth its \u163\'a3362.2m net assets figure, and we add \u163\'a315m for other assets and property .\par 2009: \u163\'a3265m, 215=\par 179= \u163\'a3375m\par Vivian Imerman Spirits and food\par South African entrepreneur Imerman is involved in a bitter divorce battle with his estranged wife, Lisa Tche}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 guiz, who is reported to be claiming \u163\'a3100m. Known to gossip columnists as the Man from Del Monte, Lo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 don-based Imerman, 54, sold his stake in the tinned-fruit group for \u163\'a3380m. In 2004, he and his then brother-in-law, Robert Tchenguiz (qv), took full control of Whyte & Mackay, the Scottish whisky group. Imerman made about \u163\'a3396m when it was sold in 2007 .\par 2009: \u163\'a3375m, 139=\par 179= \u163\'a3375m \u163\'a3125m\par Michael Platt Finance\par When he is not trading at Bluecrest Capital Management, the hedge fund he founded with William Reeves (qv), Platt is busy in the art world, sponsoring young British talent. Platt, 42, has a \u163\'a3300m stake in Bluecrest, to which we add \u163\'a375m for sale proceeds, salaries and bonuses.\par 2009: \u163\'a3250m, 22=\par 179= \u163\'a3375m \u163\'a3125m\par William Reeves Finance\par Bluecrest Capital Management is moving part of its operation from London to Genevabecause of rising ta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es. Reeves, 46, cofounded Bluecrest with Michael Platt (qv) in 2000 and has an equal stake of \u163\'a3300m plus \u163\'a375m of sale proceeds, dividends and salaries.\par 2009: \u163\'a3250m, 22=\par 179= \u163\'a3375m \u163\'a3110m\par David Wilson and family Construction\par The Leicestershire developer Davidsons is worth at least \u163\'a375m. It was started by Wilson, 68, after he sold Wilson Bowden, his quoted housebuilder, in 2007 to Barratt Developments. We assess him on that deal and his latest assets.\par 2009: \u163\'a3265m, 215=\par 183 \u163\'a3374m \u163\'a374m\par Caspar MacDonald-Hall Property\par London & Cambridge Properties saw its net assets fall sharply from \u163\'a3579m to about \u163\'a3420m in 2008-09. MacDonald-Hall has a 40% stake in the Midlands-based operation and other property assets. The 59-year-old also has a \u163\'a315m stake in AIM Aviation.\par 2009: \u163\'a3300m, 178=\par 184 \u163\'a3373m \u163\'a317m\par Jan Mol Computers\par Chess-loving Mol sponsors an annual tournament in London, now his home city, which pits Britain against Holland, his country of origin. Mol, 68, sold his IT company, Volmac, in the 1990s and another telecoms group in 2005 for \u163\'a368m. Quote 500, which tracks the Dutch rich, put his wealth at \u163\'a3373m last year .\par 2009: \u163\'a3390m, 135\par 185 \u163\'a3367m\par Tito Tettamanti Investments\par The Swiss financier's investments have included stakes in the SIG packaging group, which he sold for \u163\'a379m, and the publisher Jean Frey, which added \u163\'a358m.\par Tettamanti, 79, spends much of the year in London, and we agree with the \u163\'a3367m valuation put on him by Bilan, the Swiss business magazine, in its 2009 rich list.\par 2009: \u163\'a3367m, 143\par 186= \u163\'a3360m \u163\'a360m\par David and Jacqueline Gold Media and lingerie\par Having sold Birmingham City football club last autumn, David Gold bought a 50% stake in West Ham United with business partner David Sullivan (qv). Gold Group International has interests from property to Ann Su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mers, which is run by daughter Jacqueline, 49. It is worth \u163\'a3120m. Proceeds from other businesses, such as Gold Air International, which was sold in 2006, 50% of Sport Newspapers, sold in 2007, and personal assets, including a Surrey mansion, take the Golds to \u163\'a3360m.\par 2009: \u163\'a3300m, 178=\par 186= \u163\'a3360m \u163\'a310m\par Stephen Rubin and family Sports goods\par Rubin, 72, runs Pentland, which has top brands such as Speedo, Berghaus and Kickers in its stable. The London firm also has a \u163\'a374.4m stake in JD Sports Fashion, the sportswear retailer. Rubin's coup was to buy a 55.5% stake in Reebok in 1981 for \u163\'a350,000. A decade later he sold up for \u163\'a3400m. Pentland, which is owned by Rubin and family trusts, made \u163\'a340m profit on \u163\'a31 billion sales in 2008. It is worth \u163\'a3340m and there are other assets. Rubin is a generous charity benefactor.\par 2009: \u163\'a3370m, 141=\par 188 \u163\'a3358m \u163\'a370m\par Hamish Ogston Business services\par See panel on page 37\par 189 \u163\'a3352m \u163\'a357m\par Harold Tillman Fashion\par Tillman, 64, and former Debenhams boss Belinda Earl (qv) bought Aquascutum, the classic English clothing brand, last September for an undisclosed sum. They already own Jaeger, which has more than 140 shops in Europe and others worldwide. Tillman's 72% stake in the combined operation is worth \u163\'a3252m. He has homes in London and Spain.\par 2009: \u163\'a3295m, 201=\par 190= \u163\'a3350m\par Marlon Abela Inheritance and restaurants\par Lebanese-born Abela, 34, runs restaurants in London, New York and Boston. He is using a fortune acquired from the family food services group to build his Mayfair-based empire, which includes private club Morton's and Marc Fine Wines.\par 2009: \u163\'a3350m, 146=\par On two wings and a prayer\par 149 \u163\'a3464m \u163\'a3282m, 155%\par Naresh Goyal and family Airline\par Goyal, 59, is afraid of flying, so each time he commutes between Mumbai and London - where his family lives - he prays before takeoff. Happily for the founder and chairman of India's Jet Airways, other people have more faith in flying, helping it to become the preferred operator for business travellers. It is easy to see the airline's appeal. First-class passengers fly in luxury: private suites offer a fully reclining bed with duck-down duvet, television, a wardrobe and meals served on hand-painted porcelain plates. Goyal founded what has become India's largest private airline in 1974, as a consultancy and advisory service. But in 1991, with India adopting an open skies policy, Goyal set up his own airline. The inaugural flight took place in 1993. The journey has not been without turbulence. In October 2008 Goyal decided against laying off hundreds of jobs. He said he couldn't bear to "see tears in their eyes". To bolster the company, Goyal forged an alliance b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tween Jet Airways and rival Kingfisher, chaired by Vijay Mallya. Last September hundreds of pilots called in sick to protest against the dismissal of two colleagues who wanted to set up a union. By the end of the year, the airline was recovering, recruiting and planning aircraft purchases. Goyal has an 80% stake in Jet Ai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ways, which is valued at \u163\'a3567m on the Indian stock market. His stake is worth \u163\'a3454m. We add \u163\'a310m for other assets.\par 2009: \u163\'a3182m, 307=\par 190= \u163\'a3350m \u163\'a347m\par Gert-Rudolf and Friedrich Christian Flick Car sales\par The German brothers, known respectively as Muck, 66, and Mick, 65, banked \u163\'a3300m in 1976 for the Me}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cedes-Benz stake they inherited. Muck is a lover of fine art and has published two books on the subject. He and his brother, both resident in London, have had costly divorces. We go with their \u163\'a3350m valuation in the 2009 German rich list from Manager magazine .\par 2009: \u163\'a3397m, 134\par 190= \u163\'a3350m \u163\'a350m\par Simon Fuller Entertainment\par Fuller recruited multi-millionpound stars such as David and Victoria Beckham (qv) to 19 Entertainment, the management company that is also a television and music producer with hits such as American Idol. He sold 19 to CKX, a New York company, in 2005 in a \u163\'a3100m deal. He stayed on as an adviser but has a new ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture, XIX. The 49-yearold, raised in Sussex, owns all of the \u163\'a3100m XIX. His CKX stake, property and pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sonal investment lift him \u163\'a350m this year.\par 2009: \u163\'a3300m, 178=\par 190= \u163\'a3350m \u163\'a3100m\par Kevin and Michael Lagan Construction\par The brothers have grown their father's Belfast building group into an international concern. We can see about \u163\'a330m profit on \u163\'a3370m sales in 2007-08 for Lagan firms, which had \u163\'a3164m net assets. The prime quarry a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets had a potential sale price of more than \u163\'a3200m at the height of the boom, but on current figures we rec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 on Kevin, 60, and Michael, 54, are worth \u163\'a3350m.\par 2009: \u163\'a3250m, 22=\par 190= \u163\'a3350m \u163\'a330m\par Toni Mascolo and family Hairdressing\par Mascolo, 67, runs the UK side of the Toni & Guy hairdressing empire, worth \u163\'a3100m. He wanted to be a la}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 yer but followed the family tradition, opening a salon in Clapham with one of his brothers, Guy, in 1963. The chain has more than 230 salons in the UK and 175 overseas. Mascolo's other interests include a television company. We add \u163\'a3200m for the 2009 sale of the Tigi hair product operation and \u163\'a350m for salaries, div}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dends and assets.\par 2009: \u163\'a3320m, 167=\par 190= \u163\'a3350m\par Steve Morgan Property\par Morgan paid a mere \u163\'a310 for Wolverhampton Wanderers in 2007, promising to invest \u163\'a330m. His reward has been Premier League football this season. Morgan's fortune comes from the housebuilder Redrow. He made \u163\'a3240m before tax from share sales there and had a \u163\'a3100m stake in the De Vere leisure group. He returned to Redrow as chairman last year, almost a decade after leaving, and has a \u163\'a365m stake.\par 2009: \u163\'a3350m, 146=\par 190= \u163\'a3350m \u163\'a350m\par Stefan Olsson Shipping\par Olsson, 61, is a Swede based in London. His wealth derives from Stena Group, founded in 1939 by his grandfather. It traded in metals and minerals before diversifying into shipping. Today, it is known for its ferry business. The Swedish business magazine Veckans Affarer put Olsson's worth at \u163\'a3534m in its last rich list but, with shipping values reduced, we believe that figure is too high.\par 2009: \u163\'a3300m, 178=\par 190= \u163\'a3350m \u163\'a350m\par Nicholas Roditi Finance\par The potential \u163\'a31 billion-plus flotation of online grocery group Ocado would produce a windfall for Roditi, 64, whose stake could be worth more than \u163\'a350m. His London businesses include PGI Group, which enco}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 passes food production in Africa and property in Russia, and Belvedere Investment Partners, focused on Asian assets. Roditi owns at least 1.5% of Russian energy company UES.\par 2009: \u163\'a3300m, 178=\par 190= \u163\'a3350m\par Ramesh and Pratibha Sachdev Nursing homes\par Ramesh, 64, is building his third nursing home business and has 11 sites with more than 1,100 beds. He started his first Life Style Care operation in 1987, selling the company in 1998 but keeping the name. The second was sold in 2007, when he kept the freehold property. Charity donations by Sachdev and wife Prat}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bha, 62, total \u163\'a32m in the past year .\par 2009: \u163\'a3350m, 146=\par 190= \u163\'a3350m \u163\'a370m\par Stephen Vernon Property\par Green Property, headed by Vernon, 60, has been in talks about taking over an \u163\'a3833m portfolio owned by Anglo Irish Bank. Vernon, a chartered surveyor, joined Dublin-based Green in 1993 and has since built his stake up to 32%. The firm's strong portfolio was valued at \u163\'a31.2 billion at its peak. In the year to June 2008, Green showed net assets of \u163\'a3392m.\par 2009: \u163\'a3280m, 207=\par 200 \u163\'a3345m \u163\'a370ms\par John Bloor Construction and motorcycles\par Triumph, the Leicestershire motorbike manufacturer, has had a renaissance under Bloor, 66. In 2009 it ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tured 13% of the British market, overtaking Kawasaki. Before buying Triumph in 1983, he turned Bloor Hol}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ings into a leading housebuilder. Bloor owns all of Triumph and we add \u163\'a325m for salaries, dividends and a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets.\par 2009: \u163\'a3275m, 211=\par 201 \u163\'a3344m \u163\'a3204m\par Simon Nixon Internet\par The co-founder of Chester-based Moneysupermarket stood down as chief executive in 2008 but still has a \u163\'a3194m stake. Nixon, 42, runs a travel site and holiday homes operation. We add \u163\'a3150m for share sales, di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 idends and property .\par 2009: \u163\'a3140m, 388=\par 202 \u163\'a3339m New entry\par Albert Heijn and family Supermarkets\par Left Bank Village, a riverside retail and leisure centre in Hereford, was sold by 83-year-old Heijn in 2007. It had been on the market for about \u163\'a34m. Heijn, a Dutchman who lives in the area, has a stake in the supe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 market group Ahold, which was founded by his grandfather. The Heijn family fortune is on the up, according to the Quote 500 Dutch rich list in 2009, which gives a total value of \u163\'a3339m.\par 203 \u163\'a3332m \u163\'a367m\par Sir Douglas Myers Brewing and technology\par Myers, 71, was knighted in New Zealand's new year honours list. Reckoned to be the 15th richest Kiwi, Lo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 don-based Myers made his fortune as head of the Campbell and Ehrenfried drinks operation. He sold his 16% stake in 1998. Three years ago, he was involved in a takeover of software firm Talgentra. Even after hefty donations to the arts, his fortune is at least \u163\'a3332m, according to National Business Review's 2009 rich list.\par 2009: \u163\'a3265m, 215= 204= \u163\'a3330m\par Sir John and Peter Beckwith Property\par London tycoons Sir John, 63, and brother Peter, 65, made their fortunes in theatres, hotels and property, notably London's Centre Point, which was sold in 2005. Sir John's Pacific Investments and Red River Capital have stakes in everything from warehouses in Asia to City property. Taking into account hotels in France and investment in a fashion agency, we stick with a \u163\'a3330m valuation .\par 2009: \u163\'a3330m, 156=\par 204= \u163\'a3330m \u163\'a3120m\par 2009: \u163\'a3397m, 134\par 190= \u163\'a3350m\par \u163\'a350m\par The Mackie family Electrical goods CEF Holdings saw profits fall from\par \u163\'a311.6m to \u163\'a33.6m in 2007-08, with net assets down sharply to \u163\'a331m. The electrical wholesaler, which has its headquarters in Warwickshire, is owned via trusts by the Swiss-based Mackie family. In the 2009 Swiss rich list, Bilan put the family at \u163\'a3592m on the back of growing Middle Eastern business, but with profits down we value the operation at just over \u163\'a3100m and the family at \u163\'a3330m.\par 2009: \u163\'a3450m, 14= 204= \u163\'a3330m New entry David Richwhite Finance The banker made his fortune in his n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tive New Zealand when, with Sir Michael Fay, he was involved in state asset sales through their company Fay Richwhite. They have been partners since 1975 and by the early 1990s were each worth \u163\'a3100m. Richwhite, 61, is now based in London and Fay in Geneva. Richwhite has been in New Zealand's National Business Review rich list for some years. He was valued at \u163\'a3330m in 2009.\par 204= \u163\'a3330m\par Nat Rothschild Finance Atticus Capital, the hedge fund co-chaired by Rothschild, closed two funds last year and returned \u163\'a31.8 billion to investors after a tough time in the markets. The 38-year-old has not lost his i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vestment appetite, reportedly buying $40m of bonds in commodities group Glencore. His holdings include a \u163\'a342m stake in RIT Capital Partners and he has homes in London and overseas.\par 2009: \u163\'a3330m, 156= 204= \u163\'a3330m Jasminder Singh and family Hotels Singh's Edwardian Group saw profits fall in 2008 from\par \u163\'a314.7m to \u163\'a33.3m. It runs 13 Radisson Edwardian hotels in London and Manchester. Singh, 59, was an a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 countant before going into the hotel business with an uncle .\par 2009: \u163\'a3330m, 156= 204= \u163\'a3330m\par \u163\'a3215m\par Ian Suttie Oil Suttie's Aberdeen-based First Oil runs 13 fields in the North Sea. In 2008-09, profits soared to \u163\'a313.5m and at current oil prices it is worth \u163\'a3250m. The 64-yearold's other operation, Nautronix, and property interests add \u163\'a380m.\par 2009: \u163\'a3115m, 474= 204= \u163\'a3330m\par \u163\'a3118m\par John Woodward Caravans and property Woodward has won approval for a 130-acre industrial park beside the M18. He is developing Woody's Adventure World and owns 20 caravan parks through Blue Anchor Le}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sure. The 67-year-old has homes in Doncaster, London, and France.\par 2009: \u163\'a3212m, 264 211= \u163\'a3325m Sir Martyn Arbib and family Finance Oxfordshire-based Arbib, 70, made about \u163\'a3413m from Perpetual, his fund manager, in 2000. He invested in digital advertising firm Litelogic and, though better known as a lover of the turf, joined a consortium that took over Swindon Town football club in 2008 .\par 2009: \u163\'a3325m, 166 211= \u163\'a3325m\par \u163\'a3175m\par Navin and Varsha Engineer Pharmaceuticals Navin, 58, and wife Varsha, 55, should see profits of \u163\'a311m in 2009-10 for Chemidex, the Surrey-based pharmaceuticals firm, and a smaller operation. The debt-free group is worth \u163\'a3300m. There is \u163\'a325m in property and assets.\par 2009: \u163\'a3150m, 362= 211= \u163\'a3325m\par \u163\'a325m\par Laurence Kirschel Property Kirschel, 47, owns lucrative chunks of London, including in the Tottenham Court Road area where the Crossrail transport project is making an impact. We can see \u163\'a3204m net assets for his Consolidated Developments and smaller operations. That total does not include Soho sites owned by Kirschel, a Hampstead resident.\par 2009: \u163\'a3300m, 178= 214= \u163\'a3320m\par Duncan Bannatyne Fitness clubs and hotels Dragons' Den star Bannatyne narrowly missed the Haiti eart}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 quake, and has pledged to invest there. The Clydebank-born tycoon, 61, operates health clubs, hotels and spas through his Darlington-based Bannatyne Group. In 2008, profits rose to \u163\'a312.5m on \u163\'a393m sales. Other assets include a villa in France.\par 2009: \u163\'a3320m, 167= 214= \u163\'a3320m\par \u163\'a395m\par John Cook and family Leisure Business is booming at the caravan park and Butlins owner Bourne Leisure, as more Britons holiday at home. In 2008, it made \u163\'a356m profit. Cook, 65, co-founded the Hertfordshire bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness and has a \u163\'a3300m stake. We add \u163\'a320m for other interests, salaries and dividends .\par 2009: \u163\'a3225m, 247=\par 214= \u163\'a3320m\par John Duffield and family Finance Duffield launched Brompton Asset Management last year after his old o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 eration, New Star Asset Management, was taken over in a \u163\'a3115m deal. He cut his teeth with Jupiter Asset Management. Share sales and other assets keep him on \u163\'a3320m.\par 2009: \u163\'a3320m, 167= 214= \u163\'a3320m\par \u163\'a320m\par Bob Edmiston Car sales and property Edmiston, 64, makes the top 10 of our Giving List again, with at least \u163\'a337m given to and by his charity, Christian Vision. Since 1998, he has donated more than \u163\'a3120m. He built IM Group, the \u163\'a3100m car importer, and IM Properties, worth \u163\'a3200m. Other interests add \u163\'a320m.\par 2009: \u163\'a3300m, 178= 214= \u163\'a3320m\par \u163\'a320m\par Harry Hyam\par Property Hyams, 82, developed London landmark Centre Point in the 1960s and is still working in property. Burglars took what was said in court to be the finest ever barometer in a multi-millionpound raid on his Wil}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 shire home.\par 2009: \u163\'a3300m, 178= 214= \u163\'a3320m\par \u163\'a325m\par Michael Oglesby and family Property Oglesby, who began as an apprentice plumber, founded Manchester's Bruntwood Property Group. The share structure is complex but we value the business at \u163\'a3300m and add \u163\'a320m to the family for smaller operations and other assets.\par 2009: \u163\'a3295m, 201=\par Customer care at full throttle\par 188 \u163\'a3358m\par \u163\'a370m, 16%t CPP Group, which offers customers protection for lost credit cards, keys and mobile phones, floated last month, valued at \u163\'a3396m. The flotation netted \u163\'a3120m for 61-year-old founder Ogston, inset. The son of a dental surgeon, he joined the Norwegian merchant navy aged 17 and worked his way around the world, his father giving him\par \u163\'a350 as he departed from London's Euston station. A vintage car enthusiast, Ogston, pictured driving his P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TER JOHNSON Hamish Ogston Business services 1921 Deemster Brooklands last year, tried his hand at a number of business ventures after graduating from university before setting up CPP with an initial investment of \u163\'a31,000 in 1980. The York group provides services to more than 11m customers worldwide despite stru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gling badly in its first decade of operation, with losses every year from 1980 until 1990. In 2008, CPP made \u163\'a325.2m profit on \u163\'a3259.5m sales. In 2009-10, turnover is expected to reach about \u163\'a3300m. Ogston retained a stake worth \u163\'a3277m after it was floated. Share sale proceeds and other assets take his wealth to \u163\'a3358m. Last year he donated more than \u163\'a31.5m to charity, chiefly to conservation and education causes.\par 2009: \u163\'a3428m, 127\par 214= \u163\'a3320m\par \u163\'a345m\par Karl-Johan Persson Fashion Hennes & Mauritz, Europe's largest fashion retailer, made Persson its chief e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ecutive last year. His father Stefan, the chairman, is estimated by Forbes to have a \u163\'a314.6 billion fortune. Persson, 35, is based in London, where he has a number of directorships.\par 2009: \u163\'a3275m, 211=\par 214= \u163\'a3320m\par \u163\'a320m\par Peter Smedvig and family Shipping and oil and gas services Scion of a line of Norwegian seafarers, London-based Smedvig, 63, sold the family business in 1995. He built up Smedvig Tankships as a leading supplier of rigs for oil and gas exploration. In 2005, the family sold its operations for more than \u163\'a3388m. Other interests include a \u163\'a320m investment in oil explorer Endeavour.\par 2009: \u163\'a3300m, 178= 214= \u163\'a3320m\par \u163\'a3120m\par Douw Steyn and family Insurance Steyn, 57, is based in Britain, having left South Africa to launch his insu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ance operation here in 1992. Peterborough-based BGL Group, formerly the Budget Group, is best known for its meerkat adverts and has 2.2m customers. The Steyn family has a stake in BGL's Guernsey parent valued at \u163\'a3270m. Dividends and assets, including stakes in a South African insurer, put the family on \u163\'a3320m.\par 2009: \u163\'a3200m, 274= 214= \u163\'a3320m\par \u163\'a320m\par Charlotte Townshend Property Townshend, 55, has 20 choice acres around London's Holland Park and 15,000 acres in Dorset, where she lives. A further 3,000 acres in Nottinghamshire were reportedly sold for \u163\'a39m. With six farming and estate companies, bloodstock and property, we raise our valuation of Townshend by \u163\'a320m.\par 2009: \u163\'a3300m, 178= 214= \u163\'a3320m\par \u163\'a360m\par Niklas Zennstrom Computers Zennstrom, 44, a keen yachtsman who won the Rolex Fastnet race last year, has been reunited with online telecom firm Skype. The London-based Swede was part of a consortium that bought back 70% of Skype from eBay in a $2 billion deal in November. Zennstrom held a \u163\'a3225m stake in Skype when it was sold for \u163\'a31.5 billion in 2005. On the back of Skype's success and his Joost online TV se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vice, we lift him by \u163\'a360m.\par 2009: \u163\'a3260m, 218= 225 \u163\'a3315m Mark Getty and family Media, inheritance and oil Grandson of the celebrated oil tycoon, Getty, 49, co-founded the world's largest photo library, Getty Images, in 1995. It was bought by a private equity firm two years ago in a deal valuing the Seattle operation at \u163\'a31 billion. London-based Getty ploughed his \u163\'a3150m stake back into it. Other assets include \u163\'a370m from the sale of a holding in the Russian energy business Gazprom and Getty's share of his father's estate.\par 2009: \u163\'a3315m, 174= 226 \u163\'a3310m\par \u163\'a39mt Lawrence Stroll Retailing London-based Canadian Stroll, 50, made \u163\'a3375m from his investment in the Tommy Hilfiger fashion brand and Pepe Jeans. He also has a stake in the New York label Michael Kors, which opened its first London outlet in Bond Street last year. He co-owned the London jeweller Asprey & Garrard, selling his stake in 2006. The 2009 Canadian Business rich list put Stroll's fortune at \u163\'a3310m.\par 2009: \u163\'a3319m, 173 227 \u163\'a3302m\par \u163\'a31m\par Peter Wilkinson Internet and software Wilkinson, 55, delisted Intechnology, his IT services provider, in 2008 saying he could achieve greater shareholder value as a private company. The Yorkshire technology tycoon founded Freeserve, a pioneer of internet for the masses, and Planet Online. Share sales and property assets are worth \u163\'a3210m, while Wilkinson's company stakes add \u163\'a392m.\par 2009: \u163\'a3301m, 177 228 \u163\'a3301m\par \u163\'a319mt Ardeshir Naghshineh and family Property Targetfollow, the Norwich property operation, was founded by Iranian-born Naghshineh in 1992. Its portfolio includes the London tower block Centre Point. Seven co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panies owned by Naghshineh and his family had \u163\'a3301m assets in 2008-09 .\par 2009: \u163\'a3320m, 167= 229= \u163\'a3300m New entry Jean-Raymond Boulle Diamonds Mauritian-born Boulle, now a British citizen, started as a buyer for De Beers. Diamond Fields Resources, which he co-founded, sold for \u163\'a31.5 billion in 1996 and he made \u163\'a3300m from his next company, Diamond Fields International. Today Boulle's mining interests include an \u163\'a311.5m stake in London-quoted Titanium Resources Group.\par 229= \u163\'a3300m\par \u163\'a310m\par Stephen Butt Finance Silchester Investors International saw profits down slightly at \u163\'a327.8m in 2008-09 on \u163\'a376m turnover. Butt, 59, owns half of the London finance business, which he set up after leaving Morgan Stanley. We value his stake at \u163\'a3225m with salaries and dividends adding to his wealth.\par 2009: \u163\'a3290m, 204= 229= \u163\'a3300m\par \u163\'a330mt Nicholas and Christian Candy Property See panel opposite 229= \u163\'a3300m New entry Bruce Craig Pharmaceuticals As a boy, Craig missed out on an England schools rugby trial because of a broken leg. His love of the sport continues, and he has just bought Bath rugby club from long-time owner Andrew Brownsword (qv). The price was not disclosed but Craig, 47, has money in the bank. He sold Marken, a pharmaceutical logistics firm, in December to a private equity buyer for a reported \u163\'a3975m and received at least \u163\'a3300m for his stake .\par 229= \u163\'a3300m\par \u163\'a3260m Philip Day Retailing Upmarket clothing chain Edinburgh Woollen Mill, based in the Borders, should make \u163\'a330m profit in 2009-10. It has more than 400 outlets nationwide and is expanding into homeware. Day, 44, owns the company, which is worth at least \u163\'a3250m. Property and other interests add \u163\'a350m.\par 2009: \u163\'a340m, 1,348= 229= \u163\'a3300m Lady Annabel Goldsmith and family Finance Goldsmith, 75, is the daug}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ter of the 8th Marquess of Londonderry and the widow of financier Sir James Goldsmith, who died in 1997. His fortune was said to have been at least \u163\'a31.2 billion. London-based Lady Annabel and her family got \u163\'a3300m.\par 2009: \u163\'a3300m, 178= 229= \u163\'a3300m\par \u163\'a390m\par Michael Hintze Finance London-based hedge fund CQS was started by Australian Hintze, 56, a prominent backer of the Conservative party. He has established the Hintze Family Charitable Foundation, supporting projects ranging from theatre and hospitals to churches and schools.\par 2009: \u163\'a3210m, 265= 229= \u163\'a3300m\par \u163\'a325m\par Anthony Lyons Property In February, Lyons, 42, had a second windfall when Liberty International took full ownership of Earls Court and Olympia - in 2007, Lyons and his partners sold half to Liberty in a deal that va}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ued it at \u163\'a3380m. London's O2 centre was recently sold by Lyons and his partners for a 36% profit in a year.\par 2009: \u163\'a3275m, 211= 229= \u163\'a3300m\par \u163\'a3100m\par Paul Marshall Finance Marshall, 50, co-founded the Marshall Wace hedge fund with Ian Wace (qv). We va}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ue it at \u163\'a3400m, with his stake worth \u163\'a3200m. Company payouts add to his total.\par 2009: \u163\'a3200m, 274= 229= \u163\'a3300m The Duke of Northumberland Land and art Northumberland Estates co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 trols 120,000 acres of land. One of the more pressing needs for the duke, 53, is to find cash for restoration work at his ancestral seat, Alnwick Castle. He has a \u163\'a3150m art collection and also owns Syon Park, which is the family's London home, land in Scotland and the 3,000-acre Albury estate in Surrey.\par 2009: \u163\'a3300m, 178= 229= \u163\'a3300m Ali Sarikhani Business services Iranian-born Sarikhani, 64, formed the London-based Chiltern Group, one of the UK's leading independent professional services groups. He sold its profitable tax planning operation, WJB Chiltern, in 2003 for a reputed \u163\'a340m.\par 2009: \u163\'a3300m, 178= 229= \u163\'a3300m\par \u163\'a3100m\par Ian Wace Finance Wace, 47, co-founded the Marshall Wace hedge fund operation in 1997 with Paul Ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 shall (qv). The company is worth \u163\'a3400m and Wace's stake is \u163\'a3200m. He has also benefited from company payouts. Wace was one of the founders of the children's charity Absolute Return for Kids and a founder tru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tee of the charity Every Child a Chance.\par 2009: \u163\'a3200m, 274= 241 \u163\'a3297m\par \u163\'a393m\par Crispin Odey and Nichola Pease Finance Hedge fund manager Odey, 51, paid himself \u163\'a330.4m in 2008-09 after his firm made a fortune betting on the near collapse of the UK banking system. Londonbased Odey A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 set Management is valued at \u163\'a3250m and Odey and his wife, Pease, 49, hold an 89.4% stake. Pease is chief executive of JO Hambro Capital Management, where she has a \u163\'a313m stake. Our total includes \u163\'a360m for Odey's salaries and dividends .\par 2009: \u163\'a3204m, 272= 242 \u163\'a3296m\par \u163\'a346m\par Sam Morrison Property Morrison, 58, runs the property business Corbo, which showed \u163\'a3296.5m of net a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets in 2008-09. He has been largely responsible for changing the look of the retail centre around Boucher Road in Belfast and has other shopping centres.\par 2009: \u163\'a3250m, 22= 243 \u163\'a3295m\par \u163\'a31m\par Sir Michael Smurfit and family Packaging and property Smurfit, 73, has a new yacht - the \u163\'a345m, 213ft Lady Ann Magee II. His remaining stake in Smurfit Kappa, the Dublin-based integrated packaging giant, is worth \u163\'a370m. Smurfit's assets include a \u163\'a340m art collection and investments in a number of private Irish firms. He is a resident of Monaco.\par 2009: \u163\'a3294m, 203 244 \u163\'a3292m\par \u163\'a32m\par Andrew Davis Hotels and aviation Davis, 46, owns 31 luxury hotels through his Von Essen company in Bri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ain and one in France. He will soon open the 70-room Hotel Verta at London Heliport in Battersea. Other interests include a property investment company, a stake in London Heliport, a fine arts business and West Country farm.\par 2009: \u163\'a3290m, 204= 245= \u163\'a3290m\par \u163\'a380mt Bhikhu and Vijay Patel Pharmaceuticals With the help of his brother, pharmacist Vijay has tran}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 formed his small chain of Essex chemists, Waymade Healthcare, into an international medicines operation. Vijay, 60, and Bhikhu, 62, above, own all the \u163\'a3200m business and have other assets.\par 2009: \u163\'a3370m, 141= 245= \u163\'a3290m\par \u163\'a320m\par The Queen Head of state See panel opposite 247 \u163\'a3285m\par \u163\'a365mt Sir Rocco Forte, Olga Polizzi and family Hotels Forte, 65, had talks with Lloyds Banking Group about \u163\'a3300m of loans to his RF Hotels and a joint venture. Crucially, the loan term\par were extended. The main holding company, Rocco Forte & Family, had \u163\'a361m net assets in 2008-09. We cut the family by \u163\'a365m, taking into account hotels owned by his sister, Polizzi, 64.\par 2009: \u163\'a3350m, 146= 248 \u163\'a3280m\par \u163\'a320mt Johan Eliasch Sports equipment Falling sales have hit Head, the sports goods manufacturer, and El}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 asch, the chief executive, has guaranteed funding for the company. He grew up in a wealthy Swedish family and will inherit a fortune when he reaches 50, in 2012. Business success and share sales have already made him a multi-millionaire, with homes in London and Marrakesh. He co-founded the charity Cool Earth to protect rainforests.\par 2009: \u163\'a3300m, 178= 249 \u163\'a3270m\par \u163\'a385m\par Tony Langley Engineering Nottinghamshire-based Langley, 55, has grown the engineering firm he started in 1976 into a multinational with more than 2,300 staff. He owns all of the \u163\'a3250m Langley Holdings and we add \u163\'a320m for other wealth.\par 2009: \u163\'a3185m, 304= 250 \u163\'a3266m\par \u163\'a316mt William Ives and family Steel and property The man of steel is supporting The Iron, as Scunthorpe United FC are nicknamed. Ives, founder of Rainham Steel, one of the town's big employers, signed a three-year sponsorship deal last year. The 66-year-old and family trusts own the \u163\'a3120m steel operation. Property companies and other assets put their total at \u163\'a3266m.\par 2009: \u163\'a3282m, 206\par Year crowned by rising wealth\par 245= \u163\'a3290m\par \u163\'a320m, 7%\par The Queen Head of state When the occasion demands, as at the state opening of parliament, nobody does pomp and circumstance like the Queen. But the sight of her catching a scheduled First Capital Connect train last December, from London King's Cross to King's Lynn en route to Sandringham, was a sign of the times. As well as conveying a green message of which her son Charles would approve (there's also a fleet of royal cars that runs on liquefied petroleum gas), the \u163\'a344.40 first-class }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  was a bargain compared with the cost of the royal train. The 84-year-old monarch has a backlog of expensive repairs to fund at Buckingham Pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ace, Windsor and other properties. Last year's Royal Public Finances report showed the head of state cost the taxpayer \u163\'a341.5m, or 69p per head over the year, and Sir Alan Reid, Keeper of the Privy Purse, noted that the royal household was paying continuous attention to "obtaining the best value for money in all areas of expenditure". Cost-cutting aside, the Queen's wealth has stood up well to recent economic turbulence, with the value of her investment portfolio, which is made up largely of shares in blue-chip British companies, ri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing to an estimated \u163\'a390m. Properties such as Sandringham and Balmoral, and the royal stud, are valued at \u163\'a3110m. We exclude the royal art collection and the Crown Estate (together worth about \u163\'a316 billion)\par from our calculations, but the Queen's jewellery, cars, horses and paintings, and the Queen Mother's legacy, lift her to \u163\'a3290m.\par 2009: \u163\'a3270m, 214\par \u163\'a320m price tag for slice of park life 229= \u163\'a3300m\par \u163\'a330m, 9%\par Nicholas and Christian Candy Property One Hyde Park, London's most expensive residential scheme, is the brainchild of the Candy brothers. It was officially launched this month when vetted and personally invited i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 terested parties viewed the show apartment for the first time. The flats are said to have bulletproof windows as well as a cinema, and the average price will be \u163\'a320m.\par Wedding bells are in the air for 35-yearold Christian, who is to marry former "It Girl" Emily Crompton. The couple, right, are planning a wedding in Monaco, where both brothers live. Nicholas, 37, inset, also has a glamorous squeeze in Holly Valance, the Australian model, actress and singer. The brothers are motoring aficionados and have doubles of each car in their garages, including two Rolls-Royces and two Ferraris. They have just the one helicopter, however. They were recently valued at \u163\'a3750m by the corporate finance chief at their Guernseybased CPC operation. The Candys are battling the Qatari royal family in the courts over the Chelsea Barracks development they jointly acquired for \u163\'a3959m in 2007. They also face legal cha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lenges relating to a $356m loan for a Beverly Hills development. Until we see progress here and at One Hyde Park, we cautiously cut them back by \u163\'a330m.\par 2009: \u163\'a3330m, 156= 251= \u163\'a3265m\par \u163\'a357m\par Lord Alliance and family Mail order and textiles Sales rose nearly 5% over the Christmas period for N Brown, the home shopping group chaired by Alliance, 78, who started out with Coats Viyella, once Britain's biggest textile company. Manchester-based N Brown's share price recovered in 2009, putting the Alliance family's stake at \u163\'a3265m.\par 2009: \u163\'a3208m, 267 251= \u163\'a3265m\par \u163\'a35m\par Paul Ruddock Finance Tory party donor Ruddock, 51, co-founded the London hedge fund Lansdowne Par}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ners, in which he has a \u163\'a3200m stake. The firm is reportedly paying Tony Blair a six-figure sum for a series of speeches. Ruddock, who has other assets, is chairman of the V&A museum's trustees and helped fund its new medieval and Renaissance galleries.\par 2009: \u163\'a3260m, 218= 253 \u163\'a3263m\par \u163\'a359m\par Mike Danson Media Danson, 47, has a \u163\'a334m stake in Progressive Digital Media, the quoted London firm that owns the New Statesman magazine. The bulk of his fortune comes from Datamonitor, the market research group, which was sold to Informa in 2007 .\par 2009: \u163\'a3204m, 272= 254 \u163\'a3262m\par \u163\'a380m\par Sir Bernard Schreier and family Industry Austrian-born Schreier made a \u163\'a351m gain on currency fluctuations in 2008. The 92-year-old, who arrived in Britain in 1955, owns the Watford business CP Holdings and has a majority stake in Danubius, a Hungarian hotel chain, and other interests.\par 2009: \u163\'a3182m, 307= 255= \u163\'a3260m\par \u163\'a310m\par Michael and Xochi Birch Internet Michael Birch, from Hertfordshire, is working with singer Julian Lennon on The Revolution, a firm that helps artists set up their own businesses. Birch started the Bebo social networ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing site in 2005 with his American wife, Xochi, 38, and brother. They made \u163\'a3260m when AOL bought Bebo in 2008. Birch, 39, a generous donor to charities, is unaffected by AOL's recent decision to close Bebo.\par 2009: \u163\'a3250m, 22= 255= \u163\'a3260m\par \u163\'a3100m\par Peter Hambro and family Mining and finance Petropavlovsk is the new name for Peter Hambro Mining, r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 branded late last year to reflect the fact that its gold mines are in Russia. London-based Hambro, 65, who made about \u163\'a393m from the sale in 2008 of the Russian Expobank to Barclays, has a \u163\'a360m stake in Petr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pavlovsk, shares in the Russian Timber Group and other assets.\par 2009: \u163\'a3160m, 350= 255= \u163\'a3260m Steven Heinz Finance Austrian Heinz, 47, has a \u163\'a3200m stake in Lan}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 downe Partners, the Mayfair hedge fund business he co-founded in 1998 with Paul Ruddock (qv), and other assets.\par 2009: \u163\'a3260m, 218= 255= \u163\'a3260m\par \u163\'a340m\par David Hood Electronics and aviation Hood, 62, co-founder of television set-top box maker Pace, saw profits soar 406% to \u163\'a369.9m on sales up 52% at the Bradford operation last year. The Yorkshire tycoon's stake in the firm is now worth \u163\'a367m. He also has an air charter operation and an 82% stake in online search group Infoserve.\par 2009: \u163\'a3220m, 251= 259 \u163\'a3253m New entry David Slager Finance After attending Haberdashers' Aske's school, Dutchman Slager, 37, went to Oxford. He worked for Goldman Sachs before being recruited by Att}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cus Capital, the New York hedge fund co-chaired by Nat Rothschild. In 2005, he made $450m, according to a survey of hedge fund managers by Alpha magazine, and $150m the following year. Last year two Atticus funds were closed but the $1.1 billion European fund, run by Slager, continued in spite of a difficult 2008. Quote 500 valued London-based Slager at \u163\'a3253m in its 2009 Dutch rich list. He helped to fund the David Slager Jewish Student Centre at Oxford, which opened in 2006 .\par 260= \u163\'a3250m\par \u163\'a390m\par Chris Dawson Retailing Dawson, 58, describes his staff as "heat-seeking missiles", always looking for new opportunities. When Plymouth was snowbound in January, 95% of his workers made it to work. Dawson knows how to tap into the British love of a bargain: there are 40 of his Range discount stores around Britain, with 10 more due to open this year. His portfolio includes a waste management business, online sales, a shopfitting company, insurance, a low-cost energy service and property in the south of France. He owns it all.\par 2009: \u163\'a3160m, 350= 260= \u163\'a3250m Dennis Gillings Pharmaceuticals Quintiles, the US pharmaceuticalservices firm founded in 1982 by London-born Gillings, has global revenues of about \u163\'a32 billion. Gillings, 66 today, moved to the US as an academic and has gifted millions to the University of North Carolina.\par 2009: \u163\'a3250m, 22= 260= \u163\'a3250m\par \u163\'a336m\par Jonas Kamprad Retailing Habitat, the home furnishings chain founded by Sir Terence Conran (qv), was sold last year by Ikea. London-based Kamprad, 44, is one of the three sons of Ikea's Swedish founder. His fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tune was put at \u163\'a3314m by Veckans Affarer's Swedish rich list but we are cautious.\par 2009: \u163\'a3214m, 261= 260= \u163\'a3250m\par \u163\'a350m\par Brian Kennedy Home improvements Kennedy, 50, owns Sale Sharks rugby club and has built a home i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 provements empire, including Weatherseal Windows. He had been supporting Kate and Gerry McCann's search for their daughter Madeleine, who went missing from a Portuguese holiday apartment in 2007, but stopped last year, citing costcutting.\par 2009: \u163\'a3300m, 178= 260= \u163\'a3250m\par \u163\'a325m\par Alan Lewis Industry Lewis, 72, runs the London-based Hartley Investment Trust, which owns J&J Crombie, Leeds maker of the classic eponymous overcoat. He also owns land in Florida and Russia.\par 2009: \u163\'a3225m, 247= 260= \u163\'a3250m\par \u163\'a370m\par James and John Martin and family Ejection seats Martin-Baker in Buckinghamshire is the world's oldest maker of ejection seats for jets. The \u163\'a3220m firm is run by the twin sons, 67, of the founder. They have other assets.\par 2009: \u163\'a3180m, 309= 260= \u163\'a3250m\par New entry Andreas Panayiotou Property Panayiotou's Cypriot mother advised him to choose business i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 stead of a boxing career. It was a good call. The Londoner, 44, sold a \u163\'a3205m chunk of his residential prope}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty portfolio just before the credit crunch and is now investing heavily in hotels. His Ability Developments showed \u163\'a3112m net assets in 2008. The accounts of his other firm\par remain private, so we value him cautiously at \u163\'a3250m.\par 260= \u163\'a3250m\par The Marquess of Salisbury Property and art The 7th marquess, 63, hosted talks about an election link-up between the Conservative party and Northern Ireland's Unionists in January at Hatfield House, his historic Hertfordshire estate. The family also has a Dorset estate, land around Leicester Square in London and in America and a treasure trove of hugely valuable artworks.\par 2009: \u163\'a3250m, 22=\par Making the right moves 287= \u163\'a3220m\par \u163\'a363m, 40%\par Peter Jones Mobile phones\par Jones, 44, tripped the light fantastic in the Sport Relief Strictly Come Dancing special, pitting his tango against the cha-cha-cha of Duncan Bannatyne (qv). Jones started a tennis coaching business at 16 and at the age of 28 was running Siemens Nixdorf's UK business. In 1998 he set up Phones International, the wir}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 less and mobile services provider now worth \u163\'a3150m. His work on Dragons' Den, the BBC's entrepreneur ta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ent show, has seen his profile soar. His Buckinghamshire-based Phones International turned in a \u163\'a35.7m profit on \u163\'a3167.1m sales in 2008-09. He also has an \u163\'a318m stake in the high-tech retailer Expansys and says all his businesses are debtfree.\par Jones's main home, in Buckinghamshire, is worth \u163\'a320m and he has other property overseas.\par 2009: \u163\'a3157m, 359= 260= \u163\'a3250m\par \u163\'a345m\par Tony Wilkinson and family Discount stores Nottinghamshire-based Wilkinson Hardware Stores has 300 home and garden outlets in the UK. In 2008, its profits fell from\par \u163\'a350.3m to \u163\'a329.4m, though sales rose to a record \u163\'a31.45 billion. We value the business, owned by Wilkinson, 73, and his family, at about \u163\'a3220m, to which we add \u163\'a330m for dividends .\par 2009: \u163\'a3205m, 268=\par 269= \u163\'a3245m\par Michael Cannon Pubs and hamburgers Durham county council granted permission in December for three tracks to be built on Wemmergill Moor in upper Teesdale, allowing visitors better access to its grouse. Ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 non, 71, bought the 17,000-acre estate in 2006. It's a new direction for the owner of the Fuddruckers ha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 burger chain in the United States, who made his initial fortune buying, refurbishing and selling several pub chains in the UK.\par 2009: \u163\'a3245m, 235= 269= \u163\'a3245m\par \u163\'a3161m\par Frank Timis Minerals, oil and gas London-based Timis, 46, from Romania, has a stake in African Minerals worth \u163\'a3162m and founded European Goldfields in 2002. Since then, he is believed to have sold shares in the firm worth about \u163\'a3100m. He also has assets in oil and gas.\par 2009: \u163\'a384m, 682= 271 \u163\'a3242m\par \u163\'a328m\par Danny Fiszman Diamonds and football Fiszman, 65, who lives in Geneva, has been leading the battle against a takeover of Arsenal, in which he has a 16.1% stake. His main source of wealth is the Star Diamond Group, which deals in every aspect of the diamond trade. He owns 91% of it.\par 2009: \u163\'a3214m, 261= 272= \u163\'a3240m Nigel Blackwell and family Media Blackwell, 63, leads the family that owns the Oxford-based eponymous bookseller. We value the business on its \u163\'a323m net assets, add \u163\'a3222m to the family's wealth for other assets, including proceeds from the sale in 2006 of its separate Blackwell Publishing operation, and deduct \u163\'a35m for a donation in 2008 by Blackwell's uncle Toby to Oxford's Bodleian Library.\par 2009: \u163\'a3240m, 237 272= \u163\'a3240m\par \u163\'a35m\par Mark Burnett and Roma Downey Television Rock'n'roll Fantasy Camp, due to be screened on the VH1 Cla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sic channel in America in July, is the latest reality TV show to emerge from Mark Burnett Productions, based in Hollywood. Essex-born Burnett, 49, owns the \u163\'a3215m firm and has other assets worth \u163\'a315m. In 2007, he married Irish actress Downey, 49. We add \u163\'a310m for her wealth.\par 2009: \u163\'a3235m, 238= 272= \u163\'a3240m\par \u163\'a320m\par Lord Iliffe and family Media Yattendon Investment Trust, the Iliffe family's Berkshire company, owns 40 local newspapers and Channel TV, plus property and marina interests. We value the family, led by Iliffe, 65, at \u163\'a3240m.\par 2009: \u163\'a3220m, 251= 272= \u163\'a3240m\par \u163\'a360m\par Harpal Matharu and family Property and hotels The Matharu brothers, Raj, Tony and Harpal, 53, began tur}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing empty offices into hotels in the 1980s. Net assets at their Globalgrange company in London grew from\par \u163\'a3224.4m to \u163\'a3267.2m in 2008-09. They take little out of the firm.\par 2009: \u163\'a3180m, 309= 272= \u163\'a3240m New entry Lance Uggla Finance Canadian bond trader Uggla, 48, co-founded the financial data provider Markit in Hertfordshire in 2001. It is 70% owned by banks, employs about 1,400 people and has offices worldwide. Recent press reports put a \u163\'a33 billion valuation on the business. Chief executive Uggla's 8% stake is worth \u163\'a3240m.\par 277 \u163\'a3238m\par \u163\'a398m\par Anthony Green and family Soap Swine flu fears last year led to soaring sales of anti-bacterial products and a 67% share price rise at soapmaker PZ Cussons. Chairman Green, 59, leads one of the Manchester firm's founding families.\par 2009: \u163\'a3140m, 388= 278 \u163\'a3235m\par \u163\'a33m\par Edward Atkin and family Babycare products Atkin's fortune comes from Cannon Avent, the Suffolk-based babycare business founded by his father, which he built up and sold in 2005, netting about \u163\'a3212m after tax for the family's stake. The 65-year-old has other assets.\par 2009: \u163\'a3232m, 242 279= \u163\'a3234m\par \u163\'a394m\par Surinder Arora and family Hotels Arora Holdings' net assets rose to \u163\'a3227m in 2008-09 on the back of the new Sofitel at Heathrow's Terminal 5, which won a "best new business hotel in the world" award last year. The operation is owned by its founder, Arora, 51, his wife, Sunita, and family trusts. The Surrey couple have other assets.\par 2009: \u163\'a3140m, 388= 279= \u163\'a3234m\par \u163\'a336m\par Cristina Stenbeck Media London-based Stenbeck, 32, was named one of the world's 50 most powerful bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nesswomen by the Financial Times in September. She chairs Kinnevik, the family empire, which includes Metro newspapers, telecom operator Tele2 and renewable energy businesses .\par 2009: \u163\'a3198m, 289 281= \u163\'a3230m Vikrant Bhargava Internet gambling SocialGO, which helps build social ne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 working sites, is the latest start-up to be backed by Veddis Ventures, an investment company founded by Bhargava, 37. The former electrical engineer, based in Gibraltar, made his first fortune with online casino Party Gaming.\par 2009: \u163\'a3230m, 243= 281= \u163\'a3230m Ray O'Rourke and family Construction Irish-born O'Rourke, 63, joined the board of mining organisation Anglo American in December. He founded the \u163\'a3200m Kent-based building group Laing O'Rourke in 1977. We add \u163\'a330m for other assets.\par 2009: \u163\'a3230m, 243= 281= \u163\'a3230m Hugh Osmond Pubs and insurance Horizon Acquisition Company, O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mond's new venture, raised more than \u163\'a3400m to spend on distressed businesses when it floated in London in February. Past lucrative ventures include Punch Taverns and the Spirit Group. Osmond, 48, also has a stake in the insurer Pearl.\par 2009: \u163\'a3230m, 243= 281= \u163\'a3230m Sir Paul and Lady Smith Fashion Smith, 63, has a stake in his own No}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tingham-based worldwide fashion brand worth \u163\'a3150m. A share sale by his wife, Pauline, 69, and other a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets put the pair on \u163\'a3230m.\par 2009: \u163\'a3230m, 243= 285= \u163\'a3225m Alexander Hoare and family Finance The historic C Hoare & Co bank in Fleet Street is owned by Hoare, 48, and his family. We value it at \u163\'a3200m and add \u163\'a325m for other interests.\par 2009: \u163\'a3225m, 247= 285= \u163\'a3225m Sir Stanley and Peter Thomas Property and transport Sir Stanley, 68, is building an \u163\'a38m golf course near Cardiff. He and his brother Peter, 66, made their fortune with Peter's Pies, the family business, before buying property and airports via the TBI group, which they sold in 2004, netting \u163\'a3106m. They have other wealth.\par 2009: \u163\'a3225m, 247=\par 287= \u163\'a3220m\par \u163\'a320m\par Manny Davidson and family Property The Manny Davidson Trust bought a parade of Guildford shops for \u163\'a313.5m in December. However, Davidson, 79, based in London, lost his right-hand man when Jonathan Rose joined the William Pears Group as its property director. The family's assets include Fungo, a property company .\par 2009: \u163\'a3200m, 274= 287= \u163\'a3220m\par \u163\'a363m\par Peter Jones Mobile phones See panel on page 41 287= \u163\'a3220m Paul Newey Finance Newey, 41, sold his Staffordshirebased loan and mortgage group, Ocean Finance, to AIG in 2006 for an undisclosed sum rec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 oned to have been about \u163\'a3200m. We add \u163\'a320m to his wealth for other assets.\par 2009: \u163\'a3220m, 251= 287= \u163\'a3220m Gerard O'Hare Property O'Hare, 52, was awarded a CBE in the new year's honours list for services to higher education and regeneration. The entrepreneur says he is not making a penny from the huge queues of shoppers coming across the Irish border to shop at his Quays shopping ce}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tre in Newry - it is his tenants who are raking in the cash. His Newry-based Parker Green International owns land in New Jersey, a shopping mall in Connecticut and assets in central and eastern Europe. He is a visiting professor at the University of Ulster, where he has endowed a chair of property development and design.\par 2009: \u163\'a3220m, 251= 287= \u163\'a3220m Josie Rowland and family Inheritance Rowland, 66, chairs Anderson & Sheppard, London tailor to the rich and famous, but is better known as the widow of Tiny Rowland, one of the great business buccaneers of the 1970s. She inherited his fortune in 1998.\par 2009: \u163\'a3220m, 251= 287= \u163\'a3220m\par \u163\'a325m\par Hugh Sloane Finance Profits at the London hedge fund Sloane Robinson fell from\par \u163\'a3340.7m to just \u163\'a361m in 2008-09. It still paid out \u163\'a383.5m to its partners, however. Sloane, 54, launched the business with George Robinson (qv)\par in 1993. We believe that Sloane owns about 25% of it.\par 2009: \u163\'a3195m, 291= 348= \u163\'a3185m\par \u163\'a310m, 6% s Sir Elton John Music It's been a busy year for John, 63, whose career shows no signs of playing itself out. This month, freshly listed as the seventh most played artist of the past decade, he celebrated the fifth anniversary of Billy Elliot, the stage show for which he wrote the songs, with 19 of the 22 actors who have played Billy at the Victoria Palace theatre in London. Asked about the milestone, he said: "I feel very young and inspired." The show, a 10-time Tony award winner, is on a sellout US tour and opens in South Korea in August. Days later, John entertained an audience of 6,000, who paid up to $800 each at a concert at the Mayan pyramids of Chichen Itza in Mexico. He and Lady Gaga may duet on the theme song for the next Bond movie and he could replace Simon Cowell (qv)\par as a judge on Pop Idol. With nearly 100 gigs to his credit in 2009, he played the last of his five-year Red P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ano shows, at $750,000 a performance, at Caesars Palace in Las Vegas, then promptly took the show to Moscow. He pocketed at least \u163\'a31m last year for appearing in the city at the birthday party of a Russian ol}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 garch's wife. John's prodigious work ethic goes in part to support his flower and designer clothing habit, but he gives back. Gleeful shoppers this spring swooped on his immaculate castoffs, donated to a Hove charity shop on behalf of the Elton John Aids Foundation. Since 2004, the Giving List has tracked \u163\'a3180m of don}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions by the star, and he spent his 63rd birthday in March improving Aids awareness in South Africa. He re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ularly gives performances in aid of other causes, notably breast cancer research and the Royal Academy of Music. Pollstar reported takings of $88m from 31 dates with Billy Joel, and $14.2m from 25 solo shows in North America last year, while three of his companies - William A Bong, J Bondi and Happenstance - have paid John more than \u163\'a3223m in salary to date. Our rock expert says his earnings came in at about \u163\'a330m a year with his touring and we raise him to \u163\'a3185m.\par 2009: \u163\'a3175m, 322= 287= \u163\'a3220m\par \u163\'a3105m\par Andrew Wates and family Construction Surrey-based Wates Group saw profits jump by \u163\'a310m to \u163\'a347m in 2008. Wates, 69, who heads the family, retired as chairman in 2006. The firm, which worked on redevelo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment of the Queen's Gallery at Buckingham Palace, is worth \u163\'a3180m and there are other assets.\par 2009: \u163\'a3115m, 474=\par 294= \u163\'a3215m\par \u163\'a310m\par Mike Clare Beds The founder of Buckinghamshire bed chain Dream\par is launching a retailer of outsize clothing. Clare, 55, sold Dream\par for \u163\'a3230m in 2008. He made \u163\'a3189m after tax, to which we add other assets and \u163\'a320m reinvested in the business .\par 2009: \u163\'a3205m, 268= 294= \u163\'a3215m\par \u163\'a320mt Damien Hirst Art Bristol-born Hirst's art suffered a steep fall in value during 2009, but this will have done little to dent his fortune. In 2008, Hirst, 44, sold \u163\'a3111m of his artworks at Sotheby's. This followed a sale the previous year that raised \u163\'a3130m. As well as owning studio space in London, he has a \u163\'a33m estate in Gloucestershire. We put Hirst at \u163\'a3215m allowing for tax.\par 2009: \u163\'a3235m, 238= 294= \u163\'a3215m Dionysios Liveras and family Food and yachts The Anglo-Cypriot Liveras family's patriarch, Andreas, was murdered in the 2008 Mumbai terrorist attack. Now led by Dionysios, 51, the family netted \u163\'a3130m when its Nottinghamshire firm, Laurens Patisseries, was taken over in 2006. There is a thriving yacht charter business in Monaco and property .\par 2009: \u163\'a3215m, 260 294= \u163\'a3215m\par \u163\'a320m\par George Robinson Finance Sloane Robinson, the London hedge fund, had a difficult 2008-09, making just \u163\'a361m. Hugh Sloane (qv), a City fund manager, teamed up with Robinson, 53, to launch Sloane Robinson Investment Management in 1994. We value the business at \u163\'a3400m. Robinson has other wealth.\par 2009: \u163\'a3195m, 291= 298 \u163\'a3214m\par \u163\'a314m Greg Coffey Finance The high-flying 39-year-old hedge fund trader had a prosperous 2009, with his Moore Emerging Markets fund up 18.3%. The Australian made the GLG operation one of the star funds in London. In late 2008, he moved to Louis Bacon's (qv)\par Moore Capital. Coffey was valued at \u163\'a3214m in the 2009 Australian rich list.\par 2009: \u163\'a3200m, 274= 299 \u163\'a3213m\par \u163\'a320m\par Geoffrey Kent Travel Monaco-based Kent, 67, is wooing wealthy Europeans to his Abercrombie & Kent bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness. He received about \u163\'a3133m for selling a stake to Intrawest, a Canadian tour group, in 2004 and his r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 maining share is worth \u163\'a370m. Assets such as property in Florida add \u163\'a310m.\par 2009: \u163\'a3193m, 296 300= \u163\'a3210m\par \u163\'a360m\par Robert Adair Oil, gas and property Melrose Resources, the Edinburgh oil exploration group started by Adair, 53, is worth \u163\'a3355m. His stake is about \u163\'a3177m and he also chairs Terrace Hill, a quoted property group.\par 2009: \u163\'a3150m, 362= 300= \u163\'a3210m\par \u163\'a360m\par Lord Heseltine and family Publishing Heseltine, 77, has handed over the reins at his Haymarket Publishing Group to his son, Rupert. It has increased profits and we raise the company's value to \u163\'a3200m, adding \u163\'a310m for other assets.\par 2009: \u163\'a3150m, 362= 300= \u163\'a3210m\par \u163\'a3115m\par The McAlpine family Construction Newarthill, the parent company of construction-to-property group Sir Ro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ert McAlpine, saw profits fall in 2008 from\par \u163\'a345.9m to \u163\'a333m. We value the Hemel Hempstead-based business at \u163\'a3200m and past dividends take the McAlpine family to \u163\'a3210m.\par 2009: \u163\'a395m, 575= 300= \u163\'a3210m\par \u163\'a3111m\par Robert Rayne and family Property Quoted property group Derwent London is worth nearly \u163\'a31.3 billion and is chaired by Rayne, 61. The family's stake is valued at \u163\'a3181m and there is also \u163\'a326m in LMS Capital. The family is involved in charity work through the Rayne Foundation .\par 2009: \u163\'a399m, 566= 300= \u163\'a3210m\par \u163\'a3110m\par Jack Tordoff Car sales A much-improved performance in 2009 saw JCT 600, Tordoff's motor trader, swing back to a \u163\'a38.2m profit on \u163\'a3465m sales. Audi dealerships were added to the Yorkshire firm's stable. Tordoff, 74, runs and owns the \u163\'a3190m business with his family trusts.\par 2009: \u163\'a3100m, 540= 305 \u163\'a3209m\par \u163\'a34m Alastair and Michael Powell Cabling and property Established by brothers Alastair, 57, and Michael, 52, Cleveland Cable distributes electrical cable in Europe. Profits at the Middlesbrough company fell from\par \u163\'a327.2m to \u163\'a36.1m in 2008-09 while a property operation, Cable Properties & Investments, showed nearly \u163\'a372m net assets.\par 2009: \u163\'a3205m, 268= 306 \u163\'a3207m\par \u163\'a312m Pierre Lagrange Finance Lagrange, 48, is a Belgian who has lived in London for 20 years. A former Goldman Sachs trader, he co-founded the GLG hedge fund in 2000. Lagrange, who sold his Oxfordshire mansion for \u163\'a312m last year, has a stake worth \u163\'a3107m and we add \u163\'a3100m for other assets.\par 2009: \u163\'a3195m, 291= 307 \u163\'a3205m\par \u163\'a390m John Kirkland and family Construction Kirkland, 72, is chairman of Bowmer & Kirkland, the Derbyshire construction group. In the year to August 2008, profits rose by 18% to a record \u163\'a343.2m. We value Bowmer & Kirkland at \u163\'a3180m and the family has other interests.\par 2009: \u163\'a3115m, 474= 308 \u163\'a3201m\par \u163\'a321m Firoz Kassam Hotels Kassam, 55, owns the land on which London's Alexandra Palace stands but has failed through his Firoka (Heythrop Park)\par operation to redevelop the site as a hotel. The former owner of Oxford United FC, he sold the club for \u163\'a31. His hotel firm\par have \u163\'a3141m net assets. Other interests and cash add \u163\'a360m.\par 2009: \u163\'a3180m, 309= 309= \u163\'a3200m Martin Ainscough and family Cranes Founded in 1976, Wigan-based Ai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 scough Crane Hire was sold in 2007 for \u163\'a3255m. Ainscough, 57, and his family received about \u163\'a3230m for their stake. After tax, the family is worth \u163\'a3200m.\par 2009: \u163\'a3200m, 274= 309= \u163\'a3200m David Babai Travel Babai, 67, netted about \u163\'a3251m before tax in 2004 when he sold London-based Gullivers Travel Associates to the Cendant travel group.\par 2009: \u163\'a3200m, 274= 309= \u163\'a3200m\par \u163\'a380mt Sir Michael Bishop Transport Bishop, 68, sold his majority stake in the Midlands airline BMI to Lufthansa for \u163\'a3223m last year as a troubled merger was completed. Allowing for tax on that payout and other assets, the former chairman of BMI is worth \u163\'a3200m.\par 2009: \u163\'a3280m, 207= 309= \u163\'a3200m\par \u163\'a320mt Steve and Clive Boultbee Brooks Property The brothers, Steve, 49, and Clive, 46, own Boultbee, the largest private owner of UK shopping centres. The London-based operation has focused on the Nordic r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gion of late, and in 2008 sold Helsinki's Kamppi shopping centre for about \u163\'a3390m.\par 2009: \u163\'a3220m, 251= 309= \u163\'a3200m\par \u163\'a320mt Sir Ronnie Cohen Finance Egyptian-born Cohen, 64, made his fortune with Apax Partners, the Lo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 don private equity group. His main work now is chairing Bridges Ventures, which invests in deprived areas. With hefty charitable donations taken into account, we lop \u163\'a320m off Cohen's fortune .\par 2009: \u163\'a3220m, 251= 309= \u163\'a3200m Janet de Botton and family Art and inheritance De Botton, 58, is one of Britain's top bridge players. She is the former wife of Michael Green (qv)\par and widow of Gilbert de Botton, the London-based Swiss financier who sold Global Asset Management for \u163\'a3234m in 1999, a year before his death.\par 2009: \u163\'a3200m, 274= 309= \u163\'a3200m\par \u163\'a350m\par Robert Earl Restaurants London-born Earl, 58, sold the Planet Hollywood Resort & Casino in Las Vegas in February for an undisclosed sum. He retains the Planet Hollywood restaurants in the United States, and is the main shareholder in Everton FC.\par 2009: \u163\'a3150m, 362= 309= \u163\'a3200m Jayne Ellis Inheritance When Joe Bamford died in 2001, the Swiss-based founder of the JCB construction empire left his \u163\'a3200m estate, and a stake in the firm, to Ellis, 64, his former secretary.\par 2009: \u163\'a3200m, 274= 309= \u163\'a3200m John Goulandris Shipping London-based Goulandris, 81, who dabbled with electric cars in the 1970s, is one of three Greek brothers with a shipping empire. He has a \u163\'a3200m slice of the family fortune .\par 2009: \u163\'a3200m, 274= 309= \u163\'a3200m New entry Andy Hall Finance Hall, 58, is one of the top oil traders on Wall Street. He joined Phibro and began betting that oil would rise from a $30-a-barrel low point in 2003. He bailed out in 2008, just before it hit a record $147, earning Citigroup, which had bought Phibro, $630m. Bri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ish-born Hall pocketed a $100m bonus last year .\par 309= \u163\'a3200m New entry James and Fitriani Hay Oil and horse racing Glasgow-born Hay, 59, was a BP senior executive. The racing enthusiast and his wife, Fitriani, own Dubai-based JMH Group. See panel on page 83.\par 309= \u163\'a3200m Colin Hill Property Originally from the East End of London, Hill, 55, has been involved in many businesses including car repossession, financing and leasing, aircraft salvage, property and timeshare. He owns property in Portugal and Peterborough United FC's ground, as well as a Suffolk mansion .\par 2009: \u163\'a3200m, 274= 309= \u163\'a3200m\par \u163\'a350m\par Barry Houghton Electronics Houghton, 62, took delivery in the summer of Salperton IV, a 147ft yacht that cost more than \u163\'a313m. It was named after his English estate. Based in Switzerland, Houghton is a shrewd developer in the high-end residential market, but initially made his money in electronics with Rainford, which he sold for \u163\'a380m.\par 2009: \u163\'a3150m, 362= 309= \u163\'a3200m New entry Nemir Kirdar Finance Kirdar, 73, left Iraq in 1958 and subs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 quently launched Investcorp, the Bahrain-based venture capital group. He now lives and works in central London.\par 309= \u163\'a3200m Arthur Landon Inheritance Landon, 28, top of our Young Rich List on page 80, recently hosted a shooting party for Prince William and Kate Middleton. His wealth comes from his late father, Tim, who was rewarded handsomely for his role in the 1970 coup that deposed the Sultan of Oman.\par 2009: \u163\'a3200m, 274= 309= \u163\'a3200m\par \u163\'a350mt Sir John Madejski Publishing, property and football Madejski made \u163\'a3174m from selling the Auto Tra}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er publishing group in 1998. He owns a majority stake in Sackville Properties, which is planning a \u163\'a3400m development next to Reading station. Madejski, 68, chairs Reading FC and owns most of the club. Other interests include a radio station, a hotel in the Galapagos Islands, a Chinese bottling plant, and publishing and printing operations. He has helped the Royal Academy of Arts, the Victoria and Albert Museum and Reading University, where he is chancellor.\par 2009: \u163\'a3250m, 22=\par Smart casual 354= \u163\'a3180m\par \u163\'a3110m, 157%\par Julian Dunkerton Fashion Street-chic hoodies are the staples of Dunkerton's Superdry clothes label, as seen on the likes of David Beckham (qv)\par and High School Musical's Zac Efron. A market float in March saw share prices in the parent company S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 perGroup soar, valuing it at \u163\'a3444m. Dunkerton's global operation has its roots in Hereford, not generally in the league of Paris and Milan but the nearest county town to where his former BBC producer father moved to make organic cider in the 1980s. "Nobody there had access to the clothing I had in London," Dunkerton, 45, said. At 19 he set up shop in Hereford, lugging clothes by the bin-bagful from London. It was Margaret Thatcher's Enterprise Allowance Scheme grant of \u163\'a340 a week that got him to Cheltenham - where Supe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Group is based - to start Cult Clothing from a market stall. SuperGroup has 40 stores in the UK, 17 of which opened last year, under the names Superdry and Cult, and 54 concessions in House of Fraser. Designer James Holder (qv), credited with the Superdry concept, and international sales head Theo Karpathios (qv)\par also received windfalls in the flotation. Dunkerton's holding is worth about \u163\'a3147.5m and he made almost \u163\'a350m more before tax from selling part of his original stake.\par 2009: \u163\'a370m, 793= 309= \u163\'a3 200m Helly Nahmad Art Nahmad, 33, is a member of an art dealing family rec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 oned to be the world's second largest after the Wildensteins. He has Italian nationality but went to school in London. The family owns up to 5,000 art works, including 300 Picassos.\par 2009: \u163\'a3 200m, 274= 309= \u163\'a3 200m\par \u163\'a3 30m\par The Shepherd family Construction The collapse of Wakefield's Trinity Walk retail scheme contributed to the Shepherd Group's \u163\'a3 1.5m loss on turnover of \u163\'a3 697.5m in the year to June 2009. Shepherd Building in York, the parent company, is owned by the family. We value it at \u163\'a3 180m and add \u163\'a3 20m for past dividends .\par 2009: \u163\'a3 170m, 33= 327 \u163\'a3 199m\par \u163\'a3 4m Peter Harrison and family Computers Harrison, 72, bought and sold three retail parks last year, making a \u163\'a3 10m profit. He won't see a penny because it was done on behalf of his Peter Harrison Foundation, which helps disabled and disadvantaged people. Harrison, a chartered accountant from Cheshire, made his fortune with Chernikeeff, a computernetwork integration firm he sold in 2000.\par 2009: \u163\'a3 195m, 291= 328 \u163\'a3 198m\par \u163\'a3 68m Lord Harris and family Carpets Harris, 67, and his family have a \u163\'a3 135m stake in Carpetright, the floor covering chain he founded, based in Essex. Other assets include a \u163\'a3 5m stake in Arsenal FC. Harris, a backer of the Tories, has given \u163\'a3 100m to charity over the years.\par 2009: \u163\'a3 130m, 406= 329 \u163\'a3 196m\par \u163\'a3 4m David Mabey and family Construction Reading-based Mabey Holdings, owned by the 48-year-old and his family, has 13 subsidiaries. One, Mabey Bridge, plans a \u163\'a338m expansion that would make it the biggest UK manufacturer of wind turbine towers. Last year another, Mabey & Johnson, was fined \u163\'a3 3.5m for breac}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing UN sanctions against Iraq and bribing foreign officials.\par 2009: \u163\'a3 200m, 274= 330= \u163\'a3 195m\par \u163\'a3 29m Michael Gooch Finance Essex-born Gooch, 51, founded GFI Group, the New York-based brokerage operation. His stake is worth about \u163\'a3 145m. He has other assets.\par 2009: \u163\'a3 166m, 344= 330= \u163\'a3 195m\par \u163\'a3 10m Mike Gooley Travel Former SAS soldier Gooley, 73, owns Trailfinders, the Londonbased travel age}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cy. In 2008-09, it made a \u163\'a3 7.4m profit on record sales of \u163\'a3 634.4m. He owns houses in Berkshire, London and Spain and would be worth more had he not made hefty donations to charity .\par 2009: \u163\'a3 205m, 268= 330= \u163\'a3 195m\par \u163\'a3 25m Manfred Gorvy and family Property and food South African-born Gorvy, 71, runs Hanover Acceptan}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es, a London-based property, food and financial services group worth \u163\'a3 180m. The family has other wealth from dividends .\par 2009: \u163\'a3 170m, 33= 330= \u163\'a3 195m\par \u163\'a3 15m Jonathan Green Finance Green, 50, has a stake in the quoted telecom\par group Sepura worth nearly \u163\'a3 10m. A notable donor to charity, he made his fortune as a co-founder of the GLG hedge fund group in London but left the business in 2003 .\par 2009: \u163\'a3 180m, 309= 334= \u163\'a3 192m\par \u163\'a3 87m Richard Harpin Household repairs\par Harpin, 45, founder of Homeserve, the Walsall-based insurance and repair services firm, is forecasting strong growth for 2009-10. His stake in the business is worth \u163\'a3 182m. We add \u163\'a3 10m for other assets.\par 2009: \u163\'a3 105m, 510= 334= \u163\'a3 192m New entry William Parente and family Inheritance Parente, 59, inherited artworks, 62,000 acres in Nottinghamshire including the Welbeck Abbey estate, 45,000 acres in Scotland, Bothal Castle in Northumberland and 30 valuable acres around Harley Street in central London when his aunt, Lady Anne Bentinck, died in 2008 .\par 336= \u163\'a3 190m\par \u163\'a3 10m Andrew Brownsword Greetings cards and hotels Brownsword, 62, owns Abode Hotels, a stylish chain, with the Michelin-starred chef Michael Caines, and the \u163\'a3 30m sports retailer Snow+ Rock. He made his first fortune building up a greetings card company in Bath, which he sold to the Hallmark group in 1994 for \u163\'a3 165m. He sold his stake in Bath rugby club to Bruce Craig (qv)\par earlier this month.\par 2009: \u163\'a3 180m, 309= 336= \u163\'a3 190m New entry Tony Cann and family Industry The parent company of ele}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tronic whiteboard maker Promethean, based in Blackburn, was valued at \u163\'a3 400m last month when it floated in London. Cann, 71, and his trusts have a \u163\'a3 160m stake in the business, which he co-founded. Other family assets include a metal group, a specialist cycle company and a chemical operation .\par 336= \u163\'a3 190m\par \u163\'a3 15m Martin Hughes Finance Hughes, known in the City as the "Rottweiler", oversaw a 47% improvement in the performance of his Toscafund hedge fund last year, after an awful 2008. With that gain, we value Tosc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fund at \u163\'a3 120m. Hughes, 48, has another London company, Toscafield, with net assets of \u163\'a3 15m. We add \u163\'a3 55m to his wealth for past dividends and salaries.\par 2009: \u163\'a3 175m, 322= 336= \u163\'a3 190m Sir Mick Jagger Music Will the Rolling Stones go on the road again? There's no word yet, but it will be hard for them to top the \u163\'a3 390m they made in gross box office receipts on their last excursion, the 2007 Bigger Bang world tour. Clearly lead singer Jagger, 66, who lives in Surrey, has considerable wealth, despite the absence of any accounts for the band. Weighing up royalties from decades of hit records, property, song rights and touring income against declining asset values and last year's inactiv}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty, our rock expert keeps him on \u163\'a3 190m.\par 2009: \u163\'a3 190m, 297= 336= \u163\'a3 190m\par \u163\'a3 42m\par Elisabeth Murdoch and Matthew Freud Media Murdoch, 41, daughter of The Sunday Times proprietor Rupert Murdoch, saw a \u163\'a3 14.3m profit on \u163\'a3 238.6m sales in 2008 at Shine, her London-based TV production co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pany. It has come up with a string of hits, including MasterChef. The stake owned by Murdoch and her trusts is worth \u163\'a3 134m. Her husband, Freud, 46, sold a 50.1% stake in his Freud Communications business to France's Publicis Groupe in 2005. His clients include Sony and Diageo.\par 2009: \u163\'a3 148m, 378= 336= \u163\'a3 190m\par \u163\'a3 10m Alan Murphy Toilet rolls and property Murphy, 61, co-founded AM Paper, a manufacturer of toilet rolls, in 1983 and made \u163\'a3 150m selling off his equity in it. The Liverpool supporter now bankrolls property group Nikal. Born in Bootle, Merseyside, he is based in Monaco.\par 2009: \u163\'a3 180m, 309= 336= \u163\'a3 190m\par \u163\'a3 25m Irvine and James Sellar Property Work started last year on the Shard of Glass building in London, the brainchild of developer Irvine Sellar, 71, above, who has a 20% stake in it. He and his son, James, 37, have plenty of other interests: we can see about \u163\'a3 134m of net assets in a dozen firm\par run by them.\par 2009: \u163\'a3 165m, 346= 336= \u163\'a3190m\par \u163\'a320m Michael Uren and family Industry Uren, 86, sold his slag cement firm, Caterham-based Civil & Marine, in 2006 and should have netted \u163\'a3 200m after tax for it.\par When asset values fell in 2008, his wealth dropped. His nest egg is a little healthier now.\par 2009: \u163\'a3 170m, 33= 336= \u163\'a3 190m Dave Whelan and family Sports goods Wigan Athletic's owner has seen the club struggle in the Premier League this season. Whelan, 73, is a former footballer whose career ended when he broke his leg playing for Blackburn Rovers in the 1960 FA Cup final. He made his fortune building up and then selling the JJB Sports retail chain.\par 2009: \u163\'a3 190m, 297= 336= \u163\'a3 190m Ed Wray Internet gambling In 2008-09, Betfair, the Londonbased online betting exchange, made a profit of \u163\'a3 42.2m on sales of \u163\'a3 292.9m. We value the firm, founded by former i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vestment banker Wray, 42, and Andrew Black (qv), at \u163\'a3 1.5 billion. Wray has a 12.1% stake and other a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets.\par 2009: \u163\'a3 190m, 297= 346 \u163\'a3 189m\par \u163\'a3 14m\par Nigel and Trevor Green Film\par Entertainment Group, the London film distributor and DVD company founded by the Green brothers'' father, Michael, made an \u163\'a3 8m profit on \u163\'a3 126.3m sales in 2008-09. We value the firm on its \u163\'a3 159m net asset figure and add \u163\'a3 30m for past salaries and dividends earned by Nigel, 53, and Trevor, 56.\par 2009: \u163\'a3 175m, 322= 347 \u163\'a3 188m\par \u163\'a3 43m\par Sten Mortstedt and family Property Mortstedt's London-based CLS property group has been selling surplus properties in France and Sweden while buying in Germany. Its share price has recovered since the crash of 2008 and the family's stake is now worth about \u163\'a3 131m. We add \u163\'a3 57m for other assets owned by the Swede, 70.\par 2009: \u163\'a3 145m, 382= 348= \u163\'a3 185m\par \u163\'a3 88m\par Assem Allam and family Marine generators Egyptian-born Allam, 70, owns Allam Marine in Hull, worth \u163\'a3 150m on its latest figures. The family also has a development firm with \u163\'a3 1.5m of net assets and \u163\'a3 35m of personal property. We knock \u163\'a3 1.5m off their wealth for a donation to the University of Hull.\par 2009: \u163\'a3 97m, 570= 348= \u163\'a3 185m Andrew Black Online gambling A professional gambler, Black founded online betting platform Betfair in 2000 with Ed Wray (qv)\par because he resented the money that bookmakers were collecting. Softbank, the Japanese group, took a stake in the London-based operation in 2006 that valued it at \u163\'a3 1.5 billion. Black, 46, has an 11.66% stake in Betfair and other assets.\par 2009: \u163\'a3 185m, 304= 348= \u163\'a3 185m\par \u163\'a3 10m\par Sir Elton John Music See panel on page 43 351= \u163\'a3 183m\par \u163\'a3 88m\par Jan Hruska Computer security Sophos, the IT security company, is hoping to float on the Nasdaq stock ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ket this year with a \u163\'a3 600m-plus valuation. The Oxford-based firm, founded by Hruska, 53, and Peter La}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mer (qv), is a world leader in anti-virus software. Hruska and Lammer each have a \u163\'a3 180m stake in the bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness, and we add \u163\'a3 3m for other assets.\par 2009: \u163\'a3 95m, 575= 351= \u163\'a3 183m\par \u163\'a3 88m\par Peter Lammer Computer security Lammer, 51, has shares worth \u163\'a3 180m in Sophos, the computer anti-virus firm he founded in Oxford with Jan Hruska (qv), and other assets.\par 2009: \u163\'a3 95m, 575= 353 \u163\'a3 182m\par \u163\'a3 82m\par Sukhpal Singh Ahluwalia Car parts Ahluwalia, 51, owns Euro Car Parts, a 70-branch supplier of specialist car parts based in Wembley. Profits in 2009 more than doubled to \u163\'a3 17m on sales of \u163\'a3 186.9m.\par 2009: \u163\'a3 100m, 540= 354= \u163\'a3 180m\par \u163\'a3 128m\par James Benamor Finance Benamor, 32, made his fortune by broking loans through his Bournemouth-based Richmond Group to borrowers turned down by mainstream lenders. Its profits rose to \u163\'a3 12.8m on \u163\'a3 36.3m sales in 2008-09, and it is worth \u163\'a3 180m.\par 2009: \u163\'a3 52m, 1,046= 354= \u163\'a3 180m The Duke of Buccleuch and family Land Buccleuch Estates, the property arm of the duke's family, plunged from a \u163\'a3 4.1m profit to a near\u163\'a3 18m loss on sales of \u163\'a3 64.6m in 2008. It had net assets of \u163\'a3 118m. Art treasures and antiques keep Buccleuch, 56, one of Scotland and Northam}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tonshire's biggest landowners, on last year's valuation.\par 2009: \u163\'a3 180m, 309= 354= \u163\'a3 180m\par \u163\'a3 75m\par Arpad Busson and Uma Thurman Finance and filmsLondon-based financier Busson's romance with Holl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 wood actress Thurman, 39, seemed to be off in the winter but they have since been seen together in London and New York. Busson chairs EIM, a hedge fund business, and the couple are third in our Giving List due to their support for Ark, the charity he founded in 2002 that has raised hundreds of millions for education, chi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dren in care and HIV/Aids causes. We value Busson at \u163\'a3 160m and Thurman at \u163\'a3 20m.\par 2009: \u163\'a3 105m, 510= 354= \u163\'a3 180m\par \u163\'a3 20mt Harry Dobson Mining A farmer's son from the Scottish Borders now based in Monaco, Dobson, 62, chairs Borders & Southern Petroleum, which has oil exploration rights around the Falklands.\par 2009: \u163\'a3 200m, 274= 354= \u163\'a3 180m\par \u163\'a3 110m\par Julian Dunkerton Fashion See panel on page 44 354= \u163\'a3 180m\par \u163\'a3 5m\par Kevin McCabe and family Property McCabe, 62, has significant leisure interests in China, including a contro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ling stake in Chengdu Blades, a top football club. Closer to home, he chairs the original Blades, Sheffield United. Most of his wealth comes from his Scarborough Property Group. In 2007, he sold his family's stake in a subsidiary for \u163\'a3 142.7m.\par 2009: \u163\'a3 175m, 322=\par Double act in demand 371= \u163\'a3 175m\par \u163\'a3 5m, 3%\par Catherine Zeta-Jones and Michael Douglas Films\par Swansea's most famous export made her Broadway debut in December. Starring as Desiree Armfeldt in a revival of Stephen Sondheim's A Little Night Music, Zeta-Jones is treading the boards for the first time in 20 years, having spent the intervening period making her name in film and television. Reviews for the New York show have been a tad sniffy but it is a hot ticket. The 40-year-old''s next project could be to star as Cleopatra in a rock musical movie produced by Steven Soderbergh. Zeta-Jones was drawn to the smell of greasepaint from an early age and landed her first big role playing the lead in Annie at the Swansea Grand Theatre aged 12. Her husband, Douglas, 65, inset, is reprising the role of Gordon Gekko from Wall Street, a part that won him an Oscar in 1987. The sequel, Wall Street: Money Never Sleeps, is to be released in September. The couple, who share the same birthday, married in 2000 and have two children, Dylan and Carys. They spend much of their time in Bermuda, where Douglas co-owns the Ariel Sands Beach Club. They have seven homes, including one in New York. "Like people collect art, we collect homes," Zeta-Jones says, adding, "a bit of art, too, but predominantly homes." She has carved out a lucrative advertising career: her work for Eli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 z}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 abeth Arden has been so successful that she is negotiating a contract giving her shares in it. She has a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 peared in TV commercials for T-Mobile, Alfa Romeo and a hair product, Lux, that earned her \u163\'a3 1.55m and was broadcast in China, Taiwan and Japan only. Her share of film and ad revenues plus signing-on fees is worth \u163\'a3 65m and Douglas adds \u163\'a3 110m.\par 2009: \u163\'a3 170m, 33= 354= \u163\'a3 180m\par \u163\'a3 80mt Michael Newton Closed-circuit television Newton, 50, is the king of CCTV technology in Britain as the owner of Warrington-based AD Group. The company''s programmers have come up with a digital video pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cessor that Newton believes will secure the next generation of CCTV technology.\par 2009: \u163\'a3 260m, 218= 354= \u163\'a3 180m\par \u163\'a3 113m\par Andrew Nisbet and family Catering equipment The Bristol catering equipment supplier Nisbets, started in 1983 by Nisbet, 49, is worth \u163\'a3 179m. The family has a stake worth \u163\'a3 161m and other assets.\par 2009: \u163\'a3 67m, 853= 354= \u163\'a3 180m\par \u163\'a3 35m\par Alastair Salvesen and family Transport and plant hire A soaring share price at Aggreko, the Glasgow-based plant hire operation, will delight Salvesen, 68, and his family, which has a near \u163\'a3 128m stake in the company. Three years ago, the family picked up \u163\'a3 60m when it sold the logistics group Christian Salvesen.\par 2009: \u163\'a3 145m, 382= 354= \u163\'a3 180m\par \u163\'a3 70m\par Ranjit and Baljinder Singh Food Husband and wife Ranjit and Baljinder, both 43, have added the Harry Ramsden's fish and chip shop chain to their West Midlands-based 2 Sisters Food Group. The couple own the parent company, Smethwick-based Boparan Holdings, best known for its Buxted chickens brand.\par 2009: \u163\'a3 110m, 492= 354= \u163\'a3 180m Sting Music Wallsend-born Sting, 58, sets off across North America this summer supported by the Royal Philharmonic Concert Orchestra. It should be happier than the Police''s r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cent reunion tour, which he likened to "going back to a dysfunctional marriage". Sting was perhaps consoled by the $ 28m that Forbes estimated each member of the group banked in 2008 .\par 2009: \u163\'a3 180m, 309= 354= \u163\'a3 180m\par \u163\'a3 60m\par Neil Taylor and family Computer games and property Taylor, 49, sold Game, a computer games company he set up with his brothers, Carey and Chris. The trio own more than 2,000 apartments in Germany. Du}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 linbased Taylor has his yacht, Nero, on the market for \u163\'a3 66m.\par 2009: \u163\'a3 120m, 438= 354= \u163\'a3 180m Stuart Wall Property Wall, 58, owns Manchester-based Opal Property Group, which provides student accommodation and affordable homes for key workers such as NHS staff.\par 2009: \u163\'a3 180m, 309= 367= \u163\'a3 178m\par \u163\'a3 59m\par Daniel Borel Computer equipment Logitech, the computer mouse company, is worth more than \u163\'a3 1.8 billion and Swiss-born Borel, 60, who has a home in London, has a stake worth \u163\'a3 122m and other assets.\par 2009: \u163\'a3 119m, 471= 367= \u163\'a3 178m\par \u163\'a3 58m\par Silvio Denz Perfume Swiss tycoon Denz, 53, who is based in London, has teamed up with The Macallan di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tillery to produce a 57-year-old single malt whisky sold in a Lalique decanter for more than \u163\'a3 10,000. His Bri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ish interests include Jaguar Fragrances. Bilan magazine put his wealth at \u163\'a3 178m in 2009.\par 2009: \u163\'a3 120m, 438= 369= \u163\'a3 176m\par \u163\'a3 17m\par Peter Dawson and family Truck rental Dawson, 71, runs the Milton Keynes firm Dawsongroup, one of the largest truck rental businesses in Europe. It is worth \u163\'a3 156m and there are additional assets.\par 2009: \u163\'a3 159m, 358 369= \u163\'a3 176m\par \u163\'a3 28m\par Alan Gibbs Industry Gibbs, 70, a London-based New Zealander, has made fortunes in everything from frid}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es to bricks. New Zealand's National Business Review valued him at \u163\'a3 176m in 2009.\par 2009: \u163\'a3 148m, 378= 371= \u163\'a3 175m\par \u163\'a3 5m\par William Arah Finance Arah, 49, has a \u163\'a3 125m stake in the London hedge fund Marathon Asset Management. Other assets and past dividends add \u163\'a3 50m.\par 2009: \u163\'a3 170m, 33= 371= \u163\'a3 175m\par \u163\'a3 25m\par David Coffer Property Coffer, 62, and Anthony Lyons (qv)\par sold their 50% stake in the Earls Court and Olympia exhibition centre to property giant Liberty International in January.\par 2009: \u163\'a3 150m, 362= 371= \u163\'a3 175m Terence Cole Property London property entrepreneurs Mark Steinberg (qv)\par and Cole run Marcol, a London-based company set up to acquire, finance andasset-manage property throughout Europe.\par 2009: \u163\'a3 175m, 322= 371= \u163\'a3 175m\par \u163\'a3 5m\par Jeremy Hosking Finance Hosking, 51, and Neil Ostrer (qv)\par set up Marathon Asset Management, one of London's top hedge funds. Hosking has a stake in model train maker Hornby and gave \u163\'a3 250,000 towards the West Somerset railway's restoration of a steam locomotive.\par 2009: \u163\'a3 170m, 33= 371= \u163\'a3 175m\par \u163\'a3 10m\par Doreen Lofthouse and family Cough lozenges Fleetwood is home to Fisherman's Friends lozenges. Lof}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 house, 80, managing director of Lofthouse of Fleetwood, has transformed the business into a global brand.\par 2009: \u163\'a3 165m, 346= 371= \u163\'a3 175m\par \u163\'a3 90m\par Sir David McMurtry Precision instruments McMurtry, 70, set up the Gloucester-based precision engineering company Renishaw in 1973 and the business floated 10 years later. His stake is worth more than \u163\'a3 159m and past dividends add to his wealth.\par 2009: \u163\'a3 85m, 657= 371= \u163\'a3 175m\par \u163\'a3 5m\par Neil Ostrer Finance Ostrer, 51, co-founded London hedge fund Marathon Asset Management in 1986. It is controlled by a partnership that includes Ostrer, Jeremy Hosking (qv)\par and Bill Arah (qv)\par as directors and is worth at least \u163\'a3 375m. We add \u163\'a3 50m for Ostrer's past salaries and dividends .\par 2009: \u163\'a3 170m, 33= 371= \u163\'a3 175m Anthony Preston and family Pet shops Cheshire-based Pets at Home, the UK's biggest pet products retailer, was sold in January in a \u163\'a3 955m deal. Beneficiaries included Bridgepoint Capital, which bought the chain in 2004 for \u163\'a3 230m from investors who included its founder, Preston, 55. He will have picked up more than \u163\'a3 85m from the latest deal.\par 2009: \u163\'a3 175m, 322= 371= \u163\'a3 175m Keith Richards Music Dartford-born Richards, 66, is best known as the hell-raising guitarist with the Rolling Stones. The band has generated more than \u163\'a3 1.8 billion in receipts from touring since 1989. In the past year, 13 of the Stones' most recent album\par have been remastered and reissued. This part of the back catalogue goes from Sticky Fingers in 1971 to A Bigger Bang in 2005.\par 2009: \u163\'a3 175m, 322= 371= \u163\'a3 175m Tom Scott and family Industry Scott, 65, the most powerful businessman in the Channel Islands, has franchises for chains including Morrisons and Marks & Spencer and helped build International Energy Group, controlling the local energy supplies. He has an extensive property portfolio and energy interests in Britain, France and Portugal.\par 2009: \u163\'a3 175m, 322= 371= \u163\'a3 175m Mark Steinberg Property Steinberg, 50, and Terence Cole (qv)\par teamed up with a private equity firm last summer to buy Median, a German rehabilitation care provider, which runs 27 acute clinics with 6,000 beds. The pair run Marcol, which was set up to acquire, finance and assetmanage real estate throughout the UK and Europe.\par 2009: \u163\'a3 175m, 322= 371= \u163\'a3 175m\par \u163\'a3 25m\par Graham Wylie Software Technology Services Group took over an IT consultancy in February - its 23rd a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 quisition since being established by Wylie in Newcastle upon Tyne in 2003. The Scottish tycoon, who netted about \u163\'a3 180m from software multinational Sage, is a prominent racehorse owner.\par 2009: \u163\'a3 150m, 362= 371= \u163\'a3 175m\par \u163\'a3 5m\par Catherine Zeta-Jones and Michael Douglas Film\par See panel on page 47 371= \u163\'a3 175m\par \u163\'a3 65m\par Sir John Zochonis Soap Zochonis, 80, is the great-nephew of one of the two founders of Stockport soap maker PZ Cussons, Greek entrepreneurs who set up Paterson Zochonis in 1884 to trade with Nigeria. A former chairman, he handed over to his nephew Anthony Green (qv)\par in 1993, but retains a \u163\'a3 167m stake and has other wealth.\par 2009: \u163\'a3 110m, 492= 385 \u163\'a3 174m\par \u163\'a3 8m\par Barbara Taylor Bradford Novels See panel opposite 386 \u163\'a3 173m\par \u163\'a3 40m\par Sir Michael Bibby and family Shipping Turnover broke the \u163\'a3 1 billion barrier at Liverpool''s Bibby Line Group in 2008 with new businesses springing up. Having sold most of its ships before the downturn, the group has diversified into debt factoring, financial services and food distribution. Bibby, 46, is the sixth generation to head the business .\par 2009: \u163\'a3 133m, 403 387 \u163\'a3 172m\par \u163\'a3 24mt Tihan Presbie Computers Presbie, 45, a London futures trader, and Rob Small set up computer games company Miniclip in 2001, launching it with a dancing game featuring George Bush as a 1970s-style disco dancer. Based in London, Miniclip has more than 57m dedicated users a month, together with 450 simple games, mostly free.\par 2009: \u163\'a3 196m, 290 388= \u163\'a3 170m\par \u163\'a3 25m\par The Astor family Property The Astor family company Sableknight went from a \u163\'a3 21.4m profit to a \u163\'a3 1.5m loss during 2008, but with a slight recovery in the property market we value the business on its net asset figure of \u163\'a3 153.3m. Over the past three years, Sableknight has paid out \u163\'a3 19m in dividends .\par 2009: \u163\'a3 145m, 382= 388= \u163\'a3 170m Barrie Haigh Pharmaceuticals and farming Haigh, 71, who runs Oxfor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 shirebased Red Kite Farms, made his money from the sale of Innovex, the pharmaceutical consultancy he set up.\par 2009: \u163\'a3 170m, 33= 388= \u163\'a3 170m\par \u163\'a3 30m\par Brian Kingham Security services Kingham, 65, founded Reliance Security, the Uxbridge-based security group, best known for its \u163\'a3 126m Scottish prisoner escort service and similar contracts worth \u163\'a3 250m in Wales and England. Other assets include Kingham Farms, which is worth its \u163\'a3 8.2m assets.\par 2009: \u163\'a3 140m, 388= 388= \u163\'a3 170m\par \u163\'a3 50m\par Kartar and Tej Lalvani Food supplements Indali Lounge, a London curry house, has been declared one of Britain's top 10 healthiest restaurants. It is owned by Kartar Lalvani, 78, founder of Vitabiotics, which makes top-selling nutritional supplements such as Osteocare. His son Tej, 35, runs the international side of the \u163\'a3 150m London-based business .\par 2009: \u163\'a3 120m, 438= 388= \u163\'a3 170m Nigel Morris Finance Essex-born Morris, 51, is the managing partner of QED Investors, a direct investment fund focused on high-growth companies in America. He helped set up the Capital One credit card.\par 2009: \u163\'a3 170m, 33= 388= \u163\'a3 170m\par \u163\'a3 108m\par Ralph Oppenheimer and family Steel Oppenheimer, 69, is chairman ofLondon-based Stemcor, the world's largest independent steel trading company, dealing in 20m tons of steel annually. Despite the problem\par within the steel industry, Stemcor has a healthy balance sheet and \u163\'a3 234m net assets.\par 2009: \u163\'a3 62m, 910= 394 \u163\'a3 168m\par \u163\'a3 2mt Lord Foster Architecture Architectural group Foster and Partners is turning its attention to the Moon. It is part of a group hoping to win a contract from the European Space Agency to test materials for building se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tlements on the lunar surface. Foster, 74, one of the world's great architects, donated \u163\'a3 2m to Yale Univers}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty's School of Architecture to fund a professorship in his name.\par 2009: \u163\'a3 170m, 33= 395= \u163\'a3 166m\par \u163\'a3 48mt Jimmy Heselden Defence equipment Hesco Bastion has seen a decline in demand for its blast walls and fortifications that protect military bases in Iraq and Afghanistan, but it still made \u163\'a3 27.1m on \u163\'a3 111m sales in 2008-09. The Leeds firm is run and owned by Heselden, 62, and is worth \u163\'a3 150m. It is diversifying into flood defences in Britain. Heselden has other assets and recently took over Segway, a US company that makes high-tech scooters. He ranks 30th in this year.''s Giving List, having paid \u163\'a3 13m into his Hesco Bast}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 on fund in 2008-09 .\par 2009: \u163\'a3 214m, 261= 395= \u163\'a3 166m\par \u163\'a3 20m\par Shamus Jennings and family Property The Northern Ireland company Ballyrogan Holdings is still owned by the Jennings family, which sold Rotary Group, a subsidiary, for almost \u163\'a3 100m in 2008. Jennings, 56, chairs Ballyrogan and the family owns the Cusp property group, with a \u163\'a3 500m portfolio.\par 2009: \u163\'a3 146m, 381\par Happy ever after 385 \u163\'a3 174m\par \u163\'a3 8m, 5% s Barbara Taylor Bradford Novels Once upon a time, there was a beautiful girl who wanted to write books. So she worked hard, wrote them, and the world read them and loved them and made her famous. The End. (Apart from all the money she made doing it, of course.)\par Barbara Taylor Bradford's 25 bestsellers have sold more than 82m copies in 90 countries, in 40 languages. The 76-year-old, born in Leeds, first earned just 7s 6d at the age of 10 for a children''s story. By 15 she was a typist at the Yorkshire Evening Post. At 20, she was working for Woman's Own in London. Our plucky heroine then fell in love with American film producer Bob Bradford, married him, dear reader, and moved to Manhattan. There, two years' hard graft (14-hour days, seven days a week)\par produced her first success, A Woman of Substance, in 1979, which has sold more than 31m copies. She has not denied estimates that she is worth $ 240m and makes close to $ 24m a year. As a result, we add \u163\'a3 8m to last year's valuation of BTB.\par 2009: \u163\'a3 166m, 344= 395= \u163\'a3166m\par \u163\'a3112m\par Andrew Pritchard Frozen food Chartered accountant Pritchard, 51, heads Iceland, the frozen food chain based in Clwyd. In 2008-09, its profits soared to \u163\'a386.8m on more than \u163\'a32 billion sales. The group has 750 stores and plans to open 100 more this year. Pritchard, who quit Iceland with Malcolm Walker (qv)\par in 2001 and returned four years later, has a 16.48% stake in the firm worth \u163\'a3165m. We add \u163\'a31m for other assets.\par 2009: \u163\'a354m, 1,001= 398= \u163\'a3165m\par \u163\'a350m\par Lance Clark and family Shoes Profits at Clarks, the Somersetbased shoe retailer, reached a record \u163\'a386.8m on \u163\'a31.12 billion sales in 2008-09. Most of the firm's shares are dispersed among the 400-strong Clark family, but about 25%, worth \u163\'a3150m, is held by a small core led by Lance, 73. He owns ethical shoe retailer Terra Plana and co-founded the Aids charity Soul of Africa.\par 2009: \u163\'a3115m, 474= 398= \u163\'a3165m\par \u163\'a345m\par Simon Cowell Music The X Factor judge signed a new deal with record giant Sony in January that will earn him millions over six years, starting with the US launch of the talent show next year. Cowell has earned \u163\'a386m in the past two years from his TV work and his production company, according to Forbes magazine. With a growing property portfolio, the 50-yearold rises by \u163\'a345m this year.\par 2009: \u163\'a3120m, 438= 398= \u163\'a3165m Henry Moser and family Finance The Blemain Group was cofounded by Moser, 60, in 1973 and specialises in secured lending to residential and commercial customers. Jerrold Holdings, the parent company, saw profits rise from\par \u163\'a368.7m to \u163\'a369m on sales of nearly \u163\'a3149.5m in the year to June 2009. We value the business at \u163\'a3200m and the family's stake at \u163\'a3140m. Past dividends amount to \u163\'a325m.\par 2009: \u163\'a3165m, 346= 398= \u163\'a3165m\par \u163\'a35m\par Gary Widdowson Recycling Essex-based Widdowson, 52, held on to 22% of his Metal & Waste Recycling business when it was sold in 2006 for \u163\'a3120m. He has moved into property through Kenninghall Holdings and owns a dock on the Thames, plus another firm, Total Waste Management.\par 2009: \u163\'a3160m, 350= 398= \u163\'a3165m\par \u163\'a333m\par Alan Wiseman and family Milk Thousands of Robert Wiseman workers received a \u163\'a3100 bonus for working long shifts during the winter. The Scottish milk business is run by the founder's sons, led by Alan, 59, as chairman. It is valued at \u163\'a3325m and the family has a \u163\'a3131m stake. Share sales add \u163\'a334m.\par 2009: \u163\'a3132m, 404 403 \u163\'a3162m\par \u163\'a32m\par Eliasz Englander and family Property The property veteran has been signing up tenants for a 100,000 sq ft office and retail project in London's Holborn. Englander, 77, has more than 130 directorships and an intricate group of companies. Through Citywise, the family owns Holborn Links, with assets of more than \u163\'a3131m in 2008. Smaller firm\par have \u163\'a3100m assets, but some stakes overlap.\par 2009: \u163\'a3160m, 350= 404 \u163\'a3161m\par \u163\'a337m\par Calum and Stuart Melville Lifting equipment A property business and other assets bulk up the wealth of brothers Calum, 41, above, and Stuart, 44, who sold the Aberdeen company GTC Group, a supplier of lifting equipment to the oil and gas industry, for \u163\'a330m in 2007. Calum is a director of Dundee FC and a member of the leaders group in the Conservative party.\par 2009: \u163\'a3124m, 436 405= \u163\'a3160m\par \u163\'a375m\par David Allen Caravan parks Having made his money with Bourne Leisure, the caravan park and holiday camp company based at Hemel Hempstead, Allen, 77, and his family run Barcham Trees, a Cambridgeshire nursery that made a profit of \u163\'a3190,000 on \u163\'a35.2m sales in 2008-09. Allen is still a Bourne shareholder.\par 2009: \u163\'a385m, 657= 405= \u163\'a3160m Sir Euan Anstruther-Gough-Calthorpe and family Property Calthorpe Hol}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ings made a \u163\'a312.85m loss in 2008-09, when its net assets fell from\par \u163\'a321.6m to \u163\'a36.5m. The company has had to revise its development of 1,550 acres in Edgbaston, Birmingham, which Anstruther-Gough-Calthorpe, 43, wants to make the Midlands' best place in which to live and work. He has interests in America and property in Europe and the Gulf.\par 2009: \u163\'a3160m, 350= 405= \u163\'a3160m\par \u163\'a310m\par John Berkley and family Mobile homes and property Berkley chairs the Berkeley Leisure Group, which stated in its 2008 annual report that its mobile homes and other freehold properties were worth \u163\'a3100m more than their \u163\'a356.8m book value. The Yeovil business is owned mainly by Berkley, 76, and his family.\par 2009: \u163\'a3150m, 362= 405= \u163\'a3160m\par \u163\'a345m\par Frank Boyd and family Property Boyd, 55, and Andrew Creighton (qv)\par jointly own William Ewart Properties, one of Northern Ireland's biggest property firms. Other assets include Killultagh Estates.\par 2009: \u163\'a3115m, 474= 405= \u163\'a3160m\par \u163\'a310m\par Victor Chandler Internet gambling Betting website owner Chandler, 59, ran a book on who killed Archie Mitchell in TV's EastEnders. The murderer was a 14-1 outsider, so he should have cleaned up. We value Chandler's Gibraltar-based business at \u163\'a3300m. Chandler has a 45% stake in addition to art, property and other investments .\par 2009: \u163\'a3150m, 362= 405= \u163\'a3160m\par \u163\'a350m\par Geoffrey Halstead and family Flooring Halstead, 80, with his family and trusts, owns nearly half of James Halstead, the AIM-listed manufacturer of vinyl tiles, based in Manchester. That stake is worth \u163\'a3148m and there are other assets.\par 2009: \u163\'a3110m, 492= 405= \u163\'a3160m\par \u163\'a320m\par Olivia and Dhani Harrison Inheritance Olivia Harrison, 62, widow of musician George, and their guitarist son, Dhani, 31, will benefit from the launch last September of the Beatles catalogue, remastered for the first time since 1987, and from the music video game Beatles Rock Band. The family's base is in Oxfordshire.\par 2009: \u163\'a3140m, 388= 405= \u163\'a3160m\par \u163\'a315m\par Michael Herbert and family Property and fast food In the 1980s, when few fast-food rivals dared venture into Belfast, Herbert, 52, set up Herbel Restaurants. It now holds the biggest Kentucky Fried Chicken franchise in Europe. We value the business at \u163\'a360m. Herbert is also developing properties in Belfast and Scotland, na}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing buildings after his wife, Lesley.\par 2009: \u163\'a3145m, 382= 405= \u163\'a3160m\par \u163\'a325mt Peter Horton and family Property Horton, 40, and his family own Horton Estates, one of the biggest property development companies in the Midlands, with net assets of nearly \u163\'a3150m. The family has taken large dividends .\par 2009: \u163\'a3185m, 304= 405= \u163\'a3160m\par \u163\'a326m Tim and Kit Kemp Hotels The Kemps' first overseas venture, the Crosby Street hotel in New York, opened to impressive reviews last year, repeating the success of their six London hotels. Kit, 50, is in charge of the award-winning look while her husband, Tim, 64, focuses on the figures. Firmdale Holdings made a \u163\'a31.4m profit on \u163\'a353.8m sales in 2008-09. The \u163\'a3156m firm is owned by the Kemps and trusts. We add \u163\'a34m for the couple's other assets.\par 2009: \u163\'a3134m, 402 405= \u163\'a3160m John King Pharmaceuticals King, 61, retained a small slice of Warner Chi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cott, the US drug firm he once headed. He made about \u163\'a3125m when it was taken over in 2005 and substa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tial sum\par before then from share sales, salaries and dividends. He donated \u163\'a32m towards new laboratories at Queen's University Belfast, where he studied and worked.\par 2009: \u163\'a3160m, 350= 405= \u163\'a3160m\par \u163\'a333m\par Alisa Moussaieff and family Retailing Moussaieff Jewellers had a record year in 2008-09 with \u163\'a316m profit on sales of \u163\'a394.8m. The family business, led by Alisa, 81, is based in London and is worth \u163\'a3120m. We add \u163\'a340m for other assets.\par 2009: \u163\'a3127m, 424 405= \u163\'a3160m\par \u163\'a315m\par Theo Paphitis Stationery and lingerie Cypriot-born Paphitis is well placed to dispense advice on TV's Dra}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ons' Den - he made about \u163\'a3100m from the sale of the La Senza lingerie chain, has a majority stake in R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 man worth \u163\'a360m and owns commercial property .\par 2009: \u163\'a3145m, 382= 405= \u163\'a3160m Brian Scowcroft and Janet Lefton Insurance and property Scowcroft ran Swinton, the insurance group founded by his father. The family, including his sister, Lefton, 51, made about \u163\'a3150m from its takeover by Sun Alliance. Scowcroft, 54, built a portfolio of business parks, headed by 400-acre Kingmoor Park in Carlisle. He sponsors two academy schools in the city.\par 2009: \u163\'a3160m, 350= 405= \u163\'a3160m The Earl of Stockton and the Macmillan family Publishing The Macmillan books empire is the root of the family fortune. London-based Stockton, 66, grandson of former prime minister Harold Macmillan, added about \u163\'a37.5m to the family fortune when he sold his Devon estate. Residual publis}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing holdings are worth \u163\'a330m.\par 2009: \u163\'a3160m, 350= 421 \u163\'a3157m\par \u163\'a3103m\par Malcolm Walker Frozen food Iceland Frozen Foods spent \u163\'a34m taking 800 managers to Disney's Florida r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sort in September, rewarding them for four years of success since Walker, 64, led a consortium that took control of the company he co-founded in 1970. It has 750 stores and plans another 100 this year. In 2008-09 its profits soared to \u163\'a386.8m as sales topped \u163\'a32 billion. Walker and his trusts have a 14.18% stake worth \u163\'a3142m and other interests.\par 2009: \u163\'a354m, 1001= 422= \u163\'a3155m\par \u163\'a365m\par Paul Caddick and family Construction Caddick, 59, founded Yorkshirebased Caddick Group, which has property and developments as well as a stake in the Headingley Carnegie sports stadium in Leeds. It is more than 90% owned by the family and in 2008 had assets of \u163\'a345.1m. There is other wealth.\par 2009: \u163\'a390m, 600= 422= \u163\'a3155m\par \u163\'a320m\par Sir Peter Michael Electronics Michael, 71, mixes business with pleasure, running a winery in California and a collection of hotels. His fortune is founded on the electronics companies Micro Consultants and Quantel and his main company, Stockford, is worth \u163\'a340m. Berkshire-based Michael has other assets.\par 2009: \u163\'a3135m, 400= 424= \u163\'a3154m\par \u163\'a340m\par John Coulter and Ann Jones Jewellery Warren James, the high street jeweller, has grown to a chain of 120 shops since being founded in 1979 by Jones, 56, and her brother, 58. The Stockport-based firm saw profits dip to \u163\'a315.2m in 2008-09 but is still worth \u163\'a3120m. They have other wealth.\par 2009: \u163\'a314m, 488 424= \u163\'a3154m\par \u163\'a350m\par Douglas Craig and family Fishing and oil services Aberdeen's Craig Group made \u163\'a315.5m profit on \u163\'a3104.6m sales in 2008-09 and the oil and fishing services operation has \u163\'a3110m net assets. It is led by Craig, 60, grandson of the founder.\par 2009: \u163\'a3104m, 531= 427 \u163\'a3153m\par \u163\'a380mt David Pearl Property At 64, Pearl still cycles around central London to view properties for his Structadene company. Profits rose from\par \u163\'a32.6m to \u163\'a34.5m in the year to September 2008, but net assets fell from\par \u163\'a3287.5m to \u163\'a3149.2m. We add \u163\'a34m for other wealth.\par 2009: \u163\'a3233m, 241 428= \u163\'a3152m John Lynch and family Construction John Lynch (Builders)\par had \u163\'a311m net assets in December 2008. But under the shrewd stewardship of Lynch, 61, the Ayr company has amassed 280 acres of development land in Scotland worth \u163\'a3100m. Other assets include farm\par and property .\par 2009: \u163\'a3152m, 361 428= \u163\'a3152m\par \u163\'a322m\par Tim Martin Pubs Martin, 54, announced in December that his JD Wetherspoon chain plans to invest \u163\'a3250m in 250 new pubs by 2014. It currently has 743. Profits for the year to July 2009 were a record \u163\'a366.2m on sales of \u163\'a3955.1m. Martin's stake is worth \u163\'a3140m and he has other assets.\par 2009: \u163\'a3130m, 406= 430 \u163\'a3151m\par \u163\'a396m\par Stephen and Peter Bond Aviation Bond Aviation Group, run and owned mainly by Stephen Bond, 59, and his brother Peter, 48, won five contracts in September worth \u163\'a3153m to service oil and gas fields and the world's largest offshore wind farm, off the Suffolk coast. The Gloucestershire firm made \u163\'a315m profit in 2008-09. The brothers' stake is worth \u163\'a395m. They also own 50% of Loganair and 25% of Alliance Airlines.\par 2009: \u163\'a355m, 986= 431= \u163\'a3150m\par \u163\'a370m\par Johnny and Patsy Byrne Construction The west London builder Byrne Group has defied the recession by posting record profits of \u163\'a311m on record sales of \u163\'a3326.2m in the year to May 2009. The business is run by Irish brothers Johnny, 64, and Patsy, 61. The family collected \u163\'a390m in salaries and dividends from 1995 to 2009.\par 2009: \u163\'a380m, 694= 431= \u163\'a3150m\par \u163\'a320m\par Charles Clowes Property The East Midlands entrepreneur, 69, owns Clowes Developments, which had nea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly \u163\'a359m net assets in 2008-09. Reports in the property press suggest he is looking to sell for \u163\'a3300m.\par 2009: \u163\'a3130m, 406= 431= \u163\'a3150m\par \u163\'a330m\par Nick Dhandsa and family Nursing homes Dhandsa, 54, a former doctor, has been investing in property, golf courses and a health clinic since selling his London nursing home operator, Associated Nursing Services, to Bupa for \u163\'a3330m in 2005. His family had 38% of the company .\par 2009: \u163\'a3120m, 438= 431= \u163\'a3150m Barney and Frances Eastwood Betting shops Barney and his wife, Frances, both 78, sold the Eastwood Bookmakers chain to Ladbrokes for \u163\'a3135m two years ago. The couple have extensive property interests and an art collection.\par 2009: \u163\'a3150m, 362= 431= \u163\'a3150m Alan and Wendy English Conference centres Alan English, 67, is involved with Hotel la Tour, which plans 12 hotels in big cities. Northamptonbased English and his wife, Wendy, 65, had a \u163\'a3150m stake in Hayley Conference Centres, sold for \u163\'a3358m in 2007 .\par 2009: \u163\'a3150m, 362= 431= \u163\'a3150m John Frieda Hairdressing Every year, almost 2m bottles of the Frizz-Ease range are sold in the UK alone, boosting profits at John Frieda Professional Hair Care. Singer Lulu's former husband, 58, who stopped cutting hair in 1990, has property and retains a few fashionable salons from a 2002 takeover.\par 2009: \u163\'a3150m, 362= 405= \u163\'a3160m\par \u163\'a33m, 2%s The Marquess of Bath Land Surrounded by erotic paintings and a bevy of "wifelets", and with ze}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ras in his garden, the 7th Marquess of Bath appears to live in a parallel universe. Don't be fooled: this is one shrewd, if eccentric, businessman. Since inheriting Longleat in 1992, he has developed the Wiltshire site into a lucrative tourist attraction. In addition to the safari park, which is featured in the BBC series Animal Park, there is a maze and a steam railway. Visitors also flock to Longleat House, which is stuffed with art trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ures, furniture and rare books, and its gardens. Bath, 77, has been married to his actress wife Anna since 1969 and recently handed control of Longleat Enterprises, which also runs the Cheddar Caves site in So}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erset, to their 35-year-old son Ceawlin, Viscount Weymouth. The marquess will continue to live at Longleat and work on his epic autobiography. Bath's wealth is made up of art treasures and Longleat's library, valued at \u163\'a372m after tax, and the Wiltshire estate, Longleat Enterprises and proceeds of past auctions, which we estimate at \u163\'a388m in total.\par 2009: \u163\'a3157m, 359=\par Card ace sets pace 424= \u163\'a3154m\par \u163\'a314m, 285%\par Dean and Janet Hoyle Greetings cards\par Text messages and emails have their place but sometimes only a card will do. Greetings cards are a year-round business, and a lucrative one in the hands of Dean Hoyle, 43, and his wife Janet, 42, inset. Wakefield-based Card Factory was established in 1997 and has about 480 stores. Hoyle, right, says of his business model: "If people could shop in Harrods and pay Netto prices, that is the perfect scenario." The formula has paid off and this month the company was sold to Charterhouse, the private equity firm, for \u163\'a3350m. Hoyle, chairman of League One football club Huddersfield Town, will still play a role at Card Factory, which raises funds for Macmillan Cancer Support. Proceeds from the sale and other assets put the couple at \u163\'a3154m.\par 2009: \u163\'a340m, 1,348= 431= \u163\'a3150m\par \u163\'a3100m\par David Gabbay and family Property Gabbay, co-founder of the O&H property operation, saw net assets fall from\par \u163\'a3478m to \u163\'a3255.5m in 2008-09. The parent company has been reorganised but we believe that Gabbay owns half of the Mayfair business, which started in residential and has expanded into offices and retail. Gabbay, 66, has banked sizeable dividends and salaries.\par 2009: \u163\'a3250m, 22= 431= \u163\'a3150m\par \u163\'a350m\par Willie Haughey and family Refrigeration City Refrigeration started life in the Glasgow home of Haughey and his wife, Susan, in 1985. Today it has customers across the UK. Haughey, 53, has a small stake in Celtic FC and has donated about \u163\'a31m to Labour since 2003. The business is worth \u163\'a3120m and there are other assets.\par 2009: \u163\'a3100m, 540= 431= \u163\'a3150m New entry Andreas Heeschen Property and finance The German tycoon made his money in property and through London investment company Pall Mall Capital. Heeschen, 49, chairs the gun company Heckler & Koch, where he holds a majority stake. Last May another Heeschen ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture, ProChemie Holding, took a 50% stake in LyondellBasell, a chemicals company owned by Leonard Blavatnik (qv), the subject of recent takeover speculation.\par 431= \u163\'a3150m\par \u163\'a330m\par Roger and Diana Jenkins Finance See panel on page 55 431= \u163\'a3150m New entry Aref Karim and family F}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nance Karim, 57, worked for the Abu Dhabi Investment Authority, the world's largest sovereign wealth fund, from 1982 to 1995. He returned to the UK to found Surrey-based hedge fund Quality Capital Management. It has been a huge success - the flagship Global Diversified Programme has generated annualised returns of 15.82% since 1995. In 2008 the business made \u163\'a342.9m profit on \u163\'a349.3m sales. Karim, a chartered accoun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ant, and his family own at least 97% of the \u163\'a3150m operation and have other assets.\par 431= \u163\'a3150m\par \u163\'a330m\par Nick Leslau Property Leslau floated Max Property Group on AIM in May 2009. It is worth \u163\'a3260m and Leslau, 50, has a \u163\'a324m stake, adding to wealth from his co-ownership of Prestbury Group with Nigel Wray (qv). Prestbury Investment Holdings had \u163\'a378.4m net assets in 2008. Leslau also has more than \u163\'a340m of div}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dends .\par 2009: \u163\'a3120m, 438= 431= \u163\'a3150m Dame Celia Lipton Farris Inheritance and investment Scots-born singer Lipton Farris, 85, who lives in Florida, is one of the great fundraisers for worthy causes. The American Ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cer Society established the Dame Celia Lipton Farris Lifetime Achievement Award in honour of her 30 years' work. She married Victor Farris, a US industrialist who died in 1985 and left her more than \u163\'a3100m, which has grown to \u163\'a3150m.\par 2009: \u163\'a3150m, 362= 431= \u163\'a3150m\par \u163\'a325m\par Sir Keith Mills Loyalty cards Having helped London secure the 2012 Olympics, Mills is trying to bring the football World Cup to England. The Essex-born entrepreneur is a keen sailor and in 1999 was one of the crew that won the Clipper Round the World yacht race. He is principal of Britain's Team Origin, which aim\par to compete in the America's Cup. Mills, 59, founded the Air Miles and Nectar loyalty schemes. He amassed \u163\'a3150m from the sale of the cards and other businesses he built.\par 2009: \u163\'a3125m, 426= 431= \u163\'a3150m\par \u163\'a348m\par Jon Moulton Finance After quitting private equity firm Alchemy Partners last year, Moulton, 59, set up i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vestment business Better Capital, which has bought the UK edition of Reader's Digest out of administration. Better Capital floated on AIM last December and Moulton has a \u163\'a316m stake. He also has \u163\'a346m in the i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vestment business Ashmore Group.\par 2009: \u163\'a3102m, 535= 431= \u163\'a3150m\par \u163\'a335m\par Sir Robert Ogden Property Property businesses underwrite Ogden's twin passions: racehorses and his char}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 table work, for which he was knighted in 2001. Ogden, 74, gives university scholarships to disadvantaged youngsters from Yorkshire pit villages. He invested early in London Docklands and in 2006 sold A Ogden & Sons, his coal-washing and processing firm, for \u163\'a324.5m.\par 2009: \u163\'a3115m, 474= 431= \u163\'a3150m\par \u163\'a320m\par Jamie Palumbo Entertainment The Ministry of Sound, the biggest independent record label in the world, is embroiled in a row over plans to build a 41-storey tower block near its south London nightclub. More than 6,000 people have signed the MoS's petition against the development. The Ministry was founded as a club in 1992 by Palumbo, 46, who set it up with \u163\'a3250,000 savings after a stint as a bond trader in the City. It is worth \u163\'a380m.\par 2009: \u163\'a3130m, 406= 431= \u163\'a3150m New entry Jim Ratcliffe Chemicals See profile on page 54 431= \u163\'a3150m\par \u163\'a330m\par Jonathan Reeves Computers Reeves, 50, runs Afore Solutions, a high-tech company in Ottawa, having sold his first networking firm, Sahara Networks, for $212m in 1997 and Sirocco System\par in 2000 for stock then worth $2.9 billion. The electronics tycoon was born in Dorset.\par 2009: \u163\'a3120m, 438= 431= \u163\'a3150m\par \u163\'a310m\par Walter Scott Finance Scott, 62, owns properties in Charlotte Square, a prime Edinburgh address. Four years ago, he received an estimated \u163\'a3150m when the US bank Mellon bought his investment company Walter Scott & Partners .\par 2009: \u163\'a3140m, 388= 431= \u163\'a3150m\par \u163\'a3100mt Eli Shahmoon and family Property The property-to-construction group O&H Holdings was cofounded by Shahmoon's father Ephraim and David Gabbay (qv). The London firm showed \u163\'a3255m net assets in its 2008-09 accounts. Shahmoon and his family own half and there is other wealth.\par 2009: \u163\'a3250m, 22= 431= \u163\'a3150m\par \u163\'a330m\par Michael Sherwood Finance Michael Sherwood, co-chief executive of Goldman Sachs International, had his pay capped at \u163\'a31m in 2009 amid public outrage against bankers. For Sherwood, 44, the hardship will be bearable; share sales and gains on options in 2009-10 came in at \u163\'a315m. He picked up at least \u163\'a310m a year for the past few years and with the recovery in Goldman Sachs shares his stake is worth \u163\'a346m. Previous share sales add to his wealth.\par 2009: \u163\'a3120m, 438= 431= \u163\'a3150m Mark Shuttleworth Internet Shuttleworth, 36, stepped down as chief exec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tive of Canonical, his London software operation, in December to spend more time developing the free Linux software. He founded Here Be Dragons, a venture capital operation, to support and mentor other entrepr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neurs after he sold an internet security company in his native Cape Town for \u163\'a3400m in 2000. He has pledged half of his fortune to charity .\par 2009: \u163\'a3150m, 362= 431= \u163\'a3150m\par \u163\'a3100mt Michael Spencer Finance Icap, the City broker founded by Spencer in 1986, saw its share price slump in February after it warned that trading volumes were badly hit. Spencer, 54, who is to step down as Tory party treasurer in the autumn, has a \u163\'a3346m Icap stake, having sold \u163\'a395m of shares. He has pledged shares as collateral to banks for loans to support his City Index spreadbetting operation and other firms. Icap's charity day, held every December, in which all brokerage fees and profits from a day's trading are gi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 en to good causes, last year raised \u163\'a311.5m. More than \u163\'a364m has been raised since 1993.\par 2009: \u163\'a3250m, 22= 431= \u163\'a3150m\par \u163\'a310m\par Sir Peter Vardy and family Car sales Peter Vardy Holdings saw 2009 profits soar from\par \u163\'a3617,000 to \u163\'a33.6m on turnover up 30% at \u163\'a3140m. The Edinburgh business is run by Peter Vardy Jr, whose father built the Reg Vardy dealership before selling to rival Pendragon in 2006 in a deal that netted the family \u163\'a3124m. Sir Peter, 63, one of Britain's leading philanthropists, paid more than \u163\'a34m into his Vardy Foundation last year, with \u163\'a31.6m paid out chiefly to religious, educational and poverty relief causes.\par 2009: \u163\'a3140m, 388= 431= \u163\'a3150m\par \u163\'a315mt Nigel Wray Property Wray, 62, has stakes in 19 quoted companies including a \u163\'a352m-plus share of Domino's Pizza UK & Ireland. It had a record 2009 with profits up 27.7% to nearly \u163\'a330m. Since 2007 he has sold \u163\'a341m of shares. Working with Nick Leslau (qv), Wray, who lives in London, has more than 47% of Prestbury Investment Holdings, which deals in property .\par 2009: \u163\'a3165m, 346= 431= \u163\'a3150m\par \u163\'a330m\par Angela Yeoman and family Aggregates Yeoman, 78, still sits on the board of quarrying company Foster Yeoman, which she chaired for 19 years. The company, founded by her father-in-law, was sold for about \u163\'a3300m in 2006 to Aggregate Industries and the family netted \u163\'a3150m after tax. Her Kingairloch Estate in the Highlands is investing \u163\'a33m to upgrade facilities for sporting visitors.\par 2009: \u163\'a3120m, 438= 4 NPr 458 \u163\'a3148m\par \u163\'a326m\par Nick Capstick-Dale Property UK Real Estate has \u163\'a3148m of net assets. It is the main London company of Capstick-Dale, 47, who has low borrowings and can buy sites at discounts, just as the former estate agent did when anticipating the 1989 property crash.\par 2009: \u163\'a3122m, 437 459= \u163\'a3145m\par \u163\'a35m\par Kaveh Alamouti Finance Alamouti, 55, owns Optimum Asset Management in London, which had nearly \u163\'a31m net assets in 2008-09, though his fortune was made as a hedge fund manager with earnings said to total \u163\'a3116m.\par 2009: \u163\'a3140m, 388= 459= \u163\'a3145m\par \u163\'a325m\par John Charman Insurance Charman, 57, a star of the London insurance market, is chief executive of Axis Capital and has a \u163\'a3129m stake in the Bermuda company. Since 2006, the year he was hit by a \u163\'a348m d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vorce, he has sold \u163\'a330m of Axis shares .\par 2009: \u163\'a3120m, 438= 4 Gr 459= \u163\'a3145m\par \u163\'a328m\par Graham Harris Pr Property London & City Group Holdings specialises in London lettings and markets in Pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 is and the French Alps. Harris, 63, owns the company, which in 2008-09 saw net assets rise from\par \u163\'a3138.8m to \u163\'a3143.3m.\par 2009: \u163\'a3117m, 473 459= \u163\'a3145m\par \u163\'a317m\par Richard Hunting and family Oil services The City-based Hunting group, a supplier of oilfield equipment, is worth nearly \u163\'a3790m. Hunting, 63, the chairman, has only a small direct holding in the firm but the family stake is worth \u163\'a3140m. Hunting is chairman of the Battle of Britain Memorial Trust.\par 2009: \u163\'a3128m, 423 459= \u163\'a3145m\par \u163\'a320m\par Mike Luckwell Media Green energy company New Energy Finance was sold in December to the Bloomberg Group for more than \u163\'a330m. It meant a payday for Luckwell, 67, who also chairs Ingenious Media Capital. We can see at least \u163\'a3104m of share sales over the years, including a \u163\'a333m deal at HIT Entertainment. Luckwell has a \u163\'a325m stake in a call centre operation, The Listening Company.\par 2009: \u163\'a3125m, 426= 459= \u163\'a3145m\par \u163\'a335mt Gerald Ronson and family Property Ronson's \u163\'a3500m Heron Tower, an office project in the City, has reached its full 46 storeys and will open next year. Alongside it, Ronson, 70, is developing the 24-storey Heron Plaza, which he intends to turn into a hotel. In 2008 Heron International, the parent company, made a \u163\'a322m profit and showed \u163\'a3434.5m net assets. Ronson, who owns about 25%, also has the Snax 24 petrol retailing business, worth at least \u163\'a360m. Down the years he has given \u163\'a335m to charities.\par 2009: \u163\'a3180m, 309= 459= \u163\'a3145m\par \u163\'a35m\par Julian and David Schild Medical equipment Huntleigh Technology was started by the late Rolf Schild, who arrived as a refugee from Nazi Germany, and run in Luton by his sons Julian, 50, and David, 49, until it was sold in 2006. The deal netted the Schild family \u163\'a3176m before tax. They are now involved in property .\par 2009: \u163\'a3140m, 388= 459= \u163\'a3145m Sir Ray Tindle Newspapers Profits fell at Tindle Press Holdings last year from\par \u163\'a38.6m to \u163\'a34m on \u163\'a346m sales. It has \u163\'a360.5m net assets. TPH is worth \u163\'a3120m and Tindle, 83, based in Su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rey, has other assets.\par 2009: \u163\'a3145m, 382= 468 \u163\'a3144m\par \u163\'a326mt Christopher Moran Finance and property Chesterlodge, Moran's main holding company, saw net a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets hit \u163\'a3210m in 2008-09. We value the business at \u163\'a3140m. Moran, 62, owns the 15th-century Crosby Hall in London's Chelsea, which he has restored. Among Chesterlodge's assets is the 48,000-acre Glenfiddich estate near Aberdeen.\par 2009: \u163\'a3170m, 33=\par Putting on the style 459= \u163\'a3145m\par \u163\'a320m, 16%\par David and Victoria Beckham Football and fashion\par So hot are Victoria Beckham's dresses that thieves stole 75 spring styles in December from a delivery van in west London. That incident apart, these are happy days for the woman formerly known as Posh, who is wo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing the world as much as footballer husband David thanks to her Victoria Beckham fashion label, which is expected to ring up $7.5m in sales in 2010. It is not all plain sailing at Brand Beckham, however, with Simon Fuller (qv)\par recently quitting as a director, although sources describe it as an "administrative move" and insist it will make no difference to their working relationship. In 2008, Brand Beckham profits soared to \u163\'a35.6m on \u163\'a39.8m sales. Beckham, 34, wanted a last hurrah with England at this summer's World Cup in South Africa but an Achilles injury put paid to that. He has less than two years remaining on his reputed \u163\'a3128m contract with LA Galaxy, a large part of which depends on his ability to attract club sponsors and to raise attendances at games. About 25% of Beckham's earnings come from Asia and he has had countless deals with blue-chip comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nies. In 2007, the couple were paid $13.7m to launch his fragrance line in the US. Forbes in its celebrity 100 list last year put Beckham's earnings at \u163\'a328m worldwide and Victoria, 36, made at least \u163\'a36m from the Spice Girls reunion tour and her fashion line. We value the pair at \u163\'a3145m.\par 2009: \u163\'a3125m, 616= 469 \u163\'a3143m New entry John Laithwaite and family Laundry equipment JLA is Europe's largest distributor of commercial laundry equipment. Laithwaite, 65, a Yorkshire entrepreneur, last month sold the Sowerby Bridge firm to HG Capital for \u163\'a3150m-\u163\'a3175m. On the lower figure, the Laithwaites' 94% stake is worth \u163\'a3141m and dividends add \u163\'a32m.\par 470 \u163\'a3142m New entry Vladimir Ni Mining As non-executive chairman of Kazakhmys, Ni, 77, helps oversee one of the world's biggest copper mining groups. The Kazakhstan operation floated on the London stock market in October 2005 and is worth more than \u163\'a36.5 billion. Ni has a \u163\'a3142m stake.\par 471 \u163\'a3141m\par \u163\'a377m\par Anthony Todd Finance The London hedge fund Aspect Capital saw profits leap in 2008 from\par \u163\'a329.3m to \u163\'a384.9m and showed \u163\'a381.3m net assets. Co-founder Todd, 49, has a 40.2% stake worth \u163\'a3121m. We add \u163\'a320m for other wealth.\par 2009: \u163\'a364m, 900= 472= \u163\'a3140m\par \u163\'a320m\par Gregory Darling and family Shipping Darling, 57, is the son of the late George Darling, who founded Gardline Shipping in 1969. Today the Gardline Group's activities range from marine sciences to satellite communic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions. In 2008-09 it made \u163\'a321.2m profit on \u163\'a3164.5m sales. With nearly \u163\'a398m net assets, it is worth \u163\'a3140m.\par 2009: \u163\'a3120m, 438= 472= \u163\'a3140m\par \u163\'a394m\par Tarsem Dhaliwal Frozen food Dhaliwal, 46, joined Iceland Food Group in 1985. In 2004 the business was taken over by former chairman Malcolm Walker (qv). Dhaliwal is his finance director and has helped revive Iceland. In 2008-09, profits rose to \u163\'a386.8m on more than \u163\'a32 billion sales. Dhaliwal has a stake worth \u163\'a3139m and other assets.\par 2009: \u163\'a346m, 1,198= 472= \u163\'a3140m\par \u163\'a360m\par Richard Goulding Internet Goulding, 40, and Simon Perr\u200\'e9e (qv)\par run the Jersey-based Play. com. The internet retailer lifted turnover in the year to January 2008 from\par \u163\'a3290m to \u163\'a3340m. It should be worth \u163\'a3300m and we value the stakes held by Goulding and Perr\u200\'e9e at \u163\'a3140m apiece.\par 2009: \u163\'a380m, 694= 472= \u163\'a3140m\par \u163\'a320m\par Sir Angus Grossart Finance Grossart, 73, continues at the helm of Noble Grossart, the Edinburgh bank he co-founded in 1969, and owns at least 85.6% with his family. It has \u163\'a377m net assets and is worth at least \u163\'a3120m. Other interests include a \u163\'a32.7m stake in Independent Investment Trust.\par 2009: \u163\'a3120m, 438= 472= \u163\'a3140m\par \u163\'a310m\par Clinton, Spencer and John McCarthy Construction Brothers Spencer, 44, and Clinton McCarthy, 45, run Churchill Retirement Living, a Hampshire housebuilder that is buying 60 new sites. In the year to May 2010, it should make a \u163\'a34.5m profit. Their father, John, 70, set up McCarthy & Stone, and left in 2004, making \u163\'a374.4m. Churchill has been valued at about \u163\'a3120m. There are other assets.\par 2009: \u163\'a3130m, 406= 472= \u163\'a3140m\par \u163\'a350m\par Stewart Milne and family Construction The Stewart Milne Group made a loss in 2008-09 of \u163\'a327m, the first in 38 years as an Aberdeen housebuilder. Sales were \u163\'a3275.7m. The group has \u163\'a3108m net assets and is 100% owned by Milne and his family. We value it at \u163\'a3120m. Milne, 59, chairs Aberdeen FC. There are other a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets.\par 2009: \u163\'a390m, 600= 472= \u163\'a3140m\par \u163\'a360m\par Simon Perr\u200\'e9e Internet Play.com, the Jersey-based internet retailer, was launched by Perr\u200\'e9e, 39, and Ric}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ard Goulding (qv)\par in 1998. Turnover in the year to January 2008 hit \u163\'a3340m, up from\par \u163\'a3290m in 2007 and the business is worth about \u163\'a3300m, valuing the stakes held by Goulding and Perr\u200\'e9e at \u163\'a3140m each.\par 2009: \u163\'a380m, 694= 472= \u163\'a3140m Sir Tim Rice Music There are more than 20 Rice shows in production worl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 wide, many of them collaborations with Andrew Lloyd Webber (qv). Rice, 65, has been paid \u163\'a317m in recent years by Heartaches, his main company, and his royalties have been shrewdly invested in art.\par 2009: \u163\'a3140m, 388= 472= \u163\'a3140m John Robinson Property Robinson, 49, retired after selling his high-end London properties in 2007. He bought them through N&R Property, which he set up having left Jupiter Asset Management with a \u163\'a350m payoff.\par 2009: \u163\'a3140m, 388= 472= \u163\'a3140m\par \u163\'a320m\par Ringo Starr Music Starr, 69, launched his Y Not album in January, a few months after the whole Beatles ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 alogue was remastered and repackaged by EMI. The main Beatles company, Apple Corps, is doing well. In the year to January 2009 it made a \u163\'a36.2m profit on \u163\'a315.7m sales. The drummer's stake is worth \u163\'a3100m. In 2008-09, his Startling Music made a \u163\'a31.4m profit on \u163\'a31.8m sales. We add royalties, the value of the back catalogue and dividends .\par 2009: \u163\'a3120m, 438= 482 \u163\'a3139m\par \u163\'a330m\par Alasdair Locke Oil services Locke, 56, stepped down as chairman of the Abbot Group in November, nearly two years after making \u163\'a3120m when he sold the Aberdeen operation for \u163\'a3906m. He has an insurance bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness and aim\par to develop Dundee waterfront.\par 2009: \u163\'a3109m, 501= 483 \u163\'a3138m\par \u163\'a339m\par Andrew and Paul Gower Computer games War of Legends is Jagex's latest computer game. It joins more than 40 other free-to-use games. The best known is RuneScape, started when Andrew Gower, 31, above, was an undergraduate at Cambridge. He formed Jagex with brother Paul, 33, and a third partner to run the game. In 2008-09, Jagex saw profits rise 24% to \u163\'a318.3m on sales of \u163\'a338.4m. Paul and Andrew own a 52% stake, worth nearly \u163\'a3130m. There are other assets.\par 2009: \u163\'a399m, 566= 484 \u163\'a3137m\par \u163\'a330m\par Leonard Polonsky Finance A veteran insurance man, Polonsky received \u163\'a3103m on cutting his stake in Ha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 son Global from 75% to the current 42% when the company he founded floated in 2006. Much of the money went into his charitable foundation . Born in New York, the British citizen, 83, is now based in Monaco. Polonsky's remaining stake is worth \u163\'a3107m and he has other assets.\par 2009: \u163\'a3107m, 507= 485 \u163\'a3136m\par \u163\'a310m\par Chris Marshall and family Property Though profits fell in 2008 from\par \u163\'a316.3m to \u163\'a35m at Marshall's Leeds company, Marshall Holdings, net assets rose from\par \u163\'a3153.7m to almost \u163\'a3160m. It is worth at least \u163\'a3130m to Marshall, 70, and his family. There is other wealth.\par 2009: \u163\'a3126m, 425 486= \u163\'a3135m\par \u163\'a35m\par Irina Abramovich Divorce The former wife of Roman Abramovich (qv)\par received \u163\'a3155m in a 2007 divorce settlement, which included Fyning Hill estate in West Sussex.\par 2009: \u163\'a3130m, 406= 486= \u163\'a3135m\par \u163\'a310m\par Anthony Brotherton-Ratcliffe and family Construction Croudace Homes made a \u163\'a31.5m profit on \u163\'a388.8m sales in 2009 and the Caterham firm has more than \u163\'a377m net assets. It is part of the property-to-housebuilding operation run by the Brotherton-Ratcliffes. Anthony, 59, and his family own two other companies, which b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tween them have \u163\'a389m net assets.\par 2009: \u163\'a3125m, 426= 486= \u163\'a3135m Sir Richard George and family Food The Georges ended a 75-year assoc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ation with the maker of Weetabix when Sir Richard, 66, who has a home in Scotland, retired as a director of the Northamptonshire business in 2008. It was bought for \u163\'a3642m in 2003, a deal that netted the family \u163\'a3128m. The Georges also control Pure Magic Industries, a property, milling and farming operation .\par 2009: \u163\'a3135m, 400= 486= \u163\'a3135m\par \u163\'a315m\par Guy Johnson Mobile phones Nine years after leaving Carphone Warehouse, Johnson, 46, is involved in property and private equity. He netted \u163\'a356m in 2004 when selling shares in the London firm he co-founded with Charles Dunstone (qv)\par and David Ross. His remaining stake is worth about \u163\'a328m.\par 2009: \u163\'a3120m, 438= 486= \u163\'a3135m\par \u163\'a35m\par Sir Tom Jones Music Approaching his 70th birthday, Jones is as busy as ever. Apart from stints at the MGM Grand in Las Vegas and other casinos and theatres, the Welsh singer undertook a European tour in 2009, playing 33 dates. His assets include a large estate in Los Angeles.\par 2009: \u163\'a3130m, 406= 486= \u163\'a3135m\par \u163\'a330m\par Bernard Matthews Turkeys Bernard Matthews Holdings, based near Norwich, announced 160 job cuts in February. Despite a loss of \u163\'a34.3m on sales of \u163\'a3335.4m in 2008, the company had nearly \u163\'a3110m net assets. Matthews, who has recruited the chef Marco Pierre White to develop new products, stepped down as a d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rector on his 80th birthday in January. He has other assets.\par 2009: \u163\'a3105m, 510= 486= \u163\'a3135m\par \u163\'a360m\par Sir Peter Ogden Computers Ogden, 62, has a \u163\'a3110m stake in Hatfield-based Computacenter and \u163\'a326m of the quoted software company Dealogic. He also has 25% of MSV Group, which owns Brands Hatch and showed nearly \u163\'a321m net assets in 2008. His Ogden Trust donates to good causes.\par 2009: \u163\'a375m, 751= 486= \u163\'a3135m\par \u163\'a320m\par The Duke of Rutland Land and art Rutland, 50, owns Belvoir Castle in Leicestershire, its 18,000 acres and Haddon Hall in Derbyshire. The acreage is worth at least \u163\'a360m and his art about \u163\'a3120m. We cut its value to \u163\'a370m after inheritance tax. Other assets add \u163\'a35m.\par 2009: \u163\'a3115m, 474= 486= \u163\'a3135m\par \u163\'a345m\par Harold Sher Metal Amalgamated Metal Corporation made a record \u163\'a367.2m profit on nearly \u163\'a3977m sales in 2008. Its chief executive, Sher, 63, led a \u163\'a3200m management buyout in December 2003. The business is now worth \u163\'a3500m, valuing Sher's stake at \u163\'a3125m. He has other wealth.\par 2009: \u163\'a390m, 600= 486= \u163\'a3135m\par \u163\'a345m\par Shiraz Dharamshi Tejani and family Paper products The Leicester business LPC Group, the UK's biggest independent maker of tissuebased hygiene products, is led by Tejani, 61, and made \u163\'a315.1m profit in 2009 on sales of \u163\'a3236.1m. The family also has property and a pharmaceuticals firm.\par 2009: \u163\'a390m, 600= 486= \u163\'a3135m\par \u163\'a315m\par Alexander and Alan Turner Industry Turner & Co (Glasgow), the diesel-to-engineering group, has nearly \u163\'a3129m net assets, with brothers Alexander, 49, and Alan, 44, directors and leading shareholders in the bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness built by their father. There are other assets.\par 2009: \u163\'a3120m, 438= 497 \u163\'a3133m\par \u163\'a343m\par Ben and Jos White Computers Ben White, 42, and his brother Jos, 40, above, founded a trio of tech firms. RBR Networks was sold for \u163\'a335m in 1998, while the sale of Gloucester-based MessageLabs in 2008 netted them about \u163\'a3104m. They still have Star Internet, whose parent, Star Technology, is worth \u163\'a343m.\par 2009: \u163\'a390m, 600= 498= \u163\'a3132m\par \u163\'a340m\par Tony Bramall and family Car sales Bramall netted \u163\'a318m when the Bramall & Jones dealership was sold last month. Yorkshire entrepreneur Bramall, 74, retains a \u163\'a346m stake in Lookers and has property and farming ventures.\par 2009: \u163\'a392m, 594= 498= \u163\'a3132m\par \u163\'a32m\par Duncan Cameron Internet Cameron, 38, set up Moneysupermarket.com in 1999 with Simon Nixon (qv)\par and made a fortune - Nixon paid him\par \u163\'a3162m for most of his share before the Flintshire-based company floated in 2007 .\par 2009: \u163\'a3130m, 406= 498= \u163\'a3132m\par \u163\'a360m\par Colin Giltrap Car sales Giltrap, 70, divides his time between London and New Zealand, where he has the biggest car dealership. He sold most of his stake in British luxury car group HR Owen. New Zealand's N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tional Business Review 2009 rich list values him at \u163\'a3132m.\par 2009: \u163\'a372m, 782= 431= \u163\'a3150m New entry Jim Ratcliffe Chemicals Ratcliffe is back after an absence of one year, but at a much reduced value. He is moving his Ineos business to Switzerland to save (EURO)450m in tax over the next four years. As head of the world's third largest chemicals operation, he faced a crisis in 2008 when orders fell 30% and the value of his oil stocks suffered an \u163\'a3850m writedown. Hampshire-based Ineos had \u163\'a36.4 billion of debt and extended its banking covenants. As negotiations with banks extended over the period of the 2009 Rich List, we took the 57-year-old out of our calculations, but he convinced most of the 230 banks owed money to change the loan terms. The management team also stripped out \u163\'a3340m of costs and sold some businesses. Ineos is looking to refinance \u163\'a3900m of debt by selling bonds. Ratcliffe's bac}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ground is tailormade for the firm. Having graduated from Birmingham University with a degree in chemical engineering, he spent a decade in the chemicals industry, followed by five years in private equity. In 1992, he led the management buyout of an offshoot of BP. Renamed Inspec, it floated in 1994 and four years later was taken over in a \u163\'a3611m deal by Laporte. That same year Ratcliffe, who had left the operation, founded Ineos by heading the \u163\'a390.5m acquisition of a plant in Belgium. Last year the firm saw profits leap from (E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RO)594m to (EURO)1.22 billion. It employs 15,000 staff in 14 countries. We value Ratcliffe's stake and other assets, including the Lime Wood hotel in the New Forest, at \u163\'a3150m.\par Partnership pays dividends 431= \u163\'a3150m\par \u163\'a330m, 25%s Roger and Diana Jenkins Finance Okay, this bald, 54-year-old banker is worth a lot of money, but yada, yada, this is the Rich List and that sort of money is just so many noughts on a spreadsheet.\par Impress me. All right - Edinburgh-born Roger, who ran for Scotland, used to work for Barclays, where he was reputed to be paid more than \u163\'a340m. There, he came up with something dubbed "double-dipping" whereby wealthy clients got tax breaks twice over. Perfectly legal, but still not that interesting. How about the fact that he rescued Barclays by arranging a \u163\'a37 billion capital injection from Qatari investors during the 2008 banking crisis? And recently he set up Dublin-based Elkstone Capital, which plans to buy portfolios of distressed property loans from Irish banks. Enough Roger already. Where this really gets interesting is his brilliant and beautiful wife, Diana, born Sanela Dijana Catic in 1971 in Sarajevo. When war broke out in 1992 she e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 caped to London, where she put herself through night school and scratched a living as a cleaner, waitress and babysitter before setting up a jewellery stall. In 1999 she married Roger, whom she met at a gym, and they have two children. But Diana turned her back on London, declaring in a Tatler interview last December that other wealthy wives in the city treated her like an "eastern European mail-order bride". Based now in Malibu, she set up the Neuro Brands drinks line and has been a massive benefactor to charity in the Ba}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 kans. We can see more than \u163\'a322.7m net assets in the 2007-08 accounts of Roger's private companies, I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ney Investments and D-Sol Systems. Together the couple are worth \u163\'a3150m.\par 2009: \u163\'a3120m, 438=\par Entries from 501 to 1,000 list individual or family wealth, detailing where and how it was made, and give last year's valuation and ranking in brackets. *denotes family wealth 501 \u163\'a3131m\par Julia Davey Property. Davey, 53, owns the Angel Group, a London property operation. The business made a \u163\'a32.9m profit on \u163\'a331.5m sales in 2008-09 and is worth more than \u163\'a380m. We add \u163\'a350m for personal assets. (\u163\'a3131m, 405)\par 502= \u163\'a3130m\par Keith Bradshaw* Care homes and car sales. Car dealer Listers of Coventry is worth \u163\'a390m and Bradshaw, 66, owns half. He made \u163\'a321m when the Takare nursing home business he co-founded was sold in 1997 and he owns property. (\u163\'a3103m, 533=)\par Philip and Patricia Brown Media. Brown, 73, and his wife, Patricia, 71, sold PJB, their scientific publishing firm in London, for \u163\'a3150m in 2003. They have further net assets in publishing, pharmaceutical and property worth \u163\'a349m. (\u163\'a3130m, 406=)\par David Crossland* Travel. Crossland, 63, sold Traveljigsaw, an online car hire broker, in 2008 following the sale of his Colorado estate for \u163\'a311.5m. He launched Airtours, which became MyTravel. (\u163\'a3130m, 406=)\par Paul Day* Haulage. Day, 51, is managing director of Turners (Soham), a Newmarketbased haulage and warehousing group worth its \u163\'a3127m net assets figure. There is other wealth. (\u163\'a3112m, 490=)\par Cyril Dennis* Property. Last year, Monaco-based Dennis, 65, spent more than \u163\'a323m on the 403-bedroom Le M\u200\'e9ridien Beach Plaza hotel in Monte Carlo, and in nearby Antibes he is converting the former Le Proven\u193\'e7al hotel into 60 apartments. He sold a 3.3-acre site on the Isle of Dogs for \u163\'a347m in September 2006. (\u163\'a3130m, 406= )\par John Dunsdon* Property. Esher-based property company Coldunell has net assets of \u163\'a3112.2m. The bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness is run by Dunsdon, 57, and owned by his family and trusts and we value it at \u163\'a3100m, adding \u163\'a330m for other assets. (\u163\'a3130m,406=)\par Sir Jack Hayward Property. Hayward sold his stake in the Grand Bahama Port Authority last year. The price was not disclosed but Hayward, 86, was offered \u163\'a387m. Now living mainly in the Bahamas, he has homes in London, New York and the Scottish Highlands. (\u163\'a3120m, 438=)\par John Hindle* Property. Hindle, 75, runs Sale developer Brookhouse and has a \u163\'a3240m portfolio. We include the family's stake and property. (\u163\'a390m, 600=)\par Ron Jelley* Construction. Jelson, the Leicester housebuilder led by Jelley, 83, has net assets of \u163\'a3106.5m. The family has other property and assets. (\u163\'a360m, 924=)\par Sir Martin Laing* Property and construction. Laing, 68, the last family chairman of the John Laing operation, stepped down in 2002. Family trusts also own Eskmuir Properties. These interests take the Laings to \u163\'a3130m. (\u163\'a3115m, 474=)\par Ian McGlinn Retailing and hotels. McGlinn, a Scot, saw his \u163\'a34,000 Body Shop stake grow to \u163\'a3137m, and bought into the Hotel du Vin chain, sold for \u163\'a366m. (\u163\'a3130m, 406=)\par Andrew Michael Internet. Michael, 30 and living in Cheltenham, dropped out of school at 17 to develop inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 net-hosting firm Fasthosts, pocketing \u163\'a345m when he sold it. He has reinvested. (\u163\'a335m, 1,550=)\par Terence Mordaunt Docks. City suitors are queuing to buy Bristol's dock operations, owned by Mordaunt, 62, and David Ord (qv). Mordaunt has equity of 60%, worth \u163\'a3120m, and other assets. (\u163\'a3130m, 406=)\par Robert Palmer Oil services. Palmer, 42, owns Bury St Edmunds-based RP Valves, Europe's leading supplier and distributor of valves for the oil, gas and petrochemical industries. The company is worth \u163\'a3124m and past salaries add \u163\'a36m. (\u163\'a375m, 751=)\par Kirit and Meena Pathak Food. Associated British Foods, the owner of Wigan-based Patak's spice brand, has relaunched it with new recipes and a TV advertising campaign focusing on the Pathak family heritage. The family sold up in 2007 for \u163\'a3200m. Under Kirit, 57, and his wife Meena, 53, the company forged ahead. Kirit is chairman of ABF's world food division. (\u163\'a3130m, 406=)\par 517= \u163\'a3129m\par Richard Koch Internet gambling. Koch, 59, struck gold with Betfair, the online betting exchange valued at \u163\'a31.5 billion, following a deal with the Japanese SoftBank operation. Koch has a stake worth \u163\'a395m. He has received \u163\'a327m cash and has other assets, including a holding in private group Zola hotels. (\u163\'a3129m, 422)\par Sir Richard Sutton* Land. Sutton, 72, and his family have valuable acreage in Lincolnshire, London, the West Country and America. His family firm, Sir Richard Sutton Settled Estates, showed \u163\'a3124m net assets in 2008-09 (\u163\'a3115m, 474=)\par 519= \u163\'a3128m\par Nigel Doughty Finance. Doughty, 52, gave the Labour party \u163\'a31m in 2009 and has invested millions in Cha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pionship football club Nottingham Forest. He runs Doughty Hanson, the West End private equity business, where his stake is worth at least \u163\'a3125m. (\u163\'a3119m, 471=)\par David and Heather Stevens Insurance. Stevens, 48, and his wife, Heather, 52, are founder managers of the motor insurance firm Admiral, with a \u163\'a3120m stake. There is other wealth and the couple established their Waterloo Foundation with \u163\'a3100m of Admiral shares. (\u163\'a3102m, 535= )\par 521 \u163\'a3127m\par Matti and Miriam Kraus Property. Husband and wife Matti, 67, and Miriam Kraus, 68, own Pall Mall Inves}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ments, worth its net asset figure of \u163\'a3125.6m. We add \u163\'a31.4m for dividends. (\u163\'a3100m, 540=)\par 522 \u163\'a3126m\par John Seddon* Construction and golf clubs. Cheshire-based Seddon Group is involved in property develo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment and running golf clubs. Seddon, 75, represents the family that owns the business. The family also owns Seddon Properties. (\u163\'a385m, 657=)\par 523= \u163\'a3125m\par John Apthorp* Frozen food and wine. Apthorp, 75 today, built the Watford-based Majestic Wine Warehouse chain. He set up Majestic after his family made \u163\'a370m from the sale of the Bejam frozen-food operation. (\u163\'a3120m, 438=)\par Bill Archer DIY. Archer, 65, founded Crewe-based Focus DIY chain with Greg Stanley (qv)\par before selling it three years ago for \u163\'a31 to a private equity group that took over its \u163\'a3174m debt. He had earlier made more than \u163\'a373m by selling part of his stake. He also bought and sold the Wickes operation. (\u163\'a3125m, 426=)\par John and William Asprey Jewellery.\par See panel on page 59\par The Baylis family Property. JT Baylis jointly developed the giant mall at Cribbs Causeway retail centre, near Bristol. The company, founded by the late Jack Baylis, reported \u163\'a35.3m profit on \u163\'a310.9m sales in 2007-08, with net assets of \u163\'a3159m. Baylis left \u163\'a396m in his will in 2006. After tax, the family is worth \u163\'a3125m. (\u163\'a3125m, 426=)\par Ad man on the ball\par 523= \u163\'a3125m\par \u163\'a342m, 51%s\par Sir Martin Sorrell Advertising\par Though more of a cricket fan himself, MCC member Sorrell will be keeping a close eye on the football World Cup this summer, hoping it delivers a global advertising boost. He described 2009 as a "brutal" year for WPP, his giant advertising group, with profits sliding by 21.4% to \u163\'a3662.6m and revenues down by 8.1%. WPP shares did well from mid-2009, however, and the company is worth \u163\'a38.1 billion. He moved its hea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 quarters to Dublin in 2008, claiming Ireland's low rate of corporation tax meant that WPP would save up to \u163\'a380m. The 65-year-old nearly drowned in a sea of debt after transforming Wire and Plastic Products, a Kent firm making supermarket baskets, into an advertising empire through the takeover of J Walter Thompson and Ogilvy Group in the late 1980s. Sorrell, a Cambridge economics graduate and Harvard MBA, brought the business back from the brink after the 1991-92 recession and today it claim\par to be the world's largest communications services group. In 2003, his 33-year marriage to Lady Sandra So}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rell, now worth \u163\'a332m, ended in divorce and he had to sell \u163\'a312.5m of shares to help fund her settlement. In 2008, he married the Italian Cristiana Falcone, a director of the World Economic Forum. Sorrell's stake in WPP is worth \u163\'a3111m. With other assets and past salaries, we value him at \u163\'a3125m.\par 2009: \u163\'a383m, 687\par 523= continued from page 57 \u163\'a3125m\par Richard Chenevix-Trench Finance. Chenevix-Trench, 51, is one of the four co-founders of London hedge fund Sloane Robinson. The Financial Times said he made \u163\'a382m in 2008 alone. (\u163\'a3120m, 438=)\par Eric Clapton Music. The 65-year-old maestro has earned more than \u163\'a3120m since 1989, and we add the pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ceeds of his back catalogue. (\u163\'a3120m, 438=)\par The Goodliffe family Business services.\par The \u163\'a3120m\par OCS Group, based in Surrey, is owned by the descendants of its founder, Frederick Goodliffe. (\u163\'a380m, 694=)\par David Reiss* Fashion. Reiss, 66, opened his first boutique in London. The eponymous high street chain has more than 90 shops worldwide. (\u163\'a3105m, 510=)\par Lord Saatchi and Charles Saatchi Advertising and art. Charles, 66, and his brother, Maurice (now Lord Saatchi), 63, built the Saatchi & Saatchi advertising agency. Charles also owns a valuable collection of art. (\u163\'a3120m, 438=)\par Michael and Robert Slowe Property .\par Cousins Michael, 75, and Robert, 73, are directors of the family-owned J Leon, a London property company. (\u163\'a395m, 575=)\par Sir Martin Sorrell Advertising. See panel on page 57 Stef and Stelio Stefanou Construction.\par Stef, 68, runs Doyle, the Hertfordshire construction group. Stelio, 57, made \u163\'a3115m when its maintenance operation was sold. The brothers funded a robotic surgery centre for cancer treatment at the Lister hospital, Stevenage. (\u163\'a3125m, 426=)\par 536 \u163\'a3123m\par Jon Aisbitt Finance. Aisbitt's stake in Man Group, the London hedge fund, is worth \u163\'a34.1m. In 1999, he made \u163\'a380m from the Goldman Sachs flotation. (\u163\'a395m, 575=)\par 537= \u163\'a3122m\par Paul and Jeremy Eakin* Medical supplies. Tom Eakin founded TG Eakin in Northern Ireland. The company is now largely in the hands of his sons, Paul, 47, and Jeremy, 42. (\u163\'a392m, 594=)\par Jonathan Ruffer Finance. Ruffer, 58, owns half of the London-based Ruffer Investment Management, which we value at \u163\'a3220m. (\u163\'a3112m, 490=)\par Michael Shanly Housebuilding. Shanly, 64, founded his housebuilding operation in 1970 and now owns d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 velopment companies worth \u163\'a3110m. (\u163\'a382m, 688=)\par 540= \u163\'a3120m\par Iqbal Ahmed* Food. The family has two main operations in Manchester: catering supplier Ibco and Seamark, a frozen-food processor. Ahmed, 53, heads the operation. (\u163\'a3120m, 438=)\par Roger Ames Music. Ames, 60, has joined US entertainment group Ticketmaster as international chief exec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tive. He worked at EMI, Warner and London Records, where he owned a significant stake when it was taken over for \u163\'a3140m. (\u163\'a390m, 600=)\par The Duke of Beaufort Land and art.\par Beaufort, 82, owns the 52,000-acre Badminton estate. We value his land at \u163\'a385m and add \u163\'a335m for his art, business and other assets. (\u163\'a3115m, 474=)\par Bart Becht Cleaning products. Dutchman Becht, 53, is chief executive of Reckitt Benckiser, the \u163\'a325 billion Berkshire-based maker of household names such as Dettol and Mr Sheen. Becht's charitable trust has \u163\'a3102m of Reckitt shares. (\u163\'a380m, 694=)\par Yevgeny Chichvarkin Mobile phones. Moscow-born Chichvarkin, 35, made \u163\'a3120m from mobile firm Euroset. He moved to London, and Russia has been seeking his extradition for an alleged kidnapping and blackmail. (New entry)\par Gordon Crawford Computers. Crawford made \u163\'a376m when London Bridge Software was sold in 2004, plus \u163\'a333m from earlier share sales. The 55-year-old has lent money to the Labour party. (\u163\'a3120m, 438=)\par Andrew Creighton Property. Creighton, 48, has a 50% stake in Belfast-based William Ewart Properties. There are \u163\'a3145m of net assets attributable to him, but we value him cautiously. (\u163\'a390m, 600=)\par Charles Davies Finance. Davies is head of Link Asset & Securities Company, the London broker sold to M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 chael Spencer's (qv)\par Icap in 2008. The 40-year-old has made about \u163\'a3105m from the performancerelated deal, with dividends. (\u163\'a397m, 570=)\par George Davies Retailing. Davies, 68, has sunk \u163\'a320m into GIVe, a chain of fashion stores aimed at women over 30. GIVe is his fourth retail brand after Next, George and Per Una. (\u163\'a3105m, 510=)\par Brian DeZille* Knitwear and health clubs.\par DeZille, 76, and his family netted \u163\'a3120m for their 80% stake in the Sweater Shop retail chain. They have a Jersey investment operation and other interests including Carrefour Health Clubs. (\u163\'a3115m, 474=)\par Lucian Freud Art. A self-portrait by Freud, showing the artist with a black eye after a fight with a taxi driver, sold for \u163\'a32,841,250 at Sotheby's in February. The 87-year-old has admitted to once being in \u163\'a3500,000 debt to the Kray twins. (\u163\'a3120m, 438=)\par Ronnie Frost Recruitment. The stake held in Hays, the London recruitment agency, by its former chairman, Frost, 74, is worth \u163\'a383m. He has other assets. (\u163\'a392m, 594=)\par John Guthrie* Property. Guthrie, 73, chairs Broadland Properties in Scarborough, which is worth \u163\'a3110m. The family has other assets. (\u163\'a3125m, 426=)\par Rupert Hambro* Finance. The family, led by Rupert, 66, sold its interest in the Hambro merchant bank for \u163\'a350m. There are other assets. (\u163\'a3100m, 540=)\par Philip Hulme Computers. Hulme, 61, has a stake worth \u163\'a388m in Computacenter, the Hatfield-based provider of IT services, and other assets. (\u163\'a361m, 921=)\par Hugh Irvine* Cheese. Irvine, 72, and his family owned the Lactalis McLelland cheese operation until 2004. His two sons now own a Glasgow-based children's clothing retailer. (\u163\'a3100m, 540=)\par Fawn and India Rose James* Inheritance. Sisters Fawn, 24, and India Rose James, 18, are the granddaug}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ters of Soho property owner and adult magazine publisher Paul Raymond, who died in 2008, leaving a huge estate. (\u163\'a3120m, 438=)\par Mark Lowe Finance. Lowe, 60, made his fortune at a Spanish hedge fund. His Mayfair firm Nomos Capital Partners was put into liquidation in late 2009, owing to the economic climate. (New entry)\par Louise MacBain Publishing. Londonbased MacBain, 51, built a publishing conglomerate in Canada with her former husband, John. After their divorce she went into art publishing. (\u163\'a3120m, 438=)\par David Roberts Property. Roberts, 53, has a \u163\'a3110m stake in London-based Edinburgh House Estates and a collection of 1,500 artworks. (\u163\'a3105m, 510=)\par Chris Rokos Finance. Rokos, 39, a senior partner at London-based Brevan Howard Asset Management, earned \u163\'a320m-\u163\'a330m in the last financial year alone. (\u163\'a390m, 600=)\par Phyllis Somers Property. Somers, 88, the widow of Nat Somers, a Jersey-based tycoon who sold Southam}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton airport for \u163\'a350m in 1988, donates to many charitable causes, including London's Great Ormond Street hospital. (\u163\'a3100m, 540=)\par Gerard Versteegh* Property. Londonbased Swede Versteegh, 49, is a director of a number of asset-rich firms, led by Gestrix, which had net assets of \u163\'a3191m in 2006. (\u163\'a3120m, 438=)\par Peter Wood Insurance. Wood led a management buyout in February of the controlling 70% stake in Esure held by Lloyds Banking Group. Wood, 63, chairs the Surrey-based business. (\u163\'a3120m, 438=)\par 564= \u163\'a3119m\par Elliott Bernerd Property. Chelsfield Partners, the London-based property company chaired by Bernerd, 65, lost \u163\'a3101.3m in 2008. (\u163\'a3219m, 259)\par Jeff Smith Engineering and property. AIM Aviation, the Southampton engineering firm, is chaired by Smith, 64. His main wealth is in property company Proudreed, where he has a \u163\'a390m stake. (\u163\'a365m, 863=)\par 566= \u163\'a3118m\par Bill Gredley* Property and racing. Apart from his Newmarket racing interests, Gredley, 77, and his family own Unex Group Holdings, a property firm worth its net assets figure of \u163\'a3102.7m. (\u163\'a395m, 575=)\par Tony Khalastchi* Property. Khalastchi, 49, sold two DIY store sites in February for \u163\'a317.8m. His family's two property groups, London-based Flodrive and Strandpark Properties, are worth their net assets figure of \u163\'a3103.4m. (\u163\'a3105m, 510=)\par David Kirch Property. Jersey-based Kirch, 73, made a fortune in London residential property, and in 2008 sold properties to Irish investors for \u163\'a348m. He runs Channel Hotels and Properties. (\u163\'a3148m, 378=)\par Stuart Monk* Property. Stockton-based property firm Jomast, run by Monk, 60, and owned by his family, is worth \u163\'a3115m. There is other wealth. (\u163\'a399m, 566=)\par 570= \u163\'a3117m Nicholas Berry* Finance. Berry, 67, is the younger son of the late Lord Hartwell, who sold the Telegraph newspaper titles to Lord Black in 1985. His family has a 91% stake in Stancroft Trust, the London-based investment company that Berry, based in Switzerland, chairs. (\u163\'a3125m, 426=)\par Hermann Hauser Computers. We clip \u163\'a38m off Hauser, 61, who runs Amadeus Capital Partners investment firm, for his funding of a centre for entrepreneurship at Cambridge University. (\u163\'a3107m, 507=)\par Ian MacKechnie* Finance. Scotsman MacKechnie, 66, and his family own Amscot Financial, a chain of chequecashing outlets in Florida, worth \u163\'a3111m. There are other assets. (\u163\'a387m, 648=)\par 573 \u163\'a3116m\par Tom and Alan Fergusson Fuel distribution. Stirling-based Fergusson Group, the solid fuel supplier, is run and owned by Tom, 47, and Alan Fergusson, 43. It is worth about \u163\'a3110m. (New entry)\par 574= \u163\'a3115m\par Robert Carter* Construction. Carter, 56, is chairman of Norwich-based construction group RG Carter, which had to cut 268 jobs after a fall in profits in 2008. (\u163\'a3105m, 510)\par Michael Cowan* Finance. Cowan, 57, is a director of Savile Row-based Silchester International Investors, and has an \u163\'a383m stake. (\u163\'a3108m, 503=)\par Sir Tom Farmer Property and football. Edinburgh tycoon Farmer, 69, who owns 90% of Hibernian FC, made his money with Kwik Fit, collecting \u163\'a378m when it was sold. He diversified into property. (\u163\'a3110m, 492=)\par Everard Goodman Property. Goodman, 78, left Yorkshire to start work in London, making \u163\'a3130m when he sold Tops Estates five years ago. He has given away millions to charity. (\u163\'a3105m, 510=)\par Andrew Page* Car parts. Leeds-based Page, a vehicle parts distributor run by the 57-year-old, was sold for \u163\'a3100m in March. The family has other assets. (\u163\'a355m, 986=)\par The Earl of Pembroke Land and art. The 18th Earl, 31, lives at the 14,000-acre Wilton House near Salisbury. His art is worth \u163\'a375m after tax and the estate is valued at \u163\'a340m. (\u163\'a3105m, 510=)\par Julian Richer Retailing. Specialist hi-fi retailer Richer Sounds is worth \u163\'a350m, and its 51-year-old owner has a \u163\'a345m property portfolio and other assets. (\u163\'a3105m, 510=)\par Barry Rubery Electronics. Rubery, 62, set up the Bradford-based software and computer company Pace M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cro, which floated in 1996. (\u163\'a395m, 575=)\par Earl Spencer Land. The earl's father, who died in 1992, left \u163\'a388m in his will, although much of that was tied up in the 8,500-acre Althorp estate in Northamptonshire and its art treasures. (\u163\'a391m, 599)\par Greg Stanley* DIY. Stanley, 64, sold his family's DIY chain as part of a \u163\'a3130m deal, then picked up at least \u163\'a3100m when he sold his stake in Focus, the Crewe-based DIY business. (\u163\'a3115m, 474=)\par Jacob and Niels Stolt-Nielsen Shipping and seafood. Stolt-Nielsen, a Norwegian shipping and seafood ope}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ation, is worth \u163\'a3630m. Jacob, 47, and Niels Stolt-Nielsen, 45, who live in London, have a \u163\'a3110m stake and other wealth. (\u163\'a355m, 986=)\par Sparkling success\par 523= \u163\'a3125m \u163\'a335m, 39%\par John and William Asprey Jewellery\par Bling is not our thing, declares the luxury retailer William & Son. The plush Mayfair store nonetheless has enough sparkle to dazzle the average highstreet shopper, as would be expected from a business run by the seventh generation of the Asprey jewellery family. William, 44, sells beautiful things to the beautiful people and has a royal warrant to emphasise the high-class clientele. Think sterling silver Martini goblets for \u163\'a3995, purple leather backgammon sets for \u163\'a31,550 and diamond-studded cufflinks - a snip at \u163\'a38,100. The hunting, shooting and fishing set are catered for with bespoke guns and rifles plus associated tweed garments. Watches are a favourite of the proprietor, whose wife Lucy, pictured with him above, has received a select number as gifts. Wine is another passion - he is said to keep 2,000 bottles. Asprey, a former army officer who has homes in London and Berkshire, set up shop in 1999. Four years earlier, Prince Jefri Bolkiah of Brunei had bought the family jewellery company chaired by father John, 72, inset. The Aspreys collected more than \u163\'a3100m for their stake in the operation, which began in 1781. Business is booming at William & Son: the parent company, WRA (Guns), made \u163\'a35.3m profit on \u163\'a310.3m sales in 2008-09. The family also has property and bloodstock interests, including the Gildridge Bloodstock and JRA Properties with \u163\'a32m of net assets between them. With the success of WRA (Guns), we raise the Aspreys by \u163\'a335m.\par 2009: \u163\'a390m, 600=\par 523= \u163\'a3125m New entry\par Jo Bradwell  Pharmaceuticals\par Bradwell, 64, a professor of medicine at Birmingham University, founded healthcare company The Binding Site in 1983. The Kings Heath-based firm has developed Freelite, used for diagnosing multiple myeloma (MM), a form of bone marrow cancer, and Hevylite, which reduces the need for painful biopsies. MM, which used to be confined mainly to people over 60 but is becoming more common among younger age groups, affects about 20,000 people in the UK. More than 15,000 cases are being diagnosed each year in the United States. The success of Freelite, which not only detects sufferers but can increase life expectancy by provi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing doctors with a sensitive test to the effectiveness of anti-MM drugs, saw the company enjoy sales of \u163\'a339m in the year to September 2008 with profits of \u163\'a35.8m. The autoimmune arm of the business manufactures a range of diagnostic assays and reagents used in hospital laboratories worldwide, to help diagnose and mon}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tor the treatment of diseases including antiphospholipid syndrome, vasculitis and coeliac disease. It saw re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 enues of about \u163\'a314m in 2008. Last June Bradwell agreed to sell the subsidiary for about \u163\'a380m. Binding Site said the sale would enable the company to focus its efforts and resources on the highly successful serum protein business, which has been growing at more than 40% a year. Bradwell and his trusts own about 53% of the company, which was valued at \u163\'a3240m before the subsidiary sale. He is worth \u163\'a3125m.\par 574= continued from page 59 \u163\'a3115m\par Michael Stone* Finance. Stone, 73, joined ED&F Man in 1957, and helped turn what had been a sugar trader and the navy's grog supplier into a top London hedge fund. We can see businesses with \u163\'a347m net assets owned by Stone, his family or where he has a sizeable stake. (\u163\'a3104m, 531=)\par Kenneth Townsley Leisure. Townsley, 64, made \u163\'a384m from the sale of the Gold Medal Travel operation to Thomas Cook. He started Trident Travel in a rented Blackpool shop, from where it grew rapidly and was r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 named. (\u163\'a360m, 924=)\par The Walduck family Hotels. Imperial London Hotels has net assets of \u163\'a3103m. The Walducks own it all. (\u163\'a385m, 657=)\par 588 \u163\'a314m\par Peter Sutherland Finance. Former BP chairman Sutherland, 64 today, had a \u163\'a387.5m stake when investment bank Goldman Sachs floated in 1995, and shares have recovered sharply. (\u163\'a374m, 778=)\par 589= \u163\'a3113m\par Eric Gadsden Property. Gadsden's Chesham-based company, WE Black, is worth \u163\'a370m. Gadsden, 65, has \u163\'a341m of net assets in two other firms, as well as racing interests. (\u163\'a3113m, 489)\par Peter and Michael Kane* Delivery services. Business Post Group changed its name in October 2009 to UK Mail. Peter, 63, is chairman of the Slough-based organisation and brother Michael, 60, a director. The family stake is worth \u163\'a3101m and there is other wealth. (\u163\'a390m, 600=)\par Sunny George Verghese Food. Verghese, 50, established a cashew-distribution project in Nigeria that b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 came Olam International, where he is chief executive. He is a British citizen but lives in Singapore and the 2009 Forbes Singapore rich list values him at \u163\'a3113m. (New entry)\par 592= \u163\'a3112m\par Peter Dawson* Property. Dawson, 57, runs Consolidated Property Wilmslow, an Alderley Edge developer worth its net assets figure of \u163\'a350.9m. He is also a director of Gemsupa, which had \u163\'a358.5m net assets in 2008-09. (\u163\'a378m, 742=)\par Steve Gibson Transport. In 2008, profits at Gibson O'Neill hit a record \u163\'a325.8m. Gibson, 52, chairman of Mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dlesbrough FC, made his money through his haulage company, Bulkhaul. Gibson O'Neill owns Bulkhaul and his stake is worth \u163\'a3105m, other interests adding \u163\'a37m. (\u163\'a382m, 688=)\par Jonathan Hitchins* Construction. Robert Hitchins Group, the Cheltenham-based developer, is worth \u163\'a387m. Hitchins, 59, as chairman, represents the family. We add \u163\'a325m for other assets. (\u163\'a390m, 600=)\par 595 \u163\'a3111m\par Bruce Robertson* Retailing. The West Country-based Trago Mills discount store chain and a development firm owned by Robertson, 57, had net assets of \u163\'a3104m in 2008. There is other wealth. (\u163\'a382m, 688=)\par 596= \u163\'a3110m\par William Ainscough* Property. Ainscough, 61, owns Merseyside property firm Langtree Group, which had \u163\'a371m assets in 2008-09, and Wain Group, which made \u163\'a35.8m profit in 2007-08. (\u163\'a3120m, 438=)\par Rod Aldridge Business services. Aldridge is a former chairman of Capita, the outsourcing firm. He retains a stake worth \u163\'a343m. Aldridge, 62, has made big gains from private equity investments, although his London-based Aldridge Foundation helps clip his wealth back. (\u163\'a399m, 566=)\par Ursula and Wilfried Bechtolsheimer Property. The daughter of Karl-Heinz Kipp, who the German magazine Manager says has a \u163\'a32.25 billion fortune, Ursula, 58, now lives with her husband, Wilfried, 61, in Glouceste}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 shire, where she runs an equestrian operation. (\u163\'a3105m, 510=)\par Martin Birrane Motor racing and property. Birrane, 74, bought the Lola racing car operation in 1997 and is keen to get back into Formula One. He made his money in property through the Peer Group. Birrane also owns Mondello Park racing circuit in Co Kildare. (\u163\'a3109m, 501=)\par David Blood Finance. Generation Investment Management, the London ethical investment operation, took a stake in the Ocado internet groceries business in 2009. Generation was set up in 2004 by former US vice-president Al Gore and former Goldman Sachs chief executive, Blood, 51. (\u163\'a370m, 793=)\par Robert Bourne and Sally Greene Property and theatre. Bourne, 59, sold stakes in companies such as Ex-Lands and Clubhaus. He owns Happybadge Projects and has a flat in Mayfair. His wife, Greene, 55, is chief executive of Old Vic Productions. (\u163\'a3110m, 492=)\par The Marquess of Bute Land and art. About 36,000 visitors flock to Bute's Mount Stuart seat on the Scottish island every year. The family also has a huge art collection. Bute, 52 tomorrow, has asset wealth of \u163\'a370m and \u163\'a340m of liquid assets. (\u163\'a3115m, 474=)\par Robin Clark* Property. Clark, 72, heads Taylor Clark, the London-based property, farming, hotels and i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vestment group, valued at \u163\'a3150m. The Clark family's stake is worth \u163\'a3110m. (\u163\'a386m, 655=)\par Wilf Corrigan Computers. The son of a Liverpool docker, Corrigan, 72, sold shares worth \u163\'a378m in LSI Logic and had a \u163\'a335m stake when he retired from the Silicon Valley operation. (\u163\'a3110m, 492= )\par Clive Cowdery Finance. Cowdery, 46, sold the life assurance assets of his Resolution Group to Pearl, pic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing up \u163\'a3145m for his stake. (\u163\'a3102m, 535=)\par Peter Dean* Egg production. Noble Foods, the UK's biggest supplier of eggs, branched out into puddings in January, spending more than \u163\'a330m buying the dessert-maker G\u184\'fc. Noble, led by Dean, 65, and based in Tring, Hertfordshire, is worth \u163\'a3120m and we value the Deans at \u163\'a3110m. (New entry)\par Tommy Dreelan* Industry. Dreelan, 53, from Wexford, set up PSL, an Aberdeen firm specialising in pumping and oil pipeline services, with brothers Mike, Sean and Ciaran. They sold PSL for \u163\'a345m and developed Qserv as an oil and gas services company, selling it for \u163\'a388m. (\u163\'a365m, 863=)\par Glenn Earle Finance. The chief operating officer for Europe at Goldman Sachs, Earle, 52, had a \u163\'a340m-plus stake at the time of the 1999 float. Past bonuses add to his wealth. (\u163\'a380m, 694=)\par Heinrich Feldman* Property. Feldman, 74, is a London property owner. His main holding company is Inre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 co 26 with net assets of \u163\'a3104.5m in 2007-08. He has other interests. (\u163\'a3105m, 510=)\par Barry and Robin Gibb Music. The surviving Bee Gees, Barry, 63, and Robin Gibb, 60, celebrated the band's 50th anniversary in 2009. With no concerts last year, our rock expert keeps the brothers at a conservative \u163\'a3110m. (\u163\'a3110m, 492=)\par Paul Gregg and family Leisure. Scarborough-born Gregg, 68, sold the Apollo Leisure chain in 1999 - his fa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ily had a stake worth \u163\'a398m. He later bought back the cinemas and bingo halls for \u163\'a322m. (\u163\'a3105m, 510=)\par Eric Grove Property. Catesby Property Group is developing a \u163\'a3200m business and retail park near the M18 in Doncaster. Grove, 80, runs the company and has retail parks in the Midlands and residential develo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ments in Jersey. (\u163\'a3108m, 503=)\par David Instance* Industry. The family, led by Instance, 71, made \u163\'a350m from the Kent company Inprint Sy}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tems. It has 90% of Eschmann Holdings, a medical equipment business worth \u163\'a345m. (\u163\'a360m, 924=)\par Alan Jackson Mobile phones. Intercity Mobile, founded by Jackson, 57, in Birmingham in 1985, is a subsid}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ary of Giftsign, which has \u163\'a365.2m net assets. He has other wealth. (\u163\'a387m, 648=)\par Luke Johnson Finance and greyhound tracks. Former Channel 4 chairman Johnson, 48, is nicknamed Cool Hand Luke in the City. His Risk Capital Partners owns East, the fashion chain and GRA dog tracks. (\u163\'a3100m, 540=)\par Adam and Samuel Kaye* Restaurants. The Prezzo pizza chain is the creation of Kaye brothers Adam, 41, and Sam, 38. The family's stake is worth \u163\'a352m. The brothers also have the Dim T chain. (\u163\'a389m, 644=)\par Jurjen and Hugo Kruisinga Finance. Jurjen, 56, and his brother Hugo, 48, are Dutch financiers who live in East Sussex. Their father, Roelof, founded the Cross Options company. They are valued at \u163\'a3110m in the 2009 Dutch Quote 500 rich list. (New entry)\par Peter Levine Oil and steel. Levine, 54, netted at least \u163\'a380m when Imperial Energy, a London-based oil e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 plorer, was taken over in 2008. Shortly after, he sold nearly \u163\'a326m of shares. (\u163\'a395m, 575=)\par Henry Lumley* Finance. Surrey-based Lumley, 79, chaired Edward Lumley Holdings, sold for \u163\'a3133m. (\u163\'a3100m, 540=)\par Jack Morris* Business services. The Morris family, led by Jack, 53, made \u163\'a325m when they sold Earls Court and Olympia in London. They own the Business Design Centre in Islington. (\u163\'a395m, 575=)\par Sir David Murray Property and football. Murray, 58, bowed out as chairman of Glasgow Rangers FC and is eager to find a buyer for the debt-ridden club. His wealth comes from the Murray International metals-to-property firm. (\u163\'a3500m, 88=)\par Christina Ong Retailing. Ong, 62, runs Club 21, whose holdings include Ishop, Asia's biggest Apple reseller, and a \u163\'a364m stake in Mulberry. She lives in Singapore and London. (\u163\'a369m, 841=)\par Sir Ridley and Tony Scott Films. The new Robin Hood movie was directed by Sir Ridley, 72, from South Shields. His films have grossed \u163\'a31.5 billion at the box office and brother Tony, 65,made Top Gun. (\u163\'a3105m, 510=)\par Joe Walker* Biscuits. Walkers Shortbread, the Speyside firm led by Walker, 72, is worth \u163\'a380m. (\u163\'a382m, 688=)\par Eric Watson Finance and white goods. London-based New Zealander Watson, 51, ran UK white goods firm Powerhouse. He has investments in finance. (\u163\'a3110m, 492=)\par Nick Wheeler and Chrissie Rucker Retailing. Husband-and-wife team Wheeler, 45, and Rucker, 41, own the shirt retailer Charles Tyrwhitt, worth \u163\'a340m, and the \u163\'a365m White Company, which sells towels and bedding. (\u163\'a363m, 906=)\par 627= \u163\'a3108m\par Phil Collins Music. While 59-year-old Collins no longer records best-selling albums with Genesis and as a solo artist, his cumulative salaries since 1986 have totalled \u163\'a3182m. (\u163\'a3108m, 503=)\par Anwar and Yakub Patel Pharmacies. Lancashire brothers Anwar Patel, 55, and Yakub, 56, still own 30 pharmacies after selling more than 100 for \u163\'a3130m in 2005. (\u163\'a3108m, 503=)\par 629= \u163\'a3107m\par Ken Cheevers* Car sales and construction. Cheevers, 74, is building the McLaughlin & Harvey construction firm in Co Antrim, having made his first fortune in the motor business. (\u163\'a340m, 1,348=)\par Simon Karimzadeh* Property .\par Karimzadeh, 47, runs London-based property business Eskar International, which we value at \u163\'a3100m. (\u163\'a3107m, 507=)\par Lennie and Ian McGeoch Retailing. Mackays Stores, the Paisley-based clothing empire, is run by Ian, 64, who bought out brother Lennie, 69, in 2001.(\u163\'a397m, 570=)\par Making profit from adversity\par 646= \u163\'a3103m \u163\'a366m, 178%\par Warren Haskins and family Retailing\par The revival of the "make do and mend" mentality that accompanies a recession has been good news for Haskins, the man behind HobbyCraft, with his fortune up \u163\'a366m on last year. Haskins, 61, is managing dire}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tor of the Dorset-based Haskins Group. He took over the family garden centre business in 1969 at the age of 20, following the death of his father. It had an annual turnover of \u163\'a317,000 and seven staff. In 1995, Haskins diversified from garden centres into HobbyCraft, the UK's only dedicated chain of arts and crafts superstores. It now has 45 stores and an online shop, with 12 more outlets due to open this year., catering for everything from card making to haberdashery, jewellery making to cake decoration. HobbyCraft and Haskins Holdings collectively made \u163\'a38.2m profit on \u163\'a392.4m sales in their 2008-09 accounts. They also have nearly \u163\'a333m net assets. They are owned by Haskins and family trusts. There has been press speculation that a management buyout could take place at HobbyCraft, backed by private equity to help fund future growth. It is being stalked by larger companies and has been valued at \u163\'a375m. We value the two businesses at \u163\'a3100m. Past salaries and assets add \u163\'a33m.\par 2009: \u163\'a337m, 1,513=\par 632 \u163\'a3106m\par Rory Sweet Computers. Sweet, 43, runs Simian Group, a Cirencester-based computer firm worth \u163\'a380m. There is other wealth. (\u163\'a374m, 778=)\par 633= \u163\'a3105m\par Jerome Booth Finance. Booth, 46, has a \u163\'a399.4m share in the profitable Ashmore Group, which deals in emerging-market debt. He has other assets. (\u163\'a362m, 910=)\par Frank Burke* Property. Cabretta Holdings, a London construction company, is the parent for the BDL Group, run by Irishman Burke, 61. (\u163\'a3105m, 510=)\par David Gorton Finance. The London Diversified hedge fund is valued at \u163\'a3100m. Co-founder Gorton, 46, has a stake worth \u163\'a360m and other wealth. (\u163\'a366m, 860=)\par Eric Herd Frozen food. Herd, 52, has turned Farmfoods, the Scottish meat business he inherited from his father, into a \u163\'a3100m business. There are additional assets. (\u163\'a345m, 1,203=)\par Marcus Margulies* Watches. Margulies, 67, is chairman of London-based Almar, which sells watches, han}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bags and branded products. (\u163\'a345m, 1,203=)\par Neil McRoberts* Debt recovery. Stockport debt collection firm Moorcroft Group, run by founder McRoberts, 67, is worth \u163\'a375m. There is other wealth. (\u163\'a3105m, 510=)\par John Morphet Leisure. Morphet, 55, owns Lancashire-based Pure Leisure Group, which includes nine hol}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 day and caravan parks, two golf estates and a 750-acre estate in Barbados. (\u163\'a385m, 657=)\par Mark Poole Finance. Poole, 48, has a \u163\'a358.4m stake in BlueBay Asset Management, the London hedge fund he started with Hugh Willis (qv). Share sales add to his wealth. (\u163\'a340m, 1,348=)\par Peter Prowting* Property. Prowting, 85, retains Prowting Investments, having sold the Uxbridge-based family property business to Westbury in 2002 for \u163\'a388.5m. (\u163\'a3105m, 510=)\par Gordon Sanders* Care homes. Sanders, 64, and his family own Essex-based Runwood Homes, which has 26 residential homes and provides home-based care. It has \u163\'a3108m assets. (\u163\'a3105m, 510=)\par Rod Stewart Music. He may be 65 but Stewart, who has homes in Essex and America, is about to start a 24-date European tour. Our rock expert values him at \u163\'a3105m. (\u163\'a3100m, 540=)\par Hugh Willis Finance. Share sales add to the fortune of Willis, 50, who has a \u163\'a358.4m stake in BlueBay Asset Management, the London hedge fund he started in 2001 with Mark Poole (qv). (\u163\'a340m, 1,348=)\par 645 \u163\'a3104m\par Albert Hay* Property. Hay, 63, and his family have a \u163\'a364m stake in Mayfair Property Group, Capital & City and sister group Capital & City Properties. There is additional wealth. (\u163\'a392m, 594=)\par 646= \u163\'a3103m\par Warren Haskins* Retailing. See panel on page 60\par Rashid and Aziz Tayub* Food distribution. The Crown Crest distribution operation based in Leicester was started by Rashid, 61, and is now run by his brother, Aziz, 54. It is worth \u163\'a3100m. (\u163\'a370m, 793=)\par 648= \u163\'a3102m\par Aidan Heavey Oil and gas exploration. Irishman Heavey, 57, has an \u163\'a385m stake in Tullow Oil, the oil and gas explorer he founded, and other wealth. (\u163\'a345m, 1,203=)\par Jeremy Herrmann Finance. Herrmann, 40, has a \u163\'a390m stake in London-based Ferox Capital Management and other assets. (New entry)\par Tamara Mellon Fashion. Mellon, 42, bought Jimmy Choo, the upmarket women's shoe brand, in 1996. A 51% stake was sold in 2004 and a takeover in 2007 netted her \u163\'a325m. (\u163\'a3102m, 535=)\par Brian and Alan Stannah Lifts. Brothers Brian, 74, and Alan, 70, head \u163\'a390m Hampshire-based stairlifts firm Stannah. There is other wealth. (\u163\'a3102m, 535=)\par 652 \u163\'a3101m\par Lady Nina Bracewell-Smith* Football and hotels. Bracewell-Smith, 54, plans to sell a \u163\'a391m stake in Arsenal football club. Her family also has proceeds from the sale of the Park Lane hotel. (\u163\'a385m, 657=)\par 653= \u163\'a3100m\par Roger Baines* Delivery services. Baines, 62, sold the Amtrak delivery business for \u163\'a386m in 1998. He has a Channel Islands home, a stud in Somerset and several companies. (\u163\'a395m, 575=)\par Audrey Baxter* Food. Baxter, 48, runs Scottish food group WA Baxter, which her parents turned into one of Britain's bestknown brands. We value it at \u163\'a395m and there is other family wealth. (\u163\'a373m, 780=)\par Anton Bilton* Property. Developer Bilton, 45, has an \u163\'a311m stake in London-based Raven Mount and \u163\'a332m in Raven Russia. His grandfather, Percy, sold a \u163\'a379.4m stake in a property empire. (\u163\'a390m, 600=)\par Judah Binstock Property. One of the biggest landowners in Marbella, Binstock, 81, started investing in Lo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 don property in the 1960s. (\u163\'a3100m, 540=)\par David Bowie Music. Bowie, 63, has spoken out against the potential closure of 6 Music, the BBC's alternative music radio station. The British star, who lives in New York, is worth \u163\'a3100m. (\u163\'a3100m, 540=)\par Ely Calil Inheritance and finance. Calil, 64, a Lebanese oil trader, inherited \u163\'a320m from his father. He has i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 terests in property and finance. Calil has homes in London, Switzerland and Nigeria. (\u163\'a3100m, 540=)\par Simon Clarke* Property. Clarke, 45, and his family have a \u163\'a365m stake in Midlandsbased St Modwen Prope}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ties, founded by his father, plus other wealth. (\u163\'a390m, 600=)\par Jeremy Coller Finance. Coller, 51, pulled off a coup in September when his Londonbased Coller Capital led the \u163\'a3130m takeover of a portfolio of private equity investments from 3i. (\u163\'a390m, 600=)\par Charles Corfield Computers. Cambridge graduate Corfield made at least \u163\'a350m when Adobe Systems bought his Frame Technology in 1995. He has other investments. (\u163\'a3100m, 540=)\par Anthony de Mulder* Meat. The UK's biggest meat renderer, Prosper de Mulder, has become a leading waste food-recycling specialist. The Doncaster firm, led by de Mulder, 66, is worth \u163\'a395m. (\u163\'a3130m, 406=)\par Rodger Dudding Property. London-based Dudding, 72, launched Lonsto, which makes ticket queuing sy}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tems for banks and supermarkets. He has about 12,000 lock-up garages in the UK. (\u163\'a390m, 600=)\par Sir Chris Evans Biotechnology. Port Talbot-born Evans, 52, has businesses such as Celsis International and Merlin Biosciences. Other assets include cars and property. (\u163\'a3100m, 540=)\par Edward Faith* Travel. When the world's biggest travel group, Cendant, paid \u163\'a3570m for Gullivers Travel A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sociates in 2004, the deal netted \u163\'a3100m for Faith, one of the founders of the London firm. (\u163\'a380m, 694= )\par Stanley Fink Finance. Fink, 52, paid \u163\'a310m in 2009 for a penthouse at St Pancras station. He left London hedge fund Man Group in 2008 with a stake worth \u163\'a350m. He has other wealth. (\u163\'a370m, 793 =)\par Andrew Goodsell Finance. Goodsell, 51, is chief executive of Acromas, formed by the \u163\'a36.2 billion merger of Folkestone-based Saga and the AA in 2007. He has assets in cash and equity. (\u163\'a3100m, 540=)\par Eva Hamren-Larsson Inheritance. A tax exile in Britain, Hamren-Larsson, 57, inherited a fortune from her father, a Swedish property developer. (100m, 540=)\par Guy and Julia Hands Finance. Guernseybased Hands, 50, is seeking new investment for EMI music group, which his Terra Firma Capital Partners bought for \u163\'a34.2 billion in 2007. His wife Julia, 50, runs Hand Picked Hotels. (\u163\'a3100m, 540=)\par Gilad Hayeem Finance. Hayeem, 43, made \u163\'a3120m when City hedge fund Marble Bar Asset Management, which he co-founded, was sold in 2007. (\u163\'a390m, 600=)\par Nigel Jagger* Finance. Jagger, 56, chairs Cert Octavian, the Hertfordshire-based logistics company. The family netted about \u163\'a390m from the sale of Atlantic Computers in 1987. (\u163\'a380m, 694=)\par Uzi Kattan Leisure. Kattan, 65, made about \u163\'a3100m in 2004, when London-based Gullivers Travel Assoc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ates, which he cofounded, was sold to the American giant Cendant. (\u163\'a380m, 694=)\par Richard Kirk Retailing. Cardiff-based fashion retailer Peacocks did well last Christmas, seeing a 17% rise in its sales. We value it at \u163\'a3500m and the stake of chief executive Kirk, 64, at \u163\'a390m, adding \u163\'a310m for other a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sets. (\u163\'a390m, 600=)\par Hilton Nathanson Finance. Australian Nathanson, 40, made about \u163\'a3120m when Marble Bar Asset Manag}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment, a City hedge fund he co-founded, was sold to a Swiss bank in 2007. (\u163\'a390m, 600=)\par Sir Philip Naylor-Leyland Land. Naylor-Leyland, 56, went to Eton and Sandhurst, and served as a Guards officer. He owns 25,000 acres in Peterborough, Yorkshire and Wales. (\u163\'a3100m, 540=)\par Sir John Ritblat* Property. The Ritblat family owns the Delancey property operation. Ritblat, 74, was chai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 man of British Land from 1970 to 2006 and sold most of his stake in the group for nearly \u163\'a357m just before he retired. (\u163\'a390m, 600=)\par Andrew Rosenfeld Property. Rosenfeld, 47, former chief executive of Minerva, has moved from London to Geneva where he has set up Air Capital to invest in the property market. (\u163\'a3100m, 540=)\par Stephen Spouge* Petrol and petrol stations. Spouge, 66, founded Extra, the motorway services chain. It is owned by Swayfields, his Lincoln-based company, with assets of \u163\'a3104.7m. (\u163\'a3100m, 540=)\par Samir Traboulsi Finance and art. In June 2009, Lebanese-born financier Traboulsi bought a Picasso, Homme \u8225\'e0 l'Ep\u200\'e9e, for \u163\'a37m at Sotheby's. Traboulsi has his main home in London. (\u163\'a3100m, 540=)\par 681 \u163\'a399m\par John and Richard Bennett Computers. The sale of Berkshire-based computer firm Kerridge Group made John, 74, Richard, 60, and family \u163\'a385m. (\u163\'a385m, 657=)\par 682= \u163\'a398m\par Edelin Davis* Construction. Broadthorpe, holding company for William Davis, the Loughborough builder owned by Davis, 75, and family, is worth \u163\'a395m. (\u163\'a378m, 742=)\par John Halewood* Beverages. Merseyside drinks operation Halewood International is run by its founder, Halewood, 62, a renowned racehorse owner. (\u163\'a358m, 966=)\par Tony Travis* Builders' merchant. Travis, 66, and family own a \u163\'a364m stake in Northamptonshire-based buil}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ers' merchant Travis Perkins. (\u163\'a390m, 600=)\par Dai and Richard Walters* Construction and mining. Dai Walters, 65, heads the Walters Group, based in A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erdare and worth \u163\'a383m. Richard, 30, Dai's son, owns Celtic Mining, worth \u163\'a315m. (\u163\'a390m, 600=)\par 686= \u163\'a397m\par Dame Margaret Barbour* Waxed jackets. South Shields-based jacket maker J Barbour is worth \u163\'a382m, and is owned by Barbour, 70, and family. (\u163\'a385m, 657=)\par Richard Biffa Waste services. Biffa, 70, sold his stake in Milton Keynes-based Shanks Group, one of E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rope's largest waste disposal companies, and has property and other assets. (\u163\'a387m, 648=)\par 688= \u163\'a395m\par Alan and Ronnie Bartlett Vegetables. The brothers have divided their \u163\'a390m vegetable-growing business, with Ronnie, 46, in charge of the Airdrie-based potato operation and Alan, 54, heading a root veg company in Cambridgeshire. (\u163\'a367m, 853=)\par Steven Blakey Finance. Blakey, 50, made \u163\'a3125m when London-based European Credit Management was sold in 2007. (\u163\'a395m, 575=)\par Peter Bromley* Shoes. Bromley, 68, chairs the \u163\'a375m London-based Russell & Bromley footwear chain, and has other interests. (\u163\'a380m, 694=)\par Robert Brooks* Auctions. Profits fell in 2008 at Bonhams, the auction house, but sales hit \u163\'a373.6m. Chairman Brooks, 53, bought Bonhams in 2000. (\u163\'a384m, 682=)\par Jackie Collins Novels. Having sold 400m copies of her raunchy novels, Collins, 72, has been promoting her 27th, Poor Little Bitch Girl. British-born Collins wanted to be a film star like her sister Joan but turned to fi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion instead. (\u163\'a390m, 600=)\par 653= \u163\'a3100m New entry\par Derek Coates Vitamins and airline\par Coates arrived on Guernsey as a child when his father worked as an engineer for the island's government. He went to university to read psychology and took an MBA before joining Unilever and becoming its youn}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 est marketing manager. He later went into advertising before starting his own agency, Holmes and Marchant, which later floated on the stock market. His stake was worth nearly \u163\'a34m when he sold up. He returned to Guernsey to retire but was persuaded to take over an advertising agency on the island, and found himself with the local post office account and a large office. Coates considered what sort of business he could run from the office and came up with health supplements, launching Healthspan in 1996. It has proved a huge success and has 60% of the direct sales market in Britain for nutritional products. Coates has refurbished three hotels and bought an airline to bring in guests. He plans more hotels in the Channel Islands and is also diversifying into financial services. Blue Islands Airlines has become the leading carrier between Jersey and Guernsey, and has expanded to the Isle of Man, Southampton, Bournemouth, Geneva and Zurich. Despite the lack of hard financial information, we value 61-year-old Coates at \u163\'a3100m as a sighting shot, but he will go higher.\par 688= \u163\'a395m\par Bob Diamond Finance. Barclays made \u163\'a311.6 billion last year but American-born Diamond, 58, the London-based president, waived his pay rise. He has a \u163\'a330m stake and other wealth. (\u163\'a375m, 751=)\par Martin Edwards Football. Edwards, 64, former chairman of Manchester United, made \u163\'a3120m from his stake in the football club. (\u163\'a392m, 594=)\par Nick Forman Hardy Media. The Forman Hardy family, led by Nick, 61, is best known for its publishing inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ests, notably the Nottingham Evening Post, which were sold in 1994 for \u163\'a392.9m. (\u163\'a384m, 682=)\par Sir David Garrard Property. Garrard, 71, helped to launch the Minerva property group. When he stood down as chairman five years ago, his family trusts sold \u163\'a337m of shares. (\u163\'a395m, 575=)\par Mahmoud Khayami* Industry and art. London-based Khayami, 80, made his fortune in the Iranian autom}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tive industry. He has one of the world's finest Persian art collections. (\u163\'a395m, 575=)\par Larry Kinch Oil services. Kinch, 56, made \u163\'a392m when Centrica took over his Aberdeen oil and gas firm Ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture Production last summer. (\u163\'a388m, 646=)\par Lennox Lewis Boxing. Lewis, 44, stopped Vitali Klitschko, the WBC heavyweight champion, in Los Angeles in 2003 and then retired. He has property in London, New York and Jamaica. (\u163\'a390m, 600=)\par George Moore* Furniture and finance. The Yorkshireman, 81, sold Moores Furniture Group for \u163\'a380m in 1987. Wilton Investments is now the family's main operation. (\u163\'a395m, 575= )\par Ozzy and Sharon Osbourne Music and television. Buckinghamshire-based Osbourne, 61, received the Le}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 end of Live award from Billboard last year for his touring. We raise the singer and his wife Sharon, 57, by \u163\'a35m. (\u163\'a390m, 600=)\par Tony Pidgley Construction. Pidgley is chairman of Surrey housebuilder Berkeley. The chairman sold \u163\'a321m of shares last year and has a \u163\'a354m stake and other wealth. (\u163\'a371m, 792)\par Simon Robertson Finance. Robertson, 69, one of the City's top bankers, is chairman of Rolls-Royce and a board member of HSBC. (\u163\'a390m, 600=)\par David Shamoon* Finance. The Londonbased Iranian-born Italian, 79, has interests that run from shipping and agriculture to antiques. (\u163\'a385m, 657=)\par Dick Watson* Construction. Regeneration specialist Keepmoat provides social housing. Scots-born Watson, 68, had an 18.26% stake when the firm was sold for \u163\'a3783m in 2007. (\u163\'a385m, 657=)\par Nick Williamson* Cleaning products. Deb Group, the Derbyshire firm behind Swarfega, was sold in March for \u163\'a3325m. Williamson, 63, the son of the handwash's inventor, and his family are worth \u163\'a395m. (\u163\'a380m, 694=)\par Ron Wood Greeting cards and property. Wood, 61, made \u163\'a390m when he sold Ron Wood Greeting Cards. He is involved in property in Manchester. (\u163\'a395m, 575=)\par Julian and Marc Worth Internet. The London-based Worth brothers, Marc, 49, and Julian, 51, made \u163\'a3116m in 2005 when they sold Worth Global Style Network, an online news service. (\u163\'a390m, 600=)\par Stephen Zinser Finance. American banker Zinser, 52, co-founded European Credit Management in London. The company was sold for \u163\'a3500m-plus in 2007. (\u163\'a395m, 575=)\par 710= \u163\'a393m\par Grahame Chilton Insurance. Chilton, 51, collected \u163\'a377m when the London insurer Benfield was taken over in 2008. He had been chief executive and remains with the new parent company. Other assets take him to \u163\'a393m. (\u163\'a368m, 843=)\par Sir Terence Conran* Retailing and restaurants. Conran Holdings saw losses grow in 2008-09. Conran, 78, seventh in our Giving List, has gifted \u163\'a310m to his eponymous foundation. (\u163\'a395m, 575=)\par Ashley Head Online payments. Head, 59, has a stake worth \u163\'a383m in DataCash, an online payment group in London and other assets. (\u163\'a3103m, 533=)\par 713 \u163\'a391m\par Fakhruddin Suterwalla* Food. Four main Suterwalla companies, including the London-based TRS Cash & Carry, made \u163\'a36.5m profit in 2008. They are run by Fakhruddin, 72, and brothers Hatim, Siraj, Mansoor and Iqbal. (\u163\'a378m, 742=)\par 714= \u163\'a390m\par Vahid Alaghband* Industry. The aviation arm of the Balli Group was fined $15m by Washington in February for illegally exporting three Boeing 747s to Iran. London-based Balli is headed by Iranianborn Alaghband, 58. (\u163\'a379m, 740=)\par Simon Borrows Finance. Borrows, 50, is the co-chief executive of banking firm Greenhill. He is based in London and has a stake worth \u163\'a338m. (\u163\'a380m, 694=)\par Robert Braithwaite* Yachts. Sunseeker International, the Poole-based leisure boat builder, is led by Braithwaite, 66. The family stake is worth \u163\'a389m. (\u163\'a370m, 793=)\par Andrew Cohen* Retailing. Hertfordshirebased Cohen, 56, turned Betterware into one of the top retailers in Britain. He has now sold his stake. (\u163\'a390m, 600=)\par Gavyn Davies Finance. London hedge fund Fulcrum Asset Management is run by 59-year-old Davies. He made \u163\'a387.5m from Goldman Sachs.(\u163\'a390m, 600=)\par Paul Deighton Finance. Deighton, 54, chief executive of the London 2012 Olympics organising committee, left Goldman Sachs with more than \u163\'a3100m. (\u163\'a380m, 694=)\par Graham Ferguson Lacey Property. Ferguson Lacey, 61, chairs the Sefton Group, based on the Isle of Man, and owns several golf clubs. (\u163\'a380m, 694=)\par Albert Fuss Finance. Fuss, 74, launched International Asset Management, with London offices, selling it to ABN Amro four years ago for about \u163\'a3150m. (\u163\'a380m, 694=)\par James Gaggero* Transport. GB Airways, part of Bland Group, was bought for \u163\'a3103m by easyJet in 2007. Gaggero, 50, is chairman of Bland, a 200-year-old family business based in Gibraltar. (New entry)\par Colin Graves* Food. York-based Costcutter was started by Graves, 62. A controlling stake was sold to Bibby Group in 2007 in a \u163\'a3100m deal. (\u163\'a345m, 1,203=)\par David Gundlach Insurance. Gundlach, 54, helped set up the Admiral car insurance business and founded Hastings, selling the Bexhill-on-Sea broker to Insurance Australia Group. (\u163\'a390m, 600=)\par Aaron and Tania Hillman Spirits. Angus Dundee, based in London, supplies whisky, gin, vodka and liqueurs. It is run by Terry Hillman and owned by his children, Aaron, 45, and Tania, 47. (\u163\'a348m, 1,152)\par Ray Horney Property. Real Estate Opportunities, chaired by Horney, 73, owns Battersea power station. He made \u163\'a321m selling a white goods firm and \u163\'a327m from a West Indies hotel chain. (\u163\'a380m, 694=)\par Yan Huo Finance. Huo, 41, heads Capula Investment Management, which has offices in London and Tokyo. A Goldman Sachs private equity fund bought a 20% share in 2008 and the Japanese Mitsubishi Corporation has a stake. (\u163\'a370m, 793=)\par James Lupton Finance. Lupton, 54, works for American investment bank Greenhill in London and has a stake worth \u163\'a370m. He has other wealth and gave \u163\'a325,000 to the Conservative party in 2009. (\u163\'a378m, 742=)\par Michael Marks Finance. NewSmith Capital Partners was able to pay out \u163\'a329.4m to its top 33 staff in 2008, when most of the City was close to crisis. Marks, 68, is co-founder of City-based NewSmith. We put its worth at \u163\'a3200m. (\u163\'a390m, 600=)\par Peter Martin* Property. Radnor Walk Investments is a London property company. Owned by his family and run by Martin, 81, the Chelsea-based company had \u163\'a358m assets in 2008-09 and there is other wealth. (\u163\'a370m, 793=)\par Don McCarthy Shoes and fashion. The House of Fraser had its best Christmas in 2009. Its London-based chairman McCarthy, 54, made \u163\'a3135m from the 2006 sale of Rubicon, the shoes and fashion group. (\u163\'a390m, 600=)\par Sir George Meyrick Property. Meyrick, 69, owns large tracts of land in the southwest and Wales. His family played an important role in the development of Bournemouth. (\u163\'a380m, 694=)\par George Michael Music. Our rock expert keeps Michael, 46, who is based in London and had a quiet 2009 (apart from a cameo appearance on the X Factor), at \u163\'a390m on the strength of his enduring appeal and his back catalogue. (\u163\'a390m, 600=)\par The Marquess of Milford Haven Internet. A cousin of the Queen, Switzerland-based Milford Haven, 48, had the idea for uSwitch, a website that compared utility prices. His trusts received \u163\'a3105m when he sold it. He also owns a small aviation company. (\u163\'a385m, 657=)\par Joe Moore Industry. Moore, 70, sold his Yorkshire window and door hardware firm to SIG Group in 1993. He has sold other companies and has interests in the Far East and in healthcare and internet services. (\u163\'a390m, 600=)\par The Morris family Property. The family's empire started with post-war housebuilding. Today the Morris oper}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion, based in Surrey, involves at least 12 companies. (\u163\'a390m, 600=)\par Robert Morton Property. Based in Jersey, Morton, 68, has stakes in 17 quoted companies worth \u163\'a312.5m. With interests in other firms and trust funds, Morton is worth \u163\'a390m. (\u163\'a380m, 694=)\par The Marquess of Northampton Land. Northampton's Tandridge and Chesham Estates in Surrey are under offer for \u163\'a325m. The 64-year-old also has other land and a London estate. (\u163\'a365m, 863=)\par Michael Oliver* Industry. Cheshire-based Oliver, 71, is in the oil and gas industry. The Oliver operations are worth \u163\'a380m and we add \u163\'a310m for past salaries. (\u163\'a368m, 843=)\par Nicholas Oughtred* Food. Oughtred, 49, chairs Humberside-based William Jackson & Sons, which runs a bakery, and Kwoks, producer of Chinese food. There is also Tryton Foods, including the Aunt Bessie's brand. (\u163\'a385m, 657=)\par Alan Parker Public relations. PR Week magazine last year named Parker, 53, the second most powerful pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lic-relations executive in the City, thanks to his Brunswick operation. (\u163\'a367m, 853=)\par Lennart Perlhagen Pharmaceuticals. Swedish tycoon Perlhagen, 67, has been based in London since 1984. His pharmaceuticals operation, Cross Pharma, merged with the Swedish company Meda in 1999. (\u163\'a380m, 694=)\par Lord Rana* Hotels and property. Indianborn Rana, 71, has added two new Ibis hotels to his Belfast business empire. His company, Andras House, owned by Rana, 71, and his family, is worth \u163\'a370m and we add \u163\'a320m for other assets. (\u163\'a380m, 694=)\par The Duke of Roxburghe Land. The 10th duke, 55, inherited his title and ancestral home, Floors Castle, at the age of 19. The Borders estate includes a hotel and a racing stud. (\u163\'a380m, 694=)\par Paul Roy Finance. Roy chairs the British Horseracing Authority and is paid \u163\'a3100,000 a year for two days' work a week. Roy, 62, has a \u163\'a360m stake in NewSmith Capital Partners, the London-based fund manag}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment firm. (\u163\'a390m, 600=)\par Joe Sloan* Food and drink distribution. Brands such as Douwe Egberts use the sales and marketing expe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tise of SHS. The \u163\'a3160m group was co-founded by Sloan, 63, in Belfast in 1975. (\u163\'a390m, 600=)\par Andy Stewart Finance. Stewart, 58, has stepped back from his role at Cenkos, the listed City-based broking operation, to spend more time with his family following his son's recent serious snowboarding accident, and to raise funds for spinal research. (\u163\'a380m, 694=)\par Dale Vince Green energy. Vince plans an attempt in his Nemesis car on the British electric land speed re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ord of 137mph this year. Ecotricity, a Gloucestershire-based green energy company founded by Vince, 48, is worth \u163\'a390m. (\u163\'a385m, 657=)\par Stephen Zimmerman Finance.\par Zimmerman, 61, co-founded NewSmith Capital Partners. He has a \u163\'a360m stake in the London operation and additional assets. (\u163\'a390m, 600=)\par 714= \u163\'a390m New entry\par John Hitchcox Property\par Hitchcox helped to define urban chic for a generation of yuppies when in 1992 he co-founded the Manhattan Loft Corporation in London, later selling out to partner Harry Handelsman. In 1999 he teamed up with Philippe Starck, king of the lemon squeezer, to set up the property and design business Yoo. Collaborating with the likes of Jade Jagger and Kelly Hoppen, the \u163\'a3120m company blends clever branding with a frisson of celebrity. Yoo can boast involvement in 37 projects in 24 countries, from Panama City to Phuket, Thailand. The son of an architect, 48-year-old Hitchcox grew up in East Sussex and started in property development by refurbishing a house in Caterham, Surrey. He lives in a four-storey Victorian villa in Notting Hill, west Lo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 don, which he gutted and made over, pictured above. He is a keen musician with a recording studio in his basement. His band, Westbourne Circus, played at last year's Lakestock, a rock festival at the Lakes, a Yoo development near Lechlade in the Cotswolds. His share of Yoo, personal property and a stake in Green and Co, the London estate agent, take him to \u163\'a390m, allowing for losses on a bond from AIG, the American insu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er.\par 751= \u163\'a389m\par Abdul Bhatti* Cash and carry. Bestway opened a \u163\'a36m distribution centre last year. Bhatti, 74, a director of the London wholesaler, and his family have an \u163\'a386m stake and other assets. (\u163\'a368m, 843=)\par Johnnie Boden* Mail-order fashion. The Old Etonian used a legacy to set up Boden in London. Two decades on, it has 1m customers in Europe and America and sales of \u163\'a3168m. Boden, 48, and family own about half of the \u163\'a3160m firm. Salaries and dividends lift them to \u163\'a389m. (\u163\'a387m, 648=)\par John Brooksbank Waste disposal and property. Brooksbank, 54, operates waste services in Yorkshire. His property portfolio includes 350 acres in Inverness with permission for a marina and hotel with homes and shops. In all, his business assets are worth \u163\'a381m and we add \u163\'a38m for other assets. (\u163\'a372m, 782=)\par Henri Charbit Property. London-based Frenchman Charbit, 66, made his fortune in textiles and built a pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erty portfolio in Britain and Europe. He was among a partnership that reinvested \u163\'a3350m in a Czech property business. (\u163\'a3120m, 438=)\par Adalat and Arshad Chaudhary Cash and carry. Adalat, 75, and son Arshad, 50, are directors of Bestway, the Anglo-Pakistani cash and carry, cement and banking operation started by Sir Anwar Pervez (qv). The Chaudharys' stake in the London operation is worth \u163\'a386m and there is other wealth. (\u163\'a368m, 843=)\par Younus Sheikh Cash and carry. Sheikh is managing director of Bestway's cash-andcarry businesses. The London firm has 52 depots. Sheikh, 63, has an \u163\'a386m stake and other assets. (\u163\'a368m, 843=)\par 757 \u163\'a388m\par John Deer Engineering. Deer, 72, cofounded Renishaw, maker of high-tech measuring tools, with Sir David McMurtry (qv). His stake in the Gloucestershire firm is worth \u163\'a376m. Other assets include a racehorse stud. (\u163\'a344m, 1,284)\par 758= \u163\'a387m\par Ron Dennis Motor racing. See panel opposite\par David Ord Docks. First Corporate Shipping, which runs the Port of Bristol, made \u163\'a316.8m profit in 2007-08. Ord, 61, the managing director, has an \u163\'a380m stake and other wealth. (\u163\'a387m, 648=)\par 760= \u163\'a386m\par Harvey McGrath Finance. Belfast-born McGrath chairs the insurance giant Prudential and is busy with public service groups such as the London Development Agency. He banked about \u163\'a390m from his time with the Man Group hedge fund but is a generous philanthropist. (\u163\'a385m, 657=)\par Mike Walker* Construction. The family, headed by Walker, 69, has holdings worth \u163\'a382m in Edinburgh co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 struction firms, plus dividends and other assets. (\u163\'a379m, 740=)\par 763= \u163\'a385m\par Lord and Apurv Bagri Metal. Lord Bagri's mansion in Regent's Park could be worth \u163\'a350m when he completes its restoration. The 79-year-old's son, Apurv, 50, runs his main UK metal trading firm. There are also ove}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 seas interests. (\u163\'a355m, 986=)\par Clay Brendish Computers. Brendish, 62, is the new non-executive chairman of quoted recruitment firm SThree. The Berkshirebased co-founder of the Admiral software group, which was sold in 2000, has a nu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ber of directorships. (\u163\'a375m, 751=)\par William Brown* Finance. Sussex-based Brown, 75, and his family own Walsham Brothers, the Lloyd's broker. He stepped down from the board last September. There are other assets. (\u163\'a385m, 657=)\par James Caan Finance and outsourcing. Caan, 49, is chairman of The Big Issue magazine and wants to help the homeless in Pakistan, where he was born. The Dragons' Den star controls more than 40 businesses through Hamilton Bradshaw, his London private -equity company. With the proceeds of earlier outsourcing and recruitment firms and property, he is up \u163\'a320m this year. (\u163\'a365m, 863=)\par Andrew Cook* Industry. Sheffield-based William Cook, a castings-to-engineering group, increased profits in 2008-09 to \u163\'a39.5m on \u163\'a359.1m sales. Cook, 60, holds 99% of the \u163\'a360m business through trusts and his pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sion fund. He and his family have other assets. (\u163\'a380m, 694=)\par Christopher Cooper-Hohn Finance. Cooper-Hohn, 43, continues to make huge charitable donations despite a tough 2009 at his Children's Investment Fund, following a \u163\'a3556m profit in the year to August 2008. In the past four years the London hedge fund manager, who tops our Giving List for the third successive year, has put \u163\'a31.1 billion into the foundation run by his wife Jamie, which aims to tackle issues such as malnutrition. (\u163\'a385m, 657=)\par Con Folkes* Property. As the ninth generation to run the Black Country firm Folkes Holdings, Con, 56, has shifted the emphasis from engineering to property in the UK and South Africa. (\u163\'a385m, 657=)\par Michael Freeman Oil services. The North Sea veteran, 66, owns Can Holdings, which supplies inspection services and personnel. The Lancashire firm made a record \u163\'a315.8m profit in 2008. (\u163\'a340m, 1,348=)\par Roger Gabb* Wine. The family, led by Gabb, 71, netted \u163\'a355m on the sale of Telford-based Western Wines in 2004. He holds 6% of Bibendum Wine and the family has other wealth. (\u163\'a382m, 688=)\par Penelope Gorman and Victoria Cammack Inheritance. Gorman, 48, and Cammack, 45, inherited their father Douglas's stake in CMG, the London computer group he co-founded. They sold most of their shares in 1998. (\u163\'a375m, 751=)\par Richard Hanson Finance. Hanson, 54, is a director of Doughty Hanson, the \u163\'a3200m private -equity operation in London, and has a stake worth \u163\'a375m. We add past salaries and dividends. (\u163\'a385m, 657=)\par Stephen Lloyd* Schools. The ex-teacher co-founded Doncaster-based Hesley Group, which provides schoo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing and care. Half of it was sold in 2005. Lloyd, 61, and his family own the rest. (\u163\'a370m, 793=)\par Edward Lonergan Property. Deramore is developing the first new hotel on Edinburgh's Princes Street for 50 years. Lonergan, 59, runs the Belfast company and has other interests. (\u163\'a365m, 863=)\par The Macdonald family Spirits. Glenmorangie, the Scots distiller, was founded in 1893 by Roderick Macdo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ald. His descendants sold to LVMH in 2004, netting \u163\'a3100m before tax. (\u163\'a380m, 694=)\par Roy MacGregor* Energy services. Global Energy Group was founded by MacGregor, 57, who started in the family supermarket business. Sales and other assets, such as MacGregor Properties, take the family to \u163\'a385m. Football-loving MacGregor is life president of Ross County. (New entry)\par David McMullen* Brewing. Our valuation of McMullen & Sons, in Hertford, is down to \u163\'a360m owing to falling beer sales. A capital reorganisation and dividends add \u163\'a325m for the family, represented here by ex-chairman McMullen, 64. (\u163\'a385m, 657=)\par Sir Fraser and Gordon Morrison Construction. Sir Fraser, 62, and brother Gordon, 59, made their fortune from Morrison Construction, sold for \u163\'a357m in cash and 3% in shares. Gordon's Chaldean companies have \u163\'a39.5m of net assets, and other wealth adds \u163\'a320m. (\u163\'a390m, 600=)\par Owen and Karl Oyston Property and football. Karl, 43, chairs Blackpool FC, in which his father, Owen, 76, has a controlling stake. Owen has made at least \u163\'a350m from asset sales. Property and other assets add to their total. (\u163\'a385m, 657=)\par Malcolm Scott Property and grain. Scott, 46, has property interests in France and the UK. He runs the fam}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly's Edinburgh grain businesses, which had \u163\'a312m net assets in 2007-08. (\u163\'a3120m, 438=)\par Rahul and Rita Sharma Travel. The couple own London-based Best at Travel, which saw profits fall sharply in 2008 to \u163\'a3378,000, although sales hit a record \u163\'a369.6m. Rita, 49, and Rahul, 51, have property and other assets. (\u163\'a385m, 657=)\par Tony Todd Tyres. Todd, 62, has retired since selling Hampshire-based Micheldever Tyre Services in 2006. It is Britain's largest independent wholesaler and distributor of tyres. (\u163\'a378m, 742=)\par Andrew Vicari Art. Welsh-born Vicari, 72, the son of an Italian restaurateur, has had a lucrative career since being appointed painter to the Saudi royal court in 1974. He has a number of homes, including in Riyadh and London. (\u163\'a380m, 694=)\par Roger Waters Music. Waters said last year he was looking at a tour of The Wall, the Pink Floyd show. The 66-year-old receives big royalties from the band. He has homes in London and Hampshire. (\u163\'a385m, 657=)\par Charlie Watts Music. In the absence of a new Rolling Stones tour or recording, the drummer, 68, spends much of his time at his Devon farm. (\u163\'a385m, 657=)\par Robbie Williams Music. Williams reemerged in late 2009 with the studio album Reality Killed the Video Star, delivered under his reputed \u163\'a380m deal with EMI. With the proceeds of 95m album sales and 40m single sales, our rock expert values the 36-year-old star at \u163\'a35m higher this year. (\u163\'a380m, 694=)\par Robert and Patrick Wilson Pharmaceuticals. Brothers Robert, 47, and Patrick, 45, own Wimbledon-based Nelsons, which makes natural medicines such as Rescue Remedy. (\u163\'a336m, 1,525=)\par 789= \u163\'a384m\par Pradip and Manish Dhamecha Cash and carry and property. Pradip, 51, and Manish, 50, run the family cash and carry, property and paper products interests. Their headquarters is in London. (\u163\'a360m, 924=)\par Kishore Lulla* Media. London-based Lulla, 48, wants to create an Indian rival to Hollywood studios with Eros International. It has dubbed 1,300 Bollywood films into other languages. (\u163\'a348m, 1,152=)\par Harold Montgomery* Transport.\par Montgomery Transport in Northern Ireland is part of Ballyvesey Holdings. Montgomery, 61, heads the group and owns it with family trusts. (\u163\'a384m, 682=)\par John Rudd* Wine and spirits. Rudd, 83, is the biggest shareholder in Berry Bros & Rudd in London's St James's, Britain's oldest wine merchant. (\u163\'a364m, 900=)\par Peter Salussolia* Pubs and hotels. Salussolia, 66, chairs Glendola Leisure, a Wembley-based pub, hotels and restaurant group worth \u163\'a330m. The family also owns Hotel Management International, valued at \u163\'a350m. (\u163\'a340m, 1,348=)\par 794= \u163\'a383m Michael Green Media. Green, 62, has retrained as a psychotherapist, a contrast to his earlier media career with Carlton Communications. Property and art add to his share sales and payoffs. (\u163\'a380m, 694=)\par Ray Kelvin Fashion. Kelvin, 54, set up the \u163\'a3195m London business Ted Baker, which saw a 19.1% rise in Christmas sales. We add salaries to his stake. (\u163\'a358m, 966=)\par Derek Mickel* Construction. Mickel, 75, chairs Mactaggart & Mickel, the Glasgow housebuilder, with assets of \u163\'a3131m, but we value it below that figure. (\u163\'a378m, 742=)\par Peter Stephens Travel and conferences. Stephens, 60, has a \u163\'a375m stake in Lotus Group, a London bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ness that includes DialAFlight, and other wealth.(\u163\'a380m, 694)\par 798= \u163\'a382m\par Alexander Badenoch Recruitment services. Co-founder of Venn, a \u163\'a340m London firm, the 63-year-old earlier made \u163\'a372m before reinvesting it. (\u163\'a365m, 863=)\par Jack Brignall* Trucks and property. Brignall, 83, was appointed an MBE in the new year's honours list. Wyk}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 land, the Hull developer he set up after selling a truck firm, is worth \u163\'a375m. (\u163\'a372m, 782=)\par James Holder Fashion. SuperGroup, the Cheltenham-based retailer behind the popular Superdry range, listed in March. Holder, 38, the brand and design director, has a \u163\'a367m stake and sold shares at the float. (New entry)\par Iain Liddell Transport. Liddell, 46, owns Uniserve, an \u163\'a380m Essex firm that provides global sea, air and road freight services. Profits last year rose to \u163\'a313.2m. He has other assets. (\u163\'a367m, 853=)\par Bill Morris* Property. Morris & Co (Shrewsbury), a 140-year-old family business with interests in property, care homes, power generation and marketing, is run by Morris, 71. (\u163\'a365m, 863=)\par Gerald and John Murphy Scrap metal.\par Armagh-based Clearway Disposals saw profits fall to \u163\'a313.5m. John, 64, started the firm, still owned by the Murphy family and now led by Gerald, 61. (\u163\'a375m, 751=)\par Giuseppe Pecorelli* Hotels and golf.\par Pecorelli, 70, ran hotels for the Fortes and the Aga Khan before founding Exclusive Hotels. The Surrey-based parent made \u163\'a33.3m profit in 2008-09. (\u163\'a378m, 742=)\par Theo Karpathios Fashion. Share sales and a \u163\'a367m stake in Superdry, part of the SuperGroup business in Cheltenham, place the brand's 46-year-old wholesale and international head at \u163\'a382m. (New entry)\par Lee Robinson Finance. Robinson, 40, co-founded Trafalgar Asset Managers, a London hedge fund in which Goldman Sachs took a 20% stake in 2008. We add dividends to his \u163\'a370m stake. (\u163\'a370m, 793=)\par Richard Sharp Finance. Previously at Goldman Sachs, Sharp, 54, chairs the Huntsworth PR firm in London. With asset prices and his Huntsworth stake on the up, we lift his value by \u163\'a312m. (\u163\'a370m, 793=)\par 808= \u163\'a380m\par Lord Alli Media. Chorion, the London media rights group with Enid Blyton's characters in its stable, is chaired by Alli, 45. He also has a stake in Castaway Television Productions. (\u163\'a360m, 924=)\par Robert Barnett* Grain. Barnett, 64, heads W&R Barnett, a Belfast grain dealer. The family owns much of the operation, which has \u163\'a3119m net assets. (\u163\'a367m, 853=)\par Sinclair Beecham Sandwiches Beecham, 51, co-founder of sandwich chain Pret A Manger, has turned his attention to hotels, running the Hoxton Urban Lodge hotel in east London. (\u163\'a375m, 751=)\par Hotshots of the information age\par 760= \u163\'a386m \u163\'a334m, 65%\par Edwina Dunn and Clive Humby Business services\par Genius marketing innovator or data-hungry Big Brother, Dunnhumby is the force behind Tesco's Clubcard. Founded in a spare bedroom by Humby, the 55-year-old chairman, and his wife Dunn, 51, the chief exec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tive, it launched the Clubcard in 1995. Whether you have children, are a dog owner or fancy yourself as a chef, if you've got a Clubcard, Tesco has your number. While we don't know which brand of washing powder they opt for, we do know the couple have two children, she enjoys sailing and he has a head for figures. After a Clubcard trial, former Tesco chairman Lord MacLaurin famously admitted: "You know more about my cu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tomers after three months than I know after 30 years." Dunnhumby analyses the contents of 100 shopping baskets a second.When Cadbury's approached the company to help it launch chewing gum Trident, it ident}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fied 500,000 customers, sending them an offer with their Clubcard statement. Firms including Coca-Cola and Unilever buy rights to its data and Dunnhumby lends its magic to US supermarket Kroger, Macy's depar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment stores and French chain Casino. In 2008-09, the west London-based company's profits came in at \u163\'a341m on \u163\'a3122m sales. Tesco recently increased its stake from 53% to 84% by buying shares from Dunn and Humby, and chief executive Sir Terry Leahy (see page 74) has hinted it would like to launch the loyalty card in Asia. The couple are likely to have earned \u163\'a330m from the sale and their stake is worth \u163\'a364m. We raise them to \u163\'a386m after tax.\par 2009: 52m, 1,046=\par Living in the fast lane\par 758= \u163\'a387m\par Ron Dennis Motor racing\par Each night, as little Ron settled down to sleep, the hum of a vacuum cleaner drifted up the stairs as his mother ensured the house would be immaculate in the morning. It is no surprise that he grew up to be a pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fectionist. "I get a mental pain looking at things that have not been properly executed," he has said. As team principal, Dennis helped McLaren find seven Formula One world champions but stood down after a series of dramas, including the 2007 Spygate scandal when McLaren was fined \u163\'a350m after being caught in posse}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sion of sensitive Ferrari documents. Dennis, 62, insisted he had to focus 100% on McLaren's new road car division, which plans to produce 4,000 cars a year, the first of which is the MP4-12C, costing about \u163\'a3150,000. Woking-based McLaren employs 1,000 people and the new car factory will create another 300 jobs. We value McLaren at \u163\'a3450m, with Dennis's 15% stake worth \u163\'a367.5m. Other assets take him to \u163\'a387m.\par 2009: \u163\'a387m, 648=\par 808=  \u163\'a380m\par Mike Bell Property. Bell, 62, a long-time resident of Jersey, added about \u163\'a320m from the sale of Parkridge in 2007 to \u163\'a330m from an earlier property firm, and has other assets. (\u163\'a370m, 793=)\par Kip Bertram* Books and property . Bertram, 65, moved into property development after selling Bertram Books, which he founded in Norwich with his mother, in a \u163\'a354m deal. (\u163\'a370m, 793=)\par Gulshan Bhatia and Asif Bhatia Hotels.\par Owners of London's Waldorf, Gulshan, 77, and son Asif, 41, had about \u163\'a357m net assets in their main hotel companies in 2008, when they made \u163\'a38.7m profit. (\u163\'a375m, 751=)\par Robin and India Jane Birley Inheritance. Robin, 52, plans to open a private club in London's Shepherd Ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ket. He and sister India Jane, 49, are the heirs of Mark Birley, who sold his clubs business, including Ann}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bel's, for \u163\'a3102m. (\u163\'a375m, 751=)\par Chris Blackwell Music. London-born Blackwell, 72, is building luxury homes in Jamaica. His fortune grew out of Island Records, which made a star of Bob Marley and from which Blackwell made \u163\'a370m. He later deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 oped US hotels. (\u163\'a380m, 694=)\par Zameer Choudrey* Cash and carry. The Anglo-Pakistani Bestway Group is headed by Choudrey, 52. The London-based firm saw \u163\'a32.05 billion sales in 2008-09. The Choudrey family stake is worth \u163\'a378m and it has other assets. (\u163\'a358m, 966=)\par Bakir Cola* Hotels. The Westbury in London's Mayfair is part of Cola's hotel stable. With the proceeds from the \u163\'a350m sale of the Harrington Hall hotel to the Spanish group NH Hotels, we keep Cola, 67, and his family at \u163\'a380m. (\u163\'a380m, 694=)\par Sir Sean Connery Films. Connery has not appeared in a film since 2003, though he has voiced cartoons. The Bahamas-based Scotsman, 79, could have been the richest actor in the world had he agreed to play Gandalf in the Lord of the Rings series for 15% of the takings. (\u163\'a380m, 694=)\par Judy Craymer Music. The film Mamma Mia! has taken more than $600m while the stage show has topped $2 billion. Craymer, 52, the producer, has a \u163\'a362.5m stake in the London company behind the musical plus div}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dends and other assets. (\u163\'a375m, 751=)\par Danny Desmond Property. Desmond, 70, owns most of the Bride Hall property group, which he started in 1983. The latest projects of the Mayfair business include a Lichfield retail park. (\u163\'a378m, 742=)\par Friedhelm Eronat Oil. Bavarian-born Eronat, 56, is a British citizen with a \u163\'a320m home in Chelsea. He has earned millions from oil deals through his Cliveden Petroleum International. (\u163\'a370m, 793=)\par Rita Firth and the Batley family Inheritance and cash and carry. Five years ago Firth, 70, and her family sold the Yorkshire business founded by her father for \u163\'a3100m. Their pet-food operation had \u163\'a339.4m sales in 2007-08. (\u163\'a380m, 694=)\par Peter Gadsby Construction. Gadsby, 61, former chairman of Derby County, has been trying to re-acquire the football club. He made his fortune in housebuilding and, thanks to investments, private property and his De}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 by County involvement, is up by \u163\'a315m this year. (\u163\'a365m, 863=)\par Charles Gallagher* Construction. The Abbey housebuilding group, run by Gallagher, 50, and his family, made a \u163\'a347m loss in 2008-09. They have a \u163\'a343m stake and their other main operation, Matthew Homes in St Albans, has \u163\'a337m net assets. (\u163\'a380m, 694=)\par Carol Galley Finance. Galley, 61, earned at least \u163\'a380m from share options, salaries and a takeover at Me}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cury Asset Management. She has homes in London and France. (\u163\'a375m, 751=)\par Nicholas and Peter Gould Property. Brothers Nicholas, 52, and Peter, 50, run Regis Group, an Essex-based property investment operation. A new parent company, Regis Group (Holdings), made a \u163\'a33.2m loss on \u163\'a37.2m sales in the five months to March 2009. It has more than \u163\'a380.3m net assets and the Goulds or their trusts own it all. (New entry)\par Douglas Graham* Newspapers.\par Claverley, publisher of titles such as Wolverhampton's Express & Star, turned in a \u163\'a34m loss in 2008. Gr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ham, 80, chairs the \u163\'a360m firm, founded by his father. We add \u163\'a320m for other assets. (\u163\'a385m, 657=)\par Geoffrey Granter Construction. Granter chairs United House, which maintains council estates and builds new homes. The 74-year-old has a \u163\'a360m stake in the Kent firm and other assets. (\u163\'a363m, 906=)\par Tony Greaves Telecoms. Greaves founded Core Communications in 2003. It works with mobile phone ope}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ators to provide discounted international calling services. Greaves, 45, owns all of the London business, which made \u163\'a320.5m profit on \u163\'a340.7m sales in the 18 months to June 2008. (New entry)\par Michael Gregory Engineering supplies. Leicester-based Cromwell, started by Gregory in 1970, saw profits up to \u163\'a314.6m in 2007-08. (\u163\'a357m, 976=)\par Melvyn and Delia Grodner Property.\par Melvyn, 66, and Delia, 56, own a number of property companies in Liverpool. Their main operation, Atmore, had \u163\'a354.5m net assets in 2008-09. (\u163\'a380m, 694=)\par The Earl of Halifax Land. The 3rd earl, 66, has an ancestral seat near York, with 13,000 acres and some fine paintings. Last year he failed to find a buyer willing to pay \u163\'a350m for a Titian. (\u163\'a375m, 751=)\par James Hull Dentists. A bust-up with shareholders of Cardiff-based James Hull Associates in November led the founder, 49, to step down as chief executive of the dentistry chain. (\u163\'a354m, 1,001=)\par Michael Hunt* Property. Hunt, 76, made his fortune from Nissan UK, in which he had a 13% stake. He lives in Sussex and has a big property portfolio, while the family has assets in several companies. (\u163\'a380m, 694=)\par Eddie Irvine Motor racing and property . The son of a Northern Irish garage owner, Irvine, 44, earned \u163\'a340m from motor racing and turned it into asset wealth, including homes in Oxford and Italy. (\u163\'a380m, 694=)\par Zuber Issa* Petrol stations. Euro Garages moved into motorway services last year, buying Rivington services on the M61. The Lancashire-based firm is run by 37-year-old Issa. (\u163\'a360m, 924=)\par Bruce Jarvis* Property. Jarvis, 61, runs Wembley property firm Ravensale and is developing the Paddington Basin scheme with the Reubens (qv). (\u163\'a370m, 793=)\par Bob Kidd Industry. Kidd, 49, sold a stake in his oil services operation to an American private equity firm for \u163\'a334.5m last year. The Aberdeen-based global operation is worth \u163\'a3100m. (\u163\'a335m, 1,550=)\par David Kyte* Finance. Kyte, 49, was a trader before founding his own London futures business. He has a 67% stake in Kyte Group with his family, and in Kyte Capital Management. Salaries and property take the Kytes to \u163\'a380m. (\u163\'a332m, 1,673=)\par Steve Leach Media. After stints in the lingerie business and fire service, Leach, 42, started Bigmouthmedia, an Edinburgh digital marketing agency. Having sold a stake and merged with Global Media, his holding is worth \u163\'a365m. (New entry)\par Eskander Maleki Oil. London-based Maleki, 59, left Iran after the revolution. He took a stake in Tullow Oil and was on the board from 1996 to 2004. He collects art and has other assets. (\u163\'a375m, 751=)\par Peter Mallinson Finance. Mallinson, 50, bought a five-week timeshare in a \u163\'a315m yacht last year. He made his fortune as a Goldman Sachs partner in London when it floated, later joining a US hedge fund and the board of a fund manager. (\u163\'a370m, 793=)\par Michael Masterson* Construction. The 59-year-old runs and owns Masterson Holdings in Hemel Hempstead. The planthire-to-concrete firm saw sales up sharply at \u163\'a384m in 2008-09. (\u163\'a345m, 1,203=)\par Scott Mead Finance. Mead, 55, formerly at Goldman Sachs, made \u163\'a350m when the bank floated in 1999. He set up a prep school in London before joining private equity giant Apax Partners. With share prices up, we lift him \u163\'a310m. (\u163\'a370m, 793=)\par Julian Metcalfe Restaurants. Metcalfe, 50, is expanding the Itsu sushi chain. He and Sinclair Beecham (qv) each made \u163\'a350m from Pret A Manger, reinvesting some of the proceeds. Other assets include a \u163\'a310m O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fordshire home. (\u163\'a375m, 751=)\par Pamela Morgan Bell Divorce. Morgan Bell, 57, looks to have sold her shares in housebuilder Redrow, part of her divorce settlement from Steve Morgan (qv). She has a stake in a Liverpool property operation. (\u163\'a380m, 694=)\par Dennis Myers* Finance. Myers, 59, runs Assured Advances, an Essex credit and finance company. He sold Swift Advances, a mortgage and consumer credit lender, for \u163\'a3100m. (\u163\'a380m, 694=)\par John Partridge* Industry. Sonardyne is a subsea communication and navigation company set up by Pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tridge, 70, in a Hampshire garage. In 2008-09, profits fell from \u163\'a319.3m to \u163\'a313.5m but it has low borrowings. (\u163\'a380m, 694=)\par Robert Plant Music. Led Zeppelin's 61-year-old former front man, appointed a CBE last year, is focusing on his musically and financially rewarding partnership with bluegrass singer Alison Krauss. The Midlands roc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er's companies had \u163\'a319.5m cash in the bank last year. (\u163\'a375m, 751=)\par Shaf Rasul Property and computers. The 39-year-old started Edinburgh-based E-net Computers in 1999. The newsagent's son also has \u163\'a350m of private property investments. (\u163\'a348m, 1,152=)\par The Duke of Richmond and Gordon* Property and art. The 12,000-acre Goodwood estate in Sussex pushed profits in 2008 from \u163\'a32m to \u163\'a33.4m. We see about \u163\'a344.6m net assets in the Goodwood Estate Company and the duke, 80, has an outstanding art collection. (\u163\'a370m, 793=)\par Stephen Rumsey Finance. The co-founder of London asset manager European Credit Management repor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 edly made close to \u163\'a3125m when it was sold in 2007. Rumsey, 59, supports bird charities. (\u163\'a380m, 694=)\par Jake Shafran Business services. Shafran has run Jato Dynamics in Harrow, which provides automotive inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ligence, since 1984. It is worth \u163\'a350m and Shafran, 58, has other assets. (\u163\'a354m, 1,001=)\par Amanda Staveley Finance. Staveley, 37, has built her Mayfair investment advisory firm, PCP Capital Par}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ners, on the back of her Middle East and horse racing contacts. It netted \u163\'a340m from an Abu Dhabi royal family deal. (\u163\'a380m, 694=)\par Peter Wheeler Finance. Wheeler, who led the Goldman Sachs push into China, left the London branch with a \u163\'a3100m stake. He is now with New Philanthropy Capital and Standard Chartered Bank. (\u163\'a370m, 793=)\par The Earl of Yarborough Land. With a 28,000-acre estate near Grimsby, Yarborough, 46, is heavily involved in farming. The 8th earl also has assets tied up in property businesses. (\u163\'a370m, 793=)\par Charles Yeates Property. WS Yeates, the Loughborough developer, is in the happy position of having blue-chip clients and no debt. Yeates, 74, has overseas property and art. (\u163\'a375m, 751=)\par 859= \u163\'a379m\par Peter Prior* Aggregates and waste. The Berkshire firm Summerleaze has interests from gravel extraction to green energy. It is owned by Prior, 66, and his family, who have \u163\'a35m in other assets. (\u163\'a368m, 843=)\par Neil Record Financial information. Record's Windsor firm provides currency management for big firms. The 56-year-old has a \u163\'a346m stake, topped up with share sales and other wealth. (\u163\'a362m, 910=)\par 861= \u163\'a378m\par Tony Brown* Office furniture. At 73, Brown says he is too old to start making redundancies at his Surrey-based Bisley Office Equipment. It has \u163\'a367m net assets and we add \u163\'a311m to the family for dividends and sa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 aries. (\u163\'a360m, 924=)\par John Chamberlain* Property. The Chamberlain Group, originally a joinery firm, has a diverse portfolio. Chamberlain, 65, and his family own 99% of the Bedfordshire business. (\u163\'a364m, 900=)\par David Gilmour Music. Pink Floyd won a High Court ruling blocking EMI from selling tracks as individual downloads. Guitarist Gilmour, 64, had \u163\'a36.5m net assets in his two firms in 2007-08. Other assets include a Sussex home. (\u163\'a378m, 742=)\par Viscount Hambleden* Retailing. The Buckinghamshire village of Hambleden was sold in 2007 for \u163\'a339m by the heir to the WH Smith shops dynasty, Henry Smith, son of the 4th viscount. The family, led by Hambl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 den, 80, has largely moved out of WH Smith shares. (\u163\'a368m, 843=)\par Sir Michael Marshall* Industry. Marshall, 78, knighted in the new year's honours, chairs Marshall of Ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bridge (Holdings), the aviation-to-engineering group . He and his family have about 50% of the operation and other assets. (\u163\'a372m, 782=)\par Bill McCabe Property and software. Dublin-based McCabe, 53, who made \u163\'a347m from software group Smar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Force, heads LNC Property Group. He chairs the Irish Cancer Society. (\u163\'a387m, 648=)\par Alex Scott* Finance. The Scott family sold Provincial Insurance in 1994 for \u163\'a3350m and moved into wealth management. Led by Alex, 50, it has about 40% of Londonbased Stramongate. We add dividends and other payments. (\u163\'a365m, 863=)\par 868= \u163\'a377m\par Ian and Andrew Hall Food. Brothers Ian, 67, and Andrew, 60, are the fourth generation to run Preston food group James Hall & Co. It is worth \u163\'a375m and we add \u163\'a32m for past salaries. (\u163\'a372m, 782=)\par Jonathan Little* Books. Eastbournebased Little Group includes Gardners Books, a leading wholesaler. The family company, run by Little, 45, is worth \u163\'a370m and there are other assets. (\u163\'a347m, 1,189=)\par William Lloyd* Animal feed and poultry. Lloyd's (Animal) Feeds, based in Shropshire, also has poultry, pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erty and waste interests. The family is led by William, 53. (\u163\'a357m, 976=)\par Kevin McDonald Plastic pipes. Former plumber McDonald, 76, made \u163\'a356m from Polypipe, his Doncaster firm. We allow for other company assets and hefty share sales over the years. (\u163\'a375m, 751=)\par 875= \u163\'a375m \u163\'a35m, 7%\par Jimmy Page Music\par Led Zeppelin fans would flock to see Page, 66, back on stage, reprising this 1972 performance on his iconic double-neck guitar. The chances look slim, however, with singer Robert Plant (qv) ruling out a reunion. They last got together for a hugely successful gig at London's O2 arena in 2007 that will doubtless figure in Page's history of his life and times with the supergroup, to be published in a limited edition of 2,500. He formed Led Zeppelin in 1968 after success with The Yardbirds, and the multi-million-selling band still funds a rock-star lifestyle, even without new music. In April, Page, still a keen musician, promoted the first annual Show of Peace concert in Beijing. His companies, Classicberry and Succubus Music, showed \u163\'a316.8m net assets in 2008-09 with \u163\'a313.2m cash in the bank. Our rock expert raises London-based Page by \u163\'a35m - he would go much higher if Led Zeppelin re-formed.\par 2009: \u163\'a370m, 793=\par 808= \u163\'a380m New entry\par Mick Davis Mining\par The past year has seen Davis, the chief executive of Xstrata, stymied in his quest for the sort of deals that have built his company into a \u163\'a338 billion giant. In October he was rebuffed in his efforts to land Anglo Amer}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 can, a rival conglomerate, in a \u163\'a344 billion merger. Davis, a South African accountant who lives in London with his wife, Barbara, and three teenage children, is unlikely to bide his time for long. The 52-year-old made his name at Eskom, the South African utility, where half the jobs went in a restructuring. He left in 1993 and played a key role in creating BHP Billiton, the mining colossus, but departed after failing to take the reins. Since then Davis, a passionate cricket fan who at 15 was South Africa's youngest qualified umpire, has transformed Xstrata into one of the world's largest natural resources companies. Davis, who enjoys opera and history, commutes each week to Xstrata's headquarters in Switzerland and is said rarely to take more than 30 minutes to respond to an email. He is active in charity and a regular on the Jewish Chronicle's Power List 100. He admits he is an aggressive dealmaker. "Many acquisitions I have participated in have started friendly and ended hostile. I guess it reflects something about my character," he said. And that dealmaking has been well rewarded. Last year Davis received a \u163\'a327m pay package, including \u163\'a34.9m in basic pay and bonuses. He also has a \u163\'a327m stake in Xstrata.\par 872= \u163\'a376m\par Sir John Barlow* Finance. The Cheshirebased family led by Barlow, 76, has a stake worth \u163\'a356m in City i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vestment group Majedie Investments. We add \u163\'a320m for other business assets. (\u163\'a384m, 682=)\par Michael Pass Flooring and property . Pass, 73, owns Granwood Holdings of Chesterfield, whose flooring was invented in the 1900s and is used in 50 countries. He has property interests. (\u163\'a358m, 966=)\par Duncan Sinclair* Property. London-based Mountview Estates, chaired by Sinclair, 62, an accountant, has been snapping up property bargains. (\u163\'a360m, 924=)\par 875= \u163\'a375m\par Jeremy Agace Property. Agace, 69, who races veteran cars, made \u163\'a337m from the merger of estate agency Mann into Hambro Countrywide and left Britain for Monte Carlo. There is other wealth. (\u163\'a370m, 793=)\par Abdul Alimahomed* Packaging. Birmingham business Europackaging was sold back to its founding family, led by Alimahomed, 70, for \u163\'a320m, three years after being bought by a private equity group in a deal worth \u163\'a3190m. (\u163\'a375m, 751=)\par Dave Allen Leisure and football. Allen, 68, is majority shareholder at Chesterfield FC.His Sheffield-based leisure group showed \u163\'a358m net assets in 2008. He has \u163\'a317m of other assets. (\u163\'a356m, 980=)\par John and Kathleen Boyle Bookmaking. Boylesports in Ireland is owned by John and wife Kathleen, both 54. (\u163\'a388m, 646=)\par Andy Brown Finance. Brown, 54, was a fund manager before setting up Cedar Rock Capital in London. (\u163\'a370m, 793=)\par Esmond Bulmer* Cider. The family netted \u163\'a384m for its stake in HP Bulmer, the Hereford cider maker. Led by Bulmer, 74, it is now involved with the charitable Bulmer Foundation. (\u163\'a370m, 793=)\par Jon Burton Computer games. Traveller's Tales, the brainchild of Cheshire-based Burton, 40, created bes}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sellers based on Star Wars and Sonic the Hedgehog. He sold to Warner Bros for \u163\'a3100m. (\u163\'a365m, 863=)\par Graham Dacre Car sales and property . Dacre, 58, moved into property after selling his Norwich-based Lind Automotive Group for \u163\'a396m. (\u163\'a370m, 793=)\par Lord Daresbury and the Greenall family Brewing and hotels. Daresbury, 56, heads the family, which held the Warringtonbased De Vere leisure chain. They made about \u163\'a387m from share sales and dividends up to its 2006 takeover. (\u163\'a375m, 751=)\par Duncan Davidson* Construction. Davidson, 69, founded York housebuilder Persimmon in 1972 and chaired it until 2006. It was hit by the property downturn but orders are up again. (New entry)\par Michael Dawson Alarm systems. Dawson, 67, collected \u163\'a392m when Yorkshire-based personal alarm maker Tunstall Group was sold to Mercury Private Equity. We keep him at last year's figure. (\u163\'a375m, 751=)\par Dinesh Dhamija* Leisure. Dhamija, 60, got \u163\'a386.7m before tax when his Ebookers travel website sold. (\u163\'a365m, 863=)\par Anthony D'Offay Art dealing. Sheffieldborn D'Offay, 70, owns a \u163\'a350m fine art dealership and other assets. (New entry)\par Julian Green. Finance. Green, 47, is \u163\'a330m better off after selling a stake in the London-based Ashmore Group last year. He has other assets. (\u163\'a362m, 910=)\par Doug Gregory Furniture. Symphony, the Yorkshire kitchen, bathroom and bedroom maker, is owned by Channel-based Gregory, 70. (\u163\'a3120m, 438=)\par Peter Kindersley* Publishing. Kindersley, 68, made \u163\'a3105m from the Dorling Kindersley Publishing group . He is investing in Dorset-based eco retailer Neal's Yard Remedies. (\u163\'a370m, 793=)\par Don Lewin* Greetings cards. Lewin, 76, sold his first cards business on his 40th birthday and started again with Essexbased Clinton Cards. (\u163\'a336m, 1,525=)\par Jonathan Lourie Finance. London hedge fund Cheyne Capital was founded in 1999 by former investment bankers Lourie, 48, and Stuart Fiertz. (New entry)\par John Marston* Hotels and property . Marston, 75, made \u163\'a350m from Kent hotels and has property assets. (\u163\'a375m, 751=)\par Brian May Music. Queen's new Absolute Greatest compilation sold 550,000 copies by the year end - good news for Hamptonborn guitarist May, 62. (\u163\'a370m, 793=)\par Patrick McKillen Property. Belfastborn McKillen, 54, netted \u163\'a318m from the sale of the Champion Sports chain. He has become one of the leading property players in Dublin. (\u163\'a366m, 860=)\par John Muir* Construction. Muir Group, the Inverkeithing property firm, showed a sharp fall in profits from \u163\'a310.3m to \u163\'a31.1m in 2008-09. The company, run by Muir, 73, is valued at \u163\'a345m and we add \u163\'a320m for the net assets of Muir Holdings. The family has \u163\'a310m of other wealth. (\u163\'a350m, 1,077=)\par Stephen Nesbitt Finance. Nesbitt, 61, retired as a director of Man Group, the Citybased hedge fund, in 2005. (\u163\'a370m, 793=)\par Sir Gulam Noon Food. Noon, 74, set up Noon Products in Southall, which makes Indian foods for superma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 kets. It was taken over by WT Foods and Noon, who has other assets, received \u163\'a350m. (\u163\'a365m, 863=)\par Jimmy Page Music. See panel on page 69\par David Russell Property. Russell, 53, has teamed his property empire with a fund management group to i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vest \u163\'a3150m in the northwest. Born in Rochdale, he made a fortune in kitchens. (\u163\'a375m, 751=)\par Andrew Sasson Bars and nightclubs. Sasson, 40, grew up in London but is now based in the US, where he has a string of nightclubs and restaurants. (\u163\'a360m, 924=)\par Simon Shaw Finance. London financier Shaw, 49, holds a number of City directorships. His main stake is 73.2% of the EEA Group, which deals in carbon credits for its clients. (New entry)\par Chris Stamper* Computer games. Stamper, 51, co-founded Rare, the Leicester computer games operation, with brothers Tim and Stephen, and sold it to Microsoft for \u163\'a3240m. We assess them after reinvestment. (\u163\'a375m, 751=)\par Tracey Ullman and Allan McKeown Television. Ullman's satirical State of the Union television show has just finished its third season in the United States, where the 50-year-old has won seven Emmy awards. Her hu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 band, McKeown, 63, is a producer. The couple live in Los Angeles and Mayfair. (\u163\'a368m, 843=)\par 905= \u163\'a374m\par William Alexander* Chemicals. Alexander, 55, chairs Tennants Consolidated, the \u163\'a3160m Mayfair-based chemicals company that manufactures and sells solvents, vitamins and watertreatment chemicals. (\u163\'a366m, 860=)\par Bill Bottriell Recruitment services.\par Bottriell, 52, co-founded the IT recruitment operation SThree in London. It is worth \u163\'a3373m and Bottriell r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tains a \u163\'a327m stake. He has other wealth. (\u163\'a362m, 910=)\par Panico Panayi Bingo and property. Panayi, 68, sold the Buckingham bingo chain in late 2005 for \u163\'a390m. He is involved in Manchester property. (\u163\'a372m, 782=)\par Christopher Taylor* Pharmacies. Taylor, 56, runs Dudley Taylor Pharmacies, based in Warwickshire. By late 2001 the family had sold many of its pharmacies, retaining 25 core outlets. Further expansion has doubled this number. (\u163\'a364m, 900=)\par 909= \u163\'a373m\par Lady Nadine Cobham* Inheritance. Lady Nadine, 66, has a stake in Cobham, the Dorset-based defence group, worth nearly \u163\'a313m. She is the widow of its former chairman, Sir Michael. (\u163\'a380m, 694=)\par Freddy Shepherd* Industry. Former Newcastle United chairman Shepherd, 68, and his family made their fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tune from Shepherd Offshore, a warehousing, offshore services and haulage group. (\u163\'a348m, 1,152=)\par 911= \u163\'a372m\par Austin Baird* Pharmacies. Ravenhill Estates, a property development company in Northern Ireland, is owned by Baird, 44. Most of his wealth comes from the sale of Bairds Chemists for \u163\'a381m. (\u163\'a370m, 793=)\par Alan Bekhor Shipping. Bekhor, 50, a former metals trader, owns 90% of London-based British Marine, which made \u163\'a328.4m profit in 2008-09. (\u163\'a372m, 782=)\par The Brett family Quarrying. The family owns Robert Brett & Sons, a sand and gravel extractor based in Ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 terbury, with \u163\'a387.2m of net assets. (\u163\'a372m, 782=)\par Damon Buffini Finance. Buffini, 46, chairs Permira, one of Europe's biggest private equity groups, in London. (\u163\'a370m, 793=)\par Moya Doherty and John McColgan Entertainment. Dublin-based Doherty, 52, and her husband, McColgan, 64, are taking Riverdance to Asia and America. They have property and other interests. (\u163\'a367m, 853=)\par Michael Heller* Property. Heller, 73, chairs shopping centre specialist London & Associated Properties. Ot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er interests include Bisichi Mining. (\u163\'a367m, 853=)\par Brian Howard* Property. Howard Investment Company made \u163\'a32.7m profit in the year to September 2008 and had \u163\'a369m net assets. Led by Howard, 74, the family also owns another Cambridge business, Howard Ventures. (\u163\'a372m, 782=)\par The Earl of Leicester* Land. Leicester, 73, owns Holkham Hall, a vast Norfolk estate, which hosts rock co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 certs to keep the wolf from the door. The family has a valuable art collection (\u163\'a368m, 843=)\par Michael Slade Property. Slade, 63, the chief executive of London-based Helical Bar, sold investments before the property price bubble burst. (\u163\'a369m, 841=)\par Frank Van Wezel Shoes. Van Wezel, 68, runs sports-shoe firm Hi-Tec Sports. A director of Southend United, the Dutchman is valued at \u163\'a393m by the 2009 Quote 500 list, but we are more cautious. (New entry)\par Jonathan Wild* Tea and coffee. The Bettys and Taylors Group, maker of Yorkshire Tea and the owner of genteel tearooms, is run by the Wild family, led by Jonathan, 57. In the year to October 2008, it made \u163\'a37.9m profit. (\u163\'a370m, 793=)\par Wing Yip* Cash and carry. Birminghambased W Wing Yip Brothers Trading, which supplies about 2,000 Chinese restaurants, made \u163\'a35.2m profit in 2009 and has \u163\'a327.9m net assets. The family, led by Yip, 72, also owns property. (\u163\'a372m, 782=)\par 923= \u163\'a370m\par Rowan Atkinson Entertainment. Atkinson, 55, won the Whatsonstage Theatregoers' Choice award for playing Fagin in Oliver! in February. Film earnings and property assets keep him at \u163\'a370m. (\u163\'a370m, 793=)\par Linda Bennett Shoes. LK Bennett, the shoe chain based in London, has 115 stores. The 47-year-old founder sold a 70% stake for \u163\'a3100m before tax. (\u163\'a370m, 793=)\par Andrew Brode Business services. Brode, 69, runs Buckinghamshire's RWS Holdings, Europe's biggest tec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nical translation and patent search business. (\u163\'a348m, 1,152=)\par David Dein Finance and football. The former Arsenal vice-chairman, 66, sold his stake in the club for \u163\'a375m before tax and has other interests. (\u163\'a365m, 863=)\par Lord Drayson* Pharmaceuticals. Drayson, 50, founded Oxford-based vaccine business Powderject Pharm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ceuticals and sold it for \u163\'a3100m before tax. (\u163\'a370m, 793=)\par Gary Dutton Windows and conservatories. Dutton, 61, sold Nottinghamshire doubleglazing company Synseal for \u163\'a360m last year. There is other wealth. (\u163\'a365m, 863=)\par Belinda Earl Retailing. See panel on page 79\par Ros and Steve Edwards Software. The couple launched bestCourse4Me.com to help disadvantaged pupils reach university. Ros, 46, and Steve, 52, made \u163\'a3100m before tax from their Cambridge software firm, Gen}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 va Technology. (\u163\'a370m, 793=)\par Ernie Fisher* Steel. Fisher, 58, and his family own property and hotels, having sold their 66% stake in Enni}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 killen-based Fisher Engineering. (\u163\'a360m, 924=)\par Peter FitzGerald* Pharmaceuticals. Randox is a Co Antrim firm specialising in medical and veterinary dia}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nostic products. FitzGerald, 59, owns 98% of the ordinary shares. Profits soared in 2008 from \u163\'a33.6m to \u163\'a36.2m. (\u163\'a370m, 793=)\par Emmanuel Gavaudan Finance. Gavaudan, 48, left Goldman Sachs and founded Boussard & Gavaudan Partners, a London hedge fund, which in 2008 made \u163\'a323.4m profit. He has other assets. (New entry)\par Robin Hall Finance. After 22 years as managing partner of Cinven, Hall, 61, is now the London-based buyout group's executive chairman. He owns about 12% of the Cinven Group, whose main operating company, Ci}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ven Ltd, made a profit of \u163\'a31.3m in 2008. (\u163\'a370m, 793=)\par Lady Helen Hamlyn* Publishing and inheritance. Hamlyn, 76, inherited \u163\'a350m from her husband, Paul, the publishing tycoon, using the Helen Hamlyn Trust to improve lives in Britain and India. She has other assets and homes in Chelsea and Buckinghamshire. (\u163\'a373m, 780=)\par Simon Howard* Land. Howard, 54, hopes to fund more than \u163\'a320m of vital repairs at the Castle Howard e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tate in north Yorkshire by selling some of his land to housebuilders. (\u163\'a365m, 863=)\par Jeremy Isaacs Finance. Isaacs, 46, the former head of Lehman Brothers' Europe and Asia operations, has co-founded the London investment firm JRJ Group. After Lehman's collapse, US Congress was told his sal}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ry in 2007 was $22m. (New entry)\par Jim Leavesley* Property and military surplus. Staffordshire-based JT Leavesley supplies planes, cranes, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tomobiles and memorabilia from the ex-forces ships it breaks up. It is owned by Leavesley, 79, and his fam}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly. (\u163\'a354m, 1,001=)\par Sir John Mactaggart* Property. Glasgow property group Mactaggart Heritable saw net assets fall by \u163\'a39m to \u163\'a382.3m in 2008. We value the business at \u163\'a360m, adding \u163\'a310m for past dividends. (\u163\'a370m, 793=)\par The Duke of Marlborough Land and art. Blenheim Palace recently opened a \u163\'a31.3m multimedia tourist attra}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion to reveal its "untold history". Tourists are a vital source of income for the Oxfordshire estate, home to Marlborough, 84. (\u163\'a365m, 863=)\par Paris Natar Garden equipment. Gardman supplies garden and wildlife products to more than 30 countries and made \u163\'a39m profit in 2008-09. Natar, 54, founder and chairman of the Lincolnshire business, sold a co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 trolling stake in 2007 in a deal that valued the firm at \u163\'a385m. (\u163\'a370m, 793=)\par Nicholas Porter Student accommodation. Porter, 40, still has a \u163\'a31m stake in Unite, the Bristol student a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 commodation firm he founded in 1991, but is now expanding the concept overseas. (\u163\'a342m, 1,296=)\par Matthew Riley Telecoms . See panel opposite\par Daisy ringing the changes\par 923= \u163\'a370m New entry\par Matthew Riley Telecoms\par Tycoon Riley had a humble start, repairing fax machines at the age of 16. Two decades later he runs the Daisy Group, which provides phone lines and broadband to businesses. Riley believes the company is pos}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tioning itself to "give BT a run for its money". His enterprising spirit caught the attention of the judges of the Sunday Times-Bank of Scotland Entrepreneur Challenge in 2007, where Daisy triumphed - winning mento}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ship from retail tycoon Sir Philip Green (qv, left) and a \u163\'a35m interest-free loan. The former salesman founded the business in his garage in Nelson, Lancashire. Nine years later, he is still based in the town but has more than 200 employees. "We want Daisy to be a fun place," says Riley, who recently bought a Routemaster bus to use on recruitment and promotion drives. The business has grown rapidly with Riley, 36, taking over smaller companies that ran into trouble in the recession. In 2007-08, Daisy made \u163\'a31.9m profit on \u163\'a333m sales. In July 2009, the organisation floated on AIM in a \u163\'a3200m reverse takeover of two other businesses. Riley, the chief executive, has a \u163\'a351m stake and share sales take him to \u163\'a370m.\par 953= \u163\'a369m New entry\par Peter Darwell Energy\par A series of career changes has paid dividends for 60-yearold Darwell. He's a self-made, serial entrepreneur who started as a chef and later moved into insurance, starting a financial services company at the age of 33. Although Darwell Associates proved successful, its owner began to tire of bigger rivals poaching his staff. He kept a keen eye out for other commercial opportunities and soon spotted one in the deregulated electricity market. Darwell built Economy Power into Britain's largest independent electricity provider. He made \u163\'a316m when it was sold to Eon in 2005, and turned his attention to Eco2, a Cardiff-based renewable energy comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ny where he is the chairman. He has had offers valuing the business at \u163\'a3120m, making his stake worth about \u163\'a335m. Darwell, who lives in Cheshire, also chairs Tidal Energy in Cardiff, which was set up to develop technology to generate electricity from tidal currents. "One area that is going to be huge for the UK in the f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture is tidal energy," he predicts. "It's free, it's limitless and it's entirely predictable." Other assets and sale proceeds bring Darwell into the Rich List on \u163\'a369m.\par 923= \u163\'a370m\par Graham Roach* Food production. The 2004 takeover of the Cornish business Flagship Foods made about \u163\'a370m for Roach, 62, a noted racehorse owner, and his family trusts. (\u163\'a375m, 751=)\par Michael Samuel* Industry. Samuel, 57, led Mayborn, the London household and baby products maker, until a 2006 takeover that made the family \u163\'a357m. Interests include bus firm Rotala. (\u163\'a370m, 793=)\par Vidal Sassoon Hairdressing. The 82-year-old Eastender made a fortune from hairdressing salons, training schools and hair products. He has homes in Beverly Hills and Notting Hill. (\u163\'a370m, 793=)\par Norman Springford* Hotels. Accountant Springford, 65, bought an empty university building in Edinburgh in 1995 and turned it into a hotel. Now Apex Hotels has \u163\'a372.6m net assets. (\u163\'a375m, 751=)\par John Stone Finance. Luxembourg-based Lombard International Assurance, founded by Stone, 66, sold in 2004 for up to \u163\'a3414m. He owned 30% of it. (\u163\'a370m, 793=)\par John Taylor Thermostats. Isle of Man firm Strix won a Chinese court victory against two firms that were cop}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing its thermostat technology. Taylor, 73, whose father started the business, made \u163\'a370m from selling his stake. (\u163\'a370m, 793=)\par Roger Taylor Music. Queen returned to the album chart with the Absolute Greatest compilation last year. The drummer, 60, also released a solo single. (\u163\'a365m, 863=)\par Tony and Maureen Wheeler Publishing. Husband and wife Tony, 63, and Maureen, 60, retain 25% of Lonely Planet, the travel guide empire based in London that they sold to BBC Worldwide. (\u163\'a360m, 924=)\par Alastair Wylie Construction. Wylie, 59, owns 66% of Glasgow firm Campbell Construction. Profits rose to \u163\'a311.7m last year. He has other assets. (\u163\'a364m, 900=)\par 953= \u163\'a369m\par Peter Darwell Energy. See panel on page 71\par Gerald Leeke* Retailing and property . JH Leeke and Sons owns three superstores in Wales and the West Country, and is developing luxury flats. Leeke, 68, chairs the family business. (\u163\'a356m, 980=)\par Jonathan Milner Biosciences. Milner, 44, co-founded Cambridge-based Abcam to sell antibodies online. His stake in the AIM-listed company is worth \u163\'a359m. Share sales add \u163\'a310m. (\u163\'a345m, 1,203=)\par Rupert Mucklow* Property. Mucklow, 46, and his family have a \u163\'a367m stake in Birmingham developer A&J Mucklow plus salaries and dividends. (\u163\'a356m, 980=)\par 957= \u163\'a368m\par Antony Crosthwaite-Eyre* Publishing. Camusrory, an 8,100-acre Highland estate, was put on the market at \u163\'a32m last year by the Crosthwaite-Eyre family, led by Antony, 70, who made his fortune from the sale of pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lishing interests in 1987. (\u163\'a365m, 863=)\par The Morgan family Press cuttings. The family made \u163\'a372m from Romeike, the London press cuttings service. Assets include a finance operation. (\u163\'a368m, 843=)\par Firoz Tejani* Foreign exchange. Tejani, 65, runs Lenlyn, which controls the family currency operations, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cluding ICE exchange bureaux. The Tejanis are generous charity givers. (\u163\'a343m, 1,288=)\par Andrew Tinkler and William Stobart Transport. Stobart Group, the Warrington logistics firm, is run by brot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ers-in-law Tinkler, 46, and Stobart, 48. They have a \u163\'a366m stake. (\u163\'a352m, 1,046=)\par 961= \u163\'a367m\par Alexander Buchan* Fishing and transport. Buchan, 66, and his family have a \u163\'a367m stake in Peterhead-based Lunar. In 2008 it had \u163\'a356.2m sales. (\u163\'a340m, 1,348=)\par Gavin Ferris Finance. Ferris, 40, has a \u163\'a357m stake in the Aspect Capital hedge fund in London, where he is a director. Bonuses add \u163\'a310m. (\u163\'a334m, 1,631=)\par Roger Wickens* Property. Store Property, of Sussex, has a 1.5m sq ft portfolio across London and the southeast. The business is owned by Wickens, 65, and family, who have other interests. (\u163\'a389m, 644=)\par 964= \u163\'a366m\par Ian Herd Oil and gas services. Aberdeenbased Integrated Subsea Services was co-founded in 2002 by Herd, 52, and supports operations as far apart as the North Sea and Caribbean. His stake is worth \u163\'a366m. (\u163\'a339m, 1,468=)\par Seamus McAleer* Construction. McAleer & Rushe, the Northern Ireland property group, is chaired by McAleer, 68, who with his family has interests in a number of other businesses. (\u163\'a345m, 1,203=)\par Charles Wilson Retailing. Wilson, 44, is chief executive of Booker, the cash-andcarry group. We add options, salaries and share gains to his stake. (\u163\'a351m, 1,074=)\par 967= \u163\'a365m\par Terry Adams* Quarrying and landfill. Adams, 70, sold his eponymous Devon business to South West Water in 1997. He has quarry interests. (\u163\'a365m, 863=)\par Simon Arber Recruitment services. Share sales built the fortune of Arber, 51, who co-founded SThree, the London-based recruitment company. (\u163\'a365m, 863=)\par Lord Archer Novels. The London-based novelist, 70, has been making more than \u163\'a31m a year from book sales since 1982. Property investments and his art collection boost that wealth. (\u163\'a365m, 863=)\par Frank Bird* Food. Bird, 73, runs F&N Holdings, a family-owned poultry processing and farming group in Pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rith. Sales hit a record \u163\'a348.8m. We add \u163\'a323m for salaries and dividends. (\u163\'a352m, 1,046=)\par Mark and Mo Constantine Cosmetics. Lush Cosmetics in Dorset has 650 stores worldwide. Profits came in at \u163\'a313.9m on \u163\'a3214.5m sales in 2008-09. Husband-andwife founders Mark, 57, and Mo, 56, have a \u163\'a363m stake plus dividends. (\u163\'a340m, 1,348=)\par Philip Davies* Property. Davies, 89, has a portfolio focused on northern England. His Manchester-based pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vate company and other property operations have assets of \u163\'a365m. (\u163\'a352m, 1,046=)\par Simon Dolan Business services. Dolan's interests include Hertfordshire-based SJD Accountancy, a motor racing team and publishing. His businesses are worth \u163\'a358m. Past salaries and property take Dolan, 40, to \u163\'a365m. (New entry)\par Roger Guy Finance. Fund manager Guy, 43, made \u163\'a320m from the \u163\'a3676m flotation of City investment house Gartmore last year and retains a stake, but the share price has fallen sharply. (\u163\'a3120m, 438=)\par Sir John Hall* Property and football. Hall, 77, recently diagnosed with prostate cancer, developed the Metr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Centre at Gateshead. Much of the proceeds went into a stake in Newcastle United, sold in 2007. The family property business had \u163\'a324.5m assets in 2008. (\u163\'a365m, 863=)\par Timothy Ingram Hill* Motorway services. Wiltshire-based Ingram Hill, 60, and family trusts received about \u163\'a375m when the Roadchef motorway chain was sold in 1998. He has a hotel group. (\u163\'a365m, 863=)\par Michael Jacobson* Parcel delivery. Hertfordshire-based Canadian Jacobson, 60, and his family trusts r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ceived more than \u163\'a370m in the 1995 buyout of his ICS Worldwide Couriers. (\u163\'a365m, 863=)\par Bob Keiller Oil services. Aberdeen-based PSN landed a five-year deal with BP worth more than \u163\'a3200m. The firm, which services pipelines and plants, has been valued at \u163\'a3600m. Chief executive Keiller, 46, has a 10.2% stake. (\u163\'a361m, 921=)\par Mustafa and Fatma Kiamil Food. Mustafa, 53, boosted his food wholesale company's green credentials by designing an electric delivery truck. JJ Food Service, based in London, is owned by Kiamil and his wife, Fatma, 48. (\u163\'a342m, 1,296=)\par David Lewis* Property. Lewis, 70, came out of semi-retirement in 2003 to develop London offices. His co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pany, Marylebone Property Corporation, showed \u163\'a350.4m net assets in 2007-08. (\u163\'a365m, 863=)\par Christopher Mills Finance. Mills, 57, has a \u163\'a322m stake in North Atlantic Smaller Companies Investment Trust and \u163\'a331m of JO Hambro Capital Management plus other wealth. (\u163\'a396m, 573=)\par Carole Nash* Insurance. Nash, 68, sold her Cheshire-based insurance broker, specialising in motorbikes, in 2006. The Nash family owned it all. (\u163\'a365m, 863=)\par Chris Parker Travel. Parker, 62, owned half of Unijet, the Gatwick holiday group sold for \u163\'a3110m in 1998. (\u163\'a365m, 863=)\par Tim Parker Retailing. Parker, 54, now at Samsonite, got a \u163\'a340m payoff from the AA for turning it round. He also had stakes in Kwik-Fit and Kenwood. (\u163\'a365m, 863=)\par Nick Rodwell and Fanny Vlamynck Books. Vlamynck, widow of Tintin creator Georges R\u200\'e9mi, and husband Rodwell, 57, whose family owns a London industrial group, are awaiting the release of a Tintin movie in 2011. (\u163\'a365m, 863=)\par Martyn Rose Media and investments. Rose, 61, a barrister, chairs companies in sectors such as new media, art, engineering and financial services, the most high-profile being Oxford's Publishing Technology. (\u163\'a350m, 1,077=)\par Andrew and Sharon Turner Finance. Andrew, 51, owns Norwich broker Central Trust, whose profits fell in 2008 to \u163\'a32.5m. He and his wife, Sharon, 52, a director, have other assets. (\u163\'a395m, 575=)\par Sir Frank Williams Motor racing. Williams Grand Prix Engineering has not won a world championship since 1997 but the Oxfordshire team made a \u163\'a39.1m profit in 2008. After selling a stake last year, Williams, 68, has a \u163\'a350m holding topped up with salaries and dividends. (New entry)\par Tony Williams* Industry. The Williams family led by Tony, 81, enjoyed a payday of about \u163\'a385m for its holding in Williams Lea when Deutsche Post bought a 75% stake in the London information management group in 2007. (\u163\'a365m, 863=)\par 991= \u163\'a364m\par Pat Harrington Construction. Londonbased PC Harrington is a market leader in reinforced concrete. Harrin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton, 72, owns all of the company he founded, which has \u163\'a343.2m net assets and is worth \u163\'a360m. We add \u163\'a34m for other assets. (\u163\'a330m, 1,771=)\par Alex Langsam Hotels. The Heathlands in Bournemouth became the 35th location in Britannia Hotels' portf}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lio last year. The Manchester-based firm, co-founded by Langsam, 71, and Michael Morton (qv), had \u163\'a368.4m net assets. (\u163\'a360m, 924=)\par Harold Martin Industry. Derbyshire-based HW Martin Holdings provides services such as fencing and waste disposal for clients including the Highways Agency and the Prison Service. It is worth \u163\'a350m. Past salaries and dividends take the owner, Martin, 75, to \u163\'a364m. (\u163\'a345m, 1,203=)\par Michael Morton Hotels. Morton, 72, set up Britannia Hotels with Alex Langsam (qv). He holds 50% of the Manchester-based chain, which has \u163\'a368.4m net assets, and further wealth. (\u163\'a362m, 910=)\par Mayank Patel Finance. Patel's Currencies Direct made \u163\'a33.2m profit on \u163\'a31.2 billion sales in 2008-09. The London operation is worth \u163\'a380m and Patel, 42, owns 63%.Other assets and past salaries add to Patel's wealth. (\u163\'a354m, 1001=)\par Jimmy and Simon Thomas Bingo. The father-and-son team, aged 76 and 44, sold their Loughborough le}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sure business, including Beacon Bingo, for a reported \u163\'a380m in 2006. The family owns United Leisure Group (\u163\'a360m, 924=)\par Chris Wright Music. Chrysalis has recovered from a low point in late 2008 and the London business is now worth \u163\'a369m. Wright, 65, made \u163\'a323m in 2007 when Chrysalis sold its radio arm for \u163\'a3170m and returned \u163\'a396m to its shareholders in a special dividend. He has property assets. (\u163\'a355m, 986=)\par James Young* Pubs. Young & Co made \u163\'a369m from the sale of its historic Ram brewery site in Wandsworth, south London, in 2007. Much of the money has gone into its pub estate. John Young, who led the family business for more than four decades, died in the last week beer was brewed at the site. The wider family, ledby his son James, 58, has a stake worth \u163\'a359m and other assets. (\u163\'a363m, 906=)\par 999= \u163\'a363m\par Terry Smith Finance. Essex-based boxing fan Smith, 56, is chief executive of the broker Tullett Prebon, in which he has a stake worth \u163\'a333m. He runs the former subsidiary of Collins Stewart, now an investment bank, in which his holding is worth \u163\'a37m. We add \u163\'a323m for share sales and property. (\u163\'a347m, 1,189=)\par Trevor Storer* Food. See panel opposite\par 967= \u163\'a365m \u163\'a325m, 63%\par Jamie Oliver\par Food and media\par Oliver's healthy eating message didn't go down too well when he took it to America last month. He was r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 duced to tears in Huntington, West Virginia, where schoolchildren gorged on pizza for breakfast, and was told by chat show host David Letterman: "Try as hard as you might, you are never going to succeed." The Essex boy, scourge of the turkey twizzler, won't give up easily, however, and got decent ratings on US tel}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vision. Oliver made his name on TV shows in this country and has gone on to write a series of cookery books and run his own restaurants, including the Fifteen chain that gives disadvantaged youngsters the chance to forge a career in cooking. Profits at Jamie Oliver Holdings, the chef's parent company, rose by 82% from \u163\'a33.7m to \u163\'a36.8m in 2008. Oliver, 34, and his wife, Jools, awarded themselves a dividend of \u163\'a3800,000. He ranks among our top 25 philanthropists, cooking up \u163\'a32.75m for charity last year .\par 2009: \u163\'a340m, 1,348=\par The pie's the limit\par 999= \u163\'a363m \u163\'a38m, 15%\par Trevor Storer and family Food\par In times of austerity the British public's palate craves the rib-sticking, pocket-friendly qualities of pastrye}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cased meat and vegetables, hence the impressive financial performance of Pukka Pies during the recession. Explaining why people have been choosing to eat "straightforward" pies, Tim Storey, 46, left, the son of Pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ka Pies founder and chairman Trevor, 79, inset, and brother of co-managing director Andrew, 49, far left, said: "You don't want food going uneaten at a time like this." Sold in fish and chip shops, Pukka's pies, pas}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ies, sausage rolls and sausages are increasingly stocked in supermarkets and exported. The company, founded in 1962, showed publicity savvy with its sponsorship of ITV's Who Wants to Be a Millionaire?, which helped raise its profile. Pukka Pies is to create jobs and increase production with a \u163\'a36m investment at its fa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tory in Leicestershire. This will enable it to double capacity to 2m pies and pasties a week. In the year to May 2009, it made \u163\'a36.5m profit on \u163\'a334.1m sales, and showed more than \u163\'a330.5m net assets. The family is worth \u163\'a363m with other assets and past dividends .\par 2009: \u163\'a355m, 986=\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 IRON & STEEL MILLS (91%); WEALTHY PEOPLE (88%); BOAT RACING (84%); FAMILY COMPANIES (78%); TAKEOVERS (76%); CONSUMPTION (71%); 2012 LONDON SUMMER OLYMPICS (69%); SCULPTURE (68%); PLANT CONSTRUCTION (66%); EXECUTIVES (64%); LAW COURTS & TR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BUNALS (60%); SUPREME COURTS (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ARCELORMITTAL SA (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MTS (MCE) (94%); MT (PAR) (94%); MT (NYSE) (94%); MT (AMS) (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS331221 ROLLED STEEL SHAPE MANUFACTURING (94%); NAICS331110 IRON & STEEL MILLS & FERROALLOY MANUFACTURING (94%); SIC3316 COLD-ROLLED STEEL SHEET, STRIP & BARS (94%); SIC3312 STEEL WORKS, BLAST FURNACES (INCLUDING COKE OVENS) & ROLLING MILLS (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LAKSHMI N MITTAL (92%); ERNESTO BERTARELLI (66%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LONDON, ENGLAND (86%); BEIJING, CHINA (79%); NEW YORK, NY, USA (78%); KO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 KATA, INDIA (55%) NEW YORK, USA (91%); NORTH CENTRAL CHINA (79%); WEST BENGAL, INDIA (57%) UNITED STATES (94%); CHINA (79%); INDONESIA (79%); UNITED KINGDOM (69%); INDIA (57%) National Edition\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 April 25, 2010\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 CORRECTION-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 May 2, 2010\par \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 CORRECTION:}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Mike Ashley, the owner of Newcastle United football club, has asked us to make clear that he has not "pledged to make at least \u163\'a325m available this summer to buy players" as stated in last week's Sunday Times Rich List. We are happy to correct the record.\par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Peter Cruddas In the entry for Peter Cruddas, we inadvertently used a subsidiary company's figures when quoting company accounts for CMC Markets plc. The correct 2008-9 figures for CMC Markets were a \u163\'a315.1m loss on sales of \u163\'a3193.2m.\par John Whittaker In a table of political donors, we incorrectly attributed to John Whittaker, chairman of the Peel Group, a donation of \u163\'a381,409 to the United Kingdom Independence party (UKIP). We are happy to confirm that Mr Whittaker, who is not registered to vote in the UK, made no such donation and apologise for this error and the embarrassment caused. The donation was made by Dr John Whittaker, the former UKIP MEP for the North West.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 JOURNAL-CODE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 STS\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2010 Times Newspapers Limited\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; Counterfeits Bill Threatens Access to Medicine Africa News November 6, 2009 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_70}{\*\bkmkstart DOC_ID_70_0}{\*\bkmkstart doc_id_15}{\*\bkmkend DOC_ID_70}{\*\bkmkend DOC_ID_70_0}{\*\bkmkend doc_id_15}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_15"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 15 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  6, 2009 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par Counterfeits Bill Threatens Access to Medicine}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Inter Press Service (Johannesburg)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1120 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda is considering an anti-counterfeit bill which analysts say will impair the country's ability to import and export cheap but effective generic medicines. Activists fear that the bill, once enacted, will deny Ugandans access to safe, effective, quality and affordable generic medication which currently forms the bulk of Uganda's medicine imports.\par The Counterfeit Goods Bill seeks to prohibit trade in goods that ostensibly infringe intellectual property rights. The bill, which was tabled by Uganda's trade ministry, will empower the commissioner of customs to seize suspected counterfeit goods. \par The bill defines "counterfeiting" as manufacturing, producing, packaging, re-packaging, labelling or making, whether in Uganda or outside Uganda, any goods which are imitated so as to be substantially similar to the protected goods without the authority of the intellectual property right owner subsisting in the country or elsewhere.\par President Yoweri Museveni in February asked his trade ministry to draft a strict law to curb counterfeit goods that he said were affecting local industries.\par "I think in China they've got some good solutions because you remember the other man who sold milk which killed children? I think he was put in front of the firing squad. If somebody kills children, do you think the Ch}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nese are very wrong?" he asked.\par But Edgar Tabaro, a Ugandan lawyer specialising in trade-related matters, questions the necessity of the bill. He told IPS that whatever the bill ostensibly seeks to address is covered by different laws like the Trad}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 marks Act, Copyright Act, the Patents Act and the Trade Secrets Act.\par "So we are asking whether this bill is being pursued on behalf of our national agenda or whether there are some embedded interests behind this bill. Why should we deny our people cheaper drugs by making laws that are not in our interest?" he asked.\par Rosette Mutambi, executive director of the Coalition for Health Promotion and Social Development (HEPS-Uganda), regards the bill as a threat to the lives of many Ugandans who largely depend on generic anti-retroviral drugs and other medicine. HEPS is a health consumers' organisation advocating for health rights and also represents health practitioners.\par Mutambi said only about 10 percent of the medicines used in Uganda are locally manufactured. And only about five to seven percent of the imported medicines are original brands, meaning that about 93 percent of imported drugs are generics. These are mostly imported from India.\par Patrick Mubangizi, the coordinator of Health Action International Africa's (HAI-Africa) office in Nairobi, said during a recent meeting in Kampala that he was "very concerned" about the bill because policy makers and the public didn't understand its implications for public health. HAI-Africa is part of an independent global ne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 work seeking to enhance access to medicines.\par HAI-Africa is opposed to the Ugandan bill because it deviates from the official definition of counterfeit med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cine as provided by the World Health Organisation (WHO).\par "WHO describes counterfeit medicine as 'medicine which is deliberately and fraudulently mislabelled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 terfeit products may include products with the correct ingredients or with the wrong ingredients, without a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tive ingredients, with insufficient active ingredients, or with fake packaging'," explained Mubangizi.\par Geoffrey Nalima, a manager at Quality Chemicals Limited, the first antiretrovirals (ARVs) manufacturing plant in East Africa, told IPS that they were alarmed by the bill because it classifies their products as counterfeits. Moreover, the bill will make it difficult for their products to be exported to other countries in the region.\par Other countries in the region have expressed interest in the drugs, which are being manufactured under a license from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  of India.\par Sisule Musungu, a policy analyst specialising in intellectual property, trade and innovation, told IPS that Uganda, like Kenya, will become a victim of multinational companies pushing for intellectual property right enforcement.\par "Internationally, there is a big push towards intellectual property enforcement for trade reasons. With the trade negotiations going on at the World Trade Organisation (WTO), the U.S. and European Union will have to reduce subsidies for agricultural production. All that remains are technology-based goods. That is where intellectual property rights enforcement comes in," Musungu explained.\par Uganda as a least developed country (LDC) which, under the WTO's Trade-Related Aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, does not have to provide protection for trademarks, copyrights, patents and other intellectual property rights until July 2013. Regarding pharmaceuticals, Uganda does not have to put in place protections on medicine until 2016.\par The idea behind these "allowances" is for developing countries to take advantage of technological advanc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ments and gain the capacity to produce their own drugs. Uganda would therefore be preventing itself from doing so by adopting this bill, according to Musungu.\par "If Uganda wants to pass an intellectual property rights law, the benchmark should not be to comply with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  The benchmark should be determined by asking what Uganda wants for this law. And, therefore, which type of law should we have. The draft bill goes beyond }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  requirements," he said.\par Nathan Irumba, a former Ugandan ambassador to the WTO and now senior strategic advisor to the Southern and Eastern African Trade Information and Negotiations Institute (SEATINI), agreed that Ugandan gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment needed to protect its citizen from counterfeits. But, he said, the problem with the bill is that it mixes i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sues of trademarks and the question of standards.\par "I agree counterfeits should be dealt with but in the process we should not outlaw generic medicine. We should not be tricked by multinationals to have their rights enforced in our courts. We should instead utilise our space for development. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  gives us leeway. But in the bill we (Ugandans) are trying to restrain these flexibilities," he pointed out.\par Elimu Elyetu, a project manager with Uganda's Trade Capacity Enhancement project that is also steering the bill, told IPS that they were ready to include amendments to the bill to take care of activists' concerns.\par Uganda's trade minister Gagawala Wambuzi told IPS that government was determined to have the bill e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 acted into law before the end of this year. "There has been a disease of counterfeits. People are crying. Some of the counterfeits are manufactured inside here; some are from abroad. And we are saying this must stop."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 COUNTERFEITING (93%); INTELLECTUAL PROPERTY LAW (91%); GENERIC DRUGS (91%); COMMERCE DEPARTMENTS (90%); IMPORT TRADE (90%); TRADE DEVELOPMENT (89%); TRADEMARKS (89%); PATENT LAW (89%); PHARMACEUTICALS TRADE (89%); EXPORT TRADE (89%); INTELLECTUAL PROPERTY (89%); COPYRIGHT INFRINGEMENT (78%); COPYRIGHT LAW (78%); HEALTH CARE ACCESS (78%); GENERIC PRODUCTS (78%); PUBLIC POLICY (76%); TRADE SECRETS LAW (76%); PATENTS (76%); PACKAGING MATERIALS (75%); COPYRIGHT (73%); ANTIV}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RALS (73%); PREVENTION & WELLNESS (71%); TRADEMARK LAW (71%); EXECUTIVES (68%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 KAMPALA, UGANDA (79%); NAIROBI, KENYA (51%) UGANDA (99%); AFRICA (94%); INDIA (79%); CHINA (79%); KENYA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 6, 2009\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2009 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Experts Fear Flu Will Join Trip to Mecca The New York Times October 30, 2009 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_71}{\*\bkmkstart DOC_ID_71_0}{\*\bkmkstart doc_id_16}{\*\bkmkend DOC_ID_71}{\*\bkmkend DOC_ID_71_0}{\*\bkmkend doc_id_16}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_16"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 16 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The New York Times\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  30, 2009 Friday  \par Late Edition - Final\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Experts Fear Flu Will Join }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid10898414 Trip}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414  to Mecca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 By DONALD G. McNEIL Jr.\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Section A; Column 0; Foreign Desk; Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1036 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Every year, the single largest gathering on the planet is the annual pilgrimage to Mecca: 2.5 million people from 160 countries packed into a small city in Saudi Arabia for five days.\par   This year, some will be bringing swine flu.\par   The Saudi authorities, fearing that the hajj could turn their holy city into a petri dish for viral mutations and a hub for spreading a new pandemic wave around the world, are working hard to head that off. They have asked some worshipers, including pregnant women and the elderly, not to make the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  which is scheduled for the last week of November. \par   ''The hajj is a central ritual of Islam, and our country tries to make it easy for everyone to come,'' said Dr. Ziad A. Memish, the country's assistant deputy minister for preventive medicine. ''We've said we won't turn away anyone who arrives at our borders. But we are recommending to other countries whom they should let come.''\par   Although the Saudis have turned to the World Health Organization and other health agencies for help in previous public health threats to the hajj, this year the Centers for Disease Control and Prevention, the Ame}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ican government's lead disease-fighting agency, is more deeply involved because it has so much experience with this new flu strain. Consultants for the centers have gone back and forth to Riyadh, flu experts at Amer}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 can medical schools have been called in and the United States Navy's medical laboratory in Cairo is prepa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing to help with any complex flu testing that is beyond what Saudi laboratories can do.\par   While religious pilgrimages feed the souls of those who attend, they often endanger the bodies. There have been several outbreaks of meningitis in Mecca since 1987, and in 2004, Muslim pilgrims spread polio from northern Nigeria across Africa to Saudi Arabia and from there outward to Yemen and Indonesia.\par   In July 2008, about 200,000 Catholics from all over the world converged on Sydney, Australia, for World Youth Day, attended by the new pope, Benedict XVI, during the Southern Hemisphere's winter. There was a major flu outbreak, and a Tamiflu-resistant strain of seasonal flu established itself and then spread to the Northern Hemisphere, including to the United States, last winter.\par   The Saudis reacted because this new strain is the first pandemic flu since 1968. Any new flu carries the risk of gene-swapping that can form mutant viruses, and this one has some swine and avian genes that, before this April, had never been seen in humans. Both the new strain and seasonal flus will be circulating in the world, increasing the risk of flus mixing in Mecca. Also, although the flu infects younger people, the ones most likely to need hospitalization or die if they do get infected are the very young, pregnant women, the sick and the aged.\par   The hajj offers many opportunities to a virus that spreads through the air and lingers on surfaces: Pilgrims crowded into planes, boats, buses and tent cities; the endless ranks of the faithful praying shoulder to shou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 der and touching their hands to the floors around the Kaaba, to handrails as they run between the hills Safa and Marwah, or to cups of water from the Zamzam Well.\par   A paper published online  on Thursday in the journal Science describes many of the obstacles to fighting transmission there. Dr. Memish, the Saudi official, is a co-author with several Centers for Disease Control  experts.\par   For example, pilgrims are advised to wash their hands frequently and bring their own surgical masks and hand sanitizers. The first is easy: Islamic law requires washing the hands and face five times a day before prayers. But male pilgrims may not wear anything with stitches in it; they wrap themselves in two lengths of unhemmed white cloth. And women on the hajj -- even those who wear chadors at home -- are forbidden to cover their faces. Also, since Islam forbids alcohol, some believers reject most hand sanitizers. \par   Senior religious leaders have issued fatwas declaring that masks and sanitizers ''are not a problem,'' Dr. Memish said, but every religion has some conservatives who believe in keeping up standards. \par   The Saudi government has made many preparations, like buying stockpiles of generic Tamiflu from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  an Indian company. The country has 76 health facilities staffed for the hajj, and intensive-care units have been expanded. For pilgrims, all medical care for problems they develop during their visit is free.\par   ''Saudi Arabia's reputation rests on how the hajj is conducted,'' Dr. Shahul H. Ebrahim, a Centers for Di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ease Control epidemiologist who advises the Saudi government, said in a recorded interview with the Sc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ence article.  ''It's a rich country, they take a lot of national pride in it and the king is responsible. I don't think anything is lacking here except vaccines.''\par   It will be impossible to stop the flu from arriving, the authorities acknowledge, and hard to slow its spread. But they are trying to lessen the damage by keeping the most vulnerable pilgrims away. Every country gets an annual limit as to how many pilgrims it can send. This year the Saudis suggested barring anyone who is pregnant, under age 12, over age 65 or suffering from diabetes, chronic lung, heart, liver or nerve disease, or some other conditions. Psychologically, the ban is hardest on the old and the sick, Dr. Memish said. \par   In countries with large Muslim populations, many applicants get one or two chances in a lifetime at the pi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 grimage that every Muslim is supposed to make, and ''some people save money for their whole lives to do it,'' he said. More than half of all pilgrims are over 50. In a normal year, many of those desperate to come before they die are pushed in wheelchairs or carried  around the Kaaba and through the other rituals.\par   The new swine flu vaccine could end all the Saudi worries, but only a few countries have even small amounts available, and the Saudis want anyone with access to it to have the shots at least two weeks before arrival.\par   China has said it will vaccinate all the 12,700 pilgrims planning to make this year's hajj from China. The United States, from which about 15,000 Muslims go to Mecca each year, has not made them a separate vaccine-priority group.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 URL: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 http://www.nytimes.com\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PUBLIC HEALTH ADMINISTRATION (91%); INFLUENZA (91%); HEALTH DEPARTMENTS (90%); INFECTIOUS DISEASE (90%); HAJJ (90%); RELIGIOUS PILGRIMAGES (89%); MUSLIMS & ISLAM (89%); EPIDEMICS (89%); RELIGION (89%); CHRISTIANS & CHRISTIANITY (88%); CATHOLICS & C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 THOLICISM (77%); H1N1 INFLUENZA (77%); WOMEN'S HEALTH (77%); MENINGITIS (76%); MEDICAL & DIAGNOSTIC LABORATORIES (76%); GENES & CHROMOSOMES (76%); PREVENTION & WELLNESS (73%); NEUROLOGICAL DISORDERS & INJURIES (71%); SENIOR CITIZENS (70%); PREGNANCY & CHILDBIRTH (70%); NAVIES (65%); DISEASES & DISORDERS (57%); UNITED NATIONS INSTITUTIONS (52%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD HEALTH ORGANIZATION (55%); CENTERS FOR DISEASE CONTROL & PREVENTION (55%); US NAVY (54%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 POPE BENEDICT XVI (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RIYADH, SAUDI ARABIA (73%); CAIRO, EGYPT (54%); SYDNEY, AUSTRALIA (52%) KASHMIR (79%); NEW SOUTH WALES, AUSTRALIA (79%) SAUDI ARABIA (95%); UNITED STATES (94%); ASIA (79%); YEMEN (79%); NIGERIA (79%); AUSTRALIA (79%); INDONESIA (79%); AFRICA (79%); EGYPT (54%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 October 30, 2009\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHOTO: In Srinagar in Indian Kashmir, Muslim pilgrims recently prepared for the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to Mecca in Saudi Arabia, called the hajj.(PHOTOGRAPH BY FAROOQ KHAN/EUROPEAN PRESSPHOTO AGE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CY)(pg. A12)                                 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2009 The New York Times Company\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Safety Gap The New York Times November 2, 2008 Sunday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_72}{\*\bkmkstart DOC_ID_72_0}{\*\bkmkstart doc_id_17}{\*\bkmkend DOC_ID_72}{\*\bkmkend DOC_ID_72_0}{\*\bkmkend doc_id_17}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_17"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 17 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The New York Times\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  2, 2008 Sunday  \par Late Edition - Final\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 The Safety Gap}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 By GARDINER HARRIS. \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Gardiner Harris, a correspondent in The New York Times's Washington bureau, reports on public health.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Section MM; Column 0; Magazine Desk; Pg. 46\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 5079 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 In the belly of an industrial district south of Lyon, France, just past a sulfurous oil refinery and a synthetic v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nilla plant, sits a run-down, eight-story factory that makes aspirin, the first pharmaceutical blockbuster. The Lyon factory is the last of its kind. No other major facility in Europe or the United States makes generic asp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rin anymore. The market has been taken over by low-cost Chinese producers. Even Bayer, the German company that created aspirin in the 1890s and has fought for more than a century to distinguish its product as the most trustworthy one, now has backup supplies from China. \par   The Lyon plant is owned by a French chemical giant named Rhodia that has been making aspirin since 1908 and still accounts for more than 25 percent of the world's aspirin market. But now a century after its entry into the business, the company intends to quit making aspirin altogether. The plant was last renovated in 1992, and it would need an upgrade to continue operating, an investment the company can no longer just}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fy in what has become a cutthroat business. In fact, Rhodia is closing another factory about 40 miles to the south. This one makes the painkiller acetaminophen, which is found in Tylenol. It, too, is the last such facility in Western Europe.  \par   In some ways, this is a nonevent. European factories close; Chinese ones open. Consumers like their commodities cheap, in the case of aspirin as with everything else. China now produces about two-thirds of all aspirin and is poised to become the world's sole global supplier in the not-too-distant future. But are the Ch}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nese factories safe? Who knows? The U.S. Food and Drug Administration, the European Medicines Agency and other competent government regulators rarely, if ever, inspect them. (By contrast, Rhodia's plant was last inspected by the F.D.A. in July and is routinely inspected by one country or another.) Companies that import Chinese pharmaceutical ingredients, including aspirin, are required to test the supplies before using them, and some send private inspectors to China to ensure that suppliers use adequate controls. No pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 maceutical maker wants its name to become synonymous with disaster, and the vast majority of drugs that are consumed in the United States are safe. But some industry executives told me that price sensitivity in the generics industry makes it more difficult to fully vet their low-cost suppliers.\par   In China, where thousands of drug manufacturers sell products in the local markets, profit margins are razor thin, and counterfeiting and contamination are common. In 2002, the Pharmaceutical Association, a Chinese trade group, estimated that as much as 8 percent of over-the-counter drugs sold in China are counterfeit. Contaminated products extend beyond drugs, as was made tragically clear this fall when four Chinese b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bies died and 53,000 were sickened by melamine, a toxic chemical illegally added to watered-down baby formula to artificially increase the protein count and fool quality tests. \par   Though no melamine-tainted baby formula from China was found in the United States, it has shown up in other countries. This is the latest in a series of food- and drug-safety scandals. China has in recent years exported poisonous toothpaste, deadly dog food, toys made with lead paint and tainted fish. In one infamous example this spring, Chinese manufacturers substituted a cheap fake for the dried pig intestines used to make the drug heparin, which is given to dialysis and surgery patients to prevent blood clotting. As deaths among those taking the drug mounted, the F.D.A. discovered the taint and banned the contaminated drug. In the end, 81 people may have died from allergic reactions, and tens of thousands around the world were e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 posed to danger. F.D.A. officials admitted that the agency should never have approved the Chinese-made heparin for sale in the United States; the agency, it turned out, had never inspected the Chinese plant ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing it. \par   Concerns about Chinese drugs have become so intense that just three weeks ago, the Health and Human Services secretary, Michael O. Leavitt, announced that the F.D.A. would open an office in Beijing by the end of the year and offices in Shanghai and Guangzhou next year. The agency still plans to send inspectors to China from the U.S., but the offices will provide ''an infrastructure that will make those people more effective,'' Leavitt said at the time of the announcement.\par   China's leap to one of the biggest suppliers of pharmaceutical ingredients in the world happened over the last decade, as the Chinese government subsidized the construction of manufacturing plants that have u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dercut prices everywhere. Generic drug makers in the United States, where price competition is fierce, were the first to seek cheaper drug ingredients in China. Last year, generic drug applications to the F.D.A. listed 1,154 plants providing active pharmaceutical ingredients: 43 percent of them were in China, and another 39 percent were in India. Only 13 percent were in the United States. Branded drug makers, with their fatter profit margins, resisted buying ingredients from China for years, but with their businesses now suffering, even m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 jor pharmaceutical companies like AstraZeneca, Bayer, Baxter and Pfizer have announced deals to ou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 source manufacturing to China.\par   I have been writing about the drug industry for more than a decade, but I have rarely written about a subject that both branded and generic drug makers wanted to discuss less. Nearly all of the industry executives who spoke for this article did so anonymously. Even the Generic Pharmaceutical Association, a normally loqu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cious trade group, was largely silent on the issue. Not one of them, it seems, wants to talk too much about the difficulty of regulating factories across several times zones, 6,000 miles and a vast linguistic and cultural divide. \par   The F.D.A. regulates more than $1 trillion worth of consumer goods, which amounts to about 25 cents of every consumer dollar spent in this country. This includes $466 billion in food sales, $275 billion in drugs, $60 billion in cosmetics and $18 billion in vitamin supplements. The agency is responsible for monitoring a third of all imported goods, from eggplant to eyeliner, microwave ovens to monoclonal antibodies, slaughte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 houses to cellphones. But with fewer than 500 import inspectors and computer systems so old that repai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 men must be called out of retirement to fix them, the agency is increasingly beset by a sense of futility. \par   Even the F.D.A.'s staunchest defenders now acknowledge that something is terribly wrong. Among them is Peter Barton Hutt, who served as the agency's general counsel during the Nixon administration and is widely considered the dean of the F.D.A. bar in Washington. I've interviewed Hutt dozens of times over the years, and he has always defended the F.D.A. No more. ''This is a fundamentally broken agency,'' Hutt told me ea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lier this year, ''and it needs to be repaired.''\par   The breakdown is not simply about money. This summer 1,442 people around the country were sickened by tainted tomatoes -- or possibly jalepeno peppers. Such scares have become familiar, and the inability to quickly find the sources of contamination has been one of the agency's signal failures. A 2002 law requires produce processors and distributors to keep track of where food goes and comes from, but the government has yet to mandate standardized record-keeping. As a result, in response to a scare, investigators must pour over a blizzard of contradictory packing slips and incompatible computer programs as they race to save pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple.\par   To ensure the safety of imported drugs, the F.D.A. relies almost entirely on its own inspections of foreign plants. This was not much of a problem 30 years ago, when most medical products consumed in the United States were made here and F.D.A. inspectors could drive around to plants in their district. Most of those plants have since moved abroad, and now decades can pass between inspections. Testifying before Co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gress in April, Dr. Janet Woodcock, director of the F.D.A.'s drug center, spoke with rare frankness about the ability of the agency to do its job abroad. ''The F.D.A. of the last century is not configured to regulate this century's globalized pharmaceutical industry,'' she testified.\par   Other current and former F.D.A. officials I talked to echoed Woodcock's warning. Tim Wells, who was a field investigator and then a compliance officer for 24 years at the F.D.A., now does private audits of drug plants and sees the holes in the agency's safety net. ''A company I recently visited abroad hasn't been inspected for 10 years,'' he told me.\par   Besides being more frequent, domestic inspections are unannounced and more intense. And when inspe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tors find dangerous conditions at domestic plants, they generally return promptly to ensure that those cond}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions get fixed. Not so in foreign plants. In a report released Oct. 22, government auditors reported that b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tween 2002 and 2007, F.D.A. inspectors found dangerous conditions in 15 foreign plants. Only one of those plants was reinspected within two years, the auditors found. In every other case, the agency took foreign managers at their word that promised changes were made.\par   The record is particularly bad in China. Over the past six years, the F.D.A. has managed to inspect annually an average of just 15 of the 714 Chinese drug plants that export to the United States. At its present pace, the F.D.A. would need more than 50 years to visit all of these Chinese plants. By contrast, the F.D.A. inspects domestic drug plants every 2.7 years.\par   Inspectors volunteer for the grueling overseas assignments, and, it turns out, they don't much like traveling to parts of Asia. ''I went to Taiwan once, and after initially spending a night in a very nice hotel, I was tran}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ferred several hours by car to a hotel closer to the plant,'' recalls DeVaughn Edwards, who worked as an F.D.A. inspector for 14 years until he left in 2006. ''The bed consisted of two mattresses on the floor. There was no lock on the door. You had to hope that no one came in. It was dark; there were no amenities, no TV that worked. There was a shared restroom down the hall. It was only one night there, but it was enough to make you not want to revisit the plant or spend too much time there.''\par   When inspectors do go to China, their reports sometimes read like a bureaucratic rendering of Mark Twain's ''Innocents Abroad.'' During a 2001 }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  for example, two F.D.A. inspectors visited a plant that was exporting acetaminophen to the United States. The plant had never been inspected. ''The F.D.A. inspection team was met at the hotel in Wenzhou by representatives from Wenzhou No. 3 Pharmaceutical Factory and . . . tran}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ported by public ferry and then company vehicle to the manufacturing facility on Dong Tou Island off the coast of Wenzhou,'' their report states. ''There is no street address or plot number, and the address of the facility is given only by the county and province.'' \par   Once the team arrived in what seemed like the middle of nowhere, the inspectors learned the drug was b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing manufactured at another plant -- one that once had a similar name but had recently changed it. ''In fact,'' the report continues, ''inspection found that there were initially three separate and independent firms opera}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing under the names Wenzhou No. 1 Pharmaceutical Factory, Wenzhou No. 2 Pharmaceutical Factory and Wenzhou No. 3 Pharmaceutical Factory. The location of Wenzhou No. 1 Pharmaceutical Factory was also determined by the F.D.A. inspection team during the visit to Wenzhou, and it was learned that the firm is o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erating under a new Chinese name; however, the English translation of that name was not available.'' So the two inspectors flew back to the \par   United States -- at taxpayers' expense -- never having inspected a thing.\par   The F.D.A.'s apparent inability to keep names straight is no trivial matter. One reason the agency failed to inspect the Changzhou plant that produced deadly heparin, for instance, was that someone mixed up the facility's name and concluded that the plant had already been inspected. Chinese plant names, a vestige of its once strictly controlled economy, are often very similar, and translations can vary. For instance, there are 57 separate drug master files -- the basic F.D.A. record of a plant's name, location and approved product -- with ''Shanghai'' in the name. Some are obvious repeats, like the ones for ''Shanghai No. 6 Pharmaceutical Factory'' and ''Shanghai Number 6 Pharmaceutical Factory.'' But others could be separate plants. Or maybe not. It's just too hard to tell.\par   Compounding the problem is the F.D.A.'s antiquated technology. Its computer systems are so awful that officials have no way of knowing which names, or which plants, are real. To determine which factories need to be inspected, agency investigators must consult two incompatible databases, one of which lists 3,000 fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 eign drug plants exporting to the United States and the other 6,800. Which number is right? Nobody really knows. Officials have told House investigators that their best guess for the number of foreign drug plants e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 porting to the United States is 2,967, while the Government Accountability Office recently guessed 3,249. Neither can the agency tell in many cases when the plants were last inspected (or, more important, which have never been inspected), where they are located or what products they make. \par   The combined ports of Los Angeles and Long Beach receive about 45 percent of all ship-borne trade that comes to the United States, or some 5.2 million containers a year. When I visited one day in May, giant cranes were unloading and loading more than 30 ships, each bearing about 2,500 containers. Some 40 to 50 of those containers -- a tiny fraction of the total -- were trucked to a gigantic warehouse about a half-mile from the ports. There the F.D.A. and Customs and Border Protection cracked open shipping containers that they considered suspicious and then emptied the containers into a large examination area in front of the bays, arranging the boxes and crates as if they were pathologists lining up organs from an autopsy.\par   Just about every crate I saw contained some kind of food product. One crate came from Indonesia, and its manifest said it contained products with chicken inside. Indonesia plus chicken suggests avian flu to F.D.A. officials. So they decided to take a look. The crate turned out to contain chicken seasoning, but no actual chicken. Still, the cans were sent off for testing. Deeper into the guts of the container were glass jars of sa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bal terasi, a hot sauce. They would probably be sent back because the F.D.A. requires makers of low-acid foods in jars or cans to register with the agency. \par   The labels on high-end olives from Italy were lacking the required nutritional information, so back to Italy they went. Jars of jam made of figs and tangerines indicated they were produced close to Ukraine, so an F.D.A. inspector said that he wanted to sample the product for radioactive fallout from the 1986 Chernobyl disaster.\par   As I wandered through this cornucopia, I realized that I had seen similar products at specialty grocery stores all over New York. My brother is a gourmet chef, and I bet an F.D.A. inspection of his kitchen cabinets would net a sizable seizure of improperly labeled food of suspicious provenance. The F.D.A., after all, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 spects less than 1 percent of all imports.\par   This year, 18.2 million shipments of food, devices, cosmetics and drugs are expected to enter more than 300 U.S. ports; the F.D.A. had 454 investigators in 2007 -- one and a half per port -- to scrutinize them. Theirs is an almost hopeless task, made even more frustrating by the inability of one part of the F.D.A. to share even its most basic information with another. Inspectors in Los Angeles, for instance, have no way of knowing which Chinese drug or device imports really ought to be reviewed because they do not have access to records of F.D.A. plant inspections. If the agents knew, for example, that an F.D.A. inspector had found significant problems at a particular facility, they could be sure to check for the maker's name on a shipping manifest. But they have no way of knowing where to focus their attention. ''Our current nonautomated a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 proach to entry screening cannot continue,'' Woodcock of the F.D.A. told Congress. ''We need to be able to assure that both the product and site of manufacture are acceptable before a drug gets into our country.''\par   I met Yusuf K. Hamied in the lobby of the Waldorf-Astoria Hotel, where he likes to stay when visiting New York City from his home in Mumbai. He greeted me warmly and turned quickly to the matter at hand. ''Let's go eat,'' he said, steering me to a nearby Chinese restaurant where the maitre d' greeted him by name and showed us to a quiet table. \par   Hamied is the chairman and managing director of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  the giant Indian generic drug manufacturer. A small man with thinning white hair and well-tailored suits, Hamied has become something of an international public-health hero. In September 2000, Hamied walked into an international meeting on AIDS and other di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 eases and promised to sell a cocktail of AIDS drugs for about $600 per patient per year, a fraction of the price then being offered by large drug makers. ''Friends,'' he told the crowd, ''I represent the needs and asp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rations of the third world. I represent the capabilities of the third world, and above all I represent an oppo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tunity.'' \par   Until Hamied's announcement, most leaders and even many charitable organizations had dismissed the possibility of treating impoverished Africans and Asians who were infected with H.I.V. Drug combinations that kept the infection at bay cost upward of $15,000 per year, a price even those in rich nations strained to bear. But by defying Western companies that held the patents on the medicines, Hamied, whose offer was later lowered to $350 and then to $80, changed everything. \par   Hamied certainly saved many lives and, in doing so, demonstrated just how cheaply effective drugs could be made. Today, as more and more drug makers are seeking out Chinese and Indian manufacturers, the prices for all kinds of generic drugs have dropped. A result has been lower prices in industrial nations as well as the developing world. The A.A.R.P. announced earlier this year that the prices of 185 widely used generic drugs dropped nearly 10 percent last year while those of the 220 most commonly used brand-name drugs rose 7 percent. \par   If not for the low prices from Chinese and Indian producers, millions of people around the world would likely go untreated. And in the United States, buying generic drugs produced abroad is one way to tamp down the exploding health care costs confronting companies and individuals. But there is a hazard: without proper regulation, some of those drugs could be either ineffective or dangerous. A 2006 study found that more than half of anti-malarial drugs sold in Southeast Asia contained no active ingredients. The World Health Organ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 zation has estimated that as much as 10 percent of pharmaceuticals sold worldwide are counterfeit or co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 taminated. In some poor countries, the share is more than 30 percent. \par   At lunch, Hamied said that his plants are inspected routinely, and he provided an extensive schedule of i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 spections. Indeed, international drug buyers say that getting a few days to audit a }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  facility can be diff}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cult because, as a crucial supplier to dozens of companies across the world, the Indian drug maker hosts a never-ending stream of inspectors and auditors. But like everyone else, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  acquires an increasing share of its drug ingredients from plants in China. ''Yes, I've heard all those stories about problems in Chinese plants,'' Hamied said. But he added that he trusted his Chinese partners.\par   Many international drug buyers said that they are far more comfortable buying from Indian companies than Chinese ones. Language is one reason, but another is that corruption is not as endemic in India. ''We haven't had the problems with the Indians that we've had with the Chinese,'' says William F. Haddad, chairman and chief executive of Biogenerics. ''There's something missing in China, and it has a lot to do with corruption.''\par   But a few weeks after my lunch with Hamied, the U.S. Justice Department announced that it had opened a criminal investigation of Ranbaxy, the largest Indian drug maker, with $390 million in annual sales in the United States. In a motion filed in federal court in Maryland, the Justice Department accused Ranbaxy of ''a pattern of systemic fraudulent conduct,'' including filing fabricated drug data to the F.D.A. and using drug i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gredients from unapproved and uninspected plants. AIDS drugs purchased by the President's Emergency Plan for AIDS Relief were among the medicines implicated, the Justice Department charged. Leaders of a House committee sent the F.D.A. a letter in July saying that court documents showed that the agency's off}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cials knew of the allegations for 18 months but did nothing. In September, the F.D.A. banned imports of more than 30 generic drugs made by Ranbaxy, citing violations that could lead to contamination and allergic rea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions.\par   It was a hot day in June, but Dr. Andrew von Eschenbach, the commissioner of the Food and Drug Admi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 istration, was dressed as usual in a dark suit and tie with a monogrammed white dress shirt. His gold cuff links and the yellow ''Livestrong'' wristband from his ''good friend'' Lance Armstrong were visible. He was clearly excited. \par   I was following von Eschenbach on a visit to the John F. Kennedy airport international mail facility. When I visited the ports of Los Angeles and Long Beach in May, the agency agreed only at the last minute to send along its district director. Now I was getting an unusual ride-along with the agency's commissioner. In the intervening weeks, the agency went from defending its oversight of the nation's drug supply as effective to agreeing that the agency was overwhelmed. The reason for the change? A bipartisan chorus on Capitol Hill had been denouncing the agency's failings -- while at last promising more money.\par   We were herded into ''the cage,'' a 30-foot-by-20-foot area where customs and F.D.A. inspectors do their work. There are two to three F.D.A. inspectors assigned to police the flood of illegal drug shipments among the nearly 1.3 million pieces of foreign mail that flow through J.F.K. every day. Mail workers pull packages from countries that customs has decided are risky and dump them into ''the cage.''\par   Officer James Ng of Customs and Border Protection started the tour by putting a package from China through an X-ray machine. The pictures showed row upon row of vials. ''When it looks like this, it's usually anabolic steroids inside,'' Ng said. He opened the box, put on a pair of half-glasses and took out one of the vials, which was filled with a white crystalline powder. ''It says it's testosterone,'' Ng said and then handed the vial to von Eschenbach.\par   ''It's an incredible example,'' von Eschenbach said, his eyes bright. ''It's a steroid from China, but the label is written in Spanish.'' \par   Customs seizes any steroids and narcotics they find, but they give other drugs to F.D.A. inspectors, who laboriously fill out handwritten forms and send letters to intended recipients. If the recipient swears that the drugs are for his or her own personal use, the F.D.A. often releases the detained package. It takes an hour or two to process each package, ''an obstacle that makes their job functionally impossible,'' according to a 2003 Congressional investigation. Thousands of packages can pile up waiting for F.D.A. review, and the agency often releases packages without any investigation for lack of staff. \par   Even when there are inspectors on the job, they cannot be sure every ingredient in a medicine is safe. The F.D.A. confines nearly all of its regulations and much of its inspection oversight to the active part of most pills, which generally constitutes between 1 percent and 10 percent of a pill's volume. Much of a pill is fillers, binders, coatings, colorants and lubricants that are almost entirely unregulated.\par   The syrup in which cough and fever medicines are delivered has figured in at least eight mass poisonings around the world in the past two decades, with three of the four most recent cases originating in China. Hu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dreds died in Panama in 2006, at least 88 children in Haiti died in 1995 and 1996 and some 30 infants died in India in 1998 -- all from toxic syrup. In 1937, 107 people in the United States died because of similar toxic syrup. In fact, it was this incident that led to the creation of the modern F.D.A. But plants making fillers and other nondrug ingredients of pills and syrups are rarely, if ever, inspected by the F.D.A. or any other regul}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tory agency.\par   Providing money to finance the agency has been an issue through both Democratic and Republican admi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 istrations. The situation grew so dire in the early 1990s that drug makers, alarmed that it was taking up to three years for the F.D.A. to approve new drugs, agreed to pay fees to speed review times. But the comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nies put strict limits on how that fee money could be spent, and Congress went along with these limits. The parts of the agency that are not financed by fees, like the inspectorate and those charged with overseeing the safety of already approved medicines, began to whither. Indeed, the number of personnel financed by Congressional appropriations remained unchanged at the F.D.A. between 1992 and 2007. Since 1990, the volume of U.S. imports has increased by more than 900 percent. \par   Several independent assessments of the F.D.A. have called attention to the agency's poor organization and shortage of funds -- and to the hazard those shortfalls pose to the nation's supply of food and medicinal drugs. A board of scientific advisers to the F.D.A. released a report last year that concluded that nothing less than the lives of U.S. citizens were at stake. \par   In February of this year, the president asked Congress to provide the F.D.A. with $1.77 billion for 2009, which included an increase of $50.7 million over the prior year that was not enough to cover even normal salary increases. Over the ensuing months, von Eschenbach endured withering criticism from Congressional Democrats and Republicans. Repeated scandals involving tainted drugs and food led them to conclude that the F.D.A. needed to conduct far more foreign inspections. House Democrats held more than a dozen hea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ings to highlight the agency's shortcomings and to urge the administration to propose greater expenditures.\par   Eventually, after a bruising interrogation by Representative John D. Dingell, the Michigan Democrat who is the chairman of the Energy and Commerce Committee, von Eschenbach asked Congress in May for $275 million to ensure the safety of imported foods, drugs and medical devices. In June, Leavitt, the Health and Human Services secretary, urged speedy action by Congress, which soon gave the agency an emergency infusion of $150 million for this year and another $150 million for next.\par   This could be the moment to make a difference at the F.D.A. There is strong bipartisan support on Capitol Hill to beef up the agency and prevent another heparin scare. Come January, there will be a new administr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion in Washington, and no matter who wins the presidential election, change is likely: neither Barack Obama nor John McCain is apt to be as philosophically opposed to regulation as the Bush administration has been. Under Bush, the emphasis was on encouraging companies to hire private inspectors, which the F.D.A. has tried to do for some time with little success. That ethos has already changed in Congress. As Representative Joe Barton, the Texas Republican who is the ranking member on the House Energy and Commerce Commi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tee, said recently, when it comes to reforming the agency to increase foreign drug inspections, ''there isn't any daylight between Republicans and Democrats.''\par   Unlike reforming Social Security or health insurance generally, fixing the F.D.A. won't mean allocating enormous sums or necessitate reconceiving the system. It just requires some money and will. There are a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ready legislative changes in the works. Bills now circulating on Capitol Hill would require food, medical- d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vice and drug makers to pay annual registration fees to the F.D.A. Those fees would be used to allow as many inspections of foreign firms as domestic ones.\par   There also seems to be agreement that our regulatory agencies can't rely on China to police its own fact}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ries. The Chinese have lurched between vows of reform and disregard for American concerns about the quality of the country's products. When melamine was first found in Chinese-made pet food, Chinese go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ernment officials denied that the taint originated in their country and then, when that claim was disproved, said melamine would not hurt pets. During the heparin scare, Chinese officials admitted the contamination but insisted it wasn't lethal. Last year, however, the Chinese government executed the former head of the agency entrusted with oversight of food and drug industries. He was found to have approved untested med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cine in exchange for cash. The punishment shocked many at the F.D.A. but also led some to imagine that the Chinese were signaling a broader crackdown on unsafe foods and drugs, a hope that so far remains u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 realized.\par   More inspectors will certainly help, but even regular inspections of Chinese plants cannot ensure safety. Inspectors can be hoodwinked; tests can be fooled. ''No matter how many F.D.A. inspections they do,'' says Senator Sherrod Brown, Democrat of Ohio, ''our safety is still at risk if the pressure continues to cut costs.'' Brown has introduced a bill to require labels disclosing the source country of key drug ingredients. Some lawmakers have gone as far as to suggest a ban on all drugs made with Chinese ingredients, but China has become such a crucial supplier that a ban would lead to the collapse of the U.S. health care system. And our dependence is only growing: when PricewaterhouseCoopers cited the best place for pharmaceutical ou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sourcing in the world in an October report to drug companies, its pick was China. \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 URL: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 http://www.nytimes.com\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (90%); PHARMACEUTICALS INDUSTRY (89%); PHARMACEUTICAL PREPARATION MFG (89%); ANALGESICS (89%); CHEMICALS (89%); CHEMICALS MFG (78%); GENERIC DRUGS (78%); PHARMACEUTICALS ASSOCIATIONS (77%); OVER-THE-COUNTER DRUGS (77%); GENERIC PRODUCTS (76%); US FEDERAL GOVERNMENT (76%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PORT TRADE (73%); COUNTERFEITING (60%); TOXIC & HAZARDOUS SUBSTANCES (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RHODIA SA (56%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325510 PAINT & COATING MANUFACTURING (56%); NAICS325211 PLASTICS M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TERIAL & RESIN MANUFACTURING (56%); NAICS325199 ALL OTHER BASIC ORGANIC CHEMICAL MANUFACTURING (56%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LYON, FRANCE (94%) RHONE-ALPES, FRANCE (92%) CHINA (95%); FRANCE (94%); EUROPE (94%); UNITED STATES (94%); GERMANY (79%); WESTERN EUROPE (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 2, 2008\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 DRAWINGS (DRAWINGS BY MARCOS CHIN) (pg.MM45 and 49)       \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2008 The New York Times Company\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; $10m HIV Drugs Ordered From New Factory Africa News January 28, 2008 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_73}{\*\bkmkstart DOC_ID_73_0}{\*\bkmkstart doc_id_18}{\*\bkmkend DOC_ID_73}{\*\bkmkend DOC_ID_73_0}{\*\bkmkend doc_id_18}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_18"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 18 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 January}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  28, 2008 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par $10m HIV Drugs Ordered From New Factory}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 East African Business Week\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 719 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda's recently commissioned Antiretroviral and anti-malarial drugs plant starts production with a bang as government sets an order for a consignment of ARVs worth Ush17billion ($10US million).\par Uganda's health ministry is raising sh8billion ($4.3 million) and other government departments will fill the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 maining sh9billion ($5.7million) to buy the drugs, a move that is believed will mark a new era in the manag}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment of HIV/AIDS in the country.\par The ministry of health is handling the procurement of ARVs which will be deployed in the national AIDS treatment programme in which up to 100,000 Ugandans are getting free treatment. \par Statistics indicate despite reaching 42% of the population in need of Antiretroviral therapy (ART) in 2005, the number in need of ART continues to grow each year for example; 129,000 in 2007 and projected to 238,000 in 2012 - far outstripping the capacity of the system to respond.\par The case malaria is equally alarming, making the two mentioned diseases the biggest challenge to Uganda's health care system. Uganda spends $70 million on ARVs and malaria drugs every year.\par The first $10 million consignment covers the first quarter of the year, which implies that government will spend $40 million on ARV treatment throughout the year and will enlist more beneficiaries for the drugs.\par Informed observers say that this is more than half the price that government spends on imported drugs to treat a large portion of the population living with HIV/AIDS.For instance, the Public Service Ministry has re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 istered 10,000 civil servants living with HIV/AIDs and are ready fro ART but have not accessed the service yet.\par Emmanuel Katongole the managing director of the plant, last week said that Ugandan ARVs combination for a monthly subscription will be 30% cheaper than the imported drugs. "We want to focus on addressing the problems of scarcity and affordability of drugs. The triple therapy ARVs cocktail for one month cost $15 to the final consumer but with this factory we are going to sell it at $9," Katongole said. "So we are going to expand access to these drugs."\par The plant, which will in the first phase produce two million tablets per day, is a partnership between the Go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ernment, Quality Chemical Industries, a local company, and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  one of the world's leading generic man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 facturers.\par Minister of state for primary health care Dr. Emmanuel Otaala told East African Business Week that the mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 istry would source the money from donors besides the budget allocations.\par Otaala also confirmed that government has introduced a budget line for HIV/AIDS activities.\par Government has previously been importing ARVs from India which are cheaper than original drugs from E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rope's giant pharmaceuticals. However, the Indian drugs are still out of reach to the average Ugandan.\par The situation could worsen in the vent of a WTO agreement banning India from exporting relatively cheap generic ARV drugs to third world countries like Uganda.\par The WTO's Trade Related Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement which India ratified takes effect this year.\par The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  pact however provided a window for developing countries to access technology which can be used to manufacture the generic drugs locally. Uganda was the first African country to acquire this technol}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gy and set up the factory which will provide a regional market as well.\par But market concerns are at the moment taking second seat as the factory concentrates on the task of ne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tralizing disease burden on the Uganda economy.\par Katongole says that the priority of the company is to satisfy government demand, then private sector and the wider regional market.\par He also said that government is obliged to purchase ARVs from company as part of the agreement which preceded the $30 million investment. Katongole said that export to Rwanda and Tanzania will start at the end of this year.\par Katongole also said that the ARV plant was a big move towards self-reliance in supply of drugs breaking out of the york of depending on donor funding for expensive drugs.\par "Most of the drugs we have are from donor funds, what happens when donor funds dry up," he said. In 2006, government was in a crisis of shortage of ARVs after the Global Fund on Aids, Tuberclosis and Malaria which funds 80% the national ARV requirement suspended the grant over mismanagement of funds.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (94%); ANTIVIRALS (93%); AIDS & HIV TREATMENT (92%); PUBLIC HEALTH ADMINISTRATION (90%); MALARIA (90%); ANTI-INFECTIVES (90%); HEALTH DEPARTMENTS (90%); IMPORT TRADE (89%); MANUFACTURING FACILITIES (89%); DISEASES & DISORDERS (78%); PHA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MACEUTICALS INDUSTRY (78%); GENERIC DRUGS (78%); HEALTH CARE POLICY (77%); BUDGETS (77%); HEALTH CARE (75%); CHEMICALS (73%); CHEMICALS MFG (73%); GENERIC PRODUCTS (69%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (51%); SIC2834 PHARMACEUTICAL PREPARATIONS (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UGANDA (97%); INDIA (79%); EUROPE (79%); EASTERN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 January 28, 2008\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2008 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 India patent battle over Tarceva opens new CL front Pharma Marketletter January 15, 2008 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_74}{\*\bkmkstart DOC_ID_74_0}{\*\bkmkstart doc_id_19}{\*\bkmkend DOC_ID_74}{\*\bkmkend DOC_ID_74_0}{\*\bkmkend doc_id_19}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_19"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 19 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Pharma Marketletter\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 January}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  15, 2008 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 India patent battle over Tarceva opens new CL front}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 326 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The latest attempt to claim a compulsory license, adopting a mechanism introduced via the World Trade O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ganization's agreement on Trade-Related Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , has hit Swiss drug major Roche's patent in India for Tarceva (erlotinib). The Indian firm lobbying for the opportunity to manufacture a generic version of the lung cancer drug is Natco Pharma, according to an Internet report by The Hindu's BusinessLine. The copycat drug would be exported to Nepal, the company said. If the application is succes}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ful, Roche would be entitled to royalties in compensation. \par Tarceva's patent is also under fire from another Indian generics firm, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , which has filed court papers claiming that Roche's patent is invalid. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is also reported to be planning to launch its version of erlotinib. Roche has confirmed it is contesting the Natco move and is expected to announce a law suit against }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  in the event the latter launches a generic version of the oncology agent.\par Under a mechanism approved under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, a compulsory license can be issued in a case where a less-developed country lacks the infrastructure to produce a drug locally and where there would otherwise be grounds for a local patent grab by the government. Commentators in India queried Natco's d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cision to apply for the license as an export-only deal, but the relative povery of Nepal versus India means that the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  mechanism would take longer to implement, Natco said.\par The first instance of a compulsory license issued in one country for the benefit of another was taken by the Canadian Intellectual Property Office, which granted permission to Apotex, Canada's leading generic dru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 maker, to manufacture and deliver 260,000 packs of Apo-Triavir, a fixed-dose combination of three drugs under patents held by UK-based drugmakers GlaxoSmithKline and Shire and Germany's Boehringer Inge}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 heim, at cost to Rwanda's health authorities (Marketletter October 8, 2007).\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICALS INDUSTRY (90%); PHARMACEUTICAL DRUG & DEVICES LITIGATION (90%); GENERIC DRUGS (90%); PATENT LAW (90%); INTELLECTUAL PROPERTY (90%); PATENTS (90%); TRADE TREATIES & AGREEMENTS (90%); PHARMACEUTICAL PREPARATION MFG (89%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TELLECTUAL PROPERTY LAW (89%); HEALTH DEPARTMENTS (78%); LICENSES & PERMITS (78%); ROYALTIES (78%); CANCER (77%); LOBBYING (77%); CANCER DRUGS (77%); GENERIC PRODUCTS (76%); SUITS & CLAIMS (73%); PATENT INVALIDATION & REVOCATION (72%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TRIES (72%); ONCOLOGY (71%); LUNG CANCER (71%); LITIGATION (69%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ROCHE HOLDING AG (92%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (92%); NATCO PHARMA LTD (90%); GLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 X}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 OSMITHKLINE PLC (58%); BOEHRINGER INGELHEIM GMBH (53%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANIZATION (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ROG (SWX) (92%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (92%); NATCOPHARM (NSE) (90%); GSK (NYSE) (58%); GSK (LSE) (58%); BIOC (EGX) (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (92%); SIC2834 PHARMACEUTICAL PREPARATIONS (92%); NAICS325413 IN-VITRO DIAGNOSTIC SUBSTANCE MA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UFACTURING (92%); SIC5122 DRUGS, DRUG PROPRIETARIES, & DRUGGISTS' SUNDRIES (53%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 INDIA (95%); NEPAL (92%); CANADA (92%); RWANDA (79%); GERMANY (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 January 15, 2008\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2008 Marketletter Publications Ltd.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda joint venture with Indian Rx firm Pharma Marketletter November 30, 2007 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_75}{\*\bkmkstart DOC_ID_75_0}{\*\bkmkstart doc_id_20}{\*\bkmkend DOC_ID_75}{\*\bkmkend DOC_ID_75_0}{\*\bkmkend doc_id_20}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_20"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 20 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Pharma Marketletter\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  30, 2007 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda joint venture with Indian Rx firm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 264 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Details have emerged of a joint HIV/AIDS drugs venture between Indian generic firm }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Uganda's Quality Chemical Industries (Marketletter October 15). A site has been selected near Kampala, Uganda, for the construction of a plant for the local production of triommune, a triple fixed-dose combination antiretroviral (lamivudine, stavudine and nevirapine). The QCI/}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  facility will eventually make 1.8 billion tablets of the medication per year. \par The India-based newspaper, the Mangalorean, reports that "India has been the world's leading producer of generic [ARV] drugs because it was one of the few drug-producing countries that did not obey regulations on patenting." Yasin Masani, director of the Kampala-based Astra Pharma, a drug and surgical products impor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er, told the Mangalorean that "once Indian drugs started to come to Africa, around 1988-89, there was a near revolution." He added that the price of HIV/AIDS therapies fell from about $3,500 to $350-$400.\par However, restrictions on the export of licensed drugs under the World Trade Organization's Trade-Related aspects of Intellectual Property rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs;}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Marketletters passim) have meant that Indian generic comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nies have been forced to adopt different strategies to supply drugs to countries such as Uganda, where the government "is committed to providing free ARVs for all those who need them," said QCI's managing dire}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tor, Emmanuel Katongole. He added that "for us, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is a window of opportunity. India has ratified the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, so it ceases to be a source of generic [HIV/AIDS] drugs for Africa."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV TREATMENT (92%); ANTIVIRALS (92%); PHARMACEUTICALS INDUSTRY (90%); AIDS & HIV (90%); GENERIC PRODUCTS (90%); CHEMICALS (78%); INTELLECTUAL PROPERTY (78%); JOINT VENTURES (78%); CHEMICALS MFG (78%); GENERIC DRUGS (78%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CAL PREPARATION MFG (76%); IMPORT TRADE (75%); INTELLECTUAL PROPERTY LAW (74%); E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 X}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PORT TRADE (74%); PATENTS (69%); EXPORT CONTROLS (69%); PLANT CONSTRUCTION (57%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (92%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANIZATION (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (92%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (92%); SIC2834 PHARMACEUTICAL PREPARATIONS (92%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 KAMPALA, UGANDA (93%) UGANDA (94%); INDIA (93%); AFRICA (92%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 30, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 Marketletter Publications Ltd.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; New Factory to Improve Access to Arvs Africa News October 24, 2007 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_76}{\*\bkmkstart DOC_ID_76_0}{\*\bkmkstart doc_id_21}{\*\bkmkend DOC_ID_76}{\*\bkmkend DOC_ID_76_0}{\*\bkmkend doc_id_21}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_21"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 21 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  24, 2007 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par New Factory to Improve Access to Arvs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 753 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Once the factory is completed, two million tablets will be manufactured in a single day's shift, improving not just availability but affordability of the drugs as well\par Uganda is set to be the first African country to manufacture and produce the full range of Anti-Retrovirals by the end of this year. The fete will be achieved following a partnership between Quality Chemicals Ltd (QCI) and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd of India.\par The production of the drugs could not have come at a better time. The chairperson of the Uganda Aids Commission Dr Kihumuro Apuuli raised concern over the emergence of new infections every year which could put a huge burden on finding treatment. Already, Uganda cannot meet the demand of ARVs. \par According to ministry of health official data, only 100,000 people are able to access ARVs out of the 300,000 that require them. The picture is not any different among the children, only 50,000 are on ARV treatment out of the 110,000. \par The situation is however expected to improve once drugs start rolling out of the Luzira-based $36m factory. According to Emmanuel Katongole, QCI's managing director, two million tablets will be manufactured in a single day's shift. "That is enough to cater for Uganda and the region. Therefore there is an export opportun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty," Mr Katongole said recently.\par However, it would defeat the purpose if the production of the drugs within the country does not result into affordability. Considering that the cost of production for the drugs will be lower than those imported, Mr Katongle said the prices of the drugs will be affordable to the ordinary Ugandan. President Museveni, while inaugurating the factory pledged that the government would buy the drugs from the manufacturers provided the quality is competitive. In turn, the government will avail the drugs to those in need.\par Dr Sam Zaramba, the director general for health services said that the time lag to procure the drugs will si}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nificantly shorten once production starts at the Luzira-based industry. "We shall not have to wait for shi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment," Dr Zaramba said. Shipping of the drugs usually takes close to six months, which according to Dr Z}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ramba can cause problems in case of a shortage as patients cannot go a day without taking the drugs. Uganda has experienced a shortage in the past.\par According to Mr George Baguma, QCI's Director for Marketing, the $36m project was borne of the need to address distortions imposed by India's ratification of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement of the World Trade Organisation (WTO). "The move threatened to deny Africa access to affordable medicines. Indeed the WTO recognised the predicament that this agreement would impose on the poor countries and consequently exempted the Least Developed Nations from implementation of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  accord and encouraged developed countries to transfer technology to LDCs to enable them mitigate a sure catastrophe."\par That is how the manufacturers ended up in Uganda. Dr Zaramba said with the manufacturers within the country, it will make the government's work of monitoring much easier. Uganda's market usually gets flooded with fake drugs especially anti-malarials mainly from India.\par The decline in prices means that more people will be able to access the drugs, which in turn will mean that Uganda will move closer to achieving the United Nations' Millennium goal of increasing access to ARVs and reducing deaths from malaria by 2015. QCI is to also manufacture anti-malarial drugs.\par Malaria is one of the leading causes of death, claiming 320 people in Uganda every day according to the Ministry of Health. That is the number registered at the various health centres, only God knows how many others die without getting to the centres. That figure is expected to reduce with the production of anti-malarial drugs.\par Uganda has also occasionally been hit by a shortage in the supply of ARVs. But with the manufacturers in Luzira, Dr Zaramba said that may not happen again. "The process is a long one which has to be done 2-3 months in advance," he said.\par Mr Baguma said the plant in Luzira will make Uganda self sufficient. "Our aim is to apply the discoveries of pharmaceutical sciences to improve the quality of life of our people. Our commitment is our living strength and its promise for the future," he said.\par The availability of ARVs should however not blur the population to the extent of the HIV scourge. Much as the drugs will be available, behavioural change should also be encouraged, observed Mr Elioda Tu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 wesigye, chairperson of the Parliamentary Committee on HIV/Aids.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 DEVELOPING COUNTRIES (89%); ANTIVIRALS (78%); HEALTH DEPARTMENTS (78%); AIDS & HIV (78%); MANUFACTURING FACILITIES (78%); HEALTH CARE ACCESS (78%); EMERGING MARKETS (77%); TRADE DEVELOPMENT (76%); IMPORT TRADE (74%); DRUG PRICES (73%); CHE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ICALS (72%); PUBLIC HEALTH ADMINISTRATION (70%); EXPORT TRADE (70%); INTERNATIONAL ECONOMIC ORGANIZATIONS (60%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (83%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (83%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (83%); SIC2834 PHARMACEUTICAL PREPARATIONS (83%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UGANDA (94%); INDIA (93%); AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 October 23, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa; Daily HIV/Aids Report Africa News October 9, 2007 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_77}{\*\bkmkstart DOC_ID_77_0}{\*\bkmkstart doc_id_22}{\*\bkmkend DOC_ID_77}{\*\bkmkend DOC_ID_77_0}{\*\bkmkend doc_id_22}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_22"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 22 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  9, 2007 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Africa; \par Daily HIV/Aids Report}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Kaisernetwork.org\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 3231 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Politics and Policy\par Ministers, Medical Professionals, Lawmakers Gather for Meeting To Discuss HIV/AIDS Issues in Black Community\par [Oct 09, 2007]\par Dozens of ministers from across the country on Monday in New York City gathered with representatives from the National Medical Association, the Congressional Black Caucus and other groups to develop a plan for addressing HIV/AIDS in the black community, USA Today reports.\par During the two-day meeting, convened by the National Black Leadership Commission on AIDS, participants will discuss recommendations from NMA -- which includes about 30,000 black doctors and in August d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 clared HIV/AIDS among blacks a public health emergency -- for fighting the epidemic in the U.S. The confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ence also aims to educate pastors about how they can combat HIV/AIDS in their communities, such as providing information about the disease and building relationships with social service agencies that can a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sist members living with the disease. Bishop T.D. Jakes of the Dallas-based Potter's House church, who is co-chairing the meeting, said the conference also will demonstrate to 2008 presidential candidates the i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 portance of reaching out to black congregations and supporting HIV/AIDS research and education. \par Comments \par Jakes -- whose church has more than 30,000 members -- said, "We can hold our politicians accountable," adding, "Now is the time for the church to give a clarion call to government that this is one of the issues high on our radar screen." The Rev. Calvin Butts -- senior pastor of the Abyssinian Baptist Church, who is co-chairing the meeting -- said, "Since the movement of the [1960s], we haven't seen a gathering of African-American clergy persons like this around a specific issue," adding, "At that time, it was civil rights and human rights. Now it's a major health crisis which is impacting our community." Butts also said that for "25 years we've been dealing with this crisis, ... but I don't think there's been enough attention paid to it, and I think our efforts have not had the power that they can have because we have not come together as we are doing now."\par NBLCA President Debra Fraser-Howze said, "We have a time bomb on our hands," adding, "I think that the black church will openly admit that they have not done enough in regard to HIV and AIDS. ... This is the time for them to come together to use their collective influence to make a national statement on what needs to happen." According to CDC estimates from 2005, blacks made up about 13% of the U.S. population but a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 counted for 49% of new AIDS diagnoses (Jones, USA Today, 10/8).\par Link to this story.\par Drug Access\par Ugandan President Museveni Commissions Pharmaceutical Plant That Will Produce Antiretrovirals, Antim}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 larials\par [Oct 09, 2007]\par Ugandan President Yoweri Museveni on Monday commissioned a 15-acre pharmaceutical plant in the cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 try that will produce a triple-therapy combination antiretroviral drug, as well as first-line malaria treatments, the New Vision/AllAfrica.com reports. According to New Vision/AllAfrica.com, other African countries -- such as Egypt, Nigeria and South Africa -- have factories that manufacture antiretrovirals but none produces co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bination therapies (Wendo, New Vision/AllAfrica.com, 10/5).\par The new factory, the first of its kind in Uganda, aims to lower the cost of antiretrovirals by reducing import expenses, BBC News reports. Ugandan pharmaceutical importer Quality Chemical Industries and the Indian pharmaceutical company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  will produce the medications (BBC News, 10/8). The factory will manufacture the antiretroviral combination therapy Triomune, which contains lamivudine, stavudine and nevirapine. In addition, the factory will produce the first-line antimalarial combination treatment Lumartem, which contains artemisinin and lumefantrin.\par According to Emmanuel Katongole, managing director of Quality Chemical Industries, the factory on Monday began trial runs to ensure that factory equipment measures ingredients accurately and produces pills that are uniform in size and concentration. The trial runs are expected to last until November or December, and the factory "should be in position to manufacture for the market" in January 2008, Katongole said.\par Katongole added that the factory initially will produce about two million antiretroviral and antimalarial pills da}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly, which will later increase to six million daily, or 1.8 billion pills annually. The Ugandan government will be the first client to purchase medications from the factory. About 80,000 of the estimated 150,000 to 300,000 Ugandans in need of antiretrovirals currently receive them, Katongole said, adding that the new factory "should enable [the] government to double that number."\par The factory will export antiretrovirals to neighboring countries after the Ugandan government has purchased its supply. The countries likely will begin to purchase antiretrovirals from the factory beginning in January, Katongole said.\par According to New Vision/AllAfrica.com, African countries beginning in January 2008 will no longer be able to import generic antiretrovirals from India, which has been Uganda's main source of generic antiretrovirals, because of a change in the India's patent laws (New Vision/AllAfrica.com, 10/5).\par Comments\par Leonard Okello of ActionAID International said, "The challenge is to make sure that the production is fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lowed by a good distribution system that makes sure that the drug can reach all corners of the country" (BBC News, 10/8). Jesse Kajimba, Uganda's senior presidential adviser on HIV/AIDS, said that producing a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tiretrovirals locally could give the country greater independence in determining its supply and ensuring quality control.\par Peter Mugyenyi, director of the Joint Clinical Research Centre, added that although local production is the best way to guarantee the availability of antiretrovirals, the factory should aim to produce new antiretroviral combination therapies, such as Atripla (New Vision/AllAfrica.com, 10/5).\par Link to this story.\par WTO Receives Notification From Canada Authorizing Generic Drug Company To Produce Combination A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tiretroviral for Rwanda\par [Oct 09, 2007]\par The World Trade Organization on Friday announced it had received notification from the Canadian Intelle}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tual Property Office authorizing Toronto-based generic drug company Apotex to manufacture its fixed-dose combination antiretroviral drug Apo-triAvir for Rwanda, Toronto's Globe and Mail reports (Gandhi, Globe and Mail, 10/6). According to WTO, Apo-triAvir now can be manufactured and exported to Rwanda (Higgins, A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sociated Press, 10/5).\par GlaxoSmithKline in August announced that it had given consent to Apotex to use two of GSK's patented a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tiretroviral drugs, lamivudine and zidovudine, to manufacture Apo-triAvir -- a combination of lamivudine, z}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dovudine and nevirapine. Boehringer Ingelheim agreed in July to allow Apotex to use nevirapine in the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bination.\par WTO in July in a statement announced that Rwanda plans to override the pharmaceutical patents and import 260,000 packs of Apo-triAvir. Under an August 2003 waiver to WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights, known as the "paragraph 6 system," developing countries with a public health crisis are allowed to import generic drugs when they cannot manufacture the drugs themselves. According to WTO, Rwanda is the first country to use the waiver, which would allow it to import generic drugs that are manufactured under compulsory licenses in other countries. The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  waiver submission was made last month by the Treatment and Research AIDS Centre. Rwanda plans to import the 260,000 packets during the next two years (Kaiser Daily HIV/AIDS Report, 8/10).\par Reaction\par Elie Betito, director of public and government affairs for Apotex, said the company is "in the final processes of the development of [Apo-triAvir] now, so we should be in the production stages soon." He added, "If ever}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 thing goes as planned, by mid-December we should have product flowing to Africa."\par According to the Globe and Mail, some HIV/AIDS advocates said the Canadian law that allows authorization of generic drug production needs to be changed if it is going to help other countries in need of generic a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tiretrovirals. "Even though we have the first compulsory license issued, that doesn't mean somehow that there's no problem with the legislation," Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, said, adding, "It took nearly three years to get to this point." It is "unlikely that Apotex, or any gene}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ic manufacturer, will want to go through this process again," Elliott said (Globe and Mail, 10/6).\par Link to this story.\par Media & Society\par Congo Television Pilot Featuring HIV/AIDS Stories in Local Language To Air\par [Oct 09, 2007]\par The first episode of "My Story" -- a television series inspired by people living with HIV/AIDS in the Democratic Republic of Congo -- is scheduled to air this month on Congolese television stations in Lingala, the most common local language, Inter Press Service reports. The series director, Djo Tunda Wa Munga, a Cong}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lese filmmaker who trained at Institut National Superieur des Arts du Spectacle in Brussels, Belgium, said another local program inspired him to create the series. "I was very surprised to see AIDS patients come openly and with uncovered faces to speak of the illness on television," Wa Munga said.\par At the end of 2006, he contacted the people from the show that inspired him and used experiences from their lives to create a fictional series. The pilot, "Papy," is based on the story of Papy Ilunga, a police officer who was rejected by his family after he told them he was HIV-positive. The episode was filmed in Kinshasa, DRC, and professional actors play the characters. "The foundation of reality is very important to my approach. From this, I try to establish story lines," Wa Munga said. According to Inter Press Service, the first episode tries to convey that HIV-positive people need the support of their families to fight the disease.\par Several organizations and governments -- including the International Organisation of La Francophonie, the King Baudouin Foundation, Belgium and Germany -- contributed financially to the filming of "Papy." Wa Munga's project also has the support of UNAIDS Director Peter Piot, Inter Press Service reports. KBF and Belgium gave about $71,000, according to Inter Press Service.\par Gerrit Rauws, health affairs director at KBF, said the foundation had two goals in supporting the series -- "helping a Congolese cinematic project [and] an ambitious project to fight HIV/AIDS." Sabine Ruppol, a tec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nical counselor for Belgian governmental aid, called the film a "strong signal," adding that "each Congolese can recognize themselves in it, and that's proof of success."\par The series is the first HIV/AIDS-related television program to air in Lingala. The pilot also will air on TV5 Monde and will appear at film festivals, including the Fortnight of Francophone Cinema, which begins Friday in Paris. According to UNAIDS data from 2005, there are about one million people living with HIV/AIDS in DRC, including approximately 100,000 children (Walschaerts, Inter Press Service, 10/5).\par A preview of the production can be seen on YouTube.\par Link to this story.\par Science & Medicine\par Philadelphia Inquirer Examines Effect of Merck's Failed International HIV Vaccine Trial on Research and D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 velopment\par [Oct 09, 2007]\par Merck's decision last month to halt its international HIV vaccine trial was not a "definitive blow" to HIV va}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cine research and development, but it created questions about whether research was "careening down the wrong path," the Philadelphia Inquirer reports (Stark, Philadelphia Inquirer, 10/7). Merck announced that it had ended its Phase II trial, which began in late 2004 and involved 3,000 HIV-negative volunteers, after its experimental vaccine failed to prevent HIV infection in participants or prove effective in delaying the progre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sion of the virus to AIDS. The trial was stopped by the Data and Safety Monitoring Board, an independent overseer.\par Some researchers have theorized that because HIV-positive people who have stronger T-cell responses tend to fight the virus better, a vaccine that simulated a T-cell response might be able to control HIV/AIDS. The Merck vaccine was made from a weakened version of a common cold virus that served as a mode for providing three synthetically produced genes from HIV, known as gag, pol and nef (Kaiser Daily HIV/AIDS Report, 9/24). According to Mark Feinberg, Merck's vice president for Medical Affairs for Vaccines and Infe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tious Diseases, an estimated 90% of vaccine studies were using major elements of Merck's experimental vaccine.\par Some researchers said the trial might prove useful for researchers. "The information is going to help us d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 velop a vaccine in the future," Ian Frank -- director of the HIV Vaccine Trials Unit at the University of Pen}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sylvania, which enrolled 125 people in Merck's trial -- said, adding, "I don't think people should be overly di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 appointed. We're really at the very earliest stages in this process." Gary Nabel, director of NIH's Vaccine R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 search Center, said, "To paraphrase some of my colleagues, the trial shows a failure of a specific product but not a failure of a concept," adding that it would be "truly remarkable" to see an effective vaccine developed in the next 10 years.\par John Shiver, head of Merck's basic research in vaccines, said he believes that no current approaches toward HIV vaccine development are working and that a new approach is needed. The world is spending $759 mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lion annually on HIV vaccine development, up from $150 million annually in the 1990s, Seth Berkley, pres}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dent of the International AIDS Vaccine Initiative, said. More than 90% of the funding is coming from gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ments, the Inquirer reports (Philadelphia Inquirer, 10/7).\par Related Editorial\par The halt of Merck's HIV vaccine trial is "not the death of the quest; it's an opportunity to bend more strength to it," an Inquirer editorial says. Because of previous research that did not yield an effective HIV vaccine, we know much more about how the "fiendishly well-armed retrovirus associated with AIDS operates," according to the editorial. The Inquirer adds "our failures guide us to our successes" and "failures should spur funders not only to keep backing research and development, but also to step it up." This "quest will need friends in society and government," that is, "if we really care," the editorial concludes (Philadelphia Inquirer, 10/6).\par Link to this story.\par Public Health & Education\par Peace Corps Volunteers To Begin Work on HIV/AIDS Projects in Ethiopia\par [Oct 09, 2007]\par Forty-three Peace Corps volunteers this weekend will begin two-year posts in Ethiopia that will focus on HIV/AIDS-related education and awareness projects, the organization announced last week, the AP/Minneapolis Star Tribune reports. The group of volunteers is the first that Peace Corps has stationed in Ethiopia since 1999, when the organization halted programs during a border war between the country and neighboring Eritrea, the AP/Tribune reports.\par The agency's programs will include working directly with Ethiopia's health ministry on HIV/AIDS programs in western and northern areas of the country, the AP/Star Tribune reports (AP/Minneapolis Star Tribune, 10/4). About 1.4% of Ethiopians ages 15 to 49, or one million people, are HIV-positive, according to the Ethiopia Demographic and Health Survey 2005, which was released in September 2006 (Kaiser Daily HIV/AIDS R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 port, 9/21/06).\par Henry McKoy, Africa director for the Peace Corps, on Wednesday said the organization has been preparing to launch programs in Ethiopia for two years. He added that the new programs will give the Peace Corps a "chance to renew our partnership, to build strong ties" with Ethiopia. The agency plans to have 100 volu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 teers in Ethiopia within one year.\par More than one-third of all Peace Corps volunteers, or about 2,800 volunteers, work in 25 African countries. McKoy said the Peace Corps' return to Ethiopia will not be affected by a bill (HR 2003) that would require the Ethiopian government to improve its human rights record or risk losing U.S. assistance (AP/Minneapolis Star Tribune, 10/4). The House last week by voice vote passed the bill, and it has been referred to the Senate Foreign Relations Committee (HR 2003 bill history, 10/5).\par Link to this story. \par Opinion\par Fight Against HIV/AIDS 'Far From Over,' Should Focus on Prevention, Testing, Opinion Piece Says\par [Oct 09, 2007]\par The fight against HIV/AIDS is "far from over," and the "only way to reverse the spread of" the virus is to "f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cus on prevention," Richard Holbrooke, president of the Global Business Coalition on HIV/AIDS, Tubercul}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sis and Malaria, writes in a Washington Post opinion piece. It is "heartening" that more than two million pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple living with HIV have access to antiretroviral drugs, Holbrooke writes, adding that "real progress must be measured by the only criterion that ultimately matters: Is the number of people who are HIV-positive decli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing? The answer is a resounding no."\par According to Holbrooke, HIV prevention methods need "immediate emphasis and far, far more resources." He adds that a "viable prevention strategy" should include HIV education and counseling, access to no-cost condoms, efforts to empower women, increased male circumcision efforts and abstinence programs. Ho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ever, "none of this will work without widespread testing," Holbrooke writes, adding that "[i]n no other medical epidemic in history has detection been such a low priority." Holbrooke writes that during the 19th annual World AIDS Day -- Dec. 1 -- the international health community should admit that it is "still losing" the fight against HIV/AIDS and "[a]dvocate strategies that emphasize prevention and detection, based on the su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cessful 'opt-out' testing system." He concludes, "If current policies are not changed, we will face uncontroll}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ble growth in the costs of" treating a preventable disease (Holbrooke, Washington Post, 10/9).\par Link to this story.\par African Countries Should 'Find Resolve' To Issue Compulsory Licenses 'When They See Fit,' Opinion Piece Says\par [Oct 09, 2007]\par African countries should "find the resolve to follow Thailand's example" and issue compulsory licenses to produce reduced-cost versions of patented antiretroviral drugs "when they see fit," Lara Santoro, who worked as a journalist in Africa from 1997 to 2004, writes in a Los Angeles Times opinion piece (Santoro, Los Ang}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 les Times, 10/9).\par The Thai government in November 2006 and January issued compulsory licenses to produce lower-cost ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sions of Merck's antiretroviral Efavirenz and Abbott Laboratories' antiretroviral Kaletra, respectively. Since then, the government and drug companies have continued negotiations (Kaiser Daily HIV/AIDS Report, 5/16). Santoro writes that "contrary to common perception, Thailand's move was, and remains, in perfect observance of international law." Some countries -- including Kenya, Uganda and South Africa -- "have not only the manufacturing base needed to copy and reproduce drugs for a fraction of their costs, they also have the right" to do so, Santoro writes. She adds that African countries should grant compulsory licenses b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause by doing so, "they would put an end to a drug monopoly whose human cost brings shame to us all" (Los Angeles Times, 10/9).\par Link to this story.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (94%); RACE & RACISM (90%); LEGISLATORS (90%); CONFERENCES & CO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 VENTIONS (90%); DISEASES & DISORDERS (90%); TALKS & MEETINGS (90%); CLERGY & RELIGIOUS (89%); CHRISTIANS & CHRISTIANITY (88%); AIDS POLICY (79%); POLITICAL CANDIDATES (79%); CAUCUSES (79%); AIDS & HIV TREATMENT (78%); AFRICAN AMERICANS (78%); BUSINESS & PR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 FESSIONAL ASSOCIATIONS (78%); PROTESTANTS & PROTESTANTISM (78%); EPIDEMICS (78%); PRESIDENTIAL ELECTIONS (77%); PUBLIC HEALTH ADMINISTRATION (75%); RELIGION (74%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NATIONAL MEDICAL ASSOCIATION (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW YORK, NY, USA (88%); DALLAS, TX, USA (79%) NEW YORK, USA (92%); TEXAS, USA (79%) UNITED STATES (95%); UGANDA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 October 9, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda begins making triple therapy AIDS drug BBC Monitoring Africa - PoliticalSupplied by BBC Worldwide Monitoring October 8, 2007 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_78}{\*\bkmkstart DOC_ID_78_0}{\*\bkmkstart doc_id_23}{\*\bkmkend DOC_ID_78}{\*\bkmkend DOC_ID_78_0}{\*\bkmkend doc_id_23}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_23"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 23 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BBC Monitoring Africa - Political\par Supplied by BBC Worldwide Monitoring\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  8, 2007 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda begins making triple therapy AIDS drug}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 953 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Text of report by Charles Wendo entitled "Uganda: Country now makes ARVs" published by Ugandan new}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 paper The New Vision website on 6 October\par A year ago it was a potato garden. Now the 15-acre plot is hosting a hi-tech pharmaceutical factory, the first of its kind in Africa. The factory, to be commissioned by President Yoweri Museveni on Monday [8 October], will produce the full triple therapy combination of anti-retroviral (ARV) drugs, something that has not been done in Africa before. "South Africa has a plant for producing ARVs but they do not do triple therapy comb}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nations," said Emmanuel Katongole, Managing Director Quality Chemical Industries (QCI).\par Likewise, a few African countries like Egypt and Nigeria have ARV factories, but none of them produces the full range of three drugs required for treatment of HIV/AIDS. \par The new factory, located adjacent to Luzira Women's Prison, is a joint venture between QCI and the Indian pharmaceutical }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  It will produce Triomune, a combination that contains lamivudine, stavudine and nev}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rapine. Out of 80,000 people on ARVs in Uganda, three quarters are taking Triomune.\par The factory will also produce the first-line anti-malarial combination Lumartem, containing artemisinin and lumefantrin. This is equivalent to Coartem, which the government now uses as the first-line anti-malarial drug.\par Katongole said they would begin trial runs on Monday soon after the president commissions the plant. The trial runs, technically referred to as validation, are likely to go on till November or December. The validation will help to ensure that the machines measure the ingredients accurately, mix in the right proportions and produce pills that are perfectly uniform in size and concentration. "By January, we should be in position to manufacture for the market," said Katongole.\par This will come just in time to save Uganda from a new law which will stop India from exporting cheaper ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sions of anti-retroviral drugs, commonly known as generics. India has been Uganda's main source of generic ARVs, which are far cheaper than those manufactured by the companies that invented these drugs in E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rope and USA.\par Since the late 1990s Indian companies have been able to produce and sell generic drugs without the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sent of the patent holders in Europe and USA. However, having ratified the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  [Trade-Related Aspects of Intellectual Property Rights] agreement of the World Trade Organization, India will ban the exportation of g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neric drugs by the end of this year.\par According to Katongole, the factory will initially produce two million pills a day, but this will eventually i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 crease to six million. This means in future it can produce 1.8 billion pills a year. This number includes ARVs and anti-malaria pills. "Our first client is going to be the government, which is committed to providing free ARVs for all those who need it," said Katongole. "There are between 150,000 and 300,000 Ugandans who need ARV treatment now. At the moment 80,000 of these are taking ARVs, and this factory should enable government to double that number," he added.\par The surplus will be exported to neighbouring countries. These countries are likely to turn to Uganda because effective January 2008, they will not be able to import from India, which has been the biggest supplier of g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neric ARVs to Africa. "For us }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is a window of opportunity," said Katongole. "India has ratified the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement so it ceases to be a source of generic drugs for Africa."\par The Government donated 15 acres of land on which the factory has been constructed, and President Mus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 veni has been closely monitoring the progress. "The Government has been very supportive, especially the President. Every month he has been calling to check on the progress. He has also called us several times to State House for meetings," said Katongole.\par The Senior Presidential Adviser on HIV/AIDS, Dr Jesse Kajimba, said local production of ARVs would lead to more independence in terms of guaranteeing supply and quality control. "We have been having ARVs an}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 way, but having the capacity to produce it locally is a starting point for other things. The President is thinking beyond simply making ARVs available," Kajimba said.\par Dr Peter Mugyenyi, Director of the Joint Clinical Research Centre, said local production was the best way to guarantee availability of ARVs in Africa. "We are very excited to have a factory that produces ARVs in our country," said Mugyenyi, one of the pioneers in prescribing ARVs in Uganda. "Our people were dying b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause we had to go and beg others."\par Mugyenyi, however, cautioned that the pharmaceutical should not rely too much on Triomune. He said the factory should move quickly to start producing newer combinations such as Atripla, which contains Tenofovir, Efavirenz and FTC.\par The new factory will manufacture the anti-malarial drug Lumartem, Lumartem, containing artemisinin and lumefantrin, at a cost of $2.4 per dose. The equivalent, Cortem, is produced at a cost of $12 per dose.\par The factory will buy the plant artemisia from farmers in Kabale for making the antimalarial drug. "Uganda, especially Kabale, has been found to have one of the best soils for to grow Artemisia. Now there is a comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ny that has started large-scale growing of Artemisia in Kabale. There are over 10,000 hectares of Artemisia," said Emmanuel Katongole, managing director Quality Chemical Industries. He added, "We are going to buy artemnisia from them and take it to India for extraction of the active artemisinin. In the long run we are going to negotiate with government to support us so that in the long run we can do the extraction here instead of taking it to India."\par Source: The New Vision website, Kampala, in English 6 Oct 07\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ANTIVIRALS (91%); AIDS & HIV (91%); AIDS & HIV TREATMENT (91%); MALARIA (90%); GENERIC DRUGS (89%); PRESCRIPTION DRUGS (89%); ANTI-INFECTIVES (77%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CALS INDUSTRY (77%); PHARMACEUTICAL PREPARATION MFG (77%); MANUFACTURING FACIL}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TIES (77%); INTELLECTUAL PROPERTY (77%); EXPORT TRADE (74%); CHEMICALS (70%); CHEM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CALS MFG (70%); PATENT LAW (67%); JOINT VENTURES (67%); GENERIC PRODUCTS (66%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TENTS (65%); INTELLECTUAL PROPERTY LAW (60%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (58%); SIC2834 PHARMACEUTICAL PREPARATIONS (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UGANDA (96%); AFRICA (94%); INDIA (93%); EUROPE (92%); NIGERIA (79%); EGYPT (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 October 8, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Transcript\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 British Broadcasting Corporation\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; Factory Opens to Produce HIV/Aids Drugs Africa News October 5, 2007 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_79}{\*\bkmkstart DOC_ID_79_0}{\*\bkmkstart doc_id_24}{\*\bkmkend DOC_ID_79}{\*\bkmkend DOC_ID_79_0}{\*\bkmkend doc_id_24}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_24"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 24 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  5, 2007 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par Factory Opens to Produce HIV/Aids Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 New Vision\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 908 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 A year ago it was a potato garden. Now the 15-acre plot is hosting a hi-tech pharmaceutical factory, the first of its kind in Africa. The factory, to be commissioned by President Yoweri Museveni on Monday, will produce the full triple therapy combination of antiretroviral (ARV) drugs, something that has not been done in Africa before. "South Africa has a plant for producing ARVs but they do not do triple therapy combinations," said Emmanuel Katongole, Managing Director Quality Chemical Industries (QCI).\par Likewise, a few African countries like Egypt and Nigeria have ARV factories, but none of them produces the full range of three drugs required for treatment of HIV/AIDS. \par The new factory, located adjacent to Luzira Women's Prison, is a joint venture between QCI and the Indian pharmaceutical }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  It will produce Triomune, a combination that contains lamivudine, stavudine and nev}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rapine. Out of 80,000 people on ARVs in Uganda, three quarters are taking Triomune.\par The factory will also produce the first-line anti-malarial combination Lumartem, containing artemisinin and lumefantrin. This is equivalent to Coartem, which the Government now uses as the first-line anti-malarial drug.\par Katongole said they would begin trial runs on Monday soon after the President commissions the plant. The trial runs, technically referred to as validation, are likely to go on till November or December. The validation will help to ensure that the machines measure the ingredients accurately, mix in the right proportions and produce pills that are perfectly uniform in size and concentration. "By January, we should be in position to manufacture for the market," said Katongole.\par This will come just in time to save Uganda from a new law which will stop India from exporting cheaper ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sions of antiretroviral drugs, commonly known as generics. India has been Uganda's main source of generic ARVs, which are far cheaper than those manufactured by the companies that invented these drugs in E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rope and USA.\par Since the late 1990s Indian companies have been able to produce and sell generic drugs without the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sent of the patent holders in Europe and USA. However, having ratified the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement of the World Trade Organisation, India will ban the exportation of generic drugs by the end of this year.\par According to Katongole, the factory will initially produce two million pills a day, but this will eventually i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 crease to six million. This means in future it can produce 1.8billion pills a year. This number includes ARVs and anti-malaria pills. "Our first client is going to be the Government, which is committed to providing free ARVs for all those who need it," said Katongole. "There are between 150,000 and 300,000 Ugandans who need ARV treatment now. At the moment 80,000 of these are taking ARVs, and this factory should enable Government to double that number," he added.\par The surplus will be exported to neighbouring countries. These countries are likely to turn to Uganda because effective January 2008, they will not be able to import from India, which has been the biggest supplier of g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neric ARVs to Africa. "For us }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is a window of opportunity," said Katongole. "India has ratified the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement so it ceases to be a source of generic drugs for Africa."\par The Government donated 15 acres of land on which the factory has been constructed, and President Mus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 veni has been closely monitoring the progress. "The Government has been very supportive, especially the President. Every month he has been calling to check on the progress. He has also called us several times to State House for meetings," said Katongole.\par The Senior Presidential Advisor on HIV/AIDS, Dr. Jesse Kajimba, said local production of ARVs would lead to more independence in terms of guaranteeing supply and quality control. "We have been having ARVs a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 yway, but having the capacity to produce it locally is a starting point for other things. The President is thinking beyond simply making ARVs available," Kajimba said. \par Dr. Peter Mugyenyi, Director of the Joint Clinical Research Centre, said local production was the best way to guarantee availability of ARVs in Africa. "We are very excited to have a factory that produces ARVs in our country," said Mugyenyi, one of the pioneers in prescribing ARVs in Uganda. "Our people were dying b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause we had to go and beg others."\par Mugyenyi, however, cautioned that the pharmaceutical should not rely too much on Triomune. He said the factory should move quickly to start producing newer combinations such as Atripla, which contains Tenofovir, Efavirenz and FTC.\par The new factory will manufacture the anti-malarial drug Lumartem, Lumartem, containing artemisinin and lumefantrin, at a cost of $2.4 per dose. The equivalent, Cortem, is produced at a cost of $12 per dose.\par The factory will buy the plant artemisia from farmers in Kabale for making the antimalarial drug. "Uganda, especially Kabale, has been found to have one of the best soils for to grow Artemisia. Now there is a comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ny that has started large-scale growing of Artemisia in Kabale. There are over 10,000 hectares of Artemisia," said Emmanuel Katongole, Managing Director, Quality Chemical Industries. He added, "We are going to buy artemnisia from them and take it to India for extraction of the active artemisinin. In the long run we are going to negotiate with government to support us so that in the long run we can do the extraction here instead of taking it to India."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV TREATMENT (91%); ANTIVIRALS (91%); AIDS & HIV (90%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CALS INDUSTRY (90%); MALARIA (90%); PHARMACEUTICAL PREPARATION MFG (89%); PRESCRI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TION DRUGS (89%); GENERIC DRUGS (89%); MANUFACTURING FACILITIES (78%); ANTI-INFECTIVES (78%); TROPICAL DISEASES (77%); EXPORT TRADE (75%); CHEMICALS MFG (71%); CHEMICALS (71%); JOINT VENTURES (68%); GENERIC PRODUCTS (68%); PATENTS (66%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UGANDA (95%); AFRICA (94%); INDIA (93%); EUROPE (92%); EGYPT (79%); NIGERIA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 October 6, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; ARVs Production Starts Monday Africa News October 5, 2007 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_80}{\*\bkmkstart DOC_ID_80_0}{\*\bkmkstart doc_id_25}{\*\bkmkend DOC_ID_80}{\*\bkmkend DOC_ID_80_0}{\*\bkmkend doc_id_25}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_25"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 25 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  5, 2007 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par ARVs Production Starts Monday}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 New Vision\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 908 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 A YEAR ago it was a potato garden. Now the 15-acre plot is hosting a hi-tech pharmaceutical factory, the first of its kind in Africa.\par The factory, to be commissioned by President Yoweri Museveni on Monday, will produce the full triple ther}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 py combination of antiretroviral (ARV) drugs, something that has not been done in Africa before.\par "South Africa has a plant for producing ARVs but they do not do triple therapy combinations," said Emmanuel Katongole, Managing Director Quality Chemical Industries (QCI). \par Likewise, a few African countries like Egypt and Nigeria have ARV factories, but none of them produces the full range of three drugs required for treatment of HIV/AIDS.\par The new factory, located adjacent to Luzira Women's Prison, is a joint venture between QCI and the Indian pharmaceutical }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  It will produce Triomune, a combination that contains lamivudine, stavudine and nev}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rapine. Out of 80,000 people on ARVs in Uganda, three quarters are taking Triomune.\par The factory will also produce the first-line anti-malarial combination Lumartem, containing artemisinin and lumefantrin. This is equivalent to Coartem, which the Government now uses as the first-line anti-malarial drug.\par Katongole said they would begin trial runs on Monday soon after the President commissions the plant. The trial runs, technically referred to as validation, are likely to go on till November or December. The validation will help to ensure that the machines measure the ingredients accurately, mix in the right proportions and produce pills that are perfectly uniform in size and concentration. "By January, we should be in position to manufacture for the market," said Katongole.\par This will come just in time to save Uganda from a new law which will stop India from exporting cheaper ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sions of antiretroviral drugs, commonly known as generics. India has been Uganda's main source of generic ARVs, which are far cheaper than those manufactured by the companies that invented these drugs in E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rope and USA.\par Since the late 1990s Indian companies have been able to produce and sell generic drugs without the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sent of the patent holders in Europe and USA. However, having ratified the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement of the World Trade Organisation, India will ban the exportation of generic drugs by the end of this year.\par According to Katongole, the factory will initially produce two million pills a day, but this will eventually i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 crease to six million. This means in future it can produce 1.8billion pills a year. This number includes ARVs and anti-malaria pills. "Our first client is going to be the Government, which is committed to providing free ARVs for all those who need it," said Katongole. "There are between 150,000 and 300,000 Ugandans who need ARV treatment now. At the moment 80,000 of these are taking ARVs, and this factory should enable Government to double that number," he added.\par The surplus will be exported to neighbouring countries. These countries are likely to turn to Uganda because effective January 2008, they will not be able to import from India, which has been the biggest supplier of g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neric ARVs to Africa. "For us }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is a window of opportunity," said Katongole. "India has ratified the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement so it ceases to be a source of generic drugs for Africa."\par The Government donated 15 acres of land on which the factory has been constructed, and President Mus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 veni has been closely monitoring the progress. "The Government has been very supportive, especially the President. Every month he has been calling to check on the progress. He has also called us several times to State House for meetings," said Katongole. \par The Senior Presidential Advisor on HIV/AIDS, Dr. Jesse Kajimba, said local production of ARVs would lead to more independence in terms of guaranteeing supply and quality control. "We have been having ARVs a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 yway, but having the capacity to produce it locally is a starting point for other things. The President is thinking beyond simply making ARVs available," Kajimba said.\par Dr. Peter Mugyenyi, Director of the Joint Clinical Research Centre, said local production was the best way to guarantee availability of ARVs in Africa. "We are very excited to have a factory that produces ARVs in our country," said Mugyenyi, one of the pioneers in prescribing ARVs in Uganda. "Our people were dying b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause we had to go and beg others."\par Mugyenyi, however, cautioned that the pharmaceutical should not rely too much on Triomune. He said the factory should move quickly to start producing newer combinations such as Atripla, which contains Tenofovir, Efavirenz and FTC.\par The new factory will manufacture the anti-malarial drug Lumartem, Lumartem, containing artemisinin and lumefantrin, at a cost of $2.4 per dose. The equivalent, Cortem, is produced at a cost of $12 per dose.\par The factory will buy the plant artemisia from farmers in Kabale for making the antimalarial drug. "Uganda, especially Kabale, has been found to have one of the best soils for to grow Artemisia. Now there is a comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ny that has started large-scale growing of Artemisia in Kabale.\par There are over 10,000 hectares of Artemisia," said Emmanuel Katongole, Managing Director, Quality Chem}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cal Industries. He added, "We are going to buy artemnisia from them and take it to India for extraction of the active artemisinin.\par In the long run we are going to negotiate with government to support us so that in the long run we can do the extraction here instead of taking it to India."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ANTIVIRALS (91%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS INDUSTRY (90%); MALARIA (90%); PHARMACEUTICAL PREPARATION MFG (89%); PRESCRIPTION DRUGS (89%); G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NERIC DRUGS (89%); MANUFACTURING FACILITIES (78%); ANTI-INFECTIVES (78%); AIDS & HIV (77%); TROPICAL DISEASES (77%); EXPORT TRADE (75%); CHEMICALS MFG (71%); CHEMICALS (71%); JOINT VENTURES (68%); GENERIC PRODUCTS (68%); PATENTS (66%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UGANDA (95%); AFRICA (94%); INDIA (93%); EUROPE (92%); EGYPT (79%); NIGERIA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 October 8, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; Country to Begin Producing ARVs Africa News September 21, 2007 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_81}{\*\bkmkstart DOC_ID_81_0}{\*\bkmkstart doc_id_26}{\*\bkmkend DOC_ID_81}{\*\bkmkend DOC_ID_81_0}{\*\bkmkend doc_id_26}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_26"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 26 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 September}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  21, 2007 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par Country to Begin Producing ARVs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 371 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BEGINNING next month, Uganda will start manufacturing generic Anti-Retroviral drugs, giving hope to many living on the life saving tablets.\par Two companies; Quality Chemicals Ltd and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd of India will produce the drugs at their plant in Luzira, Kampala. The firms will also manufacture anti-malarial drugs in a move that has been saluted by the Ministry of Health. \par This will boost access and affordability of anti-retroviral drugs in the country. Dr Sam Zaramba, the director general of health services, told Daily Monitor yesterday that the time taken to procure the drugs will signif}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cantly shorten once production starts.\par "We shall not have to wait for shipment," he said. Shipping of the drugs usually takes close to six months, which according to Dr Zaramba can cause problems in case of shortage as patients cannot go a day without taking the drugs. Uganda has experienced a shortage in the past.\par The prices, Dr Zaramba, said will be competitive as before, but will be cheaper. Currently a monthly dose of ARVs goes for Shs30,000.\par But laboratory and CD4 volume tests, that are a necessary procedure before usage of the drugs, are very expensive. CD4 count shows the status of the body's immunity.\par The decline in prices means that more people would access the drugs, enabling Uganda to move closer to achieving the UN Millennium Goal of increasing access to ARVs and reducing malaria-induced deaths by 2015.\par According to Dr Elizabeth Madraa, the head of the Aids Control Programme, 100, 000 people currently a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cess ARVs as opposed to the 300, 000 that should. Ministry of Health figures show that Malaria on the other hand claims 320 people in Uganda every day.\par According to the Quality Chemicals' Director for Marketing, Mr George Baguma, the $30 million project was borne out of the need to address distortions imposed by India's ratification of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement of the World Trade Organisation (WTO).\par "The move threatened to deny Africa access to affordable medicines. Indeed the WTO recognised the pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dicament that this agreement would impose on the poor countries," he said.\par Dr Zaramba said with the manufacturers now here, the government's work of monitoring the importation of anti-malarials and ARVs would be easier.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (90%); GENERIC DRUGS (90%); ANTIVIRALS (90%); CHEMICALS MFG (89%); CHEMICALS (89%); MALARIA (89%); HEALTH DEPARTMENTS (78%); TROPICAL DISEASES (78%); GENERIC PRODUCTS (78%); ANTI-INFECTIVES (78%); PUBLIC HEALTH ADMINISTRATION (77%); HEALTH CARE ACCESS (76%); INTERNATIONAL ECONOMIC ORGANIZATIONS (63%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (93%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UNITED NATIONS (54%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (93%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 KAMPALA, UGANDA (92%) UGANDA (94%); INDIA (93%); AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 September 20, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa; Q&A on Second-Line HIV/Aids Treatment Africa News May 8, 2007 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_82}{\*\bkmkstart DOC_ID_82_0}{\*\bkmkstart doc_id_27}{\*\bkmkend DOC_ID_82}{\*\bkmkend DOC_ID_82_0}{\*\bkmkend doc_id_27}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_27"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 27 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  8, 2007 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Africa; \par Q&A on Second-Line HIV/Aids Treatment}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 William J. Clinton Foundation\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 3336 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The following is a Q&A on Second-Line HIV/Aids treatment from the Clinton Foundation and Unitaid. \par Q&A on Second-Line HIV/AIDS Treatment\par Q. What are second-line antiretrovirals? How are they different from first-line ARVs and why do they cost more? \par A. Over time, a patient s initial regimen of ARV medications ( first-line  therapy) may start failing to control the level of the HIV virus in the body as the virus develops resistance to the first-line drugs. The likelihood of d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 veloping resistance varies greatly between patients. When this occurs, there is a need to switch the patient to a new combination of ARV medications that together comprise  second-line  therapy. One of the drugs typically in  second-line  regimens is a protease inhibitor, a class of ARVs that is not generally included in first-line therapy in developing countries and that is primarily responsible for the efficacy of second-line treatment. Drugs included in second-line regimens, and particularly protease inhibitors, are typically bigger and more complex than first-line drugs at a molecular level. A number of second-line drugs are also dosed at higher levels, requiring more active ingredient per day of treatment. These features help to explain the grea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er cost of second-line medicines. Low production volumes also play an important role. There has been little demand for second-line medications in most of the developing world as treatment programs are relatively young and most patients have not begun to encounter treatment failure. The limited demand has prevented manufacturers from achieving volume-based efficiencies and cost savings. Increasing volumes over the coming years will enable further price reductions.\par Q. Why are so few people on second-line treatment in developing countries?\par A. According to the latest WHO/UNAIDS Progress Report on Universal Access to Treatment, as of the end of 2006 roughly two million people, or 28% of those in need, are receiving ARV treatment in low and middle income countries. CHAI estimates that in 2006 only 80,000 of these two million patients, or 4% of the total, were on second-line therapy. Several factors account for the relatively low level of second-line treatment. First, and most importantly, the majority of these two million ARV patients began treatment only within the last four years and have not yet experienced treatment failure with their first-line medications. In addition, some studies have indicated that treatment failure rates in Africa have been lower than in other regions, though robust data does not yet exist. The need for second-line regimens is expected to rise significantly across developing countries in coming years as the initial wave of patients reached during the early years of the scale-up of AIDS therapy begins to experience treatment failure. CHAI estimates that nearly half a million people will require second-line treatment in 2010. In addition to the relatively low need for second-line ther}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 py, the need that does exist has been under-addressed. Weak diagnostic and laboratory capacity in many countries has made it difficult for healthcare workers to diagnose treatment failure promptly. Thus, some p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tients stay on first-line regimens beyond the point of virologic or immunologic failure, until clinical failure b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 comes evident. And even where treatment failure is accurately diagnosed, the high cost of second-line med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cations has led some countries to hesitate in making second-line treatment widely available.\par Q. Will more patients on second-line treatment result in the diversion of funding away from patients who need first-line treatment?\par A. No   donors and governments are committed to continued and expanded funding for all existing treatment   efforts. Treatment providers routinely set enrollment targets based on their capacity constraints, which most   frequently include human resources, infrastructure, management capacity, and the ability to identify new p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tients   through counseling and testing or other treatment entry points. Treatment budgets generally assume that a certain   proportion of patients will need to shift to second-line treatment over time, and set aside fun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing for that purpose.   Meanwhile, donors providing funding for second-line treatment are taking steps to e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sure the  additionality  of their   funding, so that funding for second-line treatment does not displace existing activities.\par Q. Apart from reducing prices, how is CHAI helping to ensure sustainable and high-quality second-line treatment?\par A. The most effective way to make treatment affordable and sustainable is to minimize the rate at which p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tients   begin to experience treatment failure on first-line drugs. By training healthcare workers to prescribe the most   effective first-line regimens, providing hands-on adherence support to patients, and monitoring patients  response   to treatment very closely, governments and other treatment providers can maximize the efficacy and duration of   first-line therapy. CHAI partners with national governments to help treatment pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 viders to incorporate these   approaches.   Effective diagnosis of treatment failure is also a major challenge, especially in the absence of easily accessible CD4   count and viral load testing. Building on the reduced pricing that CHAI has negotiated for these critical   diagnostics with CD4 count tests available at $3 to $8 per test and viral load tests at $25 to $45 CHAI and other   partners are providing extensive technical assistance to help build laboratory capacity and train key laboratory   personnel.   Finally, the provision of second-line treatment will depend on effective procurement systems. Beyond price   reductions, key changes include revision of national protocols to adopt the best possible second-line regimens as   well as improvements to forecasting and supply chain management. CHAI supports these efforts by providing   direct technical assi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tance and by disseminating information to improve transparency of price trends, regulatory   approvals, and the entry of new suppliers and products into the market.\par Q. Will patent protection for second-line ARVs be a major barrier to the availability of affordable secondline   treatment?\par A. Generally, no   for most key drugs in most countries, patents will not represent a significant barrier in the near   term. The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  framework strikes a balance between requiring reasonable patent protection to pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vide R&D   incentives for originators and creating flexibility to ensure that developing nations can afford e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sential medicines.   Recognizing this balance, both governments and manufacturers are taking steps to e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pand access and lower prices   in developing countries while preserving the profit margins in the wealthier markets that drive overall returns to   R&D investment.   Virtually all second-line drugs are still under patent in high-income countries, yet most second-line drugs in most   developing countries are either not under p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tent or have been licensed voluntarily by originators to enable generic   competition. Generic versions of some drugs will not be available in some countries due to patent protection in the   country of export or i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 port. This is particularly true in middle-income countries. In these situations, differential   pricing by origin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tors helps but does not produce the same level of affordability as generic competition.   3   Q&A on  Next Generation  First-Line AIDS Treatment\par Q. What is  next generation  first-line treatment and why is it increasingly important?\par A. The key  next generation  first-line regimens include the same medicines as today s leading first-line reg}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mens   except that tenofovir (TDF) or zidovudine (AZT) is used in place of stavudine (d4T). While d4T has until now   been a central component of most first-line treatment in developing countries, there is increasing evidence   demonstrating that this drug causes significant side effects for patients and produces inferior ou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 comes to those   achieved with TDF or AZT. The WHO has therefore recently recommended that countries using d4T in first-line   therapy move toward the use of TDF or AZT instead, and demand for the  next gene}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ation  regimens is increasing   quickly.   TDF is particularly important due to its excellent safety and efficacy profile together with its once-daily dosing   schedule. This dosing schedule makes it possible to provide a one-pill, once-daily treatment regimen based on   TDF; lamivudine (3TC) or emtricitabine (FTC); and efav}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 renz (EFV). Patients are more likely to adhere to this   simplified regimen, which in turn leads to reduced drug resistance and improved treatment outcomes.\par Q. Why haven t countries adopted these  next generation  first-line combinations earlier?\par A. The body of clinical evidence indicating the extent of d4T toxicity and the superior outcomes achieved with   TDF or AZT has been growing over the past five years. Not until mid-2006 did the WHO formally change its   guidelines to recommend movement away from d4T use in first-line therapy. Even when these guidelines were   issued, countries were not in a position to move away from d4T immediately. Before doing so, cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tries have to   change national treatment protocols, use up existing stocks of d4T-based products, and order the newly preferred   products from suppliers.   In addition, the higher cost of AZT and TDF has led some countries to delay the shift away from d4T. Further,   manufacturers have needed to develop new products, particularly fixed-dose combinations including TDF, and find   ways to lower their prices. With the significant price reductions announced today by CHAI, it is expected that the   shift towards these  next generation  re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 imens will accelerate. Several African countries with high HIV/AIDS   prevalence have already indicated that they will likely adopt TDF-based first-line regimens in the coming months.\par Q. What effect will the emergence of once-a-day ARVs have on the success of AIDS treatment?\par A. The introduction of an affordable once-a-day pill for AIDS treatment is expected to have a major impact on   treatment success by making it easier for patients to adhere to treatment. Most patients currently on first-line   treatment are taking drugs that require two to three pills per day and twice-daily dosing. Adherence to this type of   treatment regimen has been encouragingly high, but those patients who struggle to adhere to their prescribed   regimens are significantly more prone to develop drug resistance. In light of the high costs of second-line therapy   and the relatively limited treatment options beyond second-line drugs, maximum a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 herence to first-line therapy is   an imperative for treatment programs. The availability of a one-pill, once-daily regimen will greatly facilitate this   goal.\par Q&A on New Antiretroviral Pricing Agreements\par Q. How do CHAI s new prices compare to current prices in the market?\par A. CHAI s newest agreements include price reductions for 16 ARV formulations. The prices and reductions are   detailed in the table below. To determine the degree of reduction, new CHAI ceiling rates are compared to the   lowest available prices per market (low income and middle income) listed in several publicly available sources,   including analysis of purchases captured in the WHO s Global Price Reporting Mechanism, the lowest generic price   reported in M\u200\'e9decins Sans Fronti\u203\'e8res   Untangling the Web of Price Reductions,  and the access prices cited by   originators.   The average price reduction for the seven formulations of the key second-line ARVs abacavir, didanosine,   lopinavir/ritonavir, and tenofovir is 27% for low income countries and 53% for middle countries. These figures   represent the mean of the reduction for each of the seven fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mulations, with the reduction per product based on   the comparison of the CHAI ceiling price to the lowest available rate per market. In cases in which the lowest rate   is from MSF but of a product that is not a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 proved by the WHO or U.S. FDA, this rate is not used for purposes of   comparison (e.g., ddI EC).   The key price reduction for  next generation  first-line treatment is based on the fixed-dose combination of   tenofovir (TDF), lamivudine (3TC) and efavirenz (EFV). The price reduction of 45% for low income countries and   67% for middle income countries is based on the comparison of the CHAI ceiling price to the originator pri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing for   the fixed-dose combination of TDF, EFV and emtricitabine (FTC). 300mg of 3TC dosed once-daily is regarded as   a clinically equivalent alternative to FTC, and WHO treatment guidelines, noting this, have stated that developing   countries only need to stock either 3TC or FTC, not both.   The price reductions are generally greater for middle income countries because, to date, most manufacturers have   followed a tiered pricing structure that includes higher prices for wealthier countries (as defined by the World   Bank s country income index or the Human Development Index). The principal companies involved in the   agreements a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nounced today, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Matrix, have agreed to extend the reduced prices to all 66 countries in the CHAI Procurement Consortium.\par Q. How did CHAI work with suppliers to reduce prices?\par A. CHAI has been providing cost reduction assistance to partner suppliers for more than a year, helping to secure   lower prices on key raw materials, addressing important chemistry challenges, and modeling vo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ume-based cost   savings in anticipation of increased demand.   CHAI s partnership with UNITAID to pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 chase and provide second-line ARVs to 27 countries is built on this cost   reduction approach by providing guaranteed purchase volumes to suppliers and creating a competitive bidding   process for participation in the program. Acting on behalf of UNITAID, CHAI issued a formal expression of   interest to all manufacturers producing the relevant ARVs, requesting that they indicate the regulatory status of each   product they wished to supply and their ability to supply products to each UNITAID beneficiary country. Suppliers   were also asked to either indicate the price at which they would provide the product or indicate their willingness to   engage in transparent  cost-plus  price negotiations with CHAI. CHAI then began in-depth conversations with   those suppliers willing to engage in these negotiations, reviewing their production cost structures and ident}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fying   potential cost reduction opportunities. The prices generated through these negotiations were then compared to   those submitted by other suppliers to determine the pool of manufacturers eligible for the UNITAID program.\par Q. Are there any hidden or additional costs that purchasers will need to pay?\par A. In general, CHAI prices are ceiling rates at or below the rates at which CHAI partner suppliers must quote in   response to tenders. The ceiling prices themselves are in  Free on Board  (FOB) terms, meaning that they do not   include applicable shipping and handling charges from the point of export. It is common for the prices of ARVs to   be reported on an FOB basis. Shipping and handling fees add to the FOB price of a product. In addition, some   purchasers choose to use procurement agents such as UNICEF, IDA or Crown Agents, which typically adds 5-10%   to the price. These costs are not particular to products and prices o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fered under CHAI agreements.\par Q. Will CHAI procure these products? Will others be able to procure these products at the negotiated   pri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es?\par A. Yes, for second-line ARVs   CHAI will manage the procurement of UNITAID-financed volumes of these   formulations for 27 countries in 2007-08. For these countries, CHAI will contract with an experienced   pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 curement agent to ensure the timely ordering and delivery of these ARVs so that they can be effectively   integrated into the national treatment programs of the beneficiary countries.   In addition to the countries benefiting from the UNITAID second-line treatment program, all countries in the   CHAI Procurement Conso}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tium, which currently includes 66 nations, will be able to purchase the full range of   products included in the current agreements at the negotiated prices. Procurement of the products will be the   responsibility of each government using its existing procurement systems and either domestic resources or funds   from donors such as the Global Fund.\par Q. Why is CHAI working with these particular companies? Is CHAI limiting competition by not working   with others?\par A. CHAI welcomes the opportunity to partner with other manufacturers, including originators, for second-line formulations and other products. Pricing under CHAI agreements requires suppliers to treat the market of   developing countries as a low-margin, high-volume business. Suppliers like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Matrix, who partner with   CHAI, agree to take a  cost-plus  approach, whereby they agree to price on the basis of an agreed production cost   structure plus a reasonable profit margin. This approach makes possible the price redu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions announced today   while ensuring that }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Matrix will earn a healthy and sustainable profit on sales of these products.   6   Other CHAI partners, including Aspen, Ranbaxy and Strides, have not collab}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rated on a  cost-plus  basis for these   products but remain partners to CHAI in the supply of other ARVs, consistent with prior agreements. Also, CHAI   will not be limiting the supply of formulations under its UNITAID-financed second-line program only to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and   Matrix. CHAI also expects to purchase second-line ARVs from Abbott, Bristol-Myers Squibb, Gilead, Ranbaxy and   others, based on responses to its invit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion and the product requirements of UNITAID beneficiaries.\par Q. How do CHAI and UNITAID ensure that the products they support are of high quality?\par A. All of the products included in today s announcement have either been approved by or submitted to a stringent   regulatory authority such as the WHO or U.S. FDA, or will be submitted to these authorities in the next few   months. Submissions to the WHO or FDA include data establishing bioequivalence of the generic medicines to   originator products, based on tests by research laboratories that have been successfully a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dited by the WHO and/or   FDA.   For those products which are being procured with UNITAID funds that have not yet received final regulatory   approval, additional conditions have been applied consistent with the quality assurance policy adopted by the   UNITAID board. These conditions include certification that the faci}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ities where the drugs are produced meet the   international standard of Good Manufacturing Practice and submission of a complete regulatory dossier to the   WHO or other stringent regulatory authority.   CHAI will also ensure that all products supplied through its partnership with UNITAID are of high quality through   a comprehensive quality control process. This will include inspecting shipments to ensure that they meet the   required specifications and testing random samples of product batches in independent labs to ensure that the   chemical composition of the drugs match these specifications.\par Q. How do reduced prices improve the quality of care?\par A. Reduced prices enable countries to use products with preferred clinical outcomes that may have previou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly been   inaccessible due to high costs. For example, many countries have been reluctant to switch from stavudine-based   first-line regimens, which are associated with higher levels of toxicity, because of the cost of alternative tenofovirbased   regimens.   In addition, the high cost of second-line therapy has discouraged some countries from prioritizing the provision of   these drugs to patients who experience treatment failure. It is expected that the lower prices for second-line ARVs   achieved through the partnership between CHAI and UNITAID will enable countries to devote more attention and   resources to this area, which is critical for su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 taining the quality of care for patients.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (95%); AIDS & HIV TREATMENT (94%); ANTIVIRALS (91%); DEVELOPING COUNTRIES (89%); PROTEIN BASED DRUGS (76%); ENZYME INHIBITORS (76%); VIRUSES (72%); LOW INCOME PERSONS (63%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AFRICA (93%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 May 8, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; Quality Courts Cipla for Drugs Africa News April 3, 2007 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_83}{\*\bkmkstart DOC_ID_83_0}{\*\bkmkstart doc_id_28}{\*\bkmkend DOC_ID_83}{\*\bkmkend DOC_ID_83_0}{\*\bkmkend doc_id_28}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_28"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 28 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  3, 2007 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par Quality Courts }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414  for Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 591 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 UGANDA is stepping up efforts to manufacture its own life-saving medicines so that it does not have to rely on imports from foreign pharmaceutical companies.\par Quality Chemicals Ltd, a distributor of pharmaceutical products in Uganda has teamed up with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd of India, one of the world's leading generic pharmaceutical manufacturers, to put up a world-class plant in the country to manufacture antiretrovirals, drugs used to treat people living with HIV/AIDS.\par This was after President Museveni in particular approached }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Limited and asked them to invest in Uga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 da. \par According to the World Health Organisation (WHO), the population of people living with HIV/AIDS in the world is approximately 33 million. Of these, 80 per cent are found in Africa (about 26 million people). Further more, 10 to 15 per cent are in need of therapy if they are to stay alive.\par According to WHO, by the end of 2006, only 17 per cent of the 4.7 million people in sub-Saharan Africa in need of anti-retroviral treatment had access to them.\par Despite this, Africa depends on anti-retroviral drug imports from other countries especially India.\par This new Quality Chemicals Anti-retroviral drugs (ARV) / anti-malarial project is borne of the cognisance that India, the biggest source of pharmaceuticals in Africa has ratified the Trade Related Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement under the World Trade Organisation (WTO) and hence it will soon cease to be a reliable source of relevant, and affordable pharmaceutical products.\par This changed status poses the biggest risk to Uganda and Africa in their effort to contain these killer disea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es.\par Favours\par Uganda though a signatory to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement is exempt from implementing the agreement for the next 16 years because it is counted among the Least Developed Countries, which means it can manufacture any patented product without breaking the law.\par Against this backdrop, Quality Chemicals formed a joint venture with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to locally produce ARVs and anti-malaria drugs at a fraction of the cost of some Western drugs.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  will bring on board its extensive resources and know-how in drug manufacture.\par Construction of the factory is still underway having started at the beginning of July last year. Once comple}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed, the US$28 million (Shs50.4 billion) plant is likely to increase access to affordable and safe pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cals likely to result into 30 per cent reduction in prices of ARVs and anti-malarial drugs.\par Household incomes\par The Finance Director Quality Chemicals, Fred Mutebi Kitaka, said: "Apart from providing a platform for our local remedies to developed, it will also boost household income through the local production of Artemisinin, a key ingredient in the manufacture of Artemether-based malarial drugs.\par In the past, when Western drug prices have been too high, African countries have traditionally turned to Ind}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 an companies, which have made copies of drugs designed in the West at lower prices.\par At those times, up to 80 per cent of these generic drugs supplied to some African countries including Uganda came from India.\par Constant supply\par Given the uncertainty over the prices of foreign supplies, Mr Mutebi says it is vital to have a constant supply of drugs for those Ugandans already being treated, as well as to meet the future explosion in demand for treatment.\par "It is important for us to be self-sufficient and resourceful," he adds.\par The company says it will take advantage of the fact that under WTO rules, the world's poorest countries are able to copy drugs and get away with it without breaking patent laws.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ANTIVIRALS (92%); PHARMACEUTICAL PREPARATION MFG (92%); PHARMACEUTICALS INDUSTRY (91%); AIDS & HIV (91%); CHEMICALS MFG (90%); IMPORT TRADE (90%); CHEMICALS (90%); PHARMACEUTICALS WHOLESALERS (90%); PHARMACEUTICALS TRADE (90%); AIDS & HIV TREATMENT (90%); MALARIA (89%); DRUG PRICES (89%); ANTI-INFECTIVES (89%); INFECTIOUS DISEASE (89%); DISEASES & DISORDERS (78%); HEALTH DEPARTMENTS (78%); GENERIC DRUGS (78%); INTELLECTUAL PROPERTY (78%); POPULATION SIZE (77%); PUBLIC HEALTH ADMINISTR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TION (75%); DRUG SAFETY (73%); DEVELOPING COUNTRIES (72%); INTERNATIONAL ECONOMIC ORGANIZATIONS (71%); PLANT CONSTRUCTION (71%); PATENT LAW (69%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ERTY LAW (69%); PRICE CHANGES (69%); JOINT VENTURES (64%); PATENTS (64%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD HEALTH ORGANIZATION (90%); WORLD TRADE ORGANIZATION (71%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (96%); SIC2834 PHARMACEUTICAL PREPARATIONS (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AFRICA (95%); UGANDA (94%); SUB SAHARAN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 April 2, 2007\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2007 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The one-pill wonder Daily Deal/The Deal August 31, 2006 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_84}{\*\bkmkstart DOC_ID_84_0}{\*\bkmkstart doc_id_29}{\*\bkmkend DOC_ID_84}{\*\bkmkend DOC_ID_84_0}{\*\bkmkend doc_id_29}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_29"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 29 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Daily Deal/The Deal\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  31, 2006 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 The one-pill wonder}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 by Alex Lash and Tara Croft\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEWSWEEKLY\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 3061 words\par \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 HIGHLIGHT:}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  The cocktails used to treat HIV have involved ever more complex numbers of pills in a patient's day. A new combination pill developed by Gilead and Bristol-Myers is changing that. But it hasn't been easy.\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 When people in the HIV community say that AIDS in the First World has become a chronic, lifelong disease instead of a sure killer, they could well be talking about Bruce.\par Bruce, who asked to keep his last name private, is a retired nonprofit media producer in Berkeley, Calif. He is 65 years old, and he's been taking antiretroviral drugs to fight his HIV infection since 1990.\par But he started only after six years of untreated infection that culminated in a violent seizure, leaving him ho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pitalized and non compos mentis for three weeks.\par "Without my knowing it, the [hospital staff] put me on AZT," he recalls. "They might have consulted with me, but I was out of it. I have no memory of those three weeks and emerged from it very foggy." \par Thanks to staff intervention, Bruce is alive today. For 16 years, he says he has meticulously followed an e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er-more-complicated regimen, juggling several AIDS drugs at once, often tinkering with different combin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions to combat the virus' shifting attack.\par Within a couple of months, however, his life will get much simpler: He'll switch from four medicines totaling eight pills a day to a regimen of just two medicines and three pills a day. For HIV-positive people like Bruce, simplifying the "cocktail" of AIDS drugs will be a welcome development. For those in more precarious situ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions, be they poor or homeless in the first world, or living with little to no educational and health infrastru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture in the developing world, such a step could be lifesaving.\par In mid-July, pharmaceuticals behemoth Bristol-Myers Squibb Co. and biotech firm Gilead Sciences Inc. got Food and Drug Administration approval for a pill that should ease the lives of thousands of AIDS patients. They each contributed medicine and rolled three different doses into one pill that doctors and patients alike hail as remarkable.\par "This is a huge step forward," says Mary Romeyn, a professor at the University of California, San Francisco School of Medicine who specializes in HIV and nutrition. "Such industry cooperation is phenomenal when you think they didn't have the parts to make this until recently." Romeyn has begun prescribing the pill to her patients, including Bruce.\par Efforts to make the triple pill, branded in the U.S. as Atripla, began as negotiations in late 2003 between Bri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tol-Myers Squibb and Gilead. Other AIDS pills have combined more than one drug, but Atripla is the first to combine drugs made by two companies.\par It rolls into one pill three of the war horses of HIV-AIDS treatment with fewer side effects than many AIDS meds, and the companies have promised not to charge a premium beyond the combined price of the three drugs sold separately. In the U.S., the wholesale price is $1,150 a month. That may seem high, but an AIDS drug-price watchdog group praised the companies for not going higher.\par The deal the companies struck to work together is also unusual. First, it turns upside down the typical power relationship between biotechs and big pharmaceuticals firms. Instead of a licensing deal that gives the Big Pharma partner the lead role, Gilead and BMS traveled a much more complex path, creating a joint venture to produce Atripla.\par "Big pharmas and biotechs tend to collaborate in one of two ways: 98% of the time it's a licensing format or an acquisition," says Barbara Kosacz, who runs Cooley Godward LLP's life sciences practice in Palo Alto, Calif. "A joint venture represents the challenges of both with the clear benefits of neither." (Cooley counts Gilead as a client but did not work on the JV with Bristol-Myers.)\par So far, the choice has produced results. Atripla is on the market in the U.S., and Gilead has struck a second deal with Merck & Co., which shares with BMS the rights to efavirenz, one of the three Atripla components.\par It wasn't easy, however, and raises interesting questions: Why a joint venture, which requires setting up a new company, instead of a licensing deal, which demands a lot less paperwork? Why is it called a joint ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture when the much-smaller Gilead, with 1,900 employees and $2 billion in annual revenue (compared with BMS' 42,000 and $19 billion), is majority owner and doing the lion's share of the work? And if fixed-dose combinations are so crucial to fighting HIV, why haven't other companies been able to work together in such close fashion?\par The progress of HIV medicine in the past quarter century has been hampered by homophobia, governmental denial, grass-roots rage over premium (some would say predatory) pricing and, as the epidemic spread throughout the developing world, global politics. The World Health Organization estimates AIDS has killed more than 25 million people since 1981. Nearly 40 million people live with HIV infection worldwide, two-thirds of them in sub-Saharan Africa.\par The first HIV drug, known as AZT but officially branded Retrovir, went on the market in April 1987. Deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 oped by Research Triangle Park, N.C.-based Burroughs Wellcome Co. (now part of GlaxoSmithKline plc), it cost $10,000 a year. Burroughs Wellcome scientists found that AZT, shelved as a cancer treatment, could prolong the lives of HIV patients by blocking reverse transcriptase, a protein that HIV needs to make more copies of itself.\par In the late 1980s, doctors at the National Cancer Institute saw that alternating AZT with the then-experimental drug ddC seemed to lessen the more toxic side effects of both drugs, although it was still a few years before ddC was approved.\par In the early 1990s more drugs like AZT, known as nucleoside reverse transcriptase inhibitors, or NRTIs, hit the market. In 1991, Bristol-Myers Squibb developed ddL for those intolerant to AZT and marketed it under the name Videx. In 1992, the FDA approved Roche Laboratories' Zalcitabine, the first drug to be used in concert with AZT, for patients with advanced HIV infection and swiftly deteriorating conditions.\par A new way of attacking the virus was introduced in late 1995 with the approval of the protease inhibitor, or PI, a drug that interrupts HIV replication by binding and blocking HIV protease. Taking a PI with two other NRTIs was a one-two punch, hitting the virus at two different points in its infection cycle. It was the dawn of the HIV cocktail.\par Cocktails provided far more sophisticated attacks on the virus, but they also created a dizzying pill regimen, as each medicine could require several pills a day with its own strict set of rules. This pill burden remains a major obstacle to fighting the disease: If the patient skips a few doses, the quickly mutating virus has an open window to develop resistance.\par With that in mind, companies set about making fixed doses: In 1997 Glaxo Wellcome released Combivir, which blended two of its own branded drugs, Retrovir (AZT) and Epivir (3TC), into one pill taken twice a day. Glaxo said at the time that Combivir could allow patients to reduce their daily regimen by as many as six pills.\par Glaxo upped the ante in 2000 with a triple pill, Trizivir, but few patients medically qualified for it. Despite its limited appeal, 2005 sales of Trizivir reached $572 million, a 6% decline from the year before. Meanwhile, Combivir had 2005 sales of $1.1 billion. Combivir remains GlaxoSmithKline's top-selling HIV drug.\par Gilead was a relative latecomer to HIV. The Bay Area biotech had spent much of its first decade developing antisense, a type of genetic therapy that for some time was considered the next great biotech leap forward. The 1996 appointment of John Martin to president and CEO, however, cemented the company's new dire}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion: infectious disease. Martin joined Gilead in 1990 as VP of research and development. Before that, he was a BMS executive and scientist in the antiviral division.\par By the mid-1990s, Gilead was going after HIV, influenza and hepatitis. Its first HIV drug, Viread (tenofovir), an NRTI, was approved in 2001. It's become an antiretrovirus staple, especially for patients whose first-line treatments have failed. "Where other drugs fail, tenofovir largely works," says Kristin Peterson, a Michigan State University professor who studies AIDS policies in Africa, including recent tenofovir trials in Nigeria. "People like that it doesn't have a lot of toxic side effects."\par A fixed-dose combination seemed the next step. Not only was GSK raising the bar with a double, then a tr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple pill, but the pressure from the generics industry was building, especially from Indian firm }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd. of Mumbai and its triple pill, Trimune.\par Gilead needed another drug to combine with tenofovir. For $464 million, it found the right one at Triangle Pharmaceuticals Inc., a small North Carolina biotech that, according to its co-founder Raymond Schinazi, was "on its knees" because it had run out of money with emtricitabine, its lead HIV drug and also an NRTI, six months from approval.\par "Gilead bought Triangle for a song," says Schinazi, an Emory University professor and co-inventor of emtricitabine. Branded as Emtriva, emtricitabine was approved in July 2003. A fixed-dose pill that combined emtricitabine and tenofovir was approved and released one year later under the brand name Truvada.\par But Gilead was aiming for an all-Gilead three-in-one pill. In an article published in June 2004, Martin told the trade publication Pharmaceutical Executive that "the most important goal of our research program has been coming up with drug C."\par Drug C never materialized from Gilead's labs, at least not as part of a triple pill. Instead, the company ente}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tained an offer from Bristol-Myers to combine BMS' efavirenz -- a highly effective non-NRTI sold in the U.S. as Sustiva -- with Gilead's double pill. Although Merck invented efavirenz, Bristol-Myers owns rights in the U.S., Canada and six European countries, and getting a product onto the U.S. market first, where companies can charge premium prices, was paramount to the potential partners.\par BMS first approached in November 2003, according to the head of its U.S. pharmaceuticals business, A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 thony Hooper. "Gilead was surprised," Hooper says. "Biotechs never trust Big Pharma at first. It took us about three attempts to get them to believe we weren't just second-hand car salesmen."\par Gilead would not make any executives who worked on the joint venture available for an interview.\par Like many up-and-coming biotechs, Gilead knew what it was like to get the short end of a license deal with a Big Pharma. In Gilead's case, it was Tamiflu, the influenza treatment to which Swiss drug giant F. Hoffman-La Roche Ltd. gained worldwide rights in 1996 for $50 million, according to Gilead. A decade later, Tamiflu is being stockpiled everywhere in preparation for an avian flu epidemic. With threats to end the contract over what it called lax marketing and manufacturing on Roche's part, Gilead last year renegotiated with its "par}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ner" for an $80 million up-front payment and a new royalty rate of 14% to 22%.\par Whether Tamiflu was the touchstone for Gilead or not, it was clear to BMS' Hooper that Gilead didn't want to make a similar mistake with its HIV franchise.\par "In the beginning we would have liked a licensing deal, sure, and run it on their behalf," Hooper says. "We were both protecting and defending our turf, and we both wanted to stay in the game long-term, so why get into a turf war? It was quite clear that to keep both parties aligned and pleased, a JV made sense."\par Still, the companies couldn't come to terms for months. In April 2004, however, the Food and Drug Admi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 istration, pushed by Bush administration efforts to highlight anti-AIDS programs, made clear to the negoti}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tors, which now included Merck, that a triple pill combining the drugs in question would get a speedy review.\par An FDA official says the agency didn't apply pressure to get a deal done; the assurance that a triple pill would go to the head of the review line was enough incentive. "We said we would even outpace a priority review," says Jeffrey Murray, deputy director in the FDA's division of antiviral drug products. "With that, they knew we were serious."\par Instead of six months, Atripla sped through review in three. Three extra months of sales can mean hundreds of millions of dollars to a drugmaker.\par Given the fast track to the triple-pill market, the companies set to hammering out the joint venture, with ne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ther willing to give up rights of its drugs to the other. In some ways, what they built is a JV, and in some ways it isn't. Legally, it may be "joint," and the parent companies call it a joint venture, but because Gilead is majo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ity owner, it's not a JV in accounting terms.\par Only the oversight committees, to which each company contributes the same number of people, are split 50-50. BMS salespeople will also add Atripla to their sample cases. It's almost as though the companies struck a licensing deal, but with Gilead playing the Big Pharma role, recording the revenue and doing nearly all the actual work.\par Observers of the joint venture say Gilead seems to be in charge at nearly every turn. In the run-up to launc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing Atripla, the watchdog group Fair Pricing Coalition went to Gilead headquarters, hard by San Francisco Bay in Foster City, Calif., to lobby for reasonable pricing.\par "BMS had two representatives in the meeting, but they didn't run the show," says Martin Delaney, the coal}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion's co-founder and a veteran AIDS activist. "I'm surprised Gilead had the lead but glad, because Gilead is easier to work with."\par Gilead also did the heavy scientific lifting: the work to combine the three drugs into one pill, trying five diffe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ent formulations before getting it right. Gilead also handles the manufacturing, distribution, much of the sales and will book the sales revenue. The JV pays BMS for the raw supply of efavirenz that Gilead uses to make Atripla, but BMS doesn't receive a share of the post-sale revenue. Its sales reps receive a commission, but the main incentive to sell Atripla, says BMS spokeswoman Kathy Baum, is that it spurs the JV to buy more Sustiva from BMS.\par Delaney praises the companies for keeping Atripla's price equal to the combined prices of the three drugs sold separately. Considering that many patients who take the drugs separately will simply switch to Atripla, the partners will expand their markets only by attracting new users or users of other companies' drugs. The near-term target is GSK's Combivir, which 31,000 patients currently take alongside Sustiva, according to Gi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ead executives. A GSK spokesman declined to comment.\par Merck already distributes efavirenz internationally under the brand Stocrin and will be responsible for getting Atripla approved in most of the world, including countries where AIDS is ravaging the population. Like many drug companies, Merck and Gilead have been slammed for practices in developing countries. For years, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ternational nonprofit group Doctors Without Borders (known by its French initials, MSF, short for M\u200\'e9decins sans Fronti\u203\'e8res) has hounded Gilead for promising low prices for tenofovir in poor countries but moving slowly to submit the drug for approval. "Clearly, there's a priority for wealthy markets," says Kate Evans, a coordinator of MSF's Access to Essential Medicines campaign. The bottleneck has begun to clear this year, says Evans, "but we hope we don't experience the same type of thing with Atripla."\par For its part, Merck says it has registered efavirenz in 96 countries. In 36 of those, Merck stands to make no profit at all, says Jeffrey Sturchio, the company's vice president for external affairs.\par Over the years, a few JVs have figured prominently on the drug landscape. The erectile dysfunction trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment Cialis sprang from Lilly Icos LLC, a joint project of Icos Corp. and Eli Lilly and Co. In another JV, Merck and Schering-Plough Corp. formed MSP Singapore Co. LLC to combine their statin drugs Zetia and Zocor into one pill, branded Vytorin.\par But mention JV in biopharma, and most observers will cluck their tongues over Irish drugmaker Elan Corp plc. Starting in the late 1990s, Elan went on a spree setting up dozens of what it called "business ventures" with tiny, struggling drug companies. These ventures -- what others less charitably describe as "green ra}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bits" or "round-}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  transactions" -- allowed Elan to move money around and claim licensing fees from the JV partners as regular revenue, a variation on the off-ledger accounting by Enron Corp.\par "JV deals are disfavored for a number of reasons, and Elan's experience is one of them," says Sergio Ga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cia, co-chair of the life sciences group at law firm Fenwick & West LLP in San Francisco.\par Under federal investigation for securities fraud and hounded by shareholders, Elan in 2005 eventually settled with shareholders for $75 million and with the Securities and Exchange Commission for $15 million. It didn't admit to any of the allegations.\par "The SEC looks at [JVs] closely," says Tracy Lefteroff, who runs the life sciences practice at global accoun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing firm PricewaterhouseCoopers in San Jose, Calif. "In today's environment, they're careful to make sure these things have substance."\par With Gilead booking all sales of Atripla, it can fatten its top-line revenue. Such accounting is acceptable as long as Gilead consolidates the JV, says Lefteroff.\par With AIDS devastating sub-Saharan Africa and gaining traction in many other parts of the world, the financial technicalities behind a new key drug seem trivial in comparison. Having gained fast-track approval and an enthusiastic reception for Atripla, the BMS-Gilead collaboration may be what's needed to prod other drug companies to collaborate on HIV fixed-dose combinations.\par Observers say Merck's experimental drug MK-0518 could be a promising combination candidate. Merck just reported promising Phase 2 data on 0518, which is a new class of drug that prevents HIV from inserting its viral DNA into the host's DNA, a key step in the virus' infection cycle.\par Generics pressure is another reason for powerful drug companies to collaborate. As AIDS spreads in areas that can least afford medicines, health advocates will continue to press for low-cost treatments. On this front, Gilead, Merck and others are trying to match their deeds with their promises. In countries with powerful g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nerics industries, such as India, the drugmakers are working to protect their patents.\par The ultimate goal is an HIV vaccine. Until that comes along, drug developers are sure to heed Atripla's e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ample: the fewer the pills, the better.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 URL: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 http://www.TheDeal.com\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (96%); AIDS & HIV TREATMENT (93%); ANTIVIRALS (91%); DISEASES & DI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ORDERS (90%); PHARMACEUTICALS INDUSTRY (90%); PHARMACEUTICAL PREPARATION MFG (90%); DRUG PRICES (89%); CHRONIC DISEASES (78%); DRUG & MEDICAL DEVICES APPROVAL (78%); HOSPITALS (75%); PHYSICIANS & SURGEONS (70%); MAJOR US LAW FIRMS (63%); US FDA APPROVALS (51%); COLLEGE & UNIVERSITY PROFESSORS (50%); BIOTECHNOLOGY INDUSTRY (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BRISTOL-MYERS SQUIBB CO (84%); GILEAD SCIENCES INC (81%) Bristol-Myers Squibb; Gilead Sciences Inc.; Cooley Godward LLP\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BMY (NYSE) (84%); GILD (NASDAQ) (81%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (84%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (84%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%); NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (81%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SAN FRANCISCO BAY AREA, CA, USA (90%); SAN FRANCISCO, CA, USA (79%) CAL}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 FORNIA, USA (92%) UNITED STATES (92%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 August 31, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Web Publication\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2006 The Deal, L.L.C.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 In AIDS battle, Clinton making up for lost time The International Herald Tribune August 30, 2006 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_85}{\*\bkmkstart DOC_ID_85_0}{\*\bkmkstart doc_id_30}{\*\bkmkend DOC_ID_85}{\*\bkmkend DOC_ID_85_0}{\*\bkmkend doc_id_30}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_30"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 30 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The International Herald Tribune\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  30, 2006 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 In AIDS battle, Clinton making up for lost time}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Celia W. Dugger\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEWS; Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1696 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RWINKWAVU, Rwanda \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Bill Clinton worked the crowd of AIDS survivors, clasping the outstretched hands of children alive because of the AIDS medicines his foundation donated.\par Inside the rural hospital here that he recently helped renovate, where Rwandans were hunted down and killed during the genocide he regrets he did not try to stop as the U.S. president, Clinton heard people once skeletal from AIDS tell of their resurrections to robust health.\par Since he left office more than five years ago at age 54, Clinton has made a lasting mark in a cause that he came to only late in his presidency: fighting the AIDS pandemic across Africa and the world.\par Few public figures in the United States have spawned as much speculation about what motivates them as Clinton.\par Abroad, even fewer inspire the affectionate reception Clinton received as he raced across seven African countries in eight days in July. Crowds at roadsides and in hospitals wanted to touch him and he obliged by shaking hands, kissing babies and hugging people with AIDS. \par On Clinton's fourth visit to Rwanda, it was clear the efforts by his foundation had personal meaning. He said he was sorry his administration had failed to intervene during the 1994 genocide.\par ''The United States just blew it in Rwanda,'' he said. Paul Kagame, Rwanda's president, said he had accep}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed Clinton's repeated apologies.\par But on this }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Clinton seemed anything but a man tormented by guilt. Rather, he reveled in his role as a private citizen championing people with AIDS.\par ''The reason I do this work I do is that I really care about politics and people and public policy,'' he said in one of several interviews, scornfully dismissing questions about whether his global AIDS work is a form of r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 demption for what he failed to accomplish on the issue as president.\par Clinton was adamant he had done all he could about global AIDS with a Congress hostile to foreign aid, though he conceded that his administration fought too long to protect the patent rights of pharmaceutical companies against countries trying to make or import cheaper AIDS medicines.\par After he left office, Clinton faced some skepticism as he took up the cause of people with AIDS dying far}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 way deaths in poor countries. His administration, which sought more resources to combat AIDS domestically, had a far weaker claim to leadership on AIDS worldwide.\par When doctors specializing in public health met him at the William J. Clinton Foundation in New York in the autumn of 2002, Howard Hiatt, the former dean of the Harvard School of Public Health, bluntly asked Clinton why those present should expect that ''you'll be able to accomplish now what you didn't undertake in your presidency an attack on this plague?''\par ''Everyone was worried,'' said Richard Marlink, who headed Harvard University's AIDS Institute. ''Is this a campaign with photo ops and press releases or a long-term commitment?''\par In the years since, doctors at the forefront of AIDS treatment have worked with Clinton. Marlink volunteered to help Clinton's foundation in South Africa. Hiatt, who serves on the board of Partners in Health, a nonprofit group that works with Clinton in Rwanda, said the former president ''has really perceived the seriousness of the problem.''\par Clinton and his foundation have undertaken projects with two dozen developing countries, raising money to post nurses in rural clinics in Kenya, mustering experts to train hospital managers in Ethiopia and buying drugs for thousands of sick children, among other things.\par His foundation also has negotiated steep cuts in the price of AIDS medicines through deals with drug co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panies that cover more than 400,000 patients in dozens of countries, helping propel momentum for treatment of the destitute.\par Bernard Pecoul, who led a campaign for access to medicines for Medecins Sans Frontieres, or Doctors Without Borders, from 1998 to 2003, credited Clinton and his foundation for showing independence from the politically powerful drug industry and helping to accelerate the decline in prices for generic AIDS medicines in developing countries.\par ''They have been very clever in supporting generic policy in the United States, a country where it's not easy,'' he said. ''And sometimes they've been even more courageous than the United Nations system, which is u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 der pressure from member states.''\par The Clinton foundation's budget last year was $30 million, raised from private donors. Clinton, who oversees its operations full-time, has plunged into many causes, but he has made his most substantive contribution on AIDS.\par He said Rwanda was one of the first countries he chose to work in because ''they had a really good chance to dig out of the hole and I wanted to help them do it.''\par For years, he tried to coax Paul Farmer, known for his work caring for the poor in remote, rural Haiti, to re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 reate his model of AIDS treatment in Africa, the heart of the epidemic.\par Last year, Farmer and the group he co-founded, Partners in Health, arrived in Rwinkwavu. With support from the Clinton Foundation and others, he has transformed a dilapidated facility that lacked even a doctor into a thriving rural hospital.\par More than 1,500 people have been put on AIDS medicines here. Reproducing the pioneering model used in Haiti, Farmer has community workers, many of them peasants, deliver anti-retroviral medicines to people with AIDS every day, minimizing reliance on scarce doctors and nurses.\par Like most international leaders and U.S. advocates for people with AIDS in the 1990s, critics say, Clinton's efforts on global AIDS did not match the epic scale of the human tragedy as it unfolded across Africa and millions died and were orphaned.\par In recent years, the fight against AIDS has leapt onto the world stage, claimed by Clinton and his successor, George W. Bush.\par There is a measure of irony in this. Since 2003, Bush has marshaled billions of dollars in U.S. assistance for a global assault on the disease, financing lifesaving treatment for hundreds of thousands of people with AIDS. Yet because of his foreign policies, notably the war in Iraq, he is often met by protests when he travels abroad, while Clinton is warmly embraced across the developing world.\par ''George Bush has actually delivered more resources, but Clinton is ten times more popular in Africa,'' said Princeton Lyman, who was U.S. ambassador to South Africa under Clinton. ''That's because, just like he does everywhere, he portrays that sense that he cares.''\par On his recent tour of Africa his fifth since 2001 Clinton showed a remarkable ability to establish a human connection with people he met.\par In Johannesburg, Clinton and a frail Nelson Mandela, about to turn 88, clutched each other's hands like a long-lost son and his beloved father.\par En route to the airport in Lilongwe, Malawi, where crowds of people strained to catch a glimpse of him, Cli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton suddenly halted the motorcade, conducted an impromptu interview in the middle of the road, then plunged into a throng of young men reaching out to touch him.\par At a hospital in Mafeteng, Lesotho, Clinton strolled into a sunny courtyard with 6-year-old Arriet Moeketsi, a little girl in a polka-dot dress. Arriet, who takes AIDS medicines donated by Clinton's foundation, trustingly leaned her face against the former president and never let go of his hands during a prolonged news confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ence.\par Bill and Melinda Gates, the billionaire philanthropists, watched. Clinton had visited an AIDS project of theirs in Durban, South Africa, and they had come to Lesotho to see his work. When Clinton left the hospital with Arriet, a Clinton volunteer asked the Gateses to stay back so photographers could follow him.\par The world's wealthiest couple seemed to take no offense. The two Bills, as they have been dubbed, have taken to doing high-profile AIDS advocacy events together, with Clinton bringing star power and Gates his deep pockets.\par Clinton has come a long way on global AIDS. For most of his presidency, his trade office fought to protect the patent rights of pharmaceutical companies against attempts by developing countries to make or import cheaper generic medicines. ''I think it was wrong,'' he now says of that approach.\par During the first six years of his presidency, federal spending to fight AIDS worldwide stagnated at paltry le}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 els, never topping $141 million.\par But by his last budget, spending more than tripled to $540 million, but Clinton says that was far from enough. Even so, he contends that no one could have done better.\par The Democrats controlled Congress for only Clinton's first two years in office, he pointed out, when ''ever}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 body's obsession'' was the AIDS problem in America. After that, the Republican-dominated Congress which later supported Bush's $15 billion, five-year global AIDS plan fiercely resisted spending on foreign assi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tance.\par Michael Gerson, who was a senior adviser to Bush on global health issues, noted that the Republican Co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gress was, in fact, open to persuasion that global AIDS was a spending priority.\par But he also said the issue had ripened by the time Bush was president. The price of anti-retroviral drugs fell after Clinton left office, helping change the view that it was too costly and difficult to treat people in poor countries.\par But Gerson also said of the Clinton record: ''I don't believe they were visionary or pushed the system. I don't think they were thinking big.''\par After he left office, Clinton had a host of issues on his agenda, but quickly found himself drawn into the AIDS problem. He turned to his old friend Ira Magaziner, a fellow Rhodes scholar and corporate consultant who had managed the Clintons' failed health care reform effort. Magaziner has since led the foundation's AIDS program.\par The two men discovered in 2002 that the Bahamas was paying $3,500 per person a year for generic AIDS drugs.\par ''I said, 'Ira, please find out why in the hell these people are paying $3,500 for $500 drugs,''' Clinton said.\par They learned the Bahamas was buying through middlemen, so the foundation helped the country purchase directly from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  the Indian generic-drug manufacturer.\par ''So our first victory was a lay-down,'' Clinton said. ''All of a sudden, they could treat six times as many people for the same amount of money.''\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (92%); ETHNIC CONFLICTS (90%); HOSPITALS (89%); AIDS & HIV TREATMENT (89%); RURAL HEALTH (78%); PHARMACEUTICALS INDUSTRY (78%); EPIDEMICS (78%); US PRES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 DENTS (78%); GENOCIDE (77%); INFECTIOUS DISEASE (76%); UNIVERSITY ADMINISTRATION (76%); PHARMACEUTICAL PREPARATION MFG (73%); PUBLIC POLICY (71%); INTERVIEWS (71%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NATIONAL RELATIONS (64%); MEDICAL EDUCATION (63%); INTELLECTUAL PROPERTY LAW (61%); PATENTS (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BILL CLINTON (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW YORK, USA (79%) UNITED STATES (94%); RWANDA (94%); AFRICA (92%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 August 30, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2006 International Herald Tribune\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Clinton revels in post-presidential life The International Herald Tribune August 29, 2006 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_86}{\*\bkmkstart DOC_ID_86_0}{\*\bkmkstart doc_id_31}{\*\bkmkend DOC_ID_86}{\*\bkmkend DOC_ID_86_0}{\*\bkmkend doc_id_31}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_31"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 31 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The International Herald Tribune\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  29, 2006 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Clinton revels in post-presidential life}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Celia W. Dugger\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEWS; Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 2409 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RWINKWAVU, Rwanda \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Bill Clinton worked the crowd of AIDS survivors, joyfully shaking the outstretched hands of children who are alive because of the AIDS medicines his foundation has donated.\par Inside the rural hospital here that he recently helped renovate, where people were hunted down and killed during the genocide he regrets he didn't try to stop as president, Clinton listened earnestly as once-skeletal AIDS victims told of their resurrections to robust health.\par Since he left office more than five years ago at age 54, one of the youngest, most energetic former pres}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dents ever, Clinton has made a lasting mark in a cause that he came to only late in his presidency: fighting the AIDS pandemic across Africa and the world.\par Few American public figures have spawned as much speculation about what motivates them as Clinton and these days fewer still inspire the outpouring of admiration and affection Clinton attracts on his travels abroad.\par Throngs of people at roadsides and in hospitals reached out to touch him and he eagerly clasped hands, kissed babies and hugged AIDS victims as he raced across nine African countries in a week's time. \par On a }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  that was an adrenaline-fueled cross between a campaign romp and a dignified state visit, Clinton helicoptered to President Paul Kagame's tranquil lakeside home to have breakfast beneath an elegant white tent.\par He and Kagame then flew on together to visit the recently renovated hospital and a model AIDS program Clinton imported to Rwanda a model Kagame said he hopes to expand to other parts of the country.\par Here on Clinton's fourth visit to Rwanda, it was clear that his foundation's efforts have personal meaning for him. He said he was very sorry his administration failed to intervene during the 1994 genocide. "The United States just blew it in Rwanda," he said flatly. Kagame said he had accepted Clinton's repeated apologies.\par But Clinton seemed anything but a man tormented by guilt. Rather, he reveled in his new role as a private citizen championing AIDS victims.\par "The reason I do this work I do is that I really care about politics and people and public policy," he said in one of several interviews, scornfully dismissing questions about whether his global AIDS work is a form of r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 demption for what he failed to accomplish on the issue as president or for the Monica Lewinsky scandal.\par "I'm 60 years old now and I'm not running for anything, so I don't have to be polite any more," he said. "I think it's all a bunch of hokum, all the psychobabble crap. I have never met anybody who spent all their time tal}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing about everybody's motives who at the end of their life could talk about very many lives they had saved."\par Clinton was adamant that he'd done all he could on global AIDS with a Congress hostile to foreign aid, though he conceded his administration fought too long and hard to protect the interests of pharmaceutical companies against countries trying to make or import cheaper AIDS medicines.\par After he left office, Clinton faced some skepticism as he took up the cause of AIDS victims dying faraway deaths in poor countries. His administration, which had a strong record combating AIDS domestically, had a far weaker claim to leadership on global AIDS.\par When public health doctors met him at his foundation in New York's Harlem district in the fall of 2002, Ho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ard Hiatt, the former dean of Harvard University's School of Public Health, bluntly asked Clinton why those present should expect "you'll be able to accomplish now what you didn't undertake in your presidency an a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tack on this plague?"\par "Everyone was worried,'' said Dr. Richard Marlink, who then headed Harvard's AIDS Institute. "Is this a ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 paign with photo ops and press releases or a longterm commitment?''\par In the years since, doctors at the forefront of AIDS treatment have worked with Clinton. Marlink volunteered to help Clinton's foundation in South Africa. Hiatt, who serves on the board of Partners in Health, a nonprofit group that works with Clinton in Rwanda, said Clinton "has really perceived the seriousness of the problem.''\par Clinton and his foundation have undertaken projects with two dozen developing countries, raising money to send nurses to rural clinics in Kenya, mustering experts to train hospital managers in Ethiopia and buying drugs for thousands of sick children, among other things.\par His foundation has also negotiated steep cuts in the price of AIDS medicines through deals with drug co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panies that cover more than 400,000 patients in dozens of countries, helping propel momentum for treatment of the destitute.\par Dr. Bernard Pecoul, who headed Medecins Sans Frontieres' Access to Medicines campaign from 1998 to 2003, credited Clinton and his foundation with showing independence from the politically powerful drug i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dustry and helping accelerate the decline in prices for generic AIDS medicines in developing countries.\par "They have been very clever in supporting generic policy in the UnitedStates, a country where it's not easy,'' he said, "and sometimes they've been even more courageous than the United Nations system, which is u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 der pressure from member states.''\par The foundation's budget last year was $30 million, raised from privatedonors. Clinton, who oversees its o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erations full-time, has plunged into myriad causes, from childhood obesity to tsunami relief to global war}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing, but he has made his most substantive contribution on AIDS.\par He said Rwanda was one of the first countries he chose to work in because "they had a really good chance to dig out of the hole and I wanted to help them do it.''\par For years, he tried to coax Dr. Paul Farmer, known for his work caring for the poor in remote, rural Haiti, to recreate his model of AIDS treatment inAfrica, the epicenter of the epidemic.\par Last year, Farmer and the group he co-founded, Partners in Health, arrived in Rwinkwavu. With support from the Clinton Foundation and others, he has transformed a dilapidated facility that lacked even a doctor into a thriving hospital.\par More than 1,500 people have been put on AIDS medicines here. As in Haiti, where Farmer pioneered the approach, community workers, mostly peasants, daily deliver anti-retroviral medicines to people with AIDS.\par Like most international leaders and American AIDS advocates at the time, critics say Clinton's efforts on global AIDS through much of the 1990s did not match the epic scale of the human tragedy as it unfolded across Africa, as millions died and were orphaned.\par In recent years, the fight against AIDS worldwide has leaped onto the world stage, claimed by Clinton and his Republican successor, George W. Bush.\par There is a measure of irony in this. Since 2003, Bush has marshaled billions of dollars in American assi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tance for a global assault on the disease, financing lifesaving treatment for hundreds of thousands of victims.\par Yet because of his foreign policies, notably the war in Iraq, he is often met by protests when he travels abroad, while Clinton is warmly embraced across the developing world.\par "George Bush has actually delivered more resources, but Clinton is 10 times more popular in Africa,'' said Princeton Lyman, who was the U.S. ambassador to South Africa during Clinton's administration. "That's b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause, just like he does everywhere, he portrays that sense that he cares.''\par On his recent tour of Africa his fifth since 2001 Clinton showed an uncanny ability to establish a human co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nection with people he met.\par In Johannesburg, Clinton and a frail Nelson Mandela, about to turn 88, clutched each other's hands like a long-lost son and his beloved father.\par En route to the airport in Lilongwe, Malawi, lined with people straining to catch a glimpse of him, Clinton su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 denly halted the motorcade, conducted an impromptu interview in the middle of the road, then lunged into a sweaty mass of young men reaching out to touch him.\par At a hospital in Mafeteng, Lesotho, Clinton strolled into a sunny courtyard with 6-year-old Arriet Moeketsi, a little girl in a polka-dot dress. Arriet, who takes AIDS medicines donated by his foundation, trustingly leaned her face against him and never let go of his hands during a prolonged news conference.\par Bill and Melinda Gates, the billionaire philanthropists, looked on. Clinton had visited an AIDS project 0f theirs in Durban, South Africa, and they had come to Lesotho to see his work.\par When Clinton left the hospital with Arriet, a Clinton volunteer asked the Gateses to stay back so photogr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 phers could trail the former president.\par The world's wealthiest couple seemed to take no offense. The two Bills have taken to doing high-profile AIDS advocacy events together, with Clinton bringing star power and Gates his deep pockets .\par "He plays a unique role in shining a light on the problem,'' Gates said.\par Clinton has come a long way on global AIDS. For most of his presidency, his trade office fought to protect the patent rights of pharmaceutical companies against attempts by developing countries to make or import cheaper, generic medicines. "I think it was wrong,'' he now says of that approach.\par During the first six years of his presidency, federal spending to fight AIDS worldwide stagnated at paltry le}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 els, never topping $141 million, while it soared to over $10 billion for AIDS domestically.\par In his last budget, spending globally rose to $540 million, more than tripling, but Clinton himself says that was far from enough. Even so, he contends, no one else could have done better.\par The Democrats controlled Congress for only his first two years in office, he pointed out, when "everybody's obsession'' was the AIDS problem in America. After that, the Republican-dominated Congress, which later supported Bush's $15 billion, five-year global AIDS plan, fiercely resisted spending on foreign assistance.\par "Have you forgotten what I had in the Congress?'' he asked. "That the Republican Congress spent all their time trying to trash me?\par "And the only reason they gave money to George Bush for AIDS is they wanted to have something they looked progressive on, since they were cutting taxes for rich people like me."\par Michael Gerson, who was a senior adviser to Bush on global health, noted that the Republican Congress did turn out to be persuadable on global AIDS. But he also said the issue had ripened by the time Bush was president. The price of antiretroviral drugs plunged after Clinton left office, helping change the mainstream view that it was too costly and difficult to treat Africans.\par But Gerson also said of the Clinton record, "I don't believe they were visionary or pushed the system. I don't think they were thinking big.''\par The debate over whether Clinton missed a political opportunity to lead the charge on global AIDS years b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fore Bush seized it is far from over.\par Greg Behrman, author of "The Invisible People: How the U.S. Has Slept Through the Global AIDS Pandemic, the Greatest Humanitarian Catastrophe of Our Time,'' offers a split verdict.\par "There are two acts here,'' he said. "Clinton's post-presidential leadership has been extraordinary. As pres}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dent, though, the record is clear. Clinton was not a leader on global AIDS and the consequences have been devastating.''\par After he left office, Clinton considered his future with a keen eye onhistory, analyzing what former presidents had done.\par He concluded that another former Southern governor, Jimmy Carter, a Nobel Peace Prize winner who is now revered for his work on human rights, democracy and neglected diseases, was "the only person who'd done anything that remotely resembled what I thought I could do.''\par Clinton said in no way were his humanitarian endeavors intended to establish his place in history after a presidency damaged by impeachment.\par "I'm not proud of the mistake I made,'' he said. "And I've paid for it over and over and over again. But I'm very proud that I beat those forces of impeachment because they would have done lasting damage to the Const}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tution, the institution of the presidency and basically the very fabric of our legal system if we hadn't whipped them.''\par From the start, Clinton had a world of issues on his agenda, but quickly found himself drawn into AIDS.\par He turned to his old friend Ira Magaziner, a fellow Rhodes scholar and corporate consultant who had ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 aged the Clintons' failed health care reform effort. Magaziner has since worked punishing hours as a volu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 teer, heading the foundation's AIDS program.\par The two men discovered in 2002 that the Bahamas were paying $3,500 per person per year for generic AIDS drugs. "I said, Ira, please find out why in the hell these people are paying $3,500 for $500 drugs,'' Clinton said\par They learned the country was buying through middlemen. The foundation helped it purchase directly from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , the Indian generic drug manufacturer.\par "So our first victory was a laydown,'' Clinton said. "All of a sudden, they could treat six times as many people for the same amount of money.''\par Opportunities proliferated. Clinton's enthusiasm grew.\par His name opened doors with generic drug makers. With growing demand for AIDS drugs already on the hor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 zon and the economies of scale that come with growing volumes Magaziner took a team of volunteer co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sultants to India in 2003 to negotiate for lower prices. Companies opened their books.\par "The name Clinton in India holds more charisma and credibility than any other American name,'' explained }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  chairman, Yusuf Hamied.\par Through cost-cutting, spurred by breakthrough talks with companies that supplied ingredients to the drug makers, the team got deals. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , for example, halved the price of the most common AIDS triple therapy, already declining due to competition, to $140 a person per year.\par Similarly, Clinton was able to use his entree with political leaders, like President Thabo Mbeki of South Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ca, who had questioned whether HIV caused AIDS. The country had not begun treating its people for the disease, though five million were infected.\par "He was getting killed in the global press about it,'' Clinton recalled.\par Clinton, who knew him from his own time as president, met privately with Mbeki in 2003 as one politician to another. "I said, 'You know, I really want to help you, and as you know, I may be the only one of those i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 volved in this work who's never been publicly critical of you,''' Clinton said he told Mbeki. "'But this is som}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 thing you have to do.'''\par Mbeki soon invited Clinton's foundation to help the country write a comprehensive treatment plan. South Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ca now has more than 130,000 people on antiretroviral drugs, still far short of what critics say is needed.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (95%); HOSPITALS (90%); ETHNIC CONFLICTS (89%); AIDS & HIV TREATMENT (78%); AIDS POLICY (78%); US PRESIDENTS (78%); RURAL HEALTH (77%); INTERVIEWS (76%); EP}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 DEMICS (73%); GENOCIDE (72%); INTERNATIONAL TOURISM (68%); PUBLIC POLICY (66%); POLIT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CAL SCANDALS (60%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BILL CLINTON (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RWANDA (94%); UNITED STATES (92%); AFRICA (92%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 August 29, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2006 International Herald Tribune\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Clinton Makes Up for Lost Time in Battling AIDS The New York Times August 29, 2006 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_87}{\*\bkmkstart DOC_ID_87_0}{\*\bkmkstart doc_id_32}{\*\bkmkend DOC_ID_87}{\*\bkmkend DOC_ID_87_0}{\*\bkmkend doc_id_32}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_32"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 32 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The New York Times\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  29, 2006 Tuesday  \par Late Edition - Final\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Clinton Makes Up for Lost Time in Battling AIDS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 By CELIA W. DUGGER\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Section A; Column 2; Foreign Desk; Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 2648 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RWINKWAVU, Rwanda \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Bill Clinton worked the crowd of AIDS survivors, clasping the outstretched hands of children alive because of the AIDS medicines his foundation donated.\par   Inside the rural hospital here that he recently helped renovate, where Rwandans were hunted down and killed during the genocide he regrets he didn't try to stop as president, Mr. Clinton heard people once skeletal from AIDS tell of their resurrections to robust health.\par Since he left office more than five years ago at age 54, one of the youngest former presidents ever, Mr. Cli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton has made a lasting mark in a cause that he came to only late in his presidency: fighting the AIDS pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 demic across Africa and the world. \par   Few public figures in America have spawned as much speculation about what motivates them as Mr. Cli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton. Abroad, even fewer inspire the affectionate reception Mr. Clinton received as he raced across seven African countries in eight days in July. Crowds at roadsides and in hospitals wanted to touch him -- and he obliged by shaking hands, kissing babies and hugging people with AIDS. \par   Here on Mr. Clinton's fourth visit to Rwanda, it was clear the efforts by his foundation had personal mea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing. He said he was sorry his administration failed to intervene during the 1994 genocide. ''The United States just blew it in Rwanda,'' he said flatly. Paul Kagame, Rwanda's president, said he had accepted Mr. Clinton's repeated apologies.\par   But on this }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Mr. Clinton seemed anything but a man tormented by guilt. Rather, he reveled in his role as a private citizen championing people with AIDS. \par   ''The reason I do this work I do is that I really care about politics and people and public policy,'' he said in one of several interviews, scornfully dismissing questions about whether his global AIDS work is a form of redemption for what he failed to accomplish on the issue as president, or for the Monica Lewinsky scandal. ''I'm 60 years old now, and I'm not running for anything, so I don't have to be polite anymore,'' he said. ''I think it's all a bunch of hokum,'' he added, calling such speculation psychobabble. \par   ''I have never met anybody who spent all their time talking about everybody's motives who at the end of their life could talk about very many lives they had saved,'' he said.\par   Mr. Clinton was adamant that he had done all he could about global AIDS with a Congress hostile to foreign aid, though he conceded that his administration fought too long to protect the patent rights of pharmaceutical companies against countries trying to make or import cheaper AIDS medicines. \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par 'Everyone Was Worried'\par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414   After he left office, Mr. Clinton faced some skepticism as he took up the cause of people with AIDS dying faraway deaths in poor countries. His administration, which sought more resources to combat AIDS domest}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cally, had a far weaker claim to leadership on AIDS worldwide. \par   When doctors specializing in public health met him at the William J. Clinton Foundation in Harlem in the fall of 2002, Howard Hiatt, the former dean of the Harvard School of Public Health, bluntly asked Mr. Clinton why those present should expect that ''you'll be able to accomplish now what you didn't undertake in your pres}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dency -- an attack on this plague?'' \par   ''Everyone was worried,'' said Richard Marlink, who headed Harvard's AIDS Institute. ''Is this a campaign with photo ops and press releases or a long-term commitment?'' \par   In the years since, doctors at the forefront of AIDS treatment have worked with Mr. Clinton. Dr. Marlink vo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 unteered to help Mr. Clinton's foundation in South Africa. Dr. Hiatt, who serves on the board of Partners in Health, a nonprofit group that works with Mr. Clinton in Rwanda, said the former president ''has really pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ceived the seriousness of the problem.'' \par   Mr. Clinton and his foundation have undertaken projects with two dozen developing countries, raising mo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ey to post nurses in rural clinics in Kenya, mustering experts to train hospital managers in Ethiopia and bu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing drugs for thousands of sick children, among other things.\par   His foundation also has negotiated steep cuts in the price of AIDS medicines through deals with drug co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panies that cover more than 400,000 patients in dozens of countries, helping propel momentum for treatment of the destitute. \par   Dr. Bernard Pecoul, who led a campaign for access to medicines for Doctors Without Borders from 1998 to 2003, credited Mr. Clinton and his foundation for showing independence from the politically powerful drug industry and helping to accelerate the decline in prices for generic AIDS medicines in developing countries.\par   ''They have been very clever in supporting generic policy in the United States, a country where it's not easy,'' he said. ''And sometimes they've been even more courageous than the United Nations system, which is under pressure from member states.''\par   The Clinton foundation's budget last year was $30 million, raised from private donors. Mr. Clinton, who oversees its operations full time, has plunged into many causes, from childhood obesity to tsunami relief to global warming, but he has made his most substantive contribution on AIDS. \par   He said Rwanda was one of the first countries he chose to work in because ''they had a really good chance to dig out of the hole and I wanted to help them do it.''\par   For years, he tried to coax Dr. Paul Farmer, known for his work caring for the poor in remote, rural Haiti, to recreate his model of AIDS treatment in Africa, the heart of the epidemic.\par   Last year, Dr. Farmer and the group he co-founded, Partners in Health, arrived in Rwinkwavu. With support from the Clinton Foundation and others, he has transformed a dilapidated facility that lacked even a doctor into a thriving rural hospital. \par   More than 1,500 people have been put on AIDS medicines here. Reproducing the pioneering model used in Haiti, Dr. Farmer has community workers, many of them peasants, deliver antiretroviral medicines to people with AIDS every day, minimizing reliance on scarce doctors and nurses.\par   Like most international leaders and American advocates for people with AIDS in the 1990's, critics say, Mr. Clinton's efforts on global AIDS did not match the epic scale of the human tragedy as it unfolded across Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ca and millions died and were orphaned. \par   In recent years, the fight against AIDS has leapt onto the world stage, claimed by Mr. Clinton and his R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 publican successor, George W. Bush.\par   There is a measure of irony in this. Since 2003, Mr. Bush has marshaled billions of dollars in American a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sistance for a global assault on the disease, financing lifesaving treatment for hundreds of thousands of pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple with AIDS. Yet because of his foreign policies, notably the war in Iraq, he is often met by protests when he travels abroad, while Mr. Clinton is warmly embraced across the developing world.\par   ''George Bush has actually delivered more resources, but Clinton is ten times more popular in Africa,'' said Princeton Lyman, who was American ambassador to South Africa under Mr. Clinton. ''That's because, just like he does everywhere, he portrays that sense that he cares.''\par   On his recent tour of Africa -- his fifth since 2001 -- Mr. Clinton showed a remarkable ability to establish a human connection with people he met. \par   In Johannesburg, Mr. Clinton and a frail Nelson Mandela, about to turn 88, clutched each other's hands like a long-lost son and his beloved father. \par   En route to the airport in Lilongwe, Malawi, where crowds of people strained to catch a glimpse of him, Mr. Clinton suddenly halted the motorcade, conducted an impromptu interview in the middle of the road, then plunged into a throng of young men reaching out to touch him. \par   At a hospital in Mafeteng, Lesotho, Mr. Clinton strolled into a sunny courtyard with 6-year-old Arriet Moeketsi, a little girl in a polka-dot dress. Arriet, who takes AIDS medicines donated by Mr. Clinton's found}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion, trustingly leaned her face against the former president and never let go of his hands during a prolonged news conference. \par   Bill and Melinda Gates, the billionaire philanthropists, watched. Mr. Clinton had visited an AIDS project of theirs in Durban, South Africa, and they had come to Lesotho to see his work. When Mr. Clinton left the ho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pital with Arriet, a Clinton volunteer asked the Gateses to stay back so photographers could follow him. \par   The world's wealthiest couple seemed to take no offense. The two Bills, as they have been dubbed, have taken to doing high-profile AIDS advocacy events together, with Mr. Clinton bringing star power and Mr. Gates his deep pockets.\par   ''He plays a unique role in shining a light on the problem,'' said Mr. Gates, after he made it into the cour}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 yard.\par   Mr. Clinton has come a long way on global AIDS. For most of his presidency, his trade office fought to pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tect the patent rights of pharmaceutical companies against attempts by developing countries to make or i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 port cheaper generic medicines. ''I think it was wrong,'' he now says of that approach.\par   During the first six years of his presidency, federal spending to fight AIDS worldwide stagnated at paltry levels, never topping $141 million. \par   But by his last budget, spending more than tripled to $540 million, but Mr. Clinton says that was far from enough. Even so, he contends that no one could have done better. \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par The Role of Congress\par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414   The Democrats controlled Congress for only his first two years in office, he pointed out, when ''everybody's obsession'' was the AIDS problem in America. After that, the Republican-dominated Congress that later su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ported Mr. Bush's $15 billion, five-year global AIDS plan fiercely resisted spending on foreign assistance. \par   ''Have you forgotten what I had in the Congress?'' he asked. ''That the Republican Congress spent all their time trying to trash me? \par   ''And the only reason they gave money to George Bush for AIDS is they wanted to have something they looked progressive on since they were cutting taxes for rich people like me,'' he said.\par   Michael Gerson, who was a senior adviser to Mr. Bush on global health issues, noted that the Republican Congress was, in fact, open to persuasion that global AIDS was a spending priority. But he also said the i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sue had ripened by the time Mr. Bush was president. The price of antiretroviral drugs fell after Mr. Clinton left office, helping change the view that it was too costly and difficult to treat people in poor countries.\par   But Mr. Gerson also said of the Clinton record: ''I don't believe they were visionary or pushed the system. I don't think they were thinking big.''\par   The debate over whether Mr. Clinton missed a political opportunity to lead the charge on global AIDS years before Mr. Bush seized it is far from over.\par   Greg Behrman, the author of ''The Invisible People: How the U.S. Has Slept Through the Global AIDS Pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 demic, the Greatest Humanitarian Catastrophe of Our Time,'' offers a split verdict.\par   ''There are two acts here,'' he said. ''Clinton's post-presidential leadership has been extraordinary. As pres}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dent, though, the record is clear. Clinton was not a leader on global AIDS and the consequences have been devastating.''\par   After he left office, Mr. Clinton considered his future with a keen eye on history, analyzing what former pre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 idents had done. \par   He concluded that another former Southern governor, Jimmy Carter, a Nobel Peace Prize winner who is now recognized for his work on human rights, democracy and neglected diseases, was ''the only person who'd done anything that remotely resembled what I thought I could do.''\par   From the start, Mr. Clinton had a host of issues on his agenda, but quickly found himself drawn into AIDS. He turned to his old friend Ira Magaziner, a fellow Rhodes scholar and corporate consultant who had ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 aged the Clintons' failed health care reform effort. Mr. Magaziner has since led the foundation's AIDS pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gram. \par   The two men discovered in 2002 that the Bahamas was paying $3,500 per person a year for generic AIDS drugs. ''I said, 'Ira, please find out why in the hell these people are paying $3,500 for $500 drugs,' '' Mr. Cli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton said. \par   They learned the Bahamas was buying through middlemen, so the foundation helped the country purchase directly from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , the Indian generic-drug manufacturer. ''So our first victory was a lay-down,'' Mr. Clinton said. ''All of a sudden, they could treat six times as many people for the same amount of money.''\par   Opportunities proliferated, and Mr. Clinton's enthusiasm grew. \par   His name opened doors with generic drug makers. With growing demand for AIDS drugs already on the horizon, as well as the economies of scale that come with that, Mr. Magaziner took a team of volunteer co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sultants to India in 2003 to negotiate for lower prices. Companies opened their books. \par   ''The name Clinton in India holds more charisma and credibility than any other American name,'' said Dr. Yusuf K. Hamied, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  chairman. \par   Through cost cutting, spurred by breakthrough talks with companies that supplied ingredients to the drug makers, the team got deals. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , for example, halved the price of the most common AIDS triple-drug the}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 apy, already declining due to competition, to $140 a person per year.\par   Similarly, Mr. Clinton was able to use his relationships with political leaders, like President Thabo Mbeki of South Africa, who had questioned whether H.I.V. caused AIDS. The country had not begun treating its pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple for the disease, though almost five million had been infected. ''He was getting killed in the global press about it,'' Mr. Clinton recalled.\par   Mr. Clinton, who knew him from his own time as president, met with Mr. Mbeki in 2003 as one politician to another. ''I said, 'You know, I really want to help you, and as you know, I may be the only one of those i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 volved in this work who's never been publicly critical of you,' '' Mr. Clinton said he told Mr. Mbeki. '' 'But this is something you have to do.' '' \par   Mr. Mbeki soon invited Mr. Clinton's foundation to help the country write a comprehensive treatment plan. South Africa now has more than 130,000 people on antiretroviral drugs, still far short of what critics say is needed.\par   Since 2004, Mr. Clinton has campaigned to raise the profile of children with AIDS. A scant 20,000 children in the developing world were then getting drug treatment, while more than 500,000 a year were dying. The Clinton foundation has raised $4.4 million to buy drugs for 13,000 children, train health workers, renovate pediatric wings and pay for lab tests.\par   ''Children are alive in numbers we couldn't have imagined a couple of years ago because of what he's done,'' said Peter McDermott, chief of H.I.V. and AIDS programs at Unicef.\par   Mr. Clinton's ambitions seem to grow daily, and his foundation is now branching out in Africa from AIDS into poverty. As he relaxed one recent evening in a sumptuous, $2,260-a-night suite in Johannesburg, with zebra skin rugs underfoot (the lodgings provided to him gratis by a rich South African businessman who owned the hotel), he got excited just thinking about fertilizer.\par   Mr. Magaziner has people riding trains and trucks that carry fertilizer to figure out why a commodity that should enable farmers to grow more food and avoid hunger costs so much in Africa. \par   ''You follow the trail!'' Mr. Clinton said. \par   Mr. Clinton was joined on his }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  by Sir Tom Hunter, a Scottish entrepreneur who has promised to spend $100 million of his fortune in collaboration with the foundation, much of it on economic development. \par   ''Tom, where's Tom?'' Mr. Clinton called out excitedly as he chatted with representatives of a nonprofit group that promotes solar-powered lights during an event here in Rwinkwavu. \par   What if Rwanda could manufacture such lights locally? Mr. Clinton mused. Why not electrify villages so children can study at night? ''It might be possible to get a factory here that would serve all of central Africa!''\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 URL: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 http://www.nytimes.com\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (98%); AIDS & HIV TREATMENT (90%); ETHNIC CONFLICTS (90%); PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CEUTICALS INDUSTRY (89%); HOSPITALS (78%); RURAL HEALTH (78%); GENOCIDE (77%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 VIEWS (76%); PHARMACEUTICAL PREPARATION MFG (73%); EPIDEMICS (73%); PUBLIC POLICY (71%); INTERNATIONAL RELATIONS (64%); POLITICAL SCANDALS (63%); INTELLECTUAL PROPERTY LAW (60%); PATENTS (50%) Acquired Immune Deficiency Syndrome; Children and Youth; Drugs (Pharm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ceuticals); Acquired Immune Deficiency Syndrome; Acquired Immune Deficiency Syndrome\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Clinton, William J, Presidential Foundation\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BILL CLINTON (94%) Celia W Dugger; Bill Clinton\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 RWANDA (94%); AFRICA (94%); UNITED STATES (92%); SOUTH AFRICA (79%); LES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 THO (79%) Africa\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 August 29, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Photos: BEDSIDE -- Nelson Mandela and Bill Clinton visited sick infants in Johannesburg.\par RETURNING HEALTH -- A woman and her baby, who is H.I.V. positive but whose condition has been i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 proving, rested at a hospital in Rwinkwavu, above. The facility is being financed in part by the Clinton Fou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dation, which works with Partners in Health, a nonprofit group credited with transforming the dilapidated ou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 post, which lacked even a doctor, into a thriving rural hospital. At left, John Gumiriza stood by a photo taken of him in 2005, before he started taking antiretroviral drugs, which have been provided to him and others at reduced cost. (Photographs by Evelyn Hockstein for The New York Times)(pg. A8)\par  Bill Clinton spoke with a girl at a treatment center in Lesotho in July. The Africa }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  was his fifth since 2001. (Photo by Evelyn Hockstein for The New York Times)(pg. A1) \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2006 The New York Times Company\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; New Law Will Hinder ARV Supply Africa News July 25, 2006 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_88}{\*\bkmkstart DOC_ID_88_0}{\*\bkmkstart doc_id_33}{\*\bkmkend DOC_ID_88}{\*\bkmkend DOC_ID_88_0}{\*\bkmkend doc_id_33}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_33"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 33 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  25, 2006 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par New Law Will Hinder ARV Supply}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 New Vision\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 486 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SCARING news for the poor living with HIV/AIDS has popped up once again. Reuters reported last week that India is planning to change its drug approval system in a way that would put the price of Anti Retroviral drugs (ARVs) out of reach of millions of poor people.\par New Delhi, under pressure from the United States and global drug giants, is considering a law that could grant a monopoly to the developer of a new drug for several years even without a patent. Leena Menghaney of Swiss-based Medecins Sans Frontieres, which campaigns for better access to healthcare, says this will seriously affect accessibility to essential drugs for poor people, especially in developing countries. \par Particularly threatened are people with HIV who had developed immunity to first-line anti-retroviral drugs and were waiting for second-line drugs to become affordable, Menghaney said.\par According to a Reuters report, making generic ARVs has been easy in India. Once a new drug is approved for sale, other drug companies only need to prove that the one they are copying is identical to the original. But innovating drug companies say this is unfair. That they invest millions of dollars collecting the necessary data they need for marketing approval through clinical trials yet the system makes it difficult for them to r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cover their investment capital.\par They argue that this reduces the incentive to research and develop new drugs.\par India, as a member of the World Health Organisation (WHO), is being hard pressed to concede to the d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mands of the US and the giant companies by giving them exclusive rights to reap the benefit of their inves}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment for several years under the Trade-related aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPs)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  treaty.\par However, other campaigners including WHO argue that facts go beyond what }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  require and should not be introduced at the expense of public health.\par At least 90,000 Ugandans urgently need ARVs and India remains the main manufacturer of these lifesavers.\par But Dr Elizabeth Madra, the Head of the Aids Control Programme at the Ministry of Health, says Uganda is on the verge of manufacturing ARVs. Quality Chemicals Limited, a local agent of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd, the worlds lea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing manufacturer of generic pharmaceutical drugs, is constructing the plant in Luzira Industrial Park.\par Emmanuel Katongore, the managing director of Quality Chemicals, said the $50m project is expected to start test runs this month and the project is expected to be commissioned in October.\par Dr Philip Okumu from Bugolobi Nursing Home said generic drugs have been a blessing to the poor who ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 not afford brand names. The cost of one brand name ARV dose can purchase three doses of generic drugs. Okumu said if India yields to the US pressure, over 25 million people in sub-Saharan Africa would be affec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed. "Very few people can afford branded ARVs. This would mean that over 80% of the people in poor cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tries would be affected," he said.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICALS INDUSTRY (91%); AIDS & HIV (91%); CLINICAL TRIALS (90%); DRUG & MEDICAL DEVICES APPROVAL (90%); ANTIVIRALS (89%); PRESCRIPTION DRUGS (89%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LECTUAL PROPERTY LAW (89%); GENERIC DRUGS (89%); PUBLIC HEALTH ADMINISTRATION (87%); BRANDING (87%); MANUFACTURING OUTPUT (78%); HEALTH DEPARTMENTS (78%); DRUG DESIGN & DISCOVERY (78%); AIDS & HIV TREATMENT (78%); DEVELOPING COUNTRIES (78%); INTELLE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TUAL PROPERTY (78%); APPROVALS (77%); PATENT LAW (76%); INDUSTRIAL PROPERTY (76%); PHARMACEUTICALS PRODUCT DEVELOPMENT (76%); DRUG PRICES (73%); GENERIC PRODUCTS (72%); LEGAL MONOPOLIZATION (71%); RELIEF ORGANIZATIONS (70%); MEDICAL CHARITIES (70%); HEALTH CARE ACCESS (70%); LONG TERM HEALTH CARE (70%); LICENSING AGREEMENTS (66%); PLANT CONSTRUCTION (61%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD HEALTH ORGANIZATION (71%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (84%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW DELHI, INDIA (90%) INDIA (95%); UNITED STATES (94%); UGANDA (94%); AFR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CA (79%); SUB SAHARAN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 July 26, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2006 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 U.S. pushes to limit generic drug rights; Agreements seek to extend monopolies in exchange for improvements in trade The International Herald Tribune April 19, 2006 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_89}{\*\bkmkstart DOC_ID_89_0}{\*\bkmkstart doc_id_34}{\*\bkmkend DOC_ID_89}{\*\bkmkend DOC_ID_89_0}{\*\bkmkend doc_id_34}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_34"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 34 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The International Herald Tribune\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  19, 2006 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 U.S. pushes to limit generic drug rights; \par Agreements seek to extend monopolies in exchange for improvements in trade}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Anand Giridharadas\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEWS; Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1610 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW DELHI \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Brian Knowlton in Washington contributed reporting to this article.\par *\par Under global trading rules, the inventors of medicines ordinarily enjoy the right to a 20-year monopoly on their inventions. But five years ago, the United States joined 141 other countries to sign the Doha Declar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion, confirming the right of poor countries to break drug patents and produce cheap generic drugs in the event of contagions like HIV.\par At the time, Thailand was heartened. It had been trying everything in its fight against AIDS. It coined a jingle to promote safe sex. It placed condoms in massage parlors. Most important, it curbed deaths among the poor by giving them generic versions of medicines invented by multinational drug makers. \par So it came as a jolt in January when the United States asked Thailand to sign a free trade agreement that would, on paper, dilute its right to break patents and use generics.\par Washington said the agreement would save lives by spurring innovation and by making multinationals more confident in selling drugs in the country. But Thai officials saw the proposal as a morbid bargain: either r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fuse the U.S. offer, and thereby scuttle a trade deal with the United States worth billions of dollars, or accept it and lift the price of AIDS drugs beyond the reach of the poor.\par ''Those who require the essential drugs but cannot afford it, they will have to die,'' said Dr. Suwit Wibu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 polprasert, the Thai official who is coordinating the Public Health Ministry's response to the U.S. proposal.\par Thailand is not alone. It is merely the latest target of a quiet worldwide campaign by the administration of President George W. Bush to coax developing nations to barter away their patent-breaking rights in e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 change for lucrative trade benefits, according to public-health experts and government officials from Thailand to Brazil.\par Specifically, Washington is pushing bilateral and regional trade agreements in which countries enact ''supe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 patents'' that prolong U.S. drug makers' monopolies and limit the conditions under which their patents can be broken. These new rules, once they are adopted by developing countries, roll back the patent-breaking rights that were confirmed by the 2001 declaration at World Trade Organization talks in Doha, Qatar.\par In effect, Washington is stitching together its own parallel global patents system. The trade deals, negotiated in secret, attract little notice. But they have already been signed with developing countries battling AIDS, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cluding six in Central America. And negotiations are beginning with several nations pivotal to the fight against the virus, from Thailand to five southern African countries, including South Africa and Botswana.\par Because of these agreements, India's generics industry, the world's largest, is reining in plans to supply poor countries and refocusing on richer ones, said Dilip Shah, head of the Indian Pharmaceutical Alliance, which represents generic makers.\par "For the Indian pharma industry," he said, "it's not doomed; it will find a way out. But for the patients in the third world, it's bad."\par Public health officials warn of catastrophic consequences if the bilateral deals are applied to AIDS drugs.\par ''If you prevent countries from using generic drugs,'' said Pedro Chequer, the head of Brazil's national AIDS program, ''you are creating a concrete obstacle to providing access to drugs. You are promoting genocide, because you're killing people.''\par First-generation AIDS drugs reached the world's poorest people only when the use of generics cut their cost to $140 a year from more than $10,000. As new drugs emerge to treat patients resistant to first-line med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cines, the trade agreements make a similar drop ''extremely difficult to ensure,'' according to Medecins Sans Frontieres, or Doctors Without Borders.\par Washington maintains that the trade deals are directed toward diseases other than AIDS.\par And Richard Feachem, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, acknowledged that it was too early to tell whether the bilateral agreements would be used to block access to AIDS drugs.\par ''If we do see this in practice,'' he said, ''we should condemn it. But it really is in the interpretation of these agreements in very particular circumstances.''\par Yet, in defending the bilateral agreements, Bush administration officials often cite the AIDS example to make their case. Stronger patents save lives, the argument goes, by keeping companies confident enough in profit to keep discovering new drugs.\par Dr. Mark Dybul, the second-ranking official in the White House program to fight AIDS, said that because AIDS patients constantly grow resistant to medicines, it is disastrous to widen access today and have no drugs tomorrow.\par ''As an individual physician sitting in front of an individual patient, you will do whatever you need to for that patient now,'' said Dybul, a physician by training. ''When you're a public-health physician, you're not a phys}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cian for one person but for millions of people. And you need to be thinking about whether the action in that single setting, repeated hundreds of thousands of times, will cause a problem for the millions.''\par Spreading the new patents system are U.S. trade negotiators, who some experts believe are assuming the influence that public health experts once had over the Bush administration's AIDS policy.\par Victoria Espinel, an assistant U.S. trade representative, strongly defended the use of trade agreements to promote patents that ''have more in place'' than the patents agreed upon at the WTO talks in Doha, which she described as merely ''harmonizing minimum standards.''\par ''It is crucial to public health,'' she said, ''to promote the innovation of drugs and to make sure that research and development of drugs continues.''\par As for exempting AIDS drugs from the new accords on patent-breaking, she said, ''I want to emphasize that there is enough flexibility in our free-trade agreements to allow our partners to do what they need to do.''\par An explicit promise to exempt AIDS drugs, however, is not in the agreements, said Wibulpolprasert, the Thai official. And that, experts say, is at the heart of the problem: Nations must take Washington's word for it.\par An examination by the International Herald Tribune of several free-trade accords reveals provisions that a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pear, on paper, to limit the freedom to use generics.\par Several agreements, for example, prolong a patent monopoly beyond 20 years if the developing country's regulators show ''unreasonable delays'' in approving a patent. This provision, absent from World Trade O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ganization rules, sustains higher prices.\par Many agreements also serve to prolong patents by requiring generics to be retested as if they were new i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ventions. Retesting a drug biologically equivalent to one already approved takes time and may be unethical, since infected patients must be given placebos. The WTO rejected this five-year ban on the use by generic makers of the safety data submitted for the original branded drug.\par And while the WTO lets countries decide when to break patents, the new U.S. agreements limit this action to special cases to enforce antitrust law, for example, or during emergencies. Experts say the most important use of generics is excluded: to reduce costs by making branded products compete with generics.\par The generics question has also opened a rift in the United States, between Bush and former President Bill Clinton. On a recent visit to New Delhi, Clinton said he had confronted Bush about generics while flying to Rome for the papal funeral last April.\par ''The American position is untenable,'' Clinton recalled saying.\par In an interview, Clinton said Washington was succumbing to the influence of the drug lobby in undermining the Agreement on Trade-Related Aspects of Intellectual Property Rights, or }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  the WTO framework on which the Doha Declaration built.\par ''The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  system essentially said there was an exception for life-saving medicine,'' Clinton said. ''And b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sically, the American drug companies and the American government really put the hammer on the bill not to use the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  system.''\par Referring to generic producers, he added: ''If a company develops a new advance in AIDS, TB, malaria, you need large numbers right away and all the people who need it are in poor places. If you don't have }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ranbaxy, Hetero, Aspen in South Africa and other people to step into the breach, how are we going to do that?''\par Last year, when Brazil was faced with upgrading tens of thousands from $140-a-year generics to Kaletra, a patented drug costing more than $3,000 a year, it threatened to break the patent unless given a discount by the U.S. company Abbott Laboratories, Kaletra's inventor. Members of Congress in the United States threa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ened import tariffs in retaliation. Although the Bush administration says it was not involved, Espinel, the a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sistant U.S. trade representative, hinted at how Washington's tacit desires can be enough to make countries fall into line.\par ''Do I think that that would be the best way for a country to go about promoting itself as an innovation player and a destination for foreign investment?'' Espinel said. ''Probably not.''\par Clinton came to Brazil's rescue. His foundation tapped overseas contacts to find a generic drug for about $900 a year a price Brazil used to negotiate with Abbott, which spent $1.8 billion on research in 2005 and reported a profit of $3.4 billion\par Finally, Brazil backed down from its threat to break the patent, and Abbott gave it a discount of about 50 pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cent.\par Abbott is ''gratified to get support'' from ''people in and outside of government,'' said a company spokesman, Brian Kyhos.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GENERIC DRUGS (91%); TRADE TREATIES & AGREEMENTS (90%); AIDS & HIV (90%); TREATIES & AGREEMENTS (90%); PHARMACEUTICALS INDUSTRY (90%); GENERIC PRODUCTS (90%); INTERNATIONAL TRADE LAW (89%); TRADE DEVELOPMENT (89%); PHARMACEUTICAL PREPARATION MFG (89%); PATENTS (89%); INTERNATIONAL TRADE (89%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TRIES (89%); PHARMACEUTICALS PATENTS (78%); AGENCY RULEMAKING (78%); AIDS & HIV TREATMENT (78%); ANTIVIRALS (78%); HEALTH DEPARTMENTS (78%); MULTINATIONAL CORPOR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TIONS (78%); EMERGING MARKETS (78%); INTERGOVERNMENTAL TALKS (77%); FREE TRADE TREATIES & AGREEMENTS (77%); DRUG PRICES (73%); US PRESIDENTS (72%); PUBLIC HEALTH ADMINISTRATION (66%); MASSAGE SERVICES (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GEORGE W BUSH (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW DELHI, INDIA (79%) UNITED STATES (99%); THAILAND (93%); INDIA (92%); Q}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TAR (92%); BOTSWANA (79%); AFRICA (79%); CENTRAL AMERICA (79%); SOUTHERN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 April 19, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2006 International Herald Tribune\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 U.S. pushes to limit generic-drug rights in trade pacts The International Herald Tribune April 19, 2006 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_90}{\*\bkmkstart DOC_ID_90_0}{\*\bkmkstart doc_id_35}{\*\bkmkend DOC_ID_90}{\*\bkmkend DOC_ID_90_0}{\*\bkmkend doc_id_35}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_35"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 35 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The International Herald Tribune\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  19, 2006 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 U.S. pushes to limit generic-drug rights in trade pacts}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Anand Giridharadas\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 FINANCE; Pg. 13\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1381 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW DELHI \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Brian Knowlton in Washington contributed reporting to this article.\par *\par Under global trading rules, the inventors of medicines ordinarily have the right to a 20-year monopoly on their inventions. But five years ago, the United States joined 141 other countries in signing the Doha Declaration, confirming the right of poor countries to break drug patents and produce cheap generic drugs in the event of contagions like HIV.\par At the time, Thailand was heartened. It had been trying everything in its fight against AIDS. It coined a jingle to promote safe sex. It placed condoms in massage parlors. Most important, it curbed deaths among the poor by giving them generic versions of medicines invented by multinational drug makers. \par So it came as a jolt in January when the United States asked Thailand to sign a free trade agreement that would, on paper, dilute its right to break patents and use generics.\par Washington said the agreement would save lives by spurring innovation and by making multinationals more confident to sell drugs in the country. But Thai officials saw the proposal as a morbid bargain: either refuse the U.S. offer and scuttle a trade deal with the United States worth billions of dollars, or accept it and lift the price of AIDS drugs beyond the reach of the poor.\par ''Those who require the essential drugs but cannot afford it, they will have to die,'' said Dr. Suwit Wibu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 polprasert, the Thai official who is coordinating the Public Health Ministry's response to the U.S. proposal.\par Thailand is not alone. It is merely the latest target of a quiet worldwide campaign by the administration of President George W. Bush to coax developing nations to barter away their patent-breaking rights in e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 change for lucrative trade benefits, according to public health experts and government officials from Thailand to Brazil.\par Specifically, Washington is pushing bilateral and regional trade agreements in which countries enact ''supe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 patents'' that prolong U.S. drug makers' monopolies and limit the conditions under which their patents can be broken.\par These new rules, once they are adopted by developing countries, roll back the patent-breaking rights that were confirmed by the 2001 declaration at World Trade Organization talks in Doha, Qatar.\par In effect, Washington is stitching together a parallel global patents system.\par The trade deals, negotiated in secret, attract little notice. But they have already been signed with developing countries battling AIDS, including six in Central America. And negotiations are beginning with several nations pivotal to the fight against the virus, from Thailand to five southern African countries, including South Africa and Botswana.\par Because of these agreements, India's generics industry, the world's largest, is reining in plans to supply poor countries and refocusing on richer ones, said Dilip Shah, head of the Indian Pharmaceutical Alliance, which represents generic makers.\par ''For the Indian pharma industry,'' he said, ''it's not doomed; it will find a way out. But for the patients in the Third World, it's bad.''\par Public health officials warn of catastrophic consequences if the bilateral deals are applied to AIDS drugs.\par ''If you prevent countries from using generic drugs,'' said Pedro Chequer, the head of Brazil's national AIDS program, ''you are creating a concrete obstacle to providing access to drugs. You are promoting genocide, because you're killing people.''\par First-generation AIDS drugs reached the world's poorest people only when the use of generics cut their cost to $140 a year from more than $10,000. As new drugs emerge to treat patients resistant to first-line med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cines, the trade agreements make a similar drop ''extremely difficult to ensure,'' according to Medecins Sans Frontieres, or Doctors Without Borders.\par Washington maintains that the trade deals are directed toward diseases other than AIDS.\par And Richard Feachem, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, acknowledged that it was too early to tell whether the bilateral agreements would be used to block access to AIDS drugs.\par ''If we do see this in practice,'' he said, ''we should condemn it. But it really is in the interpretation of these agreements in very particular circumstances.''\par Yet, in defending the bilateral agreements, Bush administration officials often cite the AIDS example to make their case. Stronger patents save lives, the argument goes, by keeping companies confident enough in profit to keep discovering new drugs.\par Dr. Mark Dybul, the second-ranking official in the White House program to fight AIDS, said that because AIDS patients constantly grow resistant to medicines, it is disastrous to widen access today and have no drugs tomorrow.\par ''As an individual physician sitting in front of an individual patient, you will do whatever you need to for that patient now,'' said Dybul, a physician. ''When you're a public health physician, you're not a physician for one person but for millions of people. And you need to be thinking about whether the action in that single setting, repeated hundreds of thousands of times, will cause a problem for the millions.''\par Spreading the new patents system are U.S. trade negotiators, who some experts believe are assuming the influence that public health experts once had over the Bush administration's AIDS policy.\par Victoria Espinel, an assistant U.S. trade representative, strongly defended the use of trade agreements to promote patents that ''have more in place'' than the patents agreed upon at the WTO talks in Doha, a step she described as merely ''harmonizing minimum standards.''\par ''It is crucial to public health,'' she said, ''to promote the innovation of drugs and to make sure that research and development of drugs continues.''\par As for exempting AIDS drugs from the new accords on patent-breaking, she said, ''I want to emphasize that there is enough flexibility in our free trade agreements to allow our partners to do what they need to do.''\par An explicit promise to exempt AIDS drugs, however, is not in the agreements, said Wibulpolprasert, the Thai official. And that, experts say, is at the heart of the problem: Nations must take Washington's word for it.\par An examination by the International Herald Tribune of several free trade agreements reveals provisions that appear, on paper, to limit the freedom to use generics.\par Several agreements, for example, prolong a patent monopoly beyond 20 years if the developing country's regulators show ''unreasonable delays'' in approving a patent. This provision, absent from WTO rules, su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tains higher prices.\par Many agreements also serve to prolong patents by requiring generics to be retested as if they were new i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ventions. Retesting a drug biologically equivalent to one already approved takes time and may be unethical, since infected patients must be given placebos.\par The WTO rejected this requirement, a five-year ban on the use by generics makers of the safety data submi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ted for the original branded drug.\par And while the WTO lets countries decide when to break patents, the new U.S. agreements limit this action to special cases to enforce antitrust law, for example, or during emergencies.\par Experts say the most important use of generics is excluded: to reduce costs by making branded products compete with generics.\par The generics question has also opened a rift in the United States, between Bush and former President Bill Clinton. On a recent visit to New Delhi, Clinton said he had confronted Bush about generics while flying to Rome for the papal funeral last April.\par ''The American position is untenable,'' Clinton recalled saying.\par In an interview, Clinton said Washington was succumbing to the influence of the drug lobby in undermining the Agreement on Trade-Related Aspects of Intellectual Property Rights, or }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  the WTO framework on which the Doha declaration built.\par ''If a company develops a new advance in AIDS, TB, malaria, you need large numbers right away and all the people who need it are in poor places,'' Clinton said, referring to generics producers.\par ''If you don't have }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ranbaxy, Hetero, Aspen in South Africa and other people to step into the breach, how are we going to do that? I don't understand the apparent obsession with some of the big pharma inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ests in trying to block them off.''\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GENERIC DRUGS (91%); TRADE TREATIES & AGREEMENTS (90%); AIDS & HIV (90%); TREATIES & AGREEMENTS (90%); PHARMACEUTICALS INDUSTRY (90%); GENERIC PRODUCTS (90%); INTERNATIONAL TRADE LAW (89%); TRADE DEVELOPMENT (89%); PHARMACEUTICAL PREPARATION MFG (89%); PATENTS (89%); INTERNATIONAL TRADE (89%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TRIES (89%); PHARMACEUTICALS PATENTS (78%); AGENCY RULEMAKING (78%); AIDS & HIV TREATMENT (78%); ANTIVIRALS (78%); HEALTH DEPARTMENTS (78%); MULTINATIONAL CORPOR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TIONS (78%); EMERGING MARKETS (78%); INTERGOVERNMENTAL TALKS (77%); FREE TRADE TREATIES & AGREEMENTS (77%); DRUG PRICES (73%); US PRESIDENTS (72%); PUBLIC HEALTH ADMINISTRATION (66%); MASSAGE SERVICES (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GEORGE W BUSH (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NEW DELHI, INDIA (79%) UNITED STATES (99%); THAILAND (93%); INDIA (92%); Q}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TAR (92%); BOTSWANA (79%); AFRICA (79%); CENTRAL AMERICA (79%); SOUTHERN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 April 19, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2006 International Herald Tribune\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Same determination but a new purpose Sunday Times (South Africa) February 26, 2006 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_91}{\*\bkmkstart DOC_ID_91_0}{\*\bkmkstart doc_id_36}{\*\bkmkend DOC_ID_91}{\*\bkmkend DOC_ID_91_0}{\*\bkmkend doc_id_36}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_36"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 36 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Sunday Times (South Africa)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  26, 2006  \par Business Times Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Same determination but a new purpose}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Bobby Jordan\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ECONOMY, BUSINESS & FINANCE; Pg. 8\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 953  words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Same determination but a new purpose\par Former Scorpions boss now tracks down lucrative business deals, writes\par 'I enjoyed the Scorpions but I'm glad I'm out of it'\par 'We [Old Mutual] have great faith in the Amabubesi vision'\par BULELANI Ngcuka, veteran lawyer, political prisoner, national prosecutions chief and smear-campaign su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vivor, may be out of the political limelight but he's certainly raising eyebrows in business circles.\par His transformation from high-profile activist to deal-maker and kingpin of black economic empowerment b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gan little more than a year ago when he was appointed executive chairman of Amabubesi Investment Hol}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ings.\par In an interview in November 2004, the former National Director of Public Prosecutions told Business Times: "We have given ourselves 18 months to become a major player in the economy."\par While perhaps not yet at that level, Amabubesi has pursued an eccentric investment strategy that earlier this month saw the consortia take a 31% stake in Lancewood Cheese, near George.\par "Agriculture and the food sector has also become our focus area," Ngcuka said.\par Drugs, too, form part of the Amabubesi empire. This month the group, along with other black economic e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 powerment consortiums, acquired 90million shares in Enaleni Pharmaceuticals for R270-million.\par Enaleni is the second-largest tenderer for government pharmaceutical contracts and is the third-largest su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 plier, by volume, of generic drugs to the private market.\par This week Amabubesi announced it had acquired a 36% interest for an undisclosed amount in East London IT company ELCB Information Services.\par The one-time prosecutor with a taste for ending political careers is now boss of a company that has a taste for just about everything, from dairy products to industrial cranes. \par Commenting this week on his metamorphosis, Ngcuka said he felt comfortable in his new business role.\par "It was a relief to get out of a pressure-cooker job. Now I am able to give more opportunity to a number of people.\par "But I enjoyed my time at the Scorpions. It is something that I will treasure all my life. I enjoyed it but I'm also glad I'm out of it."\par Amabubesi recently acquired stakes in JSE-listed companies Basil Read, GrowthPoint Properties and Pi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nacle Technology Holdings. Its high-profile investments include a R1.1-billion luxury golf estate on the Ga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 den Route and the province's biggest shopping complex, outside Jeffreys Bay. (See accompanying story)\par "In the past, BEE companies took up passive shareholding in companies. Our business model does not fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 low that historical trend," Amabubesi said on its website, describing its strategy.\par "We actively participate in the businesses of our partners to ensure growth."\par Just two years after exposing the likes of Tony Yengeni and former deputy president Jacob Zuma, Ngcuka is now one of the country's foremost wheeler-dealers.\par Unlike his former political foes, however, it's so far so good for Ngcuka, give or take a controversial shopping }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  with his wife, Deputy President Phumzile Mlambo-Ngcuka.\par Foreign travel aside, Ngcuka's business activities have attracted mostly praise from both the public and the private sector.\par He is a sought-after empowerment business partner and was appointed last year as chairman of V& Wate}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 front Holdings in Cape Town.\par His focus now is on the Eastern Cape, where he was born in 1954, and where he has vowed to invest mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lions of rands.\par Ngcuka has targeted two major investment projects in the province: a housing development near East Lo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 don and an agricultural development near his home town of Middledrift.\par The investments are a major boost for the Eastern Cape economy. They are among several recent deals that make Amabubesi's investment portfolio almost as diverse as Ngcuka's CV.\par Right now the portfolio comprises healthcare, infrastructure and property, transport and logistics, technology, media, leisure and tourism, broking and, of course, cheese.\par Old Mutual, which holds a 20% stake in Amabubesi, has made investment funds available for further acquis}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions.\par Commenting on the partnership, Old Mutual SA managing director Roddy Sparks said he was delighted with the progress made so far.\par "We invested in Amabubesi because we have great faith in the capabilities and vision of the company's management. We are constantly looking at, and evaluating opportunities arising from, the funding of black economic empowerment deals.\par "Amabubesi has a strong leadership team, sound investment philosophies and a good track record in terms of deals executed. We're confident that our investment will result in good returns," Sparks said.\par In its mission statement, Amabubesi prides itself on the connections made by its founders.\par "Most businesses interface with the government at all levels, either for business or to influence strategic thinking. Our association with decision-makers at the highest level enables us to influence strategicdecisions in our country."\par Ngcuka is ideally made for his role.Imprisoned for treason against the apartheid state, he subsequently played a leading role in Codesa and the multiparty negotiations that it brought about.\par In 1998 he was appointed head of the National Prosecuting Authority (NPA).\par He quickly allayed fears that he would be a lapdog of the ruling party by investigating the likes of Yengeni and Zuma - at the time both linked to the country's controversial arms deal.\par Following counter-allegations that he had been an apartheid-era spy, Ngcuka was investigated, and cleared, by a commission of inquiry instituted by President Thabo Mbeki.\par He resigned from the NPA to pursue private business interests, central to which is Amabubesi.\par STILL UNDER PRESSURE: Bulelani Ngcuka, executive chairman of Amabubesi Investment Holdings. Pi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture: ELIZABETH SEJAKE\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HOLDING COMPANIES (90%); EXECUTIVES (90%); INSECTS & ARACHNIDS (89%); FOOD INDUSTRY (78%); PHARMACEUTICALS INDUSTRY (76%); EXECUTIVE MOVES (76%); APPOIN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MENTS (76%); INTERVIEWS (76%); FOOD MFG (75%); CHEESE (72%); DAIRY PRODUCTS (72%); JU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TICE DEPARTMENTS (72%); GENERIC DRUGS (68%); FOOD & BEVERAGE (67%); COMPUTING & I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 FORMATION TECHNOLOGY (64%) Chairman & CEO Profiles; Economic Empowerment; Unlisted Comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nies\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  MEDPRO SOUTH AFRICA LTD (55%); GROWTHPOINT PROPERTIES LTD (52%); PINNACLE TECHNOLOGY HOLDINGS LTD (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CMP (JSE) (55%); GRT (JSE) (52%); PNC (JSE) (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (55%); SIC2834 PHARMACEUTICAL PREPARATIONS (55%); NAICS531390 OTHER ACTIVITIES RELATED TO REAL ESTATE (52%); SIC6531 REAL ESTATE AGENTS & MANAGERS (52%); NAICS423430 COMPUTER & COMPUTER PERIPHERAL EQUIPMENT & SOFTWARE MERCHANT WHOLESALERS (51%); SIC7372 PREPACKAGED SOFTWARE (51%); SIC5045 COMPUTERS & COMPUTER PERIPHERAL EQUIPMENT & SOFTWARE (51%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 JACOB ZUMA (56%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LONDON, ENGLAND (69%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 February 27, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2006 Times Media Limited\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda; Uganda Enters HIV/Aids Drug Deal With India Africa News December 13, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_92}{\*\bkmkstart DOC_ID_92_0}{\*\bkmkstart doc_id_37}{\*\bkmkend DOC_ID_92}{\*\bkmkend DOC_ID_92_0}{\*\bkmkend doc_id_37}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_37"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 37 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 December}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  13, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda; \par Uganda Enters HIV/Aids Drug Deal With India}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The East African\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 417 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda has signed a deal with a leading Indian drug manufacturer, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd, to produce HIV/Aids drugs locally.\par The $15 million deal is expected to take off mid next year. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  came into the limelight when it started pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ducing generics of HIV/Aids drugs whose patents were held by powerful Western pharmaceutical comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nies. \par Although the company's move was in contravention of international patent laws, it managed to lower the cost of Aids treatment and to enable people in poor countries to access the medicines.\par However, India is scheduled to stop its companies from producing drugs still under patent, following its a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cession to the Trade Related aspects of Intellectual Property Services (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  treaty earlier this year - which has set off alarm bells throughout the developing world. In Uganda, the fear is that from 2006, badly needed first-line medicines will no longer be available.\par Should this happen, tens of thousands of people currently on antiretroviral treatment may no longer be able to afford the treatment. It is out of this concern that the Uganda government negotiated the deal with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to transfer part of its generics production capacity into the country. Uganda has a further seven and half years to accede to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par Our position is that as the Min-istry of Health of Uganda, we are going to do everything to keep our people alive," State Minister of Health for General Duties Mike Mukula said.\par Mr Mukula said work was scheduled to begin on a factory in Luzira, a suburb of Kampala.\par Among the drugs to be produced are new HIV/Aids brand drugs and anti-malaria drugs, the new and most effective, coatem, included.\par India is by far the biggest producer of generic drugs, making HIV/Aids drugs available cheaply to hundreds of thousands of patients. As illustration, before Uganda started importing generic drugs in 2001, the monthly cost of treating Aids was over $600. Today, it is $20 a month.\par The Indian accession and the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement means that the cost of Aids treatment will shoot up once more. However, experts say that more has to be done to ensure the availability of drugs to Aids patients. Under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, all drugs developed after 1996 will be subject to copyright rules. This means that older, reliable drugs will still continue to be cheaply available. But in the treatment of highly infectious diseases like malaria, tuberculosis and HIV/Aids, it spells doom as the most effective first line drugs available for the three diseases were only developed recently.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (94%); ANTIVIRALS (92%); AIDS & HIV TREATMENT (91%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CALS INDUSTRY (90%); PHARMACEUTICAL PREPARATION MFG (90%); GENERIC DRUGS (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TENTS (90%); MALARIA (89%); DISEASES & DISORDERS (89%); INFECTIOUS DISEASE (89%); ANTI-INFECTIVES (78%); CONTROLLED SUBSTANCES CRIME (78%); PLANT CAPACITY (78%); PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CEUTICALS PATENTS (78%); INTELLECTUAL PROPERTY LAW (77%); GENERIC PRODUCTS (77%); COPYRIGHT LAW (76%); HEALTH DEPARTMENTS (73%); TUBERCULOSIS (73%); INTELLECTUAL PROPERTY (73%); PATENT LAW (72%); COPYRIGHT (72%); MANUFACTURING OUTPUT (71%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (96%); SIC2834 PHARMACEUTICAL PREPARATIONS (96%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 KAMPALA, UGANDA (79%) UGANDA (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 December 13, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Newsletter\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 G2: What Grace did next: Three years ago the Guardian published an award-winning supplement featuring the story of Grace Mathanga, an ordinary African woman with HIV. To launch this year's Christmas appeal, which focuses on Aids in Africa, Sarah Boseley returns to Malawi to find out how Grace is doing now, and what her life can tell us about the future of the continent The Guardian (London) - Final Edition November 24, 2005 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_93}{\*\bkmkstart DOC_ID_93_0}{\*\bkmkstart doc_id_38}{\*\bkmkend DOC_ID_93}{\*\bkmkend DOC_ID_93_0}{\*\bkmkend doc_id_38}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_38"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 38 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Guardian (London) - Final Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  24, 2005\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 G2: What Grace did next: Three years ago the Guardian published an award-winning supplement featuring the story of Grace Mathanga, an ordinary African woman with HIV. To launch this year's Christmas a}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 peal, which focuses on Aids in Africa, Sarah Boseley returns to Malawi to find out how Grace is doing now, and what her life can tell us about the future of the continent}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Sarah Boseley\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Guardian Features Pages, Pg. 8\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 4076 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Grace Mathanga walks along the grass track, between scrub and shady trees, to the crumbling house that was her home until seven years ago. Black hoop earrings and handbag swing to her stride, her Sunday best remarkable against the ragged clothes of the dusty, barefoot children of the village. As she nears, Grace calls out, and a young woman launches herself through the door, falling into her arms with a shriek of laug}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ter.\par  The house, its cement cladding falling off red bricks, its tin roof topped with straw, is as poor as any other here. In four small rooms live two of Grace's sisters, Precious and Chipiriro, their five children, and 12-year-old Eleni, the daughter of one of two other sisters who have died. All that stands between this family and destitution is Grace and the generosity of strangers.\par  On two small tablets a day - one when the sun rises and one when it sets - Grace, who would otherwise be dead, is alive and well. Grace is part of a small miracle that is beginning to happen in Africa. Men and wo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 en who are HIV-positive, as she is, have the chance of a reprieve from the slow and painful death by emaci}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion and infection that is Aids. Drug treatment keeps the virus levels low in their bloodstreams. Those who receive antiretroviral drugs (ARVs) stay well, and are able to work and bring up both their own and others' children. \par  Grace is one of the lucky ones because she had the courage, nearly three years ago, to talk about her infe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion to the Guardian in a supplement we called Saving Grace. Her husband and her child had died of Aids. She knew she would follow them within a few years, because she had no money for ARVs, which were then available only privately and at a high price. A Dutch doctor, Hetty van Dyck, who was working as a locum in Malawi's capital, Lilongwe, read the Guardian article, tracked Grace down to the market where she sold shoes, and put her on treatment. Van Dyck went on to start a small charity to do the same for others, which she called the Saving Grace Foundation, and which the Guardian now supports.\par  When I go back to find Grace, she is still living in the house in Mwenye-Kondo - a bustling suburb of Lilon}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 we shaking to the loud boom-beat of a tavern - which she once shared with her husband and child. But she has changed. Friends and neighbours say they cannot believe the transformation since she went on ARVs. "They say I am lying when I say I am HIV- positive, because HIV people do not look like this," says Grace, laughing. "I feel happy for my life," she adds.\par  In quiet Ben Chauya village, in the hills between Lilongwe and Malawi's second city, Blantyre, Grace's si}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ters are happy too. Life for Grace means survival for them and for their children. Once a month, ever since she married and moved away seven years ago, Grace has made her way to the bus station at 4.30am for the three-hour }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to Ben Chauya. It's a further 90 minutes on foot to her old house from the main road. She stays a few hours and then makes the long return journey, arriving home at 9pm. Once she brought money that her husband had given her, but after his death, she brought money that she had earned herself, first at the market, and now as a care assistant for an organisation called the National Association of People with HIV/Aids in Malawi.\par  Grace supports all her family, but there is one child to whom she pays particular attention. Eleni and she stand apart in the shade of a tree, having a quiet conversation. When Eleni's mother, Ulemu, died, Grace was still living at home and Eleni was only five. Grace, having lost her own child, looked after Eleni like a daughter, cooking and washing for the child. Now she buys Eleni's school uniform. On a broken dresser i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 side the dark house lies a blue school exercise book, limp as a duster, filled with diagrams of circles and a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gles. Eleni does well at school, says Grace, coming in the top six for her grade.\par  Without her aunt, this thin and serious- looking girl would not be at school. At 12 Eleni would normally be working in the fields or doing chores. She might even have been sent away. In a society where most women have no status, she is vulnerable and will shortly become more vulnerable; Precious had her first baby at 14. It is not what Grace wants for Eleni. As long as she is alive, Grace will do all she can to give her a better f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ture.\par  In Malawi and all over Africa, such tiny but life-changing individual victories are being won. Because HIV/Aids is devastating the working, parenting generation - a generation that includes the continent's teac}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ers, nurses and farmers - every time the disease is thwarted, every time a man or woman is started on the drugs, the lives of a whole clutch of dependents become less precarious as well.\par  But the numbers on ARVs so far are tiny compared with the need. There are an estimated 40 million - po}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sibly up to 45 million - people infected with HIV worldwide, of whom around 26 million live in sub-Saharan Africa. Of the six million people in the developing world who desperately need antiretrovirals, only a million are on the drugs so far. Unless something is done quickly, the rest will soon be dead.\par  This is a humanitarian emergency, but even though the superpowers have mobilised - George Bush has a $ 15bn Aids plan, Bill Clinton is involved, the UK and France are heavily committed - it is taking an agonisingly long time to scale up levels of treatment. The World Health Organisation wanted to have three million people in the developing world on ARVs by the end of this year. We're nowhere near.\par  Tiny Malawi, with as big a population and as grave a problem as its much larger neighbour Zambia, is doing relatively well. Nearly one million of its 12 million people are infected and 170,000 are in urgent need of treatment. Every year 85,000 young men and women die because of Aids. Life expectancy at birth has dropped to 42. But an ambitious government programme, which began last year, has pushed the numbers on treatment from 4,000 to 32,000. That is a remarkable achievement.\par  "We are saving at least 12,000 lives every year and the numbers are going up," says Erik Schouten, the Dutch HIV/Aids coordinator in Malawi's Ministry of Health. "These are young adults - the fathers and mothers of families. One of the most important determinants of child survival is having a parent alive. This is a natio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 al emergency because this disease is really undermining society. The social structure is disappearing."\par  But the obstacles to scaling up any further loom like a cliff face. Schouten and Professor Tony Harris, the British technical adviser to the HIV unit, talk of walking into the unknown. The effort is heroic, but nothing of the kind has ever been attempted in Africa.\par  "From next year onwards, we really are going into uncharted territory," says Harris. "In a year's time, will we be able to cope with 70,000? I've no idea."\par  Walk into hospitals such as Lilongwe Central, where Grace's husband died, and one of the fundamental problems becomes clear. Male and female wards are a vision from hell. Every bed is full and sometimes has two occupants, head to toe. On the floor lie more patients on mattresses. Most have their eyes closed in pain or are unconscious; their wasted limbs are angular and contorted. There are no worried well in Malawi. Pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple come when they are very sick, whether from meningitis, malaria, TB or pneumonia. In more than a third of cases, HIV is responsible for their sickness. The virus strips out the immune system, making people prey to infections.\par  Such patients need the help of doctors and nurses. But those are in desperately short supply. District hosp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tals have one qualified doctor. Big central hospitals may have two nurses on a ward in the day and none at night. How is Africa going to assess patients with HIV and put them on drug treatment when people are dying in hospitals across the continent for lack of care?\par  All over Africa, clinical officers with just a couple of years' medical training are being employed to assess whether a patient with HIV is sick enough to need drugs. Malawi doesn't do the sophisticated blood tests, called CD4 counts, which tell you how depleted the body's immune response to the virus is. They haven't got the machines or the labs. Instead, they use check-lists of symptoms, infections and weight. When you have seen a fair number of people with advanced HIV infection, it's not so hard to recognise the large, listless eyes, the emaciation and the pain caused by the effort of placing one slow foot in front of another.\par  But there are far from enough clinical officers. Harris says that on paper, Malawi ought to be able to get half those who need treatment on it every year. That's 90,000. In practice, he says, "I don't think it's possible. We don't have the people."\par  Nor do they have the space. The rooms they are using for ARV clinics are too small; the pharmacies - now bursting with boxes of ARVs - are too cramped.\par  Infrastructure and human resources are cited everywhere as the main obstacles to saving more lives. But there is an even more fundamental question being asked about the drug roll-out across Africa. Will the rich donor countries continue to pay? Malawi's growing programme is mostly financed by grants from the Global Fund to fight Aids, Tuberculosis and Malaria, set up by the UN in 2001. Malawi has been granted $ 267m over five years, but the money runs out in 2008.\par  "We have got a plan to 2010," says Harris. "Will the money continue? It must surely, but I can't put my hand on my heart and say it is guaranteed. Two years of ARV drugs (for Malawi) cost $ 35m. That is the entire government health budget. If the donors should decide this is not a thing we should be doing - the fashion changes - we are really up the creek here. In 2010, we may be spending $ 40m on drugs alone. Who is g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing to pay for this? The Global Fund has had trouble raising enough money."\par  In fact the Global Fund has struggled to raise anything like the $ 10bn a year that Kofi Annan called for at its launch. At a replenishment conference hosted by the UK government in September, donor countries pledged $ 3.7bn for 2006 and 2007 - half what is needed. Much depends on the United States, which is constitutio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ally unable to commit funds that far ahead, but which also prefers to put its money into programmes directly under its control.\par  Wesley Sangala, Malawi's health secretary, says his country cannot afford to treat Aids patients without help. "I don't think in the next five to 10 years Malawi will be able to take on the burden of paying for ARVs," says Dr Sangala. If the donors pull out, he says, "it is a death sentence for all those people or we would have to go to the World Bank and borrow millions that we could not go on paying."\par  So in a year or two, says Harris, Malawi will have to put in another big funding bid. "If we do a good job, the international community can't pull out, having led us this way. But what if, say, bird flu becomes a major pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lem in two years' time? It is very precarious. We're on a knife edge. Something can go wrong and we can fall off."\par  Falling off, for Grace's friends, neighbours and other women like her, would be catastrophic. West of Lilon}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 we, towards Zambia, is a peaceful, tree-shaded village called Nkhwambara. This is where 34-year-old Oliveta Janga has found refuge and the hope of a life for herself and her five children.\par  It is her mother's village. Oliveta has left her husband's house in the south of the capital city. Somehow she managed to struggle the 20 miles or so with the children, aged between eight months and 14 years. She is stick-thin and walks with the telltale slow and awkward gait of an Aids sufferer. It's as if she is treading on knives.\par  Oliveta found out that she was infected with HIV at the antenatal clinic when she was expecting her last b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 by, Ignasio. All pregnant women are offered a test. Most take it now that there is drug treatment available. But when Oliveta told her husband, he took it badly. "My husband refused to go for testing," she says. "He said I was a useless woman and he would not care for me or provide food for me."\par  Her husband stayed away all day and would return late at night. Oliveta did piecework - labouring in the fields for around 200 kwacha (the local currency) a day, less than \u163\'a31. She had to feed the family, but som}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 how managed to save up 1,000 kwacha for the journey back to her mother. When she arrived, she was very weak and could no longer see.\par  Without treatment, she would have died, and another five Aids orphans would have been added to Malawi's estimated total of half a million. But Modesta Machila, her strong and striking 55-year-old mother, gave her a house and help with the children, and Oliveta went to the nearby St Gabriel's mission hospital, where she has just started on ARVs.\par  It's a typical African story with an untypically happy ending. Oliveta will not sicken and die in a dark corner. Her children will have a chance to grow up with a parent and go to school. Education increases their chances not only of climbing out of the poverty they live in, but of avoiding HIV infection themselves. Much is riding on the continuing willingness of rich donor nations to pay for the little pills that women like Oliveta will need for the rest of their lives.\par  At the same time, Oliveta's tale says much about the deeper problem of HIV in Africa. Women are dispr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 portionately hit - they make up 57% of those infected. But they have no power to insist on safe sex or indeed no sex. Grace has given Eleni her own surname because nobody knows who her father was. Precious had a baby when she was an adolescent and now has two more, with no husband in sight.\par  The women work in the fields to earn money to feed the family; the men work in the fields to buy beer, says Modesta Machila. It's a generalisation, but it's certainly her experience. Her son-in-law turned up at the vi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lage the other day, she says. He said he had some luggage to be fetched, and demanded that his eldest son and daughter come to help him. Modesta stood in the way. "If he wanted to carry luggage, he should ask the men who have bicycles," she says. "He wanted to steal the children." He would make them work and look after him in their mother's place, Modesta says. Their life chances would shrink. Uneducated, impoverished, they too would in all likelihood contract HIV.\par  It's easy to see why behaviour change has become a favoured mantra, particularly among the moral right in the USA, as the only sure way to end the Aids pandemic. But it's one thing to advise drug injectors on clean needles and supply sex workers with condoms. It is another to give Oliveta or Precious the power to refuse to have sex with a man who is potentially violent.\par  Across Africa the abstinence message is growing: just say no. It's where the conservatism of the Bush a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ministration meets the evangelism of African churches. The President's Emergency Fund for Aids Relief (Pepfar) requires any group it funds to sign a pledge condemning prostitution, which is an embarrassment in places where the key to the HIV spread is commercial sex. To US approval, the first lady of Uganda, Janet Museveni, urges young women to abstain until marriage. Even in Malawi - not on the list of Pepfar target countries, although it is getting limited help which one official describes as "Pepfar lite" - a huge billboard in Lilongwe features President Bingu wa Mutharika proclaiming the virtues of "abstinence, abstinence, abst}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nence".\par  Mutharika is said to be a very devout Christian, as most Malawians appear to be. Gospel choruses belt out of every radio. But the churches are not about to preach the rights of women, and few women have the po}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er to say no to men.\par  Some people fear that with ARVs now visible in Africa, the world will think the job is done and retreat behind the old prevention rhetoric. Jim Yong Kim, who heads the WHO's HIV/Aids programme, says the drive to get universal access to treatment, promised by the G8 this year, must not falter because millions more are going to die before efforts to bring about social change in Africa bear any fruit. "Treatment is not rocket science," he says. "Prevention is rocket science."\par  Kim, an American whose outspoken brilliance does not win him friends in the Bush administration, is the man who set the controversial "three million by 2005" target. It won't be reached, but the progress in many countries is impressive. "I have been trying to say for years that 'three by five' is going to give pace and strength to the response," he says.\par  And once there is treatment available, you can begin to build in prevention. Lesotho, one of the worst-hit countries with around 30% of its population infected, is going to offer testing and counselling to the entire population by 2007, training five people in each and every village to help. The $ 11m scheme "could pote}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tially turn the epidemic around in this country", says Kim.\par  But testing depends on the availability to all of those ARVs, which are a three-drug combination pill. The formulae were invented by the big, research-based pharmaceutical companies in the USA and Europe, and they hold the patents. Africa buys cheap copies made by generics firms such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  in India, selling for as little as $ 130 per person per year - except where Pepfar is paying. US support for the pharmaceutical giants - "big pharma" - means the president's money is spent on more expensive brand-name drugs unless the g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neric version is approved in America.\par  In August, Malawi's drug supply almost came to a halt. Floods in }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Mumbai warehouses destroyed six months' supply. It followed the removal of approval of Ranbaxy's generic drugs by WHO because of a pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lem with paperwork. The generics have since been reinstated. But seldom can a project to save so many lives have hung by such delicate threads. If patients run out of drugs, the virus in their blood will build and become resistant to the medication. Not only will they succumb, but the nightmare scenario will be upon us: the resistant virus could start to spread across Africa and beyond. "We're going to face a drug shortage," says Kim.\par  Big pharma - which is based mostly in the US, helped fund the Bush election campaign and loathes the g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 neric "pirates" - says it can make all the drugs that are needed. But it has been forced to drop its prices to the point where it makes a loss on every tablet. "Are they really going to scale up to meet demand for, say, 10 million people by 2010?" says Kim.\par  He thinks big pharma and its backer, the US government, need to step aside and allow the generics comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nies a free hand without fear of legal action or sanctions. China, he says, has told him it can make the more expensive second-line drugs - those that will be needed when resistance inevitably sets in, as it has in E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rope and the US - for $ 100 to $ 150 per person per year.\par  In Kilolo, north-west Malawi, a tiny girl sits immobile on the floor outside a wooden hall with a doll across her outstretched legs, large eyes gazing at nothing, hands hanging loose. Her aunt is inside, singing, with hu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dreds of widows and grandmothers who struggle to care for orphans. Manneyra Esna is four, but looks two. People walking in and out pay her as little attention as if she were part of the doorframe. She doesn't notice them either. The doll slowly slips off her lap. Manneyra doesn't move.\par  She is probably HIV-positive. Her mother died from Aids last year. Here at the Consol (as in consolation) Homes orphan centre, where her aunt has come for support with the four children she now cares for - two of her own as well as Manneyra and her sister Margaret, five - it is realised that the little girl should see a do}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tor. She may well need ARVs.\par  But the government programme cannot yet help. Children need to be dosed according to weight. Malawi has only adult tablets. If Manneyra is lucky, she will be seen by a paediatrician at the mission hospital who will teach the busy aunt to cut up and crush the pills twice a day and mix them with nsima, the staple maize po}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ridge. Consol Homes, a pioneering orphan support project, may pay. But most children here die. An estima}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed 660,000 children in developing countries are in urgent need of treatment, mostly in sub-Saharan Africa. Last year 570,000 died. The widespread failure across Africa to get drugs systematically to women in labour, which can prevent transmission to their baby, means that the numbers are rising inexorably.\par  If the issue of drugs for children is gaining attention, it is partly thanks to the Clinton Foundation, which is playing an interesting role in Africa's Aids pandemic, clearing logjams, cutting knots and driving through i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 novation. Ira Magaziner, Bill Clinton's former White House aide, now runs the Foundation's HIV/Aids initi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tive. He is impatient with the slow, scientifically correct approach, which demands a dozen studies, presented in full colour booklets with graphics, before anything happens.\par  "Millions of people have died because we haven't been moving faster," he says. "Until we collectively have four to five million people on treatment in the developing world, I don't think we can say we're making enough progress. Every day you move faster, people live. Every day you move slower, people die."\par  The Foundation has cajoled Paul Farmer, the Harvard medic who proved drug treatment was possible in poor countries such as Haiti, into switching to Rwanda and figuring out how you treat people in remote pla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es with no doctor or nurse for miles. And they are donating enough ARV syrup to get 10,000 children on treatment, pushing aside arguments as to whether pills or syrups are better.\par  Down the road from Grace's house in Lilongwe, the reality of what this kind of decisive action - or the lack of it - means hits you in the eye. The Mac Coffin workshop, named after its owner Mac, is one of five or six such workshops in a row. Carpenters who used to fashion beds make wooden boxes: plain wood with a red ochre stain for 2,000 kwacha (\u163\'a310); formica marble lookalike with gilt handles and pillow for 150,000 kwacha (\u163\'a3750). How many coffins do they sell? Three to five a day, they say. Big ones for mothers and fathers. Small ones for children *\par  Briefing: Antiretrovirals\par  * People with HIV need a cocktail of three different types of antiretroviral drug to keep the virus levels low in the body. Generics companies (see below) made drug treatment in Africa possible by combining the three in a single cheap pill, to be taken twice a day.\par  * Combination pills are not much used in the US and Europe for two reasons: resistance and patents. Do}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tors in the rich world change their patients' drugs if they detect any sign that their effect may be weakening because the virus in their body is becoming resistant. They usually change just one drug of the three. But there's another reason why combination pills aren't used in the developed world: the patents are held by a number of rival pharmaceutical companies, so combining them requires negotiation.\par  * Generics companies are "copycats" and sometimes, according to the pharmaceutical companies, "pirates". But it is legitimate to analyse the chemicals that make up a blockbuster drug and produce a cut-price copy once its 20-year patent expires. In many of the least developed countries, including most of Africa, patents were never taken out, which means generics companies should have free rein. But the India, China, Tha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 land and Brazil-based generics firms fear legal action by big pharma and trade sanctions from the US.\par  * Prices for the first-line combination ARVs used in Africa are down to around $ 130 per patient per year from the generics companies. But resistance will appear eventually, just as it has in Europe and the USA. Viruses are survivors: HIV mutates easily, changing its form to overcome drugs used against it, particularly if people fail to take their doses on time. Second-line drugs are much more expensive - up to $ 800 per person per year - as most have to be bought from big pharma.\par  * Children's medicines, which are not yet ordered in bulk and need to be dosed according to the child's weight, can cost up to four times as much as adult drugs.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 VAN DYCK CARPETS (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MALAWI (94%); AFRICA (93%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MALAWI (94%); AFRICA (93%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (91%); DEATHS & OBITUARIES (90%); AIDS & HIV TREATMENT (90%); CHRISTMAS (78%); WOMEN (76%); ANTIVIRALS (73%); POVERTY & HOMELESSNESS (70%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 24, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 IN BRIEF The Evening Standard (London) November 7, 2005 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_94}{\*\bkmkstart DOC_ID_94_0}{\*\bkmkstart doc_id_39}{\*\bkmkend DOC_ID_94}{\*\bkmkend DOC_ID_94_0}{\*\bkmkend doc_id_39}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_39"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 39 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Evening Standard (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  7, 2005\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 IN BRIEF}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 A_MERGE; Pg. 30\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 508 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  SCOTTISH Power is bracing itself for a hostile takeover from German giant E.On the company behind Powergen - which could come in at as much as 640p a share, which with debt would value the Glasgo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 based company at around \u163\'a313 billion. However, E.On's overtures could yet be rebuffed if Scottish Power chief executive Ian Russell, pictured, goes ahead with a mooted merger deal with great rival Scottish & Southern Energy. The two Scottish power producers are understood to have had informal talks. \par  Roche begins licensing talks on bird flu vaccine ROCHE, manufacturer of bird flu vaccine Tamiflu, has star}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed negotiations over licensing the drug to third parties. At the same time, India's private drug maker }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and the National Health Research Institute of Taiwan said they had made batches of a generic version of Tamiflu. Both moves could ease some of the pressure to produce more of the drug, which has been in de}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 perately short supply in many countries.\par  Roche said it is on target to produce 300 doses a year, but not until 2007.\par  Bollore boosts his Aegis holding close to a quarter FRENCH investor Vincent Bollore has moved within a whisker of owning a quarter of advertising group Aegis.\par  Bollore, who has been accumulating shares in the group, has increased his holding to 24.97%. Aegis has been the centre of frenzied bid activity.\par  Publicis has withdrawn its interest, but WPP and its partner Hellman & Friedman must make their intentions clear by the 25 November deadline set by the Takeover Panel.\par  Volkswagen works council cleared of expenses abuse ACCOUNTING firm KPMG has cleared Volkswagen's works council of corruption in a probe into allegations of kickbacks, slush funds and sex }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  at Europe's biggest carmaker. The scandal led to the resignations of Peter Hartz, the personnel chief, and works council head Klaus Volkert. But KPMG found no evidence of wrongdoing by current works council members.\par  Volkswagen hired KPMG in July to investigate allegations of abuse of expense accounts that included lavish holidays.\par  Final straight for bidders in French toll-roads sell-off BIDDERS have until 5pm today to table offers for the privatisation of France's three biggest toll-road companies -Autoroutes du Sud de la France, APRR and SANEF. Guy Hands's private-equity firm Terra Firma is among the frontrunners in a multibillion-euro sell-off that dwarfs the simultaneous highprofile flotation of power generator Electricite de France. Winners are e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pected to be announced in early December.\par  Snow heading for India to ease foreign ownership US Treasury Secretary John Snow kicks off a visit to India today aimed at accelerating reforms and easing rules on foreign ownership. Snow's four-day }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  takes in financial centre Mumbai and the capital New Delhi. "India is a stop along the way toward visiting all those countries - including China and Brazil which we visited earlier that we regard as having the potential to b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come the major economies of the 21st century," said Snow's deputy Tim Adams.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BOLLORE SA (92%); ROCHE HOLDING AG (92%); KPMG (83%); ELECTRICITE DE FRANCE SA (EDF) (58%); SCOTTISH & SOUTHERN ENERGY PLC (57%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (56%); PUBLICIS GROUPE SA (55%); HELLMAN & FRIEDMAN LLC (54%); AUTOROUTES DU SUD DE LA FRANCE SA (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS483111 DEEP SEA FREIGHT TRANSPORTATION (92%); SIC4412 DEEP SEA FO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 EIGN TRANSPORTATION OF FREIGHT (92%); NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (92%); NAICS325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING (92%); NAICS541211 OFFICES OF CERTIFIED PUBLIC ACCOUNTANTS (83%); SIC8721 ACCOUNTING, AUDITING, & BOOKKEEPING SERVICES (83%); SIC4911 ELECTRIC SERVICES (58%); SIC8731 CO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MERCIAL PHYSICAL & BIOLOGICAL RESEARCH (58%); SIC5063 ELECTRICAL APPARATUS & EQUI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MENT (58%); SIC4939 COMBINATION UTILITIES, NEC (58%); NAICS221122 ELECTRIC POWER DI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TRIBUTION (57%); NAICS221121 ELECTRIC BULK POWER TRANSMISSION & CONTROL (57%); N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ICS221112 FOSSIL FUEL ELECTRIC POWER GENERATION (57%); SIC2834 PHARMACEUTICAL PREPARATIONS (56%); NAICS541810 ADVERTISING AGENCIES (55%); NAICS541613 MARKETING CONSULTING SERVICES (55%); SIC8742 MANAGEMENT CONSULTING SERVICES (55%); SIC7311 ADVERTISING AGENCIES (55%); NAICS551112 OFFICES OF OTHER HOLDING COMPANIES (54%); SIC6719 OFFICES OF HOLDING COMPANIES, NEC (54%); NAICS488490 OTHER SUPPORT ACTIV}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TIES FOR ROAD TRANSPORTATION (52%); SIC4231 TERMINAL & JOINT TERMINAL MAINTENANCE FACILITIES FOR MOTOR FREIGHT TRANSPORTATION (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CITY  ELECTRIC POWER PLANTS (90%); TAKEOVERS (90%); NEWS BRIEFS (90%); AVIAN INFLUENZA (90%); NEW ISSUES (89%); INVESTIGATIONS (89%); JOINT VENTURES MERGERS & A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 QUISITIONS LAW (78%); MERGERS (78%); POWER PLANTS (78%); BUYINS & BUYOUTS (78%); PR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 VATIZATION (78%); PHARMACEUTICALS INDUSTRY (76%); AUTOMOTIVE MFG (76%); AUTOMOBILE MFG (76%); GENERIC DRUGS (76%); ANTIVIRALS (75%); INFLUENZA (75%); TALKS & MEETINGS (75%); AUTOMAKERS (75%); PRIVATE EQUITY (74%); ELECTRIC POWER INDUSTRY (73%); MARKE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ING & ADVERTISING AGENCIES (71%); VACCINES (71%); PHARMACEUTICAL PREPARATION MFG (71%); EXECUTIVES (71%); PUBLIC CONTRACTING (70%); CORRUPTION (68%); BRIBERY (68%); TOLL ROADS & TURNPIKES (66%); PUBLIC FINANCE AGENCIES & TREASURIES (64%); RESIGN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TIONS (63%); RESEARCH INSTITUTES (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 VINCENT BOLLORE (76%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 7, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 English\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUB-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Paper\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 Associated Newspapers Ltd.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Science races bird flu clock Weekend Australian October 29, 2005 Saturday Travel Edition \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_95}{\*\bkmkstart DOC_ID_95_0}{\*\bkmkstart doc_id_40}{\*\bkmkend DOC_ID_95}{\*\bkmkend DOC_ID_95_0}{\*\bkmkend doc_id_40}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_40"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 40 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Weekend Australian\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 October}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  29, 2005 Saturday Travel Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Science races bird flu clock}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SOURCE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MATP\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Leigh Dayton\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 REVIEW; HealthTable; Pg. 28\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1305 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Drug giants are scrambling to protect us from bird flu, reports science writer Leigh Dayton\par THERE'S unwelcome news for regular flu sufferers anxious to refill prescriptions for the bug-busting medic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion Tamiflu. Join the queue. Australia has contracted a serious case of bird flu panic, and the worried well have cleaned out stocks of the antiviral drug known in science circles by its chemical name of oseltamivir.\par According to the manufacturer of Tamiflu, the Swiss pharmaceutical giant Roche, chemists' shelves won't be ringing up sales again until next month. A second shipment is expected at the end of December, said local spokesperson Rita Corrente. \par Further, anyone hoping to get on the Tamiflu waiting list without a prescription will be disappointed. Earlier this month the National Drugs and Poisons Schedule Committee rejected a proposal to make it available from pharmacists over-the-counter.\par Aside from the wait, a }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to the GP, and the $50 price tag for a pack of 10 capsules, virologist Steve We}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 selingh says there's another reason why people hoping to protect themselves from bird flu should hold off, leaving Tamiflu for those at high risk of catching old-fashioned but dangerous human influenza A and B. At least for now.\par "Tamiflu or other antivirals can be utilised to prevent or to treat infection, but in terms of preventing infection you need to be taking it at the time you're exposed," says Wesselingh, director of Melbourne's Macfarlane Burnet Institute for Medical Research and Public Health. He adds the obvious: "That's difficult to predict."\par Wesselingh's point is particularly apt given that there's no evidence that Australians -- human or avian -- have contracted either of the potent strains of the avian H5N1 influenza A virus found in east Asia and parts of eastern Europe. The overseas body count remains low. As of October 24, the World Health Organisation (WHO) reports 121 people in Indonesia, Vietnam, Thailand and Cambodia have contracted the virus, prob}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bly from handling infected birds. Sixty-two have died.\par Although the immediate health risk is small, the race is on to build-up a national stockpile of Tamiflu as well as Relenza, a second -- and Australian-designed -- drug that restricts the replication of influenza in an infec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed person. Should the worst strains of H5N1 build resistance to Tamiflu, Relenza promises to be an une}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pectedly vital second line of pharmaceutical defence.\par That's a distinct possibility, cautions the WHO. Of all the 15 subtypes of avian influenza H5N1 mutates the fastest and has a "documented propensity to acquire genes from viruses infecting other animal species".\par Add it up: strains of the most worrisome subtype of bird flu are predisposed to develop the ability to not only infect people in close contact with animals, but to be transmitted easily from person to person. Worse, when it comes to H5N1 we humans are "naive", Wesselingh points out.\par "That means our immune systems will give us no immediate protection against the virus." According to We}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 selingh, it takes about two weeks to develop disease-fighting molecules called antibodies. "That means you're going to get very sick from influenza for the first few days to a week," he explains.\par Researchers worldwide are racing to design a vaccine able to prevent infection in the first place by priming the immune system to kill the invading virus. But why is it taking so long to stock up the national medicine chest and crank out what many think is little more than a fancy version of the vaccine available for each year's battle with the flu bug?\par The glib answer is, "politics and profits". Although international epidemiologists, virologists, medical providers and the WHO have warned for decades that the planet could at any time be hit by a deadly new strain of i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fluenza -- akin to the Big Ones of 1918-1919, 1957-1958 and 1968-1968 -- national leaders have until now remained reluctant to spend the money.\par Kay McNiece, a spokesperson for the Commonwealth Department of Health and Ageing, says the Gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment has contracted for 3.9 million courses of antivirals, mostly Tamiflu but also Relenza. "The minister is looking into buying more Relenza," she says.\par Until this new surge in demand for antivirals, drug companies chased dollars primarily in so-called "lifestyle drugs" such as Prozac and Viagra. Little effort and funding was given to vaccine research, with notable e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ceptions such as Australia's Melbourne-based CSL Ltd.\par The consequence is that development has been left largely to small teams of government-funded scientists like the Australians who developed Relenza. As today's Weekend Australian Magazine shows, that can be a long and often soul-destroying experience.\par With minimal attention accorded to slow-sellers like Tamiflu -- Roche sold only about two million courses worldwide in 2001 -- there's been no push to make manufacturing more efficient. Case in point: the spice star anise. A wild variety of the humble plant contains the "adjuvant", a vital ingredient Roche uses to boost Tamiflu's effectiveness.\par Until bird flu hit the headlines it mattered little that production of Tamiflu was limited by the availability of star anise, sourced in China only from March to May. Now, Roche has synthesised the active ingredient New Scientist magazine reported this month. That leaves only }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  the Indian manufacturer of a generic ve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sion, at the mercy of Mother Nature.\par Both Roche and GlaxoSmithKline, the manufacturer of Relenza, are now cranking up production. Gla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 oSmithKline has even announced plans to reopen a Melbourne production facility shut in 2000. Gearing up production, though, means just that. It takes months to get packets of tablets rolling off the production line in quantity. What's more, experiments with mice published in July suggest that the current dose may not be enough to save patients infected with a highly virulent strain of bird flu.\par The fact that some strains of H5N1 avian influenza are so lethal -- even in birds -- has also slowed the d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 velopment of a vaccine, notes University of Melbourne virologist Lorena Brown. "In poultry infected with hig}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly pathogenic strains of H5N1, the virus can infect any cell in the animal's body, not just the lungs," she says.\par The bottleneck, notes Brown, is that the virus kills cells within the eggs used to grow the virus in production. While CSL won't reveal details of how it's sidestepped this problem, Brown says the solution is a sophistica}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed process of genetic engineering called reverse genetics. It involves fiddling with the "H", or hemagglutinin, part of the virus's coat so that it's less toxic. By the way, the "N" stands for neuraminidase.\par Over at CSL, spokesperson Rachel David says experts have jumped the genetic hoops and have a cand}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 date vaccine against samples of H5N1 provided by the WHO. Two weeks ago they began the first clinical trials with 200 healthy human volunteers at two sites in Melbourne and Adelaide. If all goes well, she predic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed that so-called Phase Two clinical trials may be ready to go in early February.\par From there? "We'll compile a dossier for the Therapeutic Goods Administration, the Australian regulator," David says, optimistic that due to the urgency it will give the thumbs up or thumbs down quickly. Judging by experience from its conventional flu vaccines, David says it should take just six weeks to get the production lines rolling.\par Under the best-case scenario, it would take three months to produce the 40 million doses required to immu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ise the Australian population. Then everyone can relax, especially the usual suspects who come down with garden-variety flu despite their annual flu shot. At least, they'll know that Tamiflu will be back on the che}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ist's shelf, nestled neatly beside packs of Relenza.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AVIAN INFLUENZA (91%); INFLUENZA (91%); INFECTIOUS DISEASE (90%); PRESCRI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TION DRUGS (90%); ANTIVIRALS (90%); SCIENCE NEWS (89%); LIVESTOCK DISEASE (89%); SC}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENCE & TECHNOLOGY (89%); PUBLIC HEALTH ADMINISTRATION (87%); ANTI-INFECTIVES (79%); PHARMACEUTICALS INDUSTRY (79%); PHARMACISTS (79%); CHEMISTRY (78%); VIROLOGY (78%); MEDICAL RESEARCH (78%); PHARMACEUTICAL PREPARATION MFG (77%); VIRUSES (76%); HEALTH DEPARTMENTS (73%); ANIMALS (73%); RESEARCH INSTITUTES (73%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ROCHE HOLDING AG  (85%); ROCHE HOLDING AG (85%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ROG (SWX) (85%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING (85%); N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (85%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 STEVE WESSELINGH (75%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MELBOURNE, AUSTRALIA (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AUSTRALIA (91%); THAILAND (77%); ASIA (67%); EASTERN ASIA (53%); EASTERN E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ROPE (53%); EUROPE (53%); INDONESIA (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 October 28, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 JOURNAL-CODE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AUS\par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 Nationwide News Pty Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda;Indian Drugs Firm to Invest in Uganda Africa News August 15, 2005 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_96}{\*\bkmkstart DOC_ID_96_0}{\*\bkmkstart doc_id_41}{\*\bkmkend DOC_ID_96}{\*\bkmkend DOC_ID_96_0}{\*\bkmkend doc_id_41}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_41"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 41 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  15, 2005 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda;\par Indian Drugs Firm to Invest in Uganda}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 395 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd, one of the leading drug manufacturing companies in India, has said it is willing to invest in Uga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 da, following an invitation by the Vice president Prof. Gilbert Bukenya.\par Prof. Bukenya has just returned from a five-day official }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  from India where he visited }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd.\par "India may be a developing country, but it has advanced in many fields that can benefit other our people e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pecially in as far as drugs are concerned. We need cheap and effective drugs in Uganda and the only way we can achieve this is by attracting investors here," Bukenya said on arrival at Entebbe Airport on August 12. \par Bukenya appealed to developed countries to invest more in the health sector through drug manufacturing firms to enable people access cheap drugs and live a healthy life by fighting poverty.\par He called for technological transfer in strategic areas such as the health sector in order to improve the we}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fare of the people. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd has 30 drug manufacturing plants in India producing world standard range of human and animal drugs and exporting to over 172 countries in USA, Europe, Asia and Africa.\par Already }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  exports a range of drugs to Uganda, including ARVs for HIV/Aids and ACTs for malaria.\par Bukenya who was accompanied by two local investors Mr Emmanual Katongole, the Executive Director of Quality Chemicals Ltd and Mr Frances Kitaka, a director in the same company, held discussions with the management team of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  in which he persuaded them to invest in Uganda and start manufacturing HIV/Aids and malaria drugs.\par The Managing Director of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd, Mr Amar Lulla, said they are willing to invest in Uganda under a joint venture arrangement and commended Uganda in its fight against HIV/Aids and malaria.\par "We have been encouraged by the Vice president's visit and invitation to invest in Uganda. We hope to do this under a joint venture arrangement," he said.\par He said the commitment shown by the Vice president in the search for cheap and effective drugs for Uga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dans showed how serious the country was willing to fight the epidemic.\par India's generic drug industry has made less-expensive medications available in India and abroad for more than 30 years, making it possible for many people in developing countries to receive treatment. India is the third-largest producer and a major exporter of generic drugs in the world.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICALS INDUSTRY (90%); MANUFACTURING SECTOR PERFORMANCE (90%); AIDS & HIV (90%); PHARMACEUTICAL PREPARATION MFG (89%); GENERIC DRUGS (89%); MALARIA (89%); DISEASES & DISORDERS (78%); DEVELOPING COUNTRIES (78%); HEALTH CARE (74%); ANTI-INFECTIVES (73%); MANUFACTURING OUTPUT (73%); MANUFACTURING FACILITIES (73%); CHEMICALS (73%); VETERINARY DRUGS (73%); EPIDEMICS (71%); POVERTY & HOMELES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NESS (68%); JOINT VENTURES (63%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (97%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (97%); SIC2834 PHARMACEUTICAL PREPARATIONS (97%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GILBERT BUKENYA (93%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 INDIA (97%); UGANDA (96%); EUROPE (79%); AFRICA (79%); ASIA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (91%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 August 15, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Uganda;Indian Drugs Firm to Invest in Uganda Africa News August 15, 2005 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_97}{\*\bkmkstart DOC_ID_97_0}{\*\bkmkstart doc_id_42}{\*\bkmkend DOC_ID_97}{\*\bkmkend DOC_ID_97_0}{\*\bkmkend doc_id_42}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_42"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 42 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  15, 2005 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Uganda;\par Indian Drugs Firm to Invest in Uganda}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 395 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd, one of the leading drug manufacturing companies in India, has said it is willing to invest in Uga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 da, following an invitation by the Vice president Prof. Gilbert Bukenya.\par Prof. Bukenya has just returned from a five-day official }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  from India where he visited }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd.\par "India may be a developing country, but it has advanced in many fields that can benefit other our people e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pecially in as far as drugs are concerned. We need cheap and effective drugs in Uganda and the only way we can achieve this is by attracting investors here," Bukenya said on arrival at Entebbe Airport on August 12. \par Bukenya appealed to developed countries to invest more in the health sector through drug manufacturing firms to enable people access cheap drugs and live a healthy life by fighting poverty.\par He called for technological transfer in strategic areas such as the health sector in order to improve the we}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fare of the people. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd has 30 drug manufacturing plants in India producing world standard range of human and animal drugs and exporting to over 172 countries in USA, Europe, Asia and Africa.\par Already }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  exports a range of drugs to Uganda, including ARVs for HIV/Aids and ACTs for malaria.\par Bukenya who was accompanied by two local investors Mr Emmanual Katongole, the Executive Director of Quality Chemicals Ltd and Mr Frances Kitaka, a director in the same company, held discussions with the management team of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  in which he persuaded them to invest in Uganda and start manufacturing HIV/Aids and malaria drugs.\par The Managing Director of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ltd, Mr Amar Lulla, said they are willing to invest in Uganda under a joint venture arrangement and commended Uganda in its fight against HIV/Aids and malaria.\par "We have been encouraged by the Vice president's visit and invitation to invest in Uganda. We hope to do this under a joint venture arrangement," he said.\par He said the commitment shown by the Vice president in the search for cheap and effective drugs for Uga}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dans showed how serious the country was willing to fight the epidemic.\par India's generic drug industry has made less-expensive medications available in India and abroad for more than 30 years, making it possible for many people in developing countries to receive treatment. India is the third-largest producer and a major exporter of generic drugs in the world.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICALS INDUSTRY (90%); MANUFACTURING SECTOR PERFORMANCE (90%); AIDS & HIV (90%); PHARMACEUTICAL PREPARATION MFG (89%); GENERIC DRUGS (89%); MALARIA (89%); DISEASES & DISORDERS (78%); DEVELOPING COUNTRIES (78%); HEALTH CARE (74%); ANTI-INFECTIVES (73%); MANUFACTURING OUTPUT (73%); MANUFACTURING FACILITIES (73%); CHEMICALS (73%); VETERINARY DRUGS (73%); EPIDEMICS (71%); POVERTY & HOMELES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NESS (68%); JOINT VENTURES (63%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (97%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (97%); SIC2834 PHARMACEUTICAL PREPARATIONS (97%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GILBERT BUKENYA (93%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 INDIA (97%); UGANDA (96%); EUROPE (79%); AFRICA (79%); ASIA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (91%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 August 15, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HIV-Aids and STDs;Global Aids Treatment Drive Takes Off Africa News April 28, 2005 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_98}{\*\bkmkstart DOC_ID_98_0}{\*\bkmkstart doc_id_43}{\*\bkmkend DOC_ID_98}{\*\bkmkend DOC_ID_98_0}{\*\bkmkend doc_id_43}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_43"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 43 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  28, 2005 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 HIV-Aids and STDs;\par Global Aids Treatment Drive Takes Off}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa Renewal\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 3207 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Rapid increase in number of people receiving ARV medicines\par When a reporter first met seven-year-old Bongani in a hardscrabble shantytown near Johannesburg in 2003, it was evident the child was dying. He was too weak for school, stunted and racked by diarrhoea. There was little question that he, like his deceased parents, was infected with the human immunodeficiency virus that causes AIDS. It seemed equally certain that he would soon lie in a tiny grave next to theirs -- joining the 370,000 South Africans who died from the disease that year.\par But when the journalist, Mr. Martin Plaut of the BBC, returned a year later, he found a healthy, laughing Bo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gani poring over his lesson book. "The transformation," Mr. Plaut wrote last December, "was remarkable." \par That transformation -- and the difference between life and death for Bongani and a growing number of pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple living with HIV and AIDS in Africa -- has resulted from access to anti-retroviral drugs (ARVs) that attack the virus and can dramatically reduce AIDS deaths. For years high costs severely limited their use in Africa. The Joint UN Programme on HIV/AIDS (UNAIDS) estimated that only about 50,000 of the 4 million Africans in urgent need of the drugs were able to obtain them in 2002. But with prices dropping in the face of d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mands for treatment access and competition from generic copies of the patented medications, the politics and economics of AIDS treatment have finally begun to shift.\par In December 2003, the World Health Organization (WHO) announced an unprecedented drive to put 3 mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lion people living with HIV/AIDS in developing countries on ARV treatment by the end of 2005, the "3x5" campaign. Two months later, the US launched an ambitious programme of its own, the President's Eme}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gency Plan for AIDS Relief (PEPFAR) -- a 5-year, $15 bn initiative to provide ARV therapy to 2 million people and prevent 7 million new infections by 2008 in 15 countries, including 12 in Africa.\par 'Irresponsible' goal now in sight\par The early results are encouraging. In January 2005, WHO, joined by representatives of the US government, UNAIDS and the multilateral Global Fund to Fight AIDS, Tuberculosis and Malaria, announced that the nu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ber of people receiving ARV treatment in developing countries had increased by 75 per cent during 2004 to over 700,000 -- including an estimated 325,000 in sub-Saharan Africa. In the view of many public health e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 perts, the rapid increase vindicates what some critics derided as WHO's "irresponsible" and unrealistic 3x5 pledge.\par The results also seem to belie predictions that the mix of multilateral and bilateral funding and treatment pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 grammes would prove impossible to coordinate and only further burden overstretched health systems in the worst-affected countries. South Africa, Nigeria and India account for over 40 per cent of the total number of people still in need of ARV treatment, and experts say that a focus in those three countries could produce major gains for treatment access in a short time.\par Speaking at a press conference at the World Economic Forum in Davos on 26 January, WHO Director-General Dr. Lee Jong-wook singled out developing countries for much of the credit. "We salute the countries that have now shown us that treatment is possible and can be scaled up even in the poorest settings," he said. "AIDS treatment access is expanding every day thanks to the dedicated work of doctors, nurses, health workers and people living with HIV and AIDS, who are often working under difficult circumstances to turn the dream of universal treatment into a reality." WHO officials assert that at current rates the world is on track to reach the 3x5 goal.\par This upbeat assessment is tempered, however, by an estimated $2 bn shortfall to reach the 3 million mark by the end of this year. That amount is part of the $6 bn in additional resources UNAIDS says is needed in 2005 for the full range of HIV/AIDS programmes in developing regions. The treatment drive in many countries is hampered by severe shortages of trained medical personnel and facilities and by continuing controversies over drug prices and patents. "Unless these and other pressing issues are addressed urgently," declared the non-governmental organization Medecins sans Frontieres (MSF), "many of those living with HIV/AIDS in d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 veloping countries will never get access to life-saving treatment or may not be able to survive once on trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment over the long term."\par MSF and other advocacy groups point out that the 700,000 people in ARV treatment represent only about 12 per cent of the nearly 6 million people in developing countries who need it. With the disease taking 8,000 lives daily, and new infections topping 5 million last year alone, MSF declared that "the global picture is bleak... WHO ... and other institutions should be sounding the alarm."\par 'A tremendous determination'\par Whether one views the pill bottle as half empty or half full, the increased availability of anti-AIDS medicines in Africa is very good news. Although the percentage of Africans currently receiving the life-prolonging drugs remains a low 8 per cent of those requiring it -- ARVs are prescribed only for those in the final stages of the disease -- the continental average masks significant advances in some countries.\par In Botswana, the country with the second-highest HIV-infection rate in the world, an estimated 50 per cent of those in need currently receive ARV drugs. This is due in large part to the government's pioneering decision in 2002 to provide the medications free of charge through the public health system.\par Uganda, whose AIDS prevention campaign is already considered a model for effective programmes, now provides ARV treatment to 40 per cent of the 114,000 people who require it. In Cameroon, reports WHO, strong political leadership combined with increased funding assistance and a sharp drop in drug prices has allowed some 12,000 people to begin ARV therapy. Cameroonian authorities say they will triple that number by the end of 2005.\par Overall, notes WHO in its December 2004 3x5 Campaign Report, anti-retroviral medications are now avail}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ble at more than 700 sites across the region. The study also found that African ARV patients are equally or more likely than patients in developed countries to maintain the drugs' strict daily treatment schedule. This finding has confounded critics who argued that poor adherence rates would accelerate the emergence of drug-resistant strains of the virus.\par WHO also reported that men and women have roughly equal access to ARVs in Africa under the new trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment programmes. This means that women, who make up 57 per cent of Africans living with the virus, are underrepresented in some countries; but the numbers have allayed, at least for now, fears that women would be excluded from national treatment strategies.\par In Botswana, the country with the second-highest HIV-infection rate in the world, an estimated 50 per cent of those in need currently receive ARV drugs.\par The early success of the treatment drive, says UN Special Envoy for HIV/AIDS in Africa Stephen Lewis, r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 flects the coming together of new resources from the Global Fund and the US government, the technical support and momentum of WHO's 3x5 campaign and a new sense of urgency among African governments and civil society. Mr. Lewis, a former Canadian diplomat known for his criticism of responses to the pandemic by both donors and African governments, told Africa Renewal that in recent months "there has been a huge change for the better" among African political leaders and health officials. "It's like night and day. There is tremendous determination to meet those 3x5 targets."\par The reason for the sudden change, he notes, is that in the hardest-hit countries, HIV/AIDS can no longer be ignored. For some leaders "it was the fear that the country was falling apart, the sense that every indicator was being turned back, from life expectancy to levels of poverty to infant and maternal mortality. It made the political leadership say, 'Oh my God, we've got to turn this around.'" In the worst affected regions, "the pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vasiveness of death is almost unbelievable. They're in a life-and-death battle, and now everybody sees it that way."\par Building capacity\par Despite the progress, obstacles to treatment access remain stubbornly in place. Chief among them is the absence of the public health capacity -- hospitals and clinics, diagnostic and laboratory facilities, trained medical personnel -- to maintain millions of people on the powerful anti-retroviral medications. Although Mr. Lewis estimates that Africa already has the capacity to maintain double the current number of people now on treatment, "the need to increase capacity is huge, and there's a kind of grim, gritted-teeth determination to get it built."\par Part of the problem, notes a recent study by WHO and other international health organizations, is the "fatal flow" of African health professionals to better-paying jobs overseas. The study notes that there are more M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lawian doctors practicing in the UK city of Manchester than in Malawi itself, while Zambia, with one of the highest HIV-infection rates in the world, has lost to foreign employers 550 of the 600 doctors it has trained since independence.\par Malawi and its development partners have responded to the desperate staffing shortage with a programme to improve salaries and working conditions for health professionals and to train a new cadre of health wor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ers able to dispense ARVs and provide basic medical services.\par Rebuilding Africa's threadbare public health systems will take time, however, and for millions of people in the last stages of AIDS, time is running out. "Almost everyone would agree that the largest challenge resides around capacity," says Dr. Mark Dybul, the assistant US global AIDS coordinator and chief medical officer for the PEPFAR programme. The US, the Global Fund and WHO programmes therefore focus on "supporting new people on therapy, but simultaneously building new capacity. I don't think it's correct to say that all [the recent increases] have been done using existing capacity."\par One small PEPFAR-supported clinic in Namibia, he notes, had the resources to treat several hundred pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple. "Now they have the capacity to treat a couple of thousand people. They're taking people off the waiting list and putting them on the rolls, because they built new capacity at the same time they began treatment."\par Funding support, technical assistance and drugs and equipment could come from outside, Dr. Dybul told A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rica Renewal. But for the programme to expand, there also needs to be capacity within the country. "And that's got to begin with the national strategy commitment" of the governments and civil societies of affected countries. "What we do is support them... We [all] need to do more, and we're not there yet... but capacity has been expanded over the past year with tremendous success."\par The US programme alone added 155,000 people to the treatment rolls in just eight months in its 15 target countries: Botswana, Cote d'Ivoire, Ethiopia, Kenya, Mozambique, Namibia, Nigeria, Rwanda, Tanzania, Uganda, Zambia, Haiti, Guyana and Vietnam. Dr. Dybul says it is on track to reach the 500,000 mark by June 2006.\par "I think there are a lot of misconceptions about [ARV] drugs," Dr. Dybul adds. "The cost of anti-retroviral therapy is not drugs... The major costs are supporting and training personnel, laboratory capacity and su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 porting those laboratories."\par Dr. Dybul puts the annual cost of ARV treatment in Africa at $1,500- $2,500 per person, with drugs accoun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing for just $300-$600 of the total. "Arguments about the cost of the drugs are for us a red herring," he e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 plains. "That's not the problem right now."\par Patent, pricing controversies\par But controversies over the safety, supply and cost of anti-AIDS drugs have continued. In contrast to Dr. D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bul's assessment, WHO reported last December that "the high cost of ARV drugs remains a barrier to scaling up HIV treatment and care." Prices for the next generation of anti-AIDS drugs, which will be needed as the virus develops resistance to current medications, "remain prohibitively expensive throughout much of the world," the organization noted. It warned that action is needed now to control future costs.\par For more than a decade after the development of the first anti-retrovirals in the late 1980s, their high cost and the complexity of using them kept the life-prolonging medications out of the hands of all but a few very wealthy or very fortunate people in poor countries. At $10,000-$15,000 per year, ARV treatment was simply unaffordable. Efforts by UNAIDS to negotiate discounted prices for developing countries enjoyed only limited success, and the major Northern pharmaceutical companies generally resisted calls to licence inexpensive generic versions of their patented products.\par In 2001, however, an Indian pharmaceutical firm, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  introduced an innovative generic medication that combined three of the most effective anti-retroviral drugs into a single pill, known as the triple fixed dose combination tablet (FDC). Not only was the drug easier to administer than its patented competitors -- two pills a day compared with six or more of some of the patented formulations -- it was available initially for the unheard-of price of $350 per year. After a two-year investigation by WHO's drug prequalification programme, the triple FDC was certified safe and medically equivalent to the patented originals, and went into wide use. With prices now as low as $140 a year, the triple FDC has emerged as the pharmaceutical backbone of the 3x5 campaign and is credited with making it possible to expand ARV treatment.\par But PEPFAR requires its grantees to use only drugs certified by the US Food and Drug Administration (FDA), a policy that, in practice, has meant the programme buys only patented products, mainly from US suppliers. PEPFAR officials say the policy is necessary to ensure the safety and quality of drugs and note that a number of generic ARVs have been removed from the WHO pre-approval list after problems were di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 covered in the certification documents. They also note that foreign generics producers are welcome to su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mit their products for FDA approval under a special "fast track" procedure.\par To date, however, none of the triple FDC drugs favoured in international treatment programmes has secured FDA approval. The result, reported the US government General Accounting Office, is that PEPFAR currently pays about twice as much for anti-retroviral medications as treatment schemes using generics. The agency estimates that the costs could potentially run into hundreds of millions of dollars over the five-year span of the PEPFAR initiative, reducing the number of people who can be treated for the same money.\par In late January, the FDA approved its first generic ARV product, a two-pill package taken twice daily, and applications for other generic products, including triple FDCs, are under review. Treatment advocates we}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come the development but charge that the failure of the US to adopt the preferred triple FDC tablet is forcing participating countries to manage different supply chains and treatment regimes -- complicating the drive to expand treatment.\par Trade rules threaten affordability\par The extension of 20-year patent protections to all but the least developed countries on 1 January 2005, u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 der the World Trade Organization's agreement on Trade-Related Aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , has also set off alarm bells among advocates and health officials. The agreement makes it more difficult for India and other major exporters of generic drugs to continue to supply developing countries with low-cost ARVs and other vital medicines.\par The current generation of frontline anti-AIDS drugs are exempt from the new patent rules, says Mr. Brook Baker, a professor at Northeastern University in the US and a member of the treatment advocacy group Health Gap. "The problem will be with the next generation of ARVs in the pipeline. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  will prevent the kind of generic competition that has driven prices down in the past."\par In August 2003, the WTO's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Council, under pressure particularly from African countries to create a public-health exemption to the new rules, reached an agreement to permit the export of generic drugs for public health emergencies. But the exemption is limited and procedurally complex. To date, no country has attempted to use it.\par Mr. Baker also notes that US negotiators are seeking patent protections in excess of WTO requirements in regional and bilateral trade talks. These so-called "}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  plus" agreements, Global AIDS Fund head Richard Feacham said last year, have the effect of "either pushing [drug] prices up or preventing their fall," further limiting the availability of affordable medications.\par Canada recently amended its patent laws to permit the pharmaceutical industry to use the WTO exemption, but according to Mr. Richard Elliot, the director of legal research and policy at the Canadian HIV/AIDS Legal Network and a member of the government's Ministerial Council on AIDS, its provisions too are complex and restrictive. So far, he told Africa Renewal, no Canadian company has sought an export license under the new law.\par Short on resources, long on needs\par The rapid expansion of AIDS treatment programmes has brought with it equally dramatic demands for new resources. And while the 3x5 campaign and the US programme have short-term targets, they are creating long-term obligations to the millions of people entering treatment, since ARV therapy must continue for life. When UNAIDS was launched in 1996, the organization noted recently, global spending on the full range of HIV/AIDS initiatives in low- and moderate-income countries was $300 mn. Last year, reports the Washin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ton-based Kaiser Family Foundation, spending topped $6 bn.\par But even that impressive figure, notes the UN's Mr. Lewis, is just half the $12 bn UNAIDS estimates is nee}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed this year to continue expanding treatment programmes and meet education, prevention, counselling and research needs. The Global Fund needs $1 bn this year to cover its commitments, he says. "WHO is short $60 mn for the final vital push on 3x5 and they still don't have it. I don't understand this grudging incrementa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ism by Western countries. We're losing incredible numbers of lives every day."\par UNAIDS estimates that by 2007 $20 bn will be needed for the fight against AIDS, and Mr. Lewis calls on wealthy governments to make major new commitments at the upcoming meeting of the Group of Eight indu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 trialized countries. "We have more money now, but in a few years we'll be fighting desperately for dollars again. Prices for the next generation of drugs are very, very high. They will have to be negotiated down and ways found to make generics."\par "Everywhere we turn we have impediments," he acknowledges. "But we also have a momentum that is u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 stoppable. I see the focus everywhere in Africa. Now the commitment is tremendous."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (99%); AIDS & HIV TREATMENT (91%); SEXUALLY TRANSMITTED DISEASE (90%); PUBLIC HEALTH ADMINISTRATION (89%); HEALTH CARE ACCESS (78%); GENERIC DRUGS (78%); ANTIVIRALS (78%); DISEASES & DISORDERS (78%); AIDS POLICY (76%); VIRUSES (76%); M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LARIA (76%); PHARMACEUTICALS PATENTS (73%); HEALTH DEPARTMENTS (73%); DEVELOPING COUNTRIES (72%); UNITED NATIONS INSTITUTIONS (71%); TUBERCULOSIS (71%); INTERNATIONAL ASSISTANCE (67%); GENERIC PRODUCTS (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MARTIN PLAUT (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AFRICA (94%); SOUTH AFRICA (92%); UNITED STATES (92%); SUB SAHARAN AFRICA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 JOHANNESBURG, SOUTH AFRICA (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (81%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 May 2, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore April 12, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_99}{\*\bkmkstart DOC_ID_99_0}{\*\bkmkstart doc_id_44}{\*\bkmkend DOC_ID_99}{\*\bkmkend DOC_ID_99_0}{\*\bkmkend doc_id_44}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_44"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 44 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Is it the end of cheap drugs from India?;\par Medicine prices may soar in a few years as the country can no longer make generic drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  12, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par Yogi Aggarwal\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 THE Indian pharmaceutical industry is at a cusp. Prices of medicines could start rising sharply in three to five years and Indian companies, which had prospered under the Indian Patent Act of 1970, could see their fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tunes declining as those of the multinationals rise.\par 'What is at stake is the health of the Indian people and even their lives,' says Yusuf Hameid, the Cambridge-educated organic chemist who heads }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , one of India's largest pharmaceutical companies.\par The earlier legislation only recognised 'process' patents and allowed Indian companies to reverse engineer drugs to manufacture them by another route. It led to India having the cheapest medicine prices in the world, typically less than a tenth of those prevailing in neighbouring Pakistan, which largely imported them. \par While trade minister Kamal Nath assured the Indian Parliament when the Patent Amendment Bill was intr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 duced on March 22 that 'strong safeguards and comprehensive provisions' would check any price increases and availability of medicines, the industry, health workers and many parliamentarians were far from co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vinced.\par But if the public protest in India was muted, it was more vocal in African countries which heavily rely on Ind}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 an anti-Aids drugs in their public health programmes. A few days before the Bill was to be voted in Parli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment, there were demonstrations in Nairobi and Kampala. Many international health NGOs, including the Geneva based Doctors Without Borders (Medecin Sans Frontiers - MSF) came to India to campaign against the bill.\par Michael Angaga, African Regional Co-ordinator of Network of African People Infected with HIV/Aids, said in a telephone conversation: 'Generic drugs from India are used in public hospitals in Nairobi. People cannot a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ford patented drugs manufactured by MNCs in Kenya or other African countries. We appeal to the Indian Parliament to see this as a humanitarian issue since otherwise millions of people will die in Africa as the pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lic health system will collapse. Patented medicines cost as much as US$100, which is a family's monthly i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 come.'\par This feeling was echoed by the MSF, whose spokeswoman, Ellen Thoen, told The Business Times: 'It is very sad and a matter of great concern that India should no longer have process patents which made medicines so affordable. But we realise that India has obligations under the WTO and within that we understand the government could not do otherwise. India has modified the earlier ordinance and we take that as a positive signal.'\par While the amended bill as passed is a vast improvement on the ordinance passed by the government in D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cember 2004 (it was formulated by the earlier BJP-led government in 2003) to meet the January 2005 dea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 line under WTO, it has not used the full flexibility allowed under the trade-related aspects of intellectual pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erty rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  negotiations.\par Concern\par Many of the provisions also make the domestic pharmaceutical industry uneasy. Some of the amended se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions are worded such that 'they could have been drafted in a multinational company's office' says one o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 server.\par There are several areas of concern. One is whether patents can be extended beyond the stipulated 20 years by some small change. Another relates to whether patented medicines will compulsorily have to be licensed to Indian manufacturers or if the patent holder can retain a monopoly over their supply.\par The backdating of patents from 1995 instead of 2005 has also been criticised, and it is feared that the amb}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 guity in the royalty payable could lead to time consuming and expensive litigation. And while Indian comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nies will be allowed to export some vital drugs to countries which do not have a manufacturing base, they will not be allowed to sell them in India.\par One paradoxical fact is that while less than 25 new molecules have been discovered in the 10 years from 1995 to 2004, there are some seven to eight thousand applications for patents pending or in the 'mailbox' in the Indian patent office. This is because most of them are frivolous and even if 90 per cent are rejected by the office, this still leaves several hundred dubious applications which would have to be opposed, opening a Pandora's box of litigation.\par Spokesmen for drug industry associations concede that while many of their objections to the earlier ord}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nance were met, some were not. Says Dara Patel, secretary general of the Indian Drug Manufacturers Ass}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ciation (IDMA): 'Most of our recommendations were accepted but our suggestions on compulsory license procedure and more powers for the government did not get through.'\par 'We are not against patents, we are against monopoly,' explains Dr Hameid of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 . 'There is an intimate link between monopoly and prices, greater monopoly leading to higher prices'. He poses a vital and painful question: 'Does the globalisation of healthcare imply that we have the means to treat the sick and needy but are at a liberty to make the terrible choice between profits and lives?'\par To answer that, we have to look at how the first world chose to respond to the Aids epidemic. Before }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  started making retroviral drugs for treating Aids, the annual cost of treatment was US$ 2,000, several times the family income of those afflicted by Aids in Africa and Asia. In 2000, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  came out with a formulation which it offered to the international community for US$800 a year and within a year was able to offer an Aids treatment for under US$300 a year.\par There was an international uproar against the looting by big pharma. 'Everyone suddenly knew that effective, affordable anti-Aids drugs were available from Indian generic manufacturers. The monopoly leading to high prices of drugs the patent regime had created stood clearly exposed. Thy were forced to drop prices to US $800. This still allowed a huge profit as the cost was around US$100,' says Dr Hameid.\par Monopoly, and the advantage of controlling knowledge for profit lie at the heart of linking intellectual property rights under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to trade negotiations under the WTO. India had opposed the new IPR first proposed at the Gatt trade negotiations in the early 1990s, but like many other countries, was browbeaten into submission.\par The target of attack is the 1970 Indian Patents Act, which has allowed the Indian pharmaceutical industry to become a force to reckon with. In 1971, drug prices in India were as high as in Pakistan and 33 of the top 50 pharmaceutical companies were multinationals who had a 70 per cent market share of the total industry sales of Rs 3.6 billion. (S$126 million).\par By 1996, the industry sale had grown to 109 billion rupees with multinationals having a market share of 34 per cent. By 2004, the industry had further grown to 354 billion rupees and 37 of the top 50 companies were Indian, while the market share of Indian companies had grown to 78 per cent.\par Exports of drugs from India in 2003-04 touched US$3.18 billion while imports were just US$687 million. The wide use of affordable Indian medicines in Africa and Asia also meant that potentially lucrative markets were being lost to US and European drug companies. This had to change.\par Changes\par The powerful multinational drug companies pushed for the changes evident in the December 2004 Ord}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nance. Though they have had to yield a little ground in the bill as passed recently, the Indian industry is now on the defensive. As new patented molecules start coming into the market from 2008, their prices will be much higher.\par Indian companies will lose ground and market share. The people of India will find themselves paying much more for medicines. Many will not be able to afford them. 'In another 20 years,' muses Dr Hameid, 'we'll be back to where we started in 1970 and a large part of Indian industry will have been acquired by the multin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tionals.'\par Unless, that is, further amendments are made in the bill to ensure that affordable medicines continue to reach the Indian people without hindrance.\par The writer is a Mumbai-based journalist who contributes regularly to BT\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par  DRUG PRICES (92%); EDITORIALS & OPINIONS (91%); PHARMACEUTICALS INDUSTRY (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TENTS (90%); LEGISLATION (90%); PATENT LAW (90%); LEGISLATIVE BODIES (90%); GENERIC DRUGS (90%); PHARMACEUTICALS PATENTS (89%); PHARMACEUTICAL PREPARATION MFG (89%); MULTINATIONAL CORPORATIONS (89%); INTELLECTUAL PROPERTY LAW (89%); AIDS & HIV TREATMENT (78%); PRICE INCREASES (78%); AIDS & HIV (78%); MEDICAL CHARITIES (78%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LECTUAL PROPERTY (78%); NONGOVERNMENTAL ORGANIZATIONS (77%); COMMERCE DEPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MENTS (73%); REVERSE ENGINEERING (72%); PROTESTS & DEMONSTRATIONS (72%); PHYSICIANS & SURGEONS (70%); RELIEF ORGANIZATIONS (70%); HOSPITALS (65%); INTERNATIONAL ASSI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TANCE (65%); \par \par  CIPLA LTD (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 VIEWS AND OPINIONS; BT Comment Others\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1347 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 April 11, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Zambia;India's Cheap Medicines Africa News March 29, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_100}{\*\bkmkstart DOC_ID_100_0}{\*\bkmkstart doc_id_45}{\*\bkmkend DOC_ID_100}{\*\bkmkend DOC_ID_100_0}{\*\bkmkend doc_id_45}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_45"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 45 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  29, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Zambia;\par India's Cheap Medicines}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Post\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 776 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 INDIA'S enactment of a law making it illegal for their pharmaceutical companies to make generic copies of patented drugs will certainly deprive millions of people across the world of inexpensive life-saving medicines.\par This law was enacted in compliance with India's commitment to the World Trade Organisation's Agreement on Trade-related Aspects of Intellectual Property Rights, or }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par This law is very difficult to accept for us who believe that the highest level of political and economic thought was reached when some people became aware that no people and no human being had the right to exploit others, and that the fruits of the efforts and intelligence of each human being should reach all others; that man really had no need to be a wolf, but could be a brother to man.\par And although the Indian Congress Party government has pledged to its leftist allies and other opposition lawmakers that the new law won't push up the medicine prices in the country, we don't see how this will be guaranteed, especially for the export market. \par India's pharmaceutical market has thrived in the last three decades because the country's law had allowed patented drugs to be copied, as long as a different manufacturing process is used to make them. The co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panies were legally producing generic versions of medicines that were under patent elsewhere, including the much in demand low-cost AIDS drugs for 50 per cent of nearly one million HIV patients taking antiretroviral medicines in developing countries.\par Some of the AIDS drugs made by reputable Indian companies cost about 5 per cent of the price of similar drugs sold by United States and European Union pharmaceutical companies.\par We know that the news of the new Indian law is honey to the ears of international pharmaceutical companies but this law will spell doom for the access to medicine in poor and developing countries by sky-rocketing the drug prices, making them unaffordable.\par Indian pharmaceutical majors like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Ranbaxy were spearheading making AIDS drugs and exporting them to African nations at a very low cost as compared to multinational pharmaceutical majors. All this seems to be changing now.\par This new law spells long-term disaster for India and other Third World countries in health. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  had virtually become a household name in African countries, as its generic or chemically similar AIDS drugs took on mu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tinational companies selling in the market.\par In Africa, exports by Indian companies, helped nose-dive the annual price of antiretroviral treatment down from US $14,000 a decade ago to about $200. They also simplified the therapy by making pills containing three AIDS drugs.\par Generics made up about 15 per cent of India's $10 billion pharmaceutical industry that has 300 large and moderate-sized firms, plus 10,000 small companies, making 8 per cent of the world's drugs. According to pharmaceutical industry statistics, nearly 70 per cent of production is by the top 100 companies and about a third of that is exports, which were rising by 25 per cent a year. Indian companies will no longer be able to make copies of over-priced western drugs, which will affect poor countries around the world.\par But the WTO obligation does not require India to grant patents on new uses of known drugs, or combinations of known drugs. However, Indian lawmakers have included double-usage patents in their law. A drug like AZT, which was used against cancer in the mid '70s and now used for HIV, can be patented simply on the grounds of new usage.\par And five cancer drugs such as Gefitinib, Temozolomide, Zoledronic acid, Letrozole and Ganciclovir are set to see a multi-fold increase in prices, as a result of this new law. Prices on these drugs will increase between two and 12 times.\par And simply because India is one of the world's biggest producers of generic drugs, this law will have a s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vere ripple effect on many developing countries which depend on imported generic drugs from India.\par Under the agreement on intellectual property at the WTO, India had to introduce amendments to its existing patent Act by January 1, 2005. Unfortunately, the Indian government waited until the very last minute and then rushed it through the parliament, leaving no space for democratic debate and consideration of wider public health implications.\par We are deeply disturbed and concerned that the Congress Party government has failed to listen to the voi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 es of so many people who have entrusted them with their welfare. And it is difficult to accept the Indian go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ernment's assurance that it has enough safeguards to protect the interests of the poor. How?\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICALS INDUSTRY (91%); PHARMACEUTICAL PREPARATION MFG (90%); GENERIC PRODUCTS (90%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY COMPLIANCE (90%); PHARMACEUTICALS PATENTS (90%); AIDS & HIV TREATMENT (90%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ERTY LAW (90%); GENERIC DRUGS (90%); AIDS & HIV (90%); ANTIVIRALS (89%); DRUG PRICES (89%); INTERNATIONAL TRADE (89%); EXPORT TRADE (89%); LEGISLATION (89%); DEVELOPING COUNTRIES (89%); LEGISLATORS (78%); PATENT LAW (78%); MULTINATIONAL CORPORATIONS (77%); EXPORT PRICES (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (58%); RANBAXY (NSE) (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (58%); SIC2834 PHARMACEUTICAL PREPARATIONS (58%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ING (52%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANIZATION  (58%); WORLD TRADE ORGANIZATION (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 INDIA (95%); AFRICA (93%); ZAMBIA (92%); UNITED STATES (79%); EUROPEAN UNION MEMBER STATES (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANIZATION (60%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 March 29, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PanAfrica;Goodbye to Cheap Indian Aids Drugs? Africa News November 26, 2004 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_101}{\*\bkmkstart DOC_ID_101_0}{\*\bkmkstart doc_id_46}{\*\bkmkend DOC_ID_101}{\*\bkmkend DOC_ID_101_0}{\*\bkmkend doc_id_46}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_46"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 46 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  26, 2004 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 PanAfrica;\par Goodbye to Cheap Indian Aids Drugs?}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Inter Press Service\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1225 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 As India moves to meet a New Year's Day deadline to comply with the Trade Related Aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  regime of the World Trade Organisation (WTO) the cheap, generic anti-AIDS drugs that this country is famed for could be a thing of the past.\par On Nov.19, the World Health Organisation (WHO) announced that the Hyderabad-based pharmaceutical Hetero Drugs Limited, had voluntarily withdrawn all six of its generic antiretroviral (ARV) drugs from the world body's list of approved drugs following concerns about their laboratory tests.\par ARVs are substances used to kill or inhibit the multiplication of retroviruses such as HIV.\par It was the third time since June that an Indian company has removed anti-AIDS drugs following WHO inspe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions which claimed that bioequivalence tests -- meant to show the drugs have the same effect as the original patented brands - were faulty. And this has deeply upset those involved in fighting the global HIV/AIDS ep}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 demic. \par Earlier this month Indian pharmaceutical giant Ranbaxy pulled its AIDS drugs off the WHO's list after the global body also claimed there were discrepancies in the equivalency tests. It followed the removal by India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  of two HIV/AIDS drugs in June for similar problems..\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is the Indian company credited with introducing the 'dollar-a-day' treatment that dramatically tran}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 formed drug access for HIV-infected people around the world.\par But the fact of the matter remains.\par Both Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  were able to prove to WHO, before the voluntary pull-off, that their ARVs met the global body's bioequivalence standards -- though not before their world business had taken a knock that benefited the manufacturers of costlier patented drugs.\par That initially led to charges from non-governmental organisations (NGOs) that the world health body was acting at the behest of western pharmaceutical giants.\par However, things, now, have become more complicated.\par Why did the two Indian pharmaceutical companies pull their ARVs from the market, if they had insisted all along that their drugs met WHO pre-qualification standards?\par "We are concerned over the withdrawals. Earlier it was WHO which dropped the drugs. This time the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 panies are doing it own their own. We may ask the Drugs Controller of India (DCGI) to look into the issue," a senior health official told IPS.\par WHO's pre-qualification list was created to guide procurement by aid agencies and donors interested in fighting the global HIV/AIDS epidemic and includes more than 60 ARVs made by both patented and generic drug manufacturers.\par According to the internationally-known drug policy expert, Mira Shiva, the actual culprit in the whole debacle involving Hetero, Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  was actually the WTO and not WHO.\par Shiva who is attached to the Voluntary Health Association of India (VHAI), a leading health NGO, said Indian pharmaceutical companies that specialise in cheap generics drugs could face legal action, initiated by the WTO, if they continued to manufacture and sell them after Jan. 1, 2005.\par "The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  regime (in the WTO structure) has been identified as one of the worst international trade r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gimes and resistance to it in developing countries has come from farmers, public interest and human rights minded social action groups, as well as drug and health activists," Shiva told IPS.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement, introduced in the late 1990s, defines how products can be protected from piracy. A major criticism has been that in its current form, intellectual property rights regimes (IPR) -- like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  -- serve to stifle competition. For poor nations it makes developing their own industries independently more costly, if at all possible.\par "Excessively high levels of intellectual property protection required by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  have shifted the balance away from the public interest, towards the monopolistic privileges of IPR holders," said Martin Khor of the Mala}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sia-based Third World Network. "This undermines sustainable development objectives, including eradicating poverty, meeting public health needs, conserving biodiversity, protecting the environment and the realisation of economic, social and cultural rights."\par Shiva pointed out that a }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  review was due in 2000 but was never carried out although the WHO was both aware and concerned about the effect the regime would cause to drug prices and access especially in the developing countries.\par So far, India's pharmaceutical business has followed the fiercely nationalistic India Patents Act of 1970 that fostered the phenomenal growth of the industry that came to be hailed by the United Nations Council for Trade and Development (UNCTAD) as a model for developing countries.\par According to a World Bank study in the mid-1990's prices for four typical drugs were ten times more expe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sive in neighbouring Pakistan, 17 times more expensive in Britain and 37 times more expensive in the United States than in India.\par The Indian law has safeguards for both inventors as well as users but recognizes process patents as against the product patents regime required by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS/}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WTO.\par An amendment to the Act, designed to meet the WHO deadline is slated to be tabled by the government du}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing the winter session of the Indian Parliament next month. If the government fails to get a consensus, it is expected to resort to an ordinance.\par India signed the relevant WTO agreement on the issue in 1995 as part of its economic liberalisation under a Congress government but the party lost the elections in the following year because of widespread public pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ception that globalisation had benefited only a small elite.\par The Congress party had to wait eight years before it could return to power in May on a promise to pursue liberalisation "with a human face." But Kamal Nath its current minister for commerce and industry said the country could not avoid taking at least "credible steps" to fulfill its multi-lateral obligations.\par Political opposition to the bill that would amend the Indian Patents Act has come from the major communist parties united as the Left Front, which provides critical support to the Congress-led coalition government.\par "The Jan. 1 deadline should not be used as a plea to rush through legislation for which the country may have to pay a heavy price later," said D. Raja, National Secretary of the Communist Party of India (CPI).\par In the meanwhile Poornima Mane, director for social mobilisation and communication at UNAIDS, the U.N. body charged with fighting HIV/AIDS said patients should continue using Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  drugs that are available in the market.\par "We want to clarify this so that patients do not panic. This (the voluntary withdrawals) does not mean that the drugs are not good. The worst thing will be if people stop using these drugs and develop resistance," she said.\par But Mane said both UNAIDS and WHO were monitoring the situation in India "since this country will have to follow the WTO restrictions coming up next year and also because it is the biggest producer of generic drugs."\par India itself has 5.1 million people afflicted with HIV according to the 'AIDS Epidemic Update', an annual r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 port prepared by UNAIDS and WHO and released here this week. Globally, the number of the HIV-afflicted people has reached 39.4 million up from the 36.6 million estimated in 2002.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV TREATMENT (94%); AIDS & HIV (94%); ANTIVIRALS (92%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); INTERNATIONAL TRADE (90%); PHARMACEUTICAL PREPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TION MFG (89%); EPIDEMICS (89%); NONGOVERNMENTAL ORGANIZATIONS (89%); INTELLECTUAL PROPERTY LAW (89%); PHARMACEUTICALS INDUSTRY (89%); GENERIC DRUGS (89%); PUBLIC HEALTH ADMINISTRATION (89%); DISEASES & DISORDERS (89%); RELIEF ORGANIZATIONS (89%); PUBLIC POLICY (78%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY COMPLIANCE (78%); PHARMACEUTICALS PATENTS (77%); PRESCRIPTION FORMULARIES (77%); HEALTH DEPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MENTS (77%); VIRUSES (75%); GENERIC PRODUCTS (72%); DRUG POLICY (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (92%); RANBAXY (NSE) (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (92%); SIC2834 PHARMACEUTICAL PREPARATIONS (92%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ING (72%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MIRA SHIVA (74%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANIZATION  (91%); WORLD TRADE ORGANIZATION (91%); WORLD HEALTH ORGANIZATION  (90%); WORLD HEALTH ORGANIZATION (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 INDIA (94%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ANDHRA PRADESH, INDIA (73%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYDERABAD, INDIA (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HETERO DRUGS LTD (66%);  WORLD TRADE ORGANISATION (84%);  HETERO DRUGS LTD (72%); RANBAXY LABORATORIES LTD (55%);  WORLD TRADE ORGANIZATION  (91%); WORLD HEALTH ORGANIZATION  (90%); WORLD HEALTH ORGANIZATION (90%); WORLD TRADE ORGAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ZATION (84%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 29, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore November 4, 2004 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_102}{\*\bkmkstart DOC_ID_102_0}{\*\bkmkstart doc_id_47}{\*\bkmkend DOC_ID_102}{\*\bkmkend DOC_ID_102_0}{\*\bkmkend doc_id_47}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_47"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 47 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 India's pharma ache;\par The upcoming amendment to the Indian Patent Act may lead to i}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 creased competition from MNCs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  4, 2004 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par YOGI AGGARWAL\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 THE Indian pharmaceutical industry finds itself at a cusp. Depending on how the government approaches the necessary amendment to the Indian Patents Act, the fast-growing sector could find itself stalled or poised for a further push.\par Cheap and good: The Act has allowed India to manufacture patented drugs at a fraction of the cost in the West, making the sector the third-largest in the world\par Ever since the Indian Patent Act was enacted in 1970 to allow for reverse engineering of patented drug mo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ecules, the pharmaceutical business in India has galloped ahead using new processes to make medicines at some of the lowest prices in the world.\par Multinational drug companies have not been able to compete with the low prices of the aggressive Indian upstarts who have pushed up their market share since 1970 from under 30 per cent to 72 per cent. Growing at over 20 per cent a year, the 370-billion rupee (S$13.6 billion) Indian pharma sector is the third largest in the world in volume, but much lower down in value of output because of the low prices. \par But now the Indian Patent Act is to be amended under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (Trade Related Intellectual Property in Se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vices) of the World Trade Organization and the question uppermost in the minds of participants is whether the government will be able to protect Indian interests by resisting pressure from multinational drug giants.\par As the amendment to the Patent Act comes before parliament in the weeks ahead, the crucial battle between the contending interests is between exclusive marketing rights demanded by the multinationals and compu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sory licensing which the Indian companies want.\par Exclusive marketing rights for the drugs still under patent would mean that the patent holding companies would retain the exclusive right to import or locally manufacture the drugs. They could keep production down to push prices up, says T R Gopalakrishnan, assistant secretary-general of the Indian Drug Manufacturers Association (IDMA).\par Making drugs for the poor\par Compulsory licensing would imply that any company would have the right to manufacture a generic (non-branded) version of the drug, provided it pays the patent holder a royalty. It would also allow Indian comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nies to export much-needed patented drugs to the less developed countries which need them but don't have manufacturing facilities.\par Another anxiety voiced by Indian companies is that the bill may do away with the pre-grant opposition proc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dure. This is a mechanism to stop frivolous patents which could otherwise take years to defeat in the courts. In the absence of pre-grant opposition, around 6,000 applications are pending which would escape public scrutiny.\par A petition to the prime minister signed by several health-related NGOs states that public scrutiny is crucial in light of the fact that less than 500 drugs have been granted marketing approvals in India between 1995-2004 -- indicating that the rest are trivial applications.\par Hence, pre-grant opposition is absolutely essential for blocking trivial patents. The 1970 Patent Act and the thrust it gave to making drugs through another route was a watershed in the Indian pharmaceutical industry. Though only some 50 patented drugs are currently manufactured in the country they are widely used and account for around a fifth of total drugs sold in the country.\par More important, the reverse engineering has helped develop the kind of expertise which the Indian pharma industry now has and which could take it to the top in a couple of decades. Indian companies are adopting a number of strategies to get there.\par One way used by leading companies like Ranbaxy and Dr Reddy's is to challenge in US courts a patent for a popular drug which has expired but which the patent holder has extended beyond the normal 20-year patent period by the stratagem of making a minor change.\par They have been helped in this by a ruling of the US Food and Drug Administration (FDA), which gives excl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sive generic marketing rights for six months to a company which is successful in prevailing over a branded drug maker in court.\par Generic drug manufacturers around the world led by the giant Israeli company Teva are increasingly adop}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing this strategy. In 2002, around 83 such cases were filed by generics companies. In 2001, Dr Reddy won a case against the giant Eli Lilly over a patent on its anti-depressant Prozac.\par Though it cost the company over US$1 million to fight the case, it earned around US $70 million in those six months. Similarly, Ranbaxy challenged Glaxo SmithKline over the patent for the anti-biotic Ceftin. When it won, the rewards were tremendous for Ceftin now accounts for 40 per cent of all Ranbaxy's sales in the US.\par These are not the only successes. A notable achievement has been that of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , the Indian firm that did groundbreaking work in developing an affordable Aids treatment mode. Western companies were marketing their anti-AIDS drugs for US$12,000 per person per year.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  came out with a formulation for US$350 and it kept reducing the price. Their drug is now used in over 90 countries.\par The major driving force is globalisation, using India as the manufacturing base, noted Y K Hamied, chairman of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  in a recent speech. Once the Patent Act is amended, many multinational companies will see the great advantage in using India as a manufacturing and research base.\par With a low-cost labour force and readily available technical skills, drug manufacturing costs in India are less than half of what they are in the West. The drug giants would not only manufacture here for the local market but also for export.\par Exports now account for sales of around 140 billion rupees, says Mr Gopalakrishnan, or around 35 per cent of the total industry turnover, up nearly ten times from 14.9 billion rupees in 1993. This may increase, but multinationals manufacturing for export would eat into the share of Indian companies. R&D and the deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 opment of new molecules is another area of growth.\par It costs around US$500-600 million to develop and clinically test a new drug. This could be done in India for as little as US$15-20 million, says Mr Gopalakrishnan. While only a handful of Indian companies can curren}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ly risk spending such amounts, many of the drug giants are likely to shift part of their R&D efforts to India.\par Other growth areas are indigenous medical systems like ayurveda and health tourism. The plants needed for ayurvedic medicines need careful cultivation and cannot be done on the large scale that the drug giants would need.\par And, while their efficacy has been demonstrated over the centuries, they are unlikely to meet the strict repr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ducible needs of modern medical science. It will be left to Indian companies to use ayurvedic medicines.\par Though still small, medical tourism, with people coming to India for the low-cost medical treatment and ope}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ations is also growing. The new high-tech hospitals being built around the country are already being used by foreign patients.\par Despite the possibilities, the risks cannot be dismissed. Dr Hamied expressed it with sadness: 'The achiev}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ments of the indigenous pharmaceutical industry over the past few decades have been outstanding. Howe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 er, all this is likely to be diluted by India's agreeing to adopt }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  by January 2005. Our government has u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fortunately failed to appreciate the far-reaching implications of its action.'\par The writer is a Mumbai-based journalist who contributes regularly to BT.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par  PATENTS (95%); PHARMACEUTICALS INDUSTRY (94%); PATENT LAW (91%); PHARMACEUTICALS PATENTS (90%); MULTINATIONAL CORPORATIONS (90%); INTELLECTUAL PROPERTY LAW (90%); PHARMACEUTICALS ASSOCIATIONS (78%); HEADS OF STATE & GOVERNMENT (78%); ENGINEE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ING (78%); INTELLECTUAL PROPERTY (78%); MARKET SHARE (78%); PHARMACEUTICAL PREPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TION MFG (77%); IMPORT TRADE (76%); HOLDING COMPANIES (75%); PRICE INCREASES (74%); PRICE CHANGES (74%); REVERSE ENGINEERING (73%); BUSINESS & PROFESSIONAL ASSOCI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TIONS (73%); PRIME MINISTERS (73%); MANUFACTURING FACILITIES (72%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TRIES (72%); EXPORT TRADE (71%); NONGOVERNMENTAL ORGANIZATIONS (70%); PETITIONS (63%); \par \par  INDIAN DRUG MANUFACTURERS ASSOCIATION (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mviews\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1251 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 November 3, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2004 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS;Daily HIV/Aids Report Africa News July 15, 2004 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_103}{\*\bkmkstart DOC_ID_103_0}{\*\bkmkstart doc_id_48}{\*\bkmkend DOC_ID_103}{\*\bkmkend DOC_ID_103_0}{\*\bkmkend doc_id_48}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_48"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 48 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  15, 2004 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 AIDS;\par Daily HIV/Aids Report}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Kaisernetwork.org\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 6123 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Bangkok Daily Update\par Fifth Day of XV International AIDS Conference Sees New Money for Global Fund, Focus on Tuberculosis\par [Jul 15, 2004]\par At an evening musical event hosted by former South African president Nelson Mandela, a $50 million pledge was announced from the Bill & Melinda Gates Foundation to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Mandela called for others to do the same.\par "It is going to take much more than the resources of the Gates Foundation to achieve the scale up required to fund the fight against AIDS, TB and malaria," he said, adding, "We need to build the public-private par}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nership that is the vision of the Global Fund. We challenge everyone to help fund the fund now."\par Pledges to the Global Fund beyond 2004 fall far short of its projected need to fight the epidemic. In its first 30-plus months of operation, the Global Fund has committed $3 billion to programs in 128 countries. Dr. H}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lene Gayle is with the Gates Foundation. \par "Thanks in large part to the fund, many more people in developing countries now have access to HIV preve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion and care and life-saving interventions for TB and malaria than just two years ago," she said.\par However, there are some concerns, namely among U.S. officials, that the Global Fund is not the most eff}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cient way to get money to local AIDS programs.\par Earlier in the day, Mandela, who battled tuberculosis while in prison during apartheid, spoke about the need to improve TB detection and get patients treated sooner.\par "The world has made defeating AIDS its top priority," he said, adding, "This is a blessing, but TB remains ignored. Today we are calling on the world to recognize we can't fight AIDS unless we do much more to fight TB as well."\par TB kills an estimated one-third of AIDS patients.\par Finally, researchers continued on a familiar theme at the conference -- the need to give women more preve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion options. Dr. Zeda Rosenberg of the International Partnership for Microbicides discussed why HIV infe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion rates are rising at startling rates among women.\par "For women in many parts of the world, being poor, young and married are the most significant risk factors for acquiring HIV infection," she said.\par In many areas of the world, women's societal status makes it impossible to for them to insist their partners use condoms or be monogamous. Microbicides, topical virus killers that women can use before intercourse, would give them power to protect themselves. But viable microbicides are at least five years from becoming reality (Jill Braden, Kaiser Daily HIV/AIDS Report, 7/14).\par Video highlights of today's conference sessions are available online from kaisernetwork.org.\par XV International AIDS Conference\par U.S. Will Not Meet U.N. Secretary General's Request To Contribute $1B Annually to Global Fund, Tobias Says\par  [Jul 15, 2004]\par U.S. Ambassador Randall Tobias, head of the State Department Office of the Global AIDS Coordinator, on Wednesday said that the United States will not fulfill a request from U.N. Secretary-General Kofi Annan to contribute $1 billion annually to the Global Fund to Fight AIDS, Tuberculosis and Malaria, Reuters reports (Hirschler, Reuters, 7/14). Annan in an interview with BBC World Service on the sidelines of the XV Intern}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tional AIDS Conference in Bangkok, Thailand, requested that the United States and the European Union each contribute $1 billion per year to the fund (Kaiser Daily HIV/AIDS Report, 7/14). The House Appropri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions Committee on Friday approved by voice vote a $19.4 billion foreign aid spending bill for fiscal year 2005, which includes $2.2 billion for HIV/AIDS, tuberculosis and malaria initiatives. Although the approved funding -- most of which will go to AIDS programs -- meets President Bush's request for FY 2005, an appr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 priations subcommittee allocated a larger portion of the money to the Global Fund than Bush had requested. Bush's proposed FY 2005 budget, which is $1.9 billion more than the total amount the subcommittee a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 proved, includes $2.8 billion for international HIV/AIDS, TB and malaria programs. That amount includes $1.45 billion for the Office of the Global AIDS Coordinator, which will administer the President's Emergency Plan for AIDS Relief, and $200 million for the Global Fund. Because the draft spending bill would double the requested Global Fund contribution to $400 million, less money would go to PEPFAR (Kaiser Daily HIV/AIDS Report, 7/13). "The president has requested $200 million for next year and I think that is more than adequate to meet the requirements of the Global Fund in terms of getting money out for putting programs in place," Tobias said (Reuters, 7/14).\par Global Fund\par Tobias said that although the Global Fund is "a very promising vehicle and a critically important part" of the fight against AIDS, it is "a young venture and still maturing" (Boseley, Guardian, 7/15). Tobias said that the United States prefers to spend the majority of its AIDS funding through PEPFAR because it is an "effective mechanism to ensure that small and effective organizations can improve their work and get money fast in order to address urgent needs within communities" (Apiradee, Bangkok Post, 7/15). PEPFAR is the fastest way to "get that money to work," Tobias said. In contrast, the proposed $200 million FY 2005 contribution to the fund will end up "sitting in the World Bank in Geneva," Tobias said, adding that the Global Fund policy of waiting until enough money has accumulated to ensure completion of programs would "actually slow down" the fight against AIDS (Maugh, Los Angeles Times, 7/15). However, Annan said that the Global Fund is "ready to go," adding, "If individual governments begin to set up their own initiatives, they start from scratch, it takes longer; the money that they hold will not be spent for a long time" (Nolen, Globe and Mail, 7/15).\par Reaction\par U.N. Special Envoy for HIV/AIDS in Africa Stephen Lewis said that the Global Fund is the "most effective instrument against the pandemic," adding that PEPFAR represents the same "go-it-alone" approach that the Bush administration used for the war in Iraq. Lewis said that the United States eventually would accept the Global Fund's multinational approach to the epidemic in the same way that it is now seeking help from other nations in Iraq, according to the San Francisco Chronicle (Russell, San Francisco Chronicle, 7/15). Lewis added, "The American money going to 15 countries is not leadership on AIDS. It's a significant role, but the Global Fund is in 120 countries, ... respond[ing] to the problem in a far more universal way" (Reuters, 7/14). A senior figure connected with the fund said, "Everyone has gone out of their way to give (PEPFAR) a lot of support, but people have reached a limit." The Bush administration's suspicion of the fund is frustrating some of those working to fight global AIDS, he added, according to the Globe and Mail (Globe and Mail, 7/15).\par Cambodian Sex Workers Protest at XV IAC Session, Say Gilead Sciences' Viread Clinical Trials Unethical\par [Jul 15, 2004]\par A group of about 30 Cambodian commercial sex workers on Tuesday interrupted a session at the XV Inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 national AIDS Conference on antiretroviral drugs to protest a planned clinical trial using Gilead Sciences' Viread, the San Francisco Chronicle reports. About 30 demonstrators took over the stage for 15 minutes du}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing the Gilead-sponsored session, shouting that the company "uses sex workers for free." Gilead is planning to evaluate whether Viread -- which is known generically as tenofovir and is FDA-approved for use as a treatment for HIV infection -- is effective at reducing the risk of HIV infection. The sex workers demanded that Gilead stop the trial or provide lifetime health care for any study participants who become HIV-positive, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cording to the Chronicle. Dr. James Rooney, Gilead vice president for clinical affairs, said that the study, which involves the use of a placebo, meets the strict ethical guidelines applied to all vaccine trials, the Chronicle reports. For example, all of the women participating in the trial will be counseled about and su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 plied with condoms. However, critics of the study said that such counseling is only cursory. The sex workers said that in order for the study to be useful, some of the participants will have to become HIV-positive, ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing them "pawns in a corporate drug development scheme," according to the Chronicle (Russell, San Fra}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cisco Chronicle, 7/14).\par Bangkok Notebook\par Governments, Organizations Must Implement HIV/AIDS Prevention Programs for Displaced Persons, IAC Panel Says\par [Jul 15, 2004]\par Governments and international organizations must make commitments to implement HIV/AIDS prevention programs targeted at migrant workers, refugees and other mobile populations, participants of a session on displaced populations and AIDS said on Thursday at the XV International AIDS Conference in Bangkok, Thailand. These groups face many inequalities that facilitate the spread of HIV, including poverty, exploit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion, separation from families and partners and a disruption in familiar social environments that influence b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 haviors in established communities. Because most migrant workers lack HIV/AIDS awareness; have poor access to treatment, voluntary testing and counseling; and have no job security, many are not treated until they need emergency care, according to Dr. Cynthia Maung, who cares for displaced populations on Thailand's border with Burma. Migrants and other displaced populations "experience continuing oppression that most people hope to leave behind" when they leave their original areas, she said. Christine Amongin Aporu, minister of state for disaster preparedness and refugees in Uganda, urged national leaders to declare their commitment to HIV/AIDS prevention for displaced populations and increase funding for such programs. In addition, she called on nations to fully fund the Global Fund to Fight AIDS, Tuberculosis and Malaria, which has granted money to some programs focusing on displaced persons, and urged the United States to honor its commitment of providing $3.5 billion in 2005 through the President's Emergency Plan for AIDS R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lief.\par Mandatory Testing Denounced\par Paul Spiegel, senior HIV/AIDS technical officer with the U.N. High Commissioner for Refugees, and Irene Fernandez of CARAM Asia, denounced mandatory HIV testing for asylum seekers. HIV testing is often a r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 quirement for entry into a country, and many countries do not accept HIV-positive refugees. Fernandez said that mandatory testing "sparks fear" and can cause refugees to falsify information or never be documented. She added that required testing increases inequality, discrimination and stigmatization and can create a false sense of security among the host community because they may believe that no HIV-positive people are a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lowed entry. Spiegel said that HIV testing must be accompanied by pre- and post-test counseling and a sy}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tem for HIV care and treatment must be available to people who test HIV-positive. Several panel members also called for the inclusion of migrants and other displaced persons in HIV/AIDS prevention programs. Fe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nandez said, "HIV-positives can be catalysts for change. Without their involvement, no program will succeed" (Alyson Browett, Kaiser Daily HIV/AIDS Report, 7/15).\par A webcast of the session is available online from kaisernetwork.org.\par Global Challenges\par Gates Foundation Announces $50M Contribution to the Global Fund at XV International AIDS Conference\par [Jul 15, 2004]\par The Bill & Melinda Gates Foundation on Thursday at the XV International AIDS Conference in Bangkok, Thailand, announced it will contribute an additional $50 million to the Global Fund to Fight AIDS, Tubercul}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sis and Malaria, bringing its total contribution to $150 million, the AP/Billings Gazette reports. Dr. Helene Gayle, director of the Gates Foundation HIV, TB and Reproductive Health Program, made the announc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ment at an evening event hosted by former South African President Nelson Mandela. "The Global Fund is an extraordinary model for financing the fight against AIDS, TB and malaria," Gayle said, adding, "We urge go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ernments, the private sector and other donors to dramatically increase their contributions to the fund -- their generosity can help save millions of lives" (AP/Billings Gazette, 7/15). Mandela, who came out of retirement to attend the conference, said that the Gates Foundation's contribution was an important sign of leadership in the fight against HIV/AIDS, TB and malaria.\par Funding Shortfall\par Although the Global Fund has enough money -- $3.8 billion -- to meet its needs through the end of the year, it has received pledges for a total of only $2 billion for 2005 through 2008, which is far below the $3.6 billion the fund estimates it will need in 2005 alone. Global Fund Executive Director Richard Feachem said, "We applaud the leadership by the Gates Foundation in making this contribution and signaling its continued su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 port for the Global Fund -- especially at this critical moment when increased funding is so important. This will help leverage further funds from additional donors." Since it began funding projects in 2002, the Global Fund has approved proposals for almost 300 grants for projects in 128 countries.\par 46664 Campaign\par The session featured the premiere of "46664: The Message," a film based on the 46664 concert held in Cape Town in November 2003 (Gates Foundation release, 7/15). Mandela launched "46664" -- named after his prison number during his nearly 20-year incarceration at the South African prison Robben Island -- in O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tober 2003 as a phone and Internet campaign to raise awareness and money to fight HIV/AIDS in Africa. Mandela officially retired from public life on June 1 to complete his autobiography, but decided to make the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to Bangkok to address the delegates following the film's screening (Kaiser Daily HIV/AIDS Report, 7/8).\par A webcast of the session and the film will be available online from kaisernetwork.org after 12 p.m. on Friday, July 16.\par Nelson Mandela Says Global AIDS Fight Should Include Efforts To Combat TB; Gates Foundation Awards $45M for AIDS/TB Research\par [Jul 15, 2004]\par Global efforts to fight the HIV/AIDS epidemic should include efforts to combat tuberculosis -- which is often a "death sentence" for people living with HIV-- former South African President Nelson Mandela said on Thur}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 day at the XV International AIDS Conference in Bangkok, Thailand, Reuters reports. About 14 million of the 38 million HIV-positive people worldwide are coinfected with TB, 70% of who live in sub-Saharan Africa, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cording to Reuters. Mandela said, "The world has made defeating AIDS its top priority. This is a blessing, but TB remains ignored." He added, "We cannot win the battle against AIDS if we do not also fight TB." Mandela said that TB is "too often a death sentence for people with AIDS," adding, "It does not have to be this way" (Schuettler, Reuters, 7/15). Mandela said that although a cure for TB has existed for the past five decades, what has been lacking is the "will and the resources to quickly diagnose people with TB and get them the treatment they need" (Joshi, Associated Press, 7/15).\par Gates Grant\par The Bill & Melinda Gates Foundation on Thursday announced a $44.7 million grant aimed at curbing HIV-related TB, the Seattle Post-Intelligencer reports (Paulson, Seattle Post-Intelligencer, 7/15). The grant will go to the Consortium to Respond Effectively to the AIDS-TB Epidemics, or CREATE, which is led by researc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ers from Johns Hopkins University in Baltimore, Md., according to the Baltimore Sun (Bor, Baltimore Sun, 7/15). CREATE also includes researchers from the London School of Hygiene and Tropical Medicine, Aurum Health Research in South Africa, the University of Zambia, Stellenbosch University of South Africa, the M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 nicipal Health Secretariat of Rio de Janeiro, in addition to the World Health Organization and CDC, the Wall Street Journal reports (Chase, Wall Street Journal, 7/15). The grant will fund three studies to evaluate the use of the antibiotic isoniazid on people living with HIV. One of the studies, which will recruit participants from Zambia and South Africa, will include school- and community-based TB education and examine the benefits of administering isoniazid to all members of a households that have TB patients. Another study, based in South Africa, will focus on the impact of isoniazid on gold miners in the country, and a study in Brazil will e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 amine the effect of isoniazid on HIV-positive people with TB who are taking antiretroviral drugs (Gates r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lease, 7/15). The standard treatment for TB is directly observed treatment, short course -- or DOTS -- which involves health care workers observing TB patients taking medicine daily over several months, according to the Post-Intelligencer.\par Reaction\par Dr. Richard Chaisson, head of the JHU Center for Tuberculosis Research, said, "The traditional strategies for controlling tuberculosis don't work in communities with high rates of HIV." He added, "We're challenging the dogma here," saying, "The problem is that the dogma is not right and the DOTS approach is not enough." Dr. Helene Gayle, director of the HIV, TB and Reproductive Health program for the Gates Foundation, said, "We can't fight AIDS unless we also fight TB" (Seattle Post-Intelligencer, 7/15). "DOTS is great when HIV isn't a major problem. But once HIV moves in, control is undermined," Gayle said, adding, "DOTS just can't seem to catch up" (Wall Street Journal, 7/15).\par A webcast of Mandela's speech, as well as additional coverage of the conference, is available online from kaisernetwork.org.\par SABC News on Wednesday reported on Nelson's statements on HIV and TB coinfections (SABC News, 7/14). The complete segment is available online in RealPlayer\par Voucher Program for Injection Drug Users in China, Vietnam Could Help Contain Spread of HIV, Study Says\par [Jul 15, 2004]\par A voucher program for injection drug users in China and Vietnam could help contain the spread of HIV, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cording to a study released on Wednesday by Cambridge, Mass.-based Abt Associates at the XV Intern}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tional AIDS Conference in Bangkok, Thailand, the Wall Street Journal reports. The program, which was launched by Abt and funded by NIH and the Ford Foundation, involves trained peer educators -- who also are injection drug users -- distributing to other drug users vouchers that can be exchanged at local pharm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cies for clean needles and syringes. In some cases, the vouchers can be exchanged for medicines and co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 doms, according to the Journal. The local police have agreed not to interfere with the program -- which ta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gets injection drug users in the "remote" mountains on the border between Vietnam and China -- and pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 macists and health authorities support the project, the Journal reports. The study, which is based on data from the first year of the program, shows that although HIV transmission has not stopped completely, the number of new infections has decreased, according to Abt researcher Ted Hammett. HIV/AIDS prevalence among injection drug users has reached close to 20% on the Chinese side of the border and as high as 47% on the Vietnamese side. The program is set to run for another year, according to the Journal (Naik, Wall Street Journal, 7/15).\par Asian Leaders Have 'Window of Opportunity' To Avert HIV/AIDS Crisis, Report Says\par [Jul 15, 2004]\par Asian leaders can avert an HIV/AIDS crisis if they act quickly to break social taboos, attack stigma, encou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 age prevention programs and provide access to treatment and support systems for HIV-positive people, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cording to an Asia Pacific Leadership Forum report released Tuesday at the XV International AIDS Confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ence in Bangkok, Thailand, Agence France-Presse reports. "Political leaders in Asia and the Pacific have a precious window of opportunity to save millions of people from HIV infection. But to succeed, they will need to drastically increase spending on AIDS and scale up prevention, care and treatment programs," APLF members said (Agence France-Presse, 7/13). APLF, which is funded by Australia, Japan, New Zealand, the United Kingdom, the United States and the European Union, is an initiative founded in 2001 to promote e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fective leadership and intensify commitment to fighting HIV (UNAIDS release, 7/13). According to the report, more than seven million of the world's 38 million HIV-positive people live in the Asia-Pacific region. Of those, about one million became infected in 2003 alone. The report noted that India, where 5.1 million HIV-positive people live, "is second only to South Africa as the country with the greatest number of people living with HIV" (Agence France-Presse, 7/13). However, the report said that India -- as well as other countries in the region, including Indonesia and China -- is beginning to treat the problem with greater urgency. Anand Panyarachun, former prime minister of Thailand and chair of the APLF steering committee, said, "In a society where there are religious, social, cost and other constraints, it's even more vital to have political leadership" to combat HIV/AIDS. The report called on governments in the region to encourage civil society, nongovernmental o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ganizations, community groups and people with HIV/AIDS to help formulate a response to the disease (U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS release, 7/13).\par Discrimination, Gender Inequality Challenge HIV/AIDS Prevention Efforts in South Asia\par [Jul 15, 2004 ]\par Discrimination against people with HIV/AIDS and gender inequality remain the two most formidable cha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lenges to HIV/AIDS prevention efforts in South Asia, according to a satellite session on Tuesday at the XV International AIDS Conference, according to a UNAIDS release. "There are two epidemics spreading -- AIDS, and the stigma against people living with HIV," Zahir Uddin Swapon, secretary general of the Parli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mentary Group on HIV/AIDS and a member of Bangladesh's parliament, said. Participants at the session, which was organized by the UNAIDS South Asian Intercountry Team and South Asia's Theme Group on HIV/AIDS, said that to counter the stigma of the disease, nations must protect the rights of people with HIV/AIDS, form partnerships between health and education sectors and amend laws criminalizing margina}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ized groups vulnerable to the disease. In addition, Dr. Nafis Sadik, special envoy to the U.N. secretary ge}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 eral for HIV/AIDS in Asia and the Pacific and chair of the session, said that women in South Asia "have less opportunity to protect themselves" from the disease. Data suggest a close link between the status of women and their vulnerability to HIV, according to the release. Kathleen Cravero, deputy executive director of U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS, said, "Until women and girls have equal access to effective HIV prevention and treatment services, there is little hope to beat the epidemic" (UNAIDS release, 7/13).\par Time Examines HIV Incidence Among Injection Drug Users, Pregnant Women, Young People in Thailand\par [Jul 15, 2004]\par Time magazine's June 19 issue examines Thailand's recent increase in HIV incidence among young people, pregnant women and injection drug users. Several factors have contributed to the growing number of infe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions, including a complacency toward condom use and public education in a country that was once hailed as a "rare success story in the global battle to contain the AIDS epidemic," Time reports (Gorman, Time, 6/19). The complete article is available online.\par Drug Access\par Medicines Sans Frontieres Announces Results of Study of Generic Fixed-Dose Combination Antiretrovirals in Developing Countries\par [Jul 15, 2004]\par Medicines sans Frontieres on Wednesday at the XV International AIDS Conference presented the results of the first large-scale study of generic fixed-dose combination antiretroviral drugs in developing countries, the New York Times reports. The study, which expanded on a "much smaller" study that was published in the July 3 issue of the Lancet, was conducted in 21 countries using a generic FDC containing lamivudine, nev}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 rapine and stavudine. Indian drug makers }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Ranbaxy Laboratories each make a version of the drug (Altman, New York Times, 7/15). Patients can take the generic FDC as one pill twice a day, and it costs about $140 per person per year. A regimen of the same three drugs purchased separately from patent hol}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ers GlaxoSmithKline, Bristol-Myers Squibb and Boehringer-Ingelheim requires six pills a day and costs about $562 per patient per year (Kaiser Daily HIV/AIDS Report, 7/2). MSF since 2002 has treated a total of 12,058 HIV-positive adults with antiretrovirals, and 6,861 of them received FDCs, according to Dr. Alexandra Calmy, an HIV/AIDS adviser for MSF. Of the patients who received FDCs, 51 of them had to change medicines b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cause of side effects from one or more of the drugs contained within the FDC; patients who switched to a new regimen had to take 13 or more pills daily, according to the Times. MSF found that the one-year survival probability was 82.4% among recipients of FDCs, Calmy said, according to the Times. In addition, CD4+ cell counts among FDC recipients increased by an average of 137 cells/mm3 per year. However, FDCs failed to work in 12% of HIV-positive people in a subset of 477 people, according to the study, Times reports. Calmy said that the results offered a "very robust outcome, and the findings are important for the Global Fund [to Fight AIDS, Tuberculosis and Malaria] and other groups that are recommending" FDCs (New York Times, 7/15).\par WHO Adds Lamivudine, Three Versions of Flucanozole to List of Recommended AIDS-Related Medicines\par [Jul 15, 2004]\par The World Health Organization on Tuesday announced that it has added a generic version of antiretroviral lamivudine and three versions of the antifungal medication flucanozole to its list of recommended AIDS-related medicines, Reuters/Yahoo! News reports. In a statement released at the XV International AIDS Co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ference in Bangkok, Thailand, WHO officials announced the approval of Strides Arcolab's 150 mg tablet of the antiretroviral lamivudine, an alternative to a generic form of the same drug produced by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  that was removed from the WHO prequalification list in June (Reuters/Yahoo! News, 7/13). Dr. Lembit Rago, WHO's coordinator for quality assurance and safety of medicines, said in June that }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  versions of lamivudine and zidovudine were removed from the list because of problems detected during a routine inspection of an independent laboratory that }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  had hired to conduct bioequivalence studies of the drugs. WHO routinely conducts inspections among makers of drugs included on its list of medicines that are approved for purchase by United Nations agencies. (Kaiser Daily HIV/AIDS Report, 6/16). In addition, WHO said that it added three different dosages of the antifungal treatment fluconazole made by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to its prequalification list this week (Reuters, 7/13).\par Botswana Antiretroviral Drug Distribution Program Will Reach 50,000 People by 2005, Health Minister Says\par [Jul 15, 2004]\par Botswana Health Minister Lesego Motsumi on Tuesday at the XV International AIDS Conference in Bangkok, Thailand, said that the country will meet by next year its target of distributing antiretroviral drugs at no cost to about 50% of those who need them -- about 50,000 HIV-positive people, Reuters reports. Currently, 17,400 people are receiving antiretroviral therapy through the country's public health service; an additional 6,700 receive the medications from the private sector, Reuters reports (Reuters, 7/13). Dr. Patson Mazonde, dep}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ty permanent health secretary, said that the program had enrolled 28,000 people in 17 locations and expa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sion is planned to 15 more sites this year (SAPA, 7/13). Botswana's program is "a case study for Africa" that represents "what it will take to successfully introduce ARV therapy on a mass scale," the Ministry of Health said in a statement (South African Press Association, 7/12). However, a "crucial problem" has been that few people are undergoing HIV testing, according to Earnest Darkoh, head of operations for Botswana's national antiretroviral treatment program, Reuters reports. Botswana introduced voluntary routine HIV testing in Ja}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 uary, and HIV-positive diagnoses have increased, according to Reuters (Reuters, 7/13).\par London's Guardian on Thursday profiled Botswana's drug program (Carroll, Guardian, 7/15). The full article is available online.\par Merck Licenses Antiretroviral Drug Efavirenz to South African Pharmaceutical Company Thembalami\par [Jul 15, 2004]\par Drug company Merck announced on Tuesday that it has agreed to grant a nonexclusive, royalty-free license to South African drug company Thembalami Pharmaceuticals to produce and sell a generic version of its antiretroviral drug efavirenz, the AP/Springfield News Sun reports. Merck sells efavirenz under the brand-name Stocrin at a not-for-profit price to countries in the Southern African Development Community. The l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cense covers both public and private sector sale of the drug in SADC member countries, and Thembalami will donate a portion of its proceeds from efavirenz sales to the MSD Msizi Cares Trust -- an organization that supports the fight against HIV/AIDS in South Africa. Thembalami CEO Sotse Segoneco also will become a member of the organization's board of trustees (AP/Springfield News Sun, 7/13). Merck said it issued the license to speed access to antiretroviral drugs in South Africa and other countries affected by HIV/AIDS, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cording to Reuters (Reuters, 7/13). About 20,000 HIV-positive people in South Africa are taking the drug and under the government's national drug plan, the number is expected to grow to 50,000 by the end of the year, South Africa's Business Day reports (Cohen, Business Day, 7/14).\par HIV-Positive Patients in Asia at High Risk of Developing Drug Resistance Due to Inconsistent Treatment, Lack of Monitoring\par [Jul 15, 2004]\par HIV-positive people in China and other parts of Asia are at a high risk of developing resistance to antiretrov}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ral drugs because of the range of available drugs, inconsistent treatment and a lack of monitoring and cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 seling, experts said at the XV International AIDS Conference in Bangkok, Thailand, Agence France-Presse reports. For example, 50% of 500 rural Chinese HIV-positive people who took nevirapine for up to 11 months have become resistant to the drug, which is a standard component of antiretroviral triple therapy, according to Shao Yiming, director of the China Centers of Disease Control's Department of Virology and Immunology. Shao said that China provided the drugs free of charge, but medical personnel failed to inform patients that they had to take the drugs consistently. Many patients stopped taking the drugs for periods of time or stopped taking them altogether because of side effects. "The free drugs program was meant to ... save lives, but we should have considered whether it was sustainable," Shao said. Kevin Frost, director of TREAT Asia, said, "There's a lot of concern that we're going to begin seeing resistance to nevirapine on a more wid}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 spread basis here, and I think that's of significant concern when it's such a critical component of every first-line treatment regimen in the region" (Agence France-Presse, 7/13).\par Newsweek Examines 'Grass-Roots' Efforts To Provide HIV/AIDS Treatment in Sub-Saharan Africa\par  [Jul 15, 2004]\par Newsweek in its July 19 issue examined the "grass-roots" efforts of organizations such as Medecins Sans Frontieres and Treatment Action Campaign in sub-Saharan Africa to "mobilize millions of people" to seek HIV/AIDS treatment and create health infrastructure capable of delivering care. Although antiretroviral drug costs have dropped by 98% in the past several years and several initiatives -- including the President's Emergency Plan for AIDS Relief, the Global Fund to Fight AIDS, Tuberculosis and Malaria and the World Health Organization's 3 by 5 Initiative -- have issued grants or helped design programs to provide treatment, less than 2% of sub-Saharan Africa's HIV-positive people are receiving treatment. According to Newsweek, many countries that have received grants are not ready to absorb the money, partly because many health care workers are moving to wealthier countries and those remaining are "overwhelmed and exhausted." O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ganizations such as TAC and MSF have set up home-based care initiatives, where trained community volu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 teers help patients adhere to drug regimens, establish voluntary test sites and organize support groups that "stand up" to the stigma attached to HIV/AIDS. Such programs have proven that "grass-roots involvement is critical" to the fight against HIV/AIDS, Newsweek reports (Cowley, Newsweek, 7/19).\par Opinion\par Kaiser Daily HIV/AIDS Report Summarizes Editorials, Opinion Pieces on the XV International AIDS Confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ence\par [Jul 15, 2004]\par Several newspapers have published editorials in response to the XV International AIDS Conference taking place this week in Bangkok, Thailand. Summaries of some of the editorials and opinion pieces appear below:\par Arizona Republic: Because HIV/AIDS is increasingly affecting women, there needs to be a "coordinated push" to develop and test microbicides so that women can protect themselves against the virus, a Republic editorial says (Arizona Republic, 7/14).\par Financial Times: Advocates "must remember" that financial aid is not the only factor in combating HIV/AIDS and issues such as poverty, a Times editorial says. Improved governance and free trade are more important to encouraging growth and reducing poverty, the editorial concludes (Financial Times, 7/14).\par Thailand's Nation: There is no reason that the need for affordable HIV/AIDS drugs in developing countries and pharmaceutical companies' need for "sufficiently attractive" financial returns "remain mutually exclusive," a Nation editorial says. Both sides should "learn to accommodate one another's needs and concerns," the editorial concludes (Nation, 7/14).\par New York Times: The HIV/AIDS epidemic in Asia is at a "tipping point," and the world -- especially Asian n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions -- must increase access to antiretroviral drugs, prevention efforts and funding for global HIV/AIDS initi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tives, a Times editorial says (New York Times, 7/14).\par Wall Street Journal: Although HIV/AIDS advocates "insist on condoms for supposedly non-infectious sexual trysts," Ugandan President Yoweri Museveni spoke of "love and commitment" at the conference when he said abstinence is the best way to prevent HIV/AIDS -- a method that has proved successful in reducing the country's prevalence rate, a Journal editorial says (Wall Street Journal, 7/14).\par Wichita Eagle: Although much progress has been made in the global effort to combat HIV/AIDS, "much more remains to be done," an Eagle editorial says. The conference is an opportunity to build on that success, and it would be a "terrible waste if it gets bogged down in finger-pointing," the editorial concludes (Wichita Eagle, 7/13).\par Opinion Pieces\par Phil DiSorbo, Albany Times Union: With the global HIV/AIDS epidemic "worse[ning]," the U.S. public needs to become more personally active in the global effort to combat the disease, Times Union columnist DiSorbo writes in an opinion piece (Albany Times Union, 7/14).\par Joseph Dolman, Long Island Newsday: When Museveni on Tuesday said that abstinence is the best way to prevent HIV, "it seems logical" that he did so to stay "on the good side of [President] Bush" for financial re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sons, Newsday columnist Dolman writes in an opinion piece. Prevention methods were not "faring all that well" before Museveni's remarks, and they are now "weaker still," Dolman concludes (Long Island Newsday, 7/14).\par James Glassman, Manchester Union Leader: The United States is providing funding for and access to drugs, health care facilities and training for health care workers to fight AIDS, Glassman, a fellow at the American Enterprise Institute, writes in a Union Leader opinion piece. The United States should not attend the next conference in 2006 to "fend off insults from ingrates and morons," Glassman concludes (Manchester Union Leader, 714).\par Yoweri Museveni, Asian Wall Street Journal: Individual behavior change and personal responsibility -- based on knowledge -- offer the "best protection against AIDS and other future epidemics," Museveni writes in a Journal opinion piece (Asian Wall Street Journal, 7/14).\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AIDS & HIV (94%); TUBERCULOSIS (91%); MALARIA (90%); FOUNDATIONS (90%); CO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 FERENCES & CONVENTIONS (89%); AIDS & HIV TREATMENT (78%); EPIDEMICS (78%); DISEASES & DISORDERS (78%); PUBLIC PRIVATE PARTNERSHIPS (74%); PREVENTION & WELLNESS (71%); D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 VELOPING COUNTRIES (67%); WOMEN (66%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NELSON ROLIHLAHLA MANDELA (92%); KAISER DAILY HIV (92%); RANDALL TOBIAS (59%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 BILL & MELINDA GATES FOUNDATION  (90%); BILL & MELINDA GATES FOUND}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TION (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SOUTH AFRICA (92%); UNITED STATES (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 July 15, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore June 7, 2004 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_104}{\*\bkmkstart DOC_ID_104_0}{\*\bkmkstart doc_id_49}{\*\bkmkend DOC_ID_104}{\*\bkmkend DOC_ID_104_0}{\*\bkmkend doc_id_49}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_49"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 49 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Indian drug firms stand to gain much from WTO talks;\par Potential to carve out slice of US$15b US generics market}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 June}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  7, 2004 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par Yogi Aggarwal in Bombay\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 A HUGE opportunity awaits Indian pharmaceutical companies - if India plays its cards right during the u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 coming World Trade Organisation (WTO) negotiations.\par A research report by investment bankers JM Morgan Stanley says Indian companies have opportunities in the US$15 billion generics market in the US, and can also expect to capture a part of the US$33 billion ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ket in challenging patents for drugs that have been unduly extended by US and European companies.\par Other segments where Indian companies could score is in novel drug delivery systems and subcontracting much of the research to develop new drugs.\par In a document called Vision 21, global consulting firm McKinsey & Co estimated the total market for Indian companies to be around US$25 billion by the end of the decade, up from around US$7 billion now. \par T R Gopalakrishnan, assistant secretary general of the Indian Drug Manufacturers Association, the leading industry body, said: 'Everything boils down to the patent regime that is coming.\par 'If there are balanced patent laws that allow Indian companies to export freely as per the Doha Declaration (of the WTO) under conditions agreed upon under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (trade-related intellectual property rights), the going will be good. But non-trade barriers should not be allowed to distort trade.'\par Under the 1970 Indian Patent Act, pharmaceutical companies in India used 'reverse engineering' to man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 facture drugs to bypass US patent laws. This has enabled them to manufacture drugs for the Indian market at less than one-tenth the cost in the West.\par But multinational companies have vigorously opposed Indian companies' attempts to develop cheaper drugs, including anti-Aids drugs. Indian companies like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  could sell an anti-Aids drug in Africa for as little as US$250 for a year's treatment, compared to a cost to the patient of US$15,000 a year using Western form}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lations.\par William Haddard, a US expert on generic drugs, commented: 'The poor nations of the world now look to India to provide them with safe, effective and affordable medicines. But it is ironic that India, with enormous pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lems of its own, should be the hope of the Third World.'\par US and European pharmaceutical companies, meanwhile, have been furious at the enormous loss in profits, and the matter has not yet been fully settled despite the acrimony. With the rules of the game changing in 2005 - when patent laws are to be more strictly enforced - the fine print of the new rules will become more important.\par Some points of contention are compulsory licensing to manufacture drugs in developing countries in times of emergency, and whether the cut-off date for allowing the manufacture of patented drugs by third countries is 1995 or 2005.\par If India handles its case at the WTO well, there could be tremendous opportunities after 2005. Drugs with an annual sale of some US$55 billion to US$65 billion are going off patent in the next five years. But the patent holders can be counted on to try all manner of stratagems to extend the patent periods.\par Despite a price erosion to around one-forth the original price, the market is still worth around US$15 billion, and Indian companies should be able to capture at least part of this potential.\par Indian companies could also be a subcontractor for the testing of a new drug. It costs some US $600 million to US$900 million to develop a new molecule, much of this cost in testing. A McKinsey & Co. report says I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dian companies could get a chunk of this by conducting clinical trials.\par Bioinformatics is also a very promising area with a market potential of US$2 billion. While India has been lax in exploiting the potential of its indigenous herbal systems of medicine, this could change in the next decade.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par  PHARMACEUTICALS INDUSTRY (94%); PHARMACEUTICAL PREPARATION MFG (93%); PATENTS (91%); TRADE DEVELOPMENT (91%); PHARMACEUTICALS ASSOCIATIONS (90%); PATENT LAW (90%); INTELLECTUAL PROPERTY LAW (90%); INTERNATIONAL TRADE (90%); PHARMACEUTICALS PATENTS (89%); GENERIC PRODUCTS (89%); INTERNATIONAL ECONOMIC ORGANIZATIONS (89%); AIDS & HIV TREATMENT (78%); DRUG DELIVERY SYSTEMS (78%); DRUG DESIGN & DISCOVERY (78%); EXPORT TRADE (78%); ENGINEERING (78%); MULTINATIONAL CORPORATIONS (78%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TELLECTUAL PROPERTY (78%); GENERIC DRUGS (78%); DEVELOPING COUNTRIES (78%); INVES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MENT BANKING (77%); CONSULTING SERVICES (74%); REVERSE ENGINEERING (71%); \par \par  CIPLA LTD (90%); MCKINSEY & CO INC (83%); MORGAN STANLEY (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 THE NEWS; South Asia\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 632 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 June 6, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2004 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Zambia;New Hope to Beat Malaria Africa News April 22, 2004 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_105}{\*\bkmkstart DOC_ID_105_0}{\*\bkmkstart doc_id_50}{\*\bkmkend DOC_ID_105}{\*\bkmkend DOC_ID_105_0}{\*\bkmkend doc_id_50}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_50"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00350030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 50 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  22, 2004 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Zambia;\par New Hope to Beat Malaria}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Business Day\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1131 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ZAMBIANS roll their eyes and shrug when asked if they have had malaria. "Everybody gets it", 26-year-old Ernest Kanegamukazi says with a wry smile. His wife, his brother, his parents and even his two-year-old daughter have recently had malaria, which Zambian authorities estimate is responsible for two-fifths of all infant deaths and gives rise to one of the highest maternal mortality rates in the world.\par "This is what we mean when we say the disease is endemic," says Dr Naawa Spilanyambe, acting co-ordinator of Zambia's Malaria Control Centre. "There is nowhere in Zambia where you don't have malaria." \par Last September Kanegamukazi was one of the 50 or so suspected malaria patients arriving daily at the Chelston Clinic in Lusaka. So far he has been fortunate enough to have ready access to effective drugs each time five times so far that he has suffered the telltale fever, headache, and dizziness that follow the bite of a parasite-carrying mosquito.\par As a taxi-driver he also earns enough money to protect his family with insecticide-treated bed nets which the clinic sells for $3, and he can afford to pay a private company to douse the walls of his home with mosquito-killing chemicals.\par Even though the Zambian government has a free household-spraying programme, some people prefer not to rely on officials to do the job.\par On his last clinic visit, Kanebamukazi paid his usual $1 consultation fee, but instead of chloroquine pills, the nurse gave him a blister pack of Coartem. The yellow tablets, made by Swiss Pharmaceutical giant Novartis, are among a new class of antimalaria agents that combine a fast-acting derivative of the ancient Chinese herb artemesia with a second, slow-acting drug.\par These artemesinin-based combination therapy (ACT) drugs offer hope to many African countries that have seen a massive resurgence in malaria over the past two decades as resistance to chloroquine and su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 phadoxine-pyrimethamine (SP) spreads in the parasite pool.\par In Kenya, for example, scientists say almost 70% of malaria deaths are due to chloroquine resistance. In Zambia, officials estimate that over the past 20 years resistance to the drug rose to 60%, and by last year the case rate had risen so fast that one in three Zambians had malaria.\par Scientists say the malaria parasite is unlikely to develop resistance to ACT drugs like Coartem because the two drugs act in different ways to kill the parasite. Any parasite that survives exposure to the one will be wiped out by the other, says University of Cape Town clinical pharmacologist Dr Karen Barnes.\par This combination-drug treatment approach has been used for many years to treat diseases like tuberculosis, but has been applied only recently to malaria. Scientific studies show Coartem offers a cure rate topping 95%.\par Barnes speculates that failures may be caused by inadequate absorption of the drug, which has be taken with some fat to be absorbed properly. Sometimes patients feel too nauseous to swallow anything vaguely fatty (such as a glass of milk or peanut butter) with their pills, and others simply cannot afford it.\par Zambia is just one of many African countries scrambling to embrace the new-generation ACTs. Drawing on SA's success with the drug, which was introduced into KwaZulu-Natal in 2001 shortly after the province r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vised its household insecticide-spraying programme and reintroduced DDT, Zambia changed its malaria po}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 icy in 2002 to make Coartem its first-line treatment. Like KwaZulu-Natal, Zambia did not invite pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cal groups to bid for a drug tender, but dealt only with Novartis.\par The World Health Organisation (WHO), which has put Coartem on its essential medicines list, estimates that demand for ACTs will reach 200-million treatments by 2006, says Novartis global marketing manager Hans Rietveld.\par Novartis, he says, is likely to meet a quarter of that demand, and is confident that its Chinese partners can maintain sufficient supplies of the artemesia plant to produce the drug.\par Other companies that make highquality ACTs include Synofi-Synthelabo, which is seeking WHO prequalif}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cation for its Artesunate medicine, and Chinese pharmaceutical group Tonghe Pharmaceuticals, which offers a treatment combining dihydro-artemesinin and piperaquine. Indian generics manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is also seeking WHO prequalification for its ACTs.\par Coartem is now on offer in 28 out of 72 districts in Zambia, and the health department hopes to have cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 trywide distribution by the end of the year.\par The results so far are encouraging, says Spilanyambe. In the Choma district, she says, recorded monthly malaria deaths fell from 320 to eight in the nine months since Coartem was introduced.\par At the Chelston clinic, however, the story is slightly different. About half the malaria patients given Coartem come back to the clinic saying they have not got better, says the nursing sister in charge, Anne Katuta. "Some say it doesn't work, and some complain that there are too many tablets," she says.\par An adult course of Coartem consists of 24 pills taken in twice-daily doses over three to five days.\par "Coartem works, but the problem is that after the first day or two people feel better and stop taking the pills," says Dr Makungo Kabasa, a manager with the Lusaka district health management board. The clinic does not have data on drug compliance because it does not have the resources to do home visits, but anecdotal ev}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 dence suggests that patients hoard what they consider to be leftover drugs in the event that they or a relative succumb to malaria again.\par Although Novartis supplies the drugs to Zambia and other developing countries on a nonprofit basis, and a $17m grant from the United Nations Global Fund to Fight AIDS, TB, and Malaria enables the clinics to pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 vide the drugs free of charge, patients still have to pay for a consultation. Few African countries have the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sources SA does to provide free clinic services. As a result, many Africans self-medicate at home.\par Many African countries face massive challenges in educating communities about taking malaria drugs in a context in which the disease has become so widespread that people expect to get it again and again, and feel no sense of urgency in taking the drugs, says Barnes.\par Vinand Nantulya, senior adviser to the Global Fund's executive director, says that to eradicate malaria health authorities need to find a way along with bed nets and household-spraying programmes to get malaria drugs to people in a form that they can take safely without medical supervision.\par One day, he hopes, poor people will be able to buy cheap antimalaria pills at their corner shops, as they do today with aspirin.\par  Kahn is science and health editor. Her }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  was paid for by Novartis.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MALARIA (91%); DEATHS & DEATH RATES (89%); DRUG RESISTANCE (89%); DISEASES & DISORDERS (89%); INSECTICIDES (78%); DISEASE AGENTS & VECTORS (78%); INFANTS & TO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 DLERS (77%); PHARMACEUTICALS INDUSTRY (74%); PHARMACOLOGY (73%); WOMEN'S HEALTH (72%); ANALGESICS (72%); INFANT MORTALITY (71%); TUBERCULOSIS (71%); PHARMACEUTICAL PREPARATION MFG (69%); SCIENCE & TECHNOLOGY (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NVS (NYSE) (81%); NOVN (SWX) (81%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS339115 OPHTHALMIC GOODS MANUFACTURING (81%); NAICS325412 PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CEUTICAL PREPARATION MANUFACTURING (81%); SIC3851 OPHTHALMIC GOODS  (81%); SIC2834 PHARMACEUTICAL PREPARATIONS  (81%); SIC3851 OPHTHALMIC GOODS (81%); SIC2834 PHA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MACEUTICAL PREPARATIONS (81%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MALARIA CONTROL CENTRE (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ZAMBIA (97%); KENYA (79%); AFRICA (79%); SOUTH AFRICA (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 CAPE TOWN, SOUTH AFRICA (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MALARIA CONTROL CENTRE (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 April 22, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore September 2, 2003 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_106}{\*\bkmkstart DOC_ID_106_0}{\*\bkmkstart doc_id_51}{\*\bkmkend DOC_ID_106}{\*\bkmkend DOC_ID_106_0}{\*\bkmkend doc_id_51}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_51"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00350031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 51 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 WTO drug deal to spark competition}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 September}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  2, 2003 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par By RAVI KANTH IN GENEVA\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 THE landmark agreement to override patent provisions for addressing HIV/Aids, tuberculosis, and malaria in poor countries reached among 146 members of the World Trade Organization on Saturday is expected to result in intense competition among leading generic drug producers, analysts said.\par The historic deal will help poor countries avoid being drowned in complying with complex patent rules that provide monopoly-marketing rights to pharmaceutical giants such as Pfizer, Merck, and GlaxoSmithKline Wellcome.\par It would provide political and legal clarity to the use of what is called the compulsory-licensing instrument in the trade-related intellectual property rights , said Faisal Ismail, the South African trade envoy to the WTO. \par Under the agreement - in which Singapore's Ambassador to the WTO, Vanu Gopala Menon, played a major role - poor developing countries lacking manufacturing facilities to produce latest patented drugs could issue a compulsory licence to a third government that would enable its generic producers to supply the much-needed drug at affordable prices.\par Leading global generic drug producers in Canada, India, Brazil, Israel, the United States and Switzerland are expected to jump into fray once poor countries in Africa declare their intention to issue compulsory licences to manufacture the latest drugs for HIV/Aids, said a Geneva-based trade analyst. The compulsory licence allows WTO members to revoke the rights of a patent holder to address serious public health problems, but the existing law says that production under compulsory licensing must be predominantly for domestic co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sumption.\par To overcome this provision for poor countries with insufficient facilities to manufacture pharmaceutical pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ucts, WTO members had to struggle hard for almost two years to arrive at Saturday's agreement.\par Asked whether Canadian generic companies would export medicines under this route, the Canadian amba}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 sador to WTO, Sergio Marchi, said he would imagine all generic producers would be able to compete for any compulsory licence issued under Paragraph 6 mechanism of the Doha }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (trade-related intellectual pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 erty rights) and Public Health agreement.\par Intense competition between generic producers could lead to downward pressure on prices of most of the important life-saving drugs needed to combat HIV/Aids, an Indian pharmaceutical industry analyst said.\par Significantly, shares of leading India generic drug companies like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  Ranbaxy and Reddy Labs have ri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 en steadily over the last few days in anticipation of the WTO agreement.\par Rich countries such as the US, Japan, Canada, and the EU members cannot use this agreement as impor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ers, while nations like South Korea, Hong Kong, and Singapore among others voluntarily said they would not use it except in grave public health emergencies.\par However, Oxfam and MSF (Medicines sans Frontiers) criticised the WTO agreement saying it watered down the goals set out in the Doha declaration and would make the implementation ineffectual.\par With tightened safeguards, the agreement would not help achieve the objective of letting poor countries gain easy access to cheap copies of patented medicines, said a representative of the Penang-based Third World Network.\par 'We do not agree with this, and we are confident that we could use the compulsory licensing provisions wit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 out much hindrance,' said Mr Ismail of South Africa.\par Until now, many countries found it difficult to use compulsory licence when faced with serious public health crisis because of arm-twisting by the US administration and its pharmaceutical companies, said a Geneva-based patent law analyst.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par  PHARMACEUTICALS INDUSTRY (91%); PHARMACEUTICAL PREPARATION MFG (91%); PATENTS (90%); LICENSING AGREEMENTS (90%); PATENT LAW (90%); AIDS & HIV (90%); INTELLECTUAL PROPERTY LAW (90%); GENERIC DRUGS (90%); DEVELOPING COUNTRIES (90%); INTERNATIONAL TRADE (90%); MALARIA (90%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); AIDS & HIV TREATMENT (89%); PHARMACEUTICALS PATENTS (89%); TRADE TREATIES & AGREEMENTS (89%); PUBLIC HEALTH ADMINISTRATION (89%); INDUSTRY ANALYSTS (89%); INTELLECTUAL PROPERTY (89%); EMBASSIES & CONSULATES (89%); BUSINESS FORECASTS (89%); INTERNATIONAL TRADE LAW (89%); TUBERCULOSIS (78%); EXPORT TRADE (78%); TREATIES & AGREEMENTS (78%); PHARMACEUTICALS TRADE (78%); IMPORT TRADE (78%); CONTROLLED SUBSTANCES CRIME (77%); GENERIC PRODUCTS (77%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY CO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PLIANCE (76%); RELIEF ORGANIZATIONS (73%); EUROPEAN UNION (73%); MANUFACTURING FACI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ITIES (68%); CONSUMPTION (64%); \par \par  PFIZER INC (90%); GLAXOSMITHKLINE PLC (90%); CIPLA LTD (57%); RANBAXY LABORATORIES LTD (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 THE NEWS; World\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 610 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 September 1, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2003 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore August 29, 2003 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_107}{\*\bkmkstart DOC_ID_107_0}{\*\bkmkstart doc_id_52}{\*\bkmkend DOC_ID_107}{\*\bkmkend DOC_ID_107_0}{\*\bkmkend doc_id_52}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_52"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00350032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 52 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Proposed WTO deal set to bring hope to poorer nations;\par It calls for relaxing patent provisions, issuing of licences to producers in poorer nations}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  29, 2003 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par Ravi Kanth\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PREPARATIONS are set for a final and long delayed humanitarian deal at the World Trade Organization to allow poor countries to relax patent provisions on latest medicines and issue licences to generic producers in India and Brazil to supply them at affordable prices.\par 'We are hoping to have a deal by the end of the day,' said the architect of the proposed deal, Singapore A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 bassador to the WTO Vanu Gopala Menon.\par Ensuring poorer states unable to manufacture medicines can import cheap generic drugs when they need to is seen as vital to beating major killers such as Aids and malaria. But it also means setting aside patent laws protecting multinational firms. \par Agreement is crucial for the success of the WTO's current Doha Round of free trade talks, which is due to be discussed at a major summit in the Mexican city of Cancun next month.\par Over the last five months, Mr Menon, who now heads the WTO's Intellectual Property Council, quietly worked behind the scenes to resolve the differences between the key players such as the US, the European Union, India, Brazil, and South Africa for implementing the Doha Agreement on trade-related intellectual property rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Public Health.\par WTO members are expected to endorse the statement that Mr Menon had prepared to bring the US on the board.\par The leading US pharmaceutical companies, particularly Pfizer, were unhappy with the proposed agreement and forced their government to block the deal last year on the ground that it would be abused by generic producers like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Ranbaxy in India to produce cheap copies of Viagra and other profit-making drugs.\par Except for the US, the entire WTO membership had approved a draft deal last year to implement the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 plex 'paragraph six' mechanism requiring countries lacking manufacturing facilities to transfer their compuls}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ry licences to generic producers in India and Brazil for supply of affordable medicines.\par Faced with severe public criticism and the outbreak of Sars (severe acute respiratory syndrome) and A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 thrax, the Bush administration was forced to give up its strident opposition to this agreement.\par The final three-page chairman's statement that Mr Menon issued late on Wednesday evening to members lists the 'the good faith' intentions for members to follow during the implementation of the 'paragraph six' mechanism. It would ensure that the proposed Doha agreement on }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  and Public Health is not pursued for 'industrial or commercial policy objectives'.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par  INTERNATIONAL ECONOMIC ORGANIZATIONS (91%); PHARMACEUTICALS INDUSTRY (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TENTS (90%); TRADE DEVELOPMENT (90%); PHARMACEUTICAL PREPARATION MFG (90%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 LECTUAL PROPERTY LAW (90%); INTELLECTUAL PROPERTY (90%); INTERNATIONAL TRADE (90%); RESPIRATORY DISEASE (78%); TRADE TREATIES & AGREEMENTS (78%); TALKS & MEETINGS (78%); INTERGOVERNMENTAL TALKS (78%); PATENT LAW (78%); FREE TRADE TREATIES & AGREEMENTS (78%); PUBLIC POLICY (78%); GENERIC DRUGS (78%); LICENSES & PERMITS (77%); MALARIA (77%); MANUFACTURING FACILITIES (76%); MULTINATIONAL CORPORATIONS (73%); G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NERIC PRODUCTS (72%); APPROVALS (71%); EUROPEAN UNION (68%); SARS (61%); \par \par  PFIZER INC (58%); CIPLA LTD (58%); RANBAXY LABORATORIES LTD (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 THE NEWS; World\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 416 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 August 28, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2003 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Bush in Africa: The diplomacy: SPECIAL REPORT by Jo Revill in Gaborone: How the Aids battle can be won: In Botswana, where a third of the population has the condition, one pioneering clinic has shown it is not too late for a ravaged continent to fight back and survive the epidemic The Observer July 6, 2003 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_108}{\*\bkmkstart DOC_ID_108_0}{\*\bkmkstart doc_id_53}{\*\bkmkend DOC_ID_108}{\*\bkmkend DOC_ID_108_0}{\*\bkmkend doc_id_53}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_53"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00350033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 53 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Observer\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  6, 2003\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Bush in Africa: The diplomacy: SPECIAL REPORT by Jo Revill in Gab}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 rone: How the Aids battle can be won: In Botswana, where a third of the population has the condition, one pioneering clinic has shown it is not too late for a ravaged continent to fight back and survive the epidemic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Jo Revill\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Observer News Pages, Pg. 21\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1244 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  PATIENTS start queuing at 6am outside the two steel portable buildings of the Princess Marina Hospital in Gaborone, some standing, others supporting themselves on a stick or a child's arm. The queue looks bleak but is actually testimony to a remarkable success story in Botswana which suggests it may not be too late for Africa to start fighting back against its ferocious Aids epidemic.\par  Inside the buildings, reminiscent of a rather overcrowded NHS clinic, doctors are giving patients blood tests. If their CD4 cell count is lower than 200, which denotes a weakened immune system, they will receive the antiretroviral (ARV) drugs needed to stay alive. For some it is too late but others get better, and return to work.\par  President Bush is expected to visit the hospital when he makes a whistlestop }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  to Botswana this week as part of his five-nation African tour. He will be told the doctors have treated more than 6,000 patients with the drugs, and plan to open up new clinics. For Bush, who has pledged Dollars 15 billion over five years for Aids treatment and prevention, this is the kind of project he needs to see to know such initiatives are worthwhile. \par  There are 120,000 people eligible for these drugs in Botswana, a southern African country where an est}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 mated 36 per cent of the population has the disease. Aids arrived in the early Nineties, but very few will put themselves forward for diagnosis, knowing friends and family may shun them. Life expectancy for a Bo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 swanan, which was due to reach 72 by 2010, will have flipped back to 27.\par  Dr Ndwapi Ndwapi left his job in America to come back to his native land and help run what is now the bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 est Aids clinic in the world, seeing 120 patients a day. 'The first came here thinking they were going to be given a death sentence. Now with the drugs, we have a new beginning,' he said, squeezing between patients as they queued in the corridors.\par  It is not an easy career choice. 'I try not to get too tied up in the daily suffering - but it is tough. I'm aware I could do more, and I feel frustrated. Still, before there were ARVs, it was hopeless, you just helped people to die as comfortably as possible. Many, many lives have been changed with this treatment,' he said.\par  This project, the first full attempt to prevent and treat Aids ever undertaken in Africa, is known as the African Comprehensive HIV/Aids Partnerships, (Achap). It involves the government working with the Bill Gates Foundation, and pharmaceutical firm Merck, each putting in Dollars 50 million into a five-year-initiative. The drugs are being bought by the government at cost price from the pharmaceutical companies, and one of the medications is being given free by Merck. The total package of care per patient costs Dollars 1,000 a year.\par  SOME SEE this kind of joint partnership as the most realistic way forward; one is Professor Brian Gazzard, Aids physician at the Chelsea and Westminster Hospital in London, who comes here every six months to oversee the training of staff.\par  'HIV is rooted in poverty and ignorance and poor infrastructure,' he said. There is no GP system in Botsw}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 na, where 30,000 traditional healers have to be persuaded the new drugs do work.\par  'In some ways, Africa is caught in this time warp. It is so far behind the West in being able to provide basic healthcare. But I am optimistic because if you can treat 10,000 patients really well in Botswana you can say to the rest of the world, "For Christ's sake, this can work."'\par  But there remains great uncertainty over how the rest of Africa will find the money for such projects. The drugs companies are fighting a battle for their right to keep patents on HIV drugs, preventing others from copying them, as part of global trade negotiations. It has left companies like GlaxoSmith Kline facing accus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tions of denying the poorest nations life-saving drugs.\par  There is also cynicism over their new found philanthropy. In Botswana, Merck and Bristol Myers Squibb are putting in Dollars 200m over five years for medical pro jects. But is their beneficence any more than an e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 pensive attempt to win good publicity, against a backdrop of protests about drug pricing? The companies insist they want to help, and are well placed to do so, but only if they are able to work with governments to set up a proper health infrastructure - hospitals, clinics, trained staff - to deliver the drugs safely.\par  On the other side of the continent, Tanzania has Dollars 6 a year to spend on each resident's healthcare and has not even talked to the pharmaceutical giants about drugs. Instead, it hopes the Bill Gates Found}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion or the UN Global Fund might come up with some money.\par  As part of a }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 trip}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  funded by the International Federation of Pharmaceutical Manufacturers Associations, The Observer was taken to see various projects around the country, where compa nies and health officials were working together to cure river blindness and elephantitis. Important projects, but small beer compared with the financial and organisational challenges presented by the two biggest killers, malaria and Aids.\par  In stark contrast to Botswana, Tanzania has no access to antiretroviral drugs until someone is wealthy enough to pay Dollars 60 a month for them through a private pharmacy. The drugs companies argue they cannot come in unless the government negotiates with them, and the government says it cannot afford them.\par  ONE COUPLE are managing to bring in Aids drugs, in order to save the lives of their own staff. Doctors Richard and Carolyn Collins came out to Tanzania two years ago to work for the Teule Hospital in Muheza. They found hospital staff were dying of Aids at the rate of one a month. With the help of friends in Britain, they started a charity providing enough money to enable them to pay for imported generic HIV drugs which have saved 16 lives so far. But there is no money to pay for treatment for partners of staff, or for children.\par  The generic drugs from the Indian company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  cost Dollars 30 a month, half the price of patented med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cines. 'Thank goodness for the generics, because otherwise we would have nothing,' said Carolyn Collins.\par  She laughs at the idea that they might get financial aid from the West. 'For it to work, we would need to give them the drugs for free, because there's nothing these people can afford. People in high places say, "Why are you bothering, because these people are going to die anyway?" But back home, we give people with brain tumours another nine months of life with treatment. It's about the value you place on life.'\par  Nowhere is that value more apparent than in the orphanage in Otse, back in Botswana, where 50 children sit down to a meal of chicken stew.\par  There is a sense of hope and purpose here at the Dula Sentle Trust, as the children, from five to 17, are taught ways of coping with the loss of their parents, and given skills to survive. The girls are taught how to say no to a boy who wants sex, but in a charming way, using funny songs.\par  Its founder, Gill Fonteyn, said: 'At the moment we have 50 kids. Within five years, that's likely to be over 200 orphans. At the moment, everyone has someone they can go home to at night, even if it's a distant relative. But soon there will be a few with no adult to look after them.'\par  Richard and Karilyn Collins, who import generic Aids drugs to Tanzania's Teule hospital.\par  www.observer.co.uk/worldview\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MERCK & CO INC (84%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MRK (PAR) (84%); MRK (NYSE) (84%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 DISEASES & DISORDERS (90%); EPIDEMICS (90%); AIDS & HIV TREATMENT (89%); PHARMACEUTICALS INDUSTRY (89%); AIDS & HIV (89%); PHARMACEUTICAL PREPARATION MFG (85%); PREVENTION & WELLNESS (79%); LIFE EXPECTANCY (79%); HEALTH CARE COSTS (78%); ANTIVIRALS (75%); PHYSICIANS & SURGEONS (74%); CLINICS & OUTPATIENT SERVICES (73%); FOUNDATIONS (71%); NATIONAL HEALTH INSURANCE (71%); POPULATION & DEMOGRAPHICS (70%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 July 7, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 PUB-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PAPER\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2003 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PanAfrica;Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper Africa News May 5, 2003 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_109}{\*\bkmkstart DOC_ID_109_0}{\*\bkmkstart doc_id_54}{\*\bkmkend DOC_ID_109}{\*\bkmkend DOC_ID_109_0}{\*\bkmkend doc_id_54}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_54"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00350034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 54 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  5, 2003 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 PanAfrica;\par Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The East African\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1233 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 SEAN FLYNN, senior attorney at the Consumer Project on Technology (CPTech), a non-profit organisation in Washington DC that focuses on the impact of intellectual property protection on consumer interests, spoke to GICHINGA NDIRANGU on compulsory licensing in relation to the HIV/Aids pandemic\par What is the problem you are addressing?\par It is the lack of access to medicines needed to treat Aids. About 95 per cent of people who have HIV/Aids live in the developing world. Africa accounts for over 70 per cent of the world's Aids deaths and Aids is the leading cause of deaths in Africa. \par Since 1996, there have been antiretroviral (ARV) medicines that can cut Aids deaths by up to 70 per cent and allow people with Aids to live relatively normal lives. There are about 30 million people with Aids in Africa and between four and five million Africans need immediate access to ARV treatment or they will soon die. Yet, only 30,000-50,000 people in Africa have access to this treatment, including only about 7,000 in Kenya and 10,000 people in Uganda. We want to help increase the accessibility of treatment.\par How do you plan to do that?\par For there to be treatment, affordable medication must be available as well as effective health systems, sele}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tion of medicines through registration procedures and funding. CPTech's work focuses on expanding access to affordable medicines by attacking patent barriers that prevent low-cost/high-quality drugs from reaching African markets. We are helping citizen groups and government officials understand the flexibilities they have under national and international law to force patent holders to allow competition in the supply of life-saving products, thereby bringing the prices of the products down. Of course, to get the drugs to people who need them, the other barriers - health systems, drug registration and funding - need to be addressed.\par How can a government force a patent holder to allow competition?\par We are educating African decision makers on compulsory licensing. Patents are sets of rights granted by the government to an inventor to use and profit from an invention. Since the first international agreement regar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ing patents in the late 1800s, governments have always retained the right to allow others to use the patent without permission from the patent holder if the holder fails to serve the needs of the market on reasonable terms.\par The act of allowing another to use a patent without permission of the patent holder is called "non-voluntary use" or a "compulsory licence."\par The latest international agreement, the World Trade Organisation Agreement on Trade Related Aspects of Intellectual Property Rights (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , authorises governments to use compulsory licences for government use, to meet public emergencies or circumstances of extreme urgency (including health crises), as a remedy to anticompetitive practices or for any other public purpose, as long as certain procedures are followed.\par The Ministerial Conference of the WTO in Doha (2001) instructed states to interpret the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 TRIPS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement "in a manner supportive of WTO members' right to protect public health and, in particular, to promote access to medicines for all." Specifically, the Conference agreed that "each member has the right to grant compulsory licences and the freedom to determine the grounds upon which such licences are granted."\par Has competition affected the price of Aids drugs?\par In the past few years, several countries have allowed the manufacture of generic ARVs with the result that prices dropped. In 1998, multinational companies were charging about $12,000 per year for the cheapest ARV treatment - a combination of d4T+3TC+nevirapine. In 2000, Brazil began offering this triple drug ther}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 py for $2,767 annually after allowing local suppliers to make or import the medicines. By March 2001, Indian drug manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  was offering a generic treatment for $350 and the brand name version had dropped to $727. Today, suppliers offer the treatment for as low as $200 per year.\par Are there other benefits of competition for the supply of medicines?\par Competition has multiple benefits. One of the most dramatic in the supply of ARV medicines has been the ability to compete to provide the most innovative product for developing countries.\par For example, none of the brand name companies provides a d4T+3TC+nevirapine treatment in a single pill because the drugs are patented by different companies and they do not work together. But several generic firms now provide these treatments in a single pill, allowing increased ease of administration.\par Having one company provide each drug has also caused shortages of supplies because when the supplier runs out of a product there are no alternatives, as has happened several times recently in Kenya.\par Another benefit may be the possibility that local production could begin to capture a share of the market, providing positive feedback effects in terms of employment and technology transfer.\par There is an argument that patents cannot be a problem in Africa because most ARVs are not patented in most countries in Africa?\par It is true that not all ARV drugs are patented Africa. The multinational pharmaceutical companies use this information to argue that patents are not a problem. But when one looks at which drugs are patented in Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ca, one finds that the drugs that are the cheapest to produce and the most effective to administer are widely patented.\par For example, a drug called Indinivir is only patented in two African countries. But it is very expensive to pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 duce and is not appropriate for many patients in Africa because you must consume at least two litres of w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ter each day (more in hot areas) to prevent kidney stones. The least expensive, easy to administer and most effective treatments are (AZT or d4T)+3TC+nevirapine. One or more of these drugs or combinations are p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 tented in 37 African countries.\par When should countries grant compulsory licences?\par To maximise the ability of competition in the supply of medicines to drive down prices and foster innovation, compulsory licences of right (a licence for any supplier to compete that can meet regulatory approval r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 quirements) should be granted whenever the number of people who need access to the medicines signif}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cantly exceeds those with access; or the patent holder has not implemented an automatic licensing pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 gramme for all qualified suppliers on reasonable terms (international standard of two per cent to five 5 per cent royalties on annual sales) or if the major barrier to access is price. These drugs have been available in the West since 1996. The time to act is now.\par Are discounts and donations by the brand companies not solving the problem?\par No. Even with the most recent discounts by GlaxoSmithKline last week, the generic price for ARVs remains far cheaper than those of the brand name companies. The drug company discounts do not reach the private sector where perhaps a majority of people receive treatment now, and where more could receive treatment if prices were low enough. In addition, the prices will not fall further unless competition is allowed.\par Finally, the other benefits of competition - incentives to innovate, an increase in the number of suppliers to avert shortages and an allowance of local production - will not occur through discounts and donations.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 GENERIC PRODUCTS (90%); HEALTH CARE ACCESS (90%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS INDUSTRY (90%); AIDS & HIV (90%); PHARMACEUTICAL PREPARATION MFG (89%); INTELLECTUAL PROPERTY LAW (89%); PATENTS (89%); NONPROFIT ORGANIZATIONS (89%); LICENSING AGREEMENTS (89%); PATENT LAW (78%); ANTIVIRALS (76%); DEATHS & DEATH RATES (76%); INTERNATIONAL ECONOMIC ORGANIZATIONS (74%); EPIDEMICS (72%); RESTRAINT OF TRADE (72%); INFECTIOUS DISEASE (72%); TRADE TREATIES & AGREEMENTS (71%); INTERN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TIONAL TRADE LAW (68%); TREATIES & AGREEMENTS (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANISATION (66%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 AFRICA (94%); UNITED STATES (92%); KENYA (79%); UGANDA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 DISTRICT OF COLUMBIA, USA (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 WORLD TRADE ORGANISATION (66%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 May 13, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2003 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs The Guardian (London) February 18, 2003 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 {\*\bkmkstart DOC_ID_110}{\*\bkmkstart DOC_ID_110_0}{\*\bkmkstart doc_id_55}{\*\bkmkend DOC_ID_110}{\*\bkmkend DOC_ID_110_0}{\*\bkmkend doc_id_55}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 HYPERLINK \\l"cite_id_55"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15085367 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00350035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid10898414 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 55 of 55 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 The Guardian (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  18, 2003\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid10898414 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Guardian Special Supplement, Pg. 8\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 1353 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  The drug barons consider him a pirate and a thief. Yusuf Hamied, a Cambridge-educated multi-millionaire who lives for the summer months in what used to be Lady Shirley Porter's London apartment, believes he is doing Ghandi's bidding. He manufactures perfect copies of many of the world's best and most important medicines and sells them at a snip. Dr Hamied and his family are certainly very rich but many poor people owe him their health, without which they would be destitute indeed.\par  The question of Dr Hamied's motivation is absorbing but at the end of the day irrelevant. What matters is that he exists. He single-handedly broke the cartel of the big drug companies by offering to supply Aids drugs at less than a tenth of their prices. That audacious offer at a big European Commission meeting on Aids in September 2000 ("you could hear the breath being sucked out of the room" said Bill Haddad, former New York Post investigative journalist turned US generics boss) made everything possible. The assumption that Aids drugs were not for the poor - that they could not afford them and therefore that there was no point even thinking about ways to get people treated - was blown out of the water. \par  Now, in the post-Hamied era, the genie will not go back in the bottle. The big drug companies have been forced to drop their prices for these new and powerful drugs and offer them to a market they had no interest in developing - the impoverished African states where a whole generation of parents, teachers and workers are dying.\par  Dr Hamied's prices are still lower - his Bombay-based company, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 , offers a three-drug cocktail for around Dollars 304 per year which used to sell for around Dollars 12,000 and would now cost Dollars 727 from the brand-name companies. And yet his sales are few in countries where the need is desperate. Fewer than 50,000 people are being treated out of nearly 30 million infected with the lethal HIV virus in Africa, and - although Malawi is buying them - most of those are not getting }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  drugs.\par  Part of the reason is money - Dollars 304 is still impossible in countries with a per capita income of under Dollars 200 a year. But another part of it is a fight-back by the US and Europe-based big-name pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 cal industry, which has long wanted to wipe the buccaneering generics companies off the face of the planet. Their long-term strategy to do that, through a World Trade Organisation agreement called }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (trade rela}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ed intellectual property rights) - which will sign up every nation to protect patents on new drugs for 20 years - is now in jeopardy because of the Aids crisis and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  affordable medicines.\par  The drug giants have dropped their prices and argue that there is no need for generic piracy. But many of those who are concerned about the damage being wreaked on the economies of poor nations by a single virus have come to believe that it is not safe for the world to rely on voluntary price reductions by generous drug barons for desperately needed medicines to keep poor people alive and nations stable.\par  Campaigners in the US and Europe, as well as governments in developing countries, now see generics - or the threat of them - as the only way to get affordable medicines for all sorts of diseases that afflict the pop}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 lation of poor countries and damage their economies. Just over a year ago, they secured an exemption clause to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  called the Doha Declaration, which allows developing countries to ignore patents and buy generics in a health crisis. Now the fight is on to decide in which countries and for which diseases poor pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ple should be allowed cheap medicines - the US government, which champions the industry, wants to rule out such illnesses as asthma, diabetes and cancer and restrict the concession to the very poorest nations.\par  The crucial issue is whether the generics companies of India, Brazil and Thailand will be allowed to export to countries that cannot make their own cheap copies after the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  patent rules bite in 2005. Unless they can, new drugs invented for Aids or other diseases will be untouchable and unaffordable in Africa for 20 years.\par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  was set up as an Indian solution to India's health problems by Dr Hamied's father in 1935 when war stopped medicines arriving from Europe. Its website features a picture of Ghandi expressing his delight at visiting "this Indian enterprise". In 1972, India passed a law which permitted medicines to be copied even if they were under international patent, as long as the process was not the same. There are now hundreds of generic companies in India - many of them tiny. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  is one of the biggest, with a market capitalisation, said Dr Hamied, of about Dollars 1.4bn. "I don't want to make money on Aids drugs," he says. "I make enough money on other things. On this particular issue, can't we all pool our resources? I make 800 drugs. If I don't make money on six, why should I worry?"\par  Dr Hamied runs a free cancer hospital in India. There are reasons to believe in his altruism. "I'm not going to take it with me, so I have to leave it here," he says. But there's no doubt he stands to win all ways round. His public stand has given }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  excellent publicity. The World Health Organisation has endorsed the quality of his generic Aids drugs and approved his factories. And the fight over the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Trips}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  agreement could bring him a lot more business not only from the poorest countries but - and this is why the research-based companies are fighting so hard - also the massive developing markets of China and South America.\par  Dr Hamied, though, is frustrated. He is disappointed with the governments of Aids-hit nations, who are not placing orders for his drugs. "It is a joke," he says. "I should have the demand. Demand creates the incentive to produce, but with only 50,000 in the whole of Africa, where is the demand?"\par  If demand grew as fast as the spread of the virus, he could not keep pace. He would like to see countries set up their own generics factories, and he has offered to show them how to produce Aids drugs for free. The Global Fund should put up the money, he says. None of that is happening. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  sells a three-drug cocktail in one pill, called Triomune, to be taken twice a day, which makes treatment much easier in poor countries. Malawi buys it for the couple of thousand patients who can afford to pay Dollars 28 a month, but its Dollars 196m from the Global Fund will only buy treatment for 50,000 more.\par  Dr Hamied will shortly launch the world's first once-a-day, three-drug treatment, called Odivir. It's clearly well suited to poor countries and it will be affordable, he says, but there's no reason to suppose it will be taken up where his other drugs have not been. "India has four million cases and I'm breaking my head to make my government take a more active role," he says. "I offered totally free nevirapine (to prevent babies being i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 fected by their mothers at birth) and nobody takes it. It is up to the various governments to avail (themselves) of the opportunities offered. What has really saddened me is, firstly, the governments and, sec ondly, I have been totally disillusioned by the UN who talk, talk, talk and do nothing at all."\par  What, apart from lack of money in the poorest, is stopping the governments biting }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  hand off? The research-based pharmaceutical industry would say the political will is not there. But patents have been an issue. In Ghana, for instance, says Dr Hamied, it was GlaxoSmithKline that challenged the decision to import generic versions of drugs which were under patent there.\par  But there are countries where Aids drugs are not patented. According to Bill Haddad, who has voluntarily taken up }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  cause in the US, "the governments are too scared of the US government to buy generics". The US trade representative bats for the giant pharmaceutical companies. Whatever the WTO trade rules say about allowing countries to buy generics in a health crisis, he suggests, there are those who would rather not risk the wrath and possible sanctions of the US.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  LTD (82%);   EUROPEAN COMMISSION  (56%); EUROPEAN COMMISSION (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 EUROPEAN COMMISSION  (56%); EUROPEAN COMMISSION (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid10898414 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414  (NSE) (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (82%); SIC2834 PHARMACEUTICAL PREPARATIONS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 EUROPE (92%); AFRICA (92%); UNITED STATES (79%); MALAWI (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 EUROPE (92%); AFRICA (92%); UNITED STATES (79%); MALAWI (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 PHARMACEUTICALS INDUSTRY (90%); WEALTHY PEOPLE (90%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ERTY LAW (90%); GENERIC DRUGS (90%); AIDS & HIV TREATMENT (89%); PHARMACEUTICALS P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TENTS (89%); PATENTS (83%); PHARMACEUTICALS ASSOCIATIONS (78%); CONTROLLED SU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 STANCES CRIME (78%); AIDS & HIV (78%); INTELLECTUAL PROPERTY (78%); TRADE DEVELO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 MENT (73%); TALKS & MEETINGS (73%); GENERIC PRODUCTS (73%); INVESTIGATIONS (72%); CA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 TELS (69%); TREATIES & AGREEMENTS (50%); VIRUSES (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 February 18, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid10898414 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 Copyright 2003 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0\afs24 \ltrch\fcs0 \fs24\insrsid10898414 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid10898414 \par }{\*\themedata 504b0304140006000800000021009be8704ffc0000001c020000130000005b436f6e74656e745f54797065735d2e786d6cac91cb6ac3301045f785fe83d0b6d872ba28a5d8cea28f5d1f8bf40306796c8bd823214d42f2f71d3b2e941202856e04d2ccbdf7cca85c1fc641ed3126e7a9d2abbcd00ac9fac65157e9cfcd4b76af5562a006064f58e92326bdaeafafcacd316052a2a654e99e393c18936c8f23a4dc0724a9b43e8ec0728d9d0960b7d0a1b92d8a3b633d3112673c79e8ba7cc2167603abe7833c9f4844aed5e3a96f8aaa348430380b2ca066aa9ab3ba8843ba20dc53f38b2e5bc87251cee6a97721dd2c09efb29ae81a541f10f90d46e1302c43e2cff31548468bf965e633d1be6d9dc5c6dbdd28ebc867e3c5ec4f00abff89fece34f3dfd65f000000ffff0300504b030414000600080000002100a5d6a7e7c0000000360100000b0000005f72656c732f2e72656c73848fcf6ac3300c87ef85bd83d17d51d2c31825762fa590432fa37d00e1287f68221bdb1bebdb4fc7060abb0884a4eff7a93dfeae8bf9e194e720169aaa06c3e2433fcb68e1763dbf7f82c985a4a725085b787086a37bdbb55fbc50d1a33ccd311ba548b63095120f88d94fbc52ae4264d1c910d24a45db3462247fa791715fd71f989e19e0364cd3f51652d73760ae8fa8c9ffb3c330cc9e4fc17faf2ce545046e37944c69e462a1a82fe353bd90a865aad41ed0b5b8f9d6fd010000ffff0300504b0304140006000800000021006b799616830000008a0000001c0000007468656d652f7468656d652f7468656d654d616e616765722e786d6c0ccc4d0ac3201040e17da17790d93763bb284562b2cbaebbf600439c1a41c7a0d29fdbd7e5e38337cedf14d59b4b0d592c9c070d8a65cd2e88b7f07c2ca71ba8da481cc52c6ce1c715e6e97818c9b48d13df49c873517d23d59085adb5dd20d6b52bd521ef2cdd5eb9246a3d8b4757e8d3f729e245eb2b260a0238fd010000ffff0300504b030414000600080000002100215aa28421070000db1d0000160000007468656d652f7468656d652f7468656d65312e786d6cec594f6f1b4514bf23f11d467b2fb113274da23a55ecd80db469a3d82dea71bc3bf64e33bbb39a1927f10db547242444411ca8c48d03022ab51297f269024550a47e05deccecae77e271939400153487d63bfb7b6fdefbbd3ff367af5c3d4a183a2042529e3683fa7bb5009134e4114d47cde076bf7b69354052e134c28ca7a4194c880cae6ebcfbce15bcae62921004f2a95cc7cd20562a5b5f5890210c63f91ecf480aef865c2458c1a3182d44021f82de842d2cd66a2b0b09a66980529c80da5bc3210d09ea6b95c146a1bcc3e03155520f844cf4b46ae248186cb45fd70839916d26d00166cd00e689f8619f1ca900312c15bc680635f3172c6c5c59c0ebb9105373642b725df397cbe502d1fea299538c06e5a4f56e63edf256a9df00989ac5753a9d76a75eea33001c86e0a9b5a5aab3d15dadb70a9d1590fd39abbb5d5bae355c7c45ffd28ccd6bad566b792db7c52a3520fbb331835fadad3436171dbc0159fcf20cbed1da6cb7571cbc0159fcca0cbe7b796da5e1e20d286634dd9f41eb8076bbb9f61232e46cdb0b5f05f86a2d874f51900d6576e929863c55f3722dc1f7b8e8024003195634456a9291210e218bdb98d181a07a02bc4e70e58d1d0ae5cc909e0bc950d04c35830f320c1531d5f7f2d9772f9f3d41c7f79f1edffff1f8c183e3fb3f58458ed4364e4755a917df7cfac7a38fd0ef4fbe7ef1f0733f5e56f1bf7cfff1cf3f7de60742f94ccd79fec5e35f9f3e7efee527bf7dfbd003df14785085f7694224ba490ed11e4fc031c38a6b391988f349f4634cab129be948e214eb593cfa3b2a76d0372798610fae455c06ef08681f3ee0b5f13dc7e05e2cc62a8fb7e3d9f53871803b9cb316175e16aeebb92a34f7c7e9c83fb91857717b181ff8e66ee3d4896f679c41dfa43e95ed983866ee329c2a3c22295148bfe3fb8478f8ba4ba9c3eb0e0d05977ca8d05d8a5a987a29e9d381934d53a16d9a405c263e0321de0e373b77508b339fd75be4c045425560e631be4f9843e3353c5638f1a9ece3845509bf8155ec33b237116115d7910a223d228ca34e44a4f4c9dc12e06f25e8d7a175f8c3bec326898b148aeefb74dec09c57915b7cbf1de324f3617b348dabd8f7e53ea42846bb5cf9e03bdcad10fd0c71c0e9dc70dfa1c409f7e9dde0361d39264d1344bf190b4f2caf11eee46f6fc286989856034ddde9d5094d5fd5b813e8dbb9e317d7b8a1553effea91c7ee37b5656f0209be9ad93ed1a8e7e14eb6e73617117df3bbf3161ea7bb040a6276897adb9cdf36e7e03fdf9ce7d5f3c5b7e469178606adb74c76a36db6ddc9dc5df79032d65313466e48b3f196b0f6445d18d472e6c449ca535816c34f5dc93081831b096c6490e0ea43aae25e8c33d8b4d703ad642473d52389322ee1b06886bdba351e36feca1e3597f521c4760e89d50e8fecf0921e2ece1aa51a63d5c81c688b8996b482b34eb67439570abebdce64756dd49967ab1bd34c5374662b5dd6149b4339505eba0683259bb0a941b015029657e0ccafa786c30e6624d2bcdb1815613151f87b42947b6d1d8971446c889ce10a9b7513bb228566fcd3eed91c391f9b256b40dae94698b4989f3f6724b950302519044f56134babb5c55274d80cd69617970314e2ac190ce1980b3f930c8226f53610b311dc15854ad8ac3db5164d914e3d5ef367551d6e2ee6148c53c699906a0bcbd8c6d0bcca43c5523d93b57f71b9a193ed621cf03493b359b1b40a29f2af5901a176434b864312aa6ab02b239a3bfb9877423e5644f4e2e8100dd858ec61083f70aafd89a884db0a53d0fa01aed634dbe695db5bf34e53bdd032383b8e5916e3bc5beaab99a2e22cdcf493d206f354310f7cf3da6e9c3bbf2bbae22fca956a1affcf5cd1cb015c1e2c453a0221dcec0a8c74a534032e54cca10b65310dbb02d67dd33b205be07a165e03f970bf6cfe17e440ff6f6bceea30650d6740b547474850584e542c08d985b664b2ef1465f57ce9b12a59aec86454c55c9959b307e480b0beee812bba070728865437dd246f03067732ffdce7bc820623bd47a9d69bd3c9caa5d3d6c03fbd71b1c50c4e9dd84be8fc2df82f4d2c57f7e9ea67e58d78b146561dd12fa6bba4465115cee2b7b6964ff59a269c6501aeacb5b663cd78bcb85c1807519cf51806cbfd4c06574048ff03eb1f1521b31f2bf482dae77bd05b117c7bb0fc21c8ea4bbaab4106e906697f0d60df63076d32695596da7ce7a3592b16eb0bdea896f39e205b5b7696789f93ec7213e54ee7d4e245929d33ec706dc7e6520d913d59a230342cce212630e62b57f543141fdc83406fc195ff98d94f533283275307d9ae30d935e0d124ffc9a45d706dd6e9338c46b2748f0c118d8e8af347c9842d21fb79a4d8221bb416d389560a2ef90e0dae608ed7a276b52c85174f172e25ccccd0b24b617397e653001fc7f2c6ad8f7680b74dd67aad8bab608aa57f85b23318efa7cc7bf2392b65f6a0f8ca40bd0665eae8d594e54c0179b389079f370586a357cff45f58746ca69b94ddf8130000ffff0300504b0304140006000800000021000dd1909fb60000001b010000270000007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73848f4d0ac2301484f78277086f6fd3ba109126dd88d0add40384e4350d363f2451eced0dae2c082e8761be9969bb979dc9136332de3168aa1a083ae995719ac16db8ec8e4052164e89d93b64b060828e6f37ed1567914b284d262452282e3198720e274a939cd08a54f980ae38a38f56e422a3a641c8bbd048f7757da0f19b017cc524bd62107bd5001996509affb3fd381a89672f1f165dfe514173d9850528a2c6cce0239baa4c04ca5bbabac4df000000ffff0300504b01022d00140006000800000021009be8704ffc0000001c0200001300000000000000000000000000000000005b436f6e74656e745f54797065735d2e786d6c504b01022d0014000600080000002100a5d6a7e7c0000000360100000b000000000000000000000000002d0100005f72656c732f2e72656c73504b01022d00140006000800000021006b799616830000008a0000001c00000000000000000000000000160200007468656d652f7468656d652f7468656d654d616e616765722e786d6c504b01022d0014000600080000002100215aa28421070000db1d00001600000000000000000000000000d30200007468656d652f7468656d652f7468656d65312e786d6c504b01022d00140006000800000021000dd1909fb60000001b0100002700000000000000000000000000280a00007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73504b050600000000050005005d010000230b00000000}{\*\colorschememapping 3c3f786d6c2076657273696f6e3d22312e302220656e636f64696e673d225554462d3822207374616e64616c6f6e653d22796573223f3e0d0a3c613a636c724d617020786d6c6e733a613d22687474703a2f2f736368656d61732e6f70656e786d6c666f726d6174732e6f72672f64726177696e676d6c2f323030362f6d61696e22206267313d226c743122207478313d22646b3122206267323d226c743222207478323d22646b322220616363656e74313d22616363656e74312220616363656e74323d22616363656e74322220616363656e74333d22616363656e74332220616363656e74343d22616363656e74342220616363656e74353d22616363656e74352220616363656e74363d22616363656e74362220686c696e6b3d22686c696e6b2220666f6c486c696e6b3d22666f6c486c696e6b222f3e}{\*\latentstyles\lsdstimax276\lsdlockeddef0\lsdsemihiddendef1\lsdunhideuseddef1\lsdqformatdef0\lsdprioritydef99{\lsdlockedexcept \lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority0 \lsdlocked0 Normal;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 1;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 2;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 3;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 4;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 5;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 6;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 7;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 8;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 9;\lsdpriority39 \lsdlocked0 toc 1;\lsdpriority39 \lsdlocked0 toc 2;\lsdpriority39 \lsdlocked0 toc 3;\lsdpriority39 \lsdlocked0 toc 4;\lsdpriority39 \lsdlocked0 toc 5;\lsdpriority39 \lsdlocked0 toc 6;\lsdpriority39 \lsdlocked0 toc 7;\lsdpriority39 \lsdlocked0 toc 8;\lsdpriority39 \lsdlocked0 toc 9;\lsdqformat1 \lsdpriority35 \lsdlocked0 caption;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority10 \lsdlocked0 Title;\lsdpriority1 \lsdlocked0 Default Paragraph Font;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority11 \lsdlocked0 Subtitle;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority22 \lsdlocked0 Strong;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority20 \lsdlocked0 Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdpriority59 \lsdlocked0 Table Grid;\lsdunhideused0 \lsdlocked0 Placeholder Text;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority1 \lsdlocked0 No Spacing;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 1;\lsdunhideused0 \lsdlocked0 Revision;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority34 \lsdlocked0 List Paragraph;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority29 \lsdlocked0 Quote;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority30 \lsdlocked0 Intense Quote;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority19 \lsdlocked0 Subtle Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority21 \lsdlocked0 Intense Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority31 \lsdlocked0 Subtle Reference;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority32 \lsdlocked0 Intense Reference;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority33 \lsdlocked0 Book Title;\lsdpriority37 \lsdlocked0 Bibliography;\lsdqformat1 \lsdpriority39 \lsdlocked0 TOC Heading;}}{\*\datastore 010001000200000008000000556e6b6e6f776e00000000000000000000060000d0cf11e0a1b11ae1000000000000000000000000000000003e000300feff090006000000000000000000000001000000010000000000000000100000feffffff00000000feffffff0000000000000000fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfffffffeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff5200000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000002000500ffffffffffffffffffffffff0c6ad98892f1d411a65f0040963251e5000000000000000000000000fc2bd73ae2eace01feffffff00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000100010000000000}}